0001193125-23-145196.txt : 20230515 0001193125-23-145196.hdr.sgml : 20230515 20230515171349 ACCESSION NUMBER: 0001193125-23-145196 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 62 CONFORMED PERIOD OF REPORT: 20230331 FILED AS OF DATE: 20230515 DATE AS OF CHANGE: 20230515 FILER: COMPANY DATA: COMPANY CONFORMED NAME: NexPoint Capital, Inc. CENTRAL INDEX KEY: 0001588272 IRS NUMBER: 383926499 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 814-01074 FILM NUMBER: 23924267 BUSINESS ADDRESS: STREET 1: 300 CRESCENT COURT STREET 2: SUITE 700 CITY: DALLAS STATE: TX ZIP: 75201 BUSINESS PHONE: 214-276-6300 MAIL ADDRESS: STREET 1: 300 CRESCENT COURT STREET 2: SUITE 700 CITY: DALLAS STATE: TX ZIP: 75201 FORMER COMPANY: FORMER CONFORMED NAME: NexPoint Capital, LLC DATE OF NAME CHANGE: 20131002 10-Q 1 d421644d10q.htm 10-Q 10-Q
00falseQ1--12-310001588272The investment is not a qualifying asset under Section 55 of the 1940 Act. A business development company (“BDC”), such as the Company, may not acquire any asset other than a qualifying asset, unless at the time the acquisition is made, qualifying assets represent at least 70% of the business development company’s total assets. Non-qualifying assets represented 4.8% of the Company’s total assets as of December 31, 2022.The interest rate on these investments is subject to a base rate of 6-Month LIBOR, which at December 31, 2022 was 5.14%. The LIBOR rate used to calculate interest is the higher of the prevailing 6 month LIBOR rate in effect on the date of the semiannual reset, or the LIBOR base rate floor shown.The interest rate on these investments is subject to a base rate of 3-Month LIBOR, which at December 31, 2022 was 4.77%. The LIBOR rate used to calculate interest is the higher of the prevailing 3 month LIBOR rate in effect on the date of the quarterly reset, or the LIBOR base rate floor shown.Represents fair value as determined by the Adviser pursuant to the policies and procedures approved by the Board of Trustees (the “Board”). The Board has designated the Adviser as “valuation designee” for the Company pursuant to Rule 2a-5 of the 1940 Act. The Adviser considers fair valued securities to be securities for which market quotations are not readily available and these securities may be valued using a combination of observable and unobservable inputs. Securities with a total aggregate value of $28,500,789 or 53.0% of net assets were fair valued under the Company’s valuation procedures as of December 31, 2022.Classified as Level 3 within the three-tier fair value hierarchy. Please see Note 2 for an explanation of this hierarchy, as well as a list of unobservable inputs used in the valuation of these instruments.The interest rate on these investments is subject to a base rate of 1-Month LIBOR, which at December 31, 2022 was 4.39%. The LIBOR rate used to calculate interest is the higher of the prevailing 1 month LIBOR rate in effect on the date of the monthly reset, or the LIBOR base rate floor shown.Securities of collateralized loan obligations where an affiliate of the Adviser serves as collateral manager.The investment is considered to be the equity tranche of the issuer.Securities exempt from registration under Rule 144A of the Securities Act. These securities may only be resold in transactions exempt from registration to qualified institutional buyers. As of December 31, 2022, these securities amounted to $2,421,875, or 4.5% of net assets.The issuer is in default of its payment obligation, or is in danger of default.The interest rate on these investments is subject to a base rate of 3-Month LIBOR, which at March 31, 2023 was 5.19%. The LIBOR rate used to calculate interest is the higher of the prevailing 3 month LIBOR rate in effect on the date of the quarterly reset, or the LIBOR base rate floor shown.The investment is not a qualifying asset under Section 55 of the 1940 Act. A business development company (“BDC”), such as the Company, may not acquire any asset other than a qualifying asset, unless at the time the acquisition is made, qualifying assets represent at least 70% of the business development company’s total assets. Non-qualifying assets represented 4.9% of the Company’s total assets as of March 31, 2023.The interest rate on these investments is subject to a base rate of 3-Month SOFR, which at March 31, 2023 was 4.51%Represents fair value as determined by the Adviser (as defined in Note 1) pursuant to the policies and procedures approved by the Board of Directors (the “Board”). The Board has designated the Adviser as “valuation designee” for the Company pursuant to Rule 2a-5 of the 1940 Act. The Adviser considers fair valued securities to be securities for which market quotations are not readily available and these securities may be valued using a combination of observable and unobservable inputs. Securities with a total aggregate value of $34,445,226 or 67.3% of net assets were fair valued under the Company’s valuation procedures as of March 31, 2023.Represents an affiliated issuer. Assets with a total aggregate market value of $10,871,704, or 21.3% of net assets, were affiliated with the Company as of March 31, 2023. See Note 9.Securities exempt from registration under Rule 144A of the 1933 Act. These securities may only be resold in transactions exempt from registration to qualified institutional buyers. As of March 31, 2023, these securities amounted to $2,248,059, or 4.4% of net assets.Amortized cost represents the original cost adjusted for the amortization of premiums and/or accretion of discounts, as applicable, on investments.Non-income producing security.Represents an affiliated issuer. Assets with a total aggregate market value of $10,273,001, or 19.1% of net assets, were affiliated with the Company as of December 31, 2022. See Note 10.Unless otherwise noted, the Company did not “control” and was not an “affiliated person” of any of its portfolio companies, each as defined in the Investment Company Act of 1940, as amended (the “1940 Act”). In general, under the 1940 Act, the Company would be presumed to “control” a portfolio company if it owned 25% or more of its voting securities or had the power to exercise control over the management or policies of such portfolio company, and would be an “affiliated person” of a portfolio company if it owned 5% or more of its voting securities. Additionally, companies under common control (e.g., companies with a common owner of greater than 25% of their respective voting securities) are affiliates under the 1940 Act.All investments are denominated in United States Dollars.State Street U.S. Government Money Market Fund.Represents an in-kind transfer to the subreit. 0001588272 2023-01-01 2023-03-31 0001588272 2022-12-31 0001588272 2023-03-31 0001588272 2022-01-01 2022-03-31 0001588272 2022-03-31 0001588272 2021-12-31 0001588272 cik0001588272:AffiliatedInvestmentsMember 2022-12-31 0001588272 cik0001588272:NonControlledOrNonAffiliatedInvestmentsMember 2022-12-31 0001588272 cik0001588272:DecemberThirtyFirstTwoThousandAndTwentyFiveMember 2022-12-31 0001588272 cik0001588272:ExpenseLimitationAgreementMember 2022-12-31 0001588272 us-gaap:MoneyMarketFundsMember 2022-12-31 0001588272 cik0001588272:AdvisoryFeesAndAdministrationFeesMember 2022-12-31 0001588272 cik0001588272:AurisLuxembourgIiiS.a.r.l.Member cik0001588272:FirstLienTermLoanMember cik0001588272:SeniorSecuredLoansAtTwentySixPointZeroFivePercentMember cik0001588272:HealthcareAtTwentyFourPointFivePercentageMember 2022-12-31 0001588272 cik0001588272:CarestreamHealthIncMember cik0001588272:FirstLienTermLoanMember cik0001588272:SeniorSecuredLoansAtTwentySixPointZeroFivePercentMember cik0001588272:HealthcareAtTwentyFourPointFivePercentageMember 2022-12-31 0001588272 cik0001588272:CcsMedicalIncMember cik0001588272:FirstLienTermLoanMember cik0001588272:SeniorSecuredLoansAtTwentySixPointZeroFivePercentMember cik0001588272:HealthcareAtTwentyFourPointFivePercentageMember 2022-12-31 0001588272 cik0001588272:CntHoldingsICorpMember cik0001588272:SecondLienTermLoanMember cik0001588272:SeniorSecuredLoansAtTwentySixPointZeroFivePercentMember cik0001588272:HealthcareAtTwentyFourPointFivePercentageMember 2022-12-31 0001588272 cik0001588272:CovenantSurgicalPartnersInc.Member cik0001588272:FirstLienDelayedDrawTermLoanMember cik0001588272:SeniorSecuredLoansAtTwentySixPointZeroFivePercentMember cik0001588272:HealthcareAtTwentyFourPointFivePercentageMember 2022-12-31 0001588272 cik0001588272:CovenantSurgicalPartnersInc.Member cik0001588272:FirstLienTermLoanMember cik0001588272:SeniorSecuredLoansAtTwentySixPointZeroFivePercentMember cik0001588272:HealthcareAtTwentyFourPointFivePercentageMember 2022-12-31 0001588272 cik0001588272:EnvisionHealthcareCorp.Member cik0001588272:FirstLienTermLoanMember cik0001588272:SeniorSecuredLoansAtTwentySixPointZeroFivePercentMember cik0001588272:HealthcareAtTwentyFourPointFivePercentageMember 2022-12-31 0001588272 cik0001588272:RxbenefitsInc.Member cik0001588272:FirstLienTermLoanMember cik0001588272:SeniorSecuredLoansAtTwentySixPointZeroFivePercentMember cik0001588272:HealthcareAtTwentyFourPointFivePercentageMember 2022-12-31 0001588272 cik0001588272:SoundInpatientPhysiciansMember cik0001588272:SecondLienTermLoanMember cik0001588272:SeniorSecuredLoansAtTwentySixPointZeroFivePercentMember cik0001588272:HealthcareAtTwentyFourPointFivePercentageMember 2022-12-31 0001588272 cik0001588272:WellpathHoldingsInc.Member cik0001588272:FirstLienTermLoanMember cik0001588272:SeniorSecuredLoansAtTwentySixPointZeroFivePercentMember cik0001588272:HealthcareAtTwentyFourPointFivePercentageMember 2022-12-31 0001588272 cik0001588272:TerrestarCorp.Member cik0001588272:SeniorSecuredLoansAtTwentySixPointZeroFivePercentMember cik0001588272:FirstLienTermLoanHMember cik0001588272:TeleCommunicationServicesAtTwoPointZeroPercentageMember 2022-12-31 0001588272 cik0001588272:TerrestarCorp.Member cik0001588272:SeniorSecuredLoansAtTwentySixPointZeroFivePercentMember cik0001588272:FirstLienTermLoanFMember cik0001588272:TeleCommunicationServicesAtTwoPointZeroPercentageMember 2022-12-31 0001588272 cik0001588272:TerrestarCorp.Member cik0001588272:SeniorSecuredLoansAtTwentySixPointZeroFivePercentMember cik0001588272:FirstLienTermLoanEMember cik0001588272:TeleCommunicationServicesAtTwoPointZeroPercentageMember 2022-12-31 0001588272 cik0001588272:TerrestarCorp.Member cik0001588272:SeniorSecuredLoansAtTwentySixPointZeroFivePercentMember cik0001588272:FirstLienTermLoanGMember cik0001588272:TeleCommunicationServicesAtTwoPointZeroPercentageMember 2022-12-31 0001588272 cik0001588272:HadrianMergerSubInc.Member cik0001588272:CorporateBondsAtFivePointZeroPercentMember cik0001588272:HealthcareAtFourPointFivePercentMember 2022-12-31 0001588272 cik0001588272:IheartcommunicationsInc.Member cik0001588272:MediaAndTelecommunicationsAtZeroPointFivePercentMember cik0001588272:CorporateBondsAtFivePointZeroPercentMember cik0001588272:InterestRateAtSixPointThreeEightPercentageMember 2022-12-31 0001588272 cik0001588272:IheartcommunicationsInc.Member cik0001588272:CorporateBondsAtFivePointZeroPercentMember cik0001588272:MediaAndTelecommunicationsAtZeroPointFivePercentMember cik0001588272:InterestRateAtEightPointThreeEightPercentageMember 2022-12-31 0001588272 cik0001588272:GraysonInvestorCorp.Member cik0001588272:AssetBackedSecuritiesAtZeroPointZeroPercentMember cik0001588272:FinancialsAtZeroPointZeroPercentMember 2022-12-31 0001588272 cik0001588272:PamcoClo19971abMember cik0001588272:AssetBackedSecuritiesAtZeroPointZeroPercentMember cik0001588272:FinancialsAtZeroPointZeroPercentMember 2022-12-31 0001588272 cik0001588272:SeniorSecuredLoansAtTwentySixPointZeroFivePercentMember cik0001588272:HealthcareAtTwentyFourPointFivePercentageMember 2022-12-31 0001588272 cik0001588272:SeniorSecuredLoansAtTwentySixPointZeroFivePercentMember cik0001588272:TeleCommunicationServicesAtTwoPointZeroPercentageMember 2022-12-31 0001588272 cik0001588272:SeniorSecuredLoansAtTwentySixPointZeroFivePercentMember 2022-12-31 0001588272 cik0001588272:AssetBackedSecuritiesAtZeroPointZeroPercentMember cik0001588272:FinancialsAtZeroPointZeroPercentMember 2022-12-31 0001588272 cik0001588272:AssetBackedSecuritiesAtZeroPointZeroPercentMember 2022-12-31 0001588272 cik0001588272:CorporateBondsAtFivePointZeroPercentMember cik0001588272:MediaAndTelecommunicationsAtZeroPointFivePercentMember 2022-12-31 0001588272 cik0001588272:CorporateBondsAtFivePointZeroPercentMember 2022-12-31 0001588272 cik0001588272:NexpointResidentialTrustInc.Member cik0001588272:RealEstateInvestmentTrustAtOnePointNinePercentageMember cik0001588272:CommonStocksAtThirtySixPointThreePercentMember 2022-12-31 0001588272 cik0001588272:WayneServicesLegacyInc.Member cik0001588272:ServiceAtZeroPointZeroPercentageMember cik0001588272:CommonStocksAtThirtySixPointThreePercentMember 2022-12-31 0001588272 cik0001588272:TelecommunicationServicesAtNinePointFivePercentageMember cik0001588272:TerrestarCorp..Member cik0001588272:CommonStocksAtThirtySixPointThreePercentMember 2022-12-31 0001588272 cik0001588272:UsGamingLlcMember cik0001588272:ConsumerProductsAtFivePointSevenPercentageMember cik0001588272:LLCInterestsAtEightPointSevenPercentMember 2022-12-31 0001588272 cik0001588272:SfrWlifIiiLlcMember cik0001588272:RealEstateAtThreePointZeroPercentageMember cik0001588272:LLCInterestsAtEightPointSevenPercentMember 2022-12-31 0001588272 cik0001588272:NexpointCapitalReitLlcSeniorLoansCommonStocksMember cik0001588272:RealEstateAtThreePointZeroPercentageMember cik0001588272:LLCInterestsAtEightPointSevenPercentMember 2022-12-31 0001588272 cik0001588272:CommonStocksAtThirtySixPointThreePercentMember cik0001588272:ChemicalsAtZeroPointOnePercentageMember cik0001588272:MpmHoldingsIncMember 2022-12-31 0001588272 cik0001588272:CommonStocksAtThirtySixPointThreePercentMember cik0001588272:EnergyAtThreePointZeroPercentageMember cik0001588272:QuarternorthEnergyInc.Member 2022-12-31 0001588272 cik0001588272:CommonStocksAtThirtySixPointThreePercentMember cik0001588272:FinancialsAtThreePointTwoPercentageMember cik0001588272:AmericanBanknoteCorpMember 2022-12-31 0001588272 cik0001588272:CommonStocksAtThirtySixPointThreePercentMember cik0001588272:RealEstateAtEighteenPointSixPercentageMember cik0001588272:NexpointRealEstateFinanceInc.Member 2022-12-31 0001588272 cik0001588272:CommonStocksAtThirtySixPointThreePercentMember cik0001588272:RealEstateAtEighteenPointSixPercentageMember cik0001588272:IqhqIncMember 2022-12-31 0001588272 cik0001588272:CommonStocksAtThirtySixPointThreePercentMember 2022-12-31 0001588272 cik0001588272:RealEstateAtThreePointZeroPercentageMember cik0001588272:LLCInterestsAtEightPointSevenPercentMember 2022-12-31 0001588272 cik0001588272:LLCInterestsAtEightPointSevenPercentMember 2022-12-31 0001588272 cik0001588272:CommonStocksAtThirtySixPointThreePercentMember cik0001588272:RealEstateAtEighteenPointSixPercentageMember 2022-12-31 0001588272 cik0001588272:QuarternorthTranche1Member cik0001588272:WarrantsAtZeroPointFourPercentMember cik0001588272:EnergyAtZeroPointThreePercentageMember 2022-12-31 0001588272 cik0001588272:QuarternorthTranche2Member cik0001588272:WarrantsAtZeroPointFourPercentMember cik0001588272:EnergyAtZeroPointThreePercentageMember 2022-12-31 0001588272 cik0001588272:MediaAndTelecommunicationsAtZeroPointOnePercentageMember cik0001588272:WarrantsAtZeroPointFourPercentMember cik0001588272:IheartmediaInc.Member 2022-12-31 0001588272 cik0001588272:SevenHundredSeventySevenPartnersLlcMember cik0001588272:PreferredStocksAtTwentyTwoPointThreePercentMember cik0001588272:FinancialsAtTwoPointSevenPercentageMember 2022-12-31 0001588272 cik0001588272:UnitedFidelityBankFsbMember cik0001588272:PreferredStocksAtTwentyTwoPointThreePercentMember cik0001588272:FinancialsAtTwoPointSevenPercentageMember 2022-12-31 0001588272 cik0001588272:ApnimedInc.Member cik0001588272:PreferredStocksAtTwentyTwoPointThreePercentMember cik0001588272:HealthcareAtNinteenPointSixPercentageMember 2022-12-31 0001588272 cik0001588272:SeriesC2Member cik0001588272:HealthcareAtNinteenPointSixPercentageMember cik0001588272:PreferredStocksAtTwentyTwoPointThreePercentMember cik0001588272:ApnimedInc.Member 2022-12-31 0001588272 us-gaap:SeriesBPreferredStockMember cik0001588272:HealthcareAtNinteenPointSixPercentageMember cik0001588272:PreferredStocksAtTwentyTwoPointThreePercentMember cik0001588272:SapienceTherapeuticsInc.Member 2022-12-31 0001588272 cik0001588272:Seriesb1preferredSharesMember cik0001588272:HealthcareAtNinteenPointSixPercentageMember cik0001588272:PreferredStocksAtTwentyTwoPointThreePercentMember cik0001588272:SapienceTherapeuticsInc.Member 2022-12-31 0001588272 cik0001588272:PreferredStocksAtTwentyTwoPointThreePercentMember cik0001588272:FinancialsAtTwoPointSevenPercentageMember 2022-12-31 0001588272 cik0001588272:PreferredStocksAtTwentyTwoPointThreePercentMember cik0001588272:HealthcareAtNinteenPointSixPercentageMember 2022-12-31 0001588272 cik0001588272:PreferredStocksAtTwentyTwoPointThreePercentMember 2022-12-31 0001588272 cik0001588272:WarrantsAtZeroPointFourPercentMember cik0001588272:EnergyAtZeroPointThreePercentageMember 2022-12-31 0001588272 cik0001588272:WarrantsAtZeroPointFourPercentMember 2022-12-31 0001588272 cik0001588272:TotalInvestmentNinetyNinePointTwoMember 2022-12-31 0001588272 cik0001588272:CashEquivalentsAtTwoPointSevenPercentageMember 2022-12-31 0001588272 cik0001588272:OtherAssetsLiabilitiesNetAtOnePointEightPercentageMember 2022-12-31 0001588272 us-gaap:AssetBackedSecuritiesMember cik0001588272:AssetBackedSecuritiesOneMember cik0001588272:GraysonInvestorCorpMember us-gaap:FairValueInputsLevel3Member 2022-12-31 0001588272 us-gaap:AssetBackedSecuritiesMember cik0001588272:AssetBackedSecuritiesOneMember cik0001588272:PamcoCloNineteenNinetySevenOneABMember us-gaap:FairValueInputsLevel3Member 2022-12-31 0001588272 us-gaap:CommonStockMember cik0001588272:CommonStockOneMember cik0001588272:AmericanBanknoteCorpMember us-gaap:FairValueInputsLevel3Member 2022-12-31 0001588272 us-gaap:CommonStockMember cik0001588272:CommonStockOneMember cik0001588272:IqhqMember us-gaap:FairValueInputsLevel3Member 2022-12-31 0001588272 us-gaap:CommonStockMember cik0001588272:CommonStockOneMember cik0001588272:TereeStarCorpMember us-gaap:FairValueInputsLevel3Member 2022-12-31 0001588272 us-gaap:CommonStockMember cik0001588272:CommonStockOneMember cik0001588272:WayneServicesLegacyIncMember us-gaap:FairValueInputsLevel3Member 2022-12-31 0001588272 cik0001588272:LlcInterestsMember cik0001588272:LlcInterestsOneMember cik0001588272:NexpointCapitalReitLlcSeniorLoansCommonStocksMember us-gaap:FairValueInputsLevel3Member 2022-12-31 0001588272 cik0001588272:LlcInterestsMember cik0001588272:LlcInterestsOneMember cik0001588272:SfrWlifThreeLlcMember us-gaap:FairValueInputsLevel3Member 2022-12-31 0001588272 cik0001588272:LlcInterestsMember cik0001588272:LlcInterestsOneMember cik0001588272:UsGamingLlcMember us-gaap:FairValueInputsLevel3Member 2022-12-31 0001588272 us-gaap:PreferredStockMember cik0001588272:PreferredStockOneMember cik0001588272:AprimedIncMember us-gaap:FairValueInputsLevel3Member 2022-12-31 0001588272 us-gaap:FairValueInputsLevel3Member cik0001588272:AprimedIncMember cik0001588272:SeriesCTwoPreferredStockMember us-gaap:PreferredStockMember 2022-12-31 0001588272 us-gaap:PreferredStockMember us-gaap:SeriesBPreferredStockMember cik0001588272:SapienceTherapauticsIncMember us-gaap:FairValueInputsLevel3Member 2022-12-31 0001588272 us-gaap:PreferredStockMember cik0001588272:SeriesBOnePreferredStockMember cik0001588272:SapienceTherapauticsIncMember us-gaap:FairValueInputsLevel3Member 2022-12-31 0001588272 cik0001588272:SeniorSecuredLoansMember cik0001588272:SeniorSecuredLoansOneMember cik0001588272:CcsMedicalIncMember us-gaap:FairValueInputsLevel3Member 2022-12-31 0001588272 cik0001588272:SeniorSecuredLoansMember cik0001588272:SeniorSecuredLoansOneMember cik0001588272:TerreStarCorpMember us-gaap:FairValueInputsLevel3Member 2022-12-31 0001588272 cik0001588272:SeniorSecuredLoansMember cik0001588272:SeniorSecuredLoansTwoMember cik0001588272:TerreStarCorpMember us-gaap:FairValueInputsLevel3Member 2022-12-31 0001588272 cik0001588272:SeniorSecuredLoansMember cik0001588272:SeniorSecuredLoansThreeMember cik0001588272:TerreStarCorpMember us-gaap:FairValueInputsLevel3Member 2022-12-31 0001588272 cik0001588272:SeniorSecuredLoansMember cik0001588272:SeniorSecuredLoansFourMember cik0001588272:TerreStarCorpMember us-gaap:FairValueInputsLevel3Member 2022-12-31 0001588272 us-gaap:HealthCareMember 2022-12-31 0001588272 us-gaap:RealEstateMember 2022-12-31 0001588272 cik0001588272:TelecommunicationServicesMember 2022-12-31 0001588272 cik0001588272:ConsumerProductsMember 2022-12-31 0001588272 us-gaap:FinancialServiceMember 2022-12-31 0001588272 cik0001588272:EnergyMember 2022-12-31 0001588272 cik0001588272:RealEstateInvestmentTrustsMember 2022-12-31 0001588272 cik0001588272:MediaAndTelecommunicationsMember 2022-12-31 0001588272 cik0001588272:ChemicalsMember 2022-12-31 0001588272 us-gaap:ServiceMember 2022-12-31 0001588272 cik0001588272:SeniorSecuredLoansFirstLienMember 2022-12-31 0001588272 cik0001588272:SeniorSecuredLoansSecondLienMember 2022-12-31 0001588272 us-gaap:AssetBackedSecuritiesMember 2022-12-31 0001588272 us-gaap:CorporateBondSecuritiesMember 2022-12-31 0001588272 us-gaap:CommonStockMember 2022-12-31 0001588272 cik0001588272:LlcMemberInterestsMember 2022-12-31 0001588272 us-gaap:PreferredStockMember 2022-12-31 0001588272 us-gaap:WarrantMember 2022-12-31 0001588272 country:KY 2022-12-31 0001588272 country:LU 2022-12-31 0001588272 country:US 2022-12-31 0001588272 us-gaap:FairValueInputsLevel1Member cik0001588272:SeniorSecuredLoansMember us-gaap:HealthCareMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel2Member cik0001588272:SeniorSecuredLoansMember us-gaap:HealthCareMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel3Member cik0001588272:SeniorSecuredLoansMember us-gaap:HealthCareMember 2022-12-31 0001588272 cik0001588272:SeniorSecuredLoansMember us-gaap:HealthCareMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel1Member cik0001588272:SeniorSecuredLoansMember cik0001588272:TelcommunicationServicesMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel2Member cik0001588272:SeniorSecuredLoansMember cik0001588272:TelcommunicationServicesMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel3Member cik0001588272:SeniorSecuredLoansMember cik0001588272:TelcommunicationServicesMember 2022-12-31 0001588272 cik0001588272:SeniorSecuredLoansMember cik0001588272:TelcommunicationServicesMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel1Member cik0001588272:AssetBackedSecuritiesOneMember cik0001588272:FinancialsMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel2Member cik0001588272:AssetBackedSecuritiesOneMember cik0001588272:FinancialsMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel3Member cik0001588272:AssetBackedSecuritiesOneMember cik0001588272:FinancialsMember 2022-12-31 0001588272 cik0001588272:AssetBackedSecuritiesOneMember cik0001588272:FinancialsMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel1Member us-gaap:HealthCareMember cik0001588272:CorporateBondsMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel2Member us-gaap:HealthCareMember cik0001588272:CorporateBondsMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel3Member us-gaap:HealthCareMember cik0001588272:CorporateBondsMember 2022-12-31 0001588272 us-gaap:HealthCareMember cik0001588272:CorporateBondsMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel1Member cik0001588272:MediaAndTelecommunicationsMember cik0001588272:CorporateBondsMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel2Member cik0001588272:MediaAndTelecommunicationsMember cik0001588272:CorporateBondsMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel3Member cik0001588272:MediaAndTelecommunicationsMember cik0001588272:CorporateBondsMember 2022-12-31 0001588272 cik0001588272:MediaAndTelecommunicationsMember cik0001588272:CorporateBondsMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel1Member us-gaap:CommonStockMember cik0001588272:ChemicalsMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel2Member us-gaap:CommonStockMember cik0001588272:ChemicalsMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel3Member us-gaap:CommonStockMember cik0001588272:ChemicalsMember 2022-12-31 0001588272 us-gaap:CommonStockMember cik0001588272:ChemicalsMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel1Member us-gaap:CommonStockMember cik0001588272:EnergyMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel2Member us-gaap:CommonStockMember cik0001588272:EnergyMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel3Member us-gaap:CommonStockMember cik0001588272:EnergyMember 2022-12-31 0001588272 us-gaap:CommonStockMember cik0001588272:EnergyMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel1Member us-gaap:CommonStockMember cik0001588272:FinancialsMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel2Member us-gaap:CommonStockMember cik0001588272:FinancialsMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel3Member us-gaap:CommonStockMember cik0001588272:FinancialsMember 2022-12-31 0001588272 us-gaap:CommonStockMember cik0001588272:FinancialsMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel1Member us-gaap:CommonStockMember us-gaap:RealEstateMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel2Member us-gaap:CommonStockMember us-gaap:RealEstateMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel3Member us-gaap:CommonStockMember us-gaap:RealEstateMember 2022-12-31 0001588272 us-gaap:CommonStockMember us-gaap:RealEstateMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel1Member us-gaap:CommonStockMember cik0001588272:RealEstateInvestmentTrustsMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel2Member us-gaap:CommonStockMember cik0001588272:RealEstateInvestmentTrustsMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel3Member us-gaap:CommonStockMember cik0001588272:RealEstateInvestmentTrustsMember 2022-12-31 0001588272 us-gaap:CommonStockMember cik0001588272:RealEstateInvestmentTrustsMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel1Member us-gaap:CommonStockMember us-gaap:ServiceMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel2Member us-gaap:CommonStockMember us-gaap:ServiceMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel3Member us-gaap:CommonStockMember us-gaap:ServiceMember 2022-12-31 0001588272 us-gaap:CommonStockMember us-gaap:ServiceMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel1Member us-gaap:CommonStockMember cik0001588272:TelecommunicationServicesMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel2Member us-gaap:CommonStockMember cik0001588272:TelecommunicationServicesMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel3Member us-gaap:CommonStockMember cik0001588272:TelecommunicationServicesMember 2022-12-31 0001588272 us-gaap:CommonStockMember cik0001588272:TelecommunicationServicesMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel1Member cik0001588272:LlcInterestsMember cik0001588272:ConsumerProductsMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel2Member cik0001588272:LlcInterestsMember cik0001588272:ConsumerProductsMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel3Member cik0001588272:LlcInterestsMember cik0001588272:ConsumerProductsMember 2022-12-31 0001588272 cik0001588272:LlcInterestsMember cik0001588272:ConsumerProductsMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel1Member cik0001588272:LlcInterestsMember us-gaap:RealEstateMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel2Member cik0001588272:LlcInterestsMember us-gaap:RealEstateMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel3Member cik0001588272:LlcInterestsMember us-gaap:RealEstateMember 2022-12-31 0001588272 cik0001588272:LlcInterestsMember us-gaap:RealEstateMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel1Member us-gaap:PreferredStockMember cik0001588272:FinancialsMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel2Member us-gaap:PreferredStockMember cik0001588272:FinancialsMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel3Member us-gaap:PreferredStockMember cik0001588272:FinancialsMember 2022-12-31 0001588272 us-gaap:PreferredStockMember cik0001588272:FinancialsMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel1Member us-gaap:PreferredStockMember us-gaap:HealthCareMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel2Member us-gaap:PreferredStockMember us-gaap:HealthCareMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel3Member us-gaap:PreferredStockMember us-gaap:HealthCareMember 2022-12-31 0001588272 us-gaap:PreferredStockMember us-gaap:HealthCareMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel1Member us-gaap:WarrantMember cik0001588272:EnergyMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel2Member us-gaap:WarrantMember cik0001588272:EnergyMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel3Member us-gaap:WarrantMember cik0001588272:EnergyMember 2022-12-31 0001588272 us-gaap:WarrantMember cik0001588272:EnergyMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel1Member us-gaap:WarrantMember cik0001588272:MediaAndTelecommunicationsMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel2Member us-gaap:WarrantMember cik0001588272:MediaAndTelecommunicationsMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel3Member us-gaap:WarrantMember cik0001588272:MediaAndTelecommunicationsMember 2022-12-31 0001588272 us-gaap:WarrantMember cik0001588272:MediaAndTelecommunicationsMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel1Member 2022-12-31 0001588272 us-gaap:FairValueInputsLevel2Member 2022-12-31 0001588272 us-gaap:FairValueInputsLevel3Member 2022-12-31 0001588272 srt:MaximumMember cik0001588272:EquityMethodInvesteeControllingInvestmentMember 2022-12-31 0001588272 srt:MinimumMember cik0001588272:EquityMethodInvesteeAffiliatedInvestmentsMember 2022-12-31 0001588272 cik0001588272:BaseRateOf6MonthLiborMember 2022-12-31 0001588272 cik0001588272:BaseRateOf3MonthLiborMember 2022-12-31 0001588272 cik0001588272:BaseRateOf1MonthLiborMember 2022-12-31 0001588272 cik0001588272:BoardOfDirectorsMember 2022-12-31 0001588272 cik0001588272:RestrictedSecuritiesMember 2022-12-31 0001588272 srt:AffiliatedEntityMember 2022-12-31 0001588272 us-gaap:MeasurementInputDiscountRateMember cik0001588272:LlcInterestsMember us-gaap:FairValueInputsLevel3Member 2022-12-31 0001588272 us-gaap:MeasurementInputOptionVolatilityMember us-gaap:PreferredStockMember us-gaap:FairValueInputsLevel3Member 2022-12-31 0001588272 us-gaap:MeasurementInputDiscountRateMember us-gaap:CommonStockMember us-gaap:FairValueInputsLevel3Member 2022-12-31 0001588272 us-gaap:MeasurementInputDiscountRateMember cik0001588272:SeniorSecuredLoansMember us-gaap:ValuationTechniqueDiscountedCashFlowMember us-gaap:FairValueInputsLevel3Member 2022-12-31 0001588272 us-gaap:MeasurementInputDiscountRateMember us-gaap:AssetBackedSecuritiesMember us-gaap:ValuationTechniqueDiscountedCashFlowMember us-gaap:FairValueInputsLevel3Member 2022-12-31 0001588272 us-gaap:MeasurementInputDiscountRateMember cik0001588272:LlcInterestsMember us-gaap:ValuationTechniqueDiscountedCashFlowMember us-gaap:FairValueInputsLevel3Member srt:MinimumMember 2022-12-31 0001588272 us-gaap:MeasurementInputDiscountRateMember cik0001588272:LlcInterestsMember us-gaap:ValuationTechniqueDiscountedCashFlowMember us-gaap:FairValueInputsLevel3Member srt:MaximumMember 2022-12-31 0001588272 us-gaap:MeasurementInputDiscountRateMember cik0001588272:LlcInterestsMember us-gaap:ValuationTechniqueDiscountedCashFlowMember us-gaap:FairValueInputsLevel3Member srt:WeightedAverageMember 2022-12-31 0001588272 us-gaap:MeasurementInputEbitdaMultipleMember cik0001588272:LlcInterestsMember cik0001588272:ValuationTechniqueMultipleAnalysisMember us-gaap:FairValueInputsLevel3Member srt:MinimumMember 2022-12-31 0001588272 us-gaap:MeasurementInputEbitdaMultipleMember cik0001588272:LlcInterestsMember cik0001588272:ValuationTechniqueMultipleAnalysisMember us-gaap:FairValueInputsLevel3Member srt:MaximumMember 2022-12-31 0001588272 us-gaap:MeasurementInputEbitdaMultipleMember cik0001588272:LlcInterestsMember cik0001588272:ValuationTechniqueMultipleAnalysisMember us-gaap:FairValueInputsLevel3Member srt:WeightedAverageMember 2022-12-31 0001588272 us-gaap:MeasurementInputOptionVolatilityMember us-gaap:PreferredStockMember us-gaap:FairValueInputsLevel3Member srt:MinimumMember 2022-12-31 0001588272 us-gaap:MeasurementInputOptionVolatilityMember us-gaap:PreferredStockMember us-gaap:FairValueInputsLevel3Member srt:MaximumMember 2022-12-31 0001588272 us-gaap:MeasurementInputOptionVolatilityMember us-gaap:PreferredStockMember us-gaap:FairValueInputsLevel3Member srt:WeightedAverageMember 2022-12-31 0001588272 us-gaap:MeasurementInputCapRateMember us-gaap:PreferredStockMember us-gaap:FairValueInputsLevel3Member 2022-12-31 0001588272 us-gaap:MeasurementInputDiscountRateMember us-gaap:CommonStockMember us-gaap:FairValueInputsLevel3Member srt:MinimumMember 2022-12-31 0001588272 us-gaap:MeasurementInputDiscountRateMember us-gaap:CommonStockMember us-gaap:FairValueInputsLevel3Member srt:MaximumMember 2022-12-31 0001588272 us-gaap:MeasurementInputDiscountRateMember us-gaap:CommonStockMember us-gaap:FairValueInputsLevel3Member srt:WeightedAverageMember 2022-12-31 0001588272 us-gaap:MeasurementInputEbitdaMultipleMember us-gaap:CommonStockMember us-gaap:FairValueInputsLevel3Member srt:MinimumMember 2022-12-31 0001588272 us-gaap:MeasurementInputEbitdaMultipleMember us-gaap:CommonStockMember us-gaap:FairValueInputsLevel3Member srt:MaximumMember 2022-12-31 0001588272 us-gaap:MeasurementInputEbitdaMultipleMember us-gaap:CommonStockMember us-gaap:FairValueInputsLevel3Member srt:WeightedAverageMember 2022-12-31 0001588272 cik0001588272:MeasurementInputUnadjustedPriceMember us-gaap:CommonStockMember us-gaap:FairValueInputsLevel3Member srt:MinimumMember 2022-12-31 0001588272 cik0001588272:MeasurementInputUnadjustedPriceMember us-gaap:CommonStockMember us-gaap:FairValueInputsLevel3Member srt:MaximumMember 2022-12-31 0001588272 cik0001588272:MeasurementInputUnadjustedPriceMember us-gaap:CommonStockMember us-gaap:FairValueInputsLevel3Member srt:WeightedAverageMember 2022-12-31 0001588272 cik0001588272:MeasurementInputEnterpriseValueMember us-gaap:CommonStockMember cik0001588272:ValuationTechniqueLiquidationAnalysisMember us-gaap:FairValueInputsLevel3Member srt:MinimumMember 2022-12-31 0001588272 cik0001588272:MeasurementInputEnterpriseValueMember us-gaap:CommonStockMember cik0001588272:ValuationTechniqueLiquidationAnalysisMember us-gaap:FairValueInputsLevel3Member srt:MaximumMember 2022-12-31 0001588272 cik0001588272:MeasurementInputEnterpriseValueMember us-gaap:CommonStockMember cik0001588272:ValuationTechniqueLiquidationAnalysisMember us-gaap:FairValueInputsLevel3Member srt:WeightedAverageMember 2022-12-31 0001588272 cik0001588272:MeasurementInputRecoveryRateMember us-gaap:CommonStockMember us-gaap:FairValueInputsLevel3Member srt:MinimumMember 2022-12-31 0001588272 cik0001588272:MeasurementInputRecoveryRateMember us-gaap:CommonStockMember us-gaap:FairValueInputsLevel3Member srt:MaximumMember 2022-12-31 0001588272 cik0001588272:MeasurementInputRecoveryRateMember us-gaap:CommonStockMember us-gaap:FairValueInputsLevel3Member srt:WeightedAverageMember 2022-12-31 0001588272 cik0001588272:MeasurementInputNavMultipleMember us-gaap:CommonStockMember cik0001588272:ValuationTechniqueNetAssetValueMember us-gaap:FairValueInputsLevel3Member 2022-12-31 0001588272 us-gaap:MeasurementInputDiscountRateMember cik0001588272:SeniorSecuredLoansMember us-gaap:ValuationTechniqueDiscountedCashFlowMember us-gaap:FairValueInputsLevel3Member srt:MinimumMember 2022-12-31 0001588272 us-gaap:MeasurementInputDiscountRateMember cik0001588272:SeniorSecuredLoansMember us-gaap:ValuationTechniqueDiscountedCashFlowMember us-gaap:FairValueInputsLevel3Member srt:MaximumMember 2022-12-31 0001588272 us-gaap:MeasurementInputDiscountRateMember cik0001588272:SeniorSecuredLoansMember us-gaap:ValuationTechniqueDiscountedCashFlowMember us-gaap:FairValueInputsLevel3Member srt:WeightedAverageMember 2022-12-31 0001588272 cik0001588272:MarchThirtyFirstTwoThousandAndTwentyFiveMember 2022-03-31 0001588272 cik0001588272:FirstLienTermLoanMember cik0001588272:AurisLuxembourgIiiS.a.r.l.Member cik0001588272:SeniorSecuredLoansAtTwentySixPointZeroFivePercentMember cik0001588272:HealthcareAtTwentyFourPointFivePercentageMember 2022-01-01 2022-12-31 0001588272 cik0001588272:CarestreamHealthIncMember cik0001588272:FirstLienTermLoanMember cik0001588272:SeniorSecuredLoansAtTwentySixPointZeroFivePercentMember cik0001588272:HealthcareAtTwentyFourPointFivePercentageMember 2022-01-01 2022-12-31 0001588272 cik0001588272:CcsMedicalIncMember cik0001588272:FirstLienTermLoanMember cik0001588272:SeniorSecuredLoansAtTwentySixPointZeroFivePercentMember cik0001588272:HealthcareAtTwentyFourPointFivePercentageMember 2022-01-01 2022-12-31 0001588272 cik0001588272:CntHoldingsICorpMember cik0001588272:SecondLienTermLoanMember cik0001588272:SeniorSecuredLoansAtTwentySixPointZeroFivePercentMember cik0001588272:HealthcareAtTwentyFourPointFivePercentageMember 2022-01-01 2022-12-31 0001588272 cik0001588272:CovenantSurgicalPartnersInc.Member cik0001588272:FirstLienDelayedDrawTermLoanMember cik0001588272:SeniorSecuredLoansAtTwentySixPointZeroFivePercentMember cik0001588272:HealthcareAtTwentyFourPointFivePercentageMember 2022-01-01 2022-12-31 0001588272 cik0001588272:CovenantSurgicalPartnersInc.Member cik0001588272:FirstLienTermLoanMember cik0001588272:SeniorSecuredLoansAtTwentySixPointZeroFivePercentMember cik0001588272:HealthcareAtTwentyFourPointFivePercentageMember 2022-01-01 2022-12-31 0001588272 cik0001588272:EnvisionHealthcareCorp.Member cik0001588272:FirstLienTermLoanMember cik0001588272:SeniorSecuredLoansAtTwentySixPointZeroFivePercentMember cik0001588272:HealthcareAtTwentyFourPointFivePercentageMember 2022-01-01 2022-12-31 0001588272 cik0001588272:RxbenefitsInc.Member cik0001588272:FirstLienTermLoanMember cik0001588272:SeniorSecuredLoansAtTwentySixPointZeroFivePercentMember cik0001588272:HealthcareAtTwentyFourPointFivePercentageMember 2022-01-01 2022-12-31 0001588272 cik0001588272:SoundInpatientPhysiciansMember cik0001588272:SecondLienTermLoanMember cik0001588272:SeniorSecuredLoansAtTwentySixPointZeroFivePercentMember cik0001588272:HealthcareAtTwentyFourPointFivePercentageMember 2022-01-01 2022-12-31 0001588272 cik0001588272:WellpathHoldingsInc.Member cik0001588272:FirstLienTermLoanMember cik0001588272:SeniorSecuredLoansAtTwentySixPointZeroFivePercentMember cik0001588272:HealthcareAtTwentyFourPointFivePercentageMember 2022-01-01 2022-12-31 0001588272 cik0001588272:TerrestarCorp.Member cik0001588272:FirstLienTermLoanHMember cik0001588272:SeniorSecuredLoansAtTwentySixPointZeroFivePercentMember cik0001588272:TeleCommunicationServicesAtTwoPointZeroPercentageMember 2022-01-01 2022-12-31 0001588272 cik0001588272:TerrestarCorp.Member cik0001588272:FirstLienTermLoanFMember cik0001588272:SeniorSecuredLoansAtTwentySixPointZeroFivePercentMember cik0001588272:TeleCommunicationServicesAtTwoPointZeroPercentageMember 2022-01-01 2022-12-31 0001588272 cik0001588272:TerrestarCorp.Member cik0001588272:FirstLienTermLoanEMember cik0001588272:SeniorSecuredLoansAtTwentySixPointZeroFivePercentMember cik0001588272:TeleCommunicationServicesAtTwoPointZeroPercentageMember 2022-01-01 2022-12-31 0001588272 cik0001588272:TerrestarCorp.Member cik0001588272:FirstLienTermLoanGMember cik0001588272:SeniorSecuredLoansAtTwentySixPointZeroFivePercentMember cik0001588272:TeleCommunicationServicesAtTwoPointZeroPercentageMember 2022-01-01 2022-12-31 0001588272 cik0001588272:GraysonInvestorCorp.Member cik0001588272:AssetBackedSecuritiesAtZeroPointZeroPercentMember cik0001588272:FinancialsAtZeroPointZeroPercentMember 2022-01-01 2022-12-31 0001588272 cik0001588272:PamcoClo19971abMember cik0001588272:AssetBackedSecuritiesAtZeroPointZeroPercentMember cik0001588272:FinancialsAtZeroPointZeroPercentMember 2022-01-01 2022-12-31 0001588272 cik0001588272:HadrianMergerSubInc.Member cik0001588272:CorporateBondsAtFivePointZeroPercentMember cik0001588272:HealthcareAtTwentyFourPointFivePercentageMember 2022-01-01 2022-12-31 0001588272 cik0001588272:IheartcommunicationsInc.Member cik0001588272:CorporateBondsAtFivePointZeroPercentMember cik0001588272:TeleCommunicationServicesAtZeroPointFivePercentageMember 2022-01-01 2022-12-31 0001588272 cik0001588272:HadrianMergerSubInc.Member cik0001588272:CorporateBondsAtFivePointZeroPercentMember cik0001588272:HealthcareAtFourPointFivePercentMember 2022-01-01 2022-12-31 0001588272 cik0001588272:IheartcommunicationsInc.Member cik0001588272:CorporateBondsAtFivePointZeroPercentMember cik0001588272:MediaAndTelecommunicationsAtZeroPointFivePercentMember cik0001588272:InterestRateAtSixPointThreeEightPercentageMember 2022-01-01 2022-12-31 0001588272 cik0001588272:IheartcommunicationsInc.Member cik0001588272:CorporateBondsAtFivePointZeroPercentMember cik0001588272:MediaAndTelecommunicationsAtZeroPointFivePercentMember cik0001588272:InterestRateAtEightPointThreeEightPercentageMember 2022-01-01 2022-12-31 0001588272 cik0001588272:RealEstateInvestmentTrustAtOnePointNinePercentageMember cik0001588272:NexpointResidentialTrustInc.Member cik0001588272:CommonStocksAtThirtySixPointThreePercentMember 2022-01-01 2022-12-31 0001588272 cik0001588272:ServiceAtZeroPointZeroPercentageMember cik0001588272:WayneServicesLegacyInc.Member cik0001588272:CommonStocksAtThirtySixPointThreePercentMember 2022-01-01 2022-12-31 0001588272 cik0001588272:TelecommunicationServicesAtNinePointFivePercentageMember cik0001588272:TerrestarCorp..Member cik0001588272:CommonStocksAtThirtySixPointThreePercentMember 2022-01-01 2022-12-31 0001588272 cik0001588272:UsGamingLlcMember cik0001588272:ConsumerProductsAtFivePointSevenPercentageMember cik0001588272:LLCInterestsAtEightPointSevenPercentMember 2022-01-01 2022-12-31 0001588272 cik0001588272:SfrWlifIiiLlcMember cik0001588272:RealEstateAtThreePointZeroPercentageMember cik0001588272:LLCInterestsAtEightPointSevenPercentMember 2022-01-01 2022-12-31 0001588272 cik0001588272:NexpointCapitalReitLlcSeniorLoansCommonStocksMember cik0001588272:RealEstateAtThreePointZeroPercentageMember cik0001588272:LLCInterestsAtEightPointSevenPercentMember 2022-01-01 2022-12-31 0001588272 cik0001588272:CommonStocksAtThirtySixPointThreePercentMember cik0001588272:ChemicalsAtZeroPointOnePercentageMember cik0001588272:MpmHoldingsIncMember 2022-01-01 2022-12-31 0001588272 cik0001588272:CommonStocksAtThirtySixPointThreePercentMember cik0001588272:EnergyAtThreePointZeroPercentageMember cik0001588272:QuarternorthEnergyInc.Member 2022-01-01 2022-12-31 0001588272 cik0001588272:CommonStocksAtThirtySixPointThreePercentMember cik0001588272:FinancialsAtThreePointTwoPercentageMember cik0001588272:AmericanBanknoteCorpMember 2022-01-01 2022-12-31 0001588272 cik0001588272:CommonStocksAtThirtySixPointThreePercentMember cik0001588272:RealEstateAtEighteenPointSixPercentageMember cik0001588272:NexpointRealEstateFinanceInc.Member 2022-01-01 2022-12-31 0001588272 cik0001588272:IqhqIncMember cik0001588272:RealEstateAtEighteenPointSixPercentageMember cik0001588272:CommonStocksAtThirtySixPointThreePercentMember 2022-01-01 2022-12-31 0001588272 cik0001588272:SevenHundredSeventySevenPartnersLlcMember cik0001588272:FinancialsAtTwoPointSevenPercentageMember cik0001588272:PreferredStocksAtTwentyTwoPointThreePercentMember 2022-01-01 2022-12-31 0001588272 cik0001588272:UnitedFidelityBankFsbMember cik0001588272:FinancialsAtTwoPointSevenPercentageMember cik0001588272:PreferredStocksAtTwentyTwoPointThreePercentMember 2022-01-01 2022-12-31 0001588272 cik0001588272:ApnimedInc.Member cik0001588272:HealthcareAtNinteenPointSixPercentageMember cik0001588272:PreferredStocksAtTwentyTwoPointThreePercentMember 2022-01-01 2022-12-31 0001588272 cik0001588272:ApnimedInc.Member cik0001588272:SeriesC2Member cik0001588272:HealthcareAtNinteenPointSixPercentageMember cik0001588272:PreferredStocksAtTwentyTwoPointThreePercentMember 2022-01-01 2022-12-31 0001588272 cik0001588272:SapienceTherapeuticsInc.Member us-gaap:SeriesBPreferredStockMember cik0001588272:HealthcareAtNinteenPointSixPercentageMember cik0001588272:PreferredStocksAtTwentyTwoPointThreePercentMember 2022-01-01 2022-12-31 0001588272 cik0001588272:SapienceTherapeuticsInc.Member cik0001588272:Seriesb1preferredSharesMember cik0001588272:HealthcareAtNinteenPointSixPercentageMember cik0001588272:PreferredStocksAtTwentyTwoPointThreePercentMember 2022-01-01 2022-12-31 0001588272 cik0001588272:QuarternorthTranche1Member cik0001588272:EnergyAtZeroPointThreePercentageMember cik0001588272:WarrantsAtZeroPointFourPercentMember 2022-01-01 2022-12-31 0001588272 cik0001588272:QuarternorthTranche2Member cik0001588272:EnergyAtZeroPointThreePercentageMember cik0001588272:WarrantsAtZeroPointFourPercentMember 2022-01-01 2022-12-31 0001588272 cik0001588272:IheartmediaInc.Member cik0001588272:WarrantsAtZeroPointFourPercentMember cik0001588272:MediaAndTelecommunicationsAtZeroPointOnePercentageMember 2022-01-01 2022-12-31 0001588272 cik0001588272:TotalInvestmentNinetyNinePointTwoMember 2022-01-01 2022-12-31 0001588272 us-gaap:AssetBackedSecuritiesMember cik0001588272:AssetBackedSecuritiesOneMember cik0001588272:GraysonInvestorCorpMember us-gaap:FairValueInputsLevel3Member 2022-01-01 2022-12-31 0001588272 us-gaap:AssetBackedSecuritiesMember cik0001588272:AssetBackedSecuritiesOneMember cik0001588272:PamcoCloNineteenNinetySevenOneABMember us-gaap:FairValueInputsLevel3Member 2022-01-01 2022-12-31 0001588272 us-gaap:CommonStockMember cik0001588272:CommonStockOneMember cik0001588272:AmericanBanknoteCorpMember us-gaap:FairValueInputsLevel3Member 2022-01-01 2022-12-31 0001588272 us-gaap:CommonStockMember cik0001588272:CommonStockOneMember cik0001588272:IqhqMember us-gaap:FairValueInputsLevel3Member 2022-01-01 2022-12-31 0001588272 us-gaap:CommonStockMember cik0001588272:CommonStockOneMember cik0001588272:TereeStarCorpMember us-gaap:FairValueInputsLevel3Member 2022-01-01 2022-12-31 0001588272 us-gaap:CommonStockMember cik0001588272:CommonStockOneMember cik0001588272:WayneServicesLegacyIncMember us-gaap:FairValueInputsLevel3Member 2022-01-01 2022-12-31 0001588272 cik0001588272:LlcInterestsMember cik0001588272:LlcInterestsOneMember cik0001588272:NexpointCapitalReitLlcSeniorLoansCommonStocksMember us-gaap:FairValueInputsLevel3Member 2022-01-01 2022-12-31 0001588272 cik0001588272:LlcInterestsMember cik0001588272:LlcInterestsOneMember cik0001588272:SfrWlifThreeLlcMember us-gaap:FairValueInputsLevel3Member 2022-01-01 2022-12-31 0001588272 cik0001588272:LlcInterestsMember cik0001588272:LlcInterestsOneMember cik0001588272:UsGamingLlcMember us-gaap:FairValueInputsLevel3Member 2022-01-01 2022-12-31 0001588272 us-gaap:PreferredStockMember cik0001588272:PreferredStockOneMember cik0001588272:AprimedIncMember us-gaap:FairValueInputsLevel3Member 2022-01-01 2022-12-31 0001588272 us-gaap:FairValueInputsLevel3Member cik0001588272:AprimedIncMember cik0001588272:SeriesCTwoPreferredStockMember us-gaap:PreferredStockMember 2022-01-01 2022-12-31 0001588272 us-gaap:PreferredStockMember us-gaap:SeriesBPreferredStockMember cik0001588272:SapienceTherapauticsIncMember us-gaap:FairValueInputsLevel3Member 2022-01-01 2022-12-31 0001588272 us-gaap:PreferredStockMember cik0001588272:SeriesBOnePreferredStockMember cik0001588272:SapienceTherapauticsIncMember us-gaap:FairValueInputsLevel3Member 2022-01-01 2022-12-31 0001588272 cik0001588272:SeniorSecuredLoansMember cik0001588272:SeniorSecuredLoansOneMember cik0001588272:CcsMedicalIncMember us-gaap:FairValueInputsLevel3Member 2022-01-01 2022-12-31 0001588272 cik0001588272:SeniorSecuredLoansMember cik0001588272:SeniorSecuredLoansOneMember cik0001588272:TerreStarCorpMember us-gaap:FairValueInputsLevel3Member 2022-01-01 2022-12-31 0001588272 cik0001588272:SeniorSecuredLoansMember cik0001588272:SeniorSecuredLoansTwoMember cik0001588272:TerreStarCorpMember us-gaap:FairValueInputsLevel3Member 2022-01-01 2022-12-31 0001588272 cik0001588272:SeniorSecuredLoansMember cik0001588272:SeniorSecuredLoansThreeMember cik0001588272:TerreStarCorpMember us-gaap:FairValueInputsLevel3Member 2022-01-01 2022-12-31 0001588272 cik0001588272:SeniorSecuredLoansMember cik0001588272:SeniorSecuredLoansFourMember cik0001588272:TerreStarCorpMember us-gaap:FairValueInputsLevel3Member 2022-01-01 2022-12-31 0001588272 us-gaap:MeasurementInputDiscountRateMember cik0001588272:LlcInterestsMember us-gaap:FairValueInputsLevel3Member 2022-01-01 2022-12-31 0001588272 us-gaap:MeasurementInputEbitdaMultipleMember cik0001588272:LlcInterestsMember cik0001588272:ValuationTechniqueMultipleAnalysisMember us-gaap:FairValueInputsLevel3Member 2022-01-01 2022-12-31 0001588272 us-gaap:MeasurementInputOptionVolatilityMember us-gaap:PreferredStockMember us-gaap:FairValueInputsLevel3Member 2022-01-01 2022-12-31 0001588272 us-gaap:MeasurementInputCapRateMember us-gaap:PreferredStockMember us-gaap:FairValueInputsLevel3Member 2022-01-01 2022-12-31 0001588272 us-gaap:MeasurementInputDiscountRateMember us-gaap:CommonStockMember us-gaap:FairValueInputsLevel3Member 2022-01-01 2022-12-31 0001588272 us-gaap:MeasurementInputEbitdaMultipleMember us-gaap:CommonStockMember us-gaap:FairValueInputsLevel3Member 2022-01-01 2022-12-31 0001588272 cik0001588272:MeasurementInputEnterpriseValueMember us-gaap:CommonStockMember cik0001588272:ValuationTechniqueLiquidationAnalysisMember us-gaap:FairValueInputsLevel3Member 2022-01-01 2022-12-31 0001588272 cik0001588272:MeasurementInputRecoveryRateMember us-gaap:CommonStockMember us-gaap:FairValueInputsLevel3Member 2022-01-01 2022-12-31 0001588272 cik0001588272:MeasurementInputNavMultipleMember us-gaap:CommonStockMember cik0001588272:ValuationTechniqueNetAssetValueMember us-gaap:FairValueInputsLevel3Member 2022-01-01 2022-12-31 0001588272 us-gaap:MeasurementInputDiscountRateMember cik0001588272:SeniorSecuredLoansMember us-gaap:ValuationTechniqueDiscountedCashFlowMember us-gaap:FairValueInputsLevel3Member 2022-01-01 2022-12-31 0001588272 us-gaap:MeasurementInputDiscountRateMember us-gaap:AssetBackedSecuritiesMember us-gaap:ValuationTechniqueDiscountedCashFlowMember us-gaap:FairValueInputsLevel3Member 2022-01-01 2022-12-31 0001588272 cik0001588272:MeasurementInputUnadjustedPriceMember us-gaap:CommonStockMember us-gaap:FairValueInputsLevel3Member 2022-01-01 2022-12-31 0001588272 cik0001588272:AffiliatedInvestmentsMember 2022-01-01 2022-03-31 0001588272 cik0001588272:NonControlledOrNonAffiliatedInvestmentsMember 2022-01-01 2022-03-31 0001588272 us-gaap:RetainedEarningsMember 2022-01-01 2022-03-31 0001588272 us-gaap:CommonStockMember 2022-01-01 2022-03-31 0001588272 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-03-31 0001588272 cik0001588272:AdviserMember 2022-01-01 2022-03-31 0001588272 us-gaap:InvestmentsMember us-gaap:PreferredStockMember us-gaap:HealthCareMember 2022-01-01 2022-03-31 0001588272 us-gaap:RealEstateMember us-gaap:InvestmentsMember cik0001588272:LlcInterestsMember 2022-01-01 2022-03-31 0001588272 us-gaap:InvestmentsMember cik0001588272:LlcInterestsMember cik0001588272:ConsumerProductsMember 2022-01-01 2022-03-31 0001588272 us-gaap:InvestmentsMember us-gaap:CommonStockMember cik0001588272:TelecommunicationServicesMember 2022-01-01 2022-03-31 0001588272 us-gaap:InvestmentsMember us-gaap:CommonStockMember us-gaap:ServiceMember 2022-01-01 2022-03-31 0001588272 us-gaap:RealEstateMember us-gaap:InvestmentsMember us-gaap:CommonStockMember 2022-01-01 2022-03-31 0001588272 us-gaap:InvestmentsMember us-gaap:CommonStockMember cik0001588272:FinancialsMember 2022-01-01 2022-03-31 0001588272 us-gaap:InvestmentsMember cik0001588272:SeniorSecuredLoansMember cik0001588272:TelcommunicationServicesMember 2022-01-01 2022-03-31 0001588272 us-gaap:InvestmentsMember cik0001588272:SeniorSecuredLoansMember us-gaap:HealthCareMember 2022-01-01 2022-03-31 0001588272 us-gaap:InvestmentsMember cik0001588272:AssetBackedSecuritiesOneMember cik0001588272:FinancialsMember 2022-01-01 2022-03-31 0001588272 us-gaap:InvestmentsMember 2022-01-01 2022-03-31 0001588272 cik0001588272:AffiliatedInvestmentsMember 2023-03-31 0001588272 cik0001588272:NonControlledOrNonAffiliatedInvestmentsMember 2023-03-31 0001588272 cik0001588272:NextPointAdvisorsL.pMember 2023-03-31 0001588272 us-gaap:UnfundedLoanCommitmentMember 2023-03-31 0001588272 cik0001588272:FirstQuarterTenderOfferMember 2023-03-31 0001588272 cik0001588272:MarchThirtyOneTwoThousandTwentySixMember 2023-03-31 0001588272 cik0001588272:ExpenseLimitationAgreementMember 2023-03-31 0001588272 us-gaap:MoneyMarketFundsMember 2023-03-31 0001588272 cik0001588272:AdvisoryFeesAndAdministrationFeesMember 2023-03-31 0001588272 cik0001588272:AdviserMember 2023-03-31 0001588272 cik0001588272:FirstLienTermLoanMember cik0001588272:SeniorSecuredLoansAtNineteenPointSixPercentMember cik0001588272:AurisLuxembourgIiiS.a.r.l.Member cik0001588272:HealthcareAtSixteenPointFivePercentageMember 2023-03-31 0001588272 cik0001588272:CarestreamHealthIncMember cik0001588272:SeniorSecuredLoansAtNineteenPointSixPercentMember cik0001588272:HealthcareAtSixteenPointFivePercentageMember cik0001588272:FirstLienTermLoanMember 2023-03-31 0001588272 cik0001588272:FirstLienTermLoanMember cik0001588272:SeniorSecuredLoansAtNineteenPointSixPercentMember cik0001588272:CcsMedicalIncMember cik0001588272:HealthcareAtSixteenPointFivePercentageMember 2023-03-31 0001588272 cik0001588272:SecondLienTermLoanMember cik0001588272:SeniorSecuredLoansAtNineteenPointSixPercentMember cik0001588272:CntHoldingsICorpMember cik0001588272:HealthcareAtSixteenPointFivePercentageMember 2023-03-31 0001588272 cik0001588272:FirstLienDelayedDrawTermLoanMember cik0001588272:SeniorSecuredLoansAtNineteenPointSixPercentMember cik0001588272:CovenantSurgicalPartnersInc.Member cik0001588272:HealthcareAtSixteenPointFivePercentageMember 2023-03-31 0001588272 cik0001588272:FirstLienTermLoanMember cik0001588272:SeniorSecuredLoansAtNineteenPointSixPercentMember cik0001588272:CovenantSurgicalPartnersInc.Member cik0001588272:HealthcareAtSixteenPointFivePercentageMember 2023-03-31 0001588272 cik0001588272:FirstLienTermLoanMember cik0001588272:SeniorSecuredLoansAtNineteenPointSixPercentMember cik0001588272:EnvisionHealthcareCorp.Member cik0001588272:HealthcareAtSixteenPointFivePercentageMember 2023-03-31 0001588272 cik0001588272:SecondLienTermLoanMember cik0001588272:SeniorSecuredLoansAtNineteenPointSixPercentMember cik0001588272:SoundInpatientPhysiciansMember cik0001588272:HealthcareAtSixteenPointFivePercentageMember 2023-03-31 0001588272 cik0001588272:FirstLienTermLoanMember cik0001588272:SeniorSecuredLoansAtNineteenPointSixPercentMember cik0001588272:WellpathHoldingsInc.Member cik0001588272:HealthcareAtSixteenPointFivePercentageMember 2023-03-31 0001588272 cik0001588272:SeniorSecuredLoansAtNineteenPointSixPercentMember cik0001588272:TerrestarCorp.Member cik0001588272:FirstLienTermLoanEMember cik0001588272:TeleCommunicationServicesAtTwoPointTwoPercentageMember 2023-03-31 0001588272 cik0001588272:SeniorSecuredLoansAtNineteenPointSixPercentMember cik0001588272:TerrestarCorp.Member cik0001588272:FirstLienTermLoanGMember cik0001588272:TeleCommunicationServicesAtTwoPointTwoPercentageMember 2023-03-31 0001588272 cik0001588272:SeniorSecuredLoansAtNineteenPointSixPercentMember cik0001588272:TerrestarCorp.Member cik0001588272:TeleCommunicationServicesAtTwoPointTwoPercentageMember cik0001588272:FirstLienTermLoanHMember 2023-03-31 0001588272 cik0001588272:SeniorSecuredLoansAtNineteenPointSixPercentMember cik0001588272:TerrestarCorp.Member cik0001588272:TeleCommunicationServicesAtTwoPointTwoPercentageMember cik0001588272:FirstLienTermLoanFMember 2023-03-31 0001588272 cik0001588272:HadrianMergerSubInc.Member cik0001588272:HealthcareAtFourPointFourPercentMember cik0001588272:CorporateBondsAtFourPointNinePercentMember 2023-03-31 0001588272 cik0001588272:InterestRateAtSixPointThreeEightPercentageMember cik0001588272:IheartcommunicationsInc.Member cik0001588272:CorporateBondsAtFourPointNinePercentMember cik0001588272:MediaAndTelecommunicationsAtZeroPointFivePercentMember 2023-03-31 0001588272 cik0001588272:InterestRateAtEightPointThreeEightPercentageMember cik0001588272:IheartcommunicationsInc.Member cik0001588272:CorporateBondsAtFourPointNinePercentMember cik0001588272:MediaAndTelecommunicationsAtZeroPointFivePercentMember 2023-03-31 0001588272 cik0001588272:FirstLienTermLoanMember cik0001588272:SeniorSecuredLoansAtNineteenPointSixPercentMember cik0001588272:RealEstateAtZeroPointNinePercentageMember cik0001588272:NexpointCapitalReitLlcSeniorLoansCommonStocksMember 2023-03-31 0001588272 cik0001588272:GraysonInvestorCorp.Member cik0001588272:AssetBackedSecuritiesAtZeroPointZeroPercentMember cik0001588272:FinancialsAtZeroPointZeroPercentMember 2023-03-31 0001588272 cik0001588272:PamcoClo19971abMember cik0001588272:FinancialsAtZeroPointZeroPercentMember cik0001588272:AssetBackedSecuritiesAtZeroPointZeroPercentMember 2023-03-31 0001588272 cik0001588272:SeniorSecuredLoansAtNineteenPointSixPercentMember cik0001588272:HealthcareAtSixteenPointFivePercentageMember 2023-03-31 0001588272 cik0001588272:SeniorSecuredLoansAtNineteenPointSixPercentMember cik0001588272:TeleCommunicationServicesAtTwoPointTwoPercentageMember 2023-03-31 0001588272 cik0001588272:SeniorSecuredLoansAtNineteenPointSixPercentMember 2023-03-31 0001588272 cik0001588272:FinancialsAtZeroPointZeroPercentMember cik0001588272:AssetBackedSecuritiesAtZeroPointZeroPercentMember 2023-03-31 0001588272 cik0001588272:AssetBackedSecuritiesAtZeroPointZeroPercentMember 2023-03-31 0001588272 cik0001588272:CorporateBondsAtFourPointNinePercentMember cik0001588272:MediaAndTelecommunicationsAtZeroPointFivePercentMember 2023-03-31 0001588272 cik0001588272:CorporateBondsAtFourPointNinePercentMember 2023-03-31 0001588272 cik0001588272:MpmHoldingsIncMember cik0001588272:ChemicalsAtZeroPointOnePercentageMember cik0001588272:CommonStocksAtTwentySevenPointTwoPercentMember 2023-03-31 0001588272 cik0001588272:QuarternorthEnergyInc.Member cik0001588272:EnergyAtThreePointTwoPercentageMember cik0001588272:CommonStocksAtTwentySevenPointTwoPercentMember 2023-03-31 0001588272 cik0001588272:AmericanBanknoteCorpMember cik0001588272:FinancialsAtThreePointFourPercentageMember cik0001588272:CommonStocksAtTwentySevenPointTwoPercentMember 2023-03-31 0001588272 cik0001588272:NexpointRealEstateFinanceInc.Member cik0001588272:RealEstateAtEightPointSevenPercentageMember cik0001588272:CommonStocksAtTwentySevenPointTwoPercentMember 2023-03-31 0001588272 cik0001588272:IqhqIncMember cik0001588272:RealEstateAtEightPointSevenPercentageMember cik0001588272:CommonStocksAtTwentySevenPointTwoPercentMember 2023-03-31 0001588272 cik0001588272:NexpointResidentialTrustInc.Member cik0001588272:RealEstateInvestmentTrustAtTwoPointZeroPercentageMember cik0001588272:CommonStocksAtTwentySevenPointTwoPercentMember 2023-03-31 0001588272 cik0001588272:WayneServicesLegacyInc.Member cik0001588272:ServiceAtZeroPointZeroPercentageMember cik0001588272:CommonStocksAtTwentySevenPointTwoPercentMember 2023-03-31 0001588272 cik0001588272:TerrestarCorp..Member cik0001588272:TelecommunicationServicesAtNinePointEightPercentageMember cik0001588272:CommonStocksAtTwentySevenPointTwoPercentMember 2023-03-31 0001588272 cik0001588272:UsGamingLlcMember cik0001588272:ConsumerProductsAtFivePointSixPercentageMember cik0001588272:LLCInterestsAtNineteenPointNinePercentMember 2023-03-31 0001588272 cik0001588272:SfrWlifIiiLlcMember cik0001588272:RealEstateAtFourteenPointThreePercentageMember cik0001588272:LLCInterestsAtNineteenPointNinePercentMember 2023-03-31 0001588272 cik0001588272:NexpointCapitalReitLlcSeniorLoansCommonStocksMember cik0001588272:RealEstateAtFourteenPointThreePercentageMember cik0001588272:LLCInterestsAtNineteenPointNinePercentMember 2023-03-31 0001588272 cik0001588272:RealEstateAtEightPointSevenPercentageMember cik0001588272:CommonStocksAtTwentySevenPointTwoPercentMember 2023-03-31 0001588272 cik0001588272:CommonStocksAtTwentySevenPointTwoPercentMember 2023-03-31 0001588272 cik0001588272:RealEstateAtFourteenPointThreePercentageMember cik0001588272:LLCInterestsAtNineteenPointNinePercentMember 2023-03-31 0001588272 cik0001588272:LLCInterestsAtNineteenPointNinePercentMember 2023-03-31 0001588272 cik0001588272:FinancialsAtTwoPointSevenPercentageMember cik0001588272:PreferredStocksAtTwentyThreePointFourPercentMember cik0001588272:SevenHundredSeventySevenPartnersLlcMember 2023-03-31 0001588272 cik0001588272:FinancialsAtTwoPointSevenPercentageMember cik0001588272:PreferredStocksAtTwentyThreePointFourPercentMember cik0001588272:UnitedFidelityBankFsbMember 2023-03-31 0001588272 cik0001588272:HealthcareAtTwentyPointSevenPercentageMember cik0001588272:PreferredStocksAtTwentyThreePointFourPercentMember cik0001588272:ApnimedInc.Member 2023-03-31 0001588272 cik0001588272:HealthcareAtTwentyPointSevenPercentageMember cik0001588272:PreferredStocksAtTwentyThreePointFourPercentMember cik0001588272:ApnimedInc.Member cik0001588272:SeriesC2Member 2023-03-31 0001588272 cik0001588272:HealthcareAtTwentyPointSevenPercentageMember cik0001588272:PreferredStocksAtTwentyThreePointFourPercentMember cik0001588272:SapienceTherapeuticsInc.Member us-gaap:SeriesBPreferredStockMember 2023-03-31 0001588272 cik0001588272:HealthcareAtTwentyPointSevenPercentageMember cik0001588272:PreferredStocksAtTwentyThreePointFourPercentMember cik0001588272:SapienceTherapeuticsInc.Member cik0001588272:Seriesb1preferredSharesMember 2023-03-31 0001588272 cik0001588272:EnergyAtZeroPointThreePercentageMember cik0001588272:WarrantsAtZeroPointThreePercentMember cik0001588272:QuarternorthTranche1Member 2023-03-31 0001588272 cik0001588272:EnergyAtZeroPointThreePercentageMember cik0001588272:WarrantsAtZeroPointThreePercentMember cik0001588272:QuarternorthTranche2Member 2023-03-31 0001588272 cik0001588272:MediaAndTelecommunicationsAtZeroPointZeroPercentageMember cik0001588272:WarrantsAtZeroPointThreePercentMember cik0001588272:IheartmediaInc.Member 2023-03-31 0001588272 cik0001588272:FinancialsAtTwoPointSevenPercentageMember cik0001588272:PreferredStocksAtTwentyThreePointFourPercentMember 2023-03-31 0001588272 cik0001588272:HealthcareAtTwentyPointSevenPercentageMember cik0001588272:PreferredStocksAtTwentyThreePointFourPercentMember 2023-03-31 0001588272 cik0001588272:PreferredStocksAtTwentyThreePointFourPercentMember 2023-03-31 0001588272 cik0001588272:EnergyAtZeroPointThreePercentageMember cik0001588272:WarrantsAtZeroPointThreePercentMember 2023-03-31 0001588272 cik0001588272:WarrantsAtZeroPointThreePercentMember 2023-03-31 0001588272 cik0001588272:TotalInvestmentNinetyFivePointThreeMember 2023-03-31 0001588272 cik0001588272:CashEquivalentsAtOnePointFivePercentageMember 2023-03-31 0001588272 cik0001588272:OtherAssetsLiabilitiesNetAtThreePointTwoPercentageMember 2023-03-31 0001588272 us-gaap:AssetBackedSecuritiesMember cik0001588272:AssetBackedSecuritiesOneMember cik0001588272:GraysonInvestorCorpMember us-gaap:FairValueInputsLevel3Member 2023-03-31 0001588272 us-gaap:AssetBackedSecuritiesMember cik0001588272:AssetBackedSecuritiesOneMember cik0001588272:PamcoCloNineteenNinetySevenOneABMember us-gaap:FairValueInputsLevel3Member 2023-03-31 0001588272 us-gaap:CommonStockMember cik0001588272:CommonStockOneMember cik0001588272:AmericanBanknoteCorpMember us-gaap:FairValueInputsLevel3Member 2023-03-31 0001588272 us-gaap:CommonStockMember cik0001588272:CommonStockOneMember cik0001588272:IqhqMember us-gaap:FairValueInputsLevel3Member 2023-03-31 0001588272 us-gaap:CommonStockMember cik0001588272:CommonStockOneMember cik0001588272:TereeStarCorpMember us-gaap:FairValueInputsLevel3Member 2023-03-31 0001588272 us-gaap:CommonStockMember cik0001588272:CommonStockOneMember cik0001588272:WayneServicesLegacyIncMember us-gaap:FairValueInputsLevel3Member 2023-03-31 0001588272 cik0001588272:LlcInterestsMember cik0001588272:LlcInterestsOneMember cik0001588272:NexpointCapitalReitLlcSeniorLoansCommonStocksMember us-gaap:FairValueInputsLevel3Member 2023-03-31 0001588272 cik0001588272:LlcInterestsMember cik0001588272:LlcInterestsOneMember cik0001588272:SfrWlifThreeLlcMember us-gaap:FairValueInputsLevel3Member 2023-03-31 0001588272 cik0001588272:LlcInterestsMember cik0001588272:LlcInterestsOneMember cik0001588272:UsGamingLlcMember us-gaap:FairValueInputsLevel3Member 2023-03-31 0001588272 us-gaap:PreferredStockMember cik0001588272:PreferredStockOneMember cik0001588272:AprimedIncMember us-gaap:FairValueInputsLevel3Member 2023-03-31 0001588272 us-gaap:FairValueInputsLevel3Member cik0001588272:AprimedIncMember cik0001588272:SeriesCTwoPreferredStockMember us-gaap:PreferredStockMember 2023-03-31 0001588272 us-gaap:PreferredStockMember us-gaap:SeriesBPreferredStockMember cik0001588272:SapienceTherapauticsIncMember us-gaap:FairValueInputsLevel3Member 2023-03-31 0001588272 us-gaap:PreferredStockMember cik0001588272:SeriesBOnePreferredStockMember cik0001588272:SapienceTherapauticsIncMember us-gaap:FairValueInputsLevel3Member 2023-03-31 0001588272 cik0001588272:SeniorSecuredLoansMember cik0001588272:SeniorSecuredLoansOneMember cik0001588272:CcsMedicalIncMember us-gaap:FairValueInputsLevel3Member 2023-03-31 0001588272 cik0001588272:SeniorSecuredLoansMember cik0001588272:SeniorSecuredLoansOneMember cik0001588272:TerreStarCorpMember us-gaap:FairValueInputsLevel3Member 2023-03-31 0001588272 cik0001588272:SeniorSecuredLoansMember cik0001588272:SeniorSecuredLoansTwoMember cik0001588272:TerreStarCorpMember us-gaap:FairValueInputsLevel3Member 2023-03-31 0001588272 cik0001588272:SeniorSecuredLoansMember cik0001588272:SeniorSecuredLoansThreeMember cik0001588272:TerreStarCorpMember us-gaap:FairValueInputsLevel3Member 2023-03-31 0001588272 cik0001588272:SeniorSecuredLoansMember cik0001588272:SeniorSecuredLoansFourMember cik0001588272:TerreStarCorpMember us-gaap:FairValueInputsLevel3Member 2023-03-31 0001588272 cik0001588272:SeniorSecuredLoansMember cik0001588272:SeniorSecuredLoansOneMember cik0001588272:NexpointCapitalReitLlc.Member us-gaap:FairValueInputsLevel3Member 2023-03-31 0001588272 us-gaap:HealthCareMember 2023-03-31 0001588272 us-gaap:RealEstateMember 2023-03-31 0001588272 cik0001588272:TelecommunicationServicesMember 2023-03-31 0001588272 us-gaap:FinancialServiceMember 2023-03-31 0001588272 cik0001588272:ConsumerProductsMember 2023-03-31 0001588272 cik0001588272:EnergyMember 2023-03-31 0001588272 cik0001588272:RealEstateInvestmentTrustsMember 2023-03-31 0001588272 cik0001588272:MediaAndTelecommunicationsMember 2023-03-31 0001588272 cik0001588272:ChemicalsMember 2023-03-31 0001588272 us-gaap:ServiceMember 2023-03-31 0001588272 cik0001588272:SeniorSecuredLoansFirstLienMember 2023-03-31 0001588272 cik0001588272:SeniorSecuredLoansSecondLienMember 2023-03-31 0001588272 us-gaap:AssetBackedSecuritiesMember 2023-03-31 0001588272 us-gaap:CorporateBondSecuritiesMember 2023-03-31 0001588272 us-gaap:CommonStockMember 2023-03-31 0001588272 cik0001588272:LlcMemberInterestsMember 2023-03-31 0001588272 us-gaap:PreferredStockMember 2023-03-31 0001588272 us-gaap:WarrantMember 2023-03-31 0001588272 country:KY 2023-03-31 0001588272 country:LU 2023-03-31 0001588272 country:US 2023-03-31 0001588272 us-gaap:FairValueInputsLevel1Member cik0001588272:SeniorSecuredLoansMember us-gaap:HealthCareMember 2023-03-31 0001588272 us-gaap:FairValueInputsLevel2Member cik0001588272:SeniorSecuredLoansMember us-gaap:HealthCareMember 2023-03-31 0001588272 us-gaap:FairValueInputsLevel3Member cik0001588272:SeniorSecuredLoansMember us-gaap:HealthCareMember 2023-03-31 0001588272 cik0001588272:SeniorSecuredLoansMember us-gaap:HealthCareMember 2023-03-31 0001588272 us-gaap:FairValueInputsLevel1Member cik0001588272:SeniorSecuredLoansMember cik0001588272:TelcommunicationServicesMember 2023-03-31 0001588272 us-gaap:FairValueInputsLevel2Member cik0001588272:SeniorSecuredLoansMember cik0001588272:TelcommunicationServicesMember 2023-03-31 0001588272 us-gaap:FairValueInputsLevel3Member cik0001588272:SeniorSecuredLoansMember cik0001588272:TelcommunicationServicesMember 2023-03-31 0001588272 cik0001588272:SeniorSecuredLoansMember cik0001588272:TelcommunicationServicesMember 2023-03-31 0001588272 us-gaap:FairValueInputsLevel1Member cik0001588272:AssetBackedSecuritiesOneMember cik0001588272:FinancialsMember 2023-03-31 0001588272 us-gaap:FairValueInputsLevel2Member cik0001588272:AssetBackedSecuritiesOneMember cik0001588272:FinancialsMember 2023-03-31 0001588272 us-gaap:FairValueInputsLevel3Member cik0001588272:AssetBackedSecuritiesOneMember cik0001588272:FinancialsMember 2023-03-31 0001588272 cik0001588272:AssetBackedSecuritiesOneMember cik0001588272:FinancialsMember 2023-03-31 0001588272 us-gaap:FairValueInputsLevel1Member us-gaap:HealthCareMember cik0001588272:CorporateBondsMember 2023-03-31 0001588272 us-gaap:FairValueInputsLevel2Member us-gaap:HealthCareMember cik0001588272:CorporateBondsMember 2023-03-31 0001588272 us-gaap:FairValueInputsLevel3Member us-gaap:HealthCareMember cik0001588272:CorporateBondsMember 2023-03-31 0001588272 us-gaap:HealthCareMember cik0001588272:CorporateBondsMember 2023-03-31 0001588272 us-gaap:FairValueInputsLevel1Member cik0001588272:MediaAndTelecommunicationsMember cik0001588272:CorporateBondsMember 2023-03-31 0001588272 us-gaap:FairValueInputsLevel2Member cik0001588272:MediaAndTelecommunicationsMember cik0001588272:CorporateBondsMember 2023-03-31 0001588272 us-gaap:FairValueInputsLevel3Member cik0001588272:MediaAndTelecommunicationsMember cik0001588272:CorporateBondsMember 2023-03-31 0001588272 cik0001588272:MediaAndTelecommunicationsMember cik0001588272:CorporateBondsMember 2023-03-31 0001588272 us-gaap:FairValueInputsLevel1Member us-gaap:CommonStockMember cik0001588272:ChemicalsMember 2023-03-31 0001588272 us-gaap:FairValueInputsLevel2Member us-gaap:CommonStockMember cik0001588272:ChemicalsMember 2023-03-31 0001588272 us-gaap:FairValueInputsLevel3Member us-gaap:CommonStockMember cik0001588272:ChemicalsMember 2023-03-31 0001588272 us-gaap:CommonStockMember cik0001588272:ChemicalsMember 2023-03-31 0001588272 us-gaap:FairValueInputsLevel1Member us-gaap:CommonStockMember cik0001588272:EnergyMember 2023-03-31 0001588272 us-gaap:FairValueInputsLevel2Member us-gaap:CommonStockMember cik0001588272:EnergyMember 2023-03-31 0001588272 us-gaap:FairValueInputsLevel3Member us-gaap:CommonStockMember cik0001588272:EnergyMember 2023-03-31 0001588272 us-gaap:CommonStockMember cik0001588272:EnergyMember 2023-03-31 0001588272 us-gaap:FairValueInputsLevel1Member us-gaap:CommonStockMember cik0001588272:FinancialsMember 2023-03-31 0001588272 us-gaap:FairValueInputsLevel2Member us-gaap:CommonStockMember cik0001588272:FinancialsMember 2023-03-31 0001588272 us-gaap:FairValueInputsLevel3Member us-gaap:CommonStockMember cik0001588272:FinancialsMember 2023-03-31 0001588272 us-gaap:CommonStockMember cik0001588272:FinancialsMember 2023-03-31 0001588272 us-gaap:FairValueInputsLevel1Member us-gaap:CommonStockMember us-gaap:RealEstateMember 2023-03-31 0001588272 us-gaap:FairValueInputsLevel2Member us-gaap:CommonStockMember us-gaap:RealEstateMember 2023-03-31 0001588272 us-gaap:FairValueInputsLevel3Member us-gaap:CommonStockMember us-gaap:RealEstateMember 2023-03-31 0001588272 us-gaap:CommonStockMember us-gaap:RealEstateMember 2023-03-31 0001588272 us-gaap:FairValueInputsLevel1Member us-gaap:CommonStockMember cik0001588272:RealEstateInvestmentTrustsMember 2023-03-31 0001588272 us-gaap:FairValueInputsLevel2Member us-gaap:CommonStockMember cik0001588272:RealEstateInvestmentTrustsMember 2023-03-31 0001588272 us-gaap:FairValueInputsLevel3Member us-gaap:CommonStockMember cik0001588272:RealEstateInvestmentTrustsMember 2023-03-31 0001588272 us-gaap:CommonStockMember cik0001588272:RealEstateInvestmentTrustsMember 2023-03-31 0001588272 us-gaap:FairValueInputsLevel1Member us-gaap:CommonStockMember us-gaap:ServiceMember 2023-03-31 0001588272 us-gaap:FairValueInputsLevel2Member us-gaap:CommonStockMember us-gaap:ServiceMember 2023-03-31 0001588272 us-gaap:FairValueInputsLevel3Member us-gaap:CommonStockMember us-gaap:ServiceMember 2023-03-31 0001588272 us-gaap:CommonStockMember us-gaap:ServiceMember 2023-03-31 0001588272 us-gaap:FairValueInputsLevel1Member us-gaap:CommonStockMember cik0001588272:TelecommunicationServicesMember 2023-03-31 0001588272 us-gaap:FairValueInputsLevel2Member us-gaap:CommonStockMember cik0001588272:TelecommunicationServicesMember 2023-03-31 0001588272 us-gaap:FairValueInputsLevel3Member us-gaap:CommonStockMember cik0001588272:TelecommunicationServicesMember 2023-03-31 0001588272 us-gaap:CommonStockMember cik0001588272:TelecommunicationServicesMember 2023-03-31 0001588272 us-gaap:FairValueInputsLevel1Member cik0001588272:LlcInterestsMember cik0001588272:ConsumerProductsMember 2023-03-31 0001588272 us-gaap:FairValueInputsLevel2Member cik0001588272:LlcInterestsMember cik0001588272:ConsumerProductsMember 2023-03-31 0001588272 us-gaap:FairValueInputsLevel3Member cik0001588272:LlcInterestsMember cik0001588272:ConsumerProductsMember 2023-03-31 0001588272 cik0001588272:LlcInterestsMember cik0001588272:ConsumerProductsMember 2023-03-31 0001588272 us-gaap:FairValueInputsLevel1Member cik0001588272:LlcInterestsMember us-gaap:RealEstateMember 2023-03-31 0001588272 us-gaap:FairValueInputsLevel2Member cik0001588272:LlcInterestsMember us-gaap:RealEstateMember 2023-03-31 0001588272 us-gaap:FairValueInputsLevel3Member cik0001588272:LlcInterestsMember us-gaap:RealEstateMember 2023-03-31 0001588272 cik0001588272:LlcInterestsMember us-gaap:RealEstateMember 2023-03-31 0001588272 us-gaap:FairValueInputsLevel1Member us-gaap:PreferredStockMember cik0001588272:FinancialsMember 2023-03-31 0001588272 us-gaap:FairValueInputsLevel2Member us-gaap:PreferredStockMember cik0001588272:FinancialsMember 2023-03-31 0001588272 us-gaap:FairValueInputsLevel3Member us-gaap:PreferredStockMember cik0001588272:FinancialsMember 2023-03-31 0001588272 us-gaap:PreferredStockMember cik0001588272:FinancialsMember 2023-03-31 0001588272 us-gaap:FairValueInputsLevel1Member us-gaap:PreferredStockMember us-gaap:HealthCareMember 2023-03-31 0001588272 us-gaap:FairValueInputsLevel2Member us-gaap:PreferredStockMember us-gaap:HealthCareMember 2023-03-31 0001588272 us-gaap:FairValueInputsLevel3Member us-gaap:PreferredStockMember us-gaap:HealthCareMember 2023-03-31 0001588272 us-gaap:PreferredStockMember us-gaap:HealthCareMember 2023-03-31 0001588272 us-gaap:FairValueInputsLevel1Member us-gaap:WarrantMember cik0001588272:EnergyMember 2023-03-31 0001588272 us-gaap:FairValueInputsLevel2Member us-gaap:WarrantMember cik0001588272:EnergyMember 2023-03-31 0001588272 us-gaap:FairValueInputsLevel3Member us-gaap:WarrantMember cik0001588272:EnergyMember 2023-03-31 0001588272 us-gaap:WarrantMember cik0001588272:EnergyMember 2023-03-31 0001588272 us-gaap:FairValueInputsLevel1Member us-gaap:WarrantMember cik0001588272:MediaAndTelecommunicationsMember 2023-03-31 0001588272 us-gaap:FairValueInputsLevel2Member us-gaap:WarrantMember cik0001588272:MediaAndTelecommunicationsMember 2023-03-31 0001588272 us-gaap:FairValueInputsLevel3Member us-gaap:WarrantMember cik0001588272:MediaAndTelecommunicationsMember 2023-03-31 0001588272 us-gaap:WarrantMember cik0001588272:MediaAndTelecommunicationsMember 2023-03-31 0001588272 us-gaap:FairValueInputsLevel1Member 2023-03-31 0001588272 us-gaap:FairValueInputsLevel2Member 2023-03-31 0001588272 us-gaap:FairValueInputsLevel3Member 2023-03-31 0001588272 cik0001588272:SeniorSecuredLoansMember us-gaap:RealEstateMember us-gaap:FairValueInputsLevel3Member 2023-03-31 0001588272 cik0001588272:SeniorSecuredLoansMember us-gaap:RealEstateMember 2023-03-31 0001588272 cik0001588272:EquityMethodInvesteeControllingInvestmentMember srt:MinimumMember 2023-03-31 0001588272 cik0001588272:EquityMethodInvesteeControllingInvestmentMember srt:MaximumMember 2023-03-31 0001588272 cik0001588272:BaseRateOf3MonthLiborMember 2023-03-31 0001588272 cik0001588272:BaseRateOf3MonthSofrMember 2023-03-31 0001588272 cik0001588272:BoardOfDirectorsMember 2023-03-31 0001588272 srt:AffiliatedEntityMember 2023-03-31 0001588272 us-gaap:MeasurementInputDiscountRateMember cik0001588272:LlcInterestsMember us-gaap:ValuationTechniqueDiscountedCashFlowMember us-gaap:FairValueInputsLevel3Member 2023-03-31 0001588272 us-gaap:MeasurementInputOptionVolatilityMember us-gaap:PreferredStockMember us-gaap:ValuationTechniqueOptionPricingModelMember us-gaap:FairValueInputsLevel3Member 2023-03-31 0001588272 us-gaap:MeasurementInputDiscountRateMember us-gaap:CommonStockMember us-gaap:ValuationTechniqueDiscountedCashFlowMember us-gaap:FairValueInputsLevel3Member 2023-03-31 0001588272 us-gaap:MeasurementInputDiscountRateMember cik0001588272:SeniorSecuredLoansMember us-gaap:ValuationTechniqueDiscountedCashFlowMember us-gaap:FairValueInputsLevel3Member 2023-03-31 0001588272 us-gaap:MeasurementInputDiscountRateMember us-gaap:AssetBackedSecuritiesMember us-gaap:ValuationTechniqueDiscountedCashFlowMember us-gaap:FairValueInputsLevel3Member 2023-03-31 0001588272 us-gaap:MeasurementInputDiscountRateMember cik0001588272:LlcInterestsMember us-gaap:ValuationTechniqueDiscountedCashFlowMember us-gaap:FairValueInputsLevel3Member srt:MinimumMember 2023-03-31 0001588272 us-gaap:MeasurementInputDiscountRateMember cik0001588272:LlcInterestsMember us-gaap:ValuationTechniqueDiscountedCashFlowMember us-gaap:FairValueInputsLevel3Member srt:MaximumMember 2023-03-31 0001588272 us-gaap:MeasurementInputDiscountRateMember cik0001588272:LlcInterestsMember us-gaap:ValuationTechniqueDiscountedCashFlowMember us-gaap:FairValueInputsLevel3Member srt:WeightedAverageMember 2023-03-31 0001588272 us-gaap:MeasurementInputEbitdaMultipleMember cik0001588272:LlcInterestsMember cik0001588272:ValuationTechniqueMultipleAnalysisMember us-gaap:FairValueInputsLevel3Member srt:MinimumMember 2023-03-31 0001588272 us-gaap:MeasurementInputEbitdaMultipleMember cik0001588272:LlcInterestsMember cik0001588272:ValuationTechniqueMultipleAnalysisMember us-gaap:FairValueInputsLevel3Member srt:MaximumMember 2023-03-31 0001588272 us-gaap:MeasurementInputOptionVolatilityMember us-gaap:PreferredStockMember us-gaap:ValuationTechniqueOptionPricingModelMember us-gaap:FairValueInputsLevel3Member srt:MinimumMember 2023-03-31 0001588272 us-gaap:MeasurementInputOptionVolatilityMember us-gaap:PreferredStockMember us-gaap:ValuationTechniqueOptionPricingModelMember us-gaap:FairValueInputsLevel3Member srt:MaximumMember 2023-03-31 0001588272 us-gaap:MeasurementInputOptionVolatilityMember us-gaap:PreferredStockMember us-gaap:ValuationTechniqueOptionPricingModelMember us-gaap:FairValueInputsLevel3Member srt:WeightedAverageMember 2023-03-31 0001588272 us-gaap:MeasurementInputDiscountRateMember us-gaap:CommonStockMember us-gaap:ValuationTechniqueDiscountedCashFlowMember us-gaap:FairValueInputsLevel3Member srt:MinimumMember 2023-03-31 0001588272 us-gaap:MeasurementInputDiscountRateMember us-gaap:CommonStockMember us-gaap:ValuationTechniqueDiscountedCashFlowMember us-gaap:FairValueInputsLevel3Member srt:MaximumMember 2023-03-31 0001588272 us-gaap:MeasurementInputDiscountRateMember us-gaap:CommonStockMember us-gaap:ValuationTechniqueDiscountedCashFlowMember us-gaap:FairValueInputsLevel3Member srt:WeightedAverageMember 2023-03-31 0001588272 us-gaap:MeasurementInputEbitdaMultipleMember us-gaap:CommonStockMember cik0001588272:ValuationTechniqueMultipleAnalysisMember us-gaap:FairValueInputsLevel3Member srt:MinimumMember 2023-03-31 0001588272 us-gaap:MeasurementInputEbitdaMultipleMember us-gaap:CommonStockMember cik0001588272:ValuationTechniqueMultipleAnalysisMember us-gaap:FairValueInputsLevel3Member srt:MaximumMember 2023-03-31 0001588272 us-gaap:MeasurementInputEbitdaMultipleMember us-gaap:CommonStockMember cik0001588272:ValuationTechniqueMultipleAnalysisMember us-gaap:FairValueInputsLevel3Member srt:WeightedAverageMember 2023-03-31 0001588272 cik0001588272:MeasurementInputUnadjustedPriceMember us-gaap:CommonStockMember us-gaap:FairValueInputsLevel3Member srt:MinimumMember 2023-03-31 0001588272 cik0001588272:MeasurementInputUnadjustedPriceMember us-gaap:CommonStockMember us-gaap:FairValueInputsLevel3Member srt:MaximumMember 2023-03-31 0001588272 cik0001588272:MeasurementInputUnadjustedPriceMember us-gaap:CommonStockMember us-gaap:FairValueInputsLevel3Member srt:WeightedAverageMember 2023-03-31 0001588272 cik0001588272:MeasurementInputEnterpriseValueMember us-gaap:CommonStockMember cik0001588272:ValuationTechniqueTransactionIndicationOfValueMember us-gaap:FairValueInputsLevel3Member 2023-03-31 0001588272 cik0001588272:MeasurementInputRecoveryRateMember us-gaap:CommonStockMember cik0001588272:ValuationTechniqueLiquidationAnalysisMember us-gaap:FairValueInputsLevel3Member srt:MinimumMember 2023-03-31 0001588272 cik0001588272:MeasurementInputRecoveryRateMember us-gaap:CommonStockMember cik0001588272:ValuationTechniqueLiquidationAnalysisMember us-gaap:FairValueInputsLevel3Member srt:MaximumMember 2023-03-31 0001588272 cik0001588272:MeasurementInputNavMultipleMember us-gaap:CommonStockMember cik0001588272:ValuationTechniqueNetAssetValueMember us-gaap:FairValueInputsLevel3Member 2023-03-31 0001588272 us-gaap:MeasurementInputDiscountRateMember cik0001588272:SeniorSecuredLoansMember us-gaap:ValuationTechniqueDiscountedCashFlowMember us-gaap:FairValueInputsLevel3Member srt:MinimumMember 2023-03-31 0001588272 us-gaap:MeasurementInputDiscountRateMember cik0001588272:SeniorSecuredLoansMember us-gaap:ValuationTechniqueDiscountedCashFlowMember us-gaap:FairValueInputsLevel3Member srt:MaximumMember 2023-03-31 0001588272 us-gaap:MeasurementInputDiscountRateMember cik0001588272:SeniorSecuredLoansMember us-gaap:ValuationTechniqueDiscountedCashFlowMember us-gaap:FairValueInputsLevel3Member srt:WeightedAverageMember 2023-03-31 0001588272 cik0001588272:LlcInterestsMember cik0001588272:ValuationTechniqueMultipleAnalysisMember srt:WeightedAverageMember us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputEbitdaMultipleMember 2023-03-31 0001588272 cik0001588272:AffiliatedInvestmentsMember 2023-01-01 2023-03-31 0001588272 cik0001588272:NonControlledOrNonAffiliatedInvestmentsMember 2023-01-01 2023-03-31 0001588272 cik0001588272:NextPointAdvisorsL.pMember 2023-01-01 2023-03-31 0001588272 cik0001588272:NexpointResidentialTrustInc.Member 2023-01-01 2023-03-31 0001588272 cik0001588272:NexpointCapitalReitLlcSeniorLoansCommonStocksMember 2023-01-01 2023-03-31 0001588272 cik0001588272:NexpointRealEstateFinanceInc.Member 2023-01-01 2023-03-31 0001588272 cik0001588272:SfrWlifIiiLlcMember 2023-01-01 2023-03-31 0001588272 cik0001588272:CoronavirusAidReliefAndEconomicSecurityActMember 2023-01-01 2023-03-31 0001588272 cik0001588272:CoronavirusAidReliefAndEconomicSecurityActMember cik0001588272:U.s.FederalReserveMember 2023-01-01 2023-03-31 0001588272 cik0001588272:FirstQuarterTenderOfferMember 2023-01-01 2023-03-31 0001588272 us-gaap:RetainedEarningsMember 2023-01-01 2023-03-31 0001588272 us-gaap:CommonStockMember 2023-01-01 2023-03-31 0001588272 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-03-31 0001588272 cik0001588272:AdviserMember 2023-01-01 2023-03-31 0001588272 cik0001588272:ExpenseLimitationAgreementMember 2023-01-01 2023-03-31 0001588272 cik0001588272:AurisLuxembourgIiiS.a.r.l.Member cik0001588272:FirstLienTermLoanMember cik0001588272:HealthcareAtSixteenPointFivePercentageMember cik0001588272:SeniorSecuredLoansAtNineteenPointSixPercentMember 2023-01-01 2023-03-31 0001588272 cik0001588272:CarestreamHealthIncMember cik0001588272:FirstLienTermLoanMember cik0001588272:HealthcareAtSixteenPointFivePercentageMember cik0001588272:SeniorSecuredLoansAtNineteenPointSixPercentMember 2023-01-01 2023-03-31 0001588272 cik0001588272:CcsMedicalIncMember cik0001588272:FirstLienTermLoanMember cik0001588272:HealthcareAtSixteenPointFivePercentageMember cik0001588272:SeniorSecuredLoansAtNineteenPointSixPercentMember 2023-01-01 2023-03-31 0001588272 cik0001588272:CntHoldingsICorpMember cik0001588272:SecondLienTermLoanMember cik0001588272:HealthcareAtSixteenPointFivePercentageMember cik0001588272:SeniorSecuredLoansAtNineteenPointSixPercentMember 2023-01-01 2023-03-31 0001588272 cik0001588272:CovenantSurgicalPartnersInc.Member cik0001588272:FirstLienDelayedDrawTermLoanMember cik0001588272:HealthcareAtSixteenPointFivePercentageMember cik0001588272:SeniorSecuredLoansAtNineteenPointSixPercentMember 2023-01-01 2023-03-31 0001588272 cik0001588272:CovenantSurgicalPartnersInc.Member cik0001588272:FirstLienTermLoanMember cik0001588272:HealthcareAtSixteenPointFivePercentageMember cik0001588272:SeniorSecuredLoansAtNineteenPointSixPercentMember 2023-01-01 2023-03-31 0001588272 cik0001588272:EnvisionHealthcareCorp.Member cik0001588272:FirstLienTermLoanMember cik0001588272:HealthcareAtSixteenPointFivePercentageMember cik0001588272:SeniorSecuredLoansAtNineteenPointSixPercentMember 2023-01-01 2023-03-31 0001588272 cik0001588272:SoundInpatientPhysiciansMember cik0001588272:SecondLienTermLoanMember cik0001588272:HealthcareAtSixteenPointFivePercentageMember cik0001588272:SeniorSecuredLoansAtNineteenPointSixPercentMember 2023-01-01 2023-03-31 0001588272 cik0001588272:WellpathHoldingsInc.Member cik0001588272:FirstLienTermLoanMember cik0001588272:HealthcareAtSixteenPointFivePercentageMember cik0001588272:SeniorSecuredLoansAtNineteenPointSixPercentMember 2023-01-01 2023-03-31 0001588272 cik0001588272:NexpointCapitalReitLlcSeniorLoansCommonStocksMember cik0001588272:FirstLienTermLoanMember cik0001588272:RealEstateAtZeroPointNinePercentageMember cik0001588272:SeniorSecuredLoansAtNineteenPointSixPercentMember 2023-01-01 2023-03-31 0001588272 cik0001588272:TerrestarCorp.Member cik0001588272:FirstLienTermLoanEMember cik0001588272:TeleCommunicationServicesAtTwoPointTwoPercentageMember cik0001588272:SeniorSecuredLoansAtNineteenPointSixPercentMember 2023-01-01 2023-03-31 0001588272 cik0001588272:TerrestarCorp.Member cik0001588272:FirstLienTermLoanGMember cik0001588272:TeleCommunicationServicesAtTwoPointTwoPercentageMember cik0001588272:SeniorSecuredLoansAtNineteenPointSixPercentMember 2023-01-01 2023-03-31 0001588272 cik0001588272:TerrestarCorp.Member cik0001588272:FirstLienTermLoanHMember cik0001588272:TeleCommunicationServicesAtTwoPointTwoPercentageMember cik0001588272:SeniorSecuredLoansAtNineteenPointSixPercentMember 2023-01-01 2023-03-31 0001588272 cik0001588272:TerrestarCorp.Member cik0001588272:FirstLienTermLoanFMember cik0001588272:TeleCommunicationServicesAtTwoPointTwoPercentageMember cik0001588272:SeniorSecuredLoansAtNineteenPointSixPercentMember 2023-01-01 2023-03-31 0001588272 cik0001588272:GraysonInvestorCorp.Member cik0001588272:AssetBackedSecuritiesAtZeroPointZeroPercentMember cik0001588272:FinancialsAtZeroPointZeroPercentMember 2023-01-01 2023-03-31 0001588272 cik0001588272:PamcoClo19971abMember cik0001588272:AssetBackedSecuritiesAtZeroPointZeroPercentMember cik0001588272:FinancialsAtZeroPointZeroPercentMember 2023-01-01 2023-03-31 0001588272 cik0001588272:HadrianMergerSubInc.Member cik0001588272:CorporateBondsAtFourPointNinePercentMember cik0001588272:HealthcareAtFourPointFourPercentMember 2023-01-01 2023-03-31 0001588272 cik0001588272:IheartcommunicationsInc.Member cik0001588272:CorporateBondsAtFourPointNinePercentMember cik0001588272:MediaAndTelecommunicationsAtZeroPointFivePercentMember cik0001588272:InterestRateAtSixPointThreeEightPercentageMember 2023-01-01 2023-03-31 0001588272 cik0001588272:IheartcommunicationsInc.Member cik0001588272:CorporateBondsAtFourPointNinePercentMember cik0001588272:MediaAndTelecommunicationsAtZeroPointFivePercentMember cik0001588272:InterestRateAtEightPointThreeEightPercentageMember 2023-01-01 2023-03-31 0001588272 cik0001588272:FirstLienTermLoanMember cik0001588272:HealthcareAtSixteenPointFivePercentageMember cik0001588272:SeniorSecuredLoansAtNineteenPointSixPercentMember 2023-01-01 2023-03-31 0001588272 cik0001588272:ChemicalsAtZeroPointOnePercentageMember cik0001588272:MpmHoldingsIncMember cik0001588272:CommonStocksAtTwentySevenPointTwoPercentMember 2023-01-01 2023-03-31 0001588272 cik0001588272:QuarternorthEnergyInc.Member cik0001588272:CommonStocksAtTwentySevenPointTwoPercentMember cik0001588272:EnergyAtThreePointTwoPercentageMember 2023-01-01 2023-03-31 0001588272 cik0001588272:AmericanBanknoteCorpMember cik0001588272:FinancialsAtThreePointFourPercentageMember cik0001588272:CommonStocksAtTwentySevenPointTwoPercentMember 2023-01-01 2023-03-31 0001588272 cik0001588272:NexpointRealEstateFinanceInc.Member cik0001588272:RealEstateAtEightPointSevenPercentageMember cik0001588272:CommonStocksAtTwentySevenPointTwoPercentMember 2023-01-01 2023-03-31 0001588272 cik0001588272:IqhqIncMember cik0001588272:RealEstateAtEightPointSevenPercentageMember cik0001588272:CommonStocksAtTwentySevenPointTwoPercentMember 2023-01-01 2023-03-31 0001588272 cik0001588272:NexpointResidentialTrustInc.Member cik0001588272:CommonStocksAtTwentySevenPointTwoPercentMember cik0001588272:RealEstateInvestmentTrustAtTwoPointZeroPercentageMember 2023-01-01 2023-03-31 0001588272 cik0001588272:WayneServicesLegacyInc.Member cik0001588272:CommonStocksAtTwentySevenPointTwoPercentMember cik0001588272:ServiceAtZeroPointZeroPercentageMember 2023-01-01 2023-03-31 0001588272 cik0001588272:TerrestarCorp..Member cik0001588272:CommonStocksAtTwentySevenPointTwoPercentMember cik0001588272:TelecommunicationServicesAtNinePointEightPercentageMember 2023-01-01 2023-03-31 0001588272 cik0001588272:UsGamingLlcMember cik0001588272:ConsumerProductsAtFivePointSixPercentageMember cik0001588272:LLCInterestsAtNineteenPointNinePercentMember 2023-01-01 2023-03-31 0001588272 cik0001588272:SfrWlifIiiLlcMember cik0001588272:RealEstateAtFourteenPointThreePercentageMember cik0001588272:LLCInterestsAtNineteenPointNinePercentMember 2023-01-01 2023-03-31 0001588272 cik0001588272:NexpointCapitalReitLlcSeniorLoansCommonStocksMember cik0001588272:RealEstateAtFourteenPointThreePercentageMember cik0001588272:LLCInterestsAtNineteenPointNinePercentMember 2023-01-01 2023-03-31 0001588272 cik0001588272:FinancialsAtTwoPointSevenPercentageMember cik0001588272:PreferredStocksAtTwentyThreePointFourPercentMember cik0001588272:SevenHundredSeventySevenPartnersLlcMember 2023-01-01 2023-03-31 0001588272 cik0001588272:FinancialsAtTwoPointSevenPercentageMember cik0001588272:PreferredStocksAtTwentyThreePointFourPercentMember cik0001588272:UnitedFidelityBankFsbMember 2023-01-01 2023-03-31 0001588272 cik0001588272:HealthcareAtTwentyPointSevenPercentageMember cik0001588272:PreferredStocksAtTwentyThreePointFourPercentMember cik0001588272:ApnimedInc.Member 2023-01-01 2023-03-31 0001588272 cik0001588272:HealthcareAtTwentyPointSevenPercentageMember cik0001588272:PreferredStocksAtTwentyThreePointFourPercentMember cik0001588272:ApnimedInc.Member cik0001588272:SeriesC2Member 2023-01-01 2023-03-31 0001588272 cik0001588272:HealthcareAtTwentyPointSevenPercentageMember cik0001588272:PreferredStocksAtTwentyThreePointFourPercentMember cik0001588272:SapienceTherapeuticsInc.Member us-gaap:SeriesBPreferredStockMember 2023-01-01 2023-03-31 0001588272 cik0001588272:HealthcareAtTwentyPointSevenPercentageMember cik0001588272:PreferredStocksAtTwentyThreePointFourPercentMember cik0001588272:SapienceTherapeuticsInc.Member cik0001588272:Seriesb1preferredSharesMember 2023-01-01 2023-03-31 0001588272 cik0001588272:EnergyAtZeroPointThreePercentageMember cik0001588272:WarrantsAtZeroPointThreePercentMember cik0001588272:QuarternorthTranche1Member 2023-01-01 2023-03-31 0001588272 cik0001588272:EnergyAtZeroPointThreePercentageMember cik0001588272:WarrantsAtZeroPointThreePercentMember cik0001588272:QuarternorthTranche2Member 2023-01-01 2023-03-31 0001588272 cik0001588272:MediaAndTelecommunicationsAtZeroPointZeroPercentageMember cik0001588272:WarrantsAtZeroPointThreePercentMember cik0001588272:IheartmediaInc.Member 2023-01-01 2023-03-31 0001588272 cik0001588272:FinancialsAtTwoPointSevenPercentageMember cik0001588272:PreferredStocksAtTwentyTwoPointThreePercentMember cik0001588272:SevenHundredSeventySevenPartnersLlcMember 2023-01-01 2023-03-31 0001588272 cik0001588272:FinancialsAtTwoPointSevenPercentageMember cik0001588272:PreferredStocksAtTwentyTwoPointThreePercentMember cik0001588272:UnitedFidelityBankFsbMember 2023-01-01 2023-03-31 0001588272 cik0001588272:HealthcareAtNinteenPointSixPercentageMember cik0001588272:PreferredStocksAtTwentyTwoPointThreePercentMember cik0001588272:ApnimedInc.Member 2023-01-01 2023-03-31 0001588272 cik0001588272:SeriesC2Member cik0001588272:HealthcareAtNinteenPointSixPercentageMember cik0001588272:PreferredStocksAtTwentyTwoPointThreePercentMember cik0001588272:ApnimedInc.Member 2023-01-01 2023-03-31 0001588272 us-gaap:SeriesBPreferredStockMember cik0001588272:HealthcareAtNinteenPointSixPercentageMember cik0001588272:PreferredStocksAtTwentyTwoPointThreePercentMember cik0001588272:SapienceTherapeuticsInc.Member 2023-01-01 2023-03-31 0001588272 cik0001588272:TotalInvestmentNinetyFivePointThreeMember 2023-01-01 2023-03-31 0001588272 us-gaap:AssetBackedSecuritiesMember cik0001588272:AssetBackedSecuritiesOneMember cik0001588272:GraysonInvestorCorpMember us-gaap:FairValueInputsLevel3Member 2023-01-01 2023-03-31 0001588272 us-gaap:AssetBackedSecuritiesMember cik0001588272:AssetBackedSecuritiesOneMember cik0001588272:PamcoCloNineteenNinetySevenOneABMember us-gaap:FairValueInputsLevel3Member 2023-01-01 2023-03-31 0001588272 us-gaap:CommonStockMember cik0001588272:CommonStockOneMember cik0001588272:AmericanBanknoteCorpMember us-gaap:FairValueInputsLevel3Member 2023-01-01 2023-03-31 0001588272 us-gaap:CommonStockMember cik0001588272:CommonStockOneMember cik0001588272:IqhqMember us-gaap:FairValueInputsLevel3Member 2023-01-01 2023-03-31 0001588272 us-gaap:CommonStockMember cik0001588272:CommonStockOneMember cik0001588272:TereeStarCorpMember us-gaap:FairValueInputsLevel3Member 2023-01-01 2023-03-31 0001588272 us-gaap:CommonStockMember cik0001588272:CommonStockOneMember cik0001588272:WayneServicesLegacyIncMember us-gaap:FairValueInputsLevel3Member 2023-01-01 2023-03-31 0001588272 cik0001588272:LlcInterestsMember cik0001588272:LlcInterestsOneMember cik0001588272:NexpointCapitalReitLlcSeniorLoansCommonStocksMember us-gaap:FairValueInputsLevel3Member 2023-01-01 2023-03-31 0001588272 cik0001588272:LlcInterestsMember cik0001588272:LlcInterestsOneMember cik0001588272:SfrWlifThreeLlcMember us-gaap:FairValueInputsLevel3Member 2023-01-01 2023-03-31 0001588272 cik0001588272:LlcInterestsMember cik0001588272:LlcInterestsOneMember cik0001588272:UsGamingLlcMember us-gaap:FairValueInputsLevel3Member 2023-01-01 2023-03-31 0001588272 us-gaap:PreferredStockMember cik0001588272:PreferredStockOneMember cik0001588272:AprimedIncMember us-gaap:FairValueInputsLevel3Member 2023-01-01 2023-03-31 0001588272 us-gaap:FairValueInputsLevel3Member cik0001588272:AprimedIncMember cik0001588272:SeriesCTwoPreferredStockMember us-gaap:PreferredStockMember 2023-01-01 2023-03-31 0001588272 us-gaap:PreferredStockMember us-gaap:SeriesBPreferredStockMember cik0001588272:SapienceTherapauticsIncMember us-gaap:FairValueInputsLevel3Member 2023-01-01 2023-03-31 0001588272 us-gaap:PreferredStockMember cik0001588272:SeriesBOnePreferredStockMember cik0001588272:SapienceTherapauticsIncMember us-gaap:FairValueInputsLevel3Member 2023-01-01 2023-03-31 0001588272 cik0001588272:SeniorSecuredLoansMember cik0001588272:SeniorSecuredLoansOneMember cik0001588272:CcsMedicalIncMember us-gaap:FairValueInputsLevel3Member 2023-01-01 2023-03-31 0001588272 cik0001588272:SeniorSecuredLoansMember cik0001588272:SeniorSecuredLoansOneMember cik0001588272:TerreStarCorpMember us-gaap:FairValueInputsLevel3Member 2023-01-01 2023-03-31 0001588272 cik0001588272:SeniorSecuredLoansMember cik0001588272:SeniorSecuredLoansTwoMember cik0001588272:TerreStarCorpMember us-gaap:FairValueInputsLevel3Member 2023-01-01 2023-03-31 0001588272 cik0001588272:SeniorSecuredLoansMember cik0001588272:SeniorSecuredLoansThreeMember cik0001588272:TerreStarCorpMember us-gaap:FairValueInputsLevel3Member 2023-01-01 2023-03-31 0001588272 cik0001588272:SeniorSecuredLoansMember cik0001588272:SeniorSecuredLoansFourMember cik0001588272:TerreStarCorpMember us-gaap:FairValueInputsLevel3Member 2023-01-01 2023-03-31 0001588272 cik0001588272:SeniorSecuredLoansMember cik0001588272:SeniorSecuredLoansOneMember cik0001588272:NexpointCapitalReitLlc.Member us-gaap:FairValueInputsLevel3Member 2023-01-01 2023-03-31 0001588272 cik0001588272:InvestmentsByIndustryMember 2023-01-01 2023-03-31 0001588272 cik0001588272:TypeOfInvestmentDebtOrEquityMember 2023-01-01 2023-03-31 0001588272 cik0001588272:InvestmentsByGeographyMember 2023-01-01 2023-03-31 0001588272 us-gaap:InvestmentsMember cik0001588272:SeniorSecuredLoansMember cik0001588272:TelcommunicationServicesMember 2023-01-01 2023-03-31 0001588272 us-gaap:InvestmentsMember cik0001588272:SeniorSecuredLoansMember us-gaap:HealthCareMember 2023-01-01 2023-03-31 0001588272 us-gaap:InvestmentsMember cik0001588272:AssetBackedSecuritiesOneMember cik0001588272:FinancialsMember 2023-01-01 2023-03-31 0001588272 us-gaap:InvestmentsMember us-gaap:CommonStockMember cik0001588272:FinancialsMember 2023-01-01 2023-03-31 0001588272 us-gaap:RealEstateMember us-gaap:InvestmentsMember us-gaap:CommonStockMember 2023-01-01 2023-03-31 0001588272 us-gaap:InvestmentsMember us-gaap:CommonStockMember us-gaap:ServiceMember 2023-01-01 2023-03-31 0001588272 us-gaap:InvestmentsMember us-gaap:CommonStockMember cik0001588272:TelecommunicationServicesMember 2023-01-01 2023-03-31 0001588272 us-gaap:InvestmentsMember cik0001588272:LlcInterestsMember cik0001588272:ConsumerProductsMember 2023-01-01 2023-03-31 0001588272 us-gaap:RealEstateMember us-gaap:InvestmentsMember cik0001588272:LlcInterestsMember 2023-01-01 2023-03-31 0001588272 us-gaap:InvestmentsMember us-gaap:PreferredStockMember us-gaap:HealthCareMember 2023-01-01 2023-03-31 0001588272 us-gaap:InvestmentsMember 2023-01-01 2023-03-31 0001588272 us-gaap:RealEstateMember cik0001588272:SeniorSecuredLoansMember us-gaap:InvestmentsMember 2023-01-01 2023-03-31 0001588272 us-gaap:MeasurementInputDiscountRateMember cik0001588272:LlcInterestsMember us-gaap:ValuationTechniqueDiscountedCashFlowMember us-gaap:FairValueInputsLevel3Member 2023-01-01 2023-03-31 0001588272 us-gaap:MeasurementInputEbitdaMultipleMember cik0001588272:LlcInterestsMember cik0001588272:ValuationTechniqueMultipleAnalysisMember us-gaap:FairValueInputsLevel3Member 2023-01-01 2023-03-31 0001588272 us-gaap:MeasurementInputOptionVolatilityMember us-gaap:PreferredStockMember us-gaap:ValuationTechniqueOptionPricingModelMember us-gaap:FairValueInputsLevel3Member 2023-01-01 2023-03-31 0001588272 us-gaap:MeasurementInputDiscountRateMember us-gaap:CommonStockMember us-gaap:ValuationTechniqueDiscountedCashFlowMember us-gaap:FairValueInputsLevel3Member 2023-01-01 2023-03-31 0001588272 us-gaap:MeasurementInputEbitdaMultipleMember us-gaap:CommonStockMember cik0001588272:ValuationTechniqueMultipleAnalysisMember us-gaap:FairValueInputsLevel3Member 2023-01-01 2023-03-31 0001588272 cik0001588272:MeasurementInputEnterpriseValueMember us-gaap:CommonStockMember cik0001588272:ValuationTechniqueTransactionIndicationOfValueMember us-gaap:FairValueInputsLevel3Member 2023-01-01 2023-03-31 0001588272 cik0001588272:MeasurementInputRecoveryRateMember us-gaap:CommonStockMember cik0001588272:ValuationTechniqueLiquidationAnalysisMember us-gaap:FairValueInputsLevel3Member 2023-01-01 2023-03-31 0001588272 cik0001588272:MeasurementInputNavMultipleMember us-gaap:CommonStockMember cik0001588272:ValuationTechniqueNetAssetValueMember us-gaap:FairValueInputsLevel3Member 2023-01-01 2023-03-31 0001588272 us-gaap:MeasurementInputDiscountRateMember cik0001588272:SeniorSecuredLoansMember us-gaap:ValuationTechniqueDiscountedCashFlowMember us-gaap:FairValueInputsLevel3Member 2023-01-01 2023-03-31 0001588272 us-gaap:MeasurementInputDiscountRateMember us-gaap:AssetBackedSecuritiesMember us-gaap:ValuationTechniqueDiscountedCashFlowMember us-gaap:FairValueInputsLevel3Member 2023-01-01 2023-03-31 0001588272 cik0001588272:MeasurementInputUnadjustedPriceMember us-gaap:CommonStockMember us-gaap:FairValueInputsLevel3Member 2023-01-01 2023-03-31 0001588272 cik0001588272:PromissoryNoteMember us-gaap:PreferredStockMember 2023-01-01 2023-03-31 0001588272 cik0001588272:DecemberThirtyFirstTwoThousandAndTwentyFourMember 2021-12-31 0001588272 cik0001588272:MarchThirtyFirstTwoThousandAndTwentyFiveMember 2022-03-31 2022-03-31 0001588272 cik0001588272:JuneThirtyTwoThousandAndTwentyFiveMember 2022-06-30 2022-06-30 0001588272 cik0001588272:JuneThirtyTwoThousandAndTwentyFiveMember 2022-06-30 0001588272 cik0001588272:SeptemberThirtyTwoThousandAndTwentyFiveMember 2022-09-30 2022-09-30 0001588272 cik0001588272:SeptemberThirtyTwoThousandAndTwentyFiveMember 2022-09-30 0001588272 cik0001588272:MarchThirtyFirstTwoThousandAndTwentyFourMember 2021-03-31 2021-03-31 0001588272 cik0001588272:MarchThirtyFirstTwoThousandAndTwentyFourMember 2021-03-31 0001588272 cik0001588272:JuneThirtyTwoThousandAndTwentyFourMember 2021-06-30 2021-06-30 0001588272 cik0001588272:JuneThirtyTwoThousandAndTwentyFourMember 2021-06-30 0001588272 cik0001588272:SeptemberThirtyTwoThousandAndTwentyFourMember 2021-09-30 2021-09-30 0001588272 cik0001588272:SeptemberThirtyTwoThousandAndTwentyFourMember 2021-09-30 0001588272 cik0001588272:DecemberThirtyFirstTwoThousandAndTwentyFourMember 2021-12-31 2021-12-31 0001588272 cik0001588272:ExpirationMember 2020-03-31 2020-03-31 0001588272 cik0001588272:ExpirationMember 2020-03-31 0001588272 cik0001588272:JuneThirtyTwoThousandAndTwentyThreeMember 2020-06-30 2020-06-30 0001588272 cik0001588272:JuneThirtyTwoThousandAndTwentyThreeMember 2020-06-30 0001588272 cik0001588272:SeptemberThirtyTwoThousandAndTwentyThreeMember 2020-09-30 2020-09-30 0001588272 cik0001588272:SeptemberThirtyTwoThousandAndTwentyThreeMember 2020-09-30 0001588272 cik0001588272:DecemberThirtyFirstTwoThousandAndTwentyThreeMember 2020-12-31 2020-12-31 0001588272 cik0001588272:DecemberThirtyFirstTwoThousandAndTwentyThreeMember 2020-12-31 0001588272 cik0001588272:StimulusReliefMember 2020-12-31 0001588272 cik0001588272:AmericanRescuePlanActMember cik0001588272:U.s.FederalReserveMember cik0001588272:CoronavirusAidReliefAndEconomicSecurityActMember 2021-03-01 2021-03-31 0001588272 cik0001588272:MarchThirtyOneTwoThousandTwentySixMember 2023-03-31 2023-03-31 0001588272 cik0001588272:DecemberThirtyFirstTwoThousandAndTwentyFiveMember 2022-12-31 2022-12-31 0001588272 us-gaap:CommonStockMember 2021-12-31 0001588272 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001588272 us-gaap:RetainedEarningsMember 2021-12-31 0001588272 us-gaap:InvestmentsMember cik0001588272:SeniorSecuredLoansMember cik0001588272:TelcommunicationServicesMember 2021-12-31 0001588272 us-gaap:InvestmentsMember cik0001588272:SeniorSecuredLoansMember us-gaap:HealthCareMember 2021-12-31 0001588272 us-gaap:InvestmentsMember cik0001588272:AssetBackedSecuritiesOneMember cik0001588272:FinancialsMember 2021-12-31 0001588272 us-gaap:InvestmentsMember 2021-12-31 0001588272 us-gaap:InvestmentsMember us-gaap:PreferredStockMember us-gaap:HealthCareMember 2021-12-31 0001588272 us-gaap:RealEstateMember us-gaap:InvestmentsMember cik0001588272:LlcInterestsMember 2021-12-31 0001588272 us-gaap:InvestmentsMember cik0001588272:LlcInterestsMember cik0001588272:ConsumerProductsMember 2021-12-31 0001588272 us-gaap:InvestmentsMember us-gaap:CommonStockMember cik0001588272:TelecommunicationServicesMember 2021-12-31 0001588272 us-gaap:InvestmentsMember us-gaap:CommonStockMember us-gaap:ServiceMember 2021-12-31 0001588272 us-gaap:RealEstateMember us-gaap:InvestmentsMember us-gaap:CommonStockMember 2021-12-31 0001588272 us-gaap:InvestmentsMember us-gaap:CommonStockMember cik0001588272:FinancialsMember 2021-12-31 0001588272 us-gaap:InvestmentsMember us-gaap:PreferredStockMember us-gaap:HealthCareMember 2022-03-31 0001588272 us-gaap:RealEstateMember us-gaap:InvestmentsMember cik0001588272:LlcInterestsMember 2022-03-31 0001588272 us-gaap:InvestmentsMember us-gaap:CommonStockMember cik0001588272:TelecommunicationServicesMember 2022-03-31 0001588272 us-gaap:InvestmentsMember cik0001588272:LlcInterestsMember cik0001588272:ConsumerProductsMember 2022-03-31 0001588272 us-gaap:InvestmentsMember 2022-03-31 0001588272 us-gaap:InvestmentsMember cik0001588272:SeniorSecuredLoansMember cik0001588272:TelcommunicationServicesMember 2022-03-31 0001588272 us-gaap:InvestmentsMember cik0001588272:SeniorSecuredLoansMember us-gaap:HealthCareMember 2022-03-31 0001588272 us-gaap:InvestmentsMember cik0001588272:AssetBackedSecuritiesOneMember cik0001588272:FinancialsMember 2022-03-31 0001588272 us-gaap:InvestmentsMember us-gaap:CommonStockMember cik0001588272:FinancialsMember 2022-03-31 0001588272 us-gaap:RealEstateMember us-gaap:InvestmentsMember us-gaap:CommonStockMember 2022-03-31 0001588272 us-gaap:InvestmentsMember us-gaap:CommonStockMember us-gaap:ServiceMember 2022-03-31 0001588272 us-gaap:CommonStockMember 2022-03-31 0001588272 us-gaap:AdditionalPaidInCapitalMember 2022-03-31 0001588272 us-gaap:RetainedEarningsMember 2022-03-31 0001588272 cik0001588272:NexpointResidentialTrustInc.Member 2022-12-31 0001588272 cik0001588272:NexpointCapitalReitLlcSeniorLoansCommonStocksMember 2022-12-31 0001588272 cik0001588272:NexpointRealEstateFinanceInc.Member 2022-12-31 0001588272 cik0001588272:SfrWlifIiiLlcMember 2022-12-31 0001588272 cik0001588272:NexpointResidentialTrustInc.Member 2023-03-31 0001588272 cik0001588272:NexpointCapitalReitLlcSeniorLoansCommonStocksMember 2023-03-31 0001588272 cik0001588272:NexpointRealEstateFinanceInc.Member 2023-03-31 0001588272 cik0001588272:SfrWlifIiiLlcMember 2023-03-31 0001588272 us-gaap:CommonStockMember 2022-12-31 0001588272 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001588272 us-gaap:RetainedEarningsMember 2022-12-31 0001588272 us-gaap:InvestmentsMember cik0001588272:SeniorSecuredLoansMember cik0001588272:TelcommunicationServicesMember 2022-12-31 0001588272 us-gaap:InvestmentsMember cik0001588272:SeniorSecuredLoansMember us-gaap:HealthCareMember 2022-12-31 0001588272 us-gaap:InvestmentsMember cik0001588272:AssetBackedSecuritiesOneMember cik0001588272:FinancialsMember 2022-12-31 0001588272 us-gaap:InvestmentsMember us-gaap:CommonStockMember cik0001588272:FinancialsMember 2022-12-31 0001588272 us-gaap:RealEstateMember us-gaap:InvestmentsMember us-gaap:CommonStockMember 2022-12-31 0001588272 us-gaap:InvestmentsMember us-gaap:CommonStockMember us-gaap:ServiceMember 2022-12-31 0001588272 us-gaap:InvestmentsMember us-gaap:CommonStockMember cik0001588272:TelecommunicationServicesMember 2022-12-31 0001588272 us-gaap:InvestmentsMember cik0001588272:LlcInterestsMember cik0001588272:ConsumerProductsMember 2022-12-31 0001588272 us-gaap:RealEstateMember us-gaap:InvestmentsMember cik0001588272:LlcInterestsMember 2022-12-31 0001588272 us-gaap:InvestmentsMember us-gaap:PreferredStockMember us-gaap:HealthCareMember 2022-12-31 0001588272 us-gaap:InvestmentsMember 2022-12-31 0001588272 us-gaap:RealEstateMember cik0001588272:SeniorSecuredLoansMember us-gaap:InvestmentsMember 2022-12-31 0001588272 us-gaap:RealEstateMember cik0001588272:SeniorSecuredLoansMember us-gaap:InvestmentsMember 2023-03-31 0001588272 us-gaap:InvestmentsMember 2023-03-31 0001588272 us-gaap:InvestmentsMember us-gaap:PreferredStockMember us-gaap:HealthCareMember 2023-03-31 0001588272 us-gaap:InvestmentsMember cik0001588272:SeniorSecuredLoansMember us-gaap:HealthCareMember 2023-03-31 0001588272 us-gaap:InvestmentsMember cik0001588272:AssetBackedSecuritiesOneMember cik0001588272:FinancialsMember 2023-03-31 0001588272 us-gaap:InvestmentsMember us-gaap:CommonStockMember cik0001588272:FinancialsMember 2023-03-31 0001588272 us-gaap:RealEstateMember us-gaap:InvestmentsMember us-gaap:CommonStockMember 2023-03-31 0001588272 us-gaap:InvestmentsMember us-gaap:CommonStockMember us-gaap:ServiceMember 2023-03-31 0001588272 us-gaap:InvestmentsMember us-gaap:CommonStockMember cik0001588272:TelecommunicationServicesMember 2023-03-31 0001588272 us-gaap:InvestmentsMember cik0001588272:LlcInterestsMember cik0001588272:ConsumerProductsMember 2023-03-31 0001588272 us-gaap:RealEstateMember us-gaap:InvestmentsMember cik0001588272:LlcInterestsMember 2023-03-31 0001588272 us-gaap:InvestmentsMember cik0001588272:SeniorSecuredLoansMember cik0001588272:TelcommunicationServicesMember 2023-03-31 0001588272 us-gaap:CommonStockMember 2023-03-31 0001588272 us-gaap:AdditionalPaidInCapitalMember 2023-03-31 0001588272 us-gaap:RetainedEarningsMember 2023-03-31 iso4217:USD xbrli:shares xbrli:pure utr:Day iso4217:USD xbrli:shares
 
 
UNITED STATES
SECURITIES AND EXCHANGE CO
MMISSION
Washington, D.C. 20549
 
 
Form
10-Q
 
 
(Mark One)
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
FOR THE QUARTERLY PERIOD ENDED March 31, 2023
OR
 
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
FOR THE TRANSITION PERIOD FROM
                
TO
                
COMMISSION FILE NUMBER: 814-01074
 
 
NexPoint Capital, Inc.
(Exact name of registrant as specified in its charter)
 
 
 
Delaware
 
38-3926499
(State or other jurisdiction of
incorporation or organization)
 
(I.R.S. Employer
Identification No.)
 
300 Crescent Court, Suite 700
   
Dallas, Texas
 
75201
(Address of principal executive offices)
 
(Zip Code)
Registrant’s telephone number, including area code (972)
628-4100
Securities registered pursuant to Section 12(b) of the Act:
None
Securities registered pursuant to Section 12(g) of the Act:
Common Stock, par value $0.001 per share
 
 
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes  ☒    No  ☐
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation
S-T
during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).    Yes  ☐    No  ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a
non-accelerated
filer, a smaller reporting company or an emerging growth company. See definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and emerging growth company” in Rule 12b-2 of the Exchange Act.
 
Large accelerated filer      Accelerated filer  
       
Non-accelerated filer      Smaller reporting company  
     
Emerging growth company        Yes  ☐    No  
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    Yes  ☐    No  
As of March 31, 2023, the Registrant had 9,548,899 shares of common stock, $0.001 par value,
outstanding.
 
 
 

Part I – Financial Information
 
Item 1.
Financial Statements
NexPoint Capital, Inc.
Statements of Assets and Liabilities
 
   
March 31, 2023
(Unaudited)
   
December 31,
2022
 
Assets
               
Unaffiliated investments, at fair value (cost of $38,023,138 and $41,687,079, respectively)
  $ 37,859,825     $ 43,020,714  
Affiliated investments, at fair value (cost of $12,788,205 and $12,324,892, respectively)
(1)
    10,871,704       10,273,001  
Cash and cash equivalents
    1,131,784       1,629,846  
Receivable for investments sold
    3,318,593           
Dividends and interest receivable
    312,746       220,194  
Receivable from Adviser
(2)
    81,858       92,216  
Prepaid expenses
    14,029       15,905  
   
 
 
   
 
 
 
Total assets
    53,590,539       55,251,876  
   
 
 
   
 
 
 
 
Liabilities
 
Payable for fund shares repurchased
    991,699           
Payable to Adviser
(2)
    317,702       314,993  
Accrued expenses and other liabilities
    262,432       371,736  
Distributions payable
    859,401       870,980  
   
 
 
   
 
 
 
Total liabilities
    2,431,234       1,557,709  
   
 
 
   
 
 
 
 
Commitments and contingencies
(3)
 
 
Net assets
 
Preferred stock, $0.001 par value (25,000,000 shares authorized, 0 shares issued and outstanding)
    —         —    
Common stock, $0.001 par value (200,000,000 shares authorized, 9,548,899 and 9,677,593 shares issued and outstanding, respectively)
    9,549       9,678  
Paid-in
capital in excess of par
    86,251,861       86,949,376  
Distributable earnings (accumulated loss)
    (35,102,105     (33,264,887
   
 
 
   
 
 
 
Total net assets
  $ 51,159,305     $ 53,694,167  
   
 
 
   
 
 
 
Net asset value per share of common stock
  $ 5.36     $ 5.55  
   
 
 
   
 
 
 
 
(1)
 
See Note 9 for a discussion of affiliated investments.
(2)
 
See Note 4 for a discussion of related party transactions and arrangements.
(3)
 
See Note 4 and Note 7 for a discussion of the commitments and contingencies of the Company (as defined in Note 1).
 
 
See Notes to Financial Statements
1

NexPoint Capital, Inc.
Statements of Operations
(Unaudited)
 
    
Three Months Ended
March 31,
 
    
2023
   
2022
 
Investment income:
 
Interest
   $ 636,822     $ 562,607  
Interest
paid-in-kind
     29,847       106,711  
Dividend income from unaffiliated investments
     36,707       95,633  
Dividend income from affiliated investments
(1)
     111,456       249,659  
    
 
 
   
 
 
 
Total investment income
     814,832       1,014,610  
    
 
 
   
 
 
 
Expenses:
 
Investment advisory fees
(2)
     265,381       299,270  
Custodian and accounting service fees
     75,988       76,747  
Administration fees
(2)
     52,321       59,601  
Stock transfer fee
     41,136       50,183  
Audit and tax fees
     40,348       39,474  
Other expenses
     25,607       20,230  
Reports to stockholders
     18,232       17,795  
Legal fees
     9,189       18,218  
Directors’ fees
(2)
     4,967       3,731  
    
 
 
   
 
 
 
Total expenses
     533,169       585,249  
Expenses (waived) or recouped by the Adviser
(2)
     (81,858     (61,761
    
 
 
   
 
 
 
Net expenses
     451,311       523,488  
    
 
 
   
 
 
 
Net investment income
     363,521       491,122  
    
 
 
   
 
 
 
Net realized and unrealized gains (losses) on investments:
 
Net realized gain (loss) on:
 
Unaffiliated investments
     20,220       241,708  
Affiliated investments
(1)
              (74,604
Net change in unrealized appreciation (depreciation) on:
 
Unaffiliated investments
     (1,496,947     (1,338,064
Affiliated investments
(1)
     135,389       1,824,855  
    
 
 
   
 
 
 
Net realized and unrealized gains (losses)
     (1,341,338     653,895  
    
 
 
   
 
 
 
Net increase (decrease) in net assets resulting from operations
     (977,817     1,145,017  
    
 
 
   
 
 
 
Per share information - basic and diluted per common share
 
Net investment income:
   $ 0.04     $ 0.05  
Earnings (loss) per share:
   $ (0.10   $ 0.11  
Weighted average shares outstanding:
     9,699,655       9,990,797  
 
(1)
 
See Note 9 for a discussion of affiliated investments.
(2)
 
See Note 4 for a discussion of related party transactions and arrangements.
 
 
See Notes to Financial Statements
2

NexPoint Capital, Inc.
Statements of Changes in Net Assets
(Unaudited)
 
    
Common Stock
                   
    
Shares
   
Par Amount
   
Paid in Capital
in
Excess of Par
   
Distributable
Earnings
   
Total
Net Assets
 
Balance at December 31, 2022
     9,677,593     $ 9,678     $ 86,949,376     $ (33,264,887   $ 53,694,167  
Increase (decrease) in net assets resulting from operations
 
Net investment income
     —         —         —         363,521       363,521  
Net realized gain (loss) on investments
     —         —         —         20,220       20,220  
Net change in unrealized appreciation (depreciation) on investments
     —         —         —         (1,361,558     (1,361,558
Shareholder distributions:
 
Repurchase of common stock
     (181,298     (181     (991,518     —         (991,699
Reinvestment of common stock
     52,604       53       294,002       —         294,055  
Distributions to stockholders from net investment income
     —         —         —         (859,401     (859,401
    
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
Total increase (decrease) for the three months ended March 31, 2023
     (128,694     (128     (697,516     (1,837,218     (2,534,862
    
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
Balance at March 31, 2023
     9,548,899     $ 9,550     $ 86,251,860     $ (35,102,105   $ 51,159,305  
    
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
Distributions to stockholders per share
     —       $ —       $ —       $ 0.09     $ 0.09  
    
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
 
 
See Notes to Financial Statements
3
NexPoint Capital, Inc.
Statements of Changes in Net Assets
(Unaudited)
 
                                         
    
Common Stock
                   
    
Shares
   
Par Amount
   
Paid in Capital
in
Excess of Par
   
Distributable
Earnings

(Accumulated

Loss)
   
Total
Net Assets
 
Balance at December 31, 2021
     9,956,228     $ 9,956     $ 91,135,719     $ (28,206,767   $ 62,938,908  
Increase (decrease) in net assets resulting from operations
 
Net investment income
     —         —         —         491,122       491,122  
Net realized gain (loss) on investments
     —         —         —         167,104       167,104  
Net change in unrealized appreciation (depreciation) on investments
     —         —         —         486,791       486,791  
Shareholder distributions:
 
Issuance of common stock
     —         —         —         —         —    
Repurchase of common stock
     (85,999     (86     (550,034     —         (550,120
Reinvestment of common stock
     48,442       49       306,103       —         306,152  
Distributions to stockholders from net investment income
     —         —         —         (892,680     (892,680
    
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
Total increase (decrease) for the three months ended March 31, 2022
     (37,557     (37     (243,931     252,337       8,369  
    
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
Balance at March 31, 2022
     9,918,671     $ 9,919     $ 90,891,788     $ (27,954,430   $ 62,947,277  
    
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
Distributions to stockholders per share
     —       $ —       $ —       $ 0.09     $ 0.09  
    
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
 
 
See Notes to Financial Statements
4

NexPoint Capital, Inc.
Statements of Cash Flows
(Unaudited)
 
    
Three Months Ended
March 31,
 
    
2023
   
2022
 
Cash flows provided by (used in) operating activities
 
Net increase (decrease) in net assets resulting from operations
   $ (977,817   $ 1,145,017  
     
Adjustments to reconcile net increase (decrease) in net assets resulting from operations to net cash provided by (used in) operating activities:
                
Purchases of investment securities
              (6,918,805
Payment-in-kind
investments
     (29,847     (106,711
Proceeds from sales and principal repayments of investment securities
     3,345,666       5,643,969  
Net realized (gain) loss on Unaffiliated investments
     (20,220     (167,104
Net change in unrealized (appreciation) depreciation on investments
     1,361,558       (486,791
Amortization of premium/discount, net
     (94,971     (87,336
Change in operating assets and liabilities:
                
(Increase) decrease in receivable for investments sold
     (3,318,593     990,537  
(Increase) decrease in dividends and interest receivable
     (92,552     (181,211
(Increase) decrease in receivable from Adviser
     10,358       37,082  
(Increase) decrease in prepaid expenses
     1,876       2,558  
Increase (decrease) in payable for fund shares repurchased
     991,699           
Increase (decrease) in payable for investments purchased
              (301,369
Increase (decrease) in payable to Adviser
     2,709       (19,351
Increase (decrease) in accrued expenses and other liabilities
     (109,304     57,764  
    
 
 
   
 
 
 
Net cash flows provided by (used in) operating activities
  
 
1,070,562
 
 
 
(391,751
    
 
 
   
 
 
 
 
Cash flows provided by (used in) financing activities
 
Repurchase of common stock, net of payable
     (991,699     (550,120
Distributions paid in cash
     (576,925     (589,909
    
 
 
   
 
 
 
Net cash flows (used in) financing activities
     (1,568,624     (1,140,029
    
 
 
   
 
 
 
Net decrease in cash and cash equivalents
  
 
(498,062
 
 
(1,531,780
    
 
 
   
 
 
 
 
Cash and cash equivalents
 
Beginning of the period
     1,629,846       2,811,171  
    
 
 
   
 
 
 
End of the period
   $ 1,131,784     $ 1,279,391  
    
 
 
   
 
 
 
 
Supplemental disclosure and
non-cash
financing activities
 
Paid-in-kind
interest income
   $ 29,847     $ 106,711  
Reinvestment of distributions paid
   $ 294,055     $ 306,152  
Local and excise taxes paid
   $ 41,919     $ 30,187  
 
 
See Notes to Financial Statements
5

NexPoint Capital, Inc.
Schedule of Investments
As of March 31, 2023
(Unaudited)
 
Portfolio Company
(1)(2)
  
Interest
Rate
    
Base Rate
Floor
   
Maturity
Date
    
Principal
Amount
    
Amortized
Cost
(3)
   
Fair Value
 
             
Senior Secured Loans – 19.6%
(4)
                                                   
Healthcare – 16.5%
                                                   
Auris Luxembourg III S.a.r.l
.
(First Lien Term Loan)
(5) (6)
     L + 375        4.93     2/27/2026      $ 1,465,094      $ 1,461,589     $ 1,331,038  
Carestream Health, Inc.
(First Lien Term Loan)
(7)
     SOFR + 750        5.00     9/30/2027        668,605        579,387       398,990  
CCS Medical, Inc
(First Lien Term Loan)
(6) (8) (9)
     L + 1400        1.00     4/7/2026        3,000,000        2,930,985       3,000,000  
CNT Holdings I Corp
(Second Lien Term Loan)
(6)
     L + 675        4.63     11/6/2028                  (783         
Covenant Surgical Partners, Inc.
(First Lien Delayed Draw Term Loan)
     4% Fixed                7/1/2026        333,333        333,783       283,057  
Covenant Surgical Partners, Inc
.
(First Lien Term Loan)
(6)
     L + 400        4.82     7/1/2026        1,609,272        1,611,581       1,366,545  
Envision Healthcare Corp.
(First Lien Term Loan)
(6)
     L + 375        5.16     10/10/2025        4,501,911        3,754,602       348,898  
Sound Inpatient Physician
s
(Second Lien Term Loan)
(6)
     L + 675        4.83     6/26/2026        1,555,556        1,486,286       1,070,222  
Wellpath Holdings, Inc
.
(First Lien Term Loan)
(6)
     L + 550        4.83     10/1/2025        982,051        978,000       667,265  
                                               
 
 
 
                                                  8,466,015  
                                               
 
 
 
             
Real Estate – 0.9%
                                                   
NexPoint Capital REIT, LLC (First Lien Term Loan)
(8) (9) (10)
     PRIME        8.00     3/25/2025        463,314        463,314       463,314  
                                               
 
 
 
             
Telecommunication Services
– 2.2%
                                                   
TerreStar Corp. (First Lien Term
Loan E)
(8) (9)
     11% PIK        11.00     2/28/2024        838,322        838,322       836,016  
TerreStar Corp. (First Lien Term
Loan G)
(8) (9)
     11% PIK        0.00     2/28/2024        35,457        35,457       35,360  
TerreStar Corp. (First Lien Term
Loan H)
(8) (9)
     11% PIK        0.00     2/28/2024        33,082        33,082       32,991  
TerreStar Corp. (First Lien Term
Loan F)
(8) (9)
     11% PIK        0.00     2/28/2024        198,467        198,467       197,921  
                                               
 
 
 
                                               
 
1,102,288
 
             
Total Senior Secured Loans
                                             
 
10,031,617
 
                                               
 
 
 
             
Asset-Backed Securities – 0.0%
                                                   
Financials – 0.0%
                                                   
Grayson Investor Corp.
(5) (8) (9) (11) (12) (13)
                               800        218,666       7,267  
PAMCO CLO
1997-1A
B
(5) (8) (9) (11) (13) (14)
                               295,435        169,875       13  
                                               
 
 
 
                                                  7,280  
                                               
 
 
 
             
Total Asset-Backed Securities
                                             
 
7,280
 
                                               
 
 
 
Corporate Bonds – 4.9%
                                                   
Healthcare – 4.4%
                                                   
Hadrian Merger Sub, Inc.
(11)
                      5/1/2026        2,728,000        2,476,999       2,240,779  
                                               
 
 
 
Media/Telecommunications
– 0.5%
                                                   
iHeartCommunications, Inc.
(5)
                      5/1/2026        116,808        313,455       103,192  
iHeartCommunications, Inc.
(5)
                      5/1/2027        214,073        584,792       156,274  
                                               
 
 
 
                                                  259,466  
                                               
 
 
 
             
Total Corporate Bonds
                                             
 
2,500,245
 
                                               
 
 
 
             
                        
Shares
              
Common Stocks – 27.2%
                                                   
Chemicals – 0.1%
                                                   
MPM Holdings, Inc.
(15)
                               8,500        17,000       42,500  
                                               
 
 
 
Energy – 3.2%
                                                   
Quarternorth Energy, Inc.
                               11,534        981,428       1,629,178  
                                               
 
 
 
Financials – 3.4%
                                                   
American Banknote Corp.
(8) (9) (15)
                               750,000        2,062,500       1,732,500  
                                               
 
 
 
Real Estate – 8.7%
                                                   
Nexpoint Real Estate Finance, Inc.
(10)
                               131,670        2,592,506       2,063,263  
IQHQ, Inc.
(8) (9)
                               100,000        1,500,000       2,359,000  
                                               
 
 
 
                                                  4,422,263  
                                               
 
 
 
 
 
See Notes to Financial Statements.
6
NexPoint Capital, Inc.
Schedule of Investments (continued)
As of March 31, 2023
(Unaudited)
 

























Real Estate Investment Trust (REIT) – 2.0%
  



 



  



  



  



  



NexPoint Residential Trust, Inc.
(5) (10)
                                23,409      $ 698,189      $ 1,022,291  
                                                 
 
 
 
Service – 0.0%
                                                     
Wayne Services Legacy Inc.
(8) (9) (15)
                                237        253,404        2,268  
                                                 
 
 
 
Telecommunication Services – 9.8%
                                                     
TerreStar Corp.
(8) (9) (15)
                                14,035        1,599,990        5,032,249  
                                                 
 
 
 
             
Total Common Stocks
                                               
 
13,883,249
 
                                                 
 
 
 
             
LLC Interests – 19.9%
                                                     
Consumer Products – 5.6%
                                                     
US Gaming, LLC
(8) (9) (15)
                                1,700        1,700,000        2,841,603  
                                                 
 
 
 
Real Estate – 14.3%
                                                     
SFR WLIF III, LLC
(8) (9) (10)
                                451,112        451,111        418,181  
NexPoint Capital REIT, LLC
(8) (9) (10)
                                727        8,583,085        6,904,655  
                                                 
 
 
 
                                                                   7,322,836  
                                                 
 
 
 
             
Total LLC Interests
                                               
 
10,164,439
 
                                                 
 
 
 
    
Preferred
Dividend
Rate
                                    
             
Preferred Stocks – 23.4%
                                                     
Financials – 2.7%
                                                     
777 Partners, LLC
    
10.00
                       750        750,000        720,000  
United Fidelity Bank FSB
    
7.00
                       1,000        1,000,000        680,000  
                                                 
 
 
 
                                                    1,400,000  
                                                 
 
 
 
Healthcare – 20.7%
                                                     
Apnimed, Inc.
(8) (9)
    
8.00
                       135,122        1,199,994        1,499,989  
Apnimed, Inc. (Series
C-2)
(8) (9)
    
8.00
                       72,065        799,993        799,993  
Sapience Therapeutics, Inc. (Series B Preferred Shares)
(8) (9)
    
8.00
                       1,619,048        4,080,000        4,581,906  
Sapience Therapeutics, Inc. (Series
B-1
Preferred Shares)
(8) (9)
    
8.00
                       1,111,111        4,000,000        3,700,000  
                                                 
 
 
 
                                                 
 
10,581,888
 
             
Total Preferred Stocks
                                               
 
11,981,888
 
                                                 
 
 
 
             
Warrants – 0.3%
                                                     
Energy – 0.3%
                                                     
QuarterNorth Tranche 1
(15)
                                5,738        16,122        58,815  
QuarterNorth Tranche 2
(15)
                                11,051        5,175        93,933  
                                                 
 
 
 
                                                    152,748  
                                                 
 
 
 
Media/Telecommunications – 0.0%
                                                     
iHeartMedia, Inc.
(5) (15)
                                2,875        52,987        10,063  
                                                 
 
 
 
             
Total Warrants
                                               
 
162,811
 
                                                 
 
 
 
Total Investments – 95.3%
                                      
$
50,811,343
 
  
$
48,731,529
 
                                        
 
 
    
 
 
 
Cash Equivalents –1.5%
(16)
                                                $ 773,826  
Other Assets & Liabilities, net – 3.2%
                                                $ 1,653,950  
                                                 
 
 
 
Net Assets – 100.0%
                                               
$
51,159,305
 
                                                 
 
 
 
 
(1)
 
Unless otherwise noted, the Company did not “control” and was not an “affiliated person” of any of its portfolio companies, each as defined in the Investment Company Act of 1940, as amended (the “1940 Act”). In general, under the 1940 Act, the Company would be presumed to “control” a portfolio company if it owned 25% or more of its voting securities or had the power to exercise control over the management or policies of such portfolio company, and would be an “affiliated person” of a portfolio company if it owned 5% or more of its voting securities. Additionally, companies under common control (e.g., companies with a common owner of greater than 25% of their respective voting securities) are affiliates under the 1940 Act.
(2)
 
All investments are denominated in United States Dollars.
(3)
 
Amortized cost represents the original cost adjusted for the amortization of premiums and/or accretion of discounts, as applicable, on investments.
(4)
 
Senior secured loans in which the Company invests generally pay interest at rates which are periodically determined by reference to a base lending rate plus a spread (unless otherwise identified, all senior secured loans carry a variable rate of interest). These base lending rates are generally (i) the Prime Rate offered by one or more major United States banks, (ii) the lending rate offered by one or more European banks such as the London Interbank Offered Rate (“LIBOR”) or (iii) the coupon rate. Rate shown represents the actual rate at March 31, 2023. Senior secured loans, while exempt from registration under the Securities Act of 1933 (the “1933 Act”), contain certain restrictions on resale and cannot be sold publicly. Senior secured floating rate loans often require prepayments from excess cash flow or permit the borrower to repay at its election. The degree to which borrowers repay, whether as a contractual requirement or at their election, cannot be predicted with accuracy. As a result, the actual remaining maturity may be substantially less than the stated maturity shown.
 
 
 
See Notes to Financial Statements.
7

NexPoint Capital, Inc.
Schedule of Investments (continued)
As of March 31, 2023
(Unaudited)
 
(5)
 
The investment is not a qualifying asset under Section 55 of the 1940 Act. A business development company (“BDC”), such as the Company, may not acquire any asset other than a qualifying asset, unless at the time the acquisition is made, qualifying assets represent at least 70% of the business development company’s total assets. Non-qualifying assets represented
 4.9% of the Company’s total assets as of March 31, 2023.
(6)
 
The interest rate on these investments is subject to a base rate of
3-Month
LIBOR, which at March 31, 2023 was 5.19%. The LIBOR rate used to calculate interest is the higher of the prevailing 3 month LIBOR rate in effect on the date of the quarterly reset, or the LIBOR base rate floor shown.
(7)
 
The interest rate on these investments is subject to a base rate of
3-Month
SOFR, which at March 31, 2023 was 4.51%
(8)
 
Represents fair value as determined by the Adviser (as defined in Note 1) pursuant to the policies and procedures approved by the Board of Directors (the “Board”). The Board has designated the Adviser as “valuation designee” for the Company pursuant to Rule 2a-5 of the 1940 Act. The Adviser considers fair valued securities to be securities for which market quotations are not readily available and these securities may be valued using a combination of observable and unobservable inputs. Securities with a total aggregate value of $
34,445,226 or 67.3% of net assets were fair valued under the Company’s valuation procedures as of March 31, 2023.
(9)
 
Classified as Level 3 within the three-tier fair value hierarchy. Please see Note 2 for an explanation of this hierarchy, as well as a list of unobservable inputs used in the valuation of these instruments.
(10)
 
Represents an affiliated issuer. Assets with a total aggregate market value of $10,871,704, or 21.3% of net assets, were affiliated with the Company as of March 31, 2023. See Note
9
.
(11)
 
Securities exempt from registration under Rule 144A of the 1933 Act. These securities may only be resold in transactions exempt from

registration to qualified institutional buyers. As of March 31, 2023, these securities amounted to $
2,248,059, or 4.4% of net assets.
(12)
 
The investment is considered to be the equity tranche of the issuer.
(13)
 
Securities of collateralized loan obligations where an affiliate of the Adviser serves as collateral manager.
(14)
 
The issuer is in default of its payment obligation, or is in danger of default.
(15)
 
Non-income
producing security.
(16)
 
State Street U.S. Government Money Market Fund.
Glossary
 
PIK
 
Payment-in-Kind
 
 
 
See Notes to Financial Statements.
8

NexPoint Capital, Inc.
Schedule of Investments
As of December 31, 2022
 
Portfolio Company
(1)(2)
  
Interest
Rate
  
Base Rate
Floor
 
  
Maturity
Date
 
  
Principal
Amount
 
  
Amortized
Cost
(3)
 
  
Fair Value
 
Senior Secured Loans – 26.5%
(4)
  
  
  
  
  
  
Healthcare – 24.5%
  
  
  
  
  
  
Auris Luxembourg III S.a.r.l.
(First Lien Term Loan)
 (5) (6)
  
L + 375
  
 
4.93%
 
  
 
2/27/2026
 
  
$
1,468,909
 
  
$
1,465,131
 
  
$
1,318,346
 
Carestream Health, Inc. (First Lien Term Loan)
 (7)
  
L + 675
  
 
12.18%
 
  
 
9/30/2027
 
  
 
668,605
 
  
 
576,001
 
  
 
511,483
 
CCS Medical, Inc (First Lien Term Loan)
 (7) (8) (9)
  
14% Fixed
  
  
 
4/7/2026
 
  
 
3,000,000
 
  
 
2,926,520
 
  
 
3,000,000
 
CNT Holdings I Corp (Second Lien Term Loan)
 (7)
  
L + 675
  
 
3.74%
 
  
 
11/6/2028
 
  
 
1,500,000
 
  
 
1,494,084
 
  
 
1,422,503
 
Covenant Surgical Partners, Inc. (First Lien Delayed Draw Term Loan)
  
4% Fixed
  
  
 
7/1/2026
 
  
 
333,333
 
  
 
333,817
 
  
 
282,500
 
Covenant Surgical Partners, Inc. (First Lien Term Loan)
 (10)
  
L + 400
  
 
4.41%
 
  
 
7/1/2026
 
  
 
1,613,305
 
  
 
1,615,775
 
  
 
1,367,276
 
Envision Healthcare Corp. (First Lien Term Loan)
 (10)
  
L + 375
  
 
4.07%
 
  
 
10/10/2025
 
  
 
4,518,572
 
  
 
3,709,077
 
  
 
1,354,645
 
RxBenefits, Inc. (First Lien Term Loan)
 (6)
  
L +450
  
 
2.11%
 
  
 
12/20/2027
 
  
 
1,993,177
 
  
 
1,963,107
 
  
 
1,888,535
 
Sound Inpatient Physicians (Second Lien Term Loan)
 (10)
  
L + 675
  
 
4.07%
 
  
 
6/26/2026
 
  
 
1,555,556
 
  
 
1,481,972
 
  
 
1,229,869
 
Wellpath Holdings, Inc. (First Lien Term Loan)
 (7)
  
L + 550
  
 
4.41%
 
  
 
10/1/2025
 
  
 
984,615
 
  
 
980,197
 
  
 
783,793
 
  
  
  
  
  
  
 
 
 
  
  
  
  
  
  
 
13,158,950
 
  
  
  
  
  
  
 
 
 
Telecommunication Services – 2.0%
  
  
  
  
  
  
TerreStar Corp. (First Lien Term Loan H)
 (8) (9)
  
11%PIK
  
  
 
2/28/2024
 
  
 
32,189
 
  
 
32,189
 
  
 
32,002
 
TerreStar Corp. (First Lien Term Loan F)
 (8) (9)
  
11%PIK
  
  
 
2/28/2024
 
  
 
193,108
 
  
 
193,108
 
  
 
191,988
 
TerreStar Corp. (First Lien Term Loan E)
 (8) (9)
  
11%PIK
  
  
 
2/28/2024
 
  
 
815,685
 
  
 
815,684
 
  
 
810,953
 
TerreStar Corp. (First Lien Term Loan G)
 (8) (9)
  
11%PIK
  
  
 
2/28/2024
 
  
 
34,500
 
  
 
34,500
 
  
 
34,300
 
  
  
  
  
  
  
 
 
 
  
  
  
  
  
  
 
1,069,243
 
  
  
  
  
  
  
 
 
 
Total Senior Secured Loans
  
  
  
  
  
  
 
14,228,193
 
  
  
  
  
  
  
 
 
 
Asset-Backed Securities – 0.0%
  
  
  
  
  
  
Financials – 0.0%
  
  
  
  
  
  
Grayson Investor Corp. 
(5) (8) (9) (11) (12) (13)
  
  
  
  
 
800
 
  
 
218,666
 
  
 
7,023
 
PAMCO CLO 1997-1A B 
(5) (8) (9) (11) (13) (14)
  
  
  
  
 
295,435
 
  
 
169,875
 
  
 
13
 
  
  
  
  
  
  
 
 
 
  
  
  
  
  
  
 
7,036
 
  
  
  
  
  
  
 
 
 
Total Asset-Backed Securities
  
  
  
  
  
  
 
7,036
 
  
  
  
  
  
  
 
 
 
Corporate Bonds – 5.0%
  
  
  
  
  
  
Healthcare – 4.5%
  
  
  
  
  
  
Hadrian Merger Sub, Inc.
(11)
  
8.500%
  
  
 
5/1/2026
 
  
 
2,728,000
 
  
 
2,460,536
 
  
 
2,414,839
 
  
  
  
  
  
  
 
 
 
Media/Telecommunications – 0.5%
  
  
  
  
  
  
iHeartCommunications, Inc.
(5)
  
6.375%
  
  
 
5/1/2026
 
  
 
116,808
 
  
 
313,455
 
  
 
107,648
 
iHeartCommunications, Inc.
(5)
  
8.375%
  
  
 
5/1/2027
 
  
 
214,073
 
  
 
584,792
 
  
 
182,430
 
  
  
  
  
  
  
 
 
 
  
  
  
  
  
  
 
290,078
 
  
  
  
  
  
  
 
 
 
Total Corporate Bonds
  
  
  
  
  
  
 
2,704,917
 
  
  
  
  
  
  
 
 
 
 
  
 
  
 
 
  
 
 
  
Shares
 
  
 
 
  
 
 
Common Stocks – 36.3%
  
  
  
  
  
  
Chemicals – 0.1%
  
  
  
  
  
  
MPM Holdings, Inc.
(15)
  
  
  
  
 
8,500
 
  
 
17,000
 
  
 
42,500
 
  
  
  
  
  
  
 
 
 
Energy – 3.0%
  
  
  
  
  
  
Quarternorth Energy, Inc.
  
  
  
  
 
11,534
 
  
 
981,428
 
  
 
1,591,692
 
  
  
  
  
  
  
 
 
 
Financials – 3.2%
  
  
  
  
  
  
American Banknote Corp. 
(8) (9) (15)
  
  
  
  
 
750,000
 
  
 
2,062,500
 
  
 
1,732,500
 
  
  
  
  
  
  
 
 
 
Real Estate – 18.6%
  
  
  
  
  
  
Nexpoint Real Estate Finance, Inc. 
(16)
  
  
  
  
 
481,670
 
  
 
9,960,591
 
  
 
7,653,730
 
IQHQ, Inc. 
(8) (9)
  
  
  
  
 
100,000
 
  
 
1,500,000
 
  
 
2,359,000
 
  
  
  
  
  
  
 
 
 
  
  
  
  
  
  
 
10,012,730
 
  
  
  
  
  
  
 
 
 
 
 
See Notes to Financial Statements.
9

NexPoint Capital, Inc.
Schedule of Investments (continued)
As of December 31, 2022
 
Real Estate Investment Trust (REIT) – 1.9%
  
  
 
  
  
  
NexPoint Residential Trust, Inc.
(5) (16)
  
  
 
  
 
23,409
 
  
$
698,189
 
  
$
1,018,779
 
  
  
 
  
  
  
 
 
 
Service – 0.0%
  
  
 
  
  
  
Wayne Services Legacy Inc.
(8) (9) (15)
  
  
 
  
 
237
 
  
 
253,404
 
  
 
2,269
 
  
  
 
  
  
  
 
 
 
Telecommunication Services – 9.5%
  
  
 
  
  
  
TerreStar Corp.
(8) (9) (15)
  
  
 
  
 
14,035
 
  
 
1,599,990
 
  
 
5,114,214
 
  
  
 
  
  
  
 
 
 
Total Common Stocks
  
  
 
  
  
  
 
19,514,684
 
  
  
 
  
  
  
 
 
 
LLC Interests – 8.7%
  
  
 
  
  
  
Consumer Products – 5.7%
  
  
 
  
  
  
US Gaming, LLC
(8) (9) (15)
  
  
 
  
 
2,000
 
  
 
2,000,000
 
  
 
3,088,750
 
  
  
 
  
  
  
 
 
 
Real Estate – 3.0%
  
  
 
  
  
  
SFR WLIF III, LLC
(8) (9) (16)
  
  
 
  
 
451,112
 
  
 
451,112
 
  
 
424,468
 
NexPoint Capital REIT, LLC 
(8) (9) (16)
  
  
 
  
 
100
 
  
 
1,215,000
 
  
 
1,176,024
 
  
  
 
  
  
  
 
 
 
  
  
 
  
  
  
 
1,600,492
 
  
  
 
  
  
  
 
 
 
Total LLC Interests
  
  
 
  
  
  
 
4,689,242
 
  
  
 
  
  
  
 
 
 
 
  
 
 
  
Preferred
Dividend
Rate
 
 
 
 
  
 
 
  
 
 
  
 
 
Preferred Stocks – 22.3%
  
  
 
  
  
  
Financials – 2.7%
  
  
 
  
  
  
777 Partners, LLC
  
  
 
10.000
 
  
 
750
 
  
 
750,000
 
  
 
740,625
 
United Fidelity Bank FSB
  
  
 
7.000
 
  
 
1,000
 
  
 
1,000,000
 
  
 
700,000
 
  
  
 
  
  
  
 
 
 
  
  
 
  
  
  
 
1,440,625
 
  
  
 
  
  
  
 
 
 
Healthcare – 19.6%
  
  
 
  
  
  
Apnimed, Inc.
(8) (9)
  
  
 
8.000
 
  
 
135,122
 
  
 
1,199,993
 
  
 
1,499,989
 
Apnimed, Inc. (Series C-2)
(8) (9)
  
  
 
8.000
 
  
 
72,065
 
  
 
799,994
 
  
 
799,994
 
Sapience Therapeutics, Inc. (Series B Preferred Shares) 
(8) (9)
  
  
 
8.000
 
  
 
1,619,048
 
  
 
4,080,000
 
  
 
4,549,525
 
Sapience Therapeutics, Inc. (Series B-1 Preferred Shares) 
(8) (9)
  
  
 
  
 
1,111,111
 
  
 
4,000,000
 
  
 
3,677,777
 
  
  
 
  
  
  
 
 
 
  
  
 
  
  
  
 
10,527,285
 
  
  
 
  
  
  
 
 
 
Total Preferred Stocks
  
  
 
  
  
  
 
11,967,910
 
  
  
 
  
  
  
 
 
 
Warrants – 0.4%
  
  
 
  
  
  
Energy – 0.3%
  
  
 
  
  
  
QuarterNorth Tranche 1
(15)
  
  
 
 
8/27/2029
 
  
 
5,738
 
  
 
16,122
 
  
 
64,553
 
QuarterNorth Tranche 2
(15)
  
  
 
 
8/27/2029
 
  
 
11,051
 
  
 
5,175
 
  
 
96,696
 
  
  
 
  
  
  
 
 
 
  
  
 
  
  
  
 
161,249
 
  
  
 
  
  
  
 
 
 
Media/Telecommunications – 0.1%
  
  
 
  
  
  
iHeartMedia, Inc.
(5) (15)
  
  
 
 
5/1/2039
 
  
 
2,875
 
  
 
52,987
 
  
 
20,484
 
  
  
 
  
  
  
 
 
 
Total Warrants
  
  
 
  
  
  
 
181,733
 
  
  
 
  
  
  
 
 
 
Total Investments- 99.2%
  
  
 
  
  
$
54,011,971
 
  
$
53,293,715
 
  
  
 
  
  
 
 
 
  
 
 
 
Cash Equivalents – 2.6%
(17)
  
  
 
  
  
  
$
1,420,428
 
Other Assets & Liabilities, net – (1.8%)
  
  
 
  
  
  
$
(1,019,976
  
  
 
  
  
  
 
 
 
Net Assets- 100.0%
  
  
 
  
  
  
$
53,694,167
 
  
  
 
  
  
  
 
 
 
 
(1)
 
   Unless otherwise noted, the Company did not “control” and was not an “affiliated person” of any of its portfolio companies, each as defined in the Investment Company Act of 1940, as amended (the “1940 Act”). In general, under the 1940 Act, the Company would be presumed to “control” a portfolio company if it owned 25% or more of its voting securities or had the power to exercise control over the management or policies of such portfolio company, and would be an “affiliated person” of a portfolio company if it owned 5% or more of its voting securities. Additionally, companies under common control (e.g., companies with a common owner of greater than 25% of their respective voting securities) are affiliates under the 1940 Act.
(2)
 
   All investments are denominated in United States Dollars.
(3)
 
   Amortized cost represents the original cost adjusted for the amortization of premiums and/or accretion of discounts, as applicable, on investments.
(4)
 
  
Senior secured loans in which the Company invests generally pay interest at rates which are periodically determined by reference to a base lending rate plus a spread (unless otherwise identified, all senior secured loans carry a variable rate of interest). These base lending rates are generally (i) the Prime Rate offered by one or more major United States banks, (ii) the lending rate offered by one or more European banks such as the London Interbank Offered Rate (“LIBOR”) or (iii) the coupon rate. Rate shown represents the actual rate at December 31, 2022. Senior secured loans, while exempt from registration under the Securities Act of 1933 (the “1933 Act”), contain certain restrictions on resale and cannot be sold publicly. Senior secured floating rate loans often require prepayments from excess cash flow or permit the borrower to repay at its election. The degree to which borrowers repay, whether as a contractual requirement or at their election, cannot be predicted with accuracy. As a result, the actual remaining maturity may be substantially less than the stated maturity shown.
(5)
 
  
The investment is not a qualifying asset under Section 55 of the 1940 Act. A business development company (“BDC”), such as the Company, may not acquire any asset other than a qualifying asset, unless at the time the acquisition is made, qualifying assets represent at least 70% of the business development company’s total assets. Non-qualifying assets represented
 4.8% of the Company’s total assets as of December 31, 202
2
.
 
 
See Notes to Financial Statements.
10

NexPoint Capital, Inc.
Schedule of Investments (continued)
As of December 31, 2022
 
(6)
 
  
The interest rate on these investments is subject to a base rate of 6-Month LIBOR, which at December 31, 2022 was 5.14%. The LIBOR rate used to calculate interest is the higher of the prevailing 6 month LIBOR rate in effect on the date of the semiannual reset, or the LIBOR base rate floor shown.
(7)
 
  
The interest rate on these investments is subject to a base rate of 3-Month LIBOR, which at December 31, 2022 was 4.77%. The LIBOR rate used to calculate interest is the higher of the prevailing 3 month LIBOR rate in effect on the date of the quarterly reset, or the LIBOR base rate floor shown.
(8)
 
  
Represents fair value as determined by the Adviser pursuant to the policies and procedures approved by the Board of Trustees (the “Board”). The Board has designated the Adviser as “valuation designee” for the Company pursuant to Rule 2a-5 of the 1940 Act. The Adviser considers fair valued securities to be securities for which market quotations are not readily available and these securities may be valued using a combination of observable and unobservable inputs. Securities with a total aggregate value of $
28,500,789 or 53.0
% of net assets were fair valued under the Company’s valuation procedures as of December 31, 2022.
(9)
 
   Classified as Level 3 within the three-tier fair value hierarchy. Please see Note 2 for an explanation of this hierarchy, as well as a list of unobservable inputs used in the valuation of these instruments.
(10)
 
   The interest rate on these investments is subject to a base rate of 1-Month LIBOR, which at December 31, 2022 was 4.39%. The LIBOR rate used to calculate interest is the higher of the prevailing 1 month LIBOR rate in effect on the date of the monthly reset, or the LIBOR base rate floor shown.
(1
1
)
 
  
Securities exempt from registration under Rule 144A of the Securities Act. These securities may only be resold in transactions exempt from registration to qualified institutional buyers. As of December 31, 2022, these securities amounted to $
2,421,875, or 4.5
% of net assets.
(1
2
)
 
   The investment is considered to be the equity tranche of the issuer.
(1
3
)
 
   Securities of collateralized loan obligations where an affiliate of the Adviser serves as collateral manager.
(1
4
)
 
   The issuer is in default of its payment obligation, or is in danger of default.
(1
5
)
 
  
Non-income
producing security.
(1
6
)
 
   Represents an affiliated issuer. Assets with a total aggregate market value of $10,273,001, or 19.1% of net assets, were affiliated with the Company as of December 31, 2022. See Note
9
.
(17)
 
   State Street U.S. Government Money Market Fund.
Glossary
 
PIK
 
Payment-in-Kind
 
 
See Notes to Financial Statements.
11

NexPoint Capital, Inc.
Notes to Financial Statements (Unaudited)
Note 1 — Organization
NexPoint Capital, Inc. (the “Company”) is an externally managed,
non-diversified,
closed-end
management investment company that has elected to be regulated as a business development company (“BDC”) under the 1940 Act. The Company follows the investment company accounting and reporting guidance of the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 946
Financial Services—Investment Companies.
The Company’s investment objective is to generate current income and capital appreciation primarily through investments in middle-market healthcare companies, middle-market companies in
non-healthcare
sectors, syndicated floating rate debt of large public and nonpublic companies and collateralized loan obligations. The Company has elected to be treated for federal income tax purposes, and intends to qualify annually thereafter, as a regulated investment company (“RIC”), under Subchapter M of the Internal Revenue Code of 1986, as amended (the “Code”). In this report, “we,” “us” and “our” refer to NexPoint Capital, Inc.
The Company was formed in Delaware on September 30, 2013 and formally commenced operations on September 2, 2014 upon satisfying the minimum offering requirement by raising gross proceeds of $10.0 million in connection with a private placement with NexPoint Advisors, L.P. (the “Adviser”), our external advisor. In aggregate as of March 31, 2023, the Adviser controls 2,549,002 total shares of common stock (or 26.7%) of the Company, including reinvestment of dividends, for a net amount of approximately $13.7 million.
The Company has retained the Adviser to manage certain aspects of its affairs on a
day-to-day
basis. NexPoint Securities, Inc. (the “Dealer Manager”), an entity under common ownership with the Adviser, served as the dealer manager of the Company’s continuous public offering prior to the termination of the offering. The Adviser and Dealer Manager are related parties and will receive fees and other compensation for services related to the investment and management of the Company’s assets and the continuous public offering. The Company’s continuous public offering ended on February 14, 2018.
Note 2 — Summary of Significant Accounting Policies
Basis of Accounting
The accompanying financial statements of the Company are prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”). Additionally, the accompanying financial statements of the Company and related financial information have been prepared pursuant to the requirements for reporting on Form
10-Q
and Article 10 of Regulation
S-X.
The current period’s results of operations will not necessarily be indicative of results that ultimately may be achieved for the fiscal year ending December 31, 2023. The interim financial data as of March 31, 2023 and for the three months ended March 31, 2023 and 2022 is unaudited. In the opinion of management, the interim financial data includes all adjustments, consisting only of the normal recurring adjustments, necessary to a fair statement of the results for the interim periods.
Use of Estimates
The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of increases and decreases in net assets from operations during the reporting period. Actual results could differ from those estimates.
Statements of Cash Flows
Information on financial transactions which have been settled through the receipt or disbursement of cash is presented in the Statements of Cash Flows. The cash amount shown in the Statements of Cash Flows is the amount included within the Company’s Statements of Assets and Liabilities and includes cash on hand at its custodian bank.
 
12

Cash and Cash Equivalents
The Company considers liquid assets deposited with a bank, money market funds, and certain short-term debt instruments with original maturities of three months or less to be cash equivalents. These investments represent amounts held with financial institutions that are readily accessible to pay Company expenses or purchase investments. Cash and cash equivalents are valued at cost plus accrued interest, which approximates fair value. The value of cash equivalents denominated in foreign currencies, if any, is determined by converting to U.S. dollars on the date of the Statements of Assets and Liabilities. As of March 31, 2023 and December 31, 2022, the Company had cash and cash equivalents of $1,131,784 and $1,629,846, respectively. As of March 31, 2023 and December 31, 2022, $773,826 and $1,420,428 was held in the State Street U.S. Government Money Market Fund, and $357,958 and $209,418 was held in a custodial account with State Street Bank and Trust Company, respectively.
Securities Sold Short and Restricted Cash
The Company may sell securities short. A security sold short is a transaction in which the Company sells a security it does not own in anticipation that the market price of that security will decline. When the Company sells a security short, it must borrow the security sold short from a broker-dealer and deliver it to the buyer upon conclusion of the transaction. The Company may have to pay a fee to borrow particular securities and is often obligated to pay over any dividends or other payments received on such borrowed securities. Cash held as collateral for securities sold short is classified as restricted cash on the Statements of Assets and Liabilities, when applicable. Securities held as collateral for securities sold short are shown on the Schedules of Investments for the Company, as applicable. As of March 31, 2023 and December 31, 2022, the Company did not have any securities sold short.
When securities are sold short, the Company intends to limit exposure to a possible market decline in the value of its portfolio companies through short sales of securities that the Adviser believes possess volatility characteristics similar to those being hedged. In addition, the Company may use short sales for
non-hedging
purposes to pursue its investment objective. Subject to the requirements of the 1940 Act and the Code, the Company will not make a short sale if, after giving effect to such sale, the market value of all securities sold short by the Company exceeds 25% of the value of its total assets.
Other Fee Income
Fee income may consist of origination/closing fees, amendment fees, administrative agent fees, transaction
break-up
fees and other miscellaneous fees. Origination fees, amendment fees, and other similar fees are
non-recurring
fee sources. Such fees are received on a transaction by transaction basis and do not constitute a regular stream of income. For the three months ended March 31, 2023 and March 31, 2022, the Company recognized $0 and $0 of fee income, respectively.
Fair Value of Financial Instruments
It is the Company’s policy to hold the investments at fair value. ASC Topic 820,
Fair Value Measurements and Disclosure
(“ASC Topic 820”) defines fair value as the price that would be received from the sale of an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. ASC Topic 820 also establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. These tiers include: Level 1, defined as observable inputs such as quoted prices in active markets; Level 2, which includes inputs such as quoted prices for similar securities in active markets and quoted prices for identical securities where there is little or no activity in the market; and Level 3, defined as unobservable inputs for which little or no market data exists, therefore requiring an entity to develop its own assumptions.
Pursuant to Rule
2a-5
under the 1940 Act, the Board has designated the Adviser as the Company’s valuation designee to perform the fair valuation determination for securities and other assets held by the Company. The Company determines the net asset value of its investment portfolio each quarter, or more frequently as needed. Securities that are publicly-traded are valued at the reported closing price on the valuation date. Securities that are not publicly-traded are valued at fair value as determined in good faith by the Adviser as valuation designee, pursuant to board-approved policies and procedures. In connection with that determination, the Adviser will consider portfolio company valuations based on relevant inputs, including indicative dealer quotes, values of like securities, recent portfolio company financial statements and forecasts, and valuations prepared by third-party valuation services. Rule
2a-5
states that a market quotation is readily available only when that quotation is a quoted price (unadjusted) in active markets for identical investments that the Company can access at the measurement date, provided that a quotation will not be readily available if it is not reliable. Market quotations may also not be “readily available” if a significant event occurs that causes the Adviser to believe that the market price of a security no longer represents the security’s current value at the time of the Company’s net asset value (“NAV”) determination.
 
13
With respect to investments for which market quotations are not readily available, the Adviser undertakes a multi-step valuation process each quarter, as described below:
 
   
The valuation process begins with each portfolio company or investment being initially valued by investment professionals of the Adviser responsible for credit monitoring or independent third party valuation firms.
 
   
Preliminary valuation conclusions are then documented and discussed with a committee comprised of certain senior management employees of the Adviser (the “Valuation Committee”) established by the Adviser to assist the Adviser in discharging its responsibilities as valuation designee.
 
   
At least once each quarter, the valuations for approximately one quarter of the portfolio investments that have been fair valued are reviewed by an independent valuation firm such that, over the course of a year, each material portfolio investment that has been fair valued shall have been reviewed by an independent valuation firm at least once.
 
   
Based on this information, the Adviser discusses valuations and determines the fair value of each investment in the portfolio in good faith pursuant to board-approved policies and procedures.
As of March 31, 2023, the Company held the following investments for which a sufficient level of current, reliable market quotations were not available:
 
Instrument
  
Type
  
Fair value
 
Grayson Investor Corp.
  
Asset-Backed Securities
   $  7,267  
PAMCO CLO
1997-1A
B
   Asset-Backed Securities      13  
American Banknote Corp.
   Common Stocks      1,732,500  
IQHQ, Inc.
   Common Stocks      2,359,000  
TerreStar Corp.
   Common Stocks      5,032,249  
Wayne Services Legacy, Inc.
   Common Stocks      2,268  
NexPoint Capital REIT, LLC
   LLC Interests      6,904,655  
SFR WLIF III, LLC
   LLC Interests      418,181  
US Gaming, LLC
   LLC Interests      2,841,603  
Apnimed, Inc.
   Preferred Stocks      1,499,989  
Apnimed, Inc.
   Preferred Stocks      799,993  
Sapience Therapeutics, Inc.
   Preferred Stocks      4,581,906  
Sapience Therapeutics, Inc.
   Preferred Stocks      3,700,000  
CCS Medical, Inc.
   Senior Secured Loans      3,000,000  
NexPoint Capital REIT
,
LLC
   Senior Secured Loans      463,314  
TerreStar Corp.
   Senior Secured Loans      836,016  
TerreStar Corp.
   Senior Secured Loans      197,921  
TerreStar Corp.
   Senior Secured Loans      35,360  
TerreStar Corp.
   Senior Secured Loans      32,991  
 
14

As of December 31, 2022, the Company held the following investments for which a sufficient level of current, reliable market quotations were not available:
 
Instrument
  
Type
  
Fair value
 
Grayson Investor Corp.
  
Asset-Backed Securities
   $  7,023  
PAMCO CLO
1997-1A
B
   Asset-Backed Securities      13  
American Banknote Corp.
   Common Stocks      1,732,500  
IQHQ, Inc.
   Common Stocks      2,359,000  
TerreStar Corp.
   Common Stocks      5,114,214  
Wayne Services Legacy, Inc.
   Common Stocks      2,269  
NexPoint Capital REIT, LLC
   LLC Interests      1,176,024  
SFR WLIF III, LLC
   LLC Interests      424,468  
US Gaming, LLC
   LLC Interests      3,088,750  
Apnimed, Inc.
   Preferred Stocks      1,499,989  
Apnimed, Inc.
   Preferred Stocks      799,994  
Sapience Therapeutics, Inc.
   Preferred Stocks      4,549,525  
Sapience Therapeutics, Inc.
   Preferred Stocks      3,677,777  
CCS Medical, Inc.
   Senior Secured Loans      3,000,000  
TerreStar Corp.
   Senior Secured Loans      810,953  
TerreStar Corp.
   Senior Secured Loans      191,988  
TerreStar Corp.
   Senior Secured Loans      34,300  
TerreStar Corp.
   Senior Secured Loans      32,002  
Determination of fair value involves subjective judgments and estimates. Accordingly, the notes to the Company’s financial statements will refer to the uncertainty with respect to the possible effect of such valuations, and any change in such valuations, in the Company’s financial statements. Below is a description of factors that the Adviser and the Valuation Committee may consider when valuing the Company’s debt and equity investments.
Valuation of fixed income investments, such as loans and debt securities, depends upon a number of factors, including prevailing interest rates for like securities, expected volatility in future interest rates, call features, put features and other relevant terms of the debt. For investments without readily available market prices, the Company may incorporate these factors into discounted cash flow models to arrive at fair value. Other factors that the Adviser and the Valuation Committee may consider include the borrower’s ability to adequately service its debt, the fair market value of the portfolio company in relation to the face amount of its outstanding debt and the quality of collateral securing the Company’s debt investments.
The Company’s equity investments in portfolio companies for which there is no liquid public market will be valued at fair value. The Adviser and the Valuation Committee, in its analysis of fair value, may consider various factors, such as multiples of earnings before interest, taxes, depreciation and amortization (“EBITDA”), cash flows, net income, revenues or, in limited instances, book value or liquidation value. All of these factors may be subject to adjustments based upon the particular circumstances of a portfolio company or the Company’s actual investment position. For example, adjustments to EBITDA may take into account compensation to previous owners or acquisition, recapitalization, restructuring or other related items.
The Adviser and the Valuation Committee may also look to private merger and acquisition statistics, public trading multiples discounted for illiquidity and other factors, valuations implied by third-party investments in the portfolio companies or industry practices in determining fair value. The Adviser and the Valuation Committee may also consider the size and scope of a portfolio company and its specific strengths and weaknesses, as well as any other factors it deems relevant in assessing the value. Generally, the value of the Company’s equity interests in public companies for which market quotations are readily available will be based upon the most recent closing public market price.
 
15

If the Company receives warrants or other equity-linked securities at nominal or no additional cost in connection with an investment in a debt security, the Company will allocate the cost basis in the investment between the debt securities and any such warrants or other equity-linked securities received at the time of origination. The Adviser and the Valuation Committee will subsequently value these warrants or other equity-linked securities received at fair value.
As applicable, the Company values its Level 2 assets by using the midpoint of the prevailing bid and ask prices from dealers on the date of the relevant period end, which is provided by an independent third-party pricing service and screened for validity by such service. For investments for which the third-party pricing service is unable to obtain quoted prices, the Company obtains bid and ask prices directly from dealers who make a market in such investments.
To the extent that the Company holds investments for which no active secondary market exists and, therefore, no bid and ask prices can be readily obtained, the Adviser and the Valuation Committee utilize an independent third-party valuation service to value such investments in a manner consistent with the Company’s multistep valuation process previously described.
The Company periodically benchmarks the bid and ask prices received from the third-party pricing service and/or dealers, as applicable, and valuations received from the third-party valuation service against the actual prices at which it purchases and sells its investments. The Company believes that these prices are reliable indicators of fair value. The Adviser and the Valuation Committee review and approve the valuation determinations made with respect to these investments in a manner consistent with the Company’s valuation procedures.
As of March 31, 2023, the Company’s investments consisted of senior secured loans, asset-backed securities, common stocks, LLC interests, preferred stocks, corporate bonds, and warrants, which may be purchased for a fraction of the price of the underlying securities. The fair value of the Company’s loans, bonds and asset-backed securities are generally based on quotes received from brokers or independent pricing services. Loans, bonds and asset-backed securities with quotes that are based on actual trades with a sufficient level of activity on or near the measurement date are classified as Level 2 assets. Loans, bonds and asset-backed securities that are priced using quotes derived from implied values, indicative bids or a limited number of actual trades are classified as Level 3 assets because the inputs used by the brokers and pricing services to derive the values are not readily observable.
The fair value of the Company’s common stocks and options that are not actively traded on national exchanges are generally priced using quotes derived from implied values, indicative bids, or a limited amount of actual trades and are classified as Level 3 assets because the inputs used by the brokers and pricing services to derive the values are not readily observable. Exchange traded options are valued based on the last trade price on the primary exchange on which they trade. If an option does not trade, the
mid-price
is utilized to value the option.
At the end of each calendar quarter, the Adviser evaluates the Level 2 and 3 investments for changes in liquidity, including: whether a broker is willing to execute at the quoted price, the depth and consistency of prices from third party services, and the existence of contemporaneous, observable trades in the market. Additionally, management evaluates the Level 1 and 2 assets and liabilities on a quarterly basis for changes in listings or delistings on national exchanges.
Due to the inherent uncertainty of determining the fair value of investments that do not have a readily available market price, the fair value of the Company’s investments may fluctuate from period to period. Additionally, the fair value of investments may differ significantly from the values that would have been used had a ready market existed for such investments and may differ materially from the values the Company may ultimately realize. Further, such investments may be subject to legal and other restrictions on resale or otherwise less liquid than publicly traded securities.
 
16

The inputs or methodology used for valuing investments are not necessarily an indication of the risk associated with investing in those investments. The following are summaries of the Company’s investments categorized within the fair value hierarchy as of March 31, 2023 and December 31, 2022:
 
    
March 31, 2023
 
Investments
  
Level 1
    
Level 2
    
Level 3
    
Total
 
                             
Assets
 
Senior Secured Loans
 
Healthcare
   $         $ 5,466,015      $ 3,000,000      $ 8,466,015  
Real Estate
     —          —          463,314        463,314  
Telecommunication Services
                         1,102,288        1,102,288  
Asset-Backed Securities
 
Financials
                         7,280        7,280  
Corporate Bonds
 
Healthcare
               2,240,779                  2,240,779  
Media/Telecommunications
               259,466                  259,466  
Common Stocks
 
Chemicals
               42,500                  42,500  
Energy
               1,629,178                  1,629,178  
Financials
                         1,732,500        1,732,500  
Real Estate
     2,063,263                  2,359,000        4,422,263  
Real Estate Investment Trusts (REITs)
     1,022,291                            1,022,291  
Service
                         2,268        2,268  
Telecommunication Services
                         5,032,249        5,032,249  
LLC Interests
 
Consumer Products
                         2,841,603        2,841,603  
Real Estate
                         7,322,836        7,322,836  
Preferred Stocks
 
Financials
               1,400,000                  1,400,000  
Healthcare
                         10,581,888        10,581,888  
Warrants
 
Energy
               152,748                  152,748  
Media/Telecommunications
               10,063                  10,063  
    
 
 
    
 
 
    
 
 
    
 
 
 
Total Assets
  
$
3,085,554
 
  
$
11,200,749
 
  
$
34,445,226
 
  
$
48,731,529
 
    
 
 
    
 
 
    
 
 
    
 
 
 
Total Investments
  
$
3,085,554
 
  
$
11,200,749
 
  
$
34,445,226
 
  
$
48,731,529
 
    
 
 
    
 
 
    
 
 
    
 
 
 
 
17


















    
December 31, 2022
 
Investments
  
Level 1
    
Level 2
    
Level 3
    
Total
 
                             
Assets
 
Senior Secured Loans
 
Healthcare
   $         $ 10,158,950      $ 3,000,000      $ 13,158,950  
Telecommunication Services
                         1,069,243        1,069,243  
Asset-Backed Securities
 
Financials
                         7,036        7,036  
Corporate Bonds
 
Healthcare
               2,414,839                  2,414,839  
Media/Telecommunications
               290,078                  290,078  
Common Stocks
 
Chemicals
               42,500                  42,500  
Energy
               1,591,692                  1,591,692  
Financials
                         1,732,500        1,732,500  
Real Estate
     7,653,730                  2,359,000        10,012,730  
Real Estate Investment Trusts (REITs)
     1,018,779                            1,018,779  
Service
                         2,269        2,269  
Telecommunication Services
                         5,114,214        5,114,214  
LLC Interests
 
Consumer Products
                         3,088,750        3,088,750  
Real Estate
                         1,600,492        1,600,492  
Preferred Stocks
 
Financials
               1,440,625                  1,440,625  
Healthcare
                         10,527,285        10,527,285  
Warrants
 
Energy
               161,249                  161,249  
Media/Telecommunications
               20,484                  20,484  
    
 
 
    
 
 
    
 
 
    
 
 
 
Total Assets
  
$
8,672,509
 
  
$
16,120,417
 
  
$
28,500,789
 
  
$
53,293,715
 
    
 
 
    
 
 
    
 
 
    
 
 
 
Total Investments
  
$
8,672,509
 
  
$
16,120,417
 
  
$
28,500,789
 
  
$
53,293,715
 
    
 
 
    
 
 
    
 
 
    
 
 
 
 
18

The table below sets forth a summary of changes in the Company’s Level 3 investments (measured at fair value using significant unobservable inputs) for the three months ended March 31, 2023. The table below includes noncash transactions for the three months ended March 31, 2023.
 














































Investments:
  
Balance as of
December 31,
2022
 
  
Transfers
into
Level 3
 
  
Transfer
s out of
Level 3
 
  
Net
amortization
(accretion) of
premium/
(discount)
 
  
Distribution
to Return
Capital
 
  
Net realized
gains/
(losses)
 
  
Net

change in
unrealized
gains/
(losses)
 
 
Purchases/
PIK
 
 
  
(Sales
and
redemptions)
 
 
Balance as of
March 31,
2023
 
  
Change in
unrealized
gain/(loss)
on Level 3
securities still
held at period
end
 
Assets
  



  



  



  



  



  



  



 



 
  



 



  



Senior Secured Loans
  



  



  



  



  



  



  



 



 
  



 



  



Telecommunication Services
   $ 1,069,243      $         $         $         $          $         $  3,198      $  29,847        $         $  1,102,288      $  3,198  
Healthcare
     3,000,000                            4,465                            (4,465 )
 
                          3,000,000        (4,465 )
Real Estate
                                                                           463,314                   463,314            
Asset-Backed Securities
                                                                                                   
Financials
     7,036                                                          244                             7,280        244  
Common Stocks
                                                                                                   
Financials
     1,732,500                                                                                         1,732,500            
Real Estate
     2,359,000                                                                                         2,359,000            
Service
     2,269                                                                                         2,268            
Telecommunication Services
     5,114,214                                                          (81,965 )                           5,032,249        (81,965 )
LLC Interests
                                                                                                   
Consumer Products
     3,088,750                                                163,314        52,853                    (463,314 )     2,841,603        52,853  
Real Estate
     1,600,492                                                          (1,645,741 )      7,368,085
(1)
 
                7,322,836        (1,645,741 )
Preferred Stocks
                                                                                                   
Healthcare
     10,527,285                                                          54,603                             10,581,888        54,603  
    
 
 
    
 
 
    
 
 
    
 
 
    
 
 
    
 
 
    
 
 
    
 
 
      
 
 
   
 
 
    
 
 
 
Total
   $ 28,500,789      $         $         $ 4,465      $         $ 163,314      $ (1,621,273 )    $ 7,861,246        $ (463,314 )
 
  $ 34,445,226      $ (1,621,273 )
 
    
 
 
    
 
 
    
 
 
    
 
 
    
 
 
    
 
 
    
 
 
    
 
 
      
 
 
   
 
 
    
 
 
 
 
(1)
 
Represents an in-kind transfer to the subreit.
The table below sets forth a summary of changes in the Company’s Level 3 investments (measured at fair value using significant unobservable inputs) for the three months ended March 31, 2022.
 













































Investments:
  
Balance as of
December 31,
2021
    
Transfers
into
Level 3
    
Transfer
out of
Level 3
    
Net
amortization
(accretion) of
premium/
(discount)
    
Distribution
to Return
Capital
    
Net realized
gains/
(losses)
   
Net

change in
unrealized
gains/
(losses)
   
Purchases/
PIK
   
(Sales
and
redemptions)
   
Balance as of
March 31,
2022
    
Change in
unrealized
gain/(loss)
on Level 3
securities still
held at period
end
 
                                                                          
Assets
                                                                                              
Senior Secured Loans
                                                                                              
Telecommunication Services
   $ 962,478      $         $         $         $         $        $        $ 26,711     $        $ 989,189      $     
Healthcare
     4,000,000                            3,809                           86,191       2,990,000       (4,080,000 )(a)      3,000,000        86,191  
Asset-Backed Securities
                                                                                              
Financials
     405,040                                                         11,787                (16,979     399,848        11,787  
Common Stocks
                                                                                              
Financials
     2,208,750                                                         (603,450                       1,605,300        (603,450
Real Estate
     1,823,000                                                         141,000                         1,964,000        141,000  
Service
     5,172                                                                                    5,172            
Telecommunication Services
     4,706,357                                                         (94,456                       4,611,901        (94,456
LLC Interests
                                                                                              
Consumer Products
     2,812,212                                                         169,426                         2,981,638        169,426  
Real Estate
     4,760,162                                                (74,603     139,367                (3,274,285 )(b)      1,550,641        (13,275
Preferred Stocks
                                                                                              
Healthcare
                                                                         8,080,000 (a)               8,080,000            
    
 
 
    
 
 
    
 
 
    
 
 
    
 
 
    
 
 
   
 
 
   
 
 
   
 
 
   
 
 
    
 
 
 
Total
   $ 21,683,171      $         $          $ 3,809      $          $ (74,603   $ (150,135   $ 11,096,711     $ (7,371,264   $ 25,187,689      $ (302,777
    
 
 
    
 
 
    
 
 
    
 
 
    
 
 
    
 
 
   
 
 
   
 
 
   
 
 
   
 
 
    
 
 
 
 
(a)
 
Denotes Sapience’s $4,080,000 promissory notes and paid in kind interest conversion to preferred stock.
(b)
 
Denotes SFR II’s LLC Interests conversion into NREF common shares.
 
19
Investments designated as Level 3 may include investments valued using quotes or indications furnished by brokers which are based on models or estimates and may not be executable prices. In light of the developing market conditions, the Adviser continues to search for observable data points and evaluate broker quotes and indications received for investments. Determination of fair values is uncertain because it involves subjective judgments and estimates that are unobservable. Transfers from Level 2 to Level 3 are due to a decrease in market activity (e.g. frequency of trades), which resulted in a decrease of available market inputs to determine price. For the three months ended March 31, 2023, there were no transfers from Level 2 to Level 3. For the three months ended March 31, 2022, there were no transfers from Level 2 to Level 3. Transfers from Level 3 to Level 2 and from Level 2 to Level 1 are due to an increase in market activity (e.g. frequency of trades), which resulted in an increase of available market inputs to determine price.
The following are summaries of significant unobservable inputs used in the fair valuations of investments categorized within Level 3 of the fair value hierarchy as of March 31, 2023 and December 31, 2022:
 
Investment
 
Fair value at

March 31, 2023
   
Valuation
technique
 
Unobservable
inputs
 
Range of input value(s)

(weighted average)
 
LLC Interest
  $ 10,164,438    
Discounted Cash Flow
Multiples Analysis
 
Discount Rate
Multiple of EBITDA
   
4.98% - 9.18% (7.08%)

5.60x - 9.95x (
7.70
x)
 
 
Preferred Stock
    10,581,888     Option Pricing Model   Volatility    
40% - 90% (65%)
 
Common Stock
    9,126,018    
Discounted Cash Flow
Multiples Analysis
 
Transaction Indication of Value
Liquidation Analysis
Net Asset Value
 
Discount Rate
Multiple of EBITDA
Unadjusted
Price/MHz-PoP
Enterprise Value ($mm)
Recovery Rate
N/A
   
11.0% - 13.0% (12.0%)

3.25x - 4.25x (
3.75x)  
$0.09 - $0.95 ($0.52)
$921.5
40% - 100%
$28
 
 
 
 
 
Senior Secured Loans
    4,565,602     Discounted Cash Flow   Discount Rate    
10.25% - 13.06% (11.40%)
 
Asset-Backed Securities
    7,280     NAV Approach   Discount Rate     70.00%  
   
 
 
                 
Total
 
$
       34,445,226
 
               
   
 
 
                 
 
Investment
 
Fair value at

December 31, 2022
   
Valuation
technique
 
Unobservable
inputs
 
Range of input value(s)

(weighted average)
LLC Interest
  $ 4,689,242    
Discounted Cash Flow
Multiples Analysis
 
Discount Rate
Multiple of EBITDA
 
4.73% - 8.93% (6.83%)

5.55x - 9.85x (7.70x)
Preferred Stock
    10,527,285    
Option Pricing Model
Transaction Indication of Value
 
Volatility
Recap Price
 
40% - 60% (50%)

$11.10
Common Stock
    9,207,983    
Discounted Cash Flow
Multiples Analysis
 
Transaction Indication of Value
Liquidation Analysis
Net Asset Value
 
Discount Rate
Multiple of EBITDA
Unadjusted Price/MHz-PoP
Enterprise Value ($mm)
Recovery Rate
N/A
 
13.50% - 15.50% (14.50%)

3.25x - 4.25x (3.75x)
$0.09 - $0.95 ($0.52)  
$872 - $969 ($920.5)  
40% - 100% (70%)
$28
Senior Secured Loans
    4,069,243     Discounted Cash Flow   Discount Rate  
   10.25% - 13.08% (11.67%)   
Asset-Backed Securities
    7,036     NAV Approach   Discount Rate   70.00%
   
 
 
             
Total
 
$
28,500,789
             
   
 
 
             
The significant unobservable inputs used in the fair value measurement of the Company’s LLC interests are: discount rate and multiples of EBITDA. Significant increases (decreases) in those inputs in isolation could result in a significantly lower (higher) fair value measurement. The significant unobservable inputs used in the fair value measurement of the Company’s common equity securities are: multiple of EBITDA,
price/MHz-PoP
multiple, liquidity discount, discount rate, enterprise value, and transaction price. Significant increases (decreases) in any of those inputs in isolation could result in a significantly lower (higher) fair value measurement. The significant unobservable inputs used in the fair value measurement of the Company’s preferred stock are: option pricing model. Significant increases (decreases) in any of those inputs in isolation could result in a significantly lower (higher) fair value measurement. The significant unobservable inputs used in the fair value measurement of the Company’s senior secured loans are: discount rate and spread adjustment. Significant increases (decreases) in either of those inputs in isolation could result in a significantly lower (higher) fair value measurement.
 
20

The significant unobservable inputs used in the fair value measurement of the Company’s asset-backed securities are: discount rate and broker quote indication of value. Significant increases (decreases) in either of those inputs in isolation could result in a significantly lower (higher) fair value measurement. The significant unobservable input used in the fair value measurement of the Company’s warrant securities is: volatility assumption. Significant increases (decreases) in this input in isolation could result in a significantly lower (higher) fair value measurement.
Derivative Transactions
The Company is subject to equity price risk, interest rate risk and foreign currency exchange rate risk in the normal course of pursuing its investment objective. The Company may invest without limitation in warrants and may also use derivatives, primarily swaps (including equity, variance and volatility swaps), options and futures contracts on securities, interest rates, commodities and/or currencies, as substitutes for direct investments the Company can make. The Company may also use derivatives such as swaps, options (including options on futures), futures, and foreign currency transactions (e.g., foreign currency swaps, futures and forwards) to any extent deemed by the Adviser to be in the best interest of the Company, and to the extent permitted by the 1940 Act, to hedge various investments for risk management and speculative purposes.
Options
The Company purchases options, subject to certain limitations. The Company may invest in options contracts to manage its exposure to the stock and bond markets and fluctuations in foreign currency values. Writing puts and buying calls tend to increase the Company’s exposure to the underlying instrument while buying puts and writing calls tend to decrease the Company’s exposure to the underlying instrument, or economically hedge other Company investments. The Company’s risks in using these contracts include changes in the value of the underlying instruments, nonperformance of the counterparties under the contracts’ terms and changes in the liquidity of the secondary market for the contracts. Options are valued at the last sale price, or if no sales occurred on that day, at the last quoted bid price. As of and during the three months ended March 31, 2023 and 2022, the Company did not hold options.
Investment Transactions
Investment transactions are accounted for on trade date. Realized gains (losses) on investments sold are recorded on the basis of specific identification method for both financial statement and U.S. federal income tax purposes. Payable for investments purchased and receivable for investments sold on the Statements of Assets and Liabilities, if any, represents the cost of purchases and proceeds from sales of investment securities, respectively, for trades that have been executed but not yet settled.
Income Recognition
Corporate actions (including cash dividends from common stock and equity tranches of asset-backed securities) are recorded on the
ex-dividend
date, net of applicable withholding taxes, except for certain foreign corporate actions, which are recorded as soon after the
ex-dividend
date as such information becomes available. Interest income is recorded on the accrual basis. The Company does not accrue as a receivable for interest or dividends on loans, asset-backed securities and other securities if there is a reason to doubt the Company’s ability to collect such income. For loans with contractual PIK
(payment-in-kind)
interest income, which represents contractual interest accrued and added to the loan balance that generally becomes due at maturity, we will not accrue PIK interest if we believe that the PIK interest is no longer collectible. Loan origination fees, original issue discount and market discount are capitalized and such amounts are amortized as interest income over the respective term of the loan or security. Upon the prepayment of a loan or security, any unamortized loan origination fees and original issue discount are recorded as interest income.
Accretion of discounts and amortization of premiums on taxable bonds, loans and asset-backed securities are computed to the call or maturity date, whichever is shorter, using the effective yield method. Withholding taxes on foreign dividends have been provided for in accordance with the Company’s understanding of the applicable country’s tax rules and rates.
Organization and Offering Costs
Organization costs are paid by the Adviser and include the cost of incorporating, such as the cost of legal services and other fees pertaining to our organization. Offering costs include legal fees, promotional costs and other costs pertaining to the public offering of our shares of common stock and are also paid by the Adviser. Prior to the termination of the offering, as we raised proceeds, these organization and offering costs were expensed and became payable to the Adviser. Organization and offering costs are limited to 1% of total gross proceeds raised and are not due and payable to the Adviser to the extent they exceed that amount. Please refer to Note 4 for additional information on Organization and Offering Costs.
 
21

Paid-in
Capital
The proceeds from the issuance of common stock as presented on the Company’s Statements of Changes in Net Assets is presented net of selling commissions and fees for the three months ended March 31, 2023 and March 31, 2022. Selling commissions and fees of $0 and $0 were paid for the three months ended March 31, 2023 and March 31, 2022, respectively.
Earnings Per Share
In accordance with the provisions of ASC Topic 260—
Earnings per Share
(“ASC Topic 260”), basic earnings per share is computed by dividing earnings available to common stockholders by the weighted average number of shares outstanding during the period. Other potentially dilutive common shares, and the related impact to earnings, are considered when calculating earnings per share on a diluted basis.
The following table sets forth the computation of the weighted average basic and diluted net increase in net assets per share from operations:
 
    
For the three months ended
March 31,
 
    
2023
    
2022
 
Net increase (decrease) in net assets resulting from operations
   $ (977,817    $ 1,145,017  
Weighted average common shares outstanding
     9,699,655        9,990,797  
Earnings (loss) per common share-basic and diluted
   $ (0.10    $ 0.11  
Distributions
Distributions to the Company’s stockholders will be recorded as of the record date. Subject to the discretion of the Board and applicable legal restrictions, the Company intends to authorize and declare ordinary cash distributions on a weekly basis and pay such distributions on a quarterly basis. Net realized capital gains, if any, will generally be distributed or deemed distributed at least every
12-month
period.
On June 24, 2020, the Board approved a change in its dividend and capital gains distribution schedule from monthly distributions to quarterly distributions, effective immediately. The first quarterly distribution was paid on October 12, 2020 to shareholders of record as of September 30, 2020. The dividends are expected to be declared in the amount of $0.09 per share of the Company’s common stock to the stockholders of record at each quarter end.
Recent Accounting Pronouncements
In March 2020, the FASB issued Accounting Standards Update (“ASU”)
No. 2020-04,
“Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting” which provides optional exceptions for applying GAAP to contract modifications, hedging relationships and other transactions affected by reference rate reform if certain criteria are met. ASU
No. 2020-04
is elective and effective for all entities as of March 12, 2020 through December 31, 2022. The Company is currently evaluating the impact of ASU
No. 2020-04.
Please refer to Note 8 for additional information.
 
22

Note 3 — Investment Portfolio
The following table shows the composition of the Company’s invested assets by industry classification at fair value at March 31, 2023:
 
    
Fair value
    
Percentage
 
Assets
                 
Healthcare
   $ 21,288,682        43.7
Real Estate
     12,208,413        25.0
Telecommunication Services
     6,134,537        12.6
Financials
     3,139,780        6.4
Consumer Products
     2,841,603        5.8
Energy
     1,781,926        3.7
Real Estate Investment Trusts (REITs)
     1,022,291        2.1
Media/Telecommunications
     269,529        0.6
Chemicals
     42,500        0.1
Service
     2,268        0.0
    
 
 
    
 
 
 
Total Assets
  
$
48,731,529
 
  
 
100.0
    
 
 
    
 
 
 
The following table shows the composition of the Company’s invested assets by industry classification at fair value at December 31, 2022:
 
    
Fair value
    
Percentage
 
Assets
                 
Healthcare
   $ 26,101,074        49.0
Real Estate
     11,613,222        21.7
Telecommunication Services
     6,183,457        11.6
Consumer Products
     3,088,750        5.8
Financials
     3,180,161        6.0
Energy
     1,752,941        3.3
Real Estate Investment Trusts (REITs)
     1,018,779        1.9
Media/Telecommunications
     310,562        0.6
Chemicals
     42,500        0.1
Service
     2,269        0.0
    
 
 
    
 
 
 
Total Assets
  
$
53,293,715
 
  
 
100.0
    
 
 
    
 
 
 
 
23

The following table summarizes the amortized cost and the fair value of the Company’s invested assets by class of financial asset as of March 31, 2023:
 
    
Amortized Cost
    
Fair value
    
Percentage of
Portfolio
(at Fair Value)
 
Assets
 
        
Senior Secured Loans - First Lien
   $ 13,218,569      $ 8,961,395        18.4
Senior Secured Loans - Second Lien
     1,485,503        1,070,222        2.2
Asset-Backed Securities
     388,541        7,280        0.0
Corporate Bonds
     3,375,246        2,500,245        5.1
Common Stocks
     9,705,017        13,883,249        28.5
LLC Interests
     10,734,196        10,164,439        20.9
Preferred Stocks
     11,829,987        11,981,888        24.6
Warrants
     74,284        162,811        0.3
    
 
 
    
 
 
    
 
 
 
Total Assets
  
$
50,811,343
 
  
$
48,731,529
 
  
 
100.0
    
 
 
    
 
 
    
 
 
 
The following table summarizes the amortized cost and the fair value of the Company’s invested assets by class of financial asset as of December 31, 2022:
 
    
Amortized Cost
    
Fair value
    
Percentage of
Portfolio
(at Fair Value)
 
Assets
 
        
Senior Secured Loans - First Lien
   $ 14,645,106      $ 11,575,821        21.7
Senior Secured Loans - Second Lien
     2,976,056        2,652,372        5.0
Asset-Backed Securities
     388,541        7,036        0.0
Corporate Bonds
     3,358,783        2,704,917        5.1
Common Stocks
     17,073,102        19,514,684        36.6
LLC Interests
     3,666,112        4,689,242        8.8
Preferred Stocks
     11,829,987        11,967,910        22.5
Warrants
     74,284        181,733        0.3
    
 
 
    
 
 
    
 
 
 
Total Assets
  
$
54,011,971
 
  
$
53,293,715
 
  
 
100.0
    
 
 
    
 
 
    
 
 
 
The following table shows the composition of the Company’s invested assets by geographic classification at March 31, 2023:
 
Geography
  
Fair value
    
Percentage
 
Assets
 
Cayman Islands
(1)
   $ 7,280        0.0
Luxembourg
(1)
     1,331,038        2.7
United States
     47,393,211        97.3
    
 
 
    
 
 
 
Total Assets
  
$
48,731,529
 
  
 
100.0
    
 
 
    
 
 
 
 
(1)
 
Investment denominated in USD
.
 
24

The following table shows the composition of the Company’s invested assets by geographic classification at December 31, 2022:
 
Geography
  
Fair value
    
Percentage
 
Assets
 
Cayman Islands
(1)
   $ 7,036        0.0
Luxembourg
(1)
     1,318,346        2.5
United States
     51,968,333        97.5
    
 
 
    
 
 
 
Total Assets
  
$
53,293,715
 
  
 
100.0
    
 
 
    
 
 
 
 
(1)
 
Investment denominated in USD.
Note 4 — Related Party Transactions and Arrangements
Investment Advisory Fee
Payments for investment advisory services under the Company’s investment advisory agreement (the “Investment Advisory Agreement”) and administrative services agreement (the “Administration Agreement”) are equal to (a) a base management fee calculated at an annual rate of 2.0% of the average value of the Company’s gross assets at the end of the two most recently completed calendar quarters and (b) an incentive fee based on the Company’s performance. Effective June 5, 2017, the Investment Advisory Agreement and the Administration Agreement were amended to exclude cash and cash equivalents from the calculation of gross assets for the purpose of calculating investment advisory and administration fees.
For the three months ended March 31, 2023 and March 31, 2022, the Company incurred investment advisory fees payable to the Adviser of $265,381 and $299,270, respectively. Amounts waived for investment advisory fees or administrative fees pertaining to periods prior to June 10, 2016 are not recoupable, but amounts waived for investment advisory fees or administrative fees pertaining to periods from and after June 10, 2016 are subject to recoupment by the Adviser within three years from the date that such fees were otherwise payable, provided that the recoupment will be limited to the amount of such voluntarily waived fees from and after June 10, 2016 and will not cause the sum of the Company’s investment advisory fees, administration fees, Other Expenses (as defined under “Expense Limits and Reimbursements” below), and any recoupment to exceed the annual rate of 3.40% of average gross assets. Effective December 20, 2017, the Adviser ended its voluntary waiver of advisory fees.
Incentive Fee
The incentive fee consists of two parts. The first part, which is referred to as the subordinated incentive fee on income, is calculated and payable quarterly in arrears, and equals 20.0% of
“pre-incentive
fee net investment income” for the immediately preceding quarter and is subject to a hurdle rate, expressed as a rate of return on the Company’s net assets, as defined in the Investment Advisory Agreement, equal to 1.875% per quarter. As a result, the Adviser will not earn this incentive fee for any quarter until the Company’s
pre-incentive
fee net investment income for such quarter exceeds the hurdle rate of 1.875%. Once the Company’s
pre-incentive
fee net investment income in any quarter exceeds the hurdle rate, the Adviser will be entitled to a
“catch-up”
fee equal to the amount of the
pre-incentive
fee net investment income in excess of the hurdle rate, until the Company’s
pre-incentive
fee net investment income for such quarter equals 2.34375% of the Company’s net assets at the end of such quarter. This
“catch-up”
feature allows the Adviser to recoup the fees foregone as a result of the existence of the hurdle rate in that quarter. Thereafter, the Adviser will receive 20.0% of the Company’s
pre-incentive
fee net investment income from the quarter.
The second part of the incentive fee, which is referred to as the incentive fee on capital gains, is determined and payable in arrears as of the end of each calendar year (or upon termination of the Investment Advisory Agreement). This fee equals 20.0% of the Company’s incentive fee capital gains, which will equal the Company’s realized capital gains on a cumulative basis from formation, calculated as of the end of the applicable period, computed net of all realized capital losses (proceeds less amortized cost) and unrealized capital depreciation on a cumulative basis, less the aggregate amount of any previously paid capital gains incentive fees. The Company will accrue for the capital gains incentive fee, which, if earned, will be paid annually. The Company will accrue for the capital gains incentive fee based on net realized and unrealized gains; however, under the terms of the Investment Advisory Agreement, the fee payable to the Adviser will be based on realized gains and no such fee will be payable with respect to unrealized gains unless and until such gains are actually realized.
For the three months ended March 31, 2023 and March 31, 2022, the Company incurred $0 and recognized a reduction $0 of incentive fees on capital gains, respectively. Since inception, the Company has accrued $0 of incentive fees on capital gains in aggregate. Effective December 20, 2017, the Adviser ended its voluntary waiver of incentive fees. No such fees have been paid with respect to realized gains to the Adviser as of March 31, 2023.
 
25

Administration Fee
Pursuant to the Administration Agreement with the Adviser, the Company also reimburses the Adviser for expenses necessary for its performance of services related to the Company’s administration and operations. The amount of the reimbursement will be the lesser of (1) the Company’s allocable portion of overhead and other expenses incurred by the Adviser in performing its obligations under the Administration Agreement and (2) 0.40% of the Company’s average gross assets, (excluding cash and cash equivalents). The Adviser is required to allocate the cost of such services to the Company based on objective factors such as assets, revenues, time allocations and/or other reasonable metrics. The Board assesses the reasonableness of such reimbursements based on the breadth, depth and quality of such services as compared to the estimated cost to the Company of obtaining similar services from third-party service providers known to be available. In addition, the Board will consider whether any single third-party service provider would be capable of providing all such services at comparable cost and quality. Finally, the Board will compare the total amount paid to the Adviser for such services as a percentage of the Company’s net assets to the same ratio as reported by other comparable BDCs.
For the three months ended March 31, 2023 and March 31, 2022, the Company incurred administration fees payable to the Adviser of $52,321 and $59,601, respectively. Amounts waived for management fees or administrative services expenses pertaining to periods prior to June 10, 2016 are not recoupable, but amounts waived for management fees or administrative services, expenses pertaining to periods from and after June 10, 2016 are subject to recoupment by the Adviser within three years from the date that such fees were otherwise payable, provided that the recoupment will be limited to the amount of such voluntarily waived fees from and after June 10, 2016 and will not cause the sum of the Company’s advisory fees, administration fees, Other Expenses, and any recoupment to exceed the annual rate of 3.40% of average gross assets. Effective December 20, 2017, the Adviser ended its voluntary waiver of administration fees.
Organization and Offering Costs
Organization costs include the cost of incorporating, such as the cost of legal services and other fees pertaining to our organization, and are paid by the Adviser. For the three months ended March 31, 2023 and March 31, 2022, the Adviser did not incur or pay organization costs on our behalf.
Offering costs include legal fees, promotional costs and other costs pertaining to the public offering of our shares of common stock, and are capitalized and amortized to expense over one year. The Company’s continuous public offering ended on February 14, 2018.
Organization costs and offering costs are limited to 1% of total gross proceeds raised in the offering and are not due and payable to the Adviser to the extent they exceed that amount. As of March 31, 2023, the cumulative aggregate amount of $5,327,574 of organization and offering costs exceeds 1% of total proceeds raised. Subsequent to the termination of the offering, the Adviser forfeited the right to reimbursement of the remaining $4,305,091 of these costs.
Fees Paid to Officers and Directors
Each director who oversees all of the portfolios in the Fund Complex (as defined below) receives an annual retainer of $
150,000 payable in quarterly installments and allocated among each portfolio in the Fund Complex based on relative net assets. The annual retainer for a director who does not oversee all of the portfolios in the Fund Complex is prorated based on the portion of the $150,000 annual retainer allocable to the portfolios overseen by such director. Directors are reimbursed for actual
out-of-pocket
expenses relating to attendance at meetings. In addition, the Chairman of the Board and the Chairman of the Audit and Qualified Legal Committee each receive an additional payment of $10,000 payable in quarterly installments and allocated among each portfolio in the Fund Complex based on relative net assets. The Directors do not receive any separate compensation in connection with service on Committees or for attending Board or Committee Meetings. They do not have any pension or retirement plan. The “Fund Complex” consists of all of the RICs advised by the Adviser and any affiliates as of the period covered by this report. The Company pays no compensation to any of its officers, all of whom are employed by the Adviser, its affiliates or Skyview Group, Inc. (“Skyview”).
For the three months ended March 31, 2023 and March 31, 2022, the Company recorded an expense relating to director fees of $4,967 and $3,731, respectively, which represents the allocation of the director fees to the Company. As of March 31, 2023, there was no expenses payable relating to director fees.
 
26

Expense Limits and Reimbursements
Pursuant to an expense limitation agreement, the Adviser is contractually obligated to waive fees and, if necessary, pay or reimburse certain other expenses to limit the ordinary “Other Expenses” to 1.0% of the
quarter-end
value of the Company’s gross assets through the one year anniversary of the effective date of the registration statement (the “Expense Limitation Agreement”). Under the Expense Limitation Agreement, “Other Expenses” are all expenses with the exception of advisor and administration fees, organization and offering costs and the following: (i) interest, taxes, dividends tied to short sales, brokerage commissions, and other expenditures which are capitalized in accordance with GAAP; (ii) expenses incurred indirectly as a result of investments in other investment companies and pooled investment vehicles; (iii) other expenses attributable to, and incurred as a result of, our investments; (iv) expenses payable to the Adviser, as administrator, for providing significant managerial assistance to our portfolio companies; and (v) other extraordinary expenses (including litigation expenses) not incurred in the ordinary course of our business. The obligation will automatically renew for
one-year
terms unless it is terminated by the Company or the Adviser upon written notice within 60 days of the end of the current term or upon termination of the Investment Advisory Agreement. The Expense Limitation Agreement will continue through at least April 30, 202
4
.
Any expenses waived or reimbursed by the Adviser pursuant to the Expense Limitation Agreement are subject to possible recoupment by the Adviser within three years from the date of the waiver or reimbursement. The recoupment by the Adviser will be limited to the amount of previously waived or reimbursed expenses and cannot cause the Company’s expenses to exceed any expense limitation in place at the time of recoupment or waiver.
Reimbursable Expenses Table
The cumulative total of fees waived by the Adviser under the Expense Limitation Agreement, which are recoupable as of March 31, 2023 is $919,754. This balance, and the balances in the tables below, only include amounts pertaining to the Expense Limitation Agreement, and do not include waived advisory and administration fees subject to recoupment discussed earlier in Note 4. The following table reflects the fee waivers and expense reimbursements due from the Adviser as of March 31, 2023, which may become subject to recoupment by the Adviser.
 
Period ended
  
 Yearly cumulative 

other expense
 
  
Yearly expense

limitation
 
  
Yearly cumulative
expense
reimbursement
 
  
Quarterly
    recoupable/    
(recouped)
amount
 
  
    Recoupment    

eligibility
expiration
 
March 31, 2023
   $ 208,486      $ 126,628      $ 81,858      $ 81,858               March 31, 2026  
 
Period ended
  
 Yearly cumulative 

other expense
    
Yearly expense
limitation
    
Yearly cumulative
expense
reimbursement
    
Quarterly
    recoupable/    
(recouped)
amount
    
Recoupment
eligibility
expiration
 
December 31, 2022
   $ 913,273      $ 535,679      $ 377,594      $ 92,216        December 31, 2025  
September 30, 2022
   $ 678,333      $ 392,955      $ 285,378      $ 124,667        September 30, 2025  
June 30, 2022
   $ 434,019      $ 273,308      $ 160,711      $ 98,950        June 30, 2025  
March 31, 2022
   $ 211,896      $ 150,135      $ 61,761      $ 61,761        March 31, 2025  
The following table reflects the fee waivers and expense reimbursements due from the Adviser as of December 31, 2021, September 30, 2021, June 30, 2021 and March 31, 2021, which may become subject to recoupment by the Adviser.
 
Period ended
  
 Yearly cumulative 

other expense
    
Yearly expense
limitation
    
Yearly cumulative
expense
reimbursement
    
Quarterly
    recoupable/    
(recouped)
amount
    
Recoupment
eligibility
expiration
 
December 31, 2021
   $ 892,640      $ 597,379      $ 295,261      $ 94,762        December 31, 2024  
September 30, 2021
   $ 664,052      $ 463,553      $ 200,499      $ 68,134        September 30, 2024  
June 30, 2021
   $ 436,866      $ 304,501      $ 132,365      $ 68,919        June 30, 2024  
March 31, 2021
   $ 220,126      $ 156,680      $ 63,446      $ 63,446        March 31, 2024  
 
27

The following table reflects the fee waivers and expense reimbursements due from the Adviser as of December 31, 2020, September 30, 2020, June 30, 2020 and March 31, 2020, which may become subject to recoupment by the Adviser.
 
Period ended
  
Yearly cumulative
other expense
    
Yearly expense
limitation
    
Yearly cumulative
expense
reimbursement
    
Quarterly
recoupable/
(recouped)
amount
   
Recoupment
eligibility
expiration
 
December 31, 2020
   $ 989,447      $ 639,959      $ 349,488      $ 101,541       December 31, 2023  
September 30, 2020
     687,228        439,281        247,947        94,039       September 30, 2023  
June 30, 2020
     445,585        291,677        153,908        (30,539     June 30, 2023  
March 31, 2020
     257,226        72,779        184,447                 Expired  
During the three months ended March 31, 2023, $184,447 of expense reimbursements that were eligible for recoupment by the Adviser expired.
There can be no assurance that the Expense Limitation Agreement will remain in effect or that the Adviser will reimburse any portion of the Company’s expenses in future quarters not covered by the Expense Limitation Agreement. Amounts shown do not include the amounts committed by the Adviser to voluntarily reimburse the Company for unrealized losses, all of which are not recoupable.
Net Increase from Amounts Committed by Affiliates
For the three months ended March 31, 2023 and March 31, 2022, the Adviser did not voluntarily reimburse the Company for unrealized losses sustained. Cumulatively since inception, the Adviser has committed $2,275,000
to voluntarily reimburse the Company for such losses. Had these commitments not been made, since inception, the NAV as of March 31, 2023 would have been lower by approximately this amount.
Amounts committed and paid by the Adviser to reimburse for unrealized losses are nonrecurring, and investors should not expect the Adviser to make similar commitments or payments in the future.
Receivable from Adviser / Payable to Adviser
As of March 31, 2023 and December 31, 2022, $81,858 and $92,216 were owed from the Adviser to the Company, respectively, largely related to the expense limitation agreement.
As of March 31, 2023 and December 31, 2022, the Company owed $317,702 and $314,993, respectively, to the Adviser, largely related to advisory fees, and administration fees.
Indemnification
Under the Company’s organizational documents, the officers and Directors have been granted certain indemnification rights against certain liabilities that may arise out of performance of their duties to the Company. Additionally, in the normal course of business, the Company may enter into contracts with service providers that contain a variety of indemnification clauses. The Company’s maximum exposure under these arrangements is dependent on future claims that may be made against the Company and, therefore, cannot be estimated.
Note 5 — U.S. Federal Income Tax Information
The Company has elected to be treated for federal income tax purposes, and intends to qualify annually, as a RIC under Subchapter M of the Code. To maintain its qualification as a RIC, the Company must, among other things, meet certain
source-of-income
and asset diversification requirements and distribute to its stockholders, for each taxable year, at least 90% of its “investment company taxable income,” which is generally the Company’s net ordinary income plus the excess, if any, of realized net short-term capital gains over realized net long-term capital losses. As a RIC, the Company will not be subject to corporate-level federal income taxes on any income that it timely distributes to its stockholders. The Company intends to make distributions in an amount sufficient to maintain its RIC status each year and to avoid any federal income taxes on income so distributed. The Company will also be subject to nondeductible federal excise taxes if it does not distribute at least 98% of net ordinary income, 98.2% of any capital gain net income, if any, and any recognized and undistributed income from prior years on which it paid no federal income taxes.
 
28

The character of income and capital gains to be distributed is determined in accordance with the Code, U.S. Treasury regulations, and other applicable authority, which may differ from GAAP. These differences include (but are not limited to) investments organized as partnerships for tax purposes, total return swaps, loan investments, and losses deferred due to wash sale transactions. Reclassifications are made to the Company’s capital accounts to reflect income and gains available for distribution (or available capital loss carryovers) under the Code, U.S. Treasury regulations, and other applicable authority. These reclassifications have no impact on net investment income, realized gains or losses, or net asset value of the Company. The calculation of net investment income per share in the Financial Highlights table excludes these adjustments.
Uncertainty in Income Taxes
The Company will evaluate its tax positions to determine if the tax positions taken meet the minimum recognition threshold in connection with accounting for uncertainties in income tax positions taken or expected to be taken for the purposes of measuring and recognizing tax benefits or liabilities in the financial statements. Recognition of a tax benefit or liability with respect to an uncertain tax position is required only when the position is “more likely than not” to be sustained assuming examination by taxing authorities. The Company’s tax returns are subject to examination by the Internal Revenue Service for a period of three fiscal years after they are filed. The Company recognizes interest and penalties, if any, related to unrecognized tax liabilities as income tax expense in the Statements of Operations. During the three months ended March 31, 2023 and March 31, 2022, the Company did not incur any interest or penalties. Furthermore, management of the Company is also not aware of any tax positions for which it is reasonably possible that the total amounts of unrecognized tax benefits will significantly change in the next 12 months.
Note 6 — Share Repurchase Program
On a quarterly basis, the Company intends to offer to repurchase shares of common stock on such terms as may be determined by the Board in its complete and absolute discretion unless, in the judgment of directors who are not “interested persons” of the Company (as defined in the 1940 Act), such repurchases would not be in the best interests of the Company’s stockholders or would violate applicable law. The Company will conduct such repurchase offers in accordance with the requirements of Rule
13e-4
of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and the 1940 Act. Any offer to repurchase shares of common stock will be conducted solely through tender offer materials furnished to each stockholder.
The Company currently intends to limit the number of shares of common stock to be repurchased during any calendar year to the number of shares of common stock it can repurchase with the proceeds it receives from the sale of shares of common stock under its distribution reinvestment plan. At the discretion of the Board, the Company may also use cash on hand, cash available from borrowings and cash from liquidation of securities investments as of the end of the applicable period to repurchase shares of common stock. In addition, the Company will limit the number of shares of common stock to be repurchased in any calendar year to 10.0% of the weighted average number of shares of common stock outstanding in the prior calendar year, or 2.5% in each quarter, though the actual number of shares of common stock that the Company offers to repurchase may be less in light of the limitations noted above. The Company intends to offer to repurchase such shares of common stock at a price (i) not less than the net asset value per share (the “NAV Per Share”) of the Company’s common stock next calculated following the Expiration Date, and (ii) not more than 2.5% greater than the NAV Per Share as of such date. The Board may amend, suspend or terminate the share repurchase program at any time, upon 30 days’ notice.
The Company conducted its quarterly tender offer for the first quarter of 2023 from February 23, 2023, until expiration of March 24 2023
,
at 4:00 p.m. New York City time, during which the Company offered to purchase for cash up to 2.5% of its outstanding shares of common stock. During the first quarter tender offer, 181,298 shares of the Company were tendered for repurchase, constituting approximately 1.86% of the Company’s outstanding shares.
For the three months ended March 31, 2023, the Company repurchased 0 shares as part of its death and disability repurchase program.
Note 7 — Economic Dependency and Commitments and Contingencies
The Adviser has entered into a Services Agreement with Skyview, effective February 25, 2021, pursuant to which the Adviser will receive administrative and operational support services to enable it to provide the required advisory services to the Company. The Adviser, and not the Company, will compensate all Adviser and Skyview personnel who provide services to the Company.
From time to time, the Company may be involved in legal proceedings in the normal course of its business. Although the outcome of such litigation cannot be predicted with any clarity, management is of the opinion, bas
ed on
the advice of legal counsel, that final dispositions of any litigation should not have a material adverse effect on the financial position of the Company as of March 31, 2023.
 
29

Unfunded commitments to provide funds to portfolio companies are not recorded in the Company’s Statements of Assets and Liabilities. Since these commitments may expire without being drawn upon, the total commitment amount does not necessarily represent future cash requirements. The Company has sufficient liquidity to fund these commitments. As of March 31, 2023, the Company had no unfunded debt commitments.
In the normal course of business, the Company enters into contracts and agreements that contain a variety of representations and warranties that provide general indemnification. The Company’s maximum exposure under these agreements is unknown, as this would involve future claims that may be made against the Company that have not occurred. The Company believes the risk of material obligations under these indemnities to be low.
Note 8 — Market and Other Risk Factors
The primary risks of investing in the Company are described below in alphabetical order:
Conflict of Interest Risk
The Adviser or its affiliates may have other clients with similar, different or competing investment objectives. In serving in these multiple capacities, they may have obligations to other clients or investors in those other entities, the fulfillment of which may not be in the best interests of us or our stockholders. For example, our Adviser and its affiliates manage or sponsor other investment funds, accounts or other investment vehicles. Our investment objective may overlap with the investment objectives of such affiliated investment funds, accounts or other investment vehicles. As a result, our Adviser may face conflicts of interest in the allocation of investment opportunities among us and other investment funds, accounts or other investment vehicles advised by or affiliated with our Adviser. Our Adviser will seek to allocate investment opportunities among eligible accounts in a manner that is fair and equitable over time and consistent with its allocation policy. However, we can offer no assurance that such opportunities will be allocated to us fairly or equitably in the short-term or over time. Where we are able to co- invest consistent with the requirements of the 1940 Act and SEC exemptive relief, if sufficient securities or loan amounts are available to satisfy our and each such account’s proposed demand, the opportunity will be allocated in accordance with our Adviser’s pre-transaction determination and the requirements of the exemptive relief. If there is an insufficient amount of an investment opportunity to satisfy our demand and that of other accounts sponsored or managed by our Adviser or its affiliates, the allocation policy and exemptive relief further provides that allocations among us and such other accounts will generally be made pro rata based on the amount that each such party would have invested if sufficient loan amounts were available. However, there can be no assurance that we will be able to participate in all suitable investment opportunities.
Concentration Risk
The Company is classified as a
non-diversified
investment company within the meaning of the 1940 Act, which means that it is not limited by the 1940 Act with respect to the proportion of the Company’s assets that it may invest in securities of a single issuer. To the extent that the Company assumes large positions in the securities of a small number of issuers, the Company’s net asset value may fluctuate to a greater extent than that of a diversified investment company as a result of changes in the financial condition or the market’s assessment of the issuer. The Company may also be more susceptible to any single economic or regulatory occurrence than a diversified investment company. Beyond the asset diversification requirements associated with the Company’s qualification as a RIC under the Code and certain contractual diversification requirements under a credit facility or other agreements, the Company does not have fixed guidelines for diversification, and its investments could be concentrated in relatively few portfolio companies. As a result, the aggregate returns the Company realizes may be significantly adversely affected if a small number of investments perform poorly or if the Company needs to write down the value of any one investment. Additionally, the Company’s investments may be concentrated in relatively few industries. As a result, a downturn in any particular industry in which the Company is invested could also significantly impact the aggregate returns realized.
Covenant-Lite Loans Risk
Loans in which the Company invests include covenant-lite loans, which carry more risk to the lender than traditional loans as they may contain fewer or less restrictive covenants on the borrower than traditionally included in loan documentation or may contain other borrower friendly characteristics. The Company may experience relatively greater difficulty or delays in enforcing its rights on its holdings of certain covenant-lite loans and debt securities than its holdings of loans or securities with the usual covenants.
Counterparty Credit Risk
Counterparty credit risk is the potential loss the Company may incur as a result of the failure of a counterparty or an issuer to make payments according to the terms of a contract. Counterparty credit risk is measured as the loss the Company would record if its counterparties failed to perform pursuant to the terms of their obligations to the Company. Because the Company may enter into
over-the-counter
forwards, options, swaps and other derivative financial instruments, the Company may be exposed to the credit risk of its counterparties. To limit the counterparty credit risk associated with such transactions, the Company conducts business only with financial institutions judged by the Adviser to present acceptable credit risk.
Credit Risk
Debt securities are subject to the risk of
non-payment
of scheduled interest and/or principal.
Non-payment
would result in a reduction of income to the Company, a reduction in the value of the obligation experiencing
non-payment
and a potential decrease in the Company’s net asset value.
Investments rated below investment grade are commonly referred to as high-yield, high risk or “junk debt.” They are regarded as predominantly speculative with respect to the issuing company’s continuing ability to meet principal and/or interest payments. Investments in high yield debt and high yield senior loans may result in greater net asset value fluctuation than if the Company did not make such investments. Corporate debt obligations, including senior loans, are subject to the risk of
non-payment
of scheduled interest and/or principal.
 
30

Non-payment
would result in a reduction of income to the Company, a reduction in the value of the corporate debt obligation experiencing
non-payment
and a potential decrease in the net asset value of the Company. Some of the loans the Company makes or acquires may provide for the payment by borrowers of
Payment-In-Kind
(“PIK”) interest or accreted original issue discount at maturity. Such loans have the effect of deferring a borrower’s payment obligation until the end of the term of the loan, which may make it difficult for the Company to identify and address developing problems with borrowers in terms of their ability to repay debt. Particularly in a rising interest rate environment, loans containing PIK and original issue discount provisions can give rise to negative amortization on a loan, resulting in a borrower owing more at the end of the term of a loan than what it owed when the loan was originated. Any such developments may increase the risk of default on the Company’s loans by borrowers.
Because loans are not ordinarily registered with the SEC or any state securities commission or listed on any securities exchange, there is usually less publicly available information about such instruments. In addition, loans may not be considered “securities” for purposes of the anti-fraud protections of the federal securities laws and, as a result, as a purchaser of these instruments, the Company may not be entitled to the anti-fraud protections of the federal securities laws. In the course of investing in such instruments, the Company may come into possession of material nonpublic information and, because of prohibitions on trading in securities of issuers while in possession of such information, the Company may be unable to enter into a transaction in a publicly-traded security of that issuer when it would otherwise be advantageous for us to do so. Alternatively, the Company may choose not to receive material nonpublic information about an issuer of such loans, with the result that the Company may have less information about such issuers than other investors who transact in such assets.
Foreign Securities Risk
Investments in foreign securities involve certain factors not typically associated with investing in U.S. securities, such as risks relating to (i) currency exchange matters, including fluctuations in the rate of exchange between the U.S. dollar (the currency in which the books of the Company are maintained) and the various foreign currencies in which the Company’s portfolio securities will be denominated and costs associated with conversion of investment principal and income from one currency into another; (ii) differences between the U.S. and foreign securities markets, including the absence of uniform accounting, auditing and financial reporting standards and practices and disclosure requirements, and less government supervision and regulation; (iii) political, social or economic instability; and (iv) the extension of credit, especially in the case of sovereign debt.
Illiquid Securities Risk
The Company will generally make investments in private companies. Substantially all of these investments will be subject to legal and other restrictions on resale or will otherwise be less liquid than publicly traded securities. The illiquidity of the Company’s investments may make it difficult for the Company to sell such investments if the need arises. In addition, if it is required to liquidate all or a portion of its portfolio quickly, the Company may realize significantly less than the value at which it has previously recorded its investments. In addition, it may face other restrictions on its ability to liquidate an investment in a portfolio company to the extent that it has material
non-public
information regarding such portfolio company or if an investment is held by one of its subsidiaries and is subject to contractual limitations on sale, such as the limitations on transfer of assets under certain circumstances under a credit facility.
The Company may seek to address its short-term liquidity needs by carefully managing the settlements of its portfolio transactions, including transactions in loans, by maintaining short-term liquid assets sufficient to meet reasonably anticipated obligations, and by maintaining a credit facility.
Interest Rate Risk
Interest Rate risk is the risk that fixed income securities will decline in value because of changes in interest rates. When interest rates decline, the value of fixed rate securities already held by the Company can be expected to rise. Conversely, when interest rates rise, the value of existing fixed rate portfolio securities can be expected to decline. A company with a longer average portfolio duration will be more sensitive to changes in interest rates than a fund with a shorter average portfolio duration Recent and potential future changes in government monetary policy may affect the level of interest rates.
 
31

Investments in Foreign Markets Risk
Investments in foreign markets involve special risks and considerations not typically associated with investing in the United States. These risks include revaluation of currencies, high rates of inflation, restrictions on repatriation of income and capital, and adverse political and economic developments. Moreover, securities issued in these markets may be less liquid, subject to government ownership controls, tariffs and taxes, subject to delays in settlements, and their prices may be more volatile. The Company may be subject to capital gains and repatriation taxes imposed by certain countries in which they invest. Such taxes are generally based on income and/or capital gains earned or repatriated. Taxes are accrued based upon net investment income, net realized gains and net unrealized appreciation as income and/or capital gains are earned.
Leverage Risk
The Company may use leverage in its investment program, including the use of borrowed funds and investments in certain types of options, such as puts, calls and warrants, which may be purchased for a fraction of the price of the underlying securities. While such strategies and techniques increase the opportunity to achieve higher returns on the amounts invested, they also increase the risk of loss. To the extent the Company purchases securities with borrowed funds, its net assets will tend to increase or decrease at a greater rate than if borrowed funds are not used. If the interest expense on borrowings were to exceed the net return on the portfolio securities purchased with borrowed funds, the Company’s use of leverage would result in a lower rate of return than if the Company were not leveraged.
LIBOR Transition and Associated Risk
LIBOR is the average offered rate for various maturities of short-term loans between major international banks who are members of the British Bankers Association. LIBOR is the most common benchmark interest rate index used to make adjustments to variable-rate loans. It is used throughout global banking and financial industries to determine interest rates for a variety of financial instruments (such as debt instruments and derivatives) and borrowing arrangements.
Due to manipulation allegations in 2012 and reduced activity in the financial markets that it measures, in July 2017, the Financial Conduct Authority (the “FCA”), the United Kingdom financial regulatory body, announced a desire to phase out the use of LIBOR by the end of 2021 and that it will stop encouraging banks to provide the quotations needed to sustain LIBOR. The ICE Benchmark Administration Limited, the administrator of LIBOR, ceased publishing most LIBOR maturities, including some US LIBOR maturities, on December 31, 2021, and is expected to cease publishing the remaining and most liquid US LIBOR maturities on June 30, 2023. It is expected that market participants have or will transition to the use of alternative reference or benchmark rates prior to the applicable LIBOR publication cessation date. Additionally, although regulators have encouraged the development and adoption of alternative rates, such as the Secured Overnight Financing Rate (“SOFR”), the future utilization of LIBOR or of any particular replacement rate remains uncertain.
Although the transition process away from LIBOR has become increasingly well defined in advance of the anticipated discontinuation dates, the impact on certain debt securities, derivatives and other financial instruments remains uncertain. It is expected that market participants will adopt alternative rates such as SOFR or otherwise amend financial instruments referencing LIBOR to include fallback provisions and other measures that contemplate the discontinuation of LIBOR or other similar market disruption events, but neither the effect of the transition process nor the viability of such measures is known. Further, uncertainty and risk remain regarding the willingness and ability of issuers and lenders to include alternative rates and revised provisions in new and existing contracts or instruments. To facilitate the transition of legacy derivatives contracts referencing LIBOR, the International Swaps and Derivatives Association, Inc. launched a protocol to incorporate fallback provisions. While the transition process away from LIBOR has become increasingly well defined in advance of the expected LIBOR cessation dates, there are obstacles to converting certain longer term securities and transactions to a new benchmark or benchmarks and the effectiveness of one alternative reference rate versus multiple alternative reference rates in new or existing financial instruments and products has not been determined. Furthermore, the risks associated with the cessation of LIBOR and transition to replacement rates may be exacerbated if an orderly transition to alternative reference rates is not completed in a timely manner. Certain proposed replacement rates to LIBOR, such as SOFR, which is a broad measure of secured overnight US Treasury repo rates, are materially different from LIBOR, and changes in the applicable spread for financial instruments transitioning away from LIBOR will need to be made to accommodate the differences. Furthermore, the risks associated with the expected discontinuation of LIBOR and transition to replacement rates may be exacerbated if an orderly transition to an alternative reference rate is not completed in a timely manner. As market participants transition away from LIBOR, LIBOR’s usefulness may deteriorate and the effects could be experienced until the permanent cessation of the majority of U.S. LIBOR rates in 2023. The transition process may lead to increased volatility and illiquidity in markets that currently rely on LIBOR to determine interest rates. LIBOR’s deterioration may adversely affect the liquidity and/or market value of securities that use LIBOR as a benchmark interest rate.
 
32

Alteration of the terms of a debt instrument or a modification of the terms of other types of contracts to replace LIBOR or another interbank offered rate (“IBOR”) with a new reference rate could result in a taxable exchange and the realization of income and gain/loss for U.S. federal income tax purposes. The Internal Revenue Service (“IRS”) has issued final regulations regarding the tax consequences of the transition from IBOR to a new reference rate in debt instruments and
non-debt
contracts. Under the final regulations, alteration or modification of the terms of a debt instrument to replace an operative rate that uses a discontinued IBOR with a qualified rate (as defined in the final regulations) including true up payments equalizing the fair market value of contracts before and after such IBOR transition, to add a qualified rate as a fallback rate to a contract whose operative rate uses a discontinued IBOR or to replace a fallback rate that uses a discontinued IBOR with a qualified rate would not be taxable. The IRS may provide additional guidance, with potential retroactive effect.
Operational and Technology Risk
The risk that cyber-attacks, disruptions, or failures that affect the Funds’ service providers, counterparties, market participants, or issuers of securities held by the Funds may adversely affect the Funds and its shareholders, including by causing losses for the Funds or impairing Fund operations.
Options Risk
There are several risks associated with transactions in options on securities. For example, there are significant differences between the securities and options markets that could result in an imperfect correlation between these markets, causing a given transaction not to achieve its objectives. A transaction in options or securities may be unsuccessful to some degree because of market behavior or unexpected events.
When the Company writes a covered call option, the Company forgoes, during the option’s life, the opportunity to profit from increases in the market value of the security covering the call option above the sum of the premium and the strike price of the call, but retains the risk of loss should the price of the underlying security decline. The writer of an option has no control over the time when it may be required to fulfill its obligation and once an option writer has received an exercise notice, it must deliver the underlying security in exchange for the strike price.
When the Company writes a covered put option, the Company bears the risk of loss if the value of the underlying stock declines below the exercise price minus the put premium. If the option is exercised, the Company could incur a loss if it is required to purchase the stock underlying the put option at a price greater than the market price of the stock at the time of exercise plus the put premium the Company received when it wrote the option. While the Company’s potential gain in writing a covered put option is limited to distributions earned on the liquid assets securing the put option plus the premium received from the purchaser of the put option, the Company risks a loss equal to the entire exercise price of the option minus the put premium.
Pandemics and Associated Economic Disruption Risk
An outbreak of respiratory disease caused by a novel coronavirus was first detected in China in late 2019 and subsequently spread globally (“COVID-19”). This coronavirus has resulted in and may continue to result in the closing of borders, enhanced health screenings, healthcare service preparation and delivery, quarantines, cancellations, disruptions to supply chains and customer activity, as well as general anxiety and economic uncertainty. The impact of this has resulted in a substantial economic volatility. Health crises caused by outbreaks of disease, such as the coronavirus, may exacerbate other
pre-existing
political, social and economic risks. The impact of this outbreak, and other epidemics and pandemics that may arise in the future, could continue to negatively affect the global economy, as well as the economies of individual countries, individual companies and the market in general in significant and unforeseen ways. For example, a widespread health crisis such as a global pandemic could cause substantial market volatility, exchange trading suspensions and closures, impact the Company’s ability to complete tender offer requests, and affect Company performance. Any such impact could adversely affect the Company’s performance, the performance of the issuers in which the Company invests, lines of credit available to the Company and may lead to losses on your investment in the Company. In addition, the increasing interconnectedness of markets around the world may result in many markets being affected by events or conditions in a single country or region or events affecting a single or small number of issuers.
The United States responded to the COVID-19 outbreak and resulting economic distress with fiscal and monetary stimulus packages, including the Coronavirus Aid, Relief, and Economic Security Act (the “CARES Act”) passed in late March 2020. The CARES Act provides for over $
2.2
 trillion in resources to small businesses, state and local governments, and individuals adversely impacted by the
COVID-19
pandemic. Further, in March 2021, the government passed the American Rescue Plan Act of 2021, a $
1.9
 trillion stimulus bill to accelerate the United States’ recovery from the economic and health effects of the
COVID-19
pandemic. In late December 2020, the government also passed a spending bill that included $900 billion in stimulus relief for the COVID-19 pandemic. In addition, in
mid-March
2020, the Fed cut interest rates to historically low levels and announced a new round of quantitative easing, including purchases of corporate and municipal government bonds. The Fed also enacted various programs to support liquidity operations and funding in the financial markets, including expanding its reverse
 
33

repurchase agreement operations, which added $1.5
trillion of liquidity to the banking system; establishing swap lines with other major central banks to provide dollar funding; establishing a program to support money market funds; easing various bank capital buffers; providing funding backstops for businesses to provide bridging loans for up to four years; and providing funding to help credit flow in asset-backed securities markets. In addition, the Fed extended credit to small- and
medium-sized
businesses. As the Fed “tapers” or reduces the amount of securities it purchases pursuant to quantitative easing, and/or if the Fed raises the federal funds rate, there is a risk that interest rates will rise, which could expose fixed-income and related markets to heightened volatility and could cause the value of the Company’s investments, and the Company’s NAV, to decline, potentially suddenly and significantly. As a result, the Company may experience high redemptions and, as a result, increased portfolio turnover, which could increase the costs that the Company incurs and may negatively impact the Company’s performance. There is no assurance that the U.S. government’s support in response to
COVID-19
economic distress will offset the adverse impact to securities in which the Company may invest and future governmental support is not guaranteed.
Senior Loans Risk
The risk that the issuer of a senior loan may fail to pay interest or principal when due, and changes in market interest rates may reduce the value of the senior loan or reduce the Company’s returns. The risks associated with senior loans are similar to the risks of high yield debt securities. Senior loans and other debt securities are also subject to the risk of price declines and to increases in interest rates, particularly long-term rates. Senior loans are also subject to the risk that, as interest rates rise, the cost of borrowing increases, which may increase the risk of default. In addition, the interest rates of floating rate loans typically only adjust to changes in short-term interest rates; long-term interest rates can vary dramatically from short-term interest rates. Therefore, senior loans may not mitigate price declines in a long-term interest rate environment. The Company’s investments in senior loans are typically below investment grade and are considered speculative because of the credit risk of their issuers.
LIBOR is the average offered rate for various maturities of short-term loans between major international banks who are members of the British Bankers Association. LIBOR is the most common benchmark interest rate index used to make adjustments to variable-rate loans. It is used throughout global banking and financial industries to determine interest rates for a variety of financial instruments (such as debt instruments and derivatives) and borrowing arrangements. Due to manipulation allegations in 2012 and reduced activity in the financial markets that it measures, in July 2017, the Financial Conduct Authority, the United Kingdom financial regulatory body, announced a desire to phase out the use of LIBOR by the end of 2021. Please refer to “LIBOR Transition and Associated Risk” for more information.
Structured Finance Securities Risk
A portion of the Company’s investments may consist of equipment trust certificates, collateralized mortgage obligations, collateralized bond obligations, collateralized loan obligations (“CLO”) or similar instruments. Such structured finance securities are generally backed by an asset or a pool of assets, which serve as collateral. Depending on the type of security, the collateral may take the form of a portfolio of mortgage loans or bonds or other assets. The Company and other investors in structured finance securities ultimately bear the credit risk of the underlying collateral. In some instances, the structured finance securities are issued in multiple tranches, offering investors various maturity and credit risk characteristics, often categorized as senior, mezzanine and subordinated/equity according to their degree of risk. The riskiest securities are the equity tranche, which bears the bulk of defaults from the bonds or loans serving as collateral, and thus may protect the other, more senior tranches from default. If there are defaults or the relevant collateral otherwise underperforms, scheduled payments to senior tranches of such securities take precedence over those of mezzanine tranches, and scheduled payments to mezzanine tranches take precedence over those to subordinated/equity tranches. A senior tranche typically has higher ratings and lower yields than the underlying securities, and may be rated investment grade. Despite the protection from the equity tranche, other tranches can experience substantial losses due to actual defaults, increased sensitivity to defaults due to previous defaults and the disappearance of protecting tranches, market anticipation of defaults and aversion to certain structured finance securities as a class.
Short-Selling Risk
Short sales by the Company that are not made where there is an offsetting long position in the asset that it is being sold short theoretically involve unlimited loss potential since the market price of securities sold short may continuously increase. Short selling allows the Company to profit from declines in market prices to the extent such decline exceeds the transaction costs and costs of borrowing the securities. However, since the borrowed securities must be replaced by purchases at market prices in order to close out the short position, any appreciation in the price of the borrowed securities would result in a loss. Purchasing securities to close out the short position can itself cause the price of securities to rise further, thereby exacerbating the loss. The Company may mitigate such losses by replacing the securities sold short before the market price has increased significantly. Under adverse market conditions, the Company might have difficulty purchasing securities to meet margin calls on its short sale delivery obligations, and might have to sell portfolio securities to raise the capital necessary to meet its short sale obligations at a time when fundamental investment considerations would not favor such sales. Further, if other short positions of the same security are closed out at the same time, a “short squeeze” can occur where demand exceeds the supply for the security sold short. A short squeeze makes it more likely that the Adviser will need to replace the borrowed security at an unfavorable price.
 
34

Valuation Risk
Certain of the Company’s assets are fair valued, including the Company’s investment in equity issued by TerreStar Corporation (“TerreStar”). TerreStar does not currently generate revenue and primarily derives its value from holding licenses of two wireless spectrum assets. The license with respect to one such spectrum asset was previously terminated by the FCC and subsequently restored on April 30, 2020 on a limited conditional basis. The restoration of such license requires TerreStar to meet certain deployment milestones for wireless medical telemetry service (“WMTS”) during a
39-month
period. Upon satisfaction of the deployment milestones, TerreStar will be able use such spectrum for other services besides WMTS as long as those services do not interfere with WMTS and TerreStar continues to provide WMTS.
If TerreStar is unsuccessful in satisfying such deployment milestones, or if other services cannot be implemented in a manner that does not interfere with WMTS, the value of the TerreStar equity would likely be materially negatively impacted. In determining the fair value of TerreStar, the Adviser has assigned a high probability of success on both conditions based on consultation with the company and its consultants.
Note 9 — Affiliated Investments
Under Section 2(a)(3) of the 1940 Act, a portfolio company is defined as “aff
iliated” if a
fund owns five percent or more of its outstanding voting securities or if the portfolio company is under common control.
 The table below includes non-cash transactions for the three months ended March 31, 2023.
The table below shows affiliated issuers of the Company as of March 31, 2023:
 
Affiliated investments
  
Shares

at

December 31,

2022
 
  
Fair value

as of

December 31,

2022
 
  
Transfers
in (out)
(at cost)
 
 
Purchases
 
  
Sales
 
  
Realized
gains
(losses)
 
  
Change in
unrealized
appreciation
(depreciation)
 
 
Fair value

as of

March 31,

2023
 
  
Shares

at

March 31,

2023
 
  
Affiliated
Dividend
income
 
NexPoint Residential Trust, Inc.
     23,409      $ 1,018,779      $         $        $        $         $ 3,512     $ 1,022,291        23,409      $ 9,832  
    
 
 
    
 
 
    
 
 
    
 
 
   
 
 
   
 
 
    
 
 
   
 
 
    
 
 
    
 
 
 
NexPoint Capital
REIT, LLC
 (Senior
Loans & Common
Stocks)
     100        1,176,024        7,368,085        463,314                          (1,639,454     7,367,969        464,041         
    
 
 
    
 
 
    
 
 
    
 
 
   
 
 
   
 
 
    
 
 
   
 
 
    
 
 
    
 
 
 
NexPoint Real Estate Finance, Inc.
     481,670        7,653,730        (7,368,085 )                               1,777,618       2,063,263        131,670        90,194  
    
 
 
    
 
 
    
 
 
    
 
 
   
 
 
   
 
 
    
 
 
   
 
 
    
 
 
    
 
 
 
SFR WLIF III, LLC
     451,112        424,468                                           (6,287     418,181        451,112        11,430  
    
 
 
    
 
 
    
 
 
    
 
 
   
 
 
   
 
 
    
 
 
   
 
 
    
 
 
    
 
 
 
Total affiliated investments
     956,291      $ 10,273,001      $         $ 463,314     $     $         $ 135,389     $ 10,871,704        1,070,232      $ 111,456  
    
 
 
    
 
 
    
 
 
    
 
 
   
 
 
   
 
 
    
 
 
   
 
 
    
 
 
    
 
 
 
 
35

Note 10 — Financial Highlights
Selected data for a share outstanding throughout the three months ended March 31, 2023 and March 31, 2022 is as follows:
 
    
For the Three Months
Ended
   
For the Three Months
Ended
 
    
March 31, 2023
(Unaudited)
   
March 31, 2022
(Unaudited)
 
Common shares per share operating performance:
 
Net asset value, beginning of period
   $ 5.55     $ 6.32  
Income from investment operations:
 
Net investment income
(1)
     0.04       0.05  
Net realized and unrealized gain (loss)
     (0.14     0.07  
    
 
 
   
 
 
 
Total from investment operations
     (0.10     0.12  
    
 
 
   
 
 
 
Less distribution declared to common shareholders:
 
From net investment income
     (0.09     (0.09
    
 
 
   
 
 
 
Total distributions declared to common shareholders
     (0.09     (0.09
    
 
 
   
 
 
 
Capital share transaction
 
Issuance of common stock
(2)
                  
Shares tendered
(1)
                  
Net asset value, end of period
   $ 5.36     $ 6.35  
Net asset value total return
(3)(4)
     (1.80 )%     1.83
Ratio and supplemental data:
 
Net assets, end of period (in 000’s)
   $ 51,159     $ 62,947  
Shares outstanding, end of period
     9,548,899       9,918,671  
Common share information at end of period:
 
Ratios based on weighted average net assets of common shares:
 
Gross operating expenses
(5)
     4.05     3.72
Fees and expenses waived or reimbursed
(5)
     (0.62 )%      (0.39 )% 
Net operating expenses
(5)
     3.43     3.33
Net investment income (loss) before fees
waived or reimbursed
(5)
     2.14     2.73
Net investment income (loss) after fees
waived or reimbursed
(5)
     2.76     3.12
Portfolio turnover rate
(4)
     1     26
Asset coverage ratio
              
Weighted average commission rate paid
(6)
   $        $     
 
(1)
Per share data was calculated using weighted average shares outstanding during the period.
(2)
The continuous issuance of common stock may cause an incremental increase in net asset value per share due to the sale of shares at the then prevailing public offering price and the receipt of net proceeds per share by the Company in excess of net asset value per share on each subscription closing date. The per share data was derived by computing (i) the sum of (A) the number of shares issued in connection with subscriptions and/or distribution reinvestment on each share transaction date times (B) the differences between the net proceeds per share and the net asset value per share on each share transaction date, divided by (ii) the total shares outstanding at the end of the period. The Company’s continuous public offering ended on February 14, 2018.
(3)
Total returns are historical and assume changes in share price and reinvestment of dividends and capital gains distributions, and assume no sales charge. Distributions, if any, are assumed for purposes of this calculation to be reinvested at prices obtained under the Company’s Dividend Reinvestment Plan. Had the Adviser not absorbed a portion of expenses, total returns would have been lower.
(4)
Not annualized.
(5)
Annualized.
(6)
Represents the total dollar amount of commissions paid on portfolio transactions divided by total number of portfolio shares purchased and sold for which commissions were charged.
Note 11 — Subsequent Events
The Company has evaluated subsequent events through the date on which these financial statements were issued.
 
36


Item 2.

Management’s Discussion and Analysis of Financial Condition and Results of Operations.

The information contained in this section should be read in conjunction with our unaudited financial statements and related notes thereto included elsewhere in this quarterly report on Form 10-Q. In this report, “we,” “us” and “our” refer to NexPoint Capital, Inc.

Forward-Looking Statements

Some of the statements in this quarterly report on Form 10-Q constitute forward-looking statements because they relate to future events or our future performance or financial condition. The forward-looking statements contained in this quarterly report on Form 10-Q may include statements as to:

 

   

our future operating results;

 

   

changes in healthcare technologies, finance and regulations adversely affecting our portfolio companies or financing model;

 

   

changes in political, economic or industry conditions, the interest rate environment or conditions affecting the financial and capital markets, which could result in changes to the value of our assets;

 

   

our business prospects and the prospects of the companies in which we may invest;

 

   

the impact of the investments that we expect to make;

 

   

the impact of increased competition;

 

   

our contractual arrangements and relationships with third parties;

 

   

the dependence of our future success on the general economy and its impact on the industries in which we may invest;

 

   

the ability of our portfolio companies to achieve their objectives;

 

   

impact and effects of the recent outbreak of COVID-19 on the future financial performance of the Company;

 

   

the relative and absolute performance of our Adviser;

 

   

our current and expected financings and investments;

 

   

our ability to make distributions to our stockholders;

 

   

the adequacy of our cash resources, financing sources and working capital;

 

   

the timing and amount of cash flows, distributions and dividends, if any, from our portfolio companies;

 

   

our use of financial leverage;

 

   

the ability of the Adviser to locate suitable investments for us and to monitor and administer our investments;

 

   

the ability of the Adviser or its affiliates to attract and retain highly talented professionals;

 

   

our ability to maintain our qualification as a regulated investment company, or RIC, and as a BDC;

 

   

the impact on our business of the Dodd-Frank Wall Street Reform and Consumer Protection Act and the rules and regulations issued thereunder;

 

   

the effect of changes to tax legislation and our tax position; and

 

   

the tax status of the enterprises in which we may invest.

Such forward-looking statements may include statements preceded by, followed by or that otherwise include the words “may,” “might,” “will,” “intend,” “should,” “could,” “can,” “would,” “expect,” “believe,” “estimate,” “anticipate,” “predict,” “potential,” “plan” or similar words. The forward-looking statements contained in this quarterly report on Form 10-Q involve risks and uncertainties. Our actual results could differ materially from those implied or expressed in the forward-looking statements for any reason, including the factors set forth elsewhere in this quarterly report on Form 10-Q and as “Risk Factors” in the prospectus relating to the continuous public offering of our common stock.

We have based the forward-looking statements included in this quarterly report on Form 10-Q on information available to us on the date of this quarterly report on Form 10-Q. Except as required by the federal securities laws, we undertake no obligation to revise or update any forward-looking statements, whether as a result of new information, future events or otherwise. Stockholders are advised to consult any additional disclosures that we may make directly to stockholders or through reports that we may file in the future with the U.S. Securities and Exchange Commission (the “SEC”), including annual reports on Form 10-K, quarterly reports on Form 10-Q and current reports on Form 8-K. The forward-looking statements and projections contained in this quarterly report on Form 10-Q are excluded from the safe harbor protection provided by Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). This quarterly report on Form 10-Q may contain statistics and other data that have been obtained from or compiled from information made available by third-party service providers. We have not independently verified such statistics or data.

 

37


Overview

We were formed in Delaware on September 30, 2013 and formally commenced operations on September 2, 2014. We are an externally managed, closed-end, non-diversified management investment company that has elected to be regulated as a BDC under the Investment Company Act of 1940, as amended (the “1940 Act”). In addition, for U.S. federal income tax purposes, we have elected to be treated as a RIC under Subchapter M of the Internal Revenue Code of 1986, as amended (the “Code”) with retroactive effect to the date we elected to be treated as a BDC. As a BDC, we are also subject to certain constraints, including limitations imposed by the 1940 Act and the Code.

NexPoint Advisors, L.P. (the “Adviser”), which serves as the adviser of the Company, is registered with the SEC as an adviser under the Investment Advisers Act of 1940, as amended. Under the general supervision of our board of directors (the “Board”) the Adviser will carry out the investment and reinvestment of the net assets of the Company, will furnish continuously an investment program with respect to the Company, and determine which securities should be purchased, sold or exchanged. In addition, the Adviser will supervise and provide oversight of the Company’s service providers.

The Adviser has also entered into a Services Agreement with Skyview Group (“Skyview”), effective February 25, 2021, pursuant to which the Adviser will receive administrative and operational support services to enable it to provide the required advisory services to the Company. The Adviser will compensate all Adviser and Skyview personnel who provide services to the Company.

Effective July 12 2022, certain Skyview personnel became dual-employees of NexPoint Services, Inc., a wholly-owned subsidiary of the Adviser. The same services are being performed by the dual-employees. The Adviser, and not the Company, will compensate all Adviser, Skyview, and dual-employee personnel who provide services to the Company.

Our investment objective is to generate high current income and long-term capital appreciation. We seek to achieve our objective by using the experience of the healthcare, credit and structured products teams of the Adviser and its affiliates to source, evaluate and structure investments, identify attractive investment opportunities that are primarily debt investments that generate high income without creating undue risk for the portfolio, make equity investments where we believe there will be attractive risk-adjusted returns that compensate for the lack of current income, and make investments in debt and equity tranches of collateralized loan obligations, or CLOs, that deliver income and high relative value. We will focus on companies that are stable, have positive cash flow and the ability to grow their business model.

Our investment policy is to invest, under normal circumstances, at least 80% of our total assets in debt and equity of middle-market companies, with an emphasis on healthcare companies, syndicated floating rate debt of large public and nonpublic companies and mezzanine and equity tranches of CLOs. Middle-market companies include companies with annual revenues between $50,000,000 and $2,500,000,000 and syndicated floating rate debt refers to loans and other instruments originated by a bank to a corporation that are sold off, or syndicated, to investors in pieces. We consider a healthcare company to be a company that is engaged in the design, development, production, sale, management or distribution of products, services or facilities used for or in connection with the healthcare industry. Additionally, we consider companies that are materially impacted by the healthcare industry (such as a contractor that derives significant revenue or profit from the construction of hospitals) as being engaged in the healthcare industry. We may invest without limit in companies that are not in the healthcare sector.

We will leverage the expertise of our Adviser with regard to distressed investing and restructuring to make opportunistic investments in distressed companies. We will utilize the Adviser’s credit underwriting capability to identify the types of companies we believe will provide high current income and/or long-term capital appreciation. In addition to the investments in the healthcare industry, we may invest a portion of our capital in other opportunistic investments in which the Adviser has expertise and where we believe an opportunity exists to achieve above average risk adjusted yields and returns. These types of opportunities may include: (1) direct lending or origination investments, (2) investments in stressed or distressed situations, (3) structured product investments, (4) equity investments and (5) other investment opportunities not typically available in other BDCs. Opportunistic investments may range from broadly syndicated deals to direct lending deals in both private and public companies and may include foreign investments. We believe this is the best approach to achieving our dual mandate of attempting to generate a high yield while also attempting to produce capital appreciation.

We seek to invest primarily in securities deemed by the Adviser to be high income generating debt investments and income generating equity securities of privately held companies in the United States. We expect the portfolio will be concentrated primarily in senior floating rate debt securities, although we may invest without limit in securities which rank lower than senior secured instruments and may invest without limit in investments with a fixed rate of interest. We will buy syndicated loans, various tranches of CLOs and other debt instruments in the secondary market as well as originate debt so we can tailor the investment parameters more

 

38


precisely to our needs. We also intend to invest a portion of the portfolio in equity securities that are non-income producing, when doing so will help us achieve our objective of long-term capital appreciation. We expect the size of our positions will range from less than $1,000,000 to $20,000,000, although investments may be larger as our asset base increases. We may selectively make investments in amounts larger than $20,000,000 in some of our portfolio companies. While our asset base increases, we may make smaller investments. We may invest up to 15% of our net assets in entities that are excluded from registration under the 1940 Act by virtue of Sections 3(c)(1) and 3(c)(7) of the 1940 Act (such as private equity funds or hedge funds). This limitation does not apply to any CLOs, certain of which may rely on Sections 3(c)(1) or 3(c)(7) of the 1940 Act.

We expect that many of the securities in which we invest will be rated below investment grade by independent rating agencies or would be rated below investment grade if they were rated. These securities, which may be referred to as “junk”, have predominantly speculative characteristics with respect to the issuer’s capacity to pay interest and repay principal. In addition, we expect that many of our debt investments will include floating interest rates that reset on a periodic basis and typically will not require the borrowers to pay down the outstanding principal of such debt prior to maturity.

We and the Adviser have obtained an exemptive order dated April 19, 2016 from the SEC to permit co-investments among the Company and certain other accounts managed by the Adviser or its affiliates, subject to certain conditions.

Public Offering

As a result of a series of private placements to the Adviser, we successfully satisfied the minimum offering requirement and officially commenced operations on September 2, 2014. In connection with the satisfaction of the minimum offering requirement and the commencement of our operations, the Investment Advisory Agreement became effective and the base management fee and any incentive fees, as applicable, payable to the Adviser under the Investment Advisory Agreement began to accrue. In aggregate as of March 31, 2023, the Adviser controls 2,549,002 total shares of common stock of the Company, including reinvestment of dividends, for a net amount of approximately $13.7 million. In February 2018, we closed our continuous public offering of shares of common stock.

Revenues

We generate a significant portion of our total revenue in the form of interest on the debt securities that we hold. We expect that the senior debt we invest in will generally have stated terms of 3 to 5 years and that the subordinated debt we invest in will generally have stated terms of 5 to 7 years. Our senior and subordinated debt investments bear interest at a fixed or floating rate. Interest on debt securities is generally payable monthly, quarterly or semiannually. In addition, some of our investments provide for deferred interest payments or payment-in-kind, or PIK, interest. We may also generate revenues in the form of dividends and other distributions on the equity or other securities we may hold. In addition, we may generate revenues in the form of commitment, closing, origination, structuring or diligence fees, monitoring fees, fees for providing managerial assistance, consulting fees, prepayment fees and performance-based fees. Any such fees generated in connection with our investments will be recognized as earned.

Expenses

We expect that our primary operating expenses will include the payment of fees to the Adviser under the Investment Advisory Agreement, our allocable portion of overhead expenses under the Administration Agreement and other operating costs described below. Prior to December 20, 2017, the Adviser was waiving most fees, subject to possible recoupment for expenses pertaining to periods from and after June 10, 2016. Effective December 20, 2017, the Adviser ended its voluntary waiver of advisory and administration fees. We bear all out-of-pocket costs and expenses of our operations and transactions, including:

 

   

our organization (expenses initially paid by the Adviser until sufficient equity proceeds are raised);

 

   

calculating our net asset value and net asset value per share (including the costs and expenses of independent valuation firms);

 

   

fees and expenses, including travel expenses, incurred by the Adviser or payable to third parties in performing due diligence on prospective portfolio companies, monitoring our investments and, if necessary, enforcing our rights;

 

   

interest payable on debt, if any, incurred to finance our investments;

 

   

the costs of this and all future offerings of common shares and other securities, and other incurrence of debt;

 

   

the base management fee and any incentive fee;

 

   

distributions on our shares;

 

   

administration fees payable to the Adviser under the Administration Agreement;

 

39


   

transfer agent and custody fees and expenses;

 

   

the actual costs incurred by the Adviser as our administrator in providing managerial assistance to those portfolio companies that request it;

 

   

amounts payable to third parties relating to, or associated with, evaluating, making and disposing of investments;

 

   

brokerage fees and commissions;

 

   

registration fees;

 

   

listing fees;

 

   

taxes;

 

   

director fees and expenses;

 

   

costs associated with our reporting and compliance obligations under the 1940 Act and applicable U.S. federal and state securities laws;

 

   

the costs of any reports, proxy statements or other notices to our stockholders, including printing costs;

 

   

costs of holding stockholder meetings;

 

   

our fidelity bond;

 

   

directors and officers/errors and omissions liability insurance, and any other insurance premiums;

 

   

litigation, indemnification and other non-recurring or extraordinary expenses;

 

   

direct costs and expenses of administration and operation, including audit and legal costs;

 

   

fees and expenses associated with marketing efforts, including deal sourcing fees and marketing to financial sponsors;

 

   

dues, fees and charges of any trade association of which we are a member; and

 

   

all other expenses reasonably incurred by us or the Adviser in connection with administering our business.

During periods of asset growth, we expect our general and administrative expenses to be relatively stable or decline as a percentage of total assets and increase during periods of asset declines.

Expense Limitation

Pursuant to an expense limitation agreement (the “Expense Limitation Agreement”), the Adviser is contractually obligated to waive fees and, if necessary, pay or reimburse certain other expenses to limit ordinary “Other Expenses” to 1.0% of the quarter-end value of the Company’s gross assets through the one-year anniversary of the effective date of the registration statement. Under the Expense Limitation Agreement, “Other Expenses” are all expenses with the exception of advisor and administration fees, organization and offering costs and the following: (i) interest, taxes, dividends tied to short sales, brokerage commissions, and other expenditures which are capitalized in accordance with GAAP; (ii) expenses incurred indirectly as a result of investments in other investment companies and pooled investment vehicles; (iii) other expenses attributable to, and incurred as a result of, our investments; (iv) expenses payable to the Adviser, as administrator, for providing significant managerial assistance to our portfolio companies; and (v) other extraordinary expenses (including litigation expenses) not incurred in the ordinary course of our business. The obligation will automatically renew for one-year terms unless it is terminated by the Company or the Adviser upon written notice within 120 days of the end of the current term or upon termination of the Investment Advisory Agreement. The Expense Limitation Agreement will continue through at least April 30, 2024.

Any expenses waived or reimbursed by the Adviser pursuant to the Expense Limitation Agreement are subject to possible recoupment by the Adviser within three years from the date of the waiver or reimbursement. The recoupment by the Adviser will be limited to the amount of previously waived or reimbursed expenses and cannot cause the Company’s expenses to exceed any expense limitation in place at the time of recoupment or waiver.

 

40


Reimbursable Expenses Table

The cumulative total of fees waived by the Adviser under the Expense Limitation Agreement which are recoupable as of March 31, 2023, is $919,754. This balance, and the balances in the tables below, only include amounts pertaining to the Expense Limitation Agreement, and do not include waived advisory and administration fees subject to recoupment discussed elsewhere herein. The following table reflects the 2023 quarterly fee waivers and expense reimbursements due from the Adviser as of March 31, 2023, which are subject to recoupment by the Adviser.

 

Quarter Ended

   Yearly Cumulative
Other Expenses
     Yearly
Expense
Limitation
     Yearly Cumulative
Expense
Reimbursement
     Quarterly
Recoupable/
(Recouped)
Amount
     Recoupment
Eligibility Expiration
 

March 31, 2023

   $  208,486      $  126,628      $  81,858      $  81,858              March 31, 2026  

The following table reflects the 2022 quarterly fee waivers and expense reimbursements due from the Adviser as of December 31, 2022, which are subject to recoupment by the Adviser.

 

Quarter Ended

   Yearly Cumulative
Other Expenses
     Yearly
Expense
Limitation
     Yearly Cumulative
Expense
Reimbursement
     Quarterly
Recoupable/
(Recouped)
Amount
     Recoupment
Eligibility Expiration
 

December 31, 2022

   $  913,273      $  535,679      $  377,594      $ 92,216        December 31, 2025  

September 30, 2022

     678,333      $ 392,955      $ 285,378      $  124,667        September 30, 2025  

June 30, 2022

     434,019      $ 273,308      $ 160,711      $ 98,950        June 30, 2025  

March 31, 2022

     211,896      $ 150,135      $ 61,761      $ 61,761        March 31, 2025  

The following table reflects the 2021 quarterly fee waivers and expense reimbursements due from the Adviser as of December 31, 2021, which are subject to recoupment by the Adviser.

 

Quarter Ended

   Yearly Cumulative
Other Expenses
     Yearly
Expense
Limitation
     Yearly Cumulative
Expense
Reimbursement
     Quarterly
Recoupable/
(Recouped)
Amount
     Recoupment
Eligibility Expiration
 

December 31, 2021

   $  892,640      $  597,379      $  295,261      $  94,762        December 31, 2024  

September 30, 2021

     664,052      $ 463,553      $ 200,499      $ 68,134        September 30, 2024  

June 30, 2021

     436,866      $ 304,501      $ 132,365      $ 68,919        June 30, 2024  

March 31, 2021

     220,126      $ 156,680      $ 63,446      $ 63,446        March 31, 2024  

The following table reflects the 2020 quarterly fee waivers and expense reimbursements due from the Adviser as of December 31, 2020, which are subject to recoupment by the Adviser.

 

Quarter Ended

   Yearly
Cumulative Other
Expenses
     Yearly
Expense
Limitation
     Yearly Cumulative
Expense
Reimbursement
     Quarterly
Recoupable/
(Recouped)
Amount
    Recoupment
Eligibility Expiration
 

December 31, 2020

   $  989,447      $  639,959      $  349,488      $  101,541       December 31, 2023  

September 30, 2020

     687,228        439,281        247,947        94,039       September 30, 2023  

June 30, 2020

     445,585        291,677        153,908        (30,539     June 30, 2023  

March 31, 2020

     257,226        72,779        184,447        -       Expired  

During the three months ended March 31, 2023, $184,447 of expense reimbursements that were eligible for recoupment by the Adviser expired.

There can be no assurance that the Expense Limitation Agreement will remain in effect or that the Adviser will reimburse any portion of our expenses in future quarters not covered by the Expense Limitation Agreement. Amounts shown do not include the amounts committed by the Adviser to voluntarily reimburse the Company for unrealized losses, all of which are not recoupable.

Portfolio Investment Activity for the three months ended March 31, 2023 and March 31, 2022:

During the three months ended March 31, 2023, we did not make long investments in portfolio companies and other investments. During the same period, we generated proceeds from sales and principal repayments on long investments of $3,345,666. As of March 31, 2023, our investment portfolio, with a total fair value of $48.7 million, consisted of 39 interests in portfolio companies (calculated as a percentage of total invested assets: 18.4% in first lien senior secured loans, 2.2% in second lien senior secured loans, 5.1% in corporate bonds, 0.0% in asset-backed securities, 0.3% in warrants, 28.5% in common stock, 24.6% in preferred stock, and 20.9% in LLC interests). On a look-through basis, the debt investments in our portfolio carry a weighted average cost price of 93.56% on par or stated value, as applicable, and our estimated gross annual portfolio yield (which represents the expected yield to be generated by us on our investment portfolio based on the composition of our portfolio as of such date), prior to leverage costs, was 3.08% based on the amortized cost of our investments. The portfolio yield does not represent an actual investment return to stockholders and does not include income from CLO equity.

During the three months ended March 31, 2022, we made long investments in portfolio companies and other investments totaling $6,918,805. During the same period, we generated proceeds from sales and principal repayments on long investments of $5,643,969. As of March 31, 2022, our investment portfolio, with a total fair value of $62.4 million, consisted of 36 interests in portfolio companies (calculated as a percentage of total invested assets: 23.4% in first lien senior secured loans, 4.9% in second lien senior secured loans, 10.8% in corporate bonds, 0.8% in asset-backed securities, 0.3% in warrants, 37.1% in common stock, 15.6% in

 

41


preferred stock, and 7.3% in LLC interests). On a look-through basis, the debt investments in our portfolio carry a weighted average cost price of 94.14% on par or stated value, as applicable, and our estimated gross annual portfolio yield (which represents the expected yield to be generated by us on our investment portfolio based on the composition of our portfolio as of such date), prior to leverage costs, was 5.42% based on the amortized cost of our investments. The portfolio yield does not represent an actual investment return to stockholders and does not include income from CLO equity.

Total Portfolio Activity

The following tables present selected information regarding our portfolio investment activity for the three months ended March 31, 2023, and March 31, 2022. The table below includes non-cash transactions for the three months ended March 31, 2023.

 

Net Investment Activity

   For the Three Months Ended
March 31, 2023
     For the Three Months
Ended March 31, 2022
 

Purchases

   $ 463,314      $ 6,918,805  

Payment-in-kind

     29,847        106,711  

Sales and Principal Repayments

     (3,808,980      (5,631,508
  

 

 

    

 

 

 

Net Portfolio Activity

   $  (3,315,819    $  (1,394,008
  

 

 

    

 

 

 

 

     For the Three Months Ended
March 31, 2023
    For the Three Months Ended
March 31, 2022
 

New Investment Activity by Asset Class

   Purchases      Percentage     Purchases      Percentage  

Senior Secured Loans—First Lien

   $  463,314        100   $ 2,910,000        42.06

Senior Secured Loans—Second Lien

     —          —         —          0.0

Corporate Bonds

     —          —         —          0.0

Preferred Stocks

     —          —         4,000,000        57.81

LLC Interests

     —          —         —          0.0

Warrants

     —          —         —          0.0

Common Stocks

     —          —         8,806        0.13
  

 

 

    

 

 

   

 

 

    

 

 

 

Total Investment Activity

   $  463,314        100   $  6,918,805        100.0
  

 

 

    

 

 

   

 

 

    

 

 

 

 

42


The following tables summarize the composition of our investment portfolio at amortized cost and fair value as of March 31, 2023, and December 31, 2022:

 

March 31, 2023  

Portfolio Composition by Investment Type

   Amortized Cost (1)      Fair Value      Percentage of
Portfolio (at fair
value)
 

Senior Secured Loans — First Lien

   $  13,218,569      $ 8,961,395        18.4

Senior Secured Loans — Second Lien

     1,485,503        1,070,222        2.2

Asset-Backed Securities

     388,541        7,280        0.0

LLC Interests

     10,734,196        10,164,439        20.9

Corporate Bonds

     3,375,246        2,500,245        5.1

Common Stocks

     9,705,017        13,883,249        28.5

Preferred Stocks

     11,829,986        11,981,888        24.6

Warrants

     74,284        162,811        0.3
  

 

 

    

 

 

    

 

 

 

Total Invested Assets

   $ 50,811,343      $  48,731,529        100.0
  

 

 

    

 

 

    

 

 

 

 

(1) 

Amortized cost represents the original cost adjusted for the amortization of premiums and/or accretion of discounts, as applicable, on investments.

 

 

December 31, 2022  

Portfolio Composition by Investment Type

   Amortized
Cost (1)
     Fair Value      Percentage of
Portfolio (at fair
value)
 

Senior Secured Loans — First Lien

   $ 14,645,107      $ 11,575,822        21.7

Senior Secured Loans — Second Lien

     2,976,056        2,652,371        5.0

Asset-Backed Securities

     388,541        7,036        0.0

LLC Interests

     3,666,112        4,689,242        8.8

Corporate Bonds

     3,358,783        2,704,917        5.1

Common Stocks

     17,073,102        19,514,684        36.6

Preferred Stocks

     11,829,986        11,967,910        22.5

Warrants

     74,284        181,733        0.3
  

 

 

    

 

 

    

 

 

 

Total Invested Assets

   $  54,011,971      $  53,293,715        100.0
  

 

 

    

 

 

    

 

 

 

 

(1) 

Amortized cost represents the original cost adjusted for the amortization of premiums and/or accretion of discounts, as applicable, on investments.

The following table presents certain selected information regarding the composition of our investment portfolio as of March 31, 2023, and December 31, 2022:

 

    March 31, 2023     December 31, 2022  

Number of Investments

    39       39  

% Variable Rate (based on fair value)

    57     71

% Non-Income Producing Equity or Other Investments (based on fair value)

    41     27

Weighted Average Cost Price of Investments (as a % of par or stated value)

    93.56     94.17

Weighted Average Credit Rating of Investments that were Rated

    Caa3       Caa1  

% of Fixed Income Investments on Non-Accrual (based on fair value)

    0.0     0.0

 

43


Portfolio Composition by Strategy and Industry

The table below summarizes the composition of our investment portfolio by strategy and enumerates the percentage, by fair value, of the total portfolio assets in such strategies as of March 31, 2023, and December 31, 2022:

 

     March 31, 2023     December 31, 2022  

Portfolio Composition by Strategy

   Fair Value      Percentage
of Portfolio
    Fair Value      Percentage
of Portfolio
 

Broadly Syndicated – Private

   $ 6,134,538        12.8   $ 6,183,456        11.6

Broadly Syndicated – Public

     2,525,336        7.7     2,561,915        4.8

Middle-Market

     37,830,863        74.4     42,133,492        74.4

Opportunistic/Other

     2,240,792        5.1     2,414,852        5.1
  

 

 

    

 

 

   

 

 

    

 

 

 

Total Invested Assets

   $  48,731,529        100.0   $  53,293,715        100.0
  

 

 

    

 

 

   

 

 

    

 

 

 

Broadly syndicated debt refers to loans and other instruments originated by a bank to a large corporation (both private and public) that are sold off, or syndicated, to investors in pieces. Middle-Market companies include companies with annual revenues between $50 million and $2.5 billion.

The table below describes investments by industry classification and enumerates the percentage, by fair value, of the total portfolio assets in such industries as of March 31, 2023, and December 31, 2022:

 

     March 31, 2023     December 31, 2022  

Industry Classifications

   Fair Value      Percentage
of Portfolio
    Fair Value      Percentage
of Portfolio
 

Chemicals

   $ 42,500        0.1   $ 42,500        0.1

Consumer Products

     2,841,603        5.8     3,088,750        5.8

Energy

     1,781,926        3.7     1,752,941        3.3

Financials

     3,139,780        6.4     3,180,161        6.0

Healthcare

     21,288,682        43.7     26,101,074        49.0

Media/Telecommunications

     269,529        0.6     310,563        0.6

Real Estate Investment Trusts (REITs)

     1,022,291        2.1     1,018,779        1.9

Real Estate

     12,208,413        25.0     11,613,122        21.8

Service

     2,268        0.0     2,268        0.0

Telecommunication Services

     6,134,537        12.6     6,183,457        11.6
  

 

 

    

 

 

   

 

 

    

 

 

 

Total Invested Assets

   $  48,731,529        100.0   $  53,293,715        100.0
  

 

 

    

 

 

   

 

 

    

 

 

 

As of March 31, 2023, the Company was an “affiliated person,” as defined in the 1940 Act, of NexPoint Real Estate Finance, Inc., NexPoint Capital, REIT, SFR WLIF III, and NexPoint Residential Trust, Inc. In general, under the 1940 Act, we are presumed to “control” a portfolio company if we owned 25% or more of its voting securities or we had the power to exercise control over the management or policies of such portfolio company and would be an “affiliated person” of a portfolio company if we owned 5% or more of its voting securities.

Summary Description of Portfolio Companies/Investments

As of March 31, 2023, and December 31, 2022, 48.3% and 53.5% (based on fair value), respectively, of our portfolio consisted of healthcare related and opportunistic investments. Information regarding these investments is provided below. Information regarding these investments is provided below. This additional information is limited to publicly available information, and does not address credit worthiness or financial viability of the issuer, or our future plans as it relates to a specific investment:

Healthcare Investments

Sapience Therapeutics, Inc.: As of March 31, 2023, and December 31, 2022, we held preferred shares of Sapience Therapeutics, Inc. with an aggregate fair value of $8.3 million and $8.1 million, respectively. Sapience Therapeutics is a clinical stage biopharmaceutical company which addresses previously ‘undruggable’ molecular targets that address protein-protein interactions via the development of peptide-based drugs.

 

44


CCS Medical, Inc.: As of March 31, 2023, and December 31, 2022, we held first lien senior secured loans of CCS Medical, Inc. with an aggregate fair value of $3.0 million and $3.0 million, respectively. CCS Medical, Inc. provides direct-to-home delivery of medical supplies. The Company offers diabetes testing, insulin pumps, prescription medications, ostomy, urological, wound care, and incontinence supplies. CCS Medical serves customers in the United States.

Hadrian Merger Sub, Inc.: As of March 31, 2023, and December 31, 2022, we held corporate bonds of Hadrian Merger Sub, Inc. with an aggregate fair value of $2.2 million and $2.4 million, respectively. Hadrian Merger Sub, Inc’s parent, Heartland Dental is a leading dental support organization in the United States and provides non-clinical administrative support services. As of March 31, 2023, the company supported more than 2,600 doctors in more than 1,650 supported dental offices across 38 states.

Covenant Surgical Partners, Inc.: As of March 31, 2023, and December 31, 2022, we held first lien senior secured loans of Covenant Surgical Partners, Inc. with an aggregate fair value of $1.6 million and $1.6 million, respectively. Covenant Physician Partners is a physician services company that partners with leading healthcare providers across the country to grow thriving practices and centers. As of March 31, 2023, the company delivered physician services to nearly 1,735 associates and physicians in 19 states.

Apnimed, Inc.: As of March 31, 2023, and December 31, 2022, we held preferred shares of Apnimed Inc, with an aggregate fair value of $2.3 million and $2.3 million, respectively. Apnimed, Inc. is a clinical-stage pharmaceutical company focused on developing oral pharmacologic therapies for the treatment of obstructive sleep apnea (OSA) and related disorders. Apnimed’ s lead development program targets the neurologic control of upper airway muscles to maintain an open airway during sleep.

Results of Operations for the three months ended March 31, 2023

Revenues

We generate a significant portion of our investment income in the form of interest on the debt securities we purchase or originate. We have invested primarily in broadly syndicated bank loans of private companies. Bank loans generally pay interest at rates which are periodically determined by reference to a base lending rate plus a spread. The base lending rate is typically the three-month LIBOR. The settlement of bank loans differs from the settlement of many other equity or debt instruments. Bank loans are manually settled through the agent by assignment. As a result, settlement can take an undetermined amount of time. Currently, according to data provided by Markit Partners, bank loans settle, on average, on the seventeenth day after the trade date. Generally, interest does not begin to accrue to the buyer until seven business days after the trade date.

Our CLO equity pays quarterly dividends based on excess cash flow available after the CLO’s payment “waterfall” provisions. Both Grayson and PAMCO CLOs are past their respective investment periods, and as a result, excess cash flow is expected to decline over time. We, therefore, expect that the quarterly dividends paid by the investments will similarly decline.

Expenses

For the three months ended March 31, 2023, we had total net operating expenses of $451,311 or $0.05 per share. For the three months ended March 31, 2022, we had total net operating expenses of $523,488 or $0.05 per share, respectively. Base management fees attributed to the Adviser were $265,381 for the three months ended March 31, 2023. Base management fees attributed to the Adviser were $299,270 for the three months ended March 31, 2022. Our expenses include administrative services expenses attributed to the Adviser of $52,321 and $59,601 for the three months ended March 31, 2023 and March 31, 2022, respectively.

Amounts waived for management fees or administrative services expenses pertaining to periods prior to June 10, 2016 are not recoupable, but amounts waived for management fees or administrative services expenses pertaining to periods from and after June 10, 2016 are subject to recoupment by the Adviser within three years from the date that such fees were otherwise payable, provided that the recoupment will be limited to the amount of such voluntarily waived fees from and after June 10, 2016 and will not cause the sum of the Company’s advisory fees, administration fees, Other Expenses, and any recoupment to exceed the annual rate of 3.40% of average gross assets. Effective December 20, 2017, the Adviser ended its voluntary waiver of advisory fees.

 

45


Our other expenses subject to the Expense Limitation Agreement for three months ended March 31, 2023, and March 31, 2022, were $208,486 and $211,896, respectively, and consisted of the following:

 

     For the Three Months
Ended March 31, 2023
     For the Three Months
Ended March 31, 2022
 

Audit and tax fees

   $ 40,348      $ 39,474  

Legal fees

     9,189        18,218  

Custodian and accounting service fees

     75,987        76,747  

Reports to stockholders

     18,232        17,795  

Stock transfer fee

     41,136        50,183  

Directors’ fees

     4,967        3,731  

Other expenses

     18,627        5,748  
  

 

 

    

 

 

 

Total

   $  208,486      $  211,896  
  

 

 

    

 

 

 

Please refer to the Expense Limitation section above for further details on expense reimbursements.

Net Investment Income

We earned net investment income of $363,521 or $0.04 per share, and $491,122 or $0.05 per share, for the three months ended March 31, 2023 and March 31, 2022, respectively.

Net Realized Gains or Losses

We had sales or principal repayments of $3,345,666 and $5,643,969 during the three months ended March 31, 2023 and March 31, 2022, respectively, from which we realized a net gains/(losses) of $20,220 and $167,104, respectively

Net Change in Unrealized Appreciation (Depreciation) on Investments

For the three months ended March 31, 2023, and March 31, 2022, the net change in unrealized appreciation (depreciation) on investments totaled $(1,361,558) or $(0.14) per share, and $486,791 or $0.05 per share, respectively. The net change in unrealized appreciation (depreciation) on our investments during the three months ended March 31, 2023, was primarily driven by the performance of Envision Healthcare Term Loan. The net change in unrealized appreciation (depreciation) on our investments during the three months ended March 31, 2022, was primarily driven by the performance of American Banknote Corp.

Net Increase from Payment from Affiliates

For the year ended December 31, 2016, the Adviser committed $872,000 to the Company to voluntarily reimburse the Company for unrealized losses sustained. No amounts were committed for the three months ended March 31, 2023, and March 31, 2022. Cumulatively since inception, the Adviser has committed $2,275,000 to voluntarily reimburse the Company for such losses. Had these payments not been made, the NAV as of March 31, 2023, would have been lower. These payments are shown in the Statement of Operations as net increase from amounts committed by affiliates, if applicable, and are not recoupable.

Net Increase (Decrease) in Net Assets Resulting from Operations

For the three months ended March 31, 2023, and March 31, 2022, the net increase/(decrease) in net assets resulting from operations was $(977,817) or $(0.10) per share, and $1,145,017 or $0.11 per share, respectively.

 

    For the Three Months
Ended March 31, 2023
    For the Three Months
Ended March 31, 2022
 

Income

  $ 814,832     $  1,014,610  

Net expenses

    (451,311     (523,488

Net realized gain/(loss)

    20,220       167,104  

Net unrealized appreciation (depreciation)

    (1,361,558     486,791  

Net increase from amounts committed by affiliates

    —         —    
 

 

 

   

 

 

 

Total

  $ (977,817   $ 1,145,017  
 

 

 

   

 

 

 

 

46


Financial Condition, Liquidity and Capital Resources

As of March 31, 2023, and March 31, 2022, we had cash and cash equivalents of $1,131,784 and $1,279,391, respectively. As of March 31, 2023, and March 31, 2022, $773,826 and $1,223,616 was held in the State Street U.S. Government Money Market Fund, and $357,958 and $55,755 was held in a custodial account with State Street Bank and Trust Company, respectively. Cash and cash equivalents are available to fund new investments, pay operating expenses and pay distributions.

In aggregate as of March 31, 2023, the Adviser controls 2,549,002 total shares of common stock of the Company, including reinvestment of dividends, for a net amount of approximately $13.7 million.

The sales commissions and dealer manager fees related to the sale of our common stock were $0 and $0 for the three months ended March 31, 2023, and March 31, 2022, respectively, and were offset against capital in excess of par value on the financial statements.

We expect to generate cash flows primarily from fees, interest and dividends earned from our investments, as well as principal repayments and proceeds from sales of our investments.

Prior to investing in securities of portfolio companies, we invest the net proceeds from the issuance of shares of common stock under our distribution reinvestment plan and from sales and paydowns of existing investments primarily in cash, cash equivalents, U.S. government securities, repurchase agreements, high-quality debt instruments maturing in one year or less from the time of investment, consistent with our BDC election and our election to be treated as a RIC. Additionally, we may invest in higher yielding, liquid credit investments such as bank loans and corporate notes and bonds, which are considered “junk” as they are rated below investment grade, to the extent that at time of purchase 70% of our portfolio is in qualified investments as required by rules and regulations under the 1940 Act.

While we are authorized to issue preferred stock, we do not currently anticipate issuing any.

Contractual Obligations and Off-Balance Sheet Arrangements

We may become a party to financial instruments with off-balance sheet risk in the normal course of our business to meet the financial needs of our portfolio companies. These instruments may include commitments to extend credit and involve, to varying degrees, elements of liquidity and credit risk in excess of the amount recognized in the balance sheet. As of March 31, 2023 and March 31, 2022, we had no outstanding commitments to fund investments.

We have certain contracts under which we have material future commitments. We have entered into the Investment Advisory Agreement with the Adviser in accordance with the 1940 Act. Under the Investment Advisory Agreement, the Adviser provides us with investment advisory and management services. For these services, we pay (1) a management fee equal to a percentage of the average value of our gross assets and (2) an incentive fee based on our performance.

The incentive fee consists of two parts. The first part, which is calculated and payable quarterly in arrears, equals Pre-Incentive Fee Net Investment Income for the immediately preceding calendar quarter and is subject to a hurdle rate, expressed as a rate of return on our net assets, equal to 1.875% per quarter. As a result, the Adviser will not earn this incentive fee for any quarter until our pre-incentive fee net investment income for such quarter exceeds the hurdle rate of 1.875%. Once our pre-incentive fee net investment income in any quarter exceeds the hurdle rate, the Adviser will be entitled to a “catch-up” fee equal to the amount of the pre-incentive fee net investment income in excess of the hurdle rate, until our pre-incentive fee net investment income for such quarter equals 2.34375% of the Company’s net assets at the end of such quarter. This “catch-up” feature allows the Adviser to recoup the fees foregone as a result of the existence of the hurdle rate. Thereafter, the Adviser will receive 20.0% of our pre-incentive fee net investment income. For purposes of calculating this part of the incentive fee, “Pre-Incentive Fee Net Investment Income” means interest income, distribution income and any other income (including any other fees, other than fees for providing managerial assistance, such as commitment, origination, structuring, diligence and consulting fees or other fees that we receive from portfolio companies) accrued during the calendar quarter, minus our operating expenses for the quarter (including the base management fee, expenses payable under the Administration Agreement and any interest expense and any dividends paid on any issued and outstanding preferred stock, but excluding the incentive fee). Pre-Incentive Fee Net Investment Income includes, in the case of investments with a deferred interest feature (such as original issue discount, debt instruments with PIK interest and zero-coupon securities), accrued income that we have not yet received in cash. Pre-Incentive Fee Net Investment Income does not include any realized capital gains, realized capital losses or unrealized capital appreciation or depreciation.

The second part of the incentive fee, which is referred to as the incentive fee on capital gains, is determined and payable in arrears as of the end of each calendar year (or upon termination of the Investment Advisory Agreement). This fee equals 20.0% of our incentive fee capital gains, which will equal our realized capital gains on a cumulative basis from formation, calculated as of the end of the applicable period, computed net of all realized capital losses (proceeds less amortized cost) and unrealized capital depreciation on a cumulative basis, less the aggregate amount of any previously paid capital gains incentive fees. We will accrue for the capital gains incentive fee, which, if earned, will be paid annually. We will accrue for the capital gains incentive fee based on net realized and

 

47


unrealized gains; however, under the terms of the Investment Advisory Agreement, the fee payable to the Adviser will be based on realized gains and no such fee will be payable with respect to unrealized gains unless and until such gains are actually realized. For the three months ended March 31, 2023, and March 31, 2022, the Company incurred $0 and $0 of incentive fees on capital gains, respectively. Effective December 20, 2017, the Adviser ended its voluntary waiver of incentive fees. No such fees have been paid with respect to realized gains as of March 31, 2023.

Under the Administration Agreement, the Adviser furnishes us with office facilities and equipment, provides us clerical, bookkeeping and record keeping services at such facilities and provides us with other administrative services necessary to conduct our day-to-day operations. We will reimburse the Adviser for the allocable portion (subject to the review and approval of the Board) of overhead and other expenses incurred by it in performing its obligations under the Administration Agreement, including rent, the fees and expenses associated with performing compliance functions and our allocable portion of the cost of our chief financial officer and chief compliance officer and their respective staffs, to the extent that such expenses do not exceed an annual rate of 0.4% of our gross assets. The Adviser also provides on our behalf significant managerial assistance to those portfolio companies to which we are required to offer to provide such assistance and any expenses payable to the Adviser for such managerial assistance are not subject to the cap on reimbursement.

Our organization and offering costs together are limited to 1% of total gross proceeds raised and are not due and payable to the Adviser to the extent they exceed that amount. The cumulative aggregate amount of organization and offering costs exceeds 1% of total proceeds raised. Subsequent to the termination of the Offering, the Adviser forfeited the right to reimbursement of the remaining $4,305,091 of these costs.

If any of the contractual obligations discussed above is terminated, our costs under any new agreements that we enter into may increase. In addition, we would likely incur significant time and expense in locating alternative parties to provide the services we receive under our Investment Advisory Agreement and our Administration Agreement. Any new investment advisory agreement would also be subject to approval by our stockholders.

If for any taxable year we were not a “publicly offered” RIC within the meaning of Code Section 67(c)(2)(B), certain of our direct and indirect expenses, including the management fee, the incentive fee and certain other advisory expenses, would be subject to special “pass-through” rules. Such rules would treat these expenses as additional dividends to certain of our direct or indirect stockholders (generally including individuals and entities that compute their taxable income in the same manner as an individual) and as deductible by those stockholders, subject to the 2% “floor” on miscellaneous itemized deductions and other significant limitations on itemized deductions set forth in the Code.

Distributions

In order to qualify for the special tax treatment accorded RICs and their shareholders, we are required under the Code, among other things, to distribute at least 90% of our net ordinary income and net short-term capital gains in excess of net long-term capital losses, or “investment company taxable income,” to our stockholders on an annual basis. We intend to authorize and declare quarterly distributions to be paid quarterly to our stockholders as determined by the Board. In addition, we also intend to distribute any realized net capital gains (i.e., realized net long-term capital gains in excess of realized net short-term capital losses) at least annually.

We may not be able to achieve operating results that will allow us to make distributions at a specific level or to increase the amount of our distributions from time to time. In addition, we may be limited in our ability to make distributions due to the asset coverage requirements applicable to us as a BDC under the 1940 Act. If we do not distribute a certain percentage of our income annually, we will suffer adverse U.S. federal income tax consequences, including possible failure to qualify for the special tax treatment accorded RICs and their shareholders. We cannot assure stockholders that they will receive any distributions.

To the extent our taxable earnings fall below the total amount of our distributions for a taxable year, a portion of those distributions may be deemed a return of capital to our stockholders for U.S. federal income tax purposes. Thus, the source of a distribution to our stockholders may be the original capital invested by the stockholder rather than our income or gains. Stockholders should read any written disclosure accompanying a distribution payment carefully and should not assume that the source of any distribution is our ordinary income or gains. Required distributions are driven by tax laws and thus tax accounting applies, not GAAP. Therefore, it is possible that we pay more in required distributions than we earn for book purposes. For the three months ended March 31, 2023, and March 31 2022, the Company did not distribute in excess of net investment income.

We have adopted an “opt in” distribution reinvestment plan for our stockholders. As a result, if we declare a cash distribution, our stockholders will receive distributions in cash unless they specifically “opt in” to the distribution reinvestment plan so as to have their cash distributions reinvested in additional shares of our common stock. However, certain state authorities or regulators may impose restrictions from time to time that may prevent or limit a stockholder’s ability to participate in our distribution reinvestment plan. Although distributions paid in the form of additional shares of our common stock will generally be subject to U.S. federal, state and local taxes in the same manner as cash distributions, stockholders participating in our dividend reinvestment plan will not receive any corresponding cash distributions with which to pay any such applicable taxes.

 

48


On June 24, 2020, the Board of Directors approved a change in its dividend and capital gains distribution schedule from monthly distributions to quarterly distributions, effective immediately. The first quarterly distribution was paid on October 12, 2020, to shareholders of record as of September 30, 2020.

For the three months ended March 31, 2023, the Company made the following distributions:

 

Payable

Date

   Dividend/
Share (1)
     Total
Dividend (1)
     Dividends
Reinvested
 

3/31/2023

   $  0.090      $  859,401      $ —    

1/2/2023(2)

     —          —          294,055  
  

 

 

    

 

 

    

 

 

 

Total

   $ 0.090      $     859,401      $     294,055  
  

 

 

    

 

 

    

 

 

 

 

1 

For the current period, there were no dividends classified as a return of capital.

2 

The December 2022 Dividend was reinvested in January 2023, see total December 2022 Dividend in table below.

For the year ended December 31, 2022, the Company made the following distributions:

 

Payable

Date

   Dividend/
Share (1)
     Total
Dividend (1)
     Dividends
Reinvested
 

12/31/2022(3)

   $ 0.090      $ 870,980      $ —    

9/30/2022

     0.090        874,461        303,070  

6/30/2022

     0.090        887,710        298,766  

3/31/2022

     0.090        892,680        301,212  

1/2/2022(2)

     —          —          306,152  
  

 

 

    

 

 

    

 

 

 

Total

   $  0.360      $  3,525,831      $   1,209,200  
  

 

 

    

 

 

    

 

 

 

 

1 

Of the total dividends shown, $1,999,373 was classified as a return of capital.

2 

The December 2021 Dividend was reinvested in January 2022, see total December 2021 Dividend in table below.

3 

The December 2022 Dividend was re invested in January 2023.

For the year ended December 31, 2021, the Company made the following distributions:

 

Payable

Date

   Dividend/
Share (1)
     Total
Dividend (1)
     Dividends
Reinvested
 

12/31/2021(3)

   $ 0.090      $ 896,061      $ —    

9/30/2021

     0.090        903,359        320,218  

6/30/2021

     0.090        909,619        322,287  

3/31/2021

     0.090        924,140        331,406  

1/2/2021(2)

     —          —          345,331  
  

 

 

    

 

 

    

 

 

 

Total

   $  0.360      $  3,633,179      $  1,319,241  
  

 

 

    

 

 

    

 

 

 

 

1 

For the current period, there were no dividends classified as a return of capital.

2 

The December 2020 Dividend was reinvested in January 2021.

3 

The December 2021 Dividend was reinvested in January 2022.

Related Party Transactions

We have entered into a number of business relationships with affiliated or related parties, including the following:

 

   

We entered into the Investment Advisory Agreement with the Adviser. James Dondero, our president, controls the Adviser by virtue of his control of its general partner, NexPoint Advisors GP, LLC.

 

   

Pursuant to an expense limitation agreement, the Adviser has agreed to waive fees or, if necessary, reimburse us to limit certain expenses to 1.0% of the quarter-end value of our gross assets.

 

   

The Adviser provides us with the office facilities and administrative services necessary to conduct our day-to-day operations pursuant to the Administration Agreement.

 

   

The dealer manager, NexPoint Securities, Inc., is an affiliate of the Adviser.

 

49


   

In aggregate as of March 31, 2023, the Adviser controls 2,549,002 total shares of common stock of the Company, including reinvestment of dividends, for a net amount of approximately $13.7 million.

 

   

Cumulatively since inception, the Adviser has paid $2,275,000 to voluntarily reimburse the Company for certain unrealized losses on investments. Had these payments not been made, the NAV as of March 31, 2023, would have been lower. These payments are not recoupable by the Adviser.

The Adviser and its affiliates also sponsor, or manage, and may in the future sponsor or manage, other investment funds, accounts or investment vehicles (together referred to as “accounts”) that have investment mandates that are similar, in whole and in part, with ours. The Adviser and its affiliates may determine that an investment is appropriate for us and for one or more of those other accounts. In such event, depending on the availability of such investment and other appropriate factors, and pursuant to the Adviser’s allocation policy and co-investment relief, the Adviser or its affiliates may determine that we should invest side-by-side with one or more other accounts. We do not intend to make any investments if they are not permitted by applicable law and interpretive positions of the SEC and its staff, or if they are inconsistent with the Adviser’s allocation procedures and co-investment relief.

In addition, we and the Adviser have each adopted a formal code of ethics that governs the conduct of our and the Adviser’s officers, directors and employees. Our officers and directors also remain subject to the duties imposed by both the 1940 Act and the Delaware General Corporations Law.

Critical Accounting Policies

The preparation of the financial statements in accordance with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses. Changes in the economic environment, financial markets and any other parameters used in determining such estimates could cause actual results to differ. We have identified the following as critical accounting policies.

Fair Value of Financial Instruments

We will value our investments in accordance with ASC Topic 820, Fair Value Measurements and Disclosure, or ASC Topic 820. ASC Topic 820 defines fair value, establishes a framework for measuring fair value and expands disclosures about assets and liabilities measured at fair value. ASC Topic 820’s definition of fair value focuses on exit price in the principal, or most advantageous, market and prioritizes the use of market-based inputs over entity-specific inputs within a measurement of fair value.

The portfolio will often include debt investments and equity investments that are fair valued. The portion of our portfolio that receives values from independent third parties are valued at their mid quotations obtained from unaffiliated market makers, other financial institutions that trade in similar investments or based on prices provided by independent third-party pricing services. For investments where there are no available bid quotations, fair value is derived using proprietary models that consider the analyses of independent valuation agents as well as credit risk, liquidity, market credit spreads, and other applicable factors for similar transactions.

Due to the nature of our strategy, our portfolio will include relatively illiquid investments that are privately held. Valuations of privately held investments are inherently uncertain, may fluctuate over short periods of time and may be based on estimates. The determination of fair value may differ materially from the values that would have been used if a ready market for these investments existed. Our net asset value could be materially affected if the determinations regarding the fair value of our investments were materially higher or lower than the values that we ultimately realize upon the disposal of such investments.

Pursuant to Rule 2a-5 under the 1940 Act, the Board has designated the Adviser as the Company’s valuation designee to perform the fair valuation determination for securities and other assets held by the Company. Pursuant to board approved policies and procedures, the Adviser, or its designee, is responsible for determining in good faith the fair value of the portfolio investments that are not publicly traded, whose market prices are not readily available on a quarterly basis or any other situation where portfolio investments require a fair value determination. Rule 2a-5 states that a market quotation is readily available only when that quotation is a quoted price (unadjusted) in active markets for identical investments that the Company can access at the measurement date, provided that a quotation will not be readily available if it is not reliable. Market quotations may also not be “readily available” if a significant event occurs that causes the Adviser to believe that the market price of a security no longer represents the security’s current value at the time of the Company’s NAV determination.

The valuation process is conducted at the end of each fiscal quarter, with a portion of our valuations of portfolio companies without market quotations subject to review by the independent valuation firms each quarter. When an external event with respect to one of our portfolio companies, such as a purchase transaction, public offering or subsequent equity sale occurs, we expect to use the pricing indicated by such external event to corroborate our valuation.

 

50


With respect to investments for which market quotations are not readily available, the Adviser undertakes a multi-step valuation process each quarter, as described below:

 

   

The valuation process begins with each portfolio company or investment being initially valued by investment professionals of the Adviser responsible for credit monitoring or independent third-party valuation firms.

 

   

Preliminary valuation conclusions are then documented and discussed with the Valuation Committee established by the Adviser to assist the Adviser in discharging its responsibilities as valuation designee.

 

   

At least once each quarter, the valuations for approximately one quarter of the portfolio investments that have been fair valued are reviewed by an independent valuation firm such that, over the course of a year, each material portfolio investment that has been fair valued shall have been reviewed by an independent valuation firm at least once.

 

   

Based on this information, the Adviser discusses valuations and determines the fair value of each investment in the portfolio in good faith pursuant to board-approved policies and procedures.

As of March 31, 2023, the Company held the following investments for which a sufficient level of current, reliable market quotations were not available:

 

Instrument

  

Type

   Fair Value  

Grayson Investor Corp.

   Asset-Backed Securities    $ 7,267  

PAMCO CLO 1997-1A B

   Asset-Backed Securities      13  

American Banknote Corp.

   Common Stocks      1,732,500  

IQHQ, Inc.

   Common Stocks      2,359,000  

TerreStar Corp.

   Common Stocks      5,032,249  

Wayne Services Legacy Inc.

   Common Stocks      2,268  

NexPoint Capital REIT, LLC

   LLC Interests      6,904,655  

SFR WLIF III, LLC

   LLC Interests      418,181  

US GAMING LLC

   LLC Interests      2,841,603  

Apnimed, Inc.

   Preferred Stocks      1,499,989  

Apnimed, Inc.

   Preferred Stocks      799,993  

Sapience Therapeutics, Inc.

   Preferred Stocks      4,581,906  

Sapience Therapeutics, Inc.

   Preferred Stocks      3,700,000  

CCS Medical, Inc.

   Senior Secured Loans      3,000,000  

NexPoint Capital REIT, LLC

   Senior Secured Loans      463,314  

TerreStar Corp.

   Senior Secured Loans      836,016  

TerreStar Corp.

   Senior Secured Loans      197,921  

TerreStar Corp.

   Senior Secured Loans      35,360  

TerreStar Corp.

   Senior Secured Loans      32,991  

As of December 31, 2022, the Company held the following investments for which a sufficient level of current, reliable market quotations were not available:

 

Instrument

  

Type

   Fair Value  

Grayson Investor Corp.

   Asset-Backed Securities    $ 7,023  

PAMCO CLO 1997-1A B

   Asset-Backed Securities      13  

American Banknote Corp.

   Common Stocks      1,732,500  

IQHQ, Inc.

   Common Stocks      2,359,000  

Terrestar Corp.

   Common Stocks      5,114,214  

Wayne Services Legacy Inc.

   Common Stocks      2,269  

NexPoint Capital REIT, LLC

   LLC Interests      1,176,024  

SFR WLIF III, LLC

   LLC Interests      424,468  

US Gaming, LLC

   LLC Interests      3,088,750  

Apnimed, Inc.

   Preferred Stocks      1,499,989  

Apnimed, Inc.

   Preferred Stocks      799,994  

Sapience Therapeutics, Inc.

   Preferred Stocks      4,549,525  

 

51


Instrument

  

Type

   Fair Value  

Sapience Therapeutics, Inc.

   Preferred Stocks    $ 3,677,777  

Carestream Health, Inc.

   Senior Secured Loans      511,483  

CCS Medical, Inc.

   Senior Secured Loans      3,000,000  

Terrestar Corp.

   Senior Secured Loans      810,953  

Terrestar Corp.

   Senior Secured Loans      191,988  

Terrestar Corp.

   Senior Secured Loans      34,300  

Terrestar Corp.

   Senior Secured Loans      32,002  

Organization Costs

Organization costs include the cost of incorporation, such as the cost of legal services and other fees pertaining to our organization. Organization costs, together with offering costs, are limited to 1% of total gross proceeds raised in the offering and are not due and payable to the Adviser to the extent they exceed that amount. For the three months ended March 31, 2023, and March 31, 2022, the Adviser did not incur or pay any organization costs on our behalf.

Offering Costs

Our offering costs include legal fees, promotional costs and other costs pertaining to the public offering of our shares of common stock and are capitalized and amortized to expense over one year. For the three months ended March 31, 2023, the Adviser incurred offering costs of $0 on our behalf. For the three months ended March 31, 2022, the Adviser incurred offering costs of $0 and on our behalf. For the three months ended March 31, 2023, the Company capitalized $0 of offering costs. For the three months ended March 31, 2022, the Company capitalized $0 of offering costs. Of the capitalized offering costs, $0 were amortized to expense during the three months ended March 31, 2023. Of the capitalized offering costs, $0 were amortized to expense during the three months ended March 31, 2022. As of March 31, 2023 and March 31, 2022, $0 and $0 remained on the Statements of Assets and Liabilities, respectively.

Organization costs and offering costs are limited to 1% of total gross proceeds raised in this offering and are not due and payable to the Adviser to the extent they exceed that amount. As of March 31, 2023, the cumulative aggregate amount of $5,327,574 of organization and offering costs exceeds 1% of total proceeds raised. Subsequent to the termination of the Offering, the Adviser forfeited the right to reimbursement of the remaining $4,305,091 of these costs.

Investment Transactions and Related Investment Income and Expense

We record our investment transactions on a trade date basis, which is the date when we have determined that all material terms have been defined for the transactions. These transactions could possibly settle on a subsequent date depending on the transaction type. All related revenue and expenses attributable to these transactions are reflected on the Statements of Operations commencing on the trade date unless otherwise specified by the transaction documents. Realized gains and losses on investment transactions are recorded on the specific identification method. We accrue interest income if we expect that ultimately we will be able to collect it. Generally, when an interest payment default occurs on a loan in our portfolio, or if our management otherwise believes that the issuer of the loan will not be able to service the loan and other obligations, we place the loan on non-accrual status and will cease recognizing interest income on that loan until all principal and interest is current through payment or until a restructuring occurs, such that the interest income is deemed to be collectible. However, we remain contractually entitled to this interest. We may make exceptions to this policy if the loan has sufficient collateral value and is in the process of collection. Accrued interest is written off when it becomes probable that such interest will not be collected, and the amount of uncollectible interest can be reasonably estimated.

 

52


We also accrue for delayed compensation, which is a pricing adjustment payable by the parties to a secondary loan trade that closes late, intended to assure that neither party derives an economic advantage from the delay. Delayed compensation begins calculating at the loan’s specific coupon rate if a trade hasn’t settled within 7 business days of trading. Original issue discounts, market discounts or premiums are accreted or amortized using the effective interest method as interest income and will be accreted or amortized over the maturity period of the investments. We will record prepayment premiums on loans and debt securities as interest income. Dividend income, if any, will be recognized on an accrual basis to the extent that we expect to collect such amount.

We may have investments in our portfolio that contain a PIK interest provision. Any PIK interest will be added to the principal balance of such investments and is recorded as income, if the portfolio company valuation indicates that such PIK interest is collectible. In order to qualify for the special tax treatment accorded RICs and their shareholders, substantially all of our income (including PIK interest) must be distributed to stockholders in the form of dividends, even if we have not collected any cash.

Interest expense is recorded on an accrual basis. Certain expenses related to legal and tax consultation, due diligence, rating fees, valuation expenses and independent collateral appraisals may arise when we make certain investments.

Loan Origination, Facility, Commitment and Amendment Fees

We may receive fees in addition to interest income from loans during the life of the investment. We may receive origination fees upon the origination of an investment. These origination fees are initially deferred and deducted from the cost basis of the investment and subsequently accreted into income over the term of the loan. We may receive facility, commitment and amendment fees, which are paid to us on an ongoing basis. Facility fees, sometimes referred to as asset management fees, are accrued as a percentage periodic fee on the base amount (either the funded facility amount or the committed principal amount). Commitment fees are based upon the undrawn portion committed by us and are recorded on an accrual basis. Amendment fees are paid in connection with loan amendments and waivers and are accounted for upon completion of the amendments or waivers, generally when such fees are receivable. Any such fees are included in other income on the Statements of Operations.

Net Realized Gains or Losses and Net Change in Unrealized Appreciation or Depreciation

We measure net realized gains or losses by the difference between the net proceeds from the repayment or sale and the amortized cost basis of the investment, without regard to unrealized appreciation or depreciation previously recognized, but considering unamortized upfront fees and prepayment penalties. Net change in unrealized appreciation or depreciation will reflect the change in portfolio investment values during the reporting period, including any reversal of previously recorded unrealized appreciation or depreciation, when gains or losses are realized.

U.S. Federal Income Taxes

We have elected to be treated as a RIC under Subchapter M of the Code and intend each year to qualify and be eligible to be treated as such. As a RIC, we generally will not have to pay corporate-level federal income taxes on any investment company taxable income or net capital gains that we distribute as dividends to our stockholders. In order to qualify for the special tax treatment accorded RICs and their shareholders, we must meet certain gross income, diversification, and distribution requirements.

Recent Accounting Pronouncements

Please refer to Note 2 to the financial statements included herein for discussion of recent accounting pronouncements.

 

Item 3.

Quantitative and Qualitative Disclosures About Market Risk

We are subject to financial market risks, most significantly changes in interest rates. As of March 31, 2023, 57% (based on fair value) of the investments in our portfolio had floating interest rates. These investments are usually based on a floating LIBOR and typically have interest rate reset provisions that adjust applicable interest rates under such loans to current market rates on a monthly or quarterly basis.

To the extent that any present or future credit facilities or other financing arrangements that we or any of our subsidiaries enter into are based on a floating interest rate, we will be subject to risks relating to changes in market interest rates. In periods of rising interest rates when we or our subsidiaries have such debt outstanding, or financing arrangements in effect, our interest expense would increase, which could reduce our net investment income, especially to the extent we hold fixed rate investments.

A rise in the general level of interest rates can be expected to lead to higher interest rates applicable to our debt investments, especially to the extent that we predominantly hold variable-rate investments, and to declines in the value of any fixed- rate investments we hold. To the extent that a majority of our investments may be in variable-rate investments, an increase in interest rates could make it easier for us to meet or exceed the hurdle rate for the income incentive fee payable to the Adviser and may result in a substantial increase in our net investment income, and also to the amount of incentive fees payable to our Adviser with respect to our increasing pre-incentive fee net investment income.

 

53


In July 2017, the Financial Conduct Authority (the authority that regulates LIBOR) announced it intends to stop compelling banks to submit rates for the calculation of LIBOR after 2022. The Alternative Reference Rates Committee (“ARRC”) has proposed the Secured Overnight Financing Rate (“SOFR”) as the recommended alternative to USD-LIBOR for use in derivatives and other financial contracts that are currently indexed to USD-LIBOR. ARRC has proposed a paced market transition plan to SOFR from USD-LIBOR and organizations are currently working on industry wide and company specific transition plans as it relates to derivatives and cash markets exposed to USD-LIBOR. We have material contracts that are indexed to USD-LIBOR and are monitoring this activity and evaluating the related risks.

In connection with the COVID-19 pandemic, the U.S. Federal Reserve and other central banks have reduced certain interest rates and LIBOR has decreased. A prolonged reduction in interest rates will reduce our gross investment income and could result in a decrease in our net investment income if such decreases in LIBOR are not offset by a corresponding increase in the spread over LIBOR that we earn on any portfolio investments, a decrease in in our operating expenses, including with respect to our income incentive fee, or a decrease in the interest rate of our floating interest rate liabilities tied to LIBOR.

Assuming that the Statement of Assets and Liabilities as of March 31, 2023 were to remain constant and that we took no actions to alter our existing interest rate sensitivity, the following table shows the annualized impact of hypothetical base rate changes in interest rates.

 

Change in interest rates    Increase (decrease) in
interest income
     (Increase) decrease in
interest expense
     Increase (decrease)
in NII
 

Down 25 basis points

   $ —      $  —      $ —  

Up 50 basis points

     55,579        —          55,579  

Up 100 basis points

     111,158        —          111,158  

Up 200 basis points

     222,316        —          222,316  

Up 300 basis points

     333,475        —          333,475  

Although we believe that this analysis is indicative of our existing sensitivity to interest rate changes, it does not adjust for changes in the credit market, credit quality, the size and composition of the assets in our portfolio and other business developments, including borrowing under future credit facilities or other borrowing. Accordingly, we can offer no assurances that actual results would not differ materially from the analysis above.

We may in the future hedge against interest rate fluctuations by using standard hedging instruments such as interest rate swaps, futures, options and forward contracts to the limited extent permitted under the 1940 Act and applicable commodities laws. While hedging activities may insulate us against adverse changes in interest rates, they may also limit our ability to participate in the benefits of lower interest rates with respect to the investments in our portfolio with fixed interest rates.

 

54


Item 4.

Controls and Procedures

Evaluation of Disclosure Controls and Procedures

The Company maintains disclosure controls and procedures that are designed to provide reasonable assurance that information required to be disclosed in the Company’s filings under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and the Investment Company Act of 1940, as amended, is recorded, processed, summarized and reported within the periods specified in the rules and forms of the Securities and Exchange Commission. Such information is accumulated and communicated to the Company’s management, including its principal executive officer and principal financial officer, as appropriate, to allow timely decisions regarding required disclosure. The Company’s management, including the principal executive officer and principal financial officer, recognizes that any set of controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives. As of the period covered by this report, we, including our president and chief financial officer, evaluated the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rule 13a-15(e) under the Exchange Act). Based upon that evaluation, our president and chief financial officer concluded that our disclosure controls and procedures were effective.

Changes in Internal Control over Financial Reporting

There have been no material changes in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) of the Exchange Act) during our most recently completed fiscal quarter that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

 

55


Part II – Other Information

 

Item 1:

Legal Proceedings.

Although we may, from time to time, be involved in litigation arising out of our operations in the normal course of business or otherwise, we are currently not a party to any pending material legal proceedings.

 

Item 1A:

Risk Factors.

None.

 

Item 2:

Unregistered Sales of Equity Securities and Use of Proceeds.

None.

 

Item 3:

Defaults Upon Senior Securities.

None.

 

Item 4:

Mine Safety Disclosures.

None.

 

Item 5:

Other Information.

None.

 

56


Item 6:

Exhibits

 

Number    Description
  3.1    Amended and Restated Certificate of Incorporation (Incorporated by reference to Exhibit (a)(3) to Post-Effective Amendment No. 1 to the Company’s Registration Statement on Form N-2 (File No. 333-196096) filed on December 12, 2014)
  3.2    Amended and Restated Bylaws (Incorporated by reference to Exhibit (b)(3) to Post-Effective Amendment No. 1 to the Company’s Registration Statement on Form N-2 (File No. 333-196096) filed on December 12, 2014)
  4.1    Forms of Subscription Agreement (Incorporated by reference to the Prospectus Appendix A. Appendix B and Appendix C filed with Post-Effective Amendment No. 7 to the Company’s Registration Statement on Form N-2 (File No. 333-196096) filed on May 11, 2017)
  4.2    Distribution Reinvestment Plan (Incorporated by reference to Exhibit (e) to Post-Effective Amendment No. 1 to the Company’s Registration Statement on Form N-2 (File No. 333-196096) filed on December 12, 2014)
10.1    Amended and Restated Investment Advisory Agreement (Incorporated by reference to Exhibit (g)(1) to Post-Effective Amendment No. 8 to the Company’s Registration Statement on Form N-2 (File No. 333-196096) filed on September 30, 2017)
10.2    Sub-Administration and Accounting Agreement (Incorporated by reference to Company’s Registration Statement on Form N-2 (File No. 333-216277) filed on February 27, 2017)
10.3    Amended and Restated Administration Agreement (Incorporated by reference to Exhibit (k)(2) to Post-Effective Amendment No. 8 to the Company’s Registration Statement on Form N-2 (File No. 333-196096) filed on September 30, 2017)
10.4    Dealer Manager Agreement (Incorporated by reference to Post-Effective Amendment No. 4 to the Company’s Registration Statement on Form N-2 (File No. 333-196096) filed on March 2, 2016)
10.5    Form of Participating Broker-Dealer Agreement (Included as Exhibit A to the Dealer Manager Agreement)
10.6    Custodian Agreement (Incorporated by reference to Post-Effective Amendment No. 4 to the Company’s Registration Statement on Form N-2 (File No. 333-196096) filed on March 2, 2016)
10.7    Form of Agency Agreement (Incorporated by reference to Pre-Effective Amendment No. 3 to the Company’s Registration Statement on Form N-2 (File No. 333-196096) filed on July 24, 2014)
10.8    Escrow Agreement (Incorporated by reference to Post-Effective Amendment No. 4 to the Company’s Registration Statement on Form N-2 (File No. 333-196096) filed on March 2, 2016)
10.9    Expense Limitation Agreement (Incorporated by reference to Post-Effective Amendment No. 4 to the Company’s Registration Statement on Form N-2 (File No. 333-196096) filed on March 2, 2016)
10.10    Control Agreement, dated and effective as of June 9, 2017, by and between NexPoint Capital, Inc. and BNP Paribas Prime Brokerage International, Ltd. and State Street Bank and Trust Company ((Incorporated by reference to Exhibit 10.10 to Registrants Quarterly Report on 10-Q (File No. 814-01074) filed on November 9, 2017)
10.11    Master Confirmation for Loan Total Return Swap Transactions, dated and effective as of June 13, 2017, by and between NexPoint Capital Inc. and BNP Paribas Prime Brokerage International, Ltd. (Incorporated by reference to Exhibit 10.11 to Registrants Quarterly Report on 10-Q (File No. 814-01074) filed on November 9, 2017)
10.12    Committed Facility Agreement, dated and effective as of October 19, 2017, by and between NexPoint Capital, Inc. and BNP Paribas Prime Brokerage International, Ltd. (Incorporated by reference to Exhibit 10.1 to Registrants Current Report on 8-K (File No. 814-01074) filed on October 19, 2017)

 

57


Number    Description
10.13    U.S. PB Agreement, dated and effective as of October 19, 2017, by and between NexPoint Capital, Inc. and BNP Paribas Prime Brokerage, Inc. (Incorporated by reference to Exhibit 10.2 to Registrants Current Report on 8-K (File No. 814-01074) filed on October 19, 2017)
10.14    International PB Agreement, dated and effective as of October 19, 2017, by and between NexPoint Capital, Inc., BNP Paribas Prime Brokerage International, Ltd., and BNP Paribas acting through its New York branch (Incorporated by reference to Exhibit 10.3 to Registrants Current Report on 8-K (File No. 814-01074) filed on October 19, 2017)
10.15    U.S. Triparty Agreement, dated and effective as of October 19, 2017, by and between NexPoint Capital, Inc., BNP Paribas Prime Brokerage, Inc. and Street Bank and Trust Company (Incorporated by reference to Exhibit 10.4 to Registrants Current Report on 8-K (File No. 814-01074) filed on October 19, 2017)
10.16    International Triparty Agreement, dated and effective as of October 19, 2017, by and between NexPoint Capital, Inc., BNP Paribas Prime Brokerage International, Ltd., and State Street Bank and Trust Company, as custodian (Incorporated by reference to Exhibit 10.5 to Registrants Current Report on 8-K (File No. 814-01074) filed on October 23, 2017)
10.17   

Amended and Restated Master Confirmation for Loan Total Return Swap Transactions, dated and effective as of April 2, 2018, by and between NexPoint Capital, Inc. and BNP Paribas (Incorporated by reference to Exhibit 10.1 to Registrants Current Report on 8-K (File No. 814-01074) filed on April 2, 2018)

31.1*    Certifications by President pursuant to Exchange Act Rule 13a-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002*
31.2*    Certifications by Chief Financial Officer pursuant to Exchange Act Rule 13a-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002*
32.1*    Certification pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002*
101.INS*    XBRL Instance Document—the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document
101.CAL*    Inline XBRL Taxonomy Extension Calculation Linkbase Document
101.SCH*    Inline XBRL Taxonomy Extension Schema Document
101.DEF*    Inline XBRL Taxonomy Extension Definition Linkbase Document
101.LAB*    Inline XBRL Taxonomy Extension Labels Linkbase Document
101.PRE*    Inline XBRL Taxonomy Extension Presentation Linkbase Document
104*    Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)

 

* Filed herewith

 

58


SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this Quarterly Report on Form 10-Q to be signed on its behalf by the undersigned, thereunto duly authorized.

 

    NEXPOINT CAPITAL, INC.
Date: May 15, 2023     By:  

/s/ James Dondero

    Name:   James Dondero
    Title:   President and Principal Executive Officer
Date: May 15, 2023     By:  

/s/ Frank Waterhouse

    Name:   Frank Waterhouse
    Title:   Treasurer, Principal Accounting Officer and Principal Financial Officer

 

59

EX-31.1 2 d421644dex311.htm EX-31.1 EX-31.1

Exhibit 31.1

Certification of Chief Executive Officer

of Periodic Report Pursuant to Rule 13a-14(a) and Rule 15d-14(a)

I, James Dondero, President, certify that:

1) I have reviewed this quarterly report on Form 10-Q of NexPoint Capital, Inc.;

2) Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3) Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4) The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15 (e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a) designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5) The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: May 15, 2023

 

/s/ James Dondero

James Dondero
President
(Principal Executive Officer)
EX-31.2 3 d421644dex312.htm EX-31.2 EX-31.2

Exhibit 31.2

Certification of Chief Financial Officer

of Periodic Report Pursuant to Rule 13a-14(a) and Rule 15d-14(a)

I, Frank Waterhouse, Chief Financial Officer, certify that:

1) I have reviewed this quarterly report on Form 10-Q of NexPoint Capital, Inc.;

2) Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3) Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4) The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15 (e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a) designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5) The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: May 15, 2023

 

/s/ Frank Waterhouse

Frank Waterhouse
Treasurer, Principal Accounting Officer and Principal Financial Officer
EX-32.1 4 d421644dex321.htm EX-32.1 EX-32.1

Exhibit 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report on Form 10-Q of NexPoint Capital, Inc. (the “Company”), for the three months ended March 31, 2023, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), we, James Dondero and Frank Waterhouse, President and Principal Financial Officer, respectively, of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to our knowledge:

 

(1)

The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

(2)

The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company as of the dates and for the periods expressed in the Report.

Date: May 15, 2023

 

/s/ James Dondero

James Dondero

President and Principal Executive Officer

/s/ Frank Waterhouse

Frank Waterhouse

Treasurer, Principal Accounting Officer and Principal Financial Officer

EX-101.SCH 5 cik0001588272-20230331.xsd XBRL TAXONOMY EXTENSION SCHEMA 1001 - Document - Cover Page link:presentationLink link:definitionLink link:calculationLink 1002 - Statement - Statements of Assets and Liabilities link:presentationLink link:definitionLink link:calculationLink 1003 - Statement - Statements of Assets and Liabilities (Parenthetical) link:presentationLink link:definitionLink link:calculationLink 1004 - Statement - Statements of Operations link:presentationLink link:definitionLink link:calculationLink 1005 - Statement - Statements of Changes in Net Assets link:presentationLink link:definitionLink link:calculationLink 1006 - Statement - Statements of Cash Flows link:presentationLink link:definitionLink link:calculationLink 1007 - Statement - Schedule of Investments link:presentationLink link:definitionLink link:calculationLink 1008 - Statement - Schedule of Investments 1 link:presentationLink link:definitionLink link:calculationLink 1009 - Statement - Schedule of Investments 2 link:presentationLink link:definitionLink link:calculationLink 1010 - Statement - Schedule of Investments (Parenthentical) link:presentationLink link:definitionLink link:calculationLink 1011 - Disclosure - Organization link:presentationLink link:definitionLink link:calculationLink 1012 - Disclosure - Summary of Significant Accounting Policies link:presentationLink link:definitionLink link:calculationLink 1013 - Disclosure - Investment Portfolio link:presentationLink link:definitionLink link:calculationLink 1014 - Disclosure - Related Party Transactions and Arrangements link:presentationLink link:definitionLink link:calculationLink 1015 - Disclosure - U.S. Federal Income Tax Information link:presentationLink link:definitionLink link:calculationLink 1016 - Disclosure - Share Repurchase Program link:presentationLink link:definitionLink link:calculationLink 1017 - Disclosure - Economic Dependency and Commitments and Contingencies link:presentationLink link:definitionLink link:calculationLink 1018 - Disclosure - Market and Other Risk Factors link:presentationLink link:definitionLink link:calculationLink 1019 - Disclosure - Affiliated Investments link:presentationLink link:definitionLink link:calculationLink 1020 - Disclosure - Financial Highlights link:presentationLink link:definitionLink link:calculationLink 1021 - Disclosure - Subsequent Events link:presentationLink link:definitionLink link:calculationLink 1022 - Disclosure - Summary of Significant Accounting Policies (Policies) link:presentationLink link:definitionLink link:calculationLink 1023 - Disclosure - Summary of Significant Accounting Policies (Tables) link:presentationLink link:definitionLink link:calculationLink 1024 - Disclosure - Investment Portfolio (Tables) link:presentationLink link:definitionLink link:calculationLink 1025 - Disclosure - Related Party Transactions and Arrangements (Tables) link:presentationLink link:definitionLink link:calculationLink 1026 - Disclosure - Affiliated Investments (Tables) link:presentationLink link:definitionLink link:calculationLink 1027 - Disclosure - Financial Highlights (Tables) link:presentationLink link:definitionLink link:calculationLink 1028 - Disclosure - Organization - Additional Information (Detail) link:presentationLink link:definitionLink link:calculationLink 1029 - Disclosure - Summary of Significant Accounting Policies - Additional Information (Detail) link:presentationLink link:definitionLink link:calculationLink 1030 - Disclosure - Summary of Significant Accounting Policies - Summary of Investments Using Significant Unobservable Input (Detail) link:presentationLink link:definitionLink link:calculationLink 1031 - Disclosure - Summary of Significant Accounting Policies - Summary of Investments Categorize into Fair Value Hierarchy (Detail) link:presentationLink link:definitionLink link:calculationLink 1032 - Disclosure - Summary of Significant Accounting Policies - Summary of Changes in the Company's Level 3 investments (Detail) link:presentationLink link:definitionLink link:calculationLink 1033 - Disclosure - Summary of Significant Accounting Policies - Summary of Changes in the Company's Level 3 investments (Parenthetical) (Detail) link:presentationLink link:definitionLink link:calculationLink 1034 - Disclosure - Summary of Significant Accounting Policies - Summary of Quantitative Information about the Company's Level 3 Asset and Liability (Detail) link:presentationLink link:definitionLink link:calculationLink 1035 - Disclosure - Summary of Significant Accounting Policies - Summary of Computation of Basic and Diluted Net (Detail) link:presentationLink link:definitionLink link:calculationLink 1036 - Disclosure - Investment Portfolio - Summary Of Investment Holdings, Schedule of Investments (Detail) link:presentationLink link:definitionLink link:calculationLink 1037 - Disclosure - Investment Portfolio - Summary Of Investment Company Assets By Industry Classification At Fair Value (Detail) link:presentationLink link:definitionLink link:calculationLink 1038 - Disclosure - Investment Portfolio - Summary Of the Company's invested assets by geographic classification (Detail) link:presentationLink link:definitionLink link:calculationLink 1039 - Disclosure - Related Party Transactions and Arrangements - Schedule Of Fee Waivers And Expense Reimbursements Due From The Adviser Which May Become Subject To Recoupment (Detail) link:presentationLink link:definitionLink link:calculationLink 1040 - Disclosure - Related Party Transactions and Arrangements - Additional Information (Detail) link:presentationLink link:definitionLink link:calculationLink 1041 - Disclosure - U.S. Federal Income Tax Information - Additional Information (Detail) link:presentationLink link:definitionLink link:calculationLink 1042 - Disclosure - Share Repurchase Program - Additional Information (Detail) link:presentationLink link:definitionLink link:calculationLink 1043 - Disclosure - Economic Dependency and Commitments and Contingencies - Additional Information (Detail) link:presentationLink link:definitionLink link:calculationLink 1044 - Disclosure - Market and Other Risk Factors - Additional Information (Detail) link:presentationLink link:definitionLink link:calculationLink 1045 - Disclosure - Affiliated Investments - Summary of Affiliated Issuers of the Company (Detail) link:presentationLink link:definitionLink link:calculationLink 1046 - Disclosure - Financial Highlights - Summary of Share Outstanding (Detail) link:presentationLink link:definitionLink link:calculationLink EX-101.CAL 6 cik0001588272-20230331_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE EX-101.DEF 7 cik0001588272-20230331_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE EX-101.LAB 8 cik0001588272-20230331_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE EX-101.PRE 9 cik0001588272-20230331_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 10 R1.htm IDEA: XBRL DOCUMENT v3.23.1
Cover Page
3 Months Ended
Mar. 31, 2023
shares
Cover [Abstract]  
Document Type 10-Q
Amendment Flag false
Document Period End Date Mar. 31, 2023
Document Fiscal Year Focus 2023
Document Fiscal Period Focus Q1
Current Fiscal Year End Date --12-31
Entity Registrant Name NexPoint Capital, Inc.
Entity Central Index Key 0001588272
Entity File Number 814-01074
Entity Tax Identification Number 38-3926499
Entity Shell Company false
Entity Filer Category Non-accelerated Filer
Entity Small Business false
Document Quarterly Report true
Document Transition Report false
Entity Incorporation, State or Country Code DE
Entity Current Reporting Status Yes
Entity Emerging Growth Company false
Entity Interactive Data Current Yes
Entity Common Stock, Shares Outstanding 9,548,899
Entity Address, Address Line One 300 Crescent Court, Suite 700
Entity Address, City or Town Dallas
Entity Address, State or Province TX
Entity Address, Postal Zip Code 75201
Local Phone Number 628-4100
City Area Code 972
Title of 12(g) Security Common Stock, par value $0.001 per share
XML 11 R2.htm IDEA: XBRL DOCUMENT v3.23.1
Statements of Assets and Liabilities - USD ($)
Mar. 31, 2023
Dec. 31, 2022
Assets    
Investments, fair value disclosure $ 48,731,529 $ 53,293,715
Cash and cash equivalents 1,131,784 1,629,846
Receivable for investments sold 3,318,593 0
Dividends and interest receivable 312,746 220,194
Receivable from Adviser 81,858 92,216
Prepaid expenses 14,029 15,905
Total assets 53,590,539 55,251,876
Liabilities    
Payable for investments purchased 991,699 0
Payable to Adviser 317,702 314,993
Accrued expenses and other liabilities 262,432 371,736
Distributions payable 859,401 870,980
Total liabilities 2,431,234 1,557,709
Commitments and Contingencies 0 0
Net assets    
Preferred stock, $0.001 par value (25,000,000 shares authorized, 0 shares issued and outstanding)
Common stock, $0.001 par value (200,000,000 shares authorized, 9,677,593 and 9,956,228 shares issued and outstanding, respectively) 9,549 9,678
Paid-in capital in excess of par 86,251,861 86,949,376
Distributable earnings (accumulated loss) (35,102,105) (33,264,887)
Total net assets $ 51,159,305 $ 53,694,167
Net asset value per share of common stock $ 5.36 $ 5.55
Unaffiliated investments    
Assets    
Investments, fair value disclosure $ 37,859,825 $ 43,020,714
Affiliated investments    
Assets    
Investments, fair value disclosure $ 10,871,704 $ 10,273,001
XML 12 R3.htm IDEA: XBRL DOCUMENT v3.23.1
Statements of Assets and Liabilities (Parenthetical) - USD ($)
Mar. 31, 2023
Dec. 31, 2022
Investments owned at cost $ 50,811,343 $ 54,011,971
Preferred stock stated or par value per share $ 0.001 $ 0.001
Preferred stock shares authorized 25,000,000 25,000,000
Preferred stock shares issued 0 0
Preferred stock shares outstanding 0 0
Common stock stated or par value per share $ 0.001 $ 0.001
Common stock shares authorized 200,000,000 200,000,000
Common stock shares issued 9,548,899 9,677,593
Common stock shares outstanding 9,548,899 9,677,593
Unaffiliated investments    
Investments owned at cost $ 38,023,138 $ 41,687,079
Affiliated investments    
Investments owned at cost $ 12,788,205 $ 12,324,892
XML 13 R4.htm IDEA: XBRL DOCUMENT v3.23.1
Statements of Operations - USD ($)
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Investment income:    
Interest $ 636,822 $ 562,607
Interest paid-in-kind 29,847 106,711
Total investment income 814,832 1,014,610
Expenses:    
Investment advisory fees 265,381 299,270
Custodian and accounting service fees 75,988 76,747
Administration fees 52,321 59,601
Stock transfer fee 41,136 50,183
Audit and tax fees 40,348 39,474
Other expenses 25,607 20,230
Reports to stockholders 18,232 17,795
Legal fees 9,189 18,218
Directors' fees 4,967 3,731
Total expenses 533,169 585,249
Expenses (waived) or recouped by the Adviser (81,858) (61,761)
Net expenses 451,311 523,488
Net investment income 363,521 491,122
Net realized and unrealized gains (losses) on investments:    
Net realized and unrealized gains (losses) (1,341,338) 653,895
Net increase (decrease) in net assets resulting from operations $ (977,817) $ 1,145,017
Net investment income: $ 0.04 $ 0.05
Earnings (loss) per share: Basic (0.1) 0.11
Earnings (loss) per share: Diluted $ (0.1) $ 0.11
Weighted average shares outstanding: Basic 9,699,655 9,990,797
Weighted average shares outstanding: Diluted 9,699,655 9,990,797
Unaffiliated investments    
Investment income:    
Dividend income $ 36,707 $ 95,633
Net realized and unrealized gains (losses) on investments:    
Net realized gain (loss) on: 20,220 241,708
Net change in unrealized appreciation (depreciation) on: (1,496,947) (1,338,064)
Affiliated investments    
Investment income:    
Dividend income 111,456 249,659
Net realized and unrealized gains (losses) on investments:    
Net realized gain (loss) on: 0 (74,604)
Net change in unrealized appreciation (depreciation) on: $ 135,389 $ 1,824,855
XML 14 R5.htm IDEA: XBRL DOCUMENT v3.23.1
Statements of Changes in Net Assets - USD ($)
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Beginning Balance $ 53,694,167 $ 62,938,908
Net investment income 363,521 491,122
Net realized gain (loss) on investments 20,220 167,104
Net change in unrealized appreciation (depreciation) on investments (1,361,558) 486,791
Repurchase of common stock $ (991,699) (550,120)
Repurchase of common stock, Shares 0  
Reinvestment of common stock $ 294,055 306,152
Distributions to stockholders from net investment income (859,401) (892,680)
Total increase (decrease) (2,534,862) 8,369
Ending Balance $ 51,159,305 $ 62,947,277
Distributions to stockholders per share $ 0.09 $ 0.09
Common Stock    
Beginning Balance $ 9,678 $ 9,956
Beginning Balance, Shares 9,677,593 9,956,228
Repurchase of common stock $ (181) $ (86)
Repurchase of common stock, Shares (181,298) (85,999)
Reinvestment of common stock $ 53 $ 49
Reinvestment of common stock, Shares 52,604 48,442
Total increase (decrease) $ (128) $ (37)
Total increase (decrease), Shares (128,694) (37,557)
Ending Balance $ 9,550 $ 9,919
Ending Balance, Shares 9,548,899 9,918,671
Paid in Capital in Excess of Par    
Beginning Balance $ 86,949,376 $ 91,135,719
Repurchase of common stock (991,518) (550,034)
Reinvestment of common stock 294,002 306,103
Total increase (decrease) (697,516) (243,931)
Ending Balance 86,251,860 90,891,788
Distributable Earnings    
Beginning Balance (33,264,887) (28,206,767)
Net investment income 363,521 491,122
Net realized gain (loss) on investments 20,220 167,104
Net change in unrealized appreciation (depreciation) on investments (1,361,558) 486,791
Distributions to stockholders from net investment income (859,401) (892,680)
Total increase (decrease) (1,837,218) 252,337
Ending Balance $ (35,102,105) $ (27,954,430)
Distributions to stockholders per share $ 0.09 $ 0.09
XML 15 R6.htm IDEA: XBRL DOCUMENT v3.23.1
Statements of Cash Flows - USD ($)
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Cash flows provided by (used in) operating activities    
Net increase (decrease) in net assets resulting from operations $ (977,817) $ 1,145,017
Adjustments to reconcile net increase (decrease) in net assets resulting from operations to net cash provided by (used in) operating activities:    
Purchases of investment securities 0 (6,918,805)
Payment-in-kind investments (29,847) (106,711)
Proceeds from sales and principal repayments of investment securities 3,345,666 5,643,969
Net realized (gain) loss on Unaffiliated investments (20,220) (167,104)
Net change in unrealized (appreciation) depreciation on investments 1,361,558 (486,791)
Amortization of premium/discount, net (94,971) (87,336)
Change in operating assets and liabilities:    
(Increase) decrease in receivable for investments sold (3,318,593) 990,537
(Increase) decrease in dividends and interest receivable (92,552) (181,211)
(Increase) decrease in receivable from Adviser 10,358 37,082
(Increase) decrease in prepaid expenses 1,876 2,558
Increase (decrease) in payable for fund shares repurchased 991,699 0
Increase (decrease) in payable for investments purchased 0 (301,369)
Increase (decrease) in payable to Adviser 2,709 (19,351)
Increase (decrease) in accrued expenses and other liabilities (109,304) 57,764
Net cash flows provided by (used in) operating activities 1,070,562 (391,751)
Cash flows provided by (used in) financing activities    
Repurchase of common stock, net of payable (991,699) (550,120)
Distributions paid in cash (576,925) (589,909)
Net cash flows (used in) financing activities (1,568,624) (1,140,029)
Net decrease in cash and cash equivalents (498,062) (1,531,780)
Cash and cash equivalents    
Beginning of the period 1,629,846 2,811,171
End of the period 1,131,784 1,279,391
Supplemental disclosure and non-cash financing activities    
Paid-in-kind interest income 29,847 106,711
Reinvestment of distributions paid 294,055 306,152
Local and excise taxes paid 41,919 30,187
Unaffiliated investments    
Adjustments to reconcile net increase (decrease) in net assets resulting from operations to net cash provided by (used in) operating activities:    
Net realized (gain) loss on Unaffiliated investments $ (20,220) $ (167,104)
XML 16 R7.htm IDEA: XBRL DOCUMENT v3.23.1
Schedule of Investments - USD ($)
3 Months Ended 12 Months Ended
Mar. 31, 2023
Dec. 31, 2022
Summary of Investment Holdings [Line Items]    
Fair Value $ 48,731,529 $ 53,293,715
Senior Secured Loans At Nineteen Point Six Percent [Member]    
Summary of Investment Holdings [Line Items]    
Fair Value 10,031,617  
Asset Backed Securities At Zero Point Zero Percent [Member]    
Summary of Investment Holdings [Line Items]    
Fair Value 7,280 7,036
Corporate Bonds At Four Point Nine Percent [Member]    
Summary of Investment Holdings [Line Items]    
Fair Value 2,500,245  
Senior Secured Loans At Twenty Six Point Zero Five Percent [Member]    
Summary of Investment Holdings [Line Items]    
Fair Value   14,228,193
Corporate Bonds At Five Point Zero Percent [Member]    
Summary of Investment Holdings [Line Items]    
Fair Value   2,704,917
Healthcare At Sixteen Point Five Percentage [Member] | Senior Secured Loans At Nineteen Point Six Percent [Member]    
Summary of Investment Holdings [Line Items]    
Fair Value 8,466,015  
Tele Communication Services At Two Point Two Percentage [Member] | Senior Secured Loans At Nineteen Point Six Percent [Member]    
Summary of Investment Holdings [Line Items]    
Fair Value 1,102,288  
Financials At Zero Point Zero Percent [Member] | Asset Backed Securities At Zero Point Zero Percent [Member]    
Summary of Investment Holdings [Line Items]    
Fair Value $ 7,280 $ 7,036
Financials At Zero Point Zero Percent [Member] | Asset Backed Securities At Zero Point Zero Percent [Member] | Grayson Investor Corp. [Member]    
Summary of Investment Holdings [Line Items]    
Portfolio Company Grayson Investor Corp. Grayson Investor Corp. [1],[2],[3],[4],[5],[6]
Principal Amount [1],[4],[5] $ 800 [7],[8],[9] $ 800 [2],[3],[6]
Amortized Cost [1],[4],[5] 218,666 [7],[8],[9],[10] 218,666 [2],[3],[6]
Fair Value [1],[4],[5] $ 7,267 [7],[8],[9] $ 7,023 [2],[3],[6]
Financials At Zero Point Zero Percent [Member] | Asset Backed Securities At Zero Point Zero Percent [Member] | PAMCO CLO19971AB [Member]    
Summary of Investment Holdings [Line Items]    
Portfolio Company PAMCO CLO 1997-1A B PAMCO CLO 1997-1A B [1],[2],[3],[4],[6],[11]
Principal Amount [1],[4],[11] $ 295,435 [7],[8],[9] $ 295,435 [2],[3],[6]
Amortized Cost [1],[4],[11] 169,875 [7],[8],[9],[10] 169,875 [2],[3],[6]
Fair Value [1],[4],[11] $ 13 [7],[8],[9] 13 [2],[3],[6]
Healthcare At Four Point Four Percent [Member] | Corporate Bonds At Four Point Nine Percent [Member] | Hadrian Merger Sub, Inc. [Member]    
Summary of Investment Holdings [Line Items]    
Portfolio Company Hadrian Merger Sub, Inc.  
Maturity Date [8] May 01, 2026  
Principal Amount [8] $ 2,728,000  
Amortized Cost [8],[10] 2,476,999  
Fair Value [8] 2,240,779  
Media And Telecommunications At Zero Point Five Percent [Member] | Corporate Bonds At Four Point Nine Percent [Member]    
Summary of Investment Holdings [Line Items]    
Fair Value $ 259,466  
Media And Telecommunications At Zero Point Five Percent [Member] | Corporate Bonds At Five Point Zero Percent [Member]    
Summary of Investment Holdings [Line Items]    
Fair Value   290,078
Healthcare At Twenty Four Point Five Percentage [Member] | Senior Secured Loans At Twenty Six Point Zero Five Percent [Member]    
Summary of Investment Holdings [Line Items]    
Fair Value   $ 13,158,950
Healthcare At Twenty Four Point Five Percentage [Member] | Corporate Bonds At Five Point Zero Percent [Member] | Hadrian Merger Sub, Inc. [Member]    
Summary of Investment Holdings [Line Items]    
Portfolio Company [3]   Hadrian Merger Sub, Inc.
Tele Communication Services At Two point Zero Percentage [Member] | Senior Secured Loans At Twenty Six Point Zero Five Percent [Member]    
Summary of Investment Holdings [Line Items]    
Fair Value   $ 1,069,243
Healthcare At Four Point Five Percent [Member] | Corporate Bonds At Five Point Zero Percent [Member] | Hadrian Merger Sub, Inc. [Member]    
Summary of Investment Holdings [Line Items]    
Interest Rate [3]   8.500%
Maturity Date [3]   May 01, 2026
Principal Amount [3]   $ 2,728,000
Amortized Cost [3]   2,460,536
Fair Value [3]   $ 2,414,839
Tele Communication Services At Zero Point Five Percentage [Member] | Corporate Bonds At Five Point Zero Percent [Member] | iHeartCommunications, Inc. [Member]    
Summary of Investment Holdings [Line Items]    
Portfolio Company [6]   iHeartCommunications, Inc.
First Lien Term Loan [Member] | Healthcare At Sixteen Point Five Percentage [Member] | Senior Secured Loans At Nineteen Point Six Percent [Member]    
Summary of Investment Holdings [Line Items]    
Base Rate Floor [1],[7],[12] 1.00  
First Lien Term Loan [Member] | Healthcare At Sixteen Point Five Percentage [Member] | Senior Secured Loans At Nineteen Point Six Percent [Member] | Auris Luxembourg III S.a.r.l. [Member]    
Summary of Investment Holdings [Line Items]    
Portfolio Company Auris Luxembourg III S.a.r.l.  
Interest Rate [9],[12] L + 375  
Base Rate Floor [9],[12] 4.93  
Maturity Date [9],[12] Feb. 27, 2026  
Principal Amount [9],[12] $ 1,465,094  
Amortized Cost [9],[10],[12] 1,461,589  
Fair Value [9],[12] $ 1,331,038  
First Lien Term Loan [Member] | Healthcare At Sixteen Point Five Percentage [Member] | Senior Secured Loans At Nineteen Point Six Percent [Member] | Carestream Health Inc [Member]    
Summary of Investment Holdings [Line Items]    
Portfolio Company Carestream Health, Inc.  
Interest Rate [13] SOFR + 750  
Base Rate Floor [13] 5.00  
Maturity Date [13] Sep. 30, 2027  
Principal Amount [13] $ 668,605  
Amortized Cost [10],[13] 579,387  
Fair Value [13] $ 398,990  
First Lien Term Loan [Member] | Healthcare At Sixteen Point Five Percentage [Member] | Senior Secured Loans At Nineteen Point Six Percent [Member] | CCS Medical, Inc [Member]    
Summary of Investment Holdings [Line Items]    
Portfolio Company CCS Medical, Inc  
Interest Rate [1],[7],[12] L + 1400  
Maturity Date [1],[7],[12] Apr. 07, 2026  
Principal Amount [1],[7],[12] $ 3,000,000  
Amortized Cost [1],[7],[10],[12] 2,930,985  
Fair Value [1],[7],[12] $ 3,000,000  
First Lien Term Loan [Member] | Healthcare At Sixteen Point Five Percentage [Member] | Senior Secured Loans At Nineteen Point Six Percent [Member] | Covenant Surgical Partners, Inc. [Member]    
Summary of Investment Holdings [Line Items]    
Portfolio Company Covenant Surgical Partners, Inc.  
Interest Rate [12] L + 400  
Base Rate Floor [12] 4.82  
Maturity Date [12] Jul. 01, 2026  
Principal Amount [12] $ 1,609,272  
Amortized Cost [10],[12] 1,611,581  
Fair Value [12] $ 1,366,545  
First Lien Term Loan [Member] | Healthcare At Sixteen Point Five Percentage [Member] | Senior Secured Loans At Nineteen Point Six Percent [Member] | Envision Healthcare Corp. [Member]    
Summary of Investment Holdings [Line Items]    
Portfolio Company Envision Healthcare Corp.  
Interest Rate [12] L + 375  
Base Rate Floor [12] 5.16  
Maturity Date [12] Oct. 10, 2025  
Principal Amount [12] $ 4,501,911  
Amortized Cost [10],[12] 3,754,602  
Fair Value [12] $ 348,898  
First Lien Term Loan [Member] | Healthcare At Sixteen Point Five Percentage [Member] | Senior Secured Loans At Nineteen Point Six Percent [Member] | Wellpath Holdings, Inc. [Member]    
Summary of Investment Holdings [Line Items]    
Portfolio Company Wellpath Holdings, Inc.  
Interest Rate [12] L + 550  
Base Rate Floor [12] 4.83  
Maturity Date [12] Oct. 01, 2025  
Principal Amount [12] $ 982,051  
Amortized Cost [10],[12] 978,000  
Fair Value [12] $ 667,265  
First Lien Term Loan [Member] | Real Estate At Zero Point Nine Percentage [Member] | Senior Secured Loans At Nineteen Point Six Percent [Member] | NexPoint Capital REIT, LLC [Member]    
Summary of Investment Holdings [Line Items]    
Portfolio Company NexPoint Capital REIT, LLC  
Interest Rate [1],[7],[14] PRIME  
Base Rate Floor [1],[7],[14] 8.00  
Maturity Date [1],[7],[14] Mar. 25, 2025  
Principal Amount [1],[7],[14] $ 463,314  
Amortized Cost [1],[7],[10],[14] 463,314  
Fair Value [1],[7],[14] $ 463,314  
First Lien Term Loan [Member] | Healthcare At Twenty Four Point Five Percentage [Member] | Senior Secured Loans At Twenty Six Point Zero Five Percent [Member] | Auris Luxembourg III S.a.r.l. [Member]    
Summary of Investment Holdings [Line Items]    
Portfolio Company [6],[15]   Auris Luxembourg III S.a.r.l.
Interest Rate [6],[15]   L + 375
Base Rate Floor [6],[15]   4.93%
Maturity Date [6],[15]   Feb. 27, 2026
Principal Amount [6],[15]   $ 1,468,909
Amortized Cost [6],[15]   1,465,131
Fair Value [6],[15]   $ 1,318,346
First Lien Term Loan [Member] | Healthcare At Twenty Four Point Five Percentage [Member] | Senior Secured Loans At Twenty Six Point Zero Five Percent [Member] | Carestream Health Inc [Member]    
Summary of Investment Holdings [Line Items]    
Portfolio Company [16]   Carestream Health, Inc.
Interest Rate [16]   L + 675
Base Rate Floor [16]   12.18%
Maturity Date [16]   Sep. 30, 2027
Principal Amount [16]   $ 668,605
Amortized Cost [16]   576,001
Fair Value [16]   $ 511,483
First Lien Term Loan [Member] | Healthcare At Twenty Four Point Five Percentage [Member] | Senior Secured Loans At Twenty Six Point Zero Five Percent [Member] | CCS Medical, Inc [Member]    
Summary of Investment Holdings [Line Items]    
Portfolio Company [1],[2],[16]   CCS Medical, Inc
Interest Rate [1],[2],[16]   14% Fixed
Maturity Date [1],[2],[16]   Apr. 07, 2026
Principal Amount [1],[2],[16]   $ 3,000,000
Amortized Cost [1],[2],[16]   2,926,520
Fair Value [1],[2],[16]   $ 3,000,000
First Lien Term Loan [Member] | Healthcare At Twenty Four Point Five Percentage [Member] | Senior Secured Loans At Twenty Six Point Zero Five Percent [Member] | Covenant Surgical Partners, Inc. [Member]    
Summary of Investment Holdings [Line Items]    
Portfolio Company [17]   Covenant Surgical Partners, Inc.
Interest Rate [17]   L + 400
Base Rate Floor [17]   4.41%
Maturity Date [17]   Jul. 01, 2026
Principal Amount [17]   $ 1,613,305
Amortized Cost [17]   1,615,775
Fair Value [17]   $ 1,367,276
First Lien Term Loan [Member] | Healthcare At Twenty Four Point Five Percentage [Member] | Senior Secured Loans At Twenty Six Point Zero Five Percent [Member] | Envision Healthcare Corp. [Member]    
Summary of Investment Holdings [Line Items]    
Portfolio Company [17]   Envision Healthcare Corp.
Interest Rate [17]   L + 375
Base Rate Floor [17]   4.07%
Maturity Date [17]   Oct. 10, 2025
Principal Amount [17]   $ 4,518,572
Amortized Cost [17]   3,709,077
Fair Value [17]   $ 1,354,645
First Lien Term Loan [Member] | Healthcare At Twenty Four Point Five Percentage [Member] | Senior Secured Loans At Twenty Six Point Zero Five Percent [Member] | RxBenefits, Inc. [Member]    
Summary of Investment Holdings [Line Items]    
Portfolio Company [15]   RxBenefits, Inc.
Interest Rate [15]   L +450
Base Rate Floor [15]   2.11%
Maturity Date [15]   Dec. 20, 2027
Principal Amount [15]   $ 1,993,177
Amortized Cost [15]   1,963,107
Fair Value [15]   $ 1,888,535
First Lien Term Loan [Member] | Healthcare At Twenty Four Point Five Percentage [Member] | Senior Secured Loans At Twenty Six Point Zero Five Percent [Member] | Wellpath Holdings, Inc. [Member]    
Summary of Investment Holdings [Line Items]    
Portfolio Company [16]   Wellpath Holdings, Inc.
Interest Rate [16]   L + 550
Base Rate Floor [16]   4.41%
Maturity Date [16]   Oct. 01, 2025
Principal Amount [16]   $ 984,615
Amortized Cost [16]   980,197
Fair Value [16]   $ 783,793
Second Lien Term Loan [Member] | Healthcare At Sixteen Point Five Percentage [Member] | Senior Secured Loans At Nineteen Point Six Percent [Member] | CNT Holdings I Corp [Member]    
Summary of Investment Holdings [Line Items]    
Portfolio Company CNT Holdings I Corp  
Interest Rate [12] L + 675  
Base Rate Floor [12] 4.63  
Maturity Date [12] Nov. 06, 2028  
Principal Amount [12] $ 0  
Amortized Cost [10],[12] (783)  
Fair Value [12] $ 0  
Second Lien Term Loan [Member] | Healthcare At Sixteen Point Five Percentage [Member] | Senior Secured Loans At Nineteen Point Six Percent [Member] | Sound Inpatient Physicians [Member]    
Summary of Investment Holdings [Line Items]    
Portfolio Company Sound Inpatient Physicians  
Interest Rate [12] L + 675  
Base Rate Floor [12] 4.83  
Maturity Date [12] Jun. 26, 2026  
Principal Amount [12] $ 1,555,556  
Amortized Cost [10],[12] 1,486,286  
Fair Value [12] $ 1,070,222  
Second Lien Term Loan [Member] | Healthcare At Twenty Four Point Five Percentage [Member] | Senior Secured Loans At Twenty Six Point Zero Five Percent [Member] | CNT Holdings I Corp [Member]    
Summary of Investment Holdings [Line Items]    
Portfolio Company [16]   CNT Holdings I Corp
Interest Rate [16]   L + 675
Base Rate Floor [16]   3.74%
Maturity Date [16]   Nov. 06, 2028
Principal Amount [16]   $ 1,500,000
Amortized Cost [16]   1,494,084
Fair Value [16]   $ 1,422,503
Second Lien Term Loan [Member] | Healthcare At Twenty Four Point Five Percentage [Member] | Senior Secured Loans At Twenty Six Point Zero Five Percent [Member] | Sound Inpatient Physicians [Member]    
Summary of Investment Holdings [Line Items]    
Portfolio Company [17]   Sound Inpatient Physicians
Interest Rate [17]   L + 675
Base Rate Floor [17]   4.07%
Maturity Date [17]   Jun. 26, 2026
Principal Amount [17]   $ 1,555,556
Amortized Cost [17]   1,481,972
Fair Value [17]   $ 1,229,869
First Lien Delayed Draw Term Loan [Member] | Healthcare At Sixteen Point Five Percentage [Member] | Senior Secured Loans At Nineteen Point Six Percent [Member] | Covenant Surgical Partners, Inc. [Member]    
Summary of Investment Holdings [Line Items]    
Portfolio Company Covenant Surgical Partners, Inc.  
Interest Rate 4% Fixed  
Maturity Date Jul. 01, 2026  
Principal Amount $ 333,333  
Amortized Cost [10],[12] 333,783  
Fair Value $ 283,057  
First Lien Delayed Draw Term Loan [Member] | Healthcare At Twenty Four Point Five Percentage [Member] | Senior Secured Loans At Twenty Six Point Zero Five Percent [Member] | Covenant Surgical Partners, Inc. [Member]    
Summary of Investment Holdings [Line Items]    
Portfolio Company   Covenant Surgical Partners, Inc.
Interest Rate   4% Fixed
Maturity Date   Jul. 01, 2026
Principal Amount   $ 333,333
Amortized Cost   333,817
Fair Value   $ 282,500
Interest Rate At Six Point Three Eight Percentage [Member] | Media And Telecommunications At Zero Point Five Percent [Member] | Corporate Bonds At Four Point Nine Percent [Member] | iHeartCommunications, Inc. [Member]    
Summary of Investment Holdings [Line Items]    
Portfolio Company iHeartCommunications, Inc.  
Maturity Date [9] May 01, 2026  
Principal Amount [9] $ 116,808  
Amortized Cost [9],[10] 313,455  
Fair Value [9] $ 103,192  
Interest Rate At Six Point Three Eight Percentage [Member] | Media And Telecommunications At Zero Point Five Percent [Member] | Corporate Bonds At Five Point Zero Percent [Member] | iHeartCommunications, Inc. [Member]    
Summary of Investment Holdings [Line Items]    
Interest Rate [6]   6.375%
Maturity Date [6]   May 01, 2026
Principal Amount [6]   $ 116,808
Amortized Cost [6]   313,455
Fair Value [6]   $ 107,648
Interest Rate At Eight Point Three Eight Percentage [Member] | Media And Telecommunications At Zero Point Five Percent [Member] | Corporate Bonds At Four Point Nine Percent [Member] | iHeartCommunications, Inc. [Member]    
Summary of Investment Holdings [Line Items]    
Portfolio Company iHeartCommunications, Inc.  
Maturity Date [9] May 01, 2027  
Principal Amount [9] $ 214,073  
Amortized Cost [9],[10] 584,792  
Fair Value [9] $ 156,274  
Interest Rate At Eight Point Three Eight Percentage [Member] | Media And Telecommunications At Zero Point Five Percent [Member] | Corporate Bonds At Five Point Zero Percent [Member] | iHeartCommunications, Inc. [Member]    
Summary of Investment Holdings [Line Items]    
Interest Rate [6]   8.375%
Maturity Date [6]   May 01, 2027
Principal Amount [6]   $ 214,073
Amortized Cost [6]   584,792
Fair Value [6]   $ 182,430
First Lien Term Loan E [Member] | Tele Communication Services At Two Point Two Percentage [Member] | Senior Secured Loans At Nineteen Point Six Percent [Member] | TerreStar Corp. [Member]    
Summary of Investment Holdings [Line Items]    
Portfolio Company TerreStar Corp.  
Interest Rate [1],[7] 11% PIK  
Base Rate Floor [1],[7] 11.00  
Maturity Date [1],[7] Feb. 28, 2024  
Principal Amount [1],[7] $ 838,322  
Amortized Cost [1],[7],[10] 838,322  
Fair Value [1],[7] $ 836,016  
First Lien Term Loan E [Member] | Tele Communication Services At Two point Zero Percentage [Member] | Senior Secured Loans At Twenty Six Point Zero Five Percent [Member] | TerreStar Corp. [Member]    
Summary of Investment Holdings [Line Items]    
Portfolio Company [1],[2]   TerreStar Corp.
Interest Rate [1],[2]   11%PIK
Maturity Date [1],[2]   Feb. 28, 2024
Principal Amount [1],[2]   $ 815,685
Amortized Cost [1],[2]   815,684
Fair Value [1],[2]   $ 810,953
First Lien Term Loan F [Member] | Tele Communication Services At Two Point Two Percentage [Member] | Senior Secured Loans At Nineteen Point Six Percent [Member] | TerreStar Corp. [Member]    
Summary of Investment Holdings [Line Items]    
Portfolio Company TerreStar Corp.  
Interest Rate [1],[7] 11% PIK  
Base Rate Floor [1],[7] 0.00  
Maturity Date [1],[7] Feb. 28, 2024  
Principal Amount [1],[7] $ 198,467  
Amortized Cost [1],[7],[10] 198,467  
Fair Value [1],[7] $ 197,921  
First Lien Term Loan F [Member] | Tele Communication Services At Two point Zero Percentage [Member] | Senior Secured Loans At Twenty Six Point Zero Five Percent [Member] | TerreStar Corp. [Member]    
Summary of Investment Holdings [Line Items]    
Portfolio Company [1],[2]   TerreStar Corp.
Interest Rate [1],[2]   11%PIK
Maturity Date [1],[2]   Feb. 28, 2024
Principal Amount [1],[2]   $ 193,108
Amortized Cost [1],[2]   193,108
Fair Value [1],[2]   $ 191,988
First Lien Term Loan G [Member] | Tele Communication Services At Two Point Two Percentage [Member] | Senior Secured Loans At Nineteen Point Six Percent [Member] | TerreStar Corp. [Member]    
Summary of Investment Holdings [Line Items]    
Portfolio Company TerreStar Corp.  
Interest Rate [1],[7] 11% PIK  
Base Rate Floor [1],[7] 0.00  
Maturity Date [1],[7] Feb. 28, 2024  
Principal Amount [1],[7] $ 35,457  
Amortized Cost [1],[7],[10] 35,457  
Fair Value [1],[7] $ 35,360  
First Lien Term Loan G [Member] | Tele Communication Services At Two point Zero Percentage [Member] | Senior Secured Loans At Twenty Six Point Zero Five Percent [Member] | TerreStar Corp. [Member]    
Summary of Investment Holdings [Line Items]    
Portfolio Company [1],[2]   TerreStar Corp.
Interest Rate [1],[2]   11%PIK
Maturity Date [1],[2]   Feb. 28, 2024
Principal Amount [1],[2]   $ 34,500
Amortized Cost [1],[2]   34,500
Fair Value [1],[2]   $ 34,300
First Lien Term Loan H [Member] | Tele Communication Services At Two Point Two Percentage [Member] | Senior Secured Loans At Nineteen Point Six Percent [Member] | TerreStar Corp. [Member]    
Summary of Investment Holdings [Line Items]    
Portfolio Company TerreStar Corp.  
Interest Rate [1],[7] 11% PIK  
Base Rate Floor [1],[7] 0.00  
Maturity Date [1],[7] Feb. 28, 2024  
Principal Amount [1],[7] $ 33,082  
Amortized Cost [1],[7],[10] 33,082  
Fair Value [1],[7] $ 32,991  
First Lien Term Loan H [Member] | Tele Communication Services At Two point Zero Percentage [Member] | Senior Secured Loans At Twenty Six Point Zero Five Percent [Member] | TerreStar Corp. [Member]    
Summary of Investment Holdings [Line Items]    
Portfolio Company [1],[2]   TerreStar Corp.
Interest Rate [1],[2]   11%PIK
Maturity Date [1],[2]   Feb. 28, 2024
Principal Amount [1],[2]   $ 32,189
Amortized Cost [1],[2]   32,189
Fair Value [1],[2]   $ 32,002
[1] Classified as Level 3 within the three-tier fair value hierarchy. Please see Note 2 for an explanation of this hierarchy, as well as a list of unobservable inputs used in the valuation of these instruments.
[2] Represents fair value as determined by the Adviser pursuant to the policies and procedures approved by the Board of Trustees (the “Board”). The Board has designated the Adviser as “valuation designee” for the Company pursuant to Rule 2a-5 of the 1940 Act. The Adviser considers fair valued securities to be securities for which market quotations are not readily available and these securities may be valued using a combination of observable and unobservable inputs. Securities with a total aggregate value of $28,500,789 or 53.0% of net assets were fair valued under the Company’s valuation procedures as of December 31, 2022.
[3] Securities exempt from registration under Rule 144A of the Securities Act. These securities may only be resold in transactions exempt from registration to qualified institutional buyers. As of December 31, 2022, these securities amounted to $2,421,875, or 4.5% of net assets.
[4] Securities of collateralized loan obligations where an affiliate of the Adviser serves as collateral manager.
[5] The investment is considered to be the equity tranche of the issuer.
[6] The investment is not a qualifying asset under Section 55 of the 1940 Act. A business development company (“BDC”), such as the Company, may not acquire any asset other than a qualifying asset, unless at the time the acquisition is made, qualifying assets represent at least 70% of the business development company’s total assets. Non-qualifying assets represented 4.8% of the Company’s total assets as of December 31, 2022.
[7] Represents fair value as determined by the Adviser (as defined in Note 1) pursuant to the policies and procedures approved by the Board of Directors (the “Board”). The Board has designated the Adviser as “valuation designee” for the Company pursuant to Rule 2a-5 of the 1940 Act. The Adviser considers fair valued securities to be securities for which market quotations are not readily available and these securities may be valued using a combination of observable and unobservable inputs. Securities with a total aggregate value of $34,445,226 or 67.3% of net assets were fair valued under the Company’s valuation procedures as of March 31, 2023.
[8] Securities exempt from registration under Rule 144A of the 1933 Act. These securities may only be resold in transactions exempt from registration to qualified institutional buyers. As of March 31, 2023, these securities amounted to $2,248,059, or 4.4% of net assets.
[9] The investment is not a qualifying asset under Section 55 of the 1940 Act. A business development company (“BDC”), such as the Company, may not acquire any asset other than a qualifying asset, unless at the time the acquisition is made, qualifying assets represent at least 70% of the business development company’s total assets. Non-qualifying assets represented 4.9% of the Company’s total assets as of March 31, 2023.
[10] Amortized cost represents the original cost adjusted for the amortization of premiums and/or accretion of discounts, as applicable, on investments.
[11] The issuer is in default of its payment obligation, or is in danger of default.
[12] The interest rate on these investments is subject to a base rate of 3-Month LIBOR, which at March 31, 2023 was 5.19%. The LIBOR rate used to calculate interest is the higher of the prevailing 3 month LIBOR rate in effect on the date of the quarterly reset, or the LIBOR base rate floor shown.
[13] The interest rate on these investments is subject to a base rate of 3-Month SOFR, which at March 31, 2023 was 4.51%
[14] Represents an affiliated issuer. Assets with a total aggregate market value of $10,871,704, or 21.3% of net assets, were affiliated with the Company as of March 31, 2023. See Note 9.
[15] The interest rate on these investments is subject to a base rate of 6-Month LIBOR, which at December 31, 2022 was 5.14%. The LIBOR rate used to calculate interest is the higher of the prevailing 6 month LIBOR rate in effect on the date of the semiannual reset, or the LIBOR base rate floor shown.
[16] The interest rate on these investments is subject to a base rate of 3-Month LIBOR, which at December 31, 2022 was 4.77%. The LIBOR rate used to calculate interest is the higher of the prevailing 3 month LIBOR rate in effect on the date of the quarterly reset, or the LIBOR base rate floor shown.
[17] The interest rate on these investments is subject to a base rate of 1-Month LIBOR, which at December 31, 2022 was 4.39%. The LIBOR rate used to calculate interest is the higher of the prevailing 1 month LIBOR rate in effect on the date of the monthly reset, or the LIBOR base rate floor shown.
XML 17 R8.htm IDEA: XBRL DOCUMENT v3.23.1
Schedule of Investments 1 - USD ($)
3 Months Ended 12 Months Ended
Mar. 31, 2023
Dec. 31, 2022
Summary of Investment Holdings [Line Items]    
Fair Value $ 48,731,529 $ 53,293,715
Common Stocks At Thirty Six Point Three Percent [Member]    
Summary of Investment Holdings [Line Items]    
Fair Value   19,514,684
LLC Interests At Eight Point Seven Percent [Member]    
Summary of Investment Holdings [Line Items]    
Fair Value   $ 4,689,242
Common Stocks At Twenty Seven Point Two Percent [Member]    
Summary of Investment Holdings [Line Items]    
Fair Value 13,883,249  
LLC Interests At Nineteen Point Nine Percent [Member]    
Summary of Investment Holdings [Line Items]    
Fair Value $ 10,164,439  
Chemicals At Zero Point One Percentage [Member] | Common Stocks At Thirty Six Point Three Percent [Member] | MPM Holdings, Inc [Member]    
Summary of Investment Holdings [Line Items]    
Portfolio Company [1]   MPM Holdings, Inc.
Shares [1]   8,500
Amortized Cost [1]   $ 17,000
Fair Value [1]   $ 42,500
Chemicals At Zero Point One Percentage [Member] | Common Stocks At Twenty Seven Point Two Percent [Member] | MPM Holdings, Inc [Member]    
Summary of Investment Holdings [Line Items]    
Portfolio Company MPM Holdings, Inc.  
Shares [1] 8,500  
Amortized Cost [1],[2] $ 17,000  
Fair Value [1] $ 42,500  
Service At Zero Point Zero Percentage [Member] | Common Stocks At Thirty Six Point Three Percent [Member] | Wayne Services Legacy, Inc. [Member]    
Summary of Investment Holdings [Line Items]    
Portfolio Company [3],[4],[5],[6]   Wayne Services Legacy Inc.
Shares [1],[7],[8]   237
Amortized Cost [2]   $ 253,404
Fair Value [1],[7],[8]   $ 2,269
Service At Zero Point Zero Percentage [Member] | Common Stocks At Twenty Seven Point Two Percent [Member] | Wayne Services Legacy, Inc. [Member]    
Summary of Investment Holdings [Line Items]    
Portfolio Company Wayne Services Legacy Inc.  
Shares [1],[7],[9] 237  
Amortized Cost [1],[2],[7],[9] $ 253,404  
Fair Value [1],[7],[9] $ 2,268  
Energy At Three Point Zero Percentage [Member] | Common Stocks At Thirty Six Point Three Percent [Member] | Quarternorth Energy, Inc. [Member]    
Summary of Investment Holdings [Line Items]    
Portfolio Company   Quarternorth Energy, Inc.
Shares   11,534
Amortized Cost   $ 981,428
Fair Value   $ 1,591,692
Financials At Three Point Two Percentage [Member] | Common Stocks At Thirty Six Point Three Percent [Member] | American Banknote Corp [Member]    
Summary of Investment Holdings [Line Items]    
Portfolio Company [1],[7],[8]   American Banknote Corp.
Shares [1],[7],[8]   750,000
Amortized Cost [1],[7],[8]   $ 2,062,500
Fair Value [1],[7],[8]   1,732,500
Real Estate At Eighteen Point Six Percentage [Member] | Common Stocks At Thirty Six Point Three Percent [Member]    
Summary of Investment Holdings [Line Items]    
Fair Value   $ 10,012,730
Real Estate At Eighteen Point Six Percentage [Member] | Common Stocks At Thirty Six Point Three Percent [Member] | IQHQ, Inc [Member]    
Summary of Investment Holdings [Line Items]    
Portfolio Company [7],[8]   IQHQ, Inc.
Shares [7],[8]   100,000
Amortized Cost [7],[8]   $ 1,500,000
Fair Value [7],[8]   $ 2,359,000
Real Estate At Eighteen Point Six Percentage [Member] | Common Stocks At Thirty Six Point Three Percent [Member] | NexPoint Real Estate Finance, Inc. [Member]    
Summary of Investment Holdings [Line Items]    
Portfolio Company [4]   Nexpoint Real Estate Finance, Inc.
Shares [4]   481,670
Amortized Cost [4]   $ 9,960,591
Fair Value [4]   $ 7,653,730
Real Estate Investment Trust At One Point Nine Percentage [Member] | Common Stocks At Thirty Six Point Three Percent [Member] | NexPoint Residential Trust, Inc. [Member]    
Summary of Investment Holdings [Line Items]    
Portfolio Company [4],[5]   NexPoint Residential Trust, Inc.
Shares [4],[5]   23,409
Amortized Cost [2]   $ 698,189
Fair Value [4],[5]   $ 1,018,779
Telecommunication Services At Nine Point Five Percentage [Member] | Common Stocks At Thirty Six Point Three Percent [Member] | TerreStar Corp.. [Member]    
Summary of Investment Holdings [Line Items]    
Portfolio Company [1],[7],[8]   TerreStar Corp.
Shares [1],[7],[8]   14,035
Amortized Cost [2]   $ 1,599,990
Fair Value [1],[7],[8]   $ 5,114,214
Consumer Products At Five Point Seven Percentage [Member] | LLC Interests At Eight Point Seven Percent [Member] | US Gaming, LLC [Member]    
Summary of Investment Holdings [Line Items]    
Portfolio Company [1],[7],[8]   US Gaming, LLC
Shares [1],[7],[8]   2,000
Amortized Cost [2]   $ 2,000,000
Fair Value [1],[7],[8]   3,088,750
Real Estate At Three Point Zero Percentage [Member] | LLC Interests At Eight Point Seven Percent [Member]    
Summary of Investment Holdings [Line Items]    
Fair Value   $ 1,600,492
Real Estate At Three Point Zero Percentage [Member] | LLC Interests At Eight Point Seven Percent [Member] | SFR WLIF III, LLC [Member]    
Summary of Investment Holdings [Line Items]    
Portfolio Company [4],[7],[8]   SFR WLIF III, LLC
Shares [4],[7],[8]   451,112
Amortized Cost [2]   $ 451,112
Fair Value [4],[7],[8]   $ 424,468
Real Estate At Three Point Zero Percentage [Member] | LLC Interests At Eight Point Seven Percent [Member] | NexPoint Capital REIT, LLC [Member]    
Summary of Investment Holdings [Line Items]    
Portfolio Company [4],[7],[8]   NexPoint Capital REIT, LLC
Shares [4],[7],[8]   100
Amortized Cost [2]   $ 1,215,000
Fair Value [4],[7],[8]   $ 1,176,024
Financials At Three Point Four Percentage [Member] | Common Stocks At Twenty Seven Point Two Percent [Member] | American Banknote Corp [Member]    
Summary of Investment Holdings [Line Items]    
Portfolio Company American Banknote Corp.  
Shares [1],[7],[9] 750,000  
Amortized Cost [1],[2],[7],[9] $ 2,062,500  
Fair Value [1],[7],[9] 1,732,500  
Real Estate At Eight Point Seven Percentage [Member] | Common Stocks At Twenty Seven Point Two Percent [Member]    
Summary of Investment Holdings [Line Items]    
Fair Value $ 4,422,263  
Real Estate At Eight Point Seven Percentage [Member] | Common Stocks At Twenty Seven Point Two Percent [Member] | IQHQ, Inc [Member]    
Summary of Investment Holdings [Line Items]    
Portfolio Company IQHQ, Inc.  
Shares [7],[9] 100,000  
Amortized Cost [2],[7],[9] $ 1,500,000  
Fair Value [7],[9] $ 2,359,000  
Real Estate At Eight Point Seven Percentage [Member] | Common Stocks At Twenty Seven Point Two Percent [Member] | NexPoint Real Estate Finance, Inc. [Member]    
Summary of Investment Holdings [Line Items]    
Portfolio Company Nexpoint Real Estate Finance, Inc.  
Shares [10] 131,670  
Amortized Cost [2],[10] $ 2,592,506  
Fair Value [10] $ 2,063,263  
Energy At Three Point Two Percentage [Member] | Common Stocks At Twenty Seven Point Two Percent [Member] | Quarternorth Energy, Inc. [Member]    
Summary of Investment Holdings [Line Items]    
Portfolio Company Quarternorth Energy, Inc.  
Shares 11,534  
Amortized Cost [2] $ 981,428  
Fair Value $ 1,629,178  
Real Estate Investment Trust At Two Point Zero Percentage [Member] | Common Stocks At Twenty Seven Point Two Percent [Member] | NexPoint Residential Trust, Inc. [Member]    
Summary of Investment Holdings [Line Items]    
Portfolio Company NexPoint Residential Trust, Inc.  
Shares [10],[11] 23,409  
Amortized Cost [2],[10],[11] $ 698,189  
Fair Value [10],[11] $ 1,022,291  
Telecommunication Services At Nine Point Eight Percentage [Member] | Common Stocks At Twenty Seven Point Two Percent [Member] | TerreStar Corp.. [Member]    
Summary of Investment Holdings [Line Items]    
Portfolio Company TerreStar Corp.  
Shares [1],[7],[9] 14,035  
Amortized Cost [1],[2],[7],[9] $ 1,599,990  
Fair Value [1],[7],[9] $ 5,032,249  
Consumer Products At Five Point Six Percentage [Member] | LLC Interests At Nineteen Point Nine Percent [Member] | US Gaming, LLC [Member]    
Summary of Investment Holdings [Line Items]    
Portfolio Company US Gaming, LLC  
Shares [1],[7],[9] 1,700  
Amortized Cost [1],[2],[7],[9] $ 1,700,000  
Fair Value [1],[7],[9] 2,841,603  
Real Estate At Fourteen Point Three Percentage [Member] | LLC Interests At Nineteen Point Nine Percent [Member]    
Summary of Investment Holdings [Line Items]    
Fair Value $ 7,322,836  
Real Estate At Fourteen Point Three Percentage [Member] | LLC Interests At Nineteen Point Nine Percent [Member] | SFR WLIF III, LLC [Member]    
Summary of Investment Holdings [Line Items]    
Portfolio Company SFR WLIF III, LLC  
Shares [7],[9],[10] 451,112  
Amortized Cost [2],[7],[9],[10] $ 451,111  
Fair Value [7],[9],[10] $ 418,181  
Real Estate At Fourteen Point Three Percentage [Member] | LLC Interests At Nineteen Point Nine Percent [Member] | NexPoint Capital REIT, LLC [Member]    
Summary of Investment Holdings [Line Items]    
Portfolio Company NexPoint Capital REIT, LLC  
Shares [7],[9],[10] 727  
Amortized Cost [2],[7],[9],[10] $ 8,583,085  
Fair Value [7],[9],[10] $ 6,904,655  
[1] Non-income producing security.
[2] Amortized cost represents the original cost adjusted for the amortization of premiums and/or accretion of discounts, as applicable, on investments.
[3] All investments are denominated in United States Dollars.
[4] Represents an affiliated issuer. Assets with a total aggregate market value of $10,273,001, or 19.1% of net assets, were affiliated with the Company as of December 31, 2022. See Note 10.
[5] The investment is not a qualifying asset under Section 55 of the 1940 Act. A business development company (“BDC”), such as the Company, may not acquire any asset other than a qualifying asset, unless at the time the acquisition is made, qualifying assets represent at least 70% of the business development company’s total assets. Non-qualifying assets represented 4.8% of the Company’s total assets as of December 31, 2022.
[6] Unless otherwise noted, the Company did not “control” and was not an “affiliated person” of any of its portfolio companies, each as defined in the Investment Company Act of 1940, as amended (the “1940 Act”). In general, under the 1940 Act, the Company would be presumed to “control” a portfolio company if it owned 25% or more of its voting securities or had the power to exercise control over the management or policies of such portfolio company, and would be an “affiliated person” of a portfolio company if it owned 5% or more of its voting securities. Additionally, companies under common control (e.g., companies with a common owner of greater than 25% of their respective voting securities) are affiliates under the 1940 Act.
[7] Classified as Level 3 within the three-tier fair value hierarchy. Please see Note 2 for an explanation of this hierarchy, as well as a list of unobservable inputs used in the valuation of these instruments.
[8] Represents fair value as determined by the Adviser pursuant to the policies and procedures approved by the Board of Trustees (the “Board”). The Board has designated the Adviser as “valuation designee” for the Company pursuant to Rule 2a-5 of the 1940 Act. The Adviser considers fair valued securities to be securities for which market quotations are not readily available and these securities may be valued using a combination of observable and unobservable inputs. Securities with a total aggregate value of $28,500,789 or 53.0% of net assets were fair valued under the Company’s valuation procedures as of December 31, 2022.
[9] Represents fair value as determined by the Adviser (as defined in Note 1) pursuant to the policies and procedures approved by the Board of Directors (the “Board”). The Board has designated the Adviser as “valuation designee” for the Company pursuant to Rule 2a-5 of the 1940 Act. The Adviser considers fair valued securities to be securities for which market quotations are not readily available and these securities may be valued using a combination of observable and unobservable inputs. Securities with a total aggregate value of $34,445,226 or 67.3% of net assets were fair valued under the Company’s valuation procedures as of March 31, 2023.
[10] Represents an affiliated issuer. Assets with a total aggregate market value of $10,871,704, or 21.3% of net assets, were affiliated with the Company as of March 31, 2023. See Note 9.
[11] The investment is not a qualifying asset under Section 55 of the 1940 Act. A business development company (“BDC”), such as the Company, may not acquire any asset other than a qualifying asset, unless at the time the acquisition is made, qualifying assets represent at least 70% of the business development company’s total assets. Non-qualifying assets represented 4.9% of the Company’s total assets as of March 31, 2023.
XML 18 R9.htm IDEA: XBRL DOCUMENT v3.23.1
Schedule of Investments 2 - USD ($)
3 Months Ended 12 Months Ended
Mar. 31, 2023
Dec. 31, 2022
Summary of Investment Holdings [Line Items]    
Fair Value $ 48,731,529 $ 53,293,715
Net Assets – 100.0% 51,159,305 53,694,167
Warrants At Zero Point Three Percent [Member]    
Summary of Investment Holdings [Line Items]    
Fair Value 162,811  
Preferred Stocks At Twenty Two Point Three Percent [Member]    
Summary of Investment Holdings [Line Items]    
Fair Value   11,967,910
Warrants At Zero Point Four Percent [Member]    
Summary of Investment Holdings [Line Items]    
Fair Value   181,733
Total Investment Ninety Nine Point Two [Member]    
Summary of Investment Holdings [Line Items]    
Amortized Cost [1]   54,011,971
Fair Value   53,293,715
Cash Equivalents At Two Point Seven Percentage [Member]    
Summary of Investment Holdings [Line Items]    
Fair Value [2]   1,420,428
Other Assets Liabilities, net At One Point Eight Percentage [Member]    
Summary of Investment Holdings [Line Items]    
Fair Value   (1,019,976)
Preferred Stocks At Twenty Three Point Four Percent [Member]    
Summary of Investment Holdings [Line Items]    
Fair Value 11,981,888  
Total Investment Ninety Five Point Three [Member]    
Summary of Investment Holdings [Line Items]    
Amortized Cost 50,811,343  
Fair Value 48,731,529  
Cash Equivalents At One Point Five Percentage [Member]    
Summary of Investment Holdings [Line Items]    
Fair Value [2] 773,826  
Other Assets Liabilities Net At Three Point Two Percentage [Member]    
Summary of Investment Holdings [Line Items]    
Fair Value $ 1,653,950  
Financials At Two Point Seven Percentage [Member] | Preferred Stocks At Twenty Two Point Three Percent [Member]    
Summary of Investment Holdings [Line Items]    
Fair Value   $ 1,440,625
Financials At Two Point Seven Percentage [Member] | Preferred Stocks At Twenty Two Point Three Percent [Member] | 777 Partners, LLC [Member]    
Summary of Investment Holdings [Line Items]    
Portfolio Company [3],[4]   777 Partners, LLC
Preferred Dividend Rate 10.00% 10.00%
Principal Amount   $ 750
Amortized Cost [1]   750,000
Fair Value   $ 740,625
Financials At Two Point Seven Percentage [Member] | Preferred Stocks At Twenty Two Point Three Percent [Member] | United Fidelity Bank FSB [Member]    
Summary of Investment Holdings [Line Items]    
Portfolio Company [3],[4]   United Fidelity Bank FSB
Preferred Dividend Rate 7.00% 7.00%
Principal Amount   $ 1,000
Amortized Cost [1]   1,000,000
Fair Value   $ 700,000
Financials At Two Point Seven Percentage [Member] | Preferred Stocks At Twenty Three Point Four Percent [Member]    
Summary of Investment Holdings [Line Items]    
Fair Value $ 1,400,000  
Financials At Two Point Seven Percentage [Member] | Preferred Stocks At Twenty Three Point Four Percent [Member] | 777 Partners, LLC [Member]    
Summary of Investment Holdings [Line Items]    
Portfolio Company 777 Partners, LLC  
Principal Amount $ 750  
Amortized Cost 750,000  
Fair Value $ 720,000  
Financials At Two Point Seven Percentage [Member] | Preferred Stocks At Twenty Three Point Four Percent [Member] | United Fidelity Bank FSB [Member]    
Summary of Investment Holdings [Line Items]    
Portfolio Company United Fidelity Bank FSB  
Principal Amount $ 1,000  
Amortized Cost 1,000,000  
Fair Value $ 680,000  
Media And Telecommunications At Zero Point Zero Percentage [Member] | Warrants At Zero Point Three Percent [Member] | iHeartMedia, Inc. [Member]    
Summary of Investment Holdings [Line Items]    
Portfolio Company iHeartMedia, Inc.  
Principal Amount [5],[6] $ 2,875  
Amortized Cost [1],[5],[6] 52,987  
Fair Value [5],[6] $ 10,063  
Media And Telecommunications At Zero Point One Percentage [Member] | Warrants At Zero Point Four Percent [Member] | iHeartMedia, Inc. [Member]    
Summary of Investment Holdings [Line Items]    
Portfolio Company [3],[4]   iHeartMedia, Inc.
Maturity Date [5],[7]   May 01, 2039
Principal Amount [5],[7]   $ 2,875
Amortized Cost [1]   52,987
Fair Value [5],[7]   20,484
Healthcare At Ninteen Point Six Percentage [Member] | Preferred Stocks At Twenty Two Point Three Percent [Member]    
Summary of Investment Holdings [Line Items]    
Fair Value   $ 10,527,285
Healthcare At Ninteen Point Six Percentage [Member] | Preferred Stocks At Twenty Two Point Three Percent [Member] | Apnimed, Inc. [Member]    
Summary of Investment Holdings [Line Items]    
Portfolio Company [3],[4]   Apnimed, Inc.
Preferred Dividend Rate [8] 8.00% [9] 8.00% [10]
Principal Amount [8],[10]   $ 135,122
Amortized Cost [1]   1,199,993
Fair Value [8],[10]   1,499,989
Energy At Zero Point Three Percentage [Member] | Warrants At Zero Point Three Percent [Member]    
Summary of Investment Holdings [Line Items]    
Fair Value $ 152,748  
Energy At Zero Point Three Percentage [Member] | Warrants At Zero Point Three Percent [Member] | QuarterNorth Tranche 1 [Member]    
Summary of Investment Holdings [Line Items]    
Portfolio Company QuarterNorth Tranche 1  
Principal Amount [5] $ 5,738  
Amortized Cost [1],[5] 16,122  
Fair Value [5] $ 58,815  
Energy At Zero Point Three Percentage [Member] | Warrants At Zero Point Three Percent [Member] | QuarterNorth Tranche 2 [Member]    
Summary of Investment Holdings [Line Items]    
Portfolio Company QuarterNorth Tranche 2  
Principal Amount [5] $ 11,051  
Amortized Cost [1],[5] 5,175  
Fair Value [5] 93,933  
Energy At Zero Point Three Percentage [Member] | Warrants At Zero Point Four Percent [Member]    
Summary of Investment Holdings [Line Items]    
Fair Value   $ 161,249
Energy At Zero Point Three Percentage [Member] | Warrants At Zero Point Four Percent [Member] | QuarterNorth Tranche 1 [Member]    
Summary of Investment Holdings [Line Items]    
Portfolio Company [3],[4]   QuarterNorth Tranche 1
Maturity Date [5]   Aug. 27, 2029
Principal Amount [5]   $ 5,738
Amortized Cost [1]   16,122
Fair Value [5]   $ 64,553
Energy At Zero Point Three Percentage [Member] | Warrants At Zero Point Four Percent [Member] | QuarterNorth Tranche 2 [Member]    
Summary of Investment Holdings [Line Items]    
Portfolio Company [3],[4]   QuarterNorth Tranche 2
Maturity Date [5]   Aug. 27, 2029
Principal Amount [5]   $ 11,051
Amortized Cost [1]   5,175
Fair Value [5]   $ 96,696
Healthcare At Twenty Point Seven Percentage [Member] | Preferred Stocks At Twenty Three Point Four Percent [Member]    
Summary of Investment Holdings [Line Items]    
Fair Value $ 10,581,888  
Healthcare At Twenty Point Seven Percentage [Member] | Preferred Stocks At Twenty Three Point Four Percent [Member] | Apnimed, Inc. [Member]    
Summary of Investment Holdings [Line Items]    
Portfolio Company Apnimed, Inc.  
Principal Amount [8],[9] $ 135,122  
Amortized Cost [1],[8],[9] 1,199,994  
Fair Value [8],[9] $ 1,499,989  
Series B Preferred Stock [Member] | Healthcare At Ninteen Point Six Percentage [Member] | Preferred Stocks At Twenty Two Point Three Percent [Member] | Sapience Therapeutics, Inc. [Member]    
Summary of Investment Holdings [Line Items]    
Portfolio Company [3],[4]   Sapience Therapeutics, Inc.
Preferred Dividend Rate [8] 8.00% [9] 8.00% [10]
Principal Amount [8],[10]   $ 1,619,048
Amortized Cost [1]   4,080,000
Fair Value [8],[10]   $ 4,549,525
Series B Preferred Stock [Member] | Healthcare At Twenty Point Seven Percentage [Member] | Preferred Stocks At Twenty Three Point Four Percent [Member] | Sapience Therapeutics, Inc. [Member]    
Summary of Investment Holdings [Line Items]    
Portfolio Company Sapience Therapeutics, Inc.  
Principal Amount [8],[9] $ 1,619,048  
Amortized Cost [1],[8],[9] 4,080,000  
Fair Value [8],[9] $ 4,581,906  
SeriesB1Preferred Shares [Member] | Healthcare At Ninteen Point Six Percentage [Member] | Preferred Stocks At Twenty Two Point Three Percent [Member] | Sapience Therapeutics, Inc. [Member]    
Summary of Investment Holdings [Line Items]    
Portfolio Company [3],[4]   Sapience Therapeutics, Inc.
Principal Amount [8],[10]   $ 1,111,111
Amortized Cost [1]   4,000,000
Fair Value [8],[10]   $ 3,677,777
SeriesB1Preferred Shares [Member] | Healthcare At Twenty Point Seven Percentage [Member] | Preferred Stocks At Twenty Three Point Four Percent [Member] | Sapience Therapeutics, Inc. [Member]    
Summary of Investment Holdings [Line Items]    
Portfolio Company Sapience Therapeutics, Inc.  
Preferred Dividend Rate [8],[9] 8.00%  
Principal Amount [8],[9] $ 1,111,111  
Amortized Cost [1],[8],[9] 4,000,000  
Fair Value [8],[9] $ 3,700,000  
Series C2 [Member] | Healthcare At Ninteen Point Six Percentage [Member] | Preferred Stocks At Twenty Two Point Three Percent [Member] | Apnimed, Inc. [Member]    
Summary of Investment Holdings [Line Items]    
Portfolio Company [3],[4]   Apnimed, Inc.
Preferred Dividend Rate [8] 8.00% [9] 8.00% [10]
Principal Amount [8],[10]   $ 72,065
Amortized Cost [1]   799,994
Fair Value [8],[10]   $ 799,994
Series C2 [Member] | Healthcare At Twenty Point Seven Percentage [Member] | Preferred Stocks At Twenty Three Point Four Percent [Member] | Apnimed, Inc. [Member]    
Summary of Investment Holdings [Line Items]    
Portfolio Company Apnimed, Inc.  
Principal Amount [8],[9] $ 72,065  
Amortized Cost [1],[8],[9] 799,993  
Fair Value [8],[9] $ 799,993  
[1] Amortized cost represents the original cost adjusted for the amortization of premiums and/or accretion of discounts, as applicable, on investments.
[2] State Street U.S. Government Money Market Fund.
[3] All investments are denominated in United States Dollars.
[4] Unless otherwise noted, the Company did not “control” and was not an “affiliated person” of any of its portfolio companies, each as defined in the Investment Company Act of 1940, as amended (the “1940 Act”). In general, under the 1940 Act, the Company would be presumed to “control” a portfolio company if it owned 25% or more of its voting securities or had the power to exercise control over the management or policies of such portfolio company, and would be an “affiliated person” of a portfolio company if it owned 5% or more of its voting securities. Additionally, companies under common control (e.g., companies with a common owner of greater than 25% of their respective voting securities) are affiliates under the 1940 Act.
[5] Non-income producing security.
[6] The investment is not a qualifying asset under Section 55 of the 1940 Act. A business development company (“BDC”), such as the Company, may not acquire any asset other than a qualifying asset, unless at the time the acquisition is made, qualifying assets represent at least 70% of the business development company’s total assets. Non-qualifying assets represented 4.9% of the Company’s total assets as of March 31, 2023.
[7] The investment is not a qualifying asset under Section 55 of the 1940 Act. A business development company (“BDC”), such as the Company, may not acquire any asset other than a qualifying asset, unless at the time the acquisition is made, qualifying assets represent at least 70% of the business development company’s total assets. Non-qualifying assets represented 4.8% of the Company’s total assets as of December 31, 2022.
[8] Classified as Level 3 within the three-tier fair value hierarchy. Please see Note 2 for an explanation of this hierarchy, as well as a list of unobservable inputs used in the valuation of these instruments.
[9] Represents fair value as determined by the Adviser (as defined in Note 1) pursuant to the policies and procedures approved by the Board of Directors (the “Board”). The Board has designated the Adviser as “valuation designee” for the Company pursuant to Rule 2a-5 of the 1940 Act. The Adviser considers fair valued securities to be securities for which market quotations are not readily available and these securities may be valued using a combination of observable and unobservable inputs. Securities with a total aggregate value of $34,445,226 or 67.3% of net assets were fair valued under the Company’s valuation procedures as of March 31, 2023.
[10] Represents fair value as determined by the Adviser pursuant to the policies and procedures approved by the Board of Trustees (the “Board”). The Board has designated the Adviser as “valuation designee” for the Company pursuant to Rule 2a-5 of the 1940 Act. The Adviser considers fair valued securities to be securities for which market quotations are not readily available and these securities may be valued using a combination of observable and unobservable inputs. Securities with a total aggregate value of $28,500,789 or 53.0% of net assets were fair valued under the Company’s valuation procedures as of December 31, 2022.
XML 19 R10.htm IDEA: XBRL DOCUMENT v3.23.1
Schedule of Investments (Parenthentical) - USD ($)
Mar. 31, 2023
Dec. 31, 2022
Summary of Investment Holdings [Line Items]    
Percentage of Non Qualifying Asset on Company's total asset 4.90% 4.80%
Percentage of Net Assets under valuation procedure 4.40%  
Equity Method Investments $ 2,248,059  
Affiliated Entity [Member]    
Summary of Investment Holdings [Line Items]    
Percentage of Net Assets under valuation procedure 21.30% 19.10%
Equity Method Investments $ 10,871,704 $ 10,273,001
Restricted Securities [Member]    
Summary of Investment Holdings [Line Items]    
Percentage of Net Assets under valuation procedure   4.50%
Equity Method Investments   $ 2,421,875
Board of Directors [Member]    
Summary of Investment Holdings [Line Items]    
Percentage of Net Assets under valuation procedure 67.30% 53.00%
Equity Method Investments $ 34,445,226 $ 28,500,789
Base Rate of 6 Month LIBOR [Member]    
Summary of Investment Holdings [Line Items]    
Investment owned ,Interest Rates   5.14%
Base Rate of 3 Month LIBOR [Member]    
Summary of Investment Holdings [Line Items]    
Investment owned ,Interest Rates 5.19% 4.77%
Base Rate of 1 Month LIBOR [Member]    
Summary of Investment Holdings [Line Items]    
Investment owned ,Interest Rates   4.39%
Base Rate of 3 Month SOFR [Member]    
Summary of Investment Holdings [Line Items]    
Investment owned ,Interest Rates 4.51%  
Maximum [Member] | Equity Method Investee Controlling Investment [Member]    
Summary of Investment Holdings [Line Items]    
Equity method investments ownership percentage 5.00% 25.00%
Minimum [Member] | Equity Method Investee Controlling Investment [Member]    
Summary of Investment Holdings [Line Items]    
Equity method investments ownership percentage 25.00%  
Minimum [Member] | Equity Method Investee Affiliated Investments [Member]    
Summary of Investment Holdings [Line Items]    
Equity method investments ownership percentage   5.00%
XML 20 R11.htm IDEA: XBRL DOCUMENT v3.23.1
Organization
3 Months Ended
Mar. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Organization
Note 1 — Organization
NexPoint Capital, Inc. (the “Company”) is an externally managed,
non-diversified,
closed-end
management investment company that has elected to be regulated as a business development company (“BDC”) under the 1940 Act. The Company follows the investment company accounting and reporting guidance of the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 946
Financial Services—Investment Companies.
The Company’s investment objective is to generate current income and capital appreciation primarily through investments in middle-market healthcare companies, middle-market companies in
non-healthcare
sectors, syndicated floating rate debt of large public and nonpublic companies and collateralized loan obligations. The Company has elected to be treated for federal income tax purposes, and intends to qualify annually thereafter, as a regulated investment company (“RIC”), under Subchapter M of the Internal Revenue Code of 1986, as amended (the “Code”). In this report, “we,” “us” and “our” refer to NexPoint Capital, Inc.
The Company was formed in Delaware on September 30, 2013 and formally commenced operations on September 2, 2014 upon satisfying the minimum offering requirement by raising gross proceeds of $10.0 million in connection with a private placement with NexPoint Advisors, L.P. (the “Adviser”), our external advisor. In aggregate as of March 31, 2023, the Adviser controls 2,549,002 total shares of common stock (or 26.7%) of the Company, including reinvestment of dividends, for a net amount of approximately $13.7 million.
The Company has retained the Adviser to manage certain aspects of its affairs on a
day-to-day
basis. NexPoint Securities, Inc. (the “Dealer Manager”), an entity under common ownership with the Adviser, served as the dealer manager of the Company’s continuous public offering prior to the termination of the offering. The Adviser and Dealer Manager are related parties and will receive fees and other compensation for services related to the investment and management of the Company’s assets and the continuous public offering. The Company’s continuous public offering ended on February 14, 2018.
XML 21 R12.htm IDEA: XBRL DOCUMENT v3.23.1
Summary of Significant Accounting Policies
3 Months Ended
Mar. 31, 2023
Accounting Policies [Abstract]  
Summary of Significant Accounting Policies
Note 2 — Summary of Significant Accounting Policies
Basis of Accounting
The accompanying financial statements of the Company are prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”). Additionally, the accompanying financial statements of the Company and related financial information have been prepared pursuant to the requirements for reporting on Form
10-Q
and Article 10 of Regulation
S-X.
The current period’s results of operations will not necessarily be indicative of results that ultimately may be achieved for the fiscal year ending December 31, 2023. The interim financial data as of March 31, 2023 and for the three months ended March 31, 2023 and 2022 is unaudited. In the opinion of management, the interim financial data includes all adjustments, consisting only of the normal recurring adjustments, necessary to a fair statement of the results for the interim periods.
Use of Estimates
The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of increases and decreases in net assets from operations during the reporting period. Actual results could differ from those estimates.
Statements of Cash Flows
Information on financial transactions which have been settled through the receipt or disbursement of cash is presented in the Statements of Cash Flows. The cash amount shown in the Statements of Cash Flows is the amount included within the Company’s Statements of Assets and Liabilities and includes cash on hand at its custodian bank.
 
Cash and Cash Equivalents
The Company considers liquid assets deposited with a bank, money market funds, and certain short-term debt instruments with original maturities of three months or less to be cash equivalents. These investments represent amounts held with financial institutions that are readily accessible to pay Company expenses or purchase investments. Cash and cash equivalents are valued at cost plus accrued interest, which approximates fair value. The value of cash equivalents denominated in foreign currencies, if any, is determined by converting to U.S. dollars on the date of the Statements of Assets and Liabilities. As of March 31, 2023 and December 31, 2022, the Company had cash and cash equivalents of $1,131,784 and $1,629,846, respectively. As of March 31, 2023 and December 31, 2022, $773,826 and $1,420,428 was held in the State Street U.S. Government Money Market Fund, and $357,958 and $209,418 was held in a custodial account with State Street Bank and Trust Company, respectively.
Securities Sold Short and Restricted Cash
The Company may sell securities short. A security sold short is a transaction in which the Company sells a security it does not own in anticipation that the market price of that security will decline. When the Company sells a security short, it must borrow the security sold short from a broker-dealer and deliver it to the buyer upon conclusion of the transaction. The Company may have to pay a fee to borrow particular securities and is often obligated to pay over any dividends or other payments received on such borrowed securities. Cash held as collateral for securities sold short is classified as restricted cash on the Statements of Assets and Liabilities, when applicable. Securities held as collateral for securities sold short are shown on the Schedules of Investments for the Company, as applicable. As of March 31, 2023 and December 31, 2022, the Company did not have any securities sold short.
When securities are sold short, the Company intends to limit exposure to a possible market decline in the value of its portfolio companies through short sales of securities that the Adviser believes possess volatility characteristics similar to those being hedged. In addition, the Company may use short sales for
non-hedging
purposes to pursue its investment objective. Subject to the requirements of the 1940 Act and the Code, the Company will not make a short sale if, after giving effect to such sale, the market value of all securities sold short by the Company exceeds 25% of the value of its total assets.
Other Fee Income
Fee income may consist of origination/closing fees, amendment fees, administrative agent fees, transaction
break-up
fees and other miscellaneous fees. Origination fees, amendment fees, and other similar fees are
non-recurring
fee sources. Such fees are received on a transaction by transaction basis and do not constitute a regular stream of income. For the three months ended March 31, 2023 and March 31, 2022, the Company recognized $0 and $0 of fee income, respectively.
Fair Value of Financial Instruments
It is the Company’s policy to hold the investments at fair value. ASC Topic 820,
Fair Value Measurements and Disclosure
(“ASC Topic 820”) defines fair value as the price that would be received from the sale of an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. ASC Topic 820 also establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. These tiers include: Level 1, defined as observable inputs such as quoted prices in active markets; Level 2, which includes inputs such as quoted prices for similar securities in active markets and quoted prices for identical securities where there is little or no activity in the market; and Level 3, defined as unobservable inputs for which little or no market data exists, therefore requiring an entity to develop its own assumptions.
Pursuant to Rule
2a-5
under the 1940 Act, the Board has designated the Adviser as the Company’s valuation designee to perform the fair valuation determination for securities and other assets held by the Company. The Company determines the net asset value of its investment portfolio each quarter, or more frequently as needed. Securities that are publicly-traded are valued at the reported closing price on the valuation date. Securities that are not publicly-traded are valued at fair value as determined in good faith by the Adviser as valuation designee, pursuant to board-approved policies and procedures. In connection with that determination, the Adviser will consider portfolio company valuations based on relevant inputs, including indicative dealer quotes, values of like securities, recent portfolio company financial statements and forecasts, and valuations prepared by third-party valuation services. Rule
2a-5
states that a market quotation is readily available only when that quotation is a quoted price (unadjusted) in active markets for identical investments that the Company can access at the measurement date, provided that a quotation will not be readily available if it is not reliable. Market quotations may also not be “readily available” if a significant event occurs that causes the Adviser to believe that the market price of a security no longer represents the security’s current value at the time of the Company’s net asset value (“NAV”) determination.
 
With respect to investments for which market quotations are not readily available, the Adviser undertakes a multi-step valuation process each quarter, as described below:
 
   
The valuation process begins with each portfolio company or investment being initially valued by investment professionals of the Adviser responsible for credit monitoring or independent third party valuation firms.
 
   
Preliminary valuation conclusions are then documented and discussed with a committee comprised of certain senior management employees of the Adviser (the “Valuation Committee”) established by the Adviser to assist the Adviser in discharging its responsibilities as valuation designee.
 
   
At least once each quarter, the valuations for approximately one quarter of the portfolio investments that have been fair valued are reviewed by an independent valuation firm such that, over the course of a year, each material portfolio investment that has been fair valued shall have been reviewed by an independent valuation firm at least once.
 
   
Based on this information, the Adviser discusses valuations and determines the fair value of each investment in the portfolio in good faith pursuant to board-approved policies and procedures.
As of March 31, 2023, the Company held the following investments for which a sufficient level of current, reliable market quotations were not available:
 
Instrument
  
Type
  
Fair value
 
Grayson Investor Corp.
  
Asset-Backed Securities
   $  7,267  
PAMCO CLO
1997-1A
B
   Asset-Backed Securities      13  
American Banknote Corp.
   Common Stocks      1,732,500  
IQHQ, Inc.
   Common Stocks      2,359,000  
TerreStar Corp.
   Common Stocks      5,032,249  
Wayne Services Legacy, Inc.
   Common Stocks      2,268  
NexPoint Capital REIT, LLC
   LLC Interests      6,904,655  
SFR WLIF III, LLC
   LLC Interests      418,181  
US Gaming, LLC
   LLC Interests      2,841,603  
Apnimed, Inc.
   Preferred Stocks      1,499,989  
Apnimed, Inc.
   Preferred Stocks      799,993  
Sapience Therapeutics, Inc.
   Preferred Stocks      4,581,906  
Sapience Therapeutics, Inc.
   Preferred Stocks      3,700,000  
CCS Medical, Inc.
   Senior Secured Loans      3,000,000  
NexPoint Capital REIT
,
LLC
   Senior Secured Loans      463,314  
TerreStar Corp.
   Senior Secured Loans      836,016  
TerreStar Corp.
   Senior Secured Loans      197,921  
TerreStar Corp.
   Senior Secured Loans      35,360  
TerreStar Corp.
   Senior Secured Loans      32,991  
 
As of December 31, 2022, the Company held the following investments for which a sufficient level of current, reliable market quotations were not available:
 
Instrument
  
Type
  
Fair value
 
Grayson Investor Corp.
  
Asset-Backed Securities
   $  7,023  
PAMCO CLO
1997-1A
B
   Asset-Backed Securities      13  
American Banknote Corp.
   Common Stocks      1,732,500  
IQHQ, Inc.
   Common Stocks      2,359,000  
TerreStar Corp.
   Common Stocks      5,114,214  
Wayne Services Legacy, Inc.
   Common Stocks      2,269  
NexPoint Capital REIT, LLC
   LLC Interests      1,176,024  
SFR WLIF III, LLC
   LLC Interests      424,468  
US Gaming, LLC
   LLC Interests      3,088,750  
Apnimed, Inc.
   Preferred Stocks      1,499,989  
Apnimed, Inc.
   Preferred Stocks      799,994  
Sapience Therapeutics, Inc.
   Preferred Stocks      4,549,525  
Sapience Therapeutics, Inc.
   Preferred Stocks      3,677,777  
CCS Medical, Inc.
   Senior Secured Loans      3,000,000  
TerreStar Corp.
   Senior Secured Loans      810,953  
TerreStar Corp.
   Senior Secured Loans      191,988  
TerreStar Corp.
   Senior Secured Loans      34,300  
TerreStar Corp.
   Senior Secured Loans      32,002  
Determination of fair value involves subjective judgments and estimates. Accordingly, the notes to the Company’s financial statements will refer to the uncertainty with respect to the possible effect of such valuations, and any change in such valuations, in the Company’s financial statements. Below is a description of factors that the Adviser and the Valuation Committee may consider when valuing the Company’s debt and equity investments.
Valuation of fixed income investments, such as loans and debt securities, depends upon a number of factors, including prevailing interest rates for like securities, expected volatility in future interest rates, call features, put features and other relevant terms of the debt. For investments without readily available market prices, the Company may incorporate these factors into discounted cash flow models to arrive at fair value. Other factors that the Adviser and the Valuation Committee may consider include the borrower’s ability to adequately service its debt, the fair market value of the portfolio company in relation to the face amount of its outstanding debt and the quality of collateral securing the Company’s debt investments.
The Company’s equity investments in portfolio companies for which there is no liquid public market will be valued at fair value. The Adviser and the Valuation Committee, in its analysis of fair value, may consider various factors, such as multiples of earnings before interest, taxes, depreciation and amortization (“EBITDA”), cash flows, net income, revenues or, in limited instances, book value or liquidation value. All of these factors may be subject to adjustments based upon the particular circumstances of a portfolio company or the Company’s actual investment position. For example, adjustments to EBITDA may take into account compensation to previous owners or acquisition, recapitalization, restructuring or other related items.
The Adviser and the Valuation Committee may also look to private merger and acquisition statistics, public trading multiples discounted for illiquidity and other factors, valuations implied by third-party investments in the portfolio companies or industry practices in determining fair value. The Adviser and the Valuation Committee may also consider the size and scope of a portfolio company and its specific strengths and weaknesses, as well as any other factors it deems relevant in assessing the value. Generally, the value of the Company’s equity interests in public companies for which market quotations are readily available will be based upon the most recent closing public market price.
 
If the Company receives warrants or other equity-linked securities at nominal or no additional cost in connection with an investment in a debt security, the Company will allocate the cost basis in the investment between the debt securities and any such warrants or other equity-linked securities received at the time of origination. The Adviser and the Valuation Committee will subsequently value these warrants or other equity-linked securities received at fair value.
As applicable, the Company values its Level 2 assets by using the midpoint of the prevailing bid and ask prices from dealers on the date of the relevant period end, which is provided by an independent third-party pricing service and screened for validity by such service. For investments for which the third-party pricing service is unable to obtain quoted prices, the Company obtains bid and ask prices directly from dealers who make a market in such investments.
To the extent that the Company holds investments for which no active secondary market exists and, therefore, no bid and ask prices can be readily obtained, the Adviser and the Valuation Committee utilize an independent third-party valuation service to value such investments in a manner consistent with the Company’s multistep valuation process previously described.
The Company periodically benchmarks the bid and ask prices received from the third-party pricing service and/or dealers, as applicable, and valuations received from the third-party valuation service against the actual prices at which it purchases and sells its investments. The Company believes that these prices are reliable indicators of fair value. The Adviser and the Valuation Committee review and approve the valuation determinations made with respect to these investments in a manner consistent with the Company’s valuation procedures.
As of March 31, 2023, the Company’s investments consisted of senior secured loans, asset-backed securities, common stocks, LLC interests, preferred stocks, corporate bonds, and warrants, which may be purchased for a fraction of the price of the underlying securities. The fair value of the Company’s loans, bonds and asset-backed securities are generally based on quotes received from brokers or independent pricing services. Loans, bonds and asset-backed securities with quotes that are based on actual trades with a sufficient level of activity on or near the measurement date are classified as Level 2 assets. Loans, bonds and asset-backed securities that are priced using quotes derived from implied values, indicative bids or a limited number of actual trades are classified as Level 3 assets because the inputs used by the brokers and pricing services to derive the values are not readily observable.
The fair value of the Company’s common stocks and options that are not actively traded on national exchanges are generally priced using quotes derived from implied values, indicative bids, or a limited amount of actual trades and are classified as Level 3 assets because the inputs used by the brokers and pricing services to derive the values are not readily observable. Exchange traded options are valued based on the last trade price on the primary exchange on which they trade. If an option does not trade, the
mid-price
is utilized to value the option.
At the end of each calendar quarter, the Adviser evaluates the Level 2 and 3 investments for changes in liquidity, including: whether a broker is willing to execute at the quoted price, the depth and consistency of prices from third party services, and the existence of contemporaneous, observable trades in the market. Additionally, management evaluates the Level 1 and 2 assets and liabilities on a quarterly basis for changes in listings or delistings on national exchanges.
Due to the inherent uncertainty of determining the fair value of investments that do not have a readily available market price, the fair value of the Company’s investments may fluctuate from period to period. Additionally, the fair value of investments may differ significantly from the values that would have been used had a ready market existed for such investments and may differ materially from the values the Company may ultimately realize. Further, such investments may be subject to legal and other restrictions on resale or otherwise less liquid than publicly traded securities.
 
The inputs or methodology used for valuing investments are not necessarily an indication of the risk associated with investing in those investments. The following are summaries of the Company’s investments categorized within the fair value hierarchy as of March 31, 2023 and December 31, 2022:
 
    
March 31, 2023
 
Investments
  
Level 1
    
Level 2
    
Level 3
    
Total
 
                             
Assets
 
Senior Secured Loans
 
Healthcare
   $ —        $ 5,466,015      $ 3,000,000      $ 8,466,015  
Real Estate
     —          —          463,314        463,314  
Telecommunication Services
     —          —          1,102,288        1,102,288  
Asset-Backed Securities
 
Financials
     —          —          7,280        7,280  
Corporate Bonds
 
Healthcare
     —          2,240,779        —          2,240,779  
Media/Telecommunications
     —          259,466        —          259,466  
Common Stocks
 
Chemicals
     —          42,500        —          42,500  
Energy
     —          1,629,178        —          1,629,178  
Financials
     —          —          1,732,500        1,732,500  
Real Estate
     2,063,263        —          2,359,000        4,422,263  
Real Estate Investment Trusts (REITs)
     1,022,291        —          —          1,022,291  
Service
     —          —          2,268        2,268  
Telecommunication Services
     —          —          5,032,249        5,032,249  
LLC Interests
 
Consumer Products
     —          —          2,841,603        2,841,603  
Real Estate
     —          —          7,322,836        7,322,836  
Preferred Stocks
 
Financials
     —          1,400,000        —          1,400,000  
Healthcare
     —          —          10,581,888        10,581,888  
Warrants
 
Energy
     —          152,748        —          152,748  
Media/Telecommunications
     —          10,063        —          10,063  
    
 
 
    
 
 
    
 
 
    
 
 
 
Total Assets
  
$
3,085,554
 
  
$
11,200,749
 
  
$
34,445,226
 
  
$
48,731,529
 
    
 
 
    
 
 
    
 
 
    
 
 
 
Total Investments
  
$
3,085,554
 
  
$
11,200,749
 
  
$
34,445,226
 
  
$
48,731,529
 
    
 
 
    
 
 
    
 
 
    
 
 
 
 

















    
December 31, 2022
 
Investments
  
Level 1
    
Level 2
    
Level 3
    
Total
 
                             
Assets
 
Senior Secured Loans
 
Healthcare
   $ —        $ 10,158,950      $ 3,000,000      $ 13,158,950  
Telecommunication Services
     —          —          1,069,243        1,069,243  
Asset-Backed Securities
 
Financials
     —          —          7,036        7,036  
Corporate Bonds
 
Healthcare
     —          2,414,839        —          2,414,839  
Media/Telecommunications
     —          290,078        —          290,078  
Common Stocks
 
Chemicals
     —          42,500        —          42,500  
Energy
     —          1,591,692        —          1,591,692  
Financials
     —          —          1,732,500        1,732,500  
Real Estate
     7,653,730        —          2,359,000        10,012,730  
Real Estate Investment Trusts (REITs)
     1,018,779        —          —          1,018,779  
Service
     —          —          2,269        2,269  
Telecommunication Services
     —          —          5,114,214        5,114,214  
LLC Interests
 
Consumer Products
     —          —          3,088,750        3,088,750  
Real Estate
     —          —          1,600,492        1,600,492  
Preferred Stocks
 
Financials
     —          1,440,625        —          1,440,625  
Healthcare
     —          —          10,527,285        10,527,285  
Warrants
 
Energy
     —          161,249        —          161,249  
Media/Telecommunications
     —          20,484        —          20,484  
    
 
 
    
 
 
    
 
 
    
 
 
 
Total Assets
  
$
8,672,509
 
  
$
16,120,417
 
  
$
28,500,789
 
  
$
53,293,715
 
    
 
 
    
 
 
    
 
 
    
 
 
 
Total Investments
  
$
8,672,509
 
  
$
16,120,417
 
  
$
28,500,789
 
  
$
53,293,715
 
    
 
 
    
 
 
    
 
 
    
 
 
 
 
The table below sets forth a summary of changes in the Company’s Level 3 investments (measured at fair value using significant unobservable inputs) for the three months ended March 31, 2023. The table below includes noncash transactions for the three months ended March 31, 2023.
 














































Investments:
  
Balance as of
December 31,
2022
 
  
Transfers
into
Level 3
 
  
Transfer
s out of
Level 3
 
  
Net
amortization
(accretion) of
premium/
(discount)
 
  
Distribution
to Return
Capital
 
  
Net realized
gains/
(losses)
 
  
Net

change in
unrealized
gains/
(losses)
 
 
Purchases/
PIK
 
 
  
(Sales
and
redemptions)
 
 
Balance as of
March 31,
2023
 
  
Change in
unrealized
gain/(loss)
on Level 3
securities still
held at period
end
 
Assets
  



  



  



  



  



  



  



 



 
  



 



  



Senior Secured Loans
  



  



  



  



  



  



  



 



 
  



 



  



Telecommunication Services
   $ 1,069,243      $ —        $ —        $ —        $  —        $ —        $  3,198      $  29,847        $  —       $  1,102,288      $  3,198  
Healthcare
     3,000,000        —          —          4,465        —          —          (4,465 )
 
     —            —         3,000,000        (4,465 )
Real Estate
     —          —          —          —          —          —          —          463,314          —         463,314        —    
Asset-Backed Securities
                                                                                                   
Financials
     7,036        —          —          —          —          —          244        —            —         7,280        244  
Common Stocks
                                                                                                   
Financials
     1,732,500        —          —          —          —          —          —          —            —         1,732,500        —    
Real Estate
     2,359,000        —          —          —          —          —          —          —            —         2,359,000        —    
Service
     2,269        —          —          —          —          —          —          —            —         2,268        —    
Telecommunication Services
     5,114,214        —          —          —          —          —          (81,965 )      —            —         5,032,249        (81,965 )
LLC Interests
                                                                                                   
Consumer Products
     3,088,750        —          —          —          —          163,314        52,853        —            (463,314 )     2,841,603        52,853  
Real Estate
     1,600,492        —          —          —          —          —          (1,645,741 )      7,368,085
(1)
 
       —         7,322,836        (1,645,741 )
Preferred Stocks
                                                                                                   
Healthcare
     10,527,285        —          —          —          —          —          54,603        —            —         10,581,888        54,603  
    
 
 
    
 
 
    
 
 
    
 
 
    
 
 
    
 
 
    
 
 
    
 
 
      
 
 
   
 
 
    
 
 
 
Total
   $ 28,500,789      $ —        $ —        $ 4,465      $ —        $ 163,314      $ (1,621,273 )    $ 7,861,246        $ (463,314 )
 
  $ 34,445,226      $ (1,621,273 )
 
    
 
 
    
 
 
    
 
 
    
 
 
    
 
 
    
 
 
    
 
 
    
 
 
      
 
 
   
 
 
    
 
 
 
 
(1)
 
Represents an in-kind transfer to the subreit.
The table below sets forth a summary of changes in the Company’s Level 3 investments (measured at fair value using significant unobservable inputs) for the three months ended March 31, 2022.
 













































Investments:
  
Balance as of
December 31,
2021
    
Transfers
into
Level 3
    
Transfer
out of
Level 3
    
Net
amortization
(accretion) of
premium/
(discount)
    
Distribution
to Return
Capital
    
Net realized
gains/
(losses)
   
Net

change in
unrealized
gains/
(losses)
   
Purchases/
PIK
   
(Sales
and
redemptions)
   
Balance as of
March 31,
2022
    
Change in
unrealized
gain/(loss)
on Level 3
securities still
held at period
end
 
                                                                          
Assets
                                                                                              
Senior Secured Loans
                                                                                              
Telecommunication Services
   $ 962,478      $ —        $ —        $ —        $ —        $ —       $ —       $ 26,711     $ —       $ 989,189      $ —    
Healthcare
     4,000,000        —          —          3,809        —          —         86,191       2,990,000       (4,080,000 )(a)      3,000,000        86,191  
Asset-Backed Securities
                                                                                              
Financials
     405,040        —          —          —          —          —         11,787       —         (16,979     399,848        11,787  
Common Stocks
                                                                                              
Financials
     2,208,750        —          —          —          —          —         (603,450     —         —         1,605,300        (603,450
Real Estate
     1,823,000        —          —          —          —          —         141,000       —         —         1,964,000        141,000  
Service
     5,172        —          —          —          —          —         —         —         —         5,172        —    
Telecommunication Services
     4,706,357        —          —          —          —          —         (94,456     —         —         4,611,901        (94,456
LLC Interests
                                                                                              
Consumer Products
     2,812,212        —          —          —          —          —         169,426       —         —         2,981,638        169,426  
Real Estate
     4,760,162        —          —          —          —          (74,603     139,367       —         (3,274,285 )(b)      1,550,641        (13,275
Preferred Stocks
                                                                                              
Healthcare
     —          —          —          —          —          —         —         8,080,000 (a)      —         8,080,000        —    
    
 
 
    
 
 
    
 
 
    
 
 
    
 
 
    
 
 
   
 
 
   
 
 
   
 
 
   
 
 
    
 
 
 
Total
   $ 21,683,171      $ —        $  —        $ 3,809      $  —        $ (74,603   $ (150,135   $ 11,096,711     $ (7,371,264   $ 25,187,689      $ (302,777
    
 
 
    
 
 
    
 
 
    
 
 
    
 
 
    
 
 
   
 
 
   
 
 
   
 
 
   
 
 
    
 
 
 
 
(a)
 
Denotes Sapience’s $4,080,000 promissory notes and paid in kind interest conversion to preferred stock.
(b)
 
Denotes SFR II’s LLC Interests conversion into NREF common shares.
 
Investments designated as Level 3 may include investments valued using quotes or indications furnished by brokers which are based on models or estimates and may not be executable prices. In light of the developing market conditions, the Adviser continues to search for observable data points and evaluate broker quotes and indications received for investments. Determination of fair values is uncertain because it involves subjective judgments and estimates that are unobservable. Transfers from Level 2 to Level 3 are due to a decrease in market activity (e.g. frequency of trades), which resulted in a decrease of available market inputs to determine price. For the three months ended March 31, 2023, there were no transfers from Level 2 to Level 3. For the three months ended March 31, 2022, there were no transfers from Level 2 to Level 3. Transfers from Level 3 to Level 2 and from Level 2 to Level 1 are due to an increase in market activity (e.g. frequency of trades), which resulted in an increase of available market inputs to determine price.
The following are summaries of significant unobservable inputs used in the fair valuations of investments categorized within Level 3 of the fair value hierarchy as of March 31, 2023 and December 31, 2022:
 
Investment
 
Fair value at

March 31, 2023
   
Valuation
technique
 
Unobservable
inputs
 
Range of input value(s)

(weighted average)
 
LLC Interest
  $ 10,164,438    
Discounted Cash Flow
Multiples Analysis
 
Discount Rate
Multiple of EBITDA
   
4.98% - 9.18% (7.08%)

5.60x - 9.95x (
7.70
x)
 
 
Preferred Stock
    10,581,888     Option Pricing Model   Volatility    
40% - 90% (65%)
 
Common Stock
    9,126,018    
Discounted Cash Flow
Multiples Analysis
 
Transaction Indication of Value
Liquidation Analysis
Net Asset Value
 
Discount Rate
Multiple of EBITDA
Unadjusted
Price/MHz-PoP
Enterprise Value ($mm)
Recovery Rate
N/A
   
11.0% - 13.0% (12.0%)

3.25x - 4.25x (
3.75x)  
$0.09 - $0.95 ($0.52)
$921.5
40% - 100%
$28
 
 
 
 
 
Senior Secured Loans
    4,565,602     Discounted Cash Flow   Discount Rate    
10.25% - 13.06% (11.40%)
 
Asset-Backed Securities
    7,280     NAV Approach   Discount Rate     70.00%  
   
 
 
                 
Total
 
$
       34,445,226
 
               
   
 
 
                 
 
Investment
 
Fair value at

December 31, 2022
   
Valuation
technique
 
Unobservable
inputs
 
Range of input value(s)

(weighted average)
LLC Interest
  $ 4,689,242    
Discounted Cash Flow
Multiples Analysis
 
Discount Rate
Multiple of EBITDA
 
4.73% - 8.93% (6.83%)

5.55x - 9.85x (7.70x)
Preferred Stock
    10,527,285    
Option Pricing Model
Transaction Indication of Value
 
Volatility
Recap Price
 
40% - 60% (50%)

$11.10
Common Stock
    9,207,983    
Discounted Cash Flow
Multiples Analysis
 
Transaction Indication of Value
Liquidation Analysis
Net Asset Value
 
Discount Rate
Multiple of EBITDA
Unadjusted Price/MHz-PoP
Enterprise Value ($mm)
Recovery Rate
N/A
 
13.50% - 15.50% (14.50%)

3.25x - 4.25x (3.75x)
$0.09 - $0.95 ($0.52)  
$872 - $969 ($920.5)  
40% - 100% (70%)
$28
Senior Secured Loans
    4,069,243     Discounted Cash Flow   Discount Rate  
   10.25% - 13.08% (11.67%)   
Asset-Backed Securities
    7,036     NAV Approach   Discount Rate   70.00%
   
 
 
             
Total
 
$
28,500,789
             
   
 
 
             
The significant unobservable inputs used in the fair value measurement of the Company’s LLC interests are: discount rate and multiples of EBITDA. Significant increases (decreases) in those inputs in isolation could result in a significantly lower (higher) fair value measurement. The significant unobservable inputs used in the fair value measurement of the Company’s common equity securities are: multiple of EBITDA,
price/MHz-PoP
multiple, liquidity discount, discount rate, enterprise value, and transaction price. Significant increases (decreases) in any of those inputs in isolation could result in a significantly lower (higher) fair value measurement. The significant unobservable inputs used in the fair value measurement of the Company’s preferred stock are: option pricing model. Significant increases (decreases) in any of those inputs in isolation could result in a significantly lower (higher) fair value measurement. The significant unobservable inputs used in the fair value measurement of the Company’s senior secured loans are: discount rate and spread adjustment. Significant increases (decreases) in either of those inputs in isolation could result in a significantly lower (higher) fair value measurement.
 
The significant unobservable inputs used in the fair value measurement of the Company’s asset-backed securities are: discount rate and broker quote indication of value. Significant increases (decreases) in either of those inputs in isolation could result in a significantly lower (higher) fair value measurement. The significant unobservable input used in the fair value measurement of the Company’s warrant securities is: volatility assumption. Significant increases (decreases) in this input in isolation could result in a significantly lower (higher) fair value measurement.
Derivative Transactions
The Company is subject to equity price risk, interest rate risk and foreign currency exchange rate risk in the normal course of pursuing its investment objective. The Company may invest without limitation in warrants and may also use derivatives, primarily swaps (including equity, variance and volatility swaps), options and futures contracts on securities, interest rates, commodities and/or currencies, as substitutes for direct investments the Company can make. The Company may also use derivatives such as swaps, options (including options on futures), futures, and foreign currency transactions (e.g., foreign currency swaps, futures and forwards) to any extent deemed by the Adviser to be in the best interest of the Company, and to the extent permitted by the 1940 Act, to hedge various investments for risk management and speculative purposes.
Options
The Company purchases options, subject to certain limitations. The Company may invest in options contracts to manage its exposure to the stock and bond markets and fluctuations in foreign currency values. Writing puts and buying calls tend to increase the Company’s exposure to the underlying instrument while buying puts and writing calls tend to decrease the Company’s exposure to the underlying instrument, or economically hedge other Company investments. The Company’s risks in using these contracts include changes in the value of the underlying instruments, nonperformance of the counterparties under the contracts’ terms and changes in the liquidity of the secondary market for the contracts. Options are valued at the last sale price, or if no sales occurred on that day, at the last quoted bid price. As of and during the three months ended March 31, 2023 and 2022, the Company did not hold options.
Investment Transactions
Investment transactions are accounted for on trade date. Realized gains (losses) on investments sold are recorded on the basis of specific identification method for both financial statement and U.S. federal income tax purposes. Payable for investments purchased and receivable for investments sold on the Statements of Assets and Liabilities, if any, represents the cost of purchases and proceeds from sales of investment securities, respectively, for trades that have been executed but not yet settled.
Income Recognition
Corporate actions (including cash dividends from common stock and equity tranches of asset-backed securities) are recorded on the
ex-dividend
date, net of applicable withholding taxes, except for certain foreign corporate actions, which are recorded as soon after the
ex-dividend
date as such information becomes available. Interest income is recorded on the accrual basis. The Company does not accrue as a receivable for interest or dividends on loans, asset-backed securities and other securities if there is a reason to doubt the Company’s ability to collect such income. For loans with contractual PIK
(payment-in-kind)
interest income, which represents contractual interest accrued and added to the loan balance that generally becomes due at maturity, we will not accrue PIK interest if we believe that the PIK interest is no longer collectible. Loan origination fees, original issue discount and market discount are capitalized and such amounts are amortized as interest income over the respective term of the loan or security. Upon the prepayment of a loan or security, any unamortized loan origination fees and original issue discount are recorded as interest income.
Accretion of discounts and amortization of premiums on taxable bonds, loans and asset-backed securities are computed to the call or maturity date, whichever is shorter, using the effective yield method. Withholding taxes on foreign dividends have been provided for in accordance with the Company’s understanding of the applicable country’s tax rules and rates.
Organization and Offering Costs
Organization costs are paid by the Adviser and include the cost of incorporating, such as the cost of legal services and other fees pertaining to our organization. Offering costs include legal fees, promotional costs and other costs pertaining to the public offering of our shares of common stock and are also paid by the Adviser. Prior to the termination of the offering, as we raised proceeds, these organization and offering costs were expensed and became payable to the Adviser. Organization and offering costs are limited to 1% of total gross proceeds raised and are not due and payable to the Adviser to the extent they exceed that amount. Please refer to Note 4 for additional information on Organization and Offering Costs.
 
Paid-in
Capital
The proceeds from the issuance of common stock as presented on the Company’s Statements of Changes in Net Assets is presented net of selling commissions and fees for the three months ended March 31, 2023 and March 31, 2022. Selling commissions and fees of $0 and $0 were paid for the three months ended March 31, 2023 and March 31, 2022, respectively.
Earnings Per Share
In accordance with the provisions of ASC Topic 260—
Earnings per Share
(“ASC Topic 260”), basic earnings per share is computed by dividing earnings available to common stockholders by the weighted average number of shares outstanding during the period. Other potentially dilutive common shares, and the related impact to earnings, are considered when calculating earnings per share on a diluted basis.
The following table sets forth the computation of the weighted average basic and diluted net increase in net assets per share from operations:
 
    
For the three months ended
March 31,
 
    
2023
    
2022
 
Net increase (decrease) in net assets resulting from operations
   $ (977,817    $ 1,145,017  
Weighted average common shares outstanding
     9,699,655        9,990,797  
Earnings (loss) per common share-basic and diluted
   $ (0.10    $ 0.11  
Distributions
Distributions to the Company’s stockholders will be recorded as of the record date. Subject to the discretion of the Board and applicable legal restrictions, the Company intends to authorize and declare ordinary cash distributions on a weekly basis and pay such distributions on a quarterly basis. Net realized capital gains, if any, will generally be distributed or deemed distributed at least every
12-month
period.
On June 24, 2020, the Board approved a change in its dividend and capital gains distribution schedule from monthly distributions to quarterly distributions, effective immediately. The first quarterly distribution was paid on October 12, 2020 to shareholders of record as of September 30, 2020. The dividends are expected to be declared in the amount of $0.09 per share of the Company’s common stock to the stockholders of record at each quarter end.
Recent Accounting Pronouncements
In March 2020, the FASB issued Accounting Standards Update (“ASU”)
No. 2020-04,
“Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting” which provides optional exceptions for applying GAAP to contract modifications, hedging relationships and other transactions affected by reference rate reform if certain criteria are met. ASU
No. 2020-04
is elective and effective for all entities as of March 12, 2020 through December 31, 2022. The Company is currently evaluating the impact of ASU
No. 2020-04.
Please refer to Note 8 for additional information.
XML 22 R13.htm IDEA: XBRL DOCUMENT v3.23.1
Investment Portfolio
3 Months Ended
Mar. 31, 2023
Schedule of Investments [Abstract]  
Investment Portfolio
Note 3 — Investment Portfolio
The following table shows the composition of the Company’s invested assets by industry classification at fair value at March 31, 2023:
 
    
Fair value
    
Percentage
 
Assets
                 
Healthcare
   $ 21,288,682        43.7
Real Estate
     12,208,413        25.0
Telecommunication Services
     6,134,537        12.6
Financials
     3,139,780        6.4
Consumer Products
     2,841,603        5.8
Energy
     1,781,926        3.7
Real Estate Investment Trusts (REITs)
     1,022,291        2.1
Media/Telecommunications
     269,529        0.6
Chemicals
     42,500        0.1
Service
     2,268        0.0
    
 
 
    
 
 
 
Total Assets
  
$
48,731,529
 
  
 
100.0
    
 
 
    
 
 
 
The following table shows the composition of the Company’s invested assets by industry classification at fair value at December 31, 2022:
 
    
Fair value
    
Percentage
 
Assets
                 
Healthcare
   $ 26,101,074        49.0
Real Estate
     11,613,222        21.7
Telecommunication Services
     6,183,457        11.6
Consumer Products
     3,088,750        5.8
Financials
     3,180,161        6.0
Energy
     1,752,941        3.3
Real Estate Investment Trusts (REITs)
     1,018,779        1.9
Media/Telecommunications
     310,562        0.6
Chemicals
     42,500        0.1
Service
     2,269        0.0
    
 
 
    
 
 
 
Total Assets
  
$
53,293,715
 
  
 
100.0
    
 
 
    
 
 
 
 
The following table summarizes the amortized cost and the fair value of the Company’s invested assets by class of financial asset as of March 31, 2023:
 
    
Amortized Cost
    
Fair value
    
Percentage of
Portfolio
(at Fair Value)
 
Assets
 
        
Senior Secured Loans - First Lien
   $ 13,218,569      $ 8,961,395        18.4
Senior Secured Loans - Second Lien
     1,485,503        1,070,222        2.2
Asset-Backed Securities
     388,541        7,280        0.0
Corporate Bonds
     3,375,246        2,500,245        5.1
Common Stocks
     9,705,017        13,883,249        28.5
LLC Interests
     10,734,196        10,164,439        20.9
Preferred Stocks
     11,829,987        11,981,888        24.6
Warrants
     74,284        162,811        0.3
    
 
 
    
 
 
    
 
 
 
Total Assets
  
$
50,811,343
 
  
$
48,731,529
 
  
 
100.0
    
 
 
    
 
 
    
 
 
 
The following table summarizes the amortized cost and the fair value of the Company’s invested assets by class of financial asset as of December 31, 2022:
 
    
Amortized Cost
    
Fair value
    
Percentage of
Portfolio
(at Fair Value)
 
Assets
 
        
Senior Secured Loans - First Lien
   $ 14,645,106      $ 11,575,821        21.7
Senior Secured Loans - Second Lien
     2,976,056        2,652,372        5.0
Asset-Backed Securities
     388,541        7,036        0.0
Corporate Bonds
     3,358,783        2,704,917        5.1
Common Stocks
     17,073,102        19,514,684        36.6
LLC Interests
     3,666,112        4,689,242        8.8
Preferred Stocks
     11,829,987        11,967,910        22.5
Warrants
     74,284        181,733        0.3
    
 
 
    
 
 
    
 
 
 
Total Assets
  
$
54,011,971
 
  
$
53,293,715
 
  
 
100.0
    
 
 
    
 
 
    
 
 
 
The following table shows the composition of the Company’s invested assets by geographic classification at March 31, 2023:
 
Geography
  
Fair value
    
Percentage
 
Assets
 
Cayman Islands
(1)
   $ 7,280        0.0
Luxembourg
(1)
     1,331,038        2.7
United States
     47,393,211        97.3
    
 
 
    
 
 
 
Total Assets
  
$
48,731,529
 
  
 
100.0
    
 
 
    
 
 
 
 
(1)
 
Investment denominated in USD
.
 
The following table shows the composition of the Company’s invested assets by geographic classification at December 31, 2022:
 
Geography
  
Fair value
    
Percentage
 
Assets
 
Cayman Islands
(1)
   $ 7,036        0.0
Luxembourg
(1)
     1,318,346        2.5
United States
     51,968,333        97.5
    
 
 
    
 
 
 
Total Assets
  
$
53,293,715
 
  
 
100.0
    
 
 
    
 
 
 
 
(1)
 
Investment denominated in USD.
XML 23 R14.htm IDEA: XBRL DOCUMENT v3.23.1
Related Party Transactions and Arrangements
3 Months Ended
Mar. 31, 2023
Related Party Transactions [Abstract]  
Related Party Transactions and Arrangements
Note 4 — Related Party Transactions and Arrangements
Investment Advisory Fee
Payments for investment advisory services under the Company’s investment advisory agreement (the “Investment Advisory Agreement”) and administrative services agreement (the “Administration Agreement”) are equal to (a) a base management fee calculated at an annual rate of 2.0% of the average value of the Company’s gross assets at the end of the two most recently completed calendar quarters and (b) an incentive fee based on the Company’s performance. Effective June 5, 2017, the Investment Advisory Agreement and the Administration Agreement were amended to exclude cash and cash equivalents from the calculation of gross assets for the purpose of calculating investment advisory and administration fees.
For the three months ended March 31, 2023 and March 31, 2022, the Company incurred investment advisory fees payable to the Adviser of $265,381 and $299,270, respectively. Amounts waived for investment advisory fees or administrative fees pertaining to periods prior to June 10, 2016 are not recoupable, but amounts waived for investment advisory fees or administrative fees pertaining to periods from and after June 10, 2016 are subject to recoupment by the Adviser within three years from the date that such fees were otherwise payable, provided that the recoupment will be limited to the amount of such voluntarily waived fees from and after June 10, 2016 and will not cause the sum of the Company’s investment advisory fees, administration fees, Other Expenses (as defined under “Expense Limits and Reimbursements” below), and any recoupment to exceed the annual rate of 3.40% of average gross assets. Effective December 20, 2017, the Adviser ended its voluntary waiver of advisory fees.
Incentive Fee
The incentive fee consists of two parts. The first part, which is referred to as the subordinated incentive fee on income, is calculated and payable quarterly in arrears, and equals 20.0% of
“pre-incentive
fee net investment income” for the immediately preceding quarter and is subject to a hurdle rate, expressed as a rate of return on the Company’s net assets, as defined in the Investment Advisory Agreement, equal to 1.875% per quarter. As a result, the Adviser will not earn this incentive fee for any quarter until the Company’s
pre-incentive
fee net investment income for such quarter exceeds the hurdle rate of 1.875%. Once the Company’s
pre-incentive
fee net investment income in any quarter exceeds the hurdle rate, the Adviser will be entitled to a
“catch-up”
fee equal to the amount of the
pre-incentive
fee net investment income in excess of the hurdle rate, until the Company’s
pre-incentive
fee net investment income for such quarter equals 2.34375% of the Company’s net assets at the end of such quarter. This
“catch-up”
feature allows the Adviser to recoup the fees foregone as a result of the existence of the hurdle rate in that quarter. Thereafter, the Adviser will receive 20.0% of the Company’s
pre-incentive
fee net investment income from the quarter.
The second part of the incentive fee, which is referred to as the incentive fee on capital gains, is determined and payable in arrears as of the end of each calendar year (or upon termination of the Investment Advisory Agreement). This fee equals 20.0% of the Company’s incentive fee capital gains, which will equal the Company’s realized capital gains on a cumulative basis from formation, calculated as of the end of the applicable period, computed net of all realized capital losses (proceeds less amortized cost) and unrealized capital depreciation on a cumulative basis, less the aggregate amount of any previously paid capital gains incentive fees. The Company will accrue for the capital gains incentive fee, which, if earned, will be paid annually. The Company will accrue for the capital gains incentive fee based on net realized and unrealized gains; however, under the terms of the Investment Advisory Agreement, the fee payable to the Adviser will be based on realized gains and no such fee will be payable with respect to unrealized gains unless and until such gains are actually realized.
For the three months ended March 31, 2023 and March 31, 2022, the Company incurred $0 and recognized a reduction $0 of incentive fees on capital gains, respectively. Since inception, the Company has accrued $0 of incentive fees on capital gains in aggregate. Effective December 20, 2017, the Adviser ended its voluntary waiver of incentive fees. No such fees have been paid with respect to realized gains to the Adviser as of March 31, 2023.
 
Administration Fee
Pursuant to the Administration Agreement with the Adviser, the Company also reimburses the Adviser for expenses necessary for its performance of services related to the Company’s administration and operations. The amount of the reimbursement will be the lesser of (1) the Company’s allocable portion of overhead and other expenses incurred by the Adviser in performing its obligations under the Administration Agreement and (2) 0.40% of the Company’s average gross assets, (excluding cash and cash equivalents). The Adviser is required to allocate the cost of such services to the Company based on objective factors such as assets, revenues, time allocations and/or other reasonable metrics. The Board assesses the reasonableness of such reimbursements based on the breadth, depth and quality of such services as compared to the estimated cost to the Company of obtaining similar services from third-party service providers known to be available. In addition, the Board will consider whether any single third-party service provider would be capable of providing all such services at comparable cost and quality. Finally, the Board will compare the total amount paid to the Adviser for such services as a percentage of the Company’s net assets to the same ratio as reported by other comparable BDCs.
For the three months ended March 31, 2023 and March 31, 2022, the Company incurred administration fees payable to the Adviser of $52,321 and $59,601, respectively. Amounts waived for management fees or administrative services expenses pertaining to periods prior to June 10, 2016 are not recoupable, but amounts waived for management fees or administrative services, expenses pertaining to periods from and after June 10, 2016 are subject to recoupment by the Adviser within three years from the date that such fees were otherwise payable, provided that the recoupment will be limited to the amount of such voluntarily waived fees from and after June 10, 2016 and will not cause the sum of the Company’s advisory fees, administration fees, Other Expenses, and any recoupment to exceed the annual rate of 3.40% of average gross assets. Effective December 20, 2017, the Adviser ended its voluntary waiver of administration fees.
Organization and Offering Costs
Organization costs include the cost of incorporating, such as the cost of legal services and other fees pertaining to our organization, and are paid by the Adviser. For the three months ended March 31, 2023 and March 31, 2022, the Adviser did not incur or pay organization costs on our behalf.
Offering costs include legal fees, promotional costs and other costs pertaining to the public offering of our shares of common stock, and are capitalized and amortized to expense over one year. The Company’s continuous public offering ended on February 14, 2018.
Organization costs and offering costs are limited to 1% of total gross proceeds raised in the offering and are not due and payable to the Adviser to the extent they exceed that amount. As of March 31, 2023, the cumulative aggregate amount of $5,327,574 of organization and offering costs exceeds 1% of total proceeds raised. Subsequent to the termination of the offering, the Adviser forfeited the right to reimbursement of the remaining $4,305,091 of these costs.
Fees Paid to Officers and Directors
Each director who oversees all of the portfolios in the Fund Complex (as defined below) receives an annual retainer of $
150,000 payable in quarterly installments and allocated among each portfolio in the Fund Complex based on relative net assets. The annual retainer for a director who does not oversee all of the portfolios in the Fund Complex is prorated based on the portion of the $150,000 annual retainer allocable to the portfolios overseen by such director. Directors are reimbursed for actual
out-of-pocket
expenses relating to attendance at meetings. In addition, the Chairman of the Board and the Chairman of the Audit and Qualified Legal Committee each receive an additional payment of $10,000 payable in quarterly installments and allocated among each portfolio in the Fund Complex based on relative net assets. The Directors do not receive any separate compensation in connection with service on Committees or for attending Board or Committee Meetings. They do not have any pension or retirement plan. The “Fund Complex” consists of all of the RICs advised by the Adviser and any affiliates as of the period covered by this report. The Company pays no compensation to any of its officers, all of whom are employed by the Adviser, its affiliates or Skyview Group, Inc. (“Skyview”).
For the three months ended March 31, 2023 and March 31, 2022, the Company recorded an expense relating to director fees of $4,967 and $3,731, respectively, which represents the allocation of the director fees to the Company. As of March 31, 2023, there was no expenses payable relating to director fees.
 
Expense Limits and Reimbursements
Pursuant to an expense limitation agreement, the Adviser is contractually obligated to waive fees and, if necessary, pay or reimburse certain other expenses to limit the ordinary “Other Expenses” to 1.0% of the
quarter-end
value of the Company’s gross assets through the one year anniversary of the effective date of the registration statement (the “Expense Limitation Agreement”). Under the Expense Limitation Agreement, “Other Expenses” are all expenses with the exception of advisor and administration fees, organization and offering costs and the following: (i) interest, taxes, dividends tied to short sales, brokerage commissions, and other expenditures which are capitalized in accordance with GAAP; (ii) expenses incurred indirectly as a result of investments in other investment companies and pooled investment vehicles; (iii) other expenses attributable to, and incurred as a result of, our investments; (iv) expenses payable to the Adviser, as administrator, for providing significant managerial assistance to our portfolio companies; and (v) other extraordinary expenses (including litigation expenses) not incurred in the ordinary course of our business. The obligation will automatically renew for
one-year
terms unless it is terminated by the Company or the Adviser upon written notice within 60 days of the end of the current term or upon termination of the Investment Advisory Agreement. The Expense Limitation Agreement will continue through at least April 30, 202
4
.
Any expenses waived or reimbursed by the Adviser pursuant to the Expense Limitation Agreement are subject to possible recoupment by the Adviser within three years from the date of the waiver or reimbursement. The recoupment by the Adviser will be limited to the amount of previously waived or reimbursed expenses and cannot cause the Company’s expenses to exceed any expense limitation in place at the time of recoupment or waiver.
Reimbursable Expenses Table
The cumulative total of fees waived by the Adviser under the Expense Limitation Agreement, which are recoupable as of March 31, 2023 is $919,754. This balance, and the balances in the tables below, only include amounts pertaining to the Expense Limitation Agreement, and do not include waived advisory and administration fees subject to recoupment discussed earlier in Note 4. The following table reflects the fee waivers and expense reimbursements due from the Adviser as of March 31, 2023, which may become subject to recoupment by the Adviser.
 
Period ended
  
 Yearly cumulative 

other expense
 
  
Yearly expense

limitation
 
  
Yearly cumulative
expense
reimbursement
 
  
Quarterly
    recoupable/    
(recouped)
amount
 
  
    Recoupment    

eligibility
expiration
 
March 31, 2023
   $ 208,486      $ 126,628      $ 81,858      $ 81,858               March 31, 2026  
 
Period ended
  
 Yearly cumulative 

other expense
    
Yearly expense
limitation
    
Yearly cumulative
expense
reimbursement
    
Quarterly
    recoupable/    
(recouped)
amount
    
Recoupment
eligibility
expiration
 
December 31, 2022
   $ 913,273      $ 535,679      $ 377,594      $ 92,216        December 31, 2025  
September 30, 2022
   $ 678,333      $ 392,955      $ 285,378      $ 124,667        September 30, 2025  
June 30, 2022
   $ 434,019      $ 273,308      $ 160,711      $ 98,950        June 30, 2025  
March 31, 2022
   $ 211,896      $ 150,135      $ 61,761      $ 61,761        March 31, 2025  
The following table reflects the fee waivers and expense reimbursements due from the Adviser as of December 31, 2021, September 30, 2021, June 30, 2021 and March 31, 2021, which may become subject to recoupment by the Adviser.
 
Period ended
  
 Yearly cumulative 

other expense
    
Yearly expense
limitation
    
Yearly cumulative
expense
reimbursement
    
Quarterly
    recoupable/    
(recouped)
amount
    
Recoupment
eligibility
expiration
 
December 31, 2021
   $ 892,640      $ 597,379      $ 295,261      $ 94,762        December 31, 2024  
September 30, 2021
   $ 664,052      $ 463,553      $ 200,499      $ 68,134        September 30, 2024  
June 30, 2021
   $ 436,866      $ 304,501      $ 132,365      $ 68,919        June 30, 2024  
March 31, 2021
   $ 220,126      $ 156,680      $ 63,446      $ 63,446        March 31, 2024  
 
The following table reflects the fee waivers and expense reimbursements due from the Adviser as of December 31, 2020, September 30, 2020, June 30, 2020 and March 31, 2020, which may become subject to recoupment by the Adviser.
 
Period ended
  
Yearly cumulative
other expense
    
Yearly expense
limitation
    
Yearly cumulative
expense
reimbursement
    
Quarterly
recoupable/
(recouped)
amount
   
Recoupment
eligibility
expiration
 
December 31, 2020
   $ 989,447      $ 639,959      $ 349,488      $ 101,541       December 31, 2023  
September 30, 2020
     687,228        439,281        247,947        94,039       September 30, 2023  
June 30, 2020
     445,585        291,677        153,908        (30,539     June 30, 2023  
March 31, 2020
     257,226        72,779        184,447        —         Expired  
During the three months ended March 31, 2023, $184,447 of expense reimbursements that were eligible for recoupment by the Adviser expired.
There can be no assurance that the Expense Limitation Agreement will remain in effect or that the Adviser will reimburse any portion of the Company’s expenses in future quarters not covered by the Expense Limitation Agreement. Amounts shown do not include the amounts committed by the Adviser to voluntarily reimburse the Company for unrealized losses, all of which are not recoupable.
Net Increase from Amounts Committed by Affiliates
For the three months ended March 31, 2023 and March 31, 2022, the Adviser did not voluntarily reimburse the Company for unrealized losses sustained. Cumulatively since inception, the Adviser has committed $2,275,000
to voluntarily reimburse the Company for such losses. Had these commitments not been made, since inception, the NAV as of March 31, 2023 would have been lower by approximately this amount.
Amounts committed and paid by the Adviser to reimburse for unrealized losses are nonrecurring, and investors should not expect the Adviser to make similar commitments or payments in the future.
Receivable from Adviser / Payable to Adviser
As of March 31, 2023 and December 31, 2022, $81,858 and $92,216 were owed from the Adviser to the Company, respectively, largely related to the expense limitation agreement.
As of March 31, 2023 and December 31, 2022, the Company owed $317,702 and $314,993, respectively, to the Adviser, largely related to advisory fees, and administration fees.
Indemnification
Under the Company’s organizational documents, the officers and Directors have been granted certain indemnification rights against certain liabilities that may arise out of performance of their duties to the Company. Additionally, in the normal course of business, the Company may enter into contracts with service providers that contain a variety of indemnification clauses. The Company’s maximum exposure under these arrangements is dependent on future claims that may be made against the Company and, therefore, cannot be estimated.
XML 24 R15.htm IDEA: XBRL DOCUMENT v3.23.1
U.S. Federal Income Tax Information
3 Months Ended
Mar. 31, 2023
Income Tax Disclosure [Abstract]  
U.S. Federal Income Tax Information
Note 5 — U.S. Federal Income Tax Information
The Company has elected to be treated for federal income tax purposes, and intends to qualify annually, as a RIC under Subchapter M of the Code. To maintain its qualification as a RIC, the Company must, among other things, meet certain
source-of-income
and asset diversification requirements and distribute to its stockholders, for each taxable year, at least 90% of its “investment company taxable income,” which is generally the Company’s net ordinary income plus the excess, if any, of realized net short-term capital gains over realized net long-term capital losses. As a RIC, the Company will not be subject to corporate-level federal income taxes on any income that it timely distributes to its stockholders. The Company intends to make distributions in an amount sufficient to maintain its RIC status each year and to avoid any federal income taxes on income so distributed. The Company will also be subject to nondeductible federal excise taxes if it does not distribute at least 98% of net ordinary income, 98.2% of any capital gain net income, if any, and any recognized and undistributed income from prior years on which it paid no federal income taxes.
 
The character of income and capital gains to be distributed is determined in accordance with the Code, U.S. Treasury regulations, and other applicable authority, which may differ from GAAP. These differences include (but are not limited to) investments organized as partnerships for tax purposes, total return swaps, loan investments, and losses deferred due to wash sale transactions. Reclassifications are made to the Company’s capital accounts to reflect income and gains available for distribution (or available capital loss carryovers) under the Code, U.S. Treasury regulations, and other applicable authority. These reclassifications have no impact on net investment income, realized gains or losses, or net asset value of the Company. The calculation of net investment income per share in the Financial Highlights table excludes these adjustments.
Uncertainty in Income Taxes
The Company will evaluate its tax positions to determine if the tax positions taken meet the minimum recognition threshold in connection with accounting for uncertainties in income tax positions taken or expected to be taken for the purposes of measuring and recognizing tax benefits or liabilities in the financial statements. Recognition of a tax benefit or liability with respect to an uncertain tax position is required only when the position is “more likely than not” to be sustained assuming examination by taxing authorities. The Company’s tax returns are subject to examination by the Internal Revenue Service for a period of three fiscal years after they are filed. The Company recognizes interest and penalties, if any, related to unrecognized tax liabilities as income tax expense in the Statements of Operations. During the three months ended March 31, 2023 and March 31, 2022, the Company did not incur any interest or penalties. Furthermore, management of the Company is also not aware of any tax positions for which it is reasonably possible that the total amounts of unrecognized tax benefits will significantly change in the next 12 months.
XML 25 R16.htm IDEA: XBRL DOCUMENT v3.23.1
Share Repurchase Program
3 Months Ended
Mar. 31, 2023
Equity [Abstract]  
Share Repurchase Program
Note 6 — Share Repurchase Program
On a quarterly basis, the Company intends to offer to repurchase shares of common stock on such terms as may be determined by the Board in its complete and absolute discretion unless, in the judgment of directors who are not “interested persons” of the Company (as defined in the 1940 Act), such repurchases would not be in the best interests of the Company’s stockholders or would violate applicable law. The Company will conduct such repurchase offers in accordance with the requirements of Rule
13e-4
of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and the 1940 Act. Any offer to repurchase shares of common stock will be conducted solely through tender offer materials furnished to each stockholder.
The Company currently intends to limit the number of shares of common stock to be repurchased during any calendar year to the number of shares of common stock it can repurchase with the proceeds it receives from the sale of shares of common stock under its distribution reinvestment plan. At the discretion of the Board, the Company may also use cash on hand, cash available from borrowings and cash from liquidation of securities investments as of the end of the applicable period to repurchase shares of common stock. In addition, the Company will limit the number of shares of common stock to be repurchased in any calendar year to 10.0% of the weighted average number of shares of common stock outstanding in the prior calendar year, or 2.5% in each quarter, though the actual number of shares of common stock that the Company offers to repurchase may be less in light of the limitations noted above. The Company intends to offer to repurchase such shares of common stock at a price (i) not less than the net asset value per share (the “NAV Per Share”) of the Company’s common stock next calculated following the Expiration Date, and (ii) not more than 2.5% greater than the NAV Per Share as of such date. The Board may amend, suspend or terminate the share repurchase program at any time, upon 30 days’ notice.
The Company conducted its quarterly tender offer for the first quarter of 2023 from February 23, 2023, until expiration of March 24 2023
,
at 4:00 p.m. New York City time, during which the Company offered to purchase for cash up to 2.5% of its outstanding shares of common stock. During the first quarter tender offer, 181,298 shares of the Company were tendered for repurchase, constituting approximately 1.86% of the Company’s outstanding shares.
For the three months ended March 31, 2023, the Company repurchased 0 shares as part of its death and disability repurchase program.
XML 26 R17.htm IDEA: XBRL DOCUMENT v3.23.1
Economic Dependency and Commitments and Contingencies
3 Months Ended
Mar. 31, 2023
Commitments and Contingencies Disclosure [Abstract]  
Economic Dependency and Commitments and Contingencies
Note 7 — Economic Dependency and Commitments and Contingencies
The Adviser has entered into a Services Agreement with Skyview, effective February 25, 2021, pursuant to which the Adviser will receive administrative and operational support services to enable it to provide the required advisory services to the Company. The Adviser, and not the Company, will compensate all Adviser and Skyview personnel who provide services to the Company.
From time to time, the Company may be involved in legal proceedings in the normal course of its business. Although the outcome of such litigation cannot be predicted with any clarity, management is of the opinion, bas
ed on
the advice of legal counsel, that final dispositions of any litigation should not have a material adverse effect on the financial position of the Company as of March 31, 2023.
 
Unfunded commitments to provide funds to portfolio companies are not recorded in the Company’s Statements of Assets and Liabilities. Since these commitments may expire without being drawn upon, the total commitment amount does not necessarily represent future cash requirements. The Company has sufficient liquidity to fund these commitments. As of March 31, 2023, the Company had no unfunded debt commitments.
In the normal course of business, the Company enters into contracts and agreements that contain a variety of representations and warranties that provide general indemnification. The Company’s maximum exposure under these agreements is unknown, as this would involve future claims that may be made against the Company that have not occurred. The Company believes the risk of material obligations under these indemnities to be low.
XML 27 R18.htm IDEA: XBRL DOCUMENT v3.23.1
Market and Other Risk Factors
3 Months Ended
Mar. 31, 2023
Risks and Uncertainties [Abstract]  
Market and Other Factors
Note 8 — Market and Other Risk Factors
The primary risks of investing in the Company are described below in alphabetical order:
Conflict of Interest Risk
The Adviser or its affiliates may have other clients with similar, different or competing investment objectives. In serving in these multiple capacities, they may have obligations to other clients or investors in those other entities, the fulfillment of which may not be in the best interests of us or our stockholders. For example, our Adviser and its affiliates manage or sponsor other investment funds, accounts or other investment vehicles. Our investment objective may overlap with the investment objectives of such affiliated investment funds, accounts or other investment vehicles. As a result, our Adviser may face conflicts of interest in the allocation of investment opportunities among us and other investment funds, accounts or other investment vehicles advised by or affiliated with our Adviser. Our Adviser will seek to allocate investment opportunities among eligible accounts in a manner that is fair and equitable over time and consistent with its allocation policy. However, we can offer no assurance that such opportunities will be allocated to us fairly or equitably in the short-term or over time. Where we are able to co- invest consistent with the requirements of the 1940 Act and SEC exemptive relief, if sufficient securities or loan amounts are available to satisfy our and each such account’s proposed demand, the opportunity will be allocated in accordance with our Adviser’s pre-transaction determination and the requirements of the exemptive relief. If there is an insufficient amount of an investment opportunity to satisfy our demand and that of other accounts sponsored or managed by our Adviser or its affiliates, the allocation policy and exemptive relief further provides that allocations among us and such other accounts will generally be made pro rata based on the amount that each such party would have invested if sufficient loan amounts were available. However, there can be no assurance that we will be able to participate in all suitable investment opportunities.
Concentration Risk
The Company is classified as a
non-diversified
investment company within the meaning of the 1940 Act, which means that it is not limited by the 1940 Act with respect to the proportion of the Company’s assets that it may invest in securities of a single issuer. To the extent that the Company assumes large positions in the securities of a small number of issuers, the Company’s net asset value may fluctuate to a greater extent than that of a diversified investment company as a result of changes in the financial condition or the market’s assessment of the issuer. The Company may also be more susceptible to any single economic or regulatory occurrence than a diversified investment company. Beyond the asset diversification requirements associated with the Company’s qualification as a RIC under the Code and certain contractual diversification requirements under a credit facility or other agreements, the Company does not have fixed guidelines for diversification, and its investments could be concentrated in relatively few portfolio companies. As a result, the aggregate returns the Company realizes may be significantly adversely affected if a small number of investments perform poorly or if the Company needs to write down the value of any one investment. Additionally, the Company’s investments may be concentrated in relatively few industries. As a result, a downturn in any particular industry in which the Company is invested could also significantly impact the aggregate returns realized.
Covenant-Lite Loans Risk
Loans in which the Company invests include covenant-lite loans, which carry more risk to the lender than traditional loans as they may contain fewer or less restrictive covenants on the borrower than traditionally included in loan documentation or may contain other borrower friendly characteristics. The Company may experience relatively greater difficulty or delays in enforcing its rights on its holdings of certain covenant-lite loans and debt securities than its holdings of loans or securities with the usual covenants.
Counterparty Credit Risk
Counterparty credit risk is the potential loss the Company may incur as a result of the failure of a counterparty or an issuer to make payments according to the terms of a contract. Counterparty credit risk is measured as the loss the Company would record if its counterparties failed to perform pursuant to the terms of their obligations to the Company. Because the Company may enter into
over-the-counter
forwards, options, swaps and other derivative financial instruments, the Company may be exposed to the credit risk of its counterparties. To limit the counterparty credit risk associated with such transactions, the Company conducts business only with financial institutions judged by the Adviser to present acceptable credit risk.
Credit Risk
Debt securities are subject to the risk of
non-payment
of scheduled interest and/or principal.
Non-payment
would result in a reduction of income to the Company, a reduction in the value of the obligation experiencing
non-payment
and a potential decrease in the Company’s net asset value.
Investments rated below investment grade are commonly referred to as high-yield, high risk or “junk debt.” They are regarded as predominantly speculative with respect to the issuing company’s continuing ability to meet principal and/or interest payments. Investments in high yield debt and high yield senior loans may result in greater net asset value fluctuation than if the Company did not make such investments. Corporate debt obligations, including senior loans, are subject to the risk of
non-payment
of scheduled interest and/or principal.
 
Non-payment
would result in a reduction of income to the Company, a reduction in the value of the corporate debt obligation experiencing
non-payment
and a potential decrease in the net asset value of the Company. Some of the loans the Company makes or acquires may provide for the payment by borrowers of
Payment-In-Kind
(“PIK”) interest or accreted original issue discount at maturity. Such loans have the effect of deferring a borrower’s payment obligation until the end of the term of the loan, which may make it difficult for the Company to identify and address developing problems with borrowers in terms of their ability to repay debt. Particularly in a rising interest rate environment, loans containing PIK and original issue discount provisions can give rise to negative amortization on a loan, resulting in a borrower owing more at the end of the term of a loan than what it owed when the loan was originated. Any such developments may increase the risk of default on the Company’s loans by borrowers.
Because loans are not ordinarily registered with the SEC or any state securities commission or listed on any securities exchange, there is usually less publicly available information about such instruments. In addition, loans may not be considered “securities” for purposes of the anti-fraud protections of the federal securities laws and, as a result, as a purchaser of these instruments, the Company may not be entitled to the anti-fraud protections of the federal securities laws. In the course of investing in such instruments, the Company may come into possession of material nonpublic information and, because of prohibitions on trading in securities of issuers while in possession of such information, the Company may be unable to enter into a transaction in a publicly-traded security of that issuer when it would otherwise be advantageous for us to do so. Alternatively, the Company may choose not to receive material nonpublic information about an issuer of such loans, with the result that the Company may have less information about such issuers than other investors who transact in such assets.
Foreign Securities Risk
Investments in foreign securities involve certain factors not typically associated with investing in U.S. securities, such as risks relating to (i) currency exchange matters, including fluctuations in the rate of exchange between the U.S. dollar (the currency in which the books of the Company are maintained) and the various foreign currencies in which the Company’s portfolio securities will be denominated and costs associated with conversion of investment principal and income from one currency into another; (ii) differences between the U.S. and foreign securities markets, including the absence of uniform accounting, auditing and financial reporting standards and practices and disclosure requirements, and less government supervision and regulation; (iii) political, social or economic instability; and (iv) the extension of credit, especially in the case of sovereign debt.
Illiquid Securities Risk
The Company will generally make investments in private companies. Substantially all of these investments will be subject to legal and other restrictions on resale or will otherwise be less liquid than publicly traded securities. The illiquidity of the Company’s investments may make it difficult for the Company to sell such investments if the need arises. In addition, if it is required to liquidate all or a portion of its portfolio quickly, the Company may realize significantly less than the value at which it has previously recorded its investments. In addition, it may face other restrictions on its ability to liquidate an investment in a portfolio company to the extent that it has material
non-public
information regarding such portfolio company or if an investment is held by one of its subsidiaries and is subject to contractual limitations on sale, such as the limitations on transfer of assets under certain circumstances under a credit facility.
The Company may seek to address its short-term liquidity needs by carefully managing the settlements of its portfolio transactions, including transactions in loans, by maintaining short-term liquid assets sufficient to meet reasonably anticipated obligations, and by maintaining a credit facility.
Interest Rate Risk
Interest Rate risk is the risk that fixed income securities will decline in value because of changes in interest rates. When interest rates decline, the value of fixed rate securities already held by the Company can be expected to rise. Conversely, when interest rates rise, the value of existing fixed rate portfolio securities can be expected to decline. A company with a longer average portfolio duration will be more sensitive to changes in interest rates than a fund with a shorter average portfolio duration Recent and potential future changes in government monetary policy may affect the level of interest rates.
 
Investments in Foreign Markets Risk
Investments in foreign markets involve special risks and considerations not typically associated with investing in the United States. These risks include revaluation of currencies, high rates of inflation, restrictions on repatriation of income and capital, and adverse political and economic developments. Moreover, securities issued in these markets may be less liquid, subject to government ownership controls, tariffs and taxes, subject to delays in settlements, and their prices may be more volatile. The Company may be subject to capital gains and repatriation taxes imposed by certain countries in which they invest. Such taxes are generally based on income and/or capital gains earned or repatriated. Taxes are accrued based upon net investment income, net realized gains and net unrealized appreciation as income and/or capital gains are earned.
Leverage Risk
The Company may use leverage in its investment program, including the use of borrowed funds and investments in certain types of options, such as puts, calls and warrants, which may be purchased for a fraction of the price of the underlying securities. While such strategies and techniques increase the opportunity to achieve higher returns on the amounts invested, they also increase the risk of loss. To the extent the Company purchases securities with borrowed funds, its net assets will tend to increase or decrease at a greater rate than if borrowed funds are not used. If the interest expense on borrowings were to exceed the net return on the portfolio securities purchased with borrowed funds, the Company’s use of leverage would result in a lower rate of return than if the Company were not leveraged.
LIBOR Transition and Associated Risk
LIBOR is the average offered rate for various maturities of short-term loans between major international banks who are members of the British Bankers Association. LIBOR is the most common benchmark interest rate index used to make adjustments to variable-rate loans. It is used throughout global banking and financial industries to determine interest rates for a variety of financial instruments (such as debt instruments and derivatives) and borrowing arrangements.
Due to manipulation allegations in 2012 and reduced activity in the financial markets that it measures, in July 2017, the Financial Conduct Authority (the “FCA”), the United Kingdom financial regulatory body, announced a desire to phase out the use of LIBOR by the end of 2021 and that it will stop encouraging banks to provide the quotations needed to sustain LIBOR. The ICE Benchmark Administration Limited, the administrator of LIBOR, ceased publishing most LIBOR maturities, including some US LIBOR maturities, on December 31, 2021, and is expected to cease publishing the remaining and most liquid US LIBOR maturities on June 30, 2023. It is expected that market participants have or will transition to the use of alternative reference or benchmark rates prior to the applicable LIBOR publication cessation date. Additionally, although regulators have encouraged the development and adoption of alternative rates, such as the Secured Overnight Financing Rate (“SOFR”), the future utilization of LIBOR or of any particular replacement rate remains uncertain.
Although the transition process away from LIBOR has become increasingly well defined in advance of the anticipated discontinuation dates, the impact on certain debt securities, derivatives and other financial instruments remains uncertain. It is expected that market participants will adopt alternative rates such as SOFR or otherwise amend financial instruments referencing LIBOR to include fallback provisions and other measures that contemplate the discontinuation of LIBOR or other similar market disruption events, but neither the effect of the transition process nor the viability of such measures is known. Further, uncertainty and risk remain regarding the willingness and ability of issuers and lenders to include alternative rates and revised provisions in new and existing contracts or instruments. To facilitate the transition of legacy derivatives contracts referencing LIBOR, the International Swaps and Derivatives Association, Inc. launched a protocol to incorporate fallback provisions. While the transition process away from LIBOR has become increasingly well defined in advance of the expected LIBOR cessation dates, there are obstacles to converting certain longer term securities and transactions to a new benchmark or benchmarks and the effectiveness of one alternative reference rate versus multiple alternative reference rates in new or existing financial instruments and products has not been determined. Furthermore, the risks associated with the cessation of LIBOR and transition to replacement rates may be exacerbated if an orderly transition to alternative reference rates is not completed in a timely manner. Certain proposed replacement rates to LIBOR, such as SOFR, which is a broad measure of secured overnight US Treasury repo rates, are materially different from LIBOR, and changes in the applicable spread for financial instruments transitioning away from LIBOR will need to be made to accommodate the differences. Furthermore, the risks associated with the expected discontinuation of LIBOR and transition to replacement rates may be exacerbated if an orderly transition to an alternative reference rate is not completed in a timely manner. As market participants transition away from LIBOR, LIBOR’s usefulness may deteriorate and the effects could be experienced until the permanent cessation of the majority of U.S. LIBOR rates in 2023. The transition process may lead to increased volatility and illiquidity in markets that currently rely on LIBOR to determine interest rates. LIBOR’s deterioration may adversely affect the liquidity and/or market value of securities that use LIBOR as a benchmark interest rate.
 
Alteration of the terms of a debt instrument or a modification of the terms of other types of contracts to replace LIBOR or another interbank offered rate (“IBOR”) with a new reference rate could result in a taxable exchange and the realization of income and gain/loss for U.S. federal income tax purposes. The Internal Revenue Service (“IRS”) has issued final regulations regarding the tax consequences of the transition from IBOR to a new reference rate in debt instruments and
non-debt
contracts. Under the final regulations, alteration or modification of the terms of a debt instrument to replace an operative rate that uses a discontinued IBOR with a qualified rate (as defined in the final regulations) including true up payments equalizing the fair market value of contracts before and after such IBOR transition, to add a qualified rate as a fallback rate to a contract whose operative rate uses a discontinued IBOR or to replace a fallback rate that uses a discontinued IBOR with a qualified rate would not be taxable. The IRS may provide additional guidance, with potential retroactive effect.
Operational and Technology Risk
The risk that cyber-attacks, disruptions, or failures that affect the Funds’ service providers, counterparties, market participants, or issuers of securities held by the Funds may adversely affect the Funds and its shareholders, including by causing losses for the Funds or impairing Fund operations.
Options Risk
There are several risks associated with transactions in options on securities. For example, there are significant differences between the securities and options markets that could result in an imperfect correlation between these markets, causing a given transaction not to achieve its objectives. A transaction in options or securities may be unsuccessful to some degree because of market behavior or unexpected events.
When the Company writes a covered call option, the Company forgoes, during the option’s life, the opportunity to profit from increases in the market value of the security covering the call option above the sum of the premium and the strike price of the call, but retains the risk of loss should the price of the underlying security decline. The writer of an option has no control over the time when it may be required to fulfill its obligation and once an option writer has received an exercise notice, it must deliver the underlying security in exchange for the strike price.
When the Company writes a covered put option, the Company bears the risk of loss if the value of the underlying stock declines below the exercise price minus the put premium. If the option is exercised, the Company could incur a loss if it is required to purchase the stock underlying the put option at a price greater than the market price of the stock at the time of exercise plus the put premium the Company received when it wrote the option. While the Company’s potential gain in writing a covered put option is limited to distributions earned on the liquid assets securing the put option plus the premium received from the purchaser of the put option, the Company risks a loss equal to the entire exercise price of the option minus the put premium.
Pandemics and Associated Economic Disruption Risk
An outbreak of respiratory disease caused by a novel coronavirus was first detected in China in late 2019 and subsequently spread globally (“COVID-19”). This coronavirus has resulted in and may continue to result in the closing of borders, enhanced health screenings, healthcare service preparation and delivery, quarantines, cancellations, disruptions to supply chains and customer activity, as well as general anxiety and economic uncertainty. The impact of this has resulted in a substantial economic volatility. Health crises caused by outbreaks of disease, such as the coronavirus, may exacerbate other
pre-existing
political, social and economic risks. The impact of this outbreak, and other epidemics and pandemics that may arise in the future, could continue to negatively affect the global economy, as well as the economies of individual countries, individual companies and the market in general in significant and unforeseen ways. For example, a widespread health crisis such as a global pandemic could cause substantial market volatility, exchange trading suspensions and closures, impact the Company’s ability to complete tender offer requests, and affect Company performance. Any such impact could adversely affect the Company’s performance, the performance of the issuers in which the Company invests, lines of credit available to the Company and may lead to losses on your investment in the Company. In addition, the increasing interconnectedness of markets around the world may result in many markets being affected by events or conditions in a single country or region or events affecting a single or small number of issuers.
The United States responded to the COVID-19 outbreak and resulting economic distress with fiscal and monetary stimulus packages, including the Coronavirus Aid, Relief, and Economic Security Act (the “CARES Act”) passed in late March 2020. The CARES Act provides for over $
2.2
 trillion in resources to small businesses, state and local governments, and individuals adversely impacted by the
COVID-19
pandemic. Further, in March 2021, the government passed the American Rescue Plan Act of 2021, a $
1.9
 trillion stimulus bill to accelerate the United States’ recovery from the economic and health effects of the
COVID-19
pandemic. In late December 2020, the government also passed a spending bill that included $900 billion in stimulus relief for the COVID-19 pandemic. In addition, in
mid-March
2020, the Fed cut interest rates to historically low levels and announced a new round of quantitative easing, including purchases of corporate and municipal government bonds. The Fed also enacted various programs to support liquidity operations and funding in the financial markets, including expanding its reverse
 
repurchase agreement operations, which added $1.5
trillion of liquidity to the banking system; establishing swap lines with other major central banks to provide dollar funding; establishing a program to support money market funds; easing various bank capital buffers; providing funding backstops for businesses to provide bridging loans for up to four years; and providing funding to help credit flow in asset-backed securities markets. In addition, the Fed extended credit to small- and
medium-sized
businesses. As the Fed “tapers” or reduces the amount of securities it purchases pursuant to quantitative easing, and/or if the Fed raises the federal funds rate, there is a risk that interest rates will rise, which could expose fixed-income and related markets to heightened volatility and could cause the value of the Company’s investments, and the Company’s NAV, to decline, potentially suddenly and significantly. As a result, the Company may experience high redemptions and, as a result, increased portfolio turnover, which could increase the costs that the Company incurs and may negatively impact the Company’s performance. There is no assurance that the U.S. government’s support in response to
COVID-19
economic distress will offset the adverse impact to securities in which the Company may invest and future governmental support is not guaranteed.
Senior Loans Risk
The risk that the issuer of a senior loan may fail to pay interest or principal when due, and changes in market interest rates may reduce the value of the senior loan or reduce the Company’s returns. The risks associated with senior loans are similar to the risks of high yield debt securities. Senior loans and other debt securities are also subject to the risk of price declines and to increases in interest rates, particularly long-term rates. Senior loans are also subject to the risk that, as interest rates rise, the cost of borrowing increases, which may increase the risk of default. In addition, the interest rates of floating rate loans typically only adjust to changes in short-term interest rates; long-term interest rates can vary dramatically from short-term interest rates. Therefore, senior loans may not mitigate price declines in a long-term interest rate environment. The Company’s investments in senior loans are typically below investment grade and are considered speculative because of the credit risk of their issuers.
LIBOR is the average offered rate for various maturities of short-term loans between major international banks who are members of the British Bankers Association. LIBOR is the most common benchmark interest rate index used to make adjustments to variable-rate loans. It is used throughout global banking and financial industries to determine interest rates for a variety of financial instruments (such as debt instruments and derivatives) and borrowing arrangements. Due to manipulation allegations in 2012 and reduced activity in the financial markets that it measures, in July 2017, the Financial Conduct Authority, the United Kingdom financial regulatory body, announced a desire to phase out the use of LIBOR by the end of 2021. Please refer to “LIBOR Transition and Associated Risk” for more information.
Structured Finance Securities Risk
A portion of the Company’s investments may consist of equipment trust certificates, collateralized mortgage obligations, collateralized bond obligations, collateralized loan obligations (“CLO”) or similar instruments. Such structured finance securities are generally backed by an asset or a pool of assets, which serve as collateral. Depending on the type of security, the collateral may take the form of a portfolio of mortgage loans or bonds or other assets. The Company and other investors in structured finance securities ultimately bear the credit risk of the underlying collateral. In some instances, the structured finance securities are issued in multiple tranches, offering investors various maturity and credit risk characteristics, often categorized as senior, mezzanine and subordinated/equity according to their degree of risk. The riskiest securities are the equity tranche, which bears the bulk of defaults from the bonds or loans serving as collateral, and thus may protect the other, more senior tranches from default. If there are defaults or the relevant collateral otherwise underperforms, scheduled payments to senior tranches of such securities take precedence over those of mezzanine tranches, and scheduled payments to mezzanine tranches take precedence over those to subordinated/equity tranches. A senior tranche typically has higher ratings and lower yields than the underlying securities, and may be rated investment grade. Despite the protection from the equity tranche, other tranches can experience substantial losses due to actual defaults, increased sensitivity to defaults due to previous defaults and the disappearance of protecting tranches, market anticipation of defaults and aversion to certain structured finance securities as a class.
Short-Selling Risk
Short sales by the Company that are not made where there is an offsetting long position in the asset that it is being sold short theoretically involve unlimited loss potential since the market price of securities sold short may continuously increase. Short selling allows the Company to profit from declines in market prices to the extent such decline exceeds the transaction costs and costs of borrowing the securities. However, since the borrowed securities must be replaced by purchases at market prices in order to close out the short position, any appreciation in the price of the borrowed securities would result in a loss. Purchasing securities to close out the short position can itself cause the price of securities to rise further, thereby exacerbating the loss. The Company may mitigate such losses by replacing the securities sold short before the market price has increased significantly. Under adverse market conditions, the Company might have difficulty purchasing securities to meet margin calls on its short sale delivery obligations, and might have to sell portfolio securities to raise the capital necessary to meet its short sale obligations at a time when fundamental investment considerations would not favor such sales. Further, if other short positions of the same security are closed out at the same time, a “short squeeze” can occur where demand exceeds the supply for the security sold short. A short squeeze makes it more likely that the Adviser will need to replace the borrowed security at an unfavorable price.
 
Valuation Risk
Certain of the Company’s assets are fair valued, including the Company’s investment in equity issued by TerreStar Corporation (“TerreStar”). TerreStar does not currently generate revenue and primarily derives its value from holding licenses of two wireless spectrum assets. The license with respect to one such spectrum asset was previously terminated by the FCC and subsequently restored on April 30, 2020 on a limited conditional basis. The restoration of such license requires TerreStar to meet certain deployment milestones for wireless medical telemetry service (“WMTS”) during a
39-month
period. Upon satisfaction of the deployment milestones, TerreStar will be able use such spectrum for other services besides WMTS as long as those services do not interfere with WMTS and TerreStar continues to provide WMTS.
If TerreStar is unsuccessful in satisfying such deployment milestones, or if other services cannot be implemented in a manner that does not interfere with WMTS, the value of the TerreStar equity would likely be materially negatively impacted. In determining the fair value of TerreStar, the Adviser has assigned a high probability of success on both conditions based on consultation with the company and its consultants.
XML 28 R19.htm IDEA: XBRL DOCUMENT v3.23.1
Affiliated Investments
3 Months Ended
Mar. 31, 2023
Investments in and Advances to Affiliates, Schedule of Investments [Abstract]  
Affiliated Investments
Note 9 — Affiliated Investments
Under Section 2(a)(3) of the 1940 Act, a portfolio company is defined as “aff
iliated” if a
fund owns five percent or more of its outstanding voting securities or if the portfolio company is under common control.
 The table below includes non-cash transactions for the three months ended March 31, 2023.
The table below shows affiliated issuers of the Company as of March 31, 2023:
 
Affiliated investments
  
Shares

at

December 31,

2022
 
  
Fair value

as of

December 31,

2022
 
  
Transfers
in (out)
(at cost)
 
 
Purchases
 
  
Sales
 
  
Realized
gains
(losses)
 
  
Change in
unrealized
appreciation
(depreciation)
 
 
Fair value

as of

March 31,

2023
 
  
Shares

at

March 31,

2023
 
  
Affiliated
Dividend
income
 
NexPoint Residential Trust, Inc.
     23,409      $ 1,018,779      $ —        $ —       $ —       $ —        $ 3,512     $ 1,022,291        23,409      $ 9,832  
    
 
 
    
 
 
    
 
 
    
 
 
   
 
 
   
 
 
    
 
 
   
 
 
    
 
 
    
 
 
 
NexPoint Capital
REIT, LLC
 (Senior
Loans & Common
Stocks)
     100        1,176,024        7,368,085        463,314       —         —          (1,639,454     7,367,969        464,041         
    
 
 
    
 
 
    
 
 
    
 
 
   
 
 
   
 
 
    
 
 
   
 
 
    
 
 
    
 
 
 
NexPoint Real Estate Finance, Inc.
     481,670        7,653,730        (7,368,085 )      —               —          1,777,618       2,063,263        131,670        90,194  
    
 
 
    
 
 
    
 
 
    
 
 
   
 
 
   
 
 
    
 
 
   
 
 
    
 
 
    
 
 
 
SFR WLIF III, LLC
     451,112        424,468        —                —         —          (6,287     418,181        451,112        11,430  
    
 
 
    
 
 
    
 
 
    
 
 
   
 
 
   
 
 
    
 
 
   
 
 
    
 
 
    
 
 
 
Total affiliated investments
     956,291      $ 10,273,001      $ —        $ 463,314     $     $ —        $ 135,389     $ 10,871,704        1,070,232      $ 111,456  
    
 
 
    
 
 
    
 
 
    
 
 
   
 
 
   
 
 
    
 
 
   
 
 
    
 
 
    
 
 
 
XML 29 R20.htm IDEA: XBRL DOCUMENT v3.23.1
Financial Highlights
3 Months Ended
Mar. 31, 2023
Investment Company, Financial Highlights [Abstract]  
Financial Highlights
Note 10 — Financial Highlights
Selected data for a share outstanding throughout the three months ended March 31, 2023 and March 31, 2022 is as follows:
 
    
For the Three Months
Ended
   
For the Three Months
Ended
 
    
March 31, 2023
(Unaudited)
   
March 31, 2022
(Unaudited)
 
Common shares per share operating performance:
 
Net asset value, beginning of period
   $ 5.55     $ 6.32  
Income from investment operations:
 
Net investment income
(1)
     0.04       0.05  
Net realized and unrealized gain (loss)
     (0.14     0.07  
    
 
 
   
 
 
 
Total from investment operations
     (0.10     0.12  
    
 
 
   
 
 
 
Less distribution declared to common shareholders:
 
From net investment income
     (0.09     (0.09
    
 
 
   
 
 
 
Total distributions declared to common shareholders
     (0.09     (0.09
    
 
 
   
 
 
 
Capital share transaction
 
Issuance of common stock
(2)
     —         —    
Shares tendered
(1)
     —         —    
Net asset value, end of period
   $ 5.36     $ 6.35  
Net asset value total return
(3)(4)
     (1.80 )%     1.83
Ratio and supplemental data:
 
Net assets, end of period (in 000’s)
   $ 51,159     $ 62,947  
Shares outstanding, end of period
     9,548,899       9,918,671  
Common share information at end of period:
 
Ratios based on weighted average net assets of common shares:
 
Gross operating expenses
(5)
     4.05     3.72
Fees and expenses waived or reimbursed
(5)
     (0.62 )%      (0.39 )% 
Net operating expenses
(5)
     3.43     3.33
Net investment income (loss) before fees
waived or reimbursed
(5)
     2.14     2.73
Net investment income (loss) after fees
waived or reimbursed
(5)
     2.76     3.12
Portfolio turnover rate
(4)
     1     26
Asset coverage ratio
     —       —  
Weighted average commission rate paid
(6)
   $ —       $ —    
 
(1)
Per share data was calculated using weighted average shares outstanding during the period.
(2)
The continuous issuance of common stock may cause an incremental increase in net asset value per share due to the sale of shares at the then prevailing public offering price and the receipt of net proceeds per share by the Company in excess of net asset value per share on each subscription closing date. The per share data was derived by computing (i) the sum of (A) the number of shares issued in connection with subscriptions and/or distribution reinvestment on each share transaction date times (B) the differences between the net proceeds per share and the net asset value per share on each share transaction date, divided by (ii) the total shares outstanding at the end of the period. The Company’s continuous public offering ended on February 14, 2018.
(3)
Total returns are historical and assume changes in share price and reinvestment of dividends and capital gains distributions, and assume no sales charge. Distributions, if any, are assumed for purposes of this calculation to be reinvested at prices obtained under the Company’s Dividend Reinvestment Plan. Had the Adviser not absorbed a portion of expenses, total returns would have been lower.
(4)
Not annualized.
(5)
Annualized.
(6)
Represents the total dollar amount of commissions paid on portfolio transactions divided by total number of portfolio shares purchased and sold for which commissions were charged.
XML 30 R21.htm IDEA: XBRL DOCUMENT v3.23.1
Subsequent Events
3 Months Ended
Mar. 31, 2023
Subsequent Events [Abstract]  
Subseqent Events
Note 11 — Subsequent Events
The Company has evaluated subsequent events through the date on which these financial statements were issued.
 
XML 31 R22.htm IDEA: XBRL DOCUMENT v3.23.1
Summary of Significant Accounting Policies (Policies)
3 Months Ended
Mar. 31, 2023
Accounting Policies [Abstract]  
Basis of Accounting
Basis of Accounting
The accompanying financial statements of the Company are prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”). Additionally, the accompanying financial statements of the Company and related financial information have been prepared pursuant to the requirements for reporting on Form
10-Q
and Article 10 of Regulation
S-X.
The current period’s results of operations will not necessarily be indicative of results that ultimately may be achieved for the fiscal year ending December 31, 2023. The interim financial data as of March 31, 2023 and for the three months ended March 31, 2023 and 2022 is unaudited. In the opinion of management, the interim financial data includes all adjustments, consisting only of the normal recurring adjustments, necessary to a fair statement of the results for the interim periods.
Use of Estimates
Use of Estimates
The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of increases and decreases in net assets from operations during the reporting period. Actual results could differ from those estimates.
Statements of Cash Flows
Statements of Cash Flows
Information on financial transactions which have been settled through the receipt or disbursement of cash is presented in the Statements of Cash Flows. The cash amount shown in the Statements of Cash Flows is the amount included within the Company’s Statements of Assets and Liabilities and includes cash on hand at its custodian bank.
Cash and Cash Equivalents
Cash and Cash Equivalents
The Company considers liquid assets deposited with a bank, money market funds, and certain short-term debt instruments with original maturities of three months or less to be cash equivalents. These investments represent amounts held with financial institutions that are readily accessible to pay Company expenses or purchase investments. Cash and cash equivalents are valued at cost plus accrued interest, which approximates fair value. The value of cash equivalents denominated in foreign currencies, if any, is determined by converting to U.S. dollars on the date of the Statements of Assets and Liabilities. As of March 31, 2023 and December 31, 2022, the Company had cash and cash equivalents of $1,131,784 and $1,629,846, respectively. As of March 31, 2023 and December 31, 2022, $773,826 and $1,420,428 was held in the State Street U.S. Government Money Market Fund, and $357,958 and $209,418 was held in a custodial account with State Street Bank and Trust Company, respectively.
Securities Sold Short and Restricted Cash
Securities Sold Short and Restricted Cash
The Company may sell securities short. A security sold short is a transaction in which the Company sells a security it does not own in anticipation that the market price of that security will decline. When the Company sells a security short, it must borrow the security sold short from a broker-dealer and deliver it to the buyer upon conclusion of the transaction. The Company may have to pay a fee to borrow particular securities and is often obligated to pay over any dividends or other payments received on such borrowed securities. Cash held as collateral for securities sold short is classified as restricted cash on the Statements of Assets and Liabilities, when applicable. Securities held as collateral for securities sold short are shown on the Schedules of Investments for the Company, as applicable. As of March 31, 2023 and December 31, 2022, the Company did not have any securities sold short.
When securities are sold short, the Company intends to limit exposure to a possible market decline in the value of its portfolio companies through short sales of securities that the Adviser believes possess volatility characteristics similar to those being hedged. In addition, the Company may use short sales for
non-hedging
purposes to pursue its investment objective. Subject to the requirements of the 1940 Act and the Code, the Company will not make a short sale if, after giving effect to such sale, the market value of all securities sold short by the Company exceeds 25% of the value of its total assets.
Other Fee Income
Other Fee Income
Fee income may consist of origination/closing fees, amendment fees, administrative agent fees, transaction
break-up
fees and other miscellaneous fees. Origination fees, amendment fees, and other similar fees are
non-recurring
fee sources. Such fees are received on a transaction by transaction basis and do not constitute a regular stream of income. For the three months ended March 31, 2023 and March 31, 2022, the Company recognized $0 and $0 of fee income, respectively.
Fair Value of Financial Instruments
Fair Value of Financial Instruments
It is the Company’s policy to hold the investments at fair value. ASC Topic 820,
Fair Value Measurements and Disclosure
(“ASC Topic 820”) defines fair value as the price that would be received from the sale of an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. ASC Topic 820 also establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. These tiers include: Level 1, defined as observable inputs such as quoted prices in active markets; Level 2, which includes inputs such as quoted prices for similar securities in active markets and quoted prices for identical securities where there is little or no activity in the market; and Level 3, defined as unobservable inputs for which little or no market data exists, therefore requiring an entity to develop its own assumptions.
Pursuant to Rule
2a-5
under the 1940 Act, the Board has designated the Adviser as the Company’s valuation designee to perform the fair valuation determination for securities and other assets held by the Company. The Company determines the net asset value of its investment portfolio each quarter, or more frequently as needed. Securities that are publicly-traded are valued at the reported closing price on the valuation date. Securities that are not publicly-traded are valued at fair value as determined in good faith by the Adviser as valuation designee, pursuant to board-approved policies and procedures. In connection with that determination, the Adviser will consider portfolio company valuations based on relevant inputs, including indicative dealer quotes, values of like securities, recent portfolio company financial statements and forecasts, and valuations prepared by third-party valuation services. Rule
2a-5
states that a market quotation is readily available only when that quotation is a quoted price (unadjusted) in active markets for identical investments that the Company can access at the measurement date, provided that a quotation will not be readily available if it is not reliable. Market quotations may also not be “readily available” if a significant event occurs that causes the Adviser to believe that the market price of a security no longer represents the security’s current value at the time of the Company’s net asset value (“NAV”) determination.
 
With respect to investments for which market quotations are not readily available, the Adviser undertakes a multi-step valuation process each quarter, as described below:
 
   
The valuation process begins with each portfolio company or investment being initially valued by investment professionals of the Adviser responsible for credit monitoring or independent third party valuation firms.
 
   
Preliminary valuation conclusions are then documented and discussed with a committee comprised of certain senior management employees of the Adviser (the “Valuation Committee”) established by the Adviser to assist the Adviser in discharging its responsibilities as valuation designee.
 
   
At least once each quarter, the valuations for approximately one quarter of the portfolio investments that have been fair valued are reviewed by an independent valuation firm such that, over the course of a year, each material portfolio investment that has been fair valued shall have been reviewed by an independent valuation firm at least once.
 
   
Based on this information, the Adviser discusses valuations and determines the fair value of each investment in the portfolio in good faith pursuant to board-approved policies and procedures.
As of March 31, 2023, the Company held the following investments for which a sufficient level of current, reliable market quotations were not available:
 
Instrument
  
Type
  
Fair value
 
Grayson Investor Corp.
  
Asset-Backed Securities
   $  7,267  
PAMCO CLO
1997-1A
B
   Asset-Backed Securities      13  
American Banknote Corp.
   Common Stocks      1,732,500  
IQHQ, Inc.
   Common Stocks      2,359,000  
TerreStar Corp.
   Common Stocks      5,032,249  
Wayne Services Legacy, Inc.
   Common Stocks      2,268  
NexPoint Capital REIT, LLC
   LLC Interests      6,904,655  
SFR WLIF III, LLC
   LLC Interests      418,181  
US Gaming, LLC
   LLC Interests      2,841,603  
Apnimed, Inc.
   Preferred Stocks      1,499,989  
Apnimed, Inc.
   Preferred Stocks      799,993  
Sapience Therapeutics, Inc.
   Preferred Stocks      4,581,906  
Sapience Therapeutics, Inc.
   Preferred Stocks      3,700,000  
CCS Medical, Inc.
   Senior Secured Loans      3,000,000  
NexPoint Capital REIT
,
LLC
   Senior Secured Loans      463,314  
TerreStar Corp.
   Senior Secured Loans      836,016  
TerreStar Corp.
   Senior Secured Loans      197,921  
TerreStar Corp.
   Senior Secured Loans      35,360  
TerreStar Corp.
   Senior Secured Loans      32,991  
 
As of December 31, 2022, the Company held the following investments for which a sufficient level of current, reliable market quotations were not available:
 
Instrument
  
Type
  
Fair value
 
Grayson Investor Corp.
  
Asset-Backed Securities
   $  7,023  
PAMCO CLO
1997-1A
B
   Asset-Backed Securities      13  
American Banknote Corp.
   Common Stocks      1,732,500  
IQHQ, Inc.
   Common Stocks      2,359,000  
TerreStar Corp.
   Common Stocks      5,114,214  
Wayne Services Legacy, Inc.
   Common Stocks      2,269  
NexPoint Capital REIT, LLC
   LLC Interests      1,176,024  
SFR WLIF III, LLC
   LLC Interests      424,468  
US Gaming, LLC
   LLC Interests      3,088,750  
Apnimed, Inc.
   Preferred Stocks      1,499,989  
Apnimed, Inc.
   Preferred Stocks      799,994  
Sapience Therapeutics, Inc.
   Preferred Stocks      4,549,525  
Sapience Therapeutics, Inc.
   Preferred Stocks      3,677,777  
CCS Medical, Inc.
   Senior Secured Loans      3,000,000  
TerreStar Corp.
   Senior Secured Loans      810,953  
TerreStar Corp.
   Senior Secured Loans      191,988  
TerreStar Corp.
   Senior Secured Loans      34,300  
TerreStar Corp.
   Senior Secured Loans      32,002  
Determination of fair value involves subjective judgments and estimates. Accordingly, the notes to the Company’s financial statements will refer to the uncertainty with respect to the possible effect of such valuations, and any change in such valuations, in the Company’s financial statements. Below is a description of factors that the Adviser and the Valuation Committee may consider when valuing the Company’s debt and equity investments.
Valuation of fixed income investments, such as loans and debt securities, depends upon a number of factors, including prevailing interest rates for like securities, expected volatility in future interest rates, call features, put features and other relevant terms of the debt. For investments without readily available market prices, the Company may incorporate these factors into discounted cash flow models to arrive at fair value. Other factors that the Adviser and the Valuation Committee may consider include the borrower’s ability to adequately service its debt, the fair market value of the portfolio company in relation to the face amount of its outstanding debt and the quality of collateral securing the Company’s debt investments.
The Company’s equity investments in portfolio companies for which there is no liquid public market will be valued at fair value. The Adviser and the Valuation Committee, in its analysis of fair value, may consider various factors, such as multiples of earnings before interest, taxes, depreciation and amortization (“EBITDA”), cash flows, net income, revenues or, in limited instances, book value or liquidation value. All of these factors may be subject to adjustments based upon the particular circumstances of a portfolio company or the Company’s actual investment position. For example, adjustments to EBITDA may take into account compensation to previous owners or acquisition, recapitalization, restructuring or other related items.
The Adviser and the Valuation Committee may also look to private merger and acquisition statistics, public trading multiples discounted for illiquidity and other factors, valuations implied by third-party investments in the portfolio companies or industry practices in determining fair value. The Adviser and the Valuation Committee may also consider the size and scope of a portfolio company and its specific strengths and weaknesses, as well as any other factors it deems relevant in assessing the value. Generally, the value of the Company’s equity interests in public companies for which market quotations are readily available will be based upon the most recent closing public market price.
 
If the Company receives warrants or other equity-linked securities at nominal or no additional cost in connection with an investment in a debt security, the Company will allocate the cost basis in the investment between the debt securities and any such warrants or other equity-linked securities received at the time of origination. The Adviser and the Valuation Committee will subsequently value these warrants or other equity-linked securities received at fair value.
As applicable, the Company values its Level 2 assets by using the midpoint of the prevailing bid and ask prices from dealers on the date of the relevant period end, which is provided by an independent third-party pricing service and screened for validity by such service. For investments for which the third-party pricing service is unable to obtain quoted prices, the Company obtains bid and ask prices directly from dealers who make a market in such investments.
To the extent that the Company holds investments for which no active secondary market exists and, therefore, no bid and ask prices can be readily obtained, the Adviser and the Valuation Committee utilize an independent third-party valuation service to value such investments in a manner consistent with the Company’s multistep valuation process previously described.
The Company periodically benchmarks the bid and ask prices received from the third-party pricing service and/or dealers, as applicable, and valuations received from the third-party valuation service against the actual prices at which it purchases and sells its investments. The Company believes that these prices are reliable indicators of fair value. The Adviser and the Valuation Committee review and approve the valuation determinations made with respect to these investments in a manner consistent with the Company’s valuation procedures.
As of March 31, 2023, the Company’s investments consisted of senior secured loans, asset-backed securities, common stocks, LLC interests, preferred stocks, corporate bonds, and warrants, which may be purchased for a fraction of the price of the underlying securities. The fair value of the Company’s loans, bonds and asset-backed securities are generally based on quotes received from brokers or independent pricing services. Loans, bonds and asset-backed securities with quotes that are based on actual trades with a sufficient level of activity on or near the measurement date are classified as Level 2 assets. Loans, bonds and asset-backed securities that are priced using quotes derived from implied values, indicative bids or a limited number of actual trades are classified as Level 3 assets because the inputs used by the brokers and pricing services to derive the values are not readily observable.
The fair value of the Company’s common stocks and options that are not actively traded on national exchanges are generally priced using quotes derived from implied values, indicative bids, or a limited amount of actual trades and are classified as Level 3 assets because the inputs used by the brokers and pricing services to derive the values are not readily observable. Exchange traded options are valued based on the last trade price on the primary exchange on which they trade. If an option does not trade, the
mid-price
is utilized to value the option.
At the end of each calendar quarter, the Adviser evaluates the Level 2 and 3 investments for changes in liquidity, including: whether a broker is willing to execute at the quoted price, the depth and consistency of prices from third party services, and the existence of contemporaneous, observable trades in the market. Additionally, management evaluates the Level 1 and 2 assets and liabilities on a quarterly basis for changes in listings or delistings on national exchanges.
Due to the inherent uncertainty of determining the fair value of investments that do not have a readily available market price, the fair value of the Company’s investments may fluctuate from period to period. Additionally, the fair value of investments may differ significantly from the values that would have been used had a ready market existed for such investments and may differ materially from the values the Company may ultimately realize. Further, such investments may be subject to legal and other restrictions on resale or otherwise less liquid than publicly traded securities.
 
The inputs or methodology used for valuing investments are not necessarily an indication of the risk associated with investing in those investments. The following are summaries of the Company’s investments categorized within the fair value hierarchy as of March 31, 2023 and December 31, 2022:
 
    
March 31, 2023
 
Investments
  
Level 1
    
Level 2
    
Level 3
    
Total
 
                             
Assets
 
Senior Secured Loans
 
Healthcare
   $ —        $ 5,466,015      $ 3,000,000      $ 8,466,015  
Real Estate
     —          —          463,314        463,314  
Telecommunication Services
     —          —          1,102,288        1,102,288  
Asset-Backed Securities
 
Financials
     —          —          7,280        7,280  
Corporate Bonds
 
Healthcare
     —          2,240,779        —          2,240,779  
Media/Telecommunications
     —          259,466        —          259,466  
Common Stocks
 
Chemicals
     —          42,500        —          42,500  
Energy
     —          1,629,178        —          1,629,178  
Financials
     —          —          1,732,500        1,732,500  
Real Estate
     2,063,263        —          2,359,000        4,422,263  
Real Estate Investment Trusts (REITs)
     1,022,291        —          —          1,022,291  
Service
     —          —          2,268        2,268  
Telecommunication Services
     —          —          5,032,249        5,032,249  
LLC Interests
 
Consumer Products
     —          —          2,841,603        2,841,603  
Real Estate
     —          —          7,322,836        7,322,836  
Preferred Stocks
 
Financials
     —          1,400,000        —          1,400,000  
Healthcare
     —          —          10,581,888        10,581,888  
Warrants
 
Energy
     —          152,748        —          152,748  
Media/Telecommunications
     —          10,063        —          10,063  
    
 
 
    
 
 
    
 
 
    
 
 
 
Total Assets
  
$
3,085,554
 
  
$
11,200,749
 
  
$
34,445,226
 
  
$
48,731,529
 
    
 
 
    
 
 
    
 
 
    
 
 
 
Total Investments
  
$
3,085,554
 
  
$
11,200,749
 
  
$
34,445,226
 
  
$
48,731,529
 
    
 
 
    
 
 
    
 
 
    
 
 
 
 

















    
December 31, 2022
 
Investments
  
Level 1
    
Level 2
    
Level 3
    
Total
 
                             
Assets
 
Senior Secured Loans
 
Healthcare
   $ —        $ 10,158,950      $ 3,000,000      $ 13,158,950  
Telecommunication Services
     —          —          1,069,243        1,069,243  
Asset-Backed Securities
 
Financials
     —          —          7,036        7,036  
Corporate Bonds
 
Healthcare
     —          2,414,839        —          2,414,839  
Media/Telecommunications
     —          290,078        —          290,078  
Common Stocks
 
Chemicals
     —          42,500        —          42,500  
Energy
     —          1,591,692        —          1,591,692  
Financials
     —          —          1,732,500        1,732,500  
Real Estate
     7,653,730        —          2,359,000        10,012,730  
Real Estate Investment Trusts (REITs)
     1,018,779        —          —          1,018,779  
Service
     —          —          2,269        2,269  
Telecommunication Services
     —          —          5,114,214        5,114,214  
LLC Interests
 
Consumer Products
     —          —          3,088,750        3,088,750  
Real Estate
     —          —          1,600,492        1,600,492  
Preferred Stocks
 
Financials
     —          1,440,625        —          1,440,625  
Healthcare
     —          —          10,527,285        10,527,285  
Warrants
 
Energy
     —          161,249        —          161,249  
Media/Telecommunications
     —          20,484        —          20,484  
    
 
 
    
 
 
    
 
 
    
 
 
 
Total Assets
  
$
8,672,509
 
  
$
16,120,417
 
  
$
28,500,789
 
  
$
53,293,715
 
    
 
 
    
 
 
    
 
 
    
 
 
 
Total Investments
  
$
8,672,509
 
  
$
16,120,417
 
  
$
28,500,789
 
  
$
53,293,715
 
    
 
 
    
 
 
    
 
 
    
 
 
 
 
The table below sets forth a summary of changes in the Company’s Level 3 investments (measured at fair value using significant unobservable inputs) for the three months ended March 31, 2023. The table below includes noncash transactions for the three months ended March 31, 2023.
 














































Investments:
  
Balance as of
December 31,
2022
 
  
Transfers
into
Level 3
 
  
Transfer
s out of
Level 3
 
  
Net
amortization
(accretion) of
premium/
(discount)
 
  
Distribution
to Return
Capital
 
  
Net realized
gains/
(losses)
 
  
Net

change in
unrealized
gains/
(losses)
 
 
Purchases/
PIK
 
 
  
(Sales
and
redemptions)
 
 
Balance as of
March 31,
2023
 
  
Change in
unrealized
gain/(loss)
on Level 3
securities still
held at period
end
 
Assets
  



  



  



  



  



  



  



 



 
  



 



  



Senior Secured Loans
  



  



  



  



  



  



  



 



 
  



 



  



Telecommunication Services
   $ 1,069,243      $ —        $ —        $ —        $  —        $ —        $  3,198      $  29,847        $  —       $  1,102,288      $  3,198  
Healthcare
     3,000,000        —          —          4,465        —          —          (4,465 )
 
     —            —         3,000,000        (4,465 )
Real Estate
     —          —          —          —          —          —          —          463,314          —         463,314        —    
Asset-Backed Securities
                                                                                                   
Financials
     7,036        —          —          —          —          —          244        —            —         7,280        244  
Common Stocks
                                                                                                   
Financials
     1,732,500        —          —          —          —          —          —          —            —         1,732,500        —    
Real Estate
     2,359,000        —          —          —          —          —          —          —            —         2,359,000        —    
Service
     2,269        —          —          —          —          —          —          —            —         2,268        —    
Telecommunication Services
     5,114,214        —          —          —          —          —          (81,965 )      —            —         5,032,249        (81,965 )
LLC Interests
                                                                                                   
Consumer Products
     3,088,750        —          —          —          —          163,314        52,853        —            (463,314 )     2,841,603        52,853  
Real Estate
     1,600,492        —          —          —          —          —          (1,645,741 )      7,368,085
(1)
 
       —         7,322,836        (1,645,741 )
Preferred Stocks
                                                                                                   
Healthcare
     10,527,285        —          —          —          —          —          54,603        —            —         10,581,888        54,603  
    
 
 
    
 
 
    
 
 
    
 
 
    
 
 
    
 
 
    
 
 
    
 
 
      
 
 
   
 
 
    
 
 
 
Total
   $ 28,500,789      $ —        $ —        $ 4,465      $ —        $ 163,314      $ (1,621,273 )    $ 7,861,246        $ (463,314 )
 
  $ 34,445,226      $ (1,621,273 )
 
    
 
 
    
 
 
    
 
 
    
 
 
    
 
 
    
 
 
    
 
 
    
 
 
      
 
 
   
 
 
    
 
 
 
 
(1)
 
Represents an in-kind transfer to the subreit.
The table below sets forth a summary of changes in the Company’s Level 3 investments (measured at fair value using significant unobservable inputs) for the three months ended March 31, 2022.
 













































Investments:
  
Balance as of
December 31,
2021
    
Transfers
into
Level 3
    
Transfer
out of
Level 3
    
Net
amortization
(accretion) of
premium/
(discount)
    
Distribution
to Return
Capital
    
Net realized
gains/
(losses)
   
Net

change in
unrealized
gains/
(losses)
   
Purchases/
PIK
   
(Sales
and
redemptions)
   
Balance as of
March 31,
2022
    
Change in
unrealized
gain/(loss)
on Level 3
securities still
held at period
end
 
                                                                          
Assets
                                                                                              
Senior Secured Loans
                                                                                              
Telecommunication Services
   $ 962,478      $ —        $ —        $ —        $ —        $ —       $ —       $ 26,711     $ —       $ 989,189      $ —    
Healthcare
     4,000,000        —          —          3,809        —          —         86,191       2,990,000       (4,080,000 )(a)      3,000,000        86,191  
Asset-Backed Securities
                                                                                              
Financials
     405,040        —          —          —          —          —         11,787       —         (16,979     399,848        11,787  
Common Stocks
                                                                                              
Financials
     2,208,750        —          —          —          —          —         (603,450     —         —         1,605,300        (603,450
Real Estate
     1,823,000        —          —          —          —          —         141,000       —         —         1,964,000        141,000  
Service
     5,172        —          —          —          —          —         —         —         —         5,172        —    
Telecommunication Services
     4,706,357        —          —          —          —          —         (94,456     —         —         4,611,901        (94,456
LLC Interests
                                                                                              
Consumer Products
     2,812,212        —          —          —          —          —         169,426       —         —         2,981,638        169,426  
Real Estate
     4,760,162        —          —          —          —          (74,603     139,367       —         (3,274,285 )(b)      1,550,641        (13,275
Preferred Stocks
                                                                                              
Healthcare
     —          —          —          —          —          —         —         8,080,000 (a)      —         8,080,000        —    
    
 
 
    
 
 
    
 
 
    
 
 
    
 
 
    
 
 
   
 
 
   
 
 
   
 
 
   
 
 
    
 
 
 
Total
   $ 21,683,171      $ —        $  —        $ 3,809      $  —        $ (74,603   $ (150,135   $ 11,096,711     $ (7,371,264   $ 25,187,689      $ (302,777
    
 
 
    
 
 
    
 
 
    
 
 
    
 
 
    
 
 
   
 
 
   
 
 
   
 
 
   
 
 
    
 
 
 
 
(a)
 
Denotes Sapience’s $4,080,000 promissory notes and paid in kind interest conversion to preferred stock.
(b)
 
Denotes SFR II’s LLC Interests conversion into NREF common shares.
 
Investments designated as Level 3 may include investments valued using quotes or indications furnished by brokers which are based on models or estimates and may not be executable prices. In light of the developing market conditions, the Adviser continues to search for observable data points and evaluate broker quotes and indications received for investments. Determination of fair values is uncertain because it involves subjective judgments and estimates that are unobservable. Transfers from Level 2 to Level 3 are due to a decrease in market activity (e.g. frequency of trades), which resulted in a decrease of available market inputs to determine price. For the three months ended March 31, 2023, there were no transfers from Level 2 to Level 3. For the three months ended March 31, 2022, there were no transfers from Level 2 to Level 3. Transfers from Level 3 to Level 2 and from Level 2 to Level 1 are due to an increase in market activity (e.g. frequency of trades), which resulted in an increase of available market inputs to determine price.
The following are summaries of significant unobservable inputs used in the fair valuations of investments categorized within Level 3 of the fair value hierarchy as of March 31, 2023 and December 31, 2022:
 
Investment
 
Fair value at

March 31, 2023
   
Valuation
technique
 
Unobservable
inputs
 
Range of input value(s)

(weighted average)
 
LLC Interest
  $ 10,164,438    
Discounted Cash Flow
Multiples Analysis
 
Discount Rate
Multiple of EBITDA
   
4.98% - 9.18% (7.08%)

5.60x - 9.95x (
7.70
x)
 
 
Preferred Stock
    10,581,888     Option Pricing Model   Volatility    
40% - 90% (65%)
 
Common Stock
    9,126,018    
Discounted Cash Flow
Multiples Analysis
 
Transaction Indication of Value
Liquidation Analysis
Net Asset Value
 
Discount Rate
Multiple of EBITDA
Unadjusted
Price/MHz-PoP
Enterprise Value ($mm)
Recovery Rate
N/A
   
11.0% - 13.0% (12.0%)

3.25x - 4.25x (
3.75x)  
$0.09 - $0.95 ($0.52)
$921.5
40% - 100%
$28
 
 
 
 
 
Senior Secured Loans
    4,565,602     Discounted Cash Flow   Discount Rate    
10.25% - 13.06% (11.40%)
 
Asset-Backed Securities
    7,280     NAV Approach   Discount Rate     70.00%  
   
 
 
                 
Total
 
$
       34,445,226
 
               
   
 
 
                 
 
Investment
 
Fair value at

December 31, 2022
   
Valuation
technique
 
Unobservable
inputs
 
Range of input value(s)

(weighted average)
LLC Interest
  $ 4,689,242    
Discounted Cash Flow
Multiples Analysis
 
Discount Rate
Multiple of EBITDA
 
4.73% - 8.93% (6.83%)

5.55x - 9.85x (7.70x)
Preferred Stock
    10,527,285    
Option Pricing Model
Transaction Indication of Value
 
Volatility
Recap Price
 
40% - 60% (50%)

$11.10
Common Stock
    9,207,983    
Discounted Cash Flow
Multiples Analysis
 
Transaction Indication of Value
Liquidation Analysis
Net Asset Value
 
Discount Rate
Multiple of EBITDA
Unadjusted Price/MHz-PoP
Enterprise Value ($mm)
Recovery Rate
N/A
 
13.50% - 15.50% (14.50%)

3.25x - 4.25x (3.75x)
$0.09 - $0.95 ($0.52)  
$872 - $969 ($920.5)  
40% - 100% (70%)
$28
Senior Secured Loans
    4,069,243     Discounted Cash Flow   Discount Rate  
   10.25% - 13.08% (11.67%)   
Asset-Backed Securities
    7,036     NAV Approach   Discount Rate   70.00%
   
 
 
             
Total
 
$
28,500,789
             
   
 
 
             
The significant unobservable inputs used in the fair value measurement of the Company’s LLC interests are: discount rate and multiples of EBITDA. Significant increases (decreases) in those inputs in isolation could result in a significantly lower (higher) fair value measurement. The significant unobservable inputs used in the fair value measurement of the Company’s common equity securities are: multiple of EBITDA,
price/MHz-PoP
multiple, liquidity discount, discount rate, enterprise value, and transaction price. Significant increases (decreases) in any of those inputs in isolation could result in a significantly lower (higher) fair value measurement. The significant unobservable inputs used in the fair value measurement of the Company’s preferred stock are: option pricing model. Significant increases (decreases) in any of those inputs in isolation could result in a significantly lower (higher) fair value measurement. The significant unobservable inputs used in the fair value measurement of the Company’s senior secured loans are: discount rate and spread adjustment. Significant increases (decreases) in either of those inputs in isolation could result in a significantly lower (higher) fair value measurement.
 
The significant unobservable inputs used in the fair value measurement of the Company’s asset-backed securities are: discount rate and broker quote indication of value. Significant increases (decreases) in either of those inputs in isolation could result in a significantly lower (higher) fair value measurement. The significant unobservable input used in the fair value measurement of the Company’s warrant securities is: volatility assumption. Significant increases (decreases) in this input in isolation could result in a significantly lower (higher) fair value measurement.
Derivative Transactions
Derivative Transactions
The Company is subject to equity price risk, interest rate risk and foreign currency exchange rate risk in the normal course of pursuing its investment objective. The Company may invest without limitation in warrants and may also use derivatives, primarily swaps (including equity, variance and volatility swaps), options and futures contracts on securities, interest rates, commodities and/or currencies, as substitutes for direct investments the Company can make. The Company may also use derivatives such as swaps, options (including options on futures), futures, and foreign currency transactions (e.g., foreign currency swaps, futures and forwards) to any extent deemed by the Adviser to be in the best interest of the Company, and to the extent permitted by the 1940 Act, to hedge various investments for risk management and speculative purposes.
Options
Options
The Company purchases options, subject to certain limitations. The Company may invest in options contracts to manage its exposure to the stock and bond markets and fluctuations in foreign currency values. Writing puts and buying calls tend to increase the Company’s exposure to the underlying instrument while buying puts and writing calls tend to decrease the Company’s exposure to the underlying instrument, or economically hedge other Company investments. The Company’s risks in using these contracts include changes in the value of the underlying instruments, nonperformance of the counterparties under the contracts’ terms and changes in the liquidity of the secondary market for the contracts. Options are valued at the last sale price, or if no sales occurred on that day, at the last quoted bid price. As of and during the three months ended March 31, 2023 and 2022, the Company did not hold options.
Investment Transactions
Investment Transactions
Investment transactions are accounted for on trade date. Realized gains (losses) on investments sold are recorded on the basis of specific identification method for both financial statement and U.S. federal income tax purposes. Payable for investments purchased and receivable for investments sold on the Statements of Assets and Liabilities, if any, represents the cost of purchases and proceeds from sales of investment securities, respectively, for trades that have been executed but not yet settled.
Income Recognition
Income Recognition
Corporate actions (including cash dividends from common stock and equity tranches of asset-backed securities) are recorded on the
ex-dividend
date, net of applicable withholding taxes, except for certain foreign corporate actions, which are recorded as soon after the
ex-dividend
date as such information becomes available. Interest income is recorded on the accrual basis. The Company does not accrue as a receivable for interest or dividends on loans, asset-backed securities and other securities if there is a reason to doubt the Company’s ability to collect such income. For loans with contractual PIK
(payment-in-kind)
interest income, which represents contractual interest accrued and added to the loan balance that generally becomes due at maturity, we will not accrue PIK interest if we believe that the PIK interest is no longer collectible. Loan origination fees, original issue discount and market discount are capitalized and such amounts are amortized as interest income over the respective term of the loan or security. Upon the prepayment of a loan or security, any unamortized loan origination fees and original issue discount are recorded as interest income.
Accretion of discounts and amortization of premiums on taxable bonds, loans and asset-backed securities are computed to the call or maturity date, whichever is shorter, using the effective yield method. Withholding taxes on foreign dividends have been provided for in accordance with the Company’s understanding of the applicable country’s tax rules and rates.
Organization and Offering Costs
Organization and Offering Costs
Organization costs are paid by the Adviser and include the cost of incorporating, such as the cost of legal services and other fees pertaining to our organization. Offering costs include legal fees, promotional costs and other costs pertaining to the public offering of our shares of common stock and are also paid by the Adviser. Prior to the termination of the offering, as we raised proceeds, these organization and offering costs were expensed and became payable to the Adviser. Organization and offering costs are limited to 1% of total gross proceeds raised and are not due and payable to the Adviser to the extent they exceed that amount. Please refer to Note 4 for additional information on Organization and Offering Costs.
Paid-in Capital
Paid-in
Capital
The proceeds from the issuance of common stock as presented on the Company’s Statements of Changes in Net Assets is presented net of selling commissions and fees for the three months ended March 31, 2023 and March 31, 2022. Selling commissions and fees of $0 and $0 were paid for the three months ended March 31, 2023 and March 31, 2022, respectively.
Earnings Per Share
Earnings Per Share
In accordance with the provisions of ASC Topic 260—
Earnings per Share
(“ASC Topic 260”), basic earnings per share is computed by dividing earnings available to common stockholders by the weighted average number of shares outstanding during the period. Other potentially dilutive common shares, and the related impact to earnings, are considered when calculating earnings per share on a diluted basis.
The following table sets forth the computation of the weighted average basic and diluted net increase in net assets per share from operations:
 
    
For the three months ended
March 31,
 
    
2023
    
2022
 
Net increase (decrease) in net assets resulting from operations
   $ (977,817    $ 1,145,017  
Weighted average common shares outstanding
     9,699,655        9,990,797  
Earnings (loss) per common share-basic and diluted
   $ (0.10    $ 0.11  
Distributions
Distributions
Distributions to the Company’s stockholders will be recorded as of the record date. Subject to the discretion of the Board and applicable legal restrictions, the Company intends to authorize and declare ordinary cash distributions on a weekly basis and pay such distributions on a quarterly basis. Net realized capital gains, if any, will generally be distributed or deemed distributed at least every
12-month
period.
On June 24, 2020, the Board approved a change in its dividend and capital gains distribution schedule from monthly distributions to quarterly distributions, effective immediately. The first quarterly distribution was paid on October 12, 2020 to shareholders of record as of September 30, 2020. The dividends are expected to be declared in the amount of $0.09 per share of the Company’s common stock to the stockholders of record at each quarter end.
Recent Accounting Pronouncements
Recent Accounting Pronouncements
In March 2020, the FASB issued Accounting Standards Update (“ASU”)
No. 2020-04,
“Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting” which provides optional exceptions for applying GAAP to contract modifications, hedging relationships and other transactions affected by reference rate reform if certain criteria are met. ASU
No. 2020-04
is elective and effective for all entities as of March 12, 2020 through December 31, 2022. The Company is currently evaluating the impact of ASU
No. 2020-04.
Please refer to Note 8 for additional information.
XML 32 R23.htm IDEA: XBRL DOCUMENT v3.23.1
Summary of Significant Accounting Policies (Tables)
3 Months Ended
Mar. 31, 2023
Accounting Policies [Abstract]  
Summary of Investments Using Significant Unobservable Input
As of March 31, 2023, the Company held the following investments for which a sufficient level of current, reliable market quotations were not available:
 
Instrument
  
Type
  
Fair value
 
Grayson Investor Corp.
  
Asset-Backed Securities
   $  7,267  
PAMCO CLO
1997-1A
B
   Asset-Backed Securities      13  
American Banknote Corp.
   Common Stocks      1,732,500  
IQHQ, Inc.
   Common Stocks      2,359,000  
TerreStar Corp.
   Common Stocks      5,032,249  
Wayne Services Legacy, Inc.
   Common Stocks      2,268  
NexPoint Capital REIT, LLC
   LLC Interests      6,904,655  
SFR WLIF III, LLC
   LLC Interests      418,181  
US Gaming, LLC
   LLC Interests      2,841,603  
Apnimed, Inc.
   Preferred Stocks      1,499,989  
Apnimed, Inc.
   Preferred Stocks      799,993  
Sapience Therapeutics, Inc.
   Preferred Stocks      4,581,906  
Sapience Therapeutics, Inc.
   Preferred Stocks      3,700,000  
CCS Medical, Inc.
   Senior Secured Loans      3,000,000  
NexPoint Capital REIT
,
LLC
   Senior Secured Loans      463,314  
TerreStar Corp.
   Senior Secured Loans      836,016  
TerreStar Corp.
   Senior Secured Loans      197,921  
TerreStar Corp.
   Senior Secured Loans      35,360  
TerreStar Corp.
   Senior Secured Loans      32,991  
 
As of December 31, 2022, the Company held the following investments for which a sufficient level of current, reliable market quotations were not available:
 
Instrument
  
Type
  
Fair value
 
Grayson Investor Corp.
  
Asset-Backed Securities
   $  7,023  
PAMCO CLO
1997-1A
B
   Asset-Backed Securities      13  
American Banknote Corp.
   Common Stocks      1,732,500  
IQHQ, Inc.
   Common Stocks      2,359,000  
TerreStar Corp.
   Common Stocks      5,114,214  
Wayne Services Legacy, Inc.
   Common Stocks      2,269  
NexPoint Capital REIT, LLC
   LLC Interests      1,176,024  
SFR WLIF III, LLC
   LLC Interests      424,468  
US Gaming, LLC
   LLC Interests      3,088,750  
Apnimed, Inc.
   Preferred Stocks      1,499,989  
Apnimed, Inc.
   Preferred Stocks      799,994  
Sapience Therapeutics, Inc.
   Preferred Stocks      4,549,525  
Sapience Therapeutics, Inc.
   Preferred Stocks      3,677,777  
CCS Medical, Inc.
   Senior Secured Loans      3,000,000  
TerreStar Corp.
   Senior Secured Loans      810,953  
TerreStar Corp.
   Senior Secured Loans      191,988  
TerreStar Corp.
   Senior Secured Loans      34,300  
TerreStar Corp.
   Senior Secured Loans      32,002  
Summary of Investments Categorize into Fair Value Hierarchy
The inputs or methodology used for valuing investments are not necessarily an indication of the risk associated with investing in those investments. The following are summaries of the Company’s investments categorized within the fair value hierarchy as of March 31, 2023 and December 31, 2022:
 
    
March 31, 2023
 
Investments
  
Level 1
    
Level 2
    
Level 3
    
Total
 
                             
Assets
 
Senior Secured Loans
 
Healthcare
   $ —        $ 5,466,015      $ 3,000,000      $ 8,466,015  
Real Estate
     —          —          463,314        463,314  
Telecommunication Services
     —          —          1,102,288        1,102,288  
Asset-Backed Securities
 
Financials
     —          —          7,280        7,280  
Corporate Bonds
 
Healthcare
     —          2,240,779        —          2,240,779  
Media/Telecommunications
     —          259,466        —          259,466  
Common Stocks
 
Chemicals
     —          42,500        —          42,500  
Energy
     —          1,629,178        —          1,629,178  
Financials
     —          —          1,732,500        1,732,500  
Real Estate
     2,063,263        —          2,359,000        4,422,263  
Real Estate Investment Trusts (REITs)
     1,022,291        —          —          1,022,291  
Service
     —          —          2,268        2,268  
Telecommunication Services
     —          —          5,032,249        5,032,249  
LLC Interests
 
Consumer Products
     —          —          2,841,603        2,841,603  
Real Estate
     —          —          7,322,836        7,322,836  
Preferred Stocks
 
Financials
     —          1,400,000        —          1,400,000  
Healthcare
     —          —          10,581,888        10,581,888  
Warrants
 
Energy
     —          152,748        —          152,748  
Media/Telecommunications
     —          10,063        —          10,063  
    
 
 
    
 
 
    
 
 
    
 
 
 
Total Assets
  
$
3,085,554
 
  
$
11,200,749
 
  
$
34,445,226
 
  
$
48,731,529
 
    
 
 
    
 
 
    
 
 
    
 
 
 
Total Investments
  
$
3,085,554
 
  
$
11,200,749
 
  
$
34,445,226
 
  
$
48,731,529
 
    
 
 
    
 
 
    
 
 
    
 
 
 
 

















    
December 31, 2022
 
Investments
  
Level 1
    
Level 2
    
Level 3
    
Total
 
                             
Assets
 
Senior Secured Loans
 
Healthcare
   $ —        $ 10,158,950      $ 3,000,000      $ 13,158,950  
Telecommunication Services
     —          —          1,069,243        1,069,243  
Asset-Backed Securities
 
Financials
     —          —          7,036        7,036  
Corporate Bonds
 
Healthcare
     —          2,414,839        —          2,414,839  
Media/Telecommunications
     —          290,078        —          290,078  
Common Stocks
 
Chemicals
     —          42,500        —          42,500  
Energy
     —          1,591,692        —          1,591,692  
Financials
     —          —          1,732,500        1,732,500  
Real Estate
     7,653,730        —          2,359,000        10,012,730  
Real Estate Investment Trusts (REITs)
     1,018,779        —          —          1,018,779  
Service
     —          —          2,269        2,269  
Telecommunication Services
     —          —          5,114,214        5,114,214  
LLC Interests
 
Consumer Products
     —          —          3,088,750        3,088,750  
Real Estate
     —          —          1,600,492        1,600,492  
Preferred Stocks
 
Financials
     —          1,440,625        —          1,440,625  
Healthcare
     —          —          10,527,285        10,527,285  
Warrants
 
Energy
     —          161,249        —          161,249  
Media/Telecommunications
     —          20,484        —          20,484  
    
 
 
    
 
 
    
 
 
    
 
 
 
Total Assets
  
$
8,672,509
 
  
$
16,120,417
 
  
$
28,500,789
 
  
$
53,293,715
 
    
 
 
    
 
 
    
 
 
    
 
 
 
Total Investments
  
$
8,672,509
 
  
$
16,120,417
 
  
$
28,500,789
 
  
$
53,293,715
 
    
 
 
    
 
 
    
 
 
    
 
 
 
Summary of Fair Value Assets Measured on Recurring Basis Unobservable input Reconciliation
The table below sets forth a summary of changes in the Company’s Level 3 investments (measured at fair value using significant unobservable inputs) for the three months ended March 31, 2023. The table below includes noncash transactions for the three months ended March 31, 2023.
 














































Investments:
  
Balance as of
December 31,
2022
 
  
Transfers
into
Level 3
 
  
Transfer
s out of
Level 3
 
  
Net
amortization
(accretion) of
premium/
(discount)
 
  
Distribution
to Return
Capital
 
  
Net realized
gains/
(losses)
 
  
Net

change in
unrealized
gains/
(losses)
 
 
Purchases/
PIK
 
 
  
(Sales
and
redemptions)
 
 
Balance as of
March 31,
2023
 
  
Change in
unrealized
gain/(loss)
on Level 3
securities still
held at period
end
 
Assets
  



  



  



  



  



  



  



 



 
  



 



  



Senior Secured Loans
  



  



  



  



  



  



  



 



 
  



 



  



Telecommunication Services
   $ 1,069,243      $ —        $ —        $ —        $  —        $ —        $  3,198      $  29,847        $  —       $  1,102,288      $  3,198  
Healthcare
     3,000,000        —          —          4,465        —          —          (4,465 )
 
     —            —         3,000,000        (4,465 )
Real Estate
     —          —          —          —          —          —          —          463,314          —         463,314        —    
Asset-Backed Securities
                                                                                                   
Financials
     7,036        —          —          —          —          —          244        —            —         7,280        244  
Common Stocks
                                                                                                   
Financials
     1,732,500        —          —          —          —          —          —          —            —         1,732,500        —    
Real Estate
     2,359,000        —          —          —          —          —          —          —            —         2,359,000        —    
Service
     2,269        —          —          —          —          —          —          —            —         2,268        —    
Telecommunication Services
     5,114,214        —          —          —          —          —          (81,965 )      —            —         5,032,249        (81,965 )
LLC Interests
                                                                                                   
Consumer Products
     3,088,750        —          —          —          —          163,314        52,853        —            (463,314 )     2,841,603        52,853  
Real Estate
     1,600,492        —          —          —          —          —          (1,645,741 )      7,368,085
(1)
 
       —         7,322,836        (1,645,741 )
Preferred Stocks
                                                                                                   
Healthcare
     10,527,285        —          —          —          —          —          54,603        —            —         10,581,888        54,603  
    
 
 
    
 
 
    
 
 
    
 
 
    
 
 
    
 
 
    
 
 
    
 
 
      
 
 
   
 
 
    
 
 
 
Total
   $ 28,500,789      $ —        $ —        $ 4,465      $ —        $ 163,314      $ (1,621,273 )    $ 7,861,246        $ (463,314 )
 
  $ 34,445,226      $ (1,621,273 )
 
    
 
 
    
 
 
    
 
 
    
 
 
    
 
 
    
 
 
    
 
 
    
 
 
      
 
 
   
 
 
    
 
 
 
 
(1)
 
Represents an in-kind transfer to the subreit.
The table below sets forth a summary of changes in the Company’s Level 3 investments (measured at fair value using significant unobservable inputs) for the three months ended March 31, 2022.
 













































Investments:
  
Balance as of
December 31,
2021
    
Transfers
into
Level 3
    
Transfer
out of
Level 3
    
Net
amortization
(accretion) of
premium/
(discount)
    
Distribution
to Return
Capital
    
Net realized
gains/
(losses)
   
Net

change in
unrealized
gains/
(losses)
   
Purchases/
PIK
   
(Sales
and
redemptions)
   
Balance as of
March 31,
2022
    
Change in
unrealized
gain/(loss)
on Level 3
securities still
held at period
end
 
                                                                          
Assets
                                                                                              
Senior Secured Loans
                                                                                              
Telecommunication Services
   $ 962,478      $ —        $ —        $ —        $ —        $ —       $ —       $ 26,711     $ —       $ 989,189      $ —    
Healthcare
     4,000,000        —          —          3,809        —          —         86,191       2,990,000       (4,080,000 )(a)      3,000,000        86,191  
Asset-Backed Securities
                                                                                              
Financials
     405,040        —          —          —          —          —         11,787       —         (16,979     399,848        11,787  
Common Stocks
                                                                                              
Financials
     2,208,750        —          —          —          —          —         (603,450     —         —         1,605,300        (603,450
Real Estate
     1,823,000        —          —          —          —          —         141,000       —         —         1,964,000        141,000  
Service
     5,172        —          —          —          —          —         —         —         —         5,172        —    
Telecommunication Services
     4,706,357        —          —          —          —          —         (94,456     —         —         4,611,901        (94,456
LLC Interests
                                                                                              
Consumer Products
     2,812,212        —          —          —          —          —         169,426       —         —         2,981,638        169,426  
Real Estate
     4,760,162        —          —          —          —          (74,603     139,367       —         (3,274,285 )(b)      1,550,641        (13,275
Preferred Stocks
                                                                                              
Healthcare
     —          —          —          —          —          —         —         8,080,000 (a)      —         8,080,000        —    
    
 
 
    
 
 
    
 
 
    
 
 
    
 
 
    
 
 
   
 
 
   
 
 
   
 
 
   
 
 
    
 
 
 
Total
   $ 21,683,171      $ —        $  —        $ 3,809      $  —        $ (74,603   $ (150,135   $ 11,096,711     $ (7,371,264   $ 25,187,689      $ (302,777
    
 
 
    
 
 
    
 
 
    
 
 
    
 
 
    
 
 
   
 
 
   
 
 
   
 
 
   
 
 
    
 
 
 
 
(a)
 
Denotes Sapience’s $4,080,000 promissory notes and paid in kind interest conversion to preferred stock.
(b)
 
Denotes SFR II’s LLC Interests conversion into NREF common shares.
Summary of Quantitative Information about the Company's Level 3 Asset and Liability
The following are summaries of significant unobservable inputs used in the fair valuations of investments categorized within Level 3 of the fair value hierarchy as of March 31, 2023 and December 31, 2022:
 
Investment
 
Fair value at

March 31, 2023
   
Valuation
technique
 
Unobservable
inputs
 
Range of input value(s)

(weighted average)
 
LLC Interest
  $ 10,164,438    
Discounted Cash Flow
Multiples Analysis
 
Discount Rate
Multiple of EBITDA
   
4.98% - 9.18% (7.08%)

5.60x - 9.95x (
7.70
x)
 
 
Preferred Stock
    10,581,888     Option Pricing Model   Volatility    
40% - 90% (65%)
 
Common Stock
    9,126,018    
Discounted Cash Flow
Multiples Analysis
 
Transaction Indication of Value
Liquidation Analysis
Net Asset Value
 
Discount Rate
Multiple of EBITDA
Unadjusted
Price/MHz-PoP
Enterprise Value ($mm)
Recovery Rate
N/A
   
11.0% - 13.0% (12.0%)

3.25x - 4.25x (
3.75x)  
$0.09 - $0.95 ($0.52)
$921.5
40% - 100%
$28
 
 
 
 
 
Senior Secured Loans
    4,565,602     Discounted Cash Flow   Discount Rate    
10.25% - 13.06% (11.40%)
 
Asset-Backed Securities
    7,280     NAV Approach   Discount Rate     70.00%  
   
 
 
                 
Total
 
$
       34,445,226
 
               
   
 
 
                 
 
Investment
 
Fair value at

December 31, 2022
   
Valuation
technique
 
Unobservable
inputs
 
Range of input value(s)

(weighted average)
LLC Interest
  $ 4,689,242    
Discounted Cash Flow
Multiples Analysis
 
Discount Rate
Multiple of EBITDA
 
4.73% - 8.93% (6.83%)

5.55x - 9.85x (7.70x)
Preferred Stock
    10,527,285    
Option Pricing Model
Transaction Indication of Value
 
Volatility
Recap Price
 
40% - 60% (50%)

$11.10
Common Stock
    9,207,983    
Discounted Cash Flow
Multiples Analysis
 
Transaction Indication of Value
Liquidation Analysis
Net Asset Value
 
Discount Rate
Multiple of EBITDA
Unadjusted Price/MHz-PoP
Enterprise Value ($mm)
Recovery Rate
N/A
 
13.50% - 15.50% (14.50%)

3.25x - 4.25x (3.75x)
$0.09 - $0.95 ($0.52)  
$872 - $969 ($920.5)  
40% - 100% (70%)
$28
Senior Secured Loans
    4,069,243     Discounted Cash Flow   Discount Rate  
   10.25% - 13.08% (11.67%)   
Asset-Backed Securities
    7,036     NAV Approach   Discount Rate   70.00%
   
 
 
             
Total
 
$
28,500,789
             
   
 
 
             
Summary of Computation of Basic and Diluted Net
The following table sets forth the computation of the weighted average basic and diluted net increase in net assets per share from operations:
 
    
For the three months ended
March 31,
 
    
2023
    
2022
 
Net increase (decrease) in net assets resulting from operations
   $ (977,817    $ 1,145,017  
Weighted average common shares outstanding
     9,699,655        9,990,797  
Earnings (loss) per common share-basic and diluted
   $ (0.10    $ 0.11  
XML 33 R24.htm IDEA: XBRL DOCUMENT v3.23.1
Investment Portfolio (Tables)
3 Months Ended
Mar. 31, 2023
Investments By Industry [Member]  
Schedule of Investments [Line Items]  
Investment Holdings, Schedule of Investments
The following table shows the composition of the Company’s invested assets by industry classification at fair value at March 31, 2023:
 
    
Fair value
    
Percentage
 
Assets
                 
Healthcare
   $ 21,288,682        43.7
Real Estate
     12,208,413        25.0
Telecommunication Services
     6,134,537        12.6
Financials
     3,139,780        6.4
Consumer Products
     2,841,603        5.8
Energy
     1,781,926        3.7
Real Estate Investment Trusts (REITs)
     1,022,291        2.1
Media/Telecommunications
     269,529        0.6
Chemicals
     42,500        0.1
Service
     2,268        0.0
    
 
 
    
 
 
 
Total Assets
  
$
48,731,529
 
  
 
100.0
    
 
 
    
 
 
 
The following table shows the composition of the Company’s invested assets by industry classification at fair value at December 31, 2022:
 
    
Fair value
    
Percentage
 
Assets
                 
Healthcare
   $ 26,101,074        49.0
Real Estate
     11,613,222        21.7
Telecommunication Services
     6,183,457        11.6
Consumer Products
     3,088,750        5.8
Financials
     3,180,161        6.0
Energy
     1,752,941        3.3
Real Estate Investment Trusts (REITs)
     1,018,779        1.9
Media/Telecommunications
     310,562        0.6
Chemicals
     42,500        0.1
Service
     2,269        0.0
    
 
 
    
 
 
 
Total Assets
  
$
53,293,715
 
  
 
100.0
    
 
 
    
 
 
 
Type of Investment Debt or Equity [Member]  
Schedule of Investments [Line Items]  
Investment Holdings, Schedule of Investments
The following table summarizes the amortized cost and the fair value of the Company’s invested assets by class of financial asset as of March 31, 2023:
 
    
Amortized Cost
    
Fair value
    
Percentage of
Portfolio
(at Fair Value)
 
Assets
 
        
Senior Secured Loans - First Lien
   $ 13,218,569      $ 8,961,395        18.4
Senior Secured Loans - Second Lien
     1,485,503        1,070,222        2.2
Asset-Backed Securities
     388,541        7,280        0.0
Corporate Bonds
     3,375,246        2,500,245        5.1
Common Stocks
     9,705,017        13,883,249        28.5
LLC Interests
     10,734,196        10,164,439        20.9
Preferred Stocks
     11,829,987        11,981,888        24.6
Warrants
     74,284        162,811        0.3
    
 
 
    
 
 
    
 
 
 
Total Assets
  
$
50,811,343
 
  
$
48,731,529
 
  
 
100.0
    
 
 
    
 
 
    
 
 
 
The following table summarizes the amortized cost and the fair value of the Company’s invested assets by class of financial asset as of December 31, 2022:
 
    
Amortized Cost
    
Fair value
    
Percentage of
Portfolio
(at Fair Value)
 
Assets
 
        
Senior Secured Loans - First Lien
   $ 14,645,106      $ 11,575,821        21.7
Senior Secured Loans - Second Lien
     2,976,056        2,652,372        5.0
Asset-Backed Securities
     388,541        7,036        0.0
Corporate Bonds
     3,358,783        2,704,917        5.1
Common Stocks
     17,073,102        19,514,684        36.6
LLC Interests
     3,666,112        4,689,242        8.8
Preferred Stocks
     11,829,987        11,967,910        22.5
Warrants
     74,284        181,733        0.3
    
 
 
    
 
 
    
 
 
 
Total Assets
  
$
54,011,971
 
  
$
53,293,715
 
  
 
100.0
    
 
 
    
 
 
    
 
 
 
Investments By Geography [Member]  
Schedule of Investments [Line Items]  
Investment Holdings, Schedule of Investments
The following table shows the composition of the Company’s invested assets by geographic classification at March 31, 2023:
 
Geography
  
Fair value
    
Percentage
 
Assets
 
Cayman Islands
(1)
   $ 7,280        0.0
Luxembourg
(1)
     1,331,038        2.7
United States
     47,393,211        97.3
    
 
 
    
 
 
 
Total Assets
  
$
48,731,529
 
  
 
100.0
    
 
 
    
 
 
 
 
(1)
 
Investment denominated in USD
.
 
The following table shows the composition of the Company’s invested assets by geographic classification at December 31, 2022:
 
Geography
  
Fair value
    
Percentage
 
Assets
 
Cayman Islands
(1)
   $ 7,036        0.0
Luxembourg
(1)
     1,318,346        2.5
United States
     51,968,333        97.5
    
 
 
    
 
 
 
Total Assets
  
$
53,293,715
 
  
 
100.0
    
 
 
    
 
 
 
 
(1)
 
Investment denominated in USD.
XML 34 R25.htm IDEA: XBRL DOCUMENT v3.23.1
Related Party Transactions and Arrangements (Tables)
3 Months Ended
Mar. 31, 2023
Related Party Transactions [Abstract]  
Schedule of fee waivers and expense reimbursements due from the adviser which may become subject to recoupment The following table reflects the fee waivers and expense reimbursements due from the Adviser as of March 31, 2023, which may become subject to recoupment by the Adviser.
 
Period ended
  
 Yearly cumulative 

other expense
 
  
Yearly expense

limitation
 
  
Yearly cumulative
expense
reimbursement
 
  
Quarterly
    recoupable/    
(recouped)
amount
 
  
    Recoupment    

eligibility
expiration
 
March 31, 2023
   $ 208,486      $ 126,628      $ 81,858      $ 81,858               March 31, 2026  
 
Period ended
  
 Yearly cumulative 

other expense
    
Yearly expense
limitation
    
Yearly cumulative
expense
reimbursement
    
Quarterly
    recoupable/    
(recouped)
amount
    
Recoupment
eligibility
expiration
 
December 31, 2022
   $ 913,273      $ 535,679      $ 377,594      $ 92,216        December 31, 2025  
September 30, 2022
   $ 678,333      $ 392,955      $ 285,378      $ 124,667        September 30, 2025  
June 30, 2022
   $ 434,019      $ 273,308      $ 160,711      $ 98,950        June 30, 2025  
March 31, 2022
   $ 211,896      $ 150,135      $ 61,761      $ 61,761        March 31, 2025  
The following table reflects the fee waivers and expense reimbursements due from the Adviser as of December 31, 2021, September 30, 2021, June 30, 2021 and March 31, 2021, which may become subject to recoupment by the Adviser.
 
Period ended
  
 Yearly cumulative 

other expense
    
Yearly expense
limitation
    
Yearly cumulative
expense
reimbursement
    
Quarterly
    recoupable/    
(recouped)
amount
    
Recoupment
eligibility
expiration
 
December 31, 2021
   $ 892,640      $ 597,379      $ 295,261      $ 94,762        December 31, 2024  
September 30, 2021
   $ 664,052      $ 463,553      $ 200,499      $ 68,134        September 30, 2024  
June 30, 2021
   $ 436,866      $ 304,501      $ 132,365      $ 68,919        June 30, 2024  
March 31, 2021
   $ 220,126      $ 156,680      $ 63,446      $ 63,446        March 31, 2024  
 
The following table reflects the fee waivers and expense reimbursements due from the Adviser as of December 31, 2020, September 30, 2020, June 30, 2020 and March 31, 2020, which may become subject to recoupment by the Adviser.
 
Period ended
  
Yearly cumulative
other expense
    
Yearly expense
limitation
    
Yearly cumulative
expense
reimbursement
    
Quarterly
recoupable/
(recouped)
amount
   
Recoupment
eligibility
expiration
 
December 31, 2020
   $ 989,447      $ 639,959      $ 349,488      $ 101,541       December 31, 2023  
September 30, 2020
     687,228        439,281        247,947        94,039       September 30, 2023  
June 30, 2020
     445,585        291,677        153,908        (30,539     June 30, 2023  
March 31, 2020
     257,226        72,779        184,447        —         Expired  
XML 35 R26.htm IDEA: XBRL DOCUMENT v3.23.1
Affiliated Investments (Tables)
3 Months Ended
Mar. 31, 2023
Investments in and Advances to Affiliates, Schedule of Investments [Abstract]  
Summary of affiliated issuers of the company The table below shows affiliated issuers of the Company as of March 31, 2023:
 
Affiliated investments
  
Shares

at

December 31,

2022
 
  
Fair value

as of

December 31,

2022
 
  
Transfers
in (out)
(at cost)
 
 
Purchases
 
  
Sales
 
  
Realized
gains
(losses)
 
  
Change in
unrealized
appreciation
(depreciation)
 
 
Fair value

as of

March 31,

2023
 
  
Shares

at

March 31,

2023
 
  
Affiliated
Dividend
income
 
NexPoint Residential Trust, Inc.
     23,409      $ 1,018,779      $ —        $ —       $ —       $ —        $ 3,512     $ 1,022,291        23,409      $ 9,832  
    
 
 
    
 
 
    
 
 
    
 
 
   
 
 
   
 
 
    
 
 
   
 
 
    
 
 
    
 
 
 
NexPoint Capital
REIT, LLC
 (Senior
Loans & Common
Stocks)
     100        1,176,024        7,368,085        463,314       —         —          (1,639,454     7,367,969        464,041         
    
 
 
    
 
 
    
 
 
    
 
 
   
 
 
   
 
 
    
 
 
   
 
 
    
 
 
    
 
 
 
NexPoint Real Estate Finance, Inc.
     481,670        7,653,730        (7,368,085 )      —               —          1,777,618       2,063,263        131,670        90,194  
    
 
 
    
 
 
    
 
 
    
 
 
   
 
 
   
 
 
    
 
 
   
 
 
    
 
 
    
 
 
 
SFR WLIF III, LLC
     451,112        424,468        —                —         —          (6,287     418,181        451,112        11,430  
    
 
 
    
 
 
    
 
 
    
 
 
   
 
 
   
 
 
    
 
 
   
 
 
    
 
 
    
 
 
 
Total affiliated investments
     956,291      $ 10,273,001      $ —        $ 463,314     $     $ —        $ 135,389     $ 10,871,704        1,070,232      $ 111,456  
    
 
 
    
 
 
    
 
 
    
 
 
   
 
 
   
 
 
    
 
 
   
 
 
    
 
 
    
 
 
 
XML 36 R27.htm IDEA: XBRL DOCUMENT v3.23.1
Financial Highlights (Tables)
3 Months Ended
Mar. 31, 2023
Investment Company, Financial Highlights [Abstract]  
Summary of share outstanding
Selected data for a share outstanding throughout the three months ended March 31, 2023 and March 31, 2022 is as follows:
 
    
For the Three Months
Ended
   
For the Three Months
Ended
 
    
March 31, 2023
(Unaudited)
   
March 31, 2022
(Unaudited)
 
Common shares per share operating performance:
 
Net asset value, beginning of period
   $ 5.55     $ 6.32  
Income from investment operations:
 
Net investment income
(1)
     0.04       0.05  
Net realized and unrealized gain (loss)
     (0.14     0.07  
    
 
 
   
 
 
 
Total from investment operations
     (0.10     0.12  
    
 
 
   
 
 
 
Less distribution declared to common shareholders:
 
From net investment income
     (0.09     (0.09
    
 
 
   
 
 
 
Total distributions declared to common shareholders
     (0.09     (0.09
    
 
 
   
 
 
 
Capital share transaction
 
Issuance of common stock
(2)
     —         —    
Shares tendered
(1)
     —         —    
Net asset value, end of period
   $ 5.36     $ 6.35  
Net asset value total return
(3)(4)
     (1.80 )%     1.83
Ratio and supplemental data:
 
Net assets, end of period (in 000’s)
   $ 51,159     $ 62,947  
Shares outstanding, end of period
     9,548,899       9,918,671  
Common share information at end of period:
 
Ratios based on weighted average net assets of common shares:
 
Gross operating expenses
(5)
     4.05     3.72
Fees and expenses waived or reimbursed
(5)
     (0.62 )%      (0.39 )% 
Net operating expenses
(5)
     3.43     3.33
Net investment income (loss) before fees
waived or reimbursed
(5)
     2.14     2.73
Net investment income (loss) after fees
waived or reimbursed
(5)
     2.76     3.12
Portfolio turnover rate
(4)
     1     26
Asset coverage ratio
     —       —  
Weighted average commission rate paid
(6)
   $ —       $ —    
 
(1)
Per share data was calculated using weighted average shares outstanding during the period.
(2)
The continuous issuance of common stock may cause an incremental increase in net asset value per share due to the sale of shares at the then prevailing public offering price and the receipt of net proceeds per share by the Company in excess of net asset value per share on each subscription closing date. The per share data was derived by computing (i) the sum of (A) the number of shares issued in connection with subscriptions and/or distribution reinvestment on each share transaction date times (B) the differences between the net proceeds per share and the net asset value per share on each share transaction date, divided by (ii) the total shares outstanding at the end of the period. The Company’s continuous public offering ended on February 14, 2018.
(3)
Total returns are historical and assume changes in share price and reinvestment of dividends and capital gains distributions, and assume no sales charge. Distributions, if any, are assumed for purposes of this calculation to be reinvested at prices obtained under the Company’s Dividend Reinvestment Plan. Had the Adviser not absorbed a portion of expenses, total returns would have been lower.
(4)
Not annualized.
(5)
Annualized.
(6)
Represents the total dollar amount of commissions paid on portfolio transactions divided by total number of portfolio shares purchased and sold for which commissions were charged.
XML 37 R28.htm IDEA: XBRL DOCUMENT v3.23.1
Organization - Additional Information (Detail) - USD ($)
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Organization [Line Items]    
Proceeds from private placement issue $ 10,000,000  
Stock issued during period new shares issued in private placement 2,549,002  
Stock issued during period value, reinvestment of dividends $ 294,055 $ 306,152
Next Point Advisors L.P [Member]    
Organization [Line Items]    
Equity method investments ownership percentage 26.70%  
Stock issued during period value, reinvestment of dividends $ 13,700,000  
XML 38 R29.htm IDEA: XBRL DOCUMENT v3.23.1
Summary of Significant Accounting Policies - Additional Information (Detail) - USD ($)
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Dec. 31, 2022
Cash and cash equivalents $ 1,131,784   $ 1,629,846
Restricted cash and cash equivalents 357,958   209,418
Securities sold short value $ 0   $ 0
Investments sold not yet purchased percentage of net assets 25.00%   25.00%
Fee Income $ 0 $ 0  
Fair value of options held $ 0 $ 0  
Offering costs as a percentage of total proceeds raised 1.00% 1.00%  
Stock issuance costs $ 0 $ 0  
Dividend per share declared $ 0.09   $ 0.09
Money Market Funds [Member]      
Cash and cash equivalents $ 773,826   $ 1,420,428
XML 39 R30.htm IDEA: XBRL DOCUMENT v3.23.1
Summary of Significant Accounting Policies - Summary of Investments Using Significant Unobservable Input (Detail) - USD ($)
3 Months Ended 12 Months Ended
Mar. 31, 2023
Dec. 31, 2022
Disclosure In Tabular Form Of Investments Using Significant Unobservable Input [Line Items]    
Fair value $ 48,731,529 $ 53,293,715
Fair Value, Inputs, Level 3 [Member]    
Disclosure In Tabular Form Of Investments Using Significant Unobservable Input [Line Items]    
Fair value $ 34,445,226 $ 28,500,789
Asset-Backed Securities [Member] | Asset Backed Securities One [Member] | Grayson Investor Corp [Member] | Fair Value, Inputs, Level 3 [Member]    
Disclosure In Tabular Form Of Investments Using Significant Unobservable Input [Line Items]    
Description of type of investment Asset-Backed Securities Asset-Backed Securities
Fair value $ 7,267 $ 7,023
Asset-Backed Securities [Member] | Asset Backed Securities One [Member] | PAMCO CLO 1997-1A B [Member] | Fair Value, Inputs, Level 3 [Member]    
Disclosure In Tabular Form Of Investments Using Significant Unobservable Input [Line Items]    
Description of type of investment Asset-Backed Securities Asset-Backed Securities
Fair value $ 13 $ 13
Common Stock [Member] | Common Stock One [Member] | American Banknote Corp [Member] | Fair Value, Inputs, Level 3 [Member]    
Disclosure In Tabular Form Of Investments Using Significant Unobservable Input [Line Items]    
Description of type of investment Common Stocks Common Stocks
Fair value $ 1,732,500 $ 1,732,500
Common Stock [Member] | Common Stock One [Member] | IQHQ, Inc [Member] | Fair Value, Inputs, Level 3 [Member]    
Disclosure In Tabular Form Of Investments Using Significant Unobservable Input [Line Items]    
Description of type of investment Common Stocks Common Stocks
Fair value $ 2,359,000 $ 2,359,000
Common Stock [Member] | Common Stock One [Member] | TerreStar Corp [Member] | Fair Value, Inputs, Level 3 [Member]    
Disclosure In Tabular Form Of Investments Using Significant Unobservable Input [Line Items]    
Description of type of investment Common Stocks Common Stocks
Fair value $ 5,032,249 $ 5,114,214
Common Stock [Member] | Common Stock One [Member] | Wayne Services Legacy, Inc [Member] | Fair Value, Inputs, Level 3 [Member]    
Disclosure In Tabular Form Of Investments Using Significant Unobservable Input [Line Items]    
Description of type of investment Common Stocks Common Stocks
Fair value $ 2,268 $ 2,269
LLC Interests [Member] | LLC Interests One [Member] | NexPoint Capital REIT, LLC [Member] | Fair Value, Inputs, Level 3 [Member]    
Disclosure In Tabular Form Of Investments Using Significant Unobservable Input [Line Items]    
Description of type of investment LLC Interests LLC Interests
Fair value $ 6,904,655 $ 1,176,024
LLC Interests [Member] | LLC Interests One [Member] | SFR WLIF III, LLC [Member] | Fair Value, Inputs, Level 3 [Member]    
Disclosure In Tabular Form Of Investments Using Significant Unobservable Input [Line Items]    
Description of type of investment LLC Interests LLC Interests
Fair value $ 418,181 $ 424,468
LLC Interests [Member] | LLC Interests One [Member] | US Gaming, LLC [Member] | Fair Value, Inputs, Level 3 [Member]    
Disclosure In Tabular Form Of Investments Using Significant Unobservable Input [Line Items]    
Description of type of investment LLC Interests LLC Interests
Fair value $ 2,841,603 $ 3,088,750
Preferred Stock [Member] | Preferred Stock One [Member] | Apnimed, Inc [Member] | Fair Value, Inputs, Level 3 [Member]    
Disclosure In Tabular Form Of Investments Using Significant Unobservable Input [Line Items]    
Description of type of investment Preferred Stocks Preferred Stocks
Fair value $ 1,499,989 $ 1,499,989
Preferred Stock [Member] | Series B Preferred Stock [Member] | Sapience Therapeutics, Inc [Member] | Fair Value, Inputs, Level 3 [Member]    
Disclosure In Tabular Form Of Investments Using Significant Unobservable Input [Line Items]    
Description of type of investment Preferred Stocks Preferred Stocks
Fair value $ 4,581,906 $ 4,549,525
Preferred Stock [Member] | Series B One Preferred Stock [Member] | Sapience Therapeutics, Inc [Member] | Fair Value, Inputs, Level 3 [Member]    
Disclosure In Tabular Form Of Investments Using Significant Unobservable Input [Line Items]    
Description of type of investment Preferred Stocks Preferred Stocks
Fair value $ 3,700,000 $ 3,677,777
Preferred Stock [Member] | Series C-2 preferred stock [Member] | Apnimed, Inc [Member] | Fair Value, Inputs, Level 3 [Member]    
Disclosure In Tabular Form Of Investments Using Significant Unobservable Input [Line Items]    
Description of type of investment Preferred Stocks Preferred Stocks
Fair value $ 799,993 $ 799,994
Senior Secured Loans [Member] | Senior Secured Loans One [Member] | CCS Medical, Inc [Member] | Fair Value, Inputs, Level 3 [Member]    
Disclosure In Tabular Form Of Investments Using Significant Unobservable Input [Line Items]    
Description of type of investment Senior Secured Loans Senior Secured Loans
Fair value $ 3,000,000 $ 3,000,000
Senior Secured Loans [Member] | Senior Secured Loans One [Member] | NexPoint Capital REIT, LLC. [Member] | Fair Value, Inputs, Level 3 [Member]    
Disclosure In Tabular Form Of Investments Using Significant Unobservable Input [Line Items]    
Description of type of investment Senior Secured Loans  
Fair value $ 463,314  
Senior Secured Loans [Member] | Senior Secured Loans One [Member] | TerreStar Corp [Member] | Fair Value, Inputs, Level 3 [Member]    
Disclosure In Tabular Form Of Investments Using Significant Unobservable Input [Line Items]    
Description of type of investment Senior Secured Loans Senior Secured Loans
Fair value $ 836,016 $ 810,953
Senior Secured Loans [Member] | Senior Secured Loans Two [Member] | TerreStar Corp [Member] | Fair Value, Inputs, Level 3 [Member]    
Disclosure In Tabular Form Of Investments Using Significant Unobservable Input [Line Items]    
Description of type of investment Senior Secured Loans Senior Secured Loans
Fair value $ 197,921 $ 191,988
Senior Secured Loans [Member] | Senior Secured Loans Three [Member] | TerreStar Corp [Member] | Fair Value, Inputs, Level 3 [Member]    
Disclosure In Tabular Form Of Investments Using Significant Unobservable Input [Line Items]    
Description of type of investment Senior Secured Loans Senior Secured Loans
Fair value $ 35,360 $ 34,300
Senior Secured Loans [Member] | Senior Secured Loans Four [Member] | TerreStar Corp [Member] | Fair Value, Inputs, Level 3 [Member]    
Disclosure In Tabular Form Of Investments Using Significant Unobservable Input [Line Items]    
Description of type of investment Senior Secured Loans Senior Secured Loans
Fair value $ 32,991 $ 32,002
XML 40 R31.htm IDEA: XBRL DOCUMENT v3.23.1
Summary of Significant Accounting Policies - Summary of Investments Categorize into Fair Value Hierarchy (Detail) - USD ($)
Mar. 31, 2023
Dec. 31, 2022
Disclosure In Tabular Form Of Investments Cateogrized Into Fair Value Hierarchy [Line Items]    
Total asset investment $ 48,731,529 $ 53,293,715
Senior Secured Loans [Member] | Health Care [Member]    
Disclosure In Tabular Form Of Investments Cateogrized Into Fair Value Hierarchy [Line Items]    
Total asset investment 8,466,015 13,158,950
Senior Secured Loans [Member] | Telcommunication Services [Member]    
Disclosure In Tabular Form Of Investments Cateogrized Into Fair Value Hierarchy [Line Items]    
Total asset investment 1,102,288 1,069,243
Senior Secured Loans [Member] | Real Estate [Member]    
Disclosure In Tabular Form Of Investments Cateogrized Into Fair Value Hierarchy [Line Items]    
Total asset investment 463,314  
Asset Backed Securities One [Member] | Financials [Member]    
Disclosure In Tabular Form Of Investments Cateogrized Into Fair Value Hierarchy [Line Items]    
Total asset investment 7,280 7,036
Corporate Bonds [Member] | Health Care [Member]    
Disclosure In Tabular Form Of Investments Cateogrized Into Fair Value Hierarchy [Line Items]    
Total asset investment 2,240,779 2,414,839
Corporate Bonds [Member] | Media And Telecommunications [Member]    
Disclosure In Tabular Form Of Investments Cateogrized Into Fair Value Hierarchy [Line Items]    
Total asset investment 259,466 290,078
Common Stock [Member] | Financials [Member]    
Disclosure In Tabular Form Of Investments Cateogrized Into Fair Value Hierarchy [Line Items]    
Total asset investment 1,732,500 1,732,500
Common Stock [Member] | Chemicals [Member]    
Disclosure In Tabular Form Of Investments Cateogrized Into Fair Value Hierarchy [Line Items]    
Total asset investment 42,500 42,500
Common Stock [Member] | Energy [Member]    
Disclosure In Tabular Form Of Investments Cateogrized Into Fair Value Hierarchy [Line Items]    
Total asset investment 1,629,178 1,591,692
Common Stock [Member] | Real Estate [Member]    
Disclosure In Tabular Form Of Investments Cateogrized Into Fair Value Hierarchy [Line Items]    
Total asset investment 4,422,263 10,012,730
Common Stock [Member] | Real Estate Investment Trusts [Member]    
Disclosure In Tabular Form Of Investments Cateogrized Into Fair Value Hierarchy [Line Items]    
Total asset investment 1,022,291 1,018,779
Common Stock [Member] | Service [Member]    
Disclosure In Tabular Form Of Investments Cateogrized Into Fair Value Hierarchy [Line Items]    
Total asset investment 2,268 2,269
Common Stock [Member] | TeleCommunication Services [Member]    
Disclosure In Tabular Form Of Investments Cateogrized Into Fair Value Hierarchy [Line Items]    
Total asset investment 5,032,249 5,114,214
LLC Interests [Member] | Real Estate [Member]    
Disclosure In Tabular Form Of Investments Cateogrized Into Fair Value Hierarchy [Line Items]    
Total asset investment 7,322,836 1,600,492
LLC Interests [Member] | Consumer Products [Member]    
Disclosure In Tabular Form Of Investments Cateogrized Into Fair Value Hierarchy [Line Items]    
Total asset investment 2,841,603 3,088,750
Preferred Stock [Member] | Health Care [Member]    
Disclosure In Tabular Form Of Investments Cateogrized Into Fair Value Hierarchy [Line Items]    
Total asset investment 10,581,888 10,527,285
Preferred Stock [Member] | Financials [Member]    
Disclosure In Tabular Form Of Investments Cateogrized Into Fair Value Hierarchy [Line Items]    
Total asset investment 1,400,000 1,440,625
Warrant [Member] | Media And Telecommunications [Member]    
Disclosure In Tabular Form Of Investments Cateogrized Into Fair Value Hierarchy [Line Items]    
Total asset investment 10,063 20,484
Warrant [Member] | Energy [Member]    
Disclosure In Tabular Form Of Investments Cateogrized Into Fair Value Hierarchy [Line Items]    
Total asset investment 152,748 161,249
Fair Value, Inputs, Level 1 [Member]    
Disclosure In Tabular Form Of Investments Cateogrized Into Fair Value Hierarchy [Line Items]    
Total asset investment 3,085,554 8,672,509
Fair Value, Inputs, Level 1 [Member] | Senior Secured Loans [Member] | Health Care [Member]    
Disclosure In Tabular Form Of Investments Cateogrized Into Fair Value Hierarchy [Line Items]    
Total asset investment 0 0
Fair Value, Inputs, Level 1 [Member] | Senior Secured Loans [Member] | Telcommunication Services [Member]    
Disclosure In Tabular Form Of Investments Cateogrized Into Fair Value Hierarchy [Line Items]    
Total asset investment 0 0
Fair Value, Inputs, Level 1 [Member] | Asset Backed Securities One [Member] | Financials [Member]    
Disclosure In Tabular Form Of Investments Cateogrized Into Fair Value Hierarchy [Line Items]    
Total asset investment 0 0
Fair Value, Inputs, Level 1 [Member] | Corporate Bonds [Member] | Health Care [Member]    
Disclosure In Tabular Form Of Investments Cateogrized Into Fair Value Hierarchy [Line Items]    
Total asset investment 0 0
Fair Value, Inputs, Level 1 [Member] | Corporate Bonds [Member] | Media And Telecommunications [Member]    
Disclosure In Tabular Form Of Investments Cateogrized Into Fair Value Hierarchy [Line Items]    
Total asset investment 0 0
Fair Value, Inputs, Level 1 [Member] | Common Stock [Member] | Financials [Member]    
Disclosure In Tabular Form Of Investments Cateogrized Into Fair Value Hierarchy [Line Items]    
Total asset investment 0 0
Fair Value, Inputs, Level 1 [Member] | Common Stock [Member] | Chemicals [Member]    
Disclosure In Tabular Form Of Investments Cateogrized Into Fair Value Hierarchy [Line Items]    
Total asset investment 0 0
Fair Value, Inputs, Level 1 [Member] | Common Stock [Member] | Energy [Member]    
Disclosure In Tabular Form Of Investments Cateogrized Into Fair Value Hierarchy [Line Items]    
Total asset investment 0 0
Fair Value, Inputs, Level 1 [Member] | Common Stock [Member] | Real Estate [Member]    
Disclosure In Tabular Form Of Investments Cateogrized Into Fair Value Hierarchy [Line Items]    
Total asset investment 2,063,263 7,653,730
Fair Value, Inputs, Level 1 [Member] | Common Stock [Member] | Real Estate Investment Trusts [Member]    
Disclosure In Tabular Form Of Investments Cateogrized Into Fair Value Hierarchy [Line Items]    
Total asset investment 1,022,291 1,018,779
Fair Value, Inputs, Level 1 [Member] | Common Stock [Member] | Service [Member]    
Disclosure In Tabular Form Of Investments Cateogrized Into Fair Value Hierarchy [Line Items]    
Total asset investment 0 0
Fair Value, Inputs, Level 1 [Member] | Common Stock [Member] | TeleCommunication Services [Member]    
Disclosure In Tabular Form Of Investments Cateogrized Into Fair Value Hierarchy [Line Items]    
Total asset investment 0 0
Fair Value, Inputs, Level 1 [Member] | LLC Interests [Member] | Real Estate [Member]    
Disclosure In Tabular Form Of Investments Cateogrized Into Fair Value Hierarchy [Line Items]    
Total asset investment 0 0
Fair Value, Inputs, Level 1 [Member] | LLC Interests [Member] | Consumer Products [Member]    
Disclosure In Tabular Form Of Investments Cateogrized Into Fair Value Hierarchy [Line Items]    
Total asset investment 0 0
Fair Value, Inputs, Level 1 [Member] | Preferred Stock [Member] | Health Care [Member]    
Disclosure In Tabular Form Of Investments Cateogrized Into Fair Value Hierarchy [Line Items]    
Total asset investment 0 0
Fair Value, Inputs, Level 1 [Member] | Preferred Stock [Member] | Financials [Member]    
Disclosure In Tabular Form Of Investments Cateogrized Into Fair Value Hierarchy [Line Items]    
Total asset investment 0 0
Fair Value, Inputs, Level 1 [Member] | Warrant [Member] | Media And Telecommunications [Member]    
Disclosure In Tabular Form Of Investments Cateogrized Into Fair Value Hierarchy [Line Items]    
Total asset investment 0 0
Fair Value, Inputs, Level 1 [Member] | Warrant [Member] | Energy [Member]    
Disclosure In Tabular Form Of Investments Cateogrized Into Fair Value Hierarchy [Line Items]    
Total asset investment 0 0
Fair Value, Inputs, Level 2 [Member]    
Disclosure In Tabular Form Of Investments Cateogrized Into Fair Value Hierarchy [Line Items]    
Total asset investment 11,200,749 16,120,417
Fair Value, Inputs, Level 2 [Member] | Senior Secured Loans [Member] | Health Care [Member]    
Disclosure In Tabular Form Of Investments Cateogrized Into Fair Value Hierarchy [Line Items]    
Total asset investment 5,466,015 10,158,950
Fair Value, Inputs, Level 2 [Member] | Senior Secured Loans [Member] | Telcommunication Services [Member]    
Disclosure In Tabular Form Of Investments Cateogrized Into Fair Value Hierarchy [Line Items]    
Total asset investment 0 0
Fair Value, Inputs, Level 2 [Member] | Asset Backed Securities One [Member] | Financials [Member]    
Disclosure In Tabular Form Of Investments Cateogrized Into Fair Value Hierarchy [Line Items]    
Total asset investment 0 0
Fair Value, Inputs, Level 2 [Member] | Corporate Bonds [Member] | Health Care [Member]    
Disclosure In Tabular Form Of Investments Cateogrized Into Fair Value Hierarchy [Line Items]    
Total asset investment 2,240,779 2,414,839
Fair Value, Inputs, Level 2 [Member] | Corporate Bonds [Member] | Media And Telecommunications [Member]    
Disclosure In Tabular Form Of Investments Cateogrized Into Fair Value Hierarchy [Line Items]    
Total asset investment 259,466 290,078
Fair Value, Inputs, Level 2 [Member] | Common Stock [Member] | Financials [Member]    
Disclosure In Tabular Form Of Investments Cateogrized Into Fair Value Hierarchy [Line Items]    
Total asset investment 0 0
Fair Value, Inputs, Level 2 [Member] | Common Stock [Member] | Chemicals [Member]    
Disclosure In Tabular Form Of Investments Cateogrized Into Fair Value Hierarchy [Line Items]    
Total asset investment 42,500 42,500
Fair Value, Inputs, Level 2 [Member] | Common Stock [Member] | Energy [Member]    
Disclosure In Tabular Form Of Investments Cateogrized Into Fair Value Hierarchy [Line Items]    
Total asset investment 1,629,178 1,591,692
Fair Value, Inputs, Level 2 [Member] | Common Stock [Member] | Real Estate [Member]    
Disclosure In Tabular Form Of Investments Cateogrized Into Fair Value Hierarchy [Line Items]    
Total asset investment 0 0
Fair Value, Inputs, Level 2 [Member] | Common Stock [Member] | Real Estate Investment Trusts [Member]    
Disclosure In Tabular Form Of Investments Cateogrized Into Fair Value Hierarchy [Line Items]    
Total asset investment 0 0
Fair Value, Inputs, Level 2 [Member] | Common Stock [Member] | Service [Member]    
Disclosure In Tabular Form Of Investments Cateogrized Into Fair Value Hierarchy [Line Items]    
Total asset investment 0 0
Fair Value, Inputs, Level 2 [Member] | Common Stock [Member] | TeleCommunication Services [Member]    
Disclosure In Tabular Form Of Investments Cateogrized Into Fair Value Hierarchy [Line Items]    
Total asset investment 0 0
Fair Value, Inputs, Level 2 [Member] | LLC Interests [Member] | Real Estate [Member]    
Disclosure In Tabular Form Of Investments Cateogrized Into Fair Value Hierarchy [Line Items]    
Total asset investment 0 0
Fair Value, Inputs, Level 2 [Member] | LLC Interests [Member] | Consumer Products [Member]    
Disclosure In Tabular Form Of Investments Cateogrized Into Fair Value Hierarchy [Line Items]    
Total asset investment 0 0
Fair Value, Inputs, Level 2 [Member] | Preferred Stock [Member] | Health Care [Member]    
Disclosure In Tabular Form Of Investments Cateogrized Into Fair Value Hierarchy [Line Items]    
Total asset investment 0 0
Fair Value, Inputs, Level 2 [Member] | Preferred Stock [Member] | Financials [Member]    
Disclosure In Tabular Form Of Investments Cateogrized Into Fair Value Hierarchy [Line Items]    
Total asset investment 1,400,000 1,440,625
Fair Value, Inputs, Level 2 [Member] | Warrant [Member] | Media And Telecommunications [Member]    
Disclosure In Tabular Form Of Investments Cateogrized Into Fair Value Hierarchy [Line Items]    
Total asset investment 10,063 20,484
Fair Value, Inputs, Level 2 [Member] | Warrant [Member] | Energy [Member]    
Disclosure In Tabular Form Of Investments Cateogrized Into Fair Value Hierarchy [Line Items]    
Total asset investment 152,748 161,249
Fair Value, Inputs, Level 3 [Member]    
Disclosure In Tabular Form Of Investments Cateogrized Into Fair Value Hierarchy [Line Items]    
Total asset investment 34,445,226 28,500,789
Fair Value, Inputs, Level 3 [Member] | Senior Secured Loans [Member] | Health Care [Member]    
Disclosure In Tabular Form Of Investments Cateogrized Into Fair Value Hierarchy [Line Items]    
Total asset investment 3,000,000 3,000,000
Fair Value, Inputs, Level 3 [Member] | Senior Secured Loans [Member] | Telcommunication Services [Member]    
Disclosure In Tabular Form Of Investments Cateogrized Into Fair Value Hierarchy [Line Items]    
Total asset investment 1,102,288 1,069,243
Fair Value, Inputs, Level 3 [Member] | Senior Secured Loans [Member] | Real Estate [Member]    
Disclosure In Tabular Form Of Investments Cateogrized Into Fair Value Hierarchy [Line Items]    
Total asset investment 463,314  
Fair Value, Inputs, Level 3 [Member] | Asset Backed Securities One [Member] | Financials [Member]    
Disclosure In Tabular Form Of Investments Cateogrized Into Fair Value Hierarchy [Line Items]    
Total asset investment 7,280 7,036
Fair Value, Inputs, Level 3 [Member] | Corporate Bonds [Member] | Health Care [Member]    
Disclosure In Tabular Form Of Investments Cateogrized Into Fair Value Hierarchy [Line Items]    
Total asset investment 0 0
Fair Value, Inputs, Level 3 [Member] | Corporate Bonds [Member] | Media And Telecommunications [Member]    
Disclosure In Tabular Form Of Investments Cateogrized Into Fair Value Hierarchy [Line Items]    
Total asset investment 0 0
Fair Value, Inputs, Level 3 [Member] | Common Stock [Member] | Financials [Member]    
Disclosure In Tabular Form Of Investments Cateogrized Into Fair Value Hierarchy [Line Items]    
Total asset investment 1,732,500 1,732,500
Fair Value, Inputs, Level 3 [Member] | Common Stock [Member] | Chemicals [Member]    
Disclosure In Tabular Form Of Investments Cateogrized Into Fair Value Hierarchy [Line Items]    
Total asset investment 0 0
Fair Value, Inputs, Level 3 [Member] | Common Stock [Member] | Energy [Member]    
Disclosure In Tabular Form Of Investments Cateogrized Into Fair Value Hierarchy [Line Items]    
Total asset investment 0 0
Fair Value, Inputs, Level 3 [Member] | Common Stock [Member] | Real Estate [Member]    
Disclosure In Tabular Form Of Investments Cateogrized Into Fair Value Hierarchy [Line Items]    
Total asset investment 2,359,000 2,359,000
Fair Value, Inputs, Level 3 [Member] | Common Stock [Member] | Real Estate Investment Trusts [Member]    
Disclosure In Tabular Form Of Investments Cateogrized Into Fair Value Hierarchy [Line Items]    
Total asset investment 0 0
Fair Value, Inputs, Level 3 [Member] | Common Stock [Member] | Service [Member]    
Disclosure In Tabular Form Of Investments Cateogrized Into Fair Value Hierarchy [Line Items]    
Total asset investment 2,268 2,269
Fair Value, Inputs, Level 3 [Member] | Common Stock [Member] | TeleCommunication Services [Member]    
Disclosure In Tabular Form Of Investments Cateogrized Into Fair Value Hierarchy [Line Items]    
Total asset investment 5,032,249 5,114,214
Fair Value, Inputs, Level 3 [Member] | LLC Interests [Member] | Real Estate [Member]    
Disclosure In Tabular Form Of Investments Cateogrized Into Fair Value Hierarchy [Line Items]    
Total asset investment 7,322,836 1,600,492
Fair Value, Inputs, Level 3 [Member] | LLC Interests [Member] | Consumer Products [Member]    
Disclosure In Tabular Form Of Investments Cateogrized Into Fair Value Hierarchy [Line Items]    
Total asset investment 2,841,603 3,088,750
Fair Value, Inputs, Level 3 [Member] | Preferred Stock [Member] | Health Care [Member]    
Disclosure In Tabular Form Of Investments Cateogrized Into Fair Value Hierarchy [Line Items]    
Total asset investment 10,581,888 10,527,285
Fair Value, Inputs, Level 3 [Member] | Preferred Stock [Member] | Financials [Member]    
Disclosure In Tabular Form Of Investments Cateogrized Into Fair Value Hierarchy [Line Items]    
Total asset investment 0 0
Fair Value, Inputs, Level 3 [Member] | Warrant [Member] | Media And Telecommunications [Member]    
Disclosure In Tabular Form Of Investments Cateogrized Into Fair Value Hierarchy [Line Items]    
Total asset investment 0 0
Fair Value, Inputs, Level 3 [Member] | Warrant [Member] | Energy [Member]    
Disclosure In Tabular Form Of Investments Cateogrized Into Fair Value Hierarchy [Line Items]    
Total asset investment $ 0 $ 0
XML 41 R32.htm IDEA: XBRL DOCUMENT v3.23.1
Summary of Significant Accounting Policies - Summary of Changes in the Company's Level 3 investments (Detail) - Investments [Member] - USD ($)
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]    
Balance as of beginning $ 28,500,789 $ 21,683,171
Transfers into Level 3 0 0
Transfers out of Level 3 0 0
Net amortization (accretion) of premium/ (discount) 4,465 3,809
Distribution to Return Capital 0 0
Net realized gains/ (losses) 163,314 (74,603)
Net change in unrealized gains/ (losses) (1,621,273) (150,135)
Purchases/ PIK 7,861,246 11,096,711
Sales and redemptions (463,314) (7,371,264)
Balance as of Ending 34,445,226 25,187,689
Change in unrealized gain/(loss) on Level 3 securities still held at period end (1,621,273) (302,777)
Senior Secured Loans [Member] | Telcommunication Services [Member]    
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]    
Balance as of beginning 1,069,243 962,478
Transfers into Level 3 0 0
Transfers out of Level 3 0 0
Net amortization (accretion) of premium/ (discount) 0 0
Distribution to Return Capital 0 0
Net realized gains/ (losses) 0 0
Net change in unrealized gains/ (losses) 3,198 0
Purchases/ PIK 29,847 26,711
Sales and redemptions 0 0
Balance as of Ending 1,102,288 989,189
Change in unrealized gain/(loss) on Level 3 securities still held at period end 3,198 0
Senior Secured Loans [Member] | Health Care [Member]    
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]    
Balance as of beginning 3,000,000 4,000,000
Transfers into Level 3 0 0
Transfers out of Level 3 0 0
Net amortization (accretion) of premium/ (discount) 4,465 3,809
Distribution to Return Capital 0 0
Net realized gains/ (losses) 0 0
Net change in unrealized gains/ (losses) (4,465) 86,191
Purchases/ PIK 0 2,990,000
Sales and redemptions 0 (4,080,000) [1]
Balance as of Ending 3,000,000 3,000,000
Change in unrealized gain/(loss) on Level 3 securities still held at period end (4,465) 86,191
Senior Secured Loans [Member] | Real Estate [Member]    
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]    
Balance as of beginning 0  
Transfers into Level 3 0  
Transfers out of Level 3 0  
Net amortization (accretion) of premium/ (discount) 0  
Distribution to Return Capital 0  
Net realized gains/ (losses) 0  
Net change in unrealized gains/ (losses) 0  
Purchases/ PIK 463,314  
Sales and redemptions 0  
Balance as of Ending 463,314  
Change in unrealized gain/(loss) on Level 3 securities still held at period end 0  
Asset Backed Securities One [Member] | Financials [Member]    
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]    
Balance as of beginning 7,036 405,040
Transfers into Level 3 0 0
Transfers out of Level 3 0 0
Net amortization (accretion) of premium/ (discount) 0 0
Distribution to Return Capital 0 0
Net realized gains/ (losses) 0 0
Net change in unrealized gains/ (losses) 244 11,787
Purchases/ PIK 0 0
Sales and redemptions 0 (16,979)
Balance as of Ending 7,280 399,848
Change in unrealized gain/(loss) on Level 3 securities still held at period end 244 11,787
Common Stock [Member] | Financials [Member]    
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]    
Balance as of beginning 1,732,500 2,208,750
Transfers into Level 3 0 0
Transfers out of Level 3 0 0
Net amortization (accretion) of premium/ (discount) 0 0
Distribution to Return Capital 0 0
Net realized gains/ (losses) 0 0
Net change in unrealized gains/ (losses) 0 (603,450)
Purchases/ PIK 0 0
Sales and redemptions 0 0
Balance as of Ending 1,732,500 1,605,300
Change in unrealized gain/(loss) on Level 3 securities still held at period end 0 (603,450)
Common Stock [Member] | Real Estate [Member]    
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]    
Balance as of beginning 2,359,000 1,823,000
Transfers into Level 3 0 0
Transfers out of Level 3 0 0
Net amortization (accretion) of premium/ (discount) 0 0
Distribution to Return Capital 0 0
Net realized gains/ (losses) 0 0
Net change in unrealized gains/ (losses) 0 141,000
Purchases/ PIK 0 0
Sales and redemptions 0 0
Balance as of Ending 2,359,000 1,964,000
Change in unrealized gain/(loss) on Level 3 securities still held at period end 0 141,000
Common Stock [Member] | Service [Member]    
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]    
Balance as of beginning 2,269 5,172
Transfers into Level 3 0 0
Transfers out of Level 3 0 0
Net amortization (accretion) of premium/ (discount) 0 0
Distribution to Return Capital 0 0
Net realized gains/ (losses) 0 0
Net change in unrealized gains/ (losses) 0 0
Purchases/ PIK 0 0
Sales and redemptions 0 0
Balance as of Ending 2,268 5,172
Change in unrealized gain/(loss) on Level 3 securities still held at period end 0 0
Common Stock [Member] | TeleCommunication Services [Member]    
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]    
Balance as of beginning 5,114,214 4,706,357
Transfers into Level 3 0 0
Transfers out of Level 3 0 0
Net amortization (accretion) of premium/ (discount) 0 0
Distribution to Return Capital 0 0
Net realized gains/ (losses) 0 0
Net change in unrealized gains/ (losses) (81,965) (94,456)
Purchases/ PIK 0 0
Sales and redemptions 0 0
Balance as of Ending 5,032,249 4,611,901
Change in unrealized gain/(loss) on Level 3 securities still held at period end (81,965) (94,456)
LLC Interests [Member] | Real Estate [Member]    
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]    
Balance as of beginning 1,600,492 4,760,162
Transfers into Level 3 0 0
Transfers out of Level 3 0 0
Net amortization (accretion) of premium/ (discount) 0 0
Distribution to Return Capital 0 0
Net realized gains/ (losses) 0 (74,603)
Net change in unrealized gains/ (losses) (1,645,741) 139,367
Purchases/ PIK 7,368,085 [2] 0
Sales and redemptions 0 (3,274,285) [3]
Balance as of Ending 7,322,836 1,550,641
Change in unrealized gain/(loss) on Level 3 securities still held at period end (1,645,741) (13,275)
LLC Interests [Member] | Consumer Products [Member]    
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]    
Balance as of beginning 3,088,750 2,812,212
Transfers into Level 3 0 0
Transfers out of Level 3 0 0
Net amortization (accretion) of premium/ (discount) 0 0
Distribution to Return Capital 0 0
Net realized gains/ (losses) 163,314 0
Net change in unrealized gains/ (losses) 52,853 169,426
Purchases/ PIK 0 0
Sales and redemptions (463,314) 0
Balance as of Ending 2,841,603 2,981,638
Change in unrealized gain/(loss) on Level 3 securities still held at period end 52,853 169,426
Preferred Stock [Member] | Health Care [Member]    
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]    
Balance as of beginning 10,527,285 0
Transfers into Level 3 0 0
Transfers out of Level 3 0 0
Net amortization (accretion) of premium/ (discount) 0 0
Distribution to Return Capital 0 0
Net realized gains/ (losses) 0 0
Net change in unrealized gains/ (losses) 54,603 0
Purchases/ PIK 0 8,080,000 [1]
Sales and redemptions 0 0
Balance as of Ending 10,581,888 8,080,000
Change in unrealized gain/(loss) on Level 3 securities still held at period end $ 54,603 $ 0
[1] Denotes Sapience’s $4,080,000 promissory notes and paid in kind interest conversion to preferred stock.
[2] Represents an in-kind transfer to the subreit.
[3] Denotes SFR II’s LLC Interests conversion into NREF common shares.
XML 42 R33.htm IDEA: XBRL DOCUMENT v3.23.1
Summary of Significant Accounting Policies - Summary of Changes in the Company's Level 3 investments (Parenthetical) (Detail)
3 Months Ended
Mar. 31, 2023
USD ($)
Preferred Stock [Member] | Promissory Note [Member]  
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]  
Debt Conversion, Converted Instrument, Amount $ 4,080,000
XML 43 R34.htm IDEA: XBRL DOCUMENT v3.23.1
Summary of Significant Accounting Policies - Summary of Quantitative Information about the Company's Level 3 Asset and Liability (Detail)
3 Months Ended 12 Months Ended
Mar. 31, 2023
USD ($)
Dec. 31, 2022
USD ($)
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Fair value $ 48,731,529 $ 53,293,715
Fair Value, Inputs, Level 3 [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Fair value 34,445,226 28,500,789
Measurement Input, Discount Rate [Member] | LLC Interests [Member] | Fair Value, Inputs, Level 3 [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Fair value   $ 4,689,242
Valuation technique   Discounted Cash Flow
Unobservable inputs   Discount Rate
Measurement Input, Discount Rate [Member] | LLC Interests [Member] | Valuation Technique, Discounted Cash Flow [Member] | Fair Value, Inputs, Level 3 [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Fair value $ 10,164,438  
Valuation technique Discounted Cash Flow  
Unobservable inputs Discount Rate  
Measurement Input, Discount Rate [Member] | LLC Interests [Member] | Valuation Technique, Discounted Cash Flow [Member] | Fair Value, Inputs, Level 3 [Member] | Maximum [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Range of input values (weighted average) 9.18 8.93
Measurement Input, Discount Rate [Member] | LLC Interests [Member] | Valuation Technique, Discounted Cash Flow [Member] | Fair Value, Inputs, Level 3 [Member] | Minimum [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Range of input values (weighted average) 4.98 4.73
Measurement Input, Discount Rate [Member] | LLC Interests [Member] | Valuation Technique, Discounted Cash Flow [Member] | Fair Value, Inputs, Level 3 [Member] | Weighted Average [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Range of input values (weighted average) 7.08 6.83
Measurement Input, Discount Rate [Member] | Common Stock [Member] | Fair Value, Inputs, Level 3 [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Fair value   $ 9,207,983
Valuation technique   Discounted Cash Flow
Unobservable inputs   Discount Rate
Measurement Input, Discount Rate [Member] | Common Stock [Member] | Fair Value, Inputs, Level 3 [Member] | Maximum [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Range of input values (weighted average)   15.5
Measurement Input, Discount Rate [Member] | Common Stock [Member] | Fair Value, Inputs, Level 3 [Member] | Minimum [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Range of input values (weighted average)   13.5
Measurement Input, Discount Rate [Member] | Common Stock [Member] | Fair Value, Inputs, Level 3 [Member] | Weighted Average [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Range of input values (weighted average)   14.5
Measurement Input, Discount Rate [Member] | Common Stock [Member] | Valuation Technique, Discounted Cash Flow [Member] | Fair Value, Inputs, Level 3 [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Fair value $ 9,126,018  
Valuation technique Discounted Cash Flow  
Unobservable inputs Discount Rate  
Measurement Input, Discount Rate [Member] | Common Stock [Member] | Valuation Technique, Discounted Cash Flow [Member] | Fair Value, Inputs, Level 3 [Member] | Maximum [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Range of input values (weighted average) 13  
Measurement Input, Discount Rate [Member] | Common Stock [Member] | Valuation Technique, Discounted Cash Flow [Member] | Fair Value, Inputs, Level 3 [Member] | Minimum [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Range of input values (weighted average) 11  
Measurement Input, Discount Rate [Member] | Common Stock [Member] | Valuation Technique, Discounted Cash Flow [Member] | Fair Value, Inputs, Level 3 [Member] | Weighted Average [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Range of input values (weighted average) 12  
Measurement Input, Discount Rate [Member] | Senior Secured Loans [Member] | Valuation Technique, Discounted Cash Flow [Member] | Fair Value, Inputs, Level 3 [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Fair value $ 4,565,602 $ 4,069,243
Valuation technique Discounted Cash Flow Discounted Cash Flow
Unobservable inputs Discount Rate Discount Rate
Measurement Input, Discount Rate [Member] | Senior Secured Loans [Member] | Valuation Technique, Discounted Cash Flow [Member] | Fair Value, Inputs, Level 3 [Member] | Maximum [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Range of input values (weighted average) 13.06 13.08
Measurement Input, Discount Rate [Member] | Senior Secured Loans [Member] | Valuation Technique, Discounted Cash Flow [Member] | Fair Value, Inputs, Level 3 [Member] | Minimum [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Range of input values (weighted average) 10.25 10.25
Measurement Input, Discount Rate [Member] | Senior Secured Loans [Member] | Valuation Technique, Discounted Cash Flow [Member] | Fair Value, Inputs, Level 3 [Member] | Weighted Average [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Range of input values (weighted average) 11.4 11.67
Measurement Input, Discount Rate [Member] | Asset-Backed Securities [Member] | Valuation Technique, Discounted Cash Flow [Member] | Fair Value, Inputs, Level 3 [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Fair value $ 7,280 $ 7,036
Valuation technique NAV Approach NAV Approach
Unobservable inputs Discount Rate Discount Rate
Range of input values (weighted average) 70 70
Measurement Input, EBITDA Multiple [Member] | LLC Interests [Member] | Valuation Technique Multiple Analysis [Member] | Fair Value, Inputs, Level 3 [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Valuation technique Multiples Analysis Multiples Analysis
Unobservable inputs Multiple of EBITDA Multiple of EBITDA
Measurement Input, EBITDA Multiple [Member] | LLC Interests [Member] | Valuation Technique Multiple Analysis [Member] | Fair Value, Inputs, Level 3 [Member] | Maximum [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Range of input values (weighted average) 9.95 9.85
Measurement Input, EBITDA Multiple [Member] | LLC Interests [Member] | Valuation Technique Multiple Analysis [Member] | Fair Value, Inputs, Level 3 [Member] | Minimum [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Range of input values (weighted average) 5.6 5.55
Measurement Input, EBITDA Multiple [Member] | LLC Interests [Member] | Valuation Technique Multiple Analysis [Member] | Fair Value, Inputs, Level 3 [Member] | Weighted Average [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Range of input values (weighted average) 7.7 7.7
Measurement Input, EBITDA Multiple [Member] | Common Stock [Member] | Fair Value, Inputs, Level 3 [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Valuation technique   Multiples Analysis
Unobservable inputs   Multiple of EBITDA
Measurement Input, EBITDA Multiple [Member] | Common Stock [Member] | Fair Value, Inputs, Level 3 [Member] | Maximum [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Range of input values (weighted average)   4.25
Measurement Input, EBITDA Multiple [Member] | Common Stock [Member] | Fair Value, Inputs, Level 3 [Member] | Minimum [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Range of input values (weighted average)   3.25
Measurement Input, EBITDA Multiple [Member] | Common Stock [Member] | Fair Value, Inputs, Level 3 [Member] | Weighted Average [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Range of input values (weighted average)   3.75
Measurement Input, EBITDA Multiple [Member] | Common Stock [Member] | Valuation Technique Multiple Analysis [Member] | Fair Value, Inputs, Level 3 [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Valuation technique Multiples Analysis  
Unobservable inputs Multiple of EBITDA  
Measurement Input, EBITDA Multiple [Member] | Common Stock [Member] | Valuation Technique Multiple Analysis [Member] | Fair Value, Inputs, Level 3 [Member] | Maximum [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Range of input values (weighted average) 4.25  
Measurement Input, EBITDA Multiple [Member] | Common Stock [Member] | Valuation Technique Multiple Analysis [Member] | Fair Value, Inputs, Level 3 [Member] | Minimum [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Range of input values (weighted average) 3.25  
Measurement Input, EBITDA Multiple [Member] | Common Stock [Member] | Valuation Technique Multiple Analysis [Member] | Fair Value, Inputs, Level 3 [Member] | Weighted Average [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Range of input values (weighted average) 3.75  
Measurement Input Unadjusted Price [Member] | Common Stock [Member] | Fair Value, Inputs, Level 3 [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Unobservable inputs Unadjusted Price/MHz-PoP Unadjusted Price/MHz-PoP
Measurement Input Unadjusted Price [Member] | Common Stock [Member] | Fair Value, Inputs, Level 3 [Member] | Maximum [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Range of input values (weighted average) 0.95 0.95
Measurement Input Unadjusted Price [Member] | Common Stock [Member] | Fair Value, Inputs, Level 3 [Member] | Minimum [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Range of input values (weighted average) 0.09 0.09
Measurement Input Unadjusted Price [Member] | Common Stock [Member] | Fair Value, Inputs, Level 3 [Member] | Weighted Average [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Range of input values (weighted average) 0.52 0.52
Measurement Input Enterprise Value [Member] | Common Stock [Member] | Valuation Technique Transaction Indication Of Value [Member] | Fair Value, Inputs, Level 3 [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Valuation technique Transaction Indication of Value  
Unobservable inputs Enterprise Value ($mm)  
Range of input values (weighted average) 921.5  
Measurement Input Enterprise Value [Member] | Common Stock [Member] | Valuation Technique Liquidation Analysis [Member] | Fair Value, Inputs, Level 3 [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Valuation technique   Transaction Indication of Value
Unobservable inputs   Enterprise Value ($mm)
Measurement Input Enterprise Value [Member] | Common Stock [Member] | Valuation Technique Liquidation Analysis [Member] | Fair Value, Inputs, Level 3 [Member] | Maximum [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Range of input values (weighted average)   969
Measurement Input Enterprise Value [Member] | Common Stock [Member] | Valuation Technique Liquidation Analysis [Member] | Fair Value, Inputs, Level 3 [Member] | Minimum [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Range of input values (weighted average)   872
Measurement Input Enterprise Value [Member] | Common Stock [Member] | Valuation Technique Liquidation Analysis [Member] | Fair Value, Inputs, Level 3 [Member] | Weighted Average [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Range of input values (weighted average)   920.5
Measurement Input Recovery Rate [Member] | Common Stock [Member] | Fair Value, Inputs, Level 3 [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Valuation technique   Liquidation Analysis
Unobservable inputs   Recovery Rate
Measurement Input Recovery Rate [Member] | Common Stock [Member] | Fair Value, Inputs, Level 3 [Member] | Maximum [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Range of input values (weighted average)   100
Measurement Input Recovery Rate [Member] | Common Stock [Member] | Fair Value, Inputs, Level 3 [Member] | Minimum [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Range of input values (weighted average)   40
Measurement Input Recovery Rate [Member] | Common Stock [Member] | Fair Value, Inputs, Level 3 [Member] | Weighted Average [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Range of input values (weighted average)   70
Measurement Input Recovery Rate [Member] | Common Stock [Member] | Valuation Technique Liquidation Analysis [Member] | Fair Value, Inputs, Level 3 [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Valuation technique Liquidation Analysis  
Unobservable inputs Recovery Rate  
Measurement Input Recovery Rate [Member] | Common Stock [Member] | Valuation Technique Liquidation Analysis [Member] | Fair Value, Inputs, Level 3 [Member] | Maximum [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Range of input values (weighted average) 100  
Measurement Input Recovery Rate [Member] | Common Stock [Member] | Valuation Technique Liquidation Analysis [Member] | Fair Value, Inputs, Level 3 [Member] | Minimum [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Range of input values (weighted average) 40  
Measurement Input NAV Multiple [Member] | Common Stock [Member] | Valuation Technique Net Asset Value [Member] | Fair Value, Inputs, Level 3 [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Valuation technique Net Asset Value Net Asset Value
Range of input values (weighted average) 28 28
Measurement Input, Option Volatility [Member] | Preferred Stock [Member] | Fair Value, Inputs, Level 3 [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Fair value   $ 10,527,285
Valuation technique   Option Pricing Model
Unobservable inputs   Volatility
Measurement Input, Option Volatility [Member] | Preferred Stock [Member] | Fair Value, Inputs, Level 3 [Member] | Maximum [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Range of input values (weighted average)   60
Measurement Input, Option Volatility [Member] | Preferred Stock [Member] | Fair Value, Inputs, Level 3 [Member] | Minimum [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Range of input values (weighted average)   40
Measurement Input, Option Volatility [Member] | Preferred Stock [Member] | Fair Value, Inputs, Level 3 [Member] | Weighted Average [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Range of input values (weighted average)   50
Measurement Input, Option Volatility [Member] | Preferred Stock [Member] | Valuation Technique, Option Pricing Model [Member] | Fair Value, Inputs, Level 3 [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Fair value $ 10,581,888  
Valuation technique Option Pricing Model  
Unobservable inputs Volatility  
Measurement Input, Option Volatility [Member] | Preferred Stock [Member] | Valuation Technique, Option Pricing Model [Member] | Fair Value, Inputs, Level 3 [Member] | Maximum [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Range of input values (weighted average) 90  
Measurement Input, Option Volatility [Member] | Preferred Stock [Member] | Valuation Technique, Option Pricing Model [Member] | Fair Value, Inputs, Level 3 [Member] | Minimum [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Range of input values (weighted average) 40  
Measurement Input, Option Volatility [Member] | Preferred Stock [Member] | Valuation Technique, Option Pricing Model [Member] | Fair Value, Inputs, Level 3 [Member] | Weighted Average [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Range of input values (weighted average) 65  
Measurement Input, Cap Rate [Member] | Preferred Stock [Member] | Fair Value, Inputs, Level 3 [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Valuation technique   Transaction Indication of Value
Unobservable inputs   Recap Price
Range of input values (weighted average)   11.1
XML 44 R35.htm IDEA: XBRL DOCUMENT v3.23.1
Summary of Significant Accounting Policies - Summary of Computation of Basic and Diluted Net (Detail) - USD ($)
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Schedule Of Earnings Per Share Basic And Diluted [Line Items]    
Net increase (decrease) in net assets resulting from operations $ (977,817) $ 1,145,017
Weighted average shares outstanding: Basic 9,699,655 9,990,797
Weighted average shares outstanding: Diluted 9,699,655 9,990,797
Earnings (loss) per share: Basic $ (0.1) $ 0.11
Earnings (loss) per share: Diluted $ (0.1) $ 0.11
XML 45 R36.htm IDEA: XBRL DOCUMENT v3.23.1
Investment Portfolio - Summary Of Investment Holdings, Schedule of Investments (Detail) - USD ($)
Mar. 31, 2023
Dec. 31, 2022
Fair value $ 48,731,529 $ 53,293,715
Percentage 100.00% 100.00%
Healthcare    
Fair value $ 21,288,682 $ 26,101,074
Percentage 43.70% 49.00%
Real Estate    
Fair value $ 12,208,413 $ 11,613,222
Percentage 25.00% 21.70%
Telecommunication Services    
Fair value $ 6,134,537 $ 6,183,457
Percentage 12.60% 11.60%
Financials    
Fair value $ 3,139,780 $ 3,180,161
Percentage 6.40% 6.00%
Consumer Products    
Fair value $ 2,841,603 $ 3,088,750
Percentage 5.80% 5.80%
Energy    
Fair value $ 1,781,926 $ 1,752,941
Percentage 3.70% 3.30%
Real Estate Investment Trusts (REITs)    
Fair value $ 1,022,291 $ 1,018,779
Percentage 2.10% 1.90%
Media/Telecommunications    
Fair value $ 269,529 $ 310,562
Percentage 0.60% 0.60%
Chemicals    
Fair value $ 42,500 $ 42,500
Percentage 0.10% 0.10%
Service    
Fair value $ 2,268 $ 2,269
Percentage 0.00% 0.00%
XML 46 R37.htm IDEA: XBRL DOCUMENT v3.23.1
Investment Portfolio - Summary Of Investment Company Assets By Industry Classification At Fair Value (Detail) - USD ($)
Mar. 31, 2023
Dec. 31, 2022
Amortized Cost $ 50,811,343 $ 54,011,971
Fair Value $ 48,731,529 $ 53,293,715
Percentage of Portfolio (at Fair Value) 100.00% 100.00%
Senior Secured Loans - First Lien    
Amortized Cost $ 13,218,569 $ 14,645,106
Fair Value $ 8,961,395 $ 11,575,821
Percentage of Portfolio (at Fair Value) 18.40% 21.70%
Senior Secured Loans - Second Lien    
Amortized Cost $ 1,485,503 $ 2,976,056
Fair Value $ 1,070,222 $ 2,652,372
Percentage of Portfolio (at Fair Value) 2.20% 5.00%
Asset-Backed Securities    
Amortized Cost $ 388,541 $ 388,541
Fair Value $ 7,280 $ 7,036
Percentage of Portfolio (at Fair Value) 0.00% 0.00%
Corporate Bonds    
Amortized Cost $ 3,375,246 $ 3,358,783
Fair Value $ 2,500,245 $ 2,704,917
Percentage of Portfolio (at Fair Value) 5.10% 5.10%
Common Stock    
Amortized Cost $ 9,705,017 $ 17,073,102
Fair Value $ 13,883,249 $ 19,514,684
Percentage of Portfolio (at Fair Value) 28.50% 36.60%
LLC Interests    
Amortized Cost $ 10,734,196 $ 3,666,112
Fair Value $ 10,164,439 $ 4,689,242
Percentage of Portfolio (at Fair Value) 20.90% 8.80%
Preferred Stocks    
Amortized Cost $ 11,829,987 $ 11,829,987
Fair Value $ 11,981,888 $ 11,967,910
Percentage of Portfolio (at Fair Value) 24.60% 22.50%
Warrants    
Amortized Cost $ 74,284 $ 74,284
Fair Value $ 162,811 $ 181,733
Percentage of Portfolio (at Fair Value) 0.30% 0.30%
XML 47 R38.htm IDEA: XBRL DOCUMENT v3.23.1
Investment Portfolio - Summary Of the Company's invested assets by geographic classification (Detail) - USD ($)
Mar. 31, 2023
Dec. 31, 2022
Fair Value $ 48,731,529 $ 53,293,715
Percentage 100.00% 100.00%
Cayman Islands    
Fair Value [1] $ 7,280 $ 7,036
Percentage [1] 0.00% 0.00%
Luxembourg    
Fair Value [1] $ 1,331,038 $ 1,318,346
Percentage [1] 2.70% 2.50%
United States    
Fair Value $ 47,393,211 $ 51,968,333
Percentage 97.30% 97.50%
[1] Investment denominated in USD
.
XML 48 R39.htm IDEA: XBRL DOCUMENT v3.23.1
Related Party Transactions and Arrangements - Schedule Of Fee Waivers And Expense Reimbursements Due From The Adviser Which May Become Subject To Recoupment (Detail) - USD ($)
Mar. 31, 2023
Dec. 31, 2022
Sep. 30, 2022
Jun. 30, 2022
Mar. 31, 2022
Dec. 31, 2021
Sep. 30, 2021
Jun. 30, 2021
Mar. 31, 2021
Dec. 31, 2020
Sep. 30, 2020
Jun. 30, 2020
Mar. 31, 2020
March 31, 2026 [Member]                          
Fee Waivers And Expense Reimbursements Due From The Adviser Which May Become Subject To Recoupment [Line Items]                          
Yearly cumulative other expense $ 208,486                        
Yearly expense limitation 126,628                        
Yearly cumulative expense reimbursement 81,858                        
Quarterly recoupable/ (recouped) amount $ 81,858                        
Recoupment eligibility expiration Mar. 31, 2026                        
December 31, 2025 [Member]                          
Fee Waivers And Expense Reimbursements Due From The Adviser Which May Become Subject To Recoupment [Line Items]                          
Yearly cumulative other expense   $ 913,273                      
Yearly expense limitation   535,679                      
Yearly cumulative expense reimbursement   377,594                      
Quarterly recoupable/ (recouped) amount   $ 92,216                      
Recoupment eligibility expiration   Dec. 31, 2025                      
September 30, 2025 [Member]                          
Fee Waivers And Expense Reimbursements Due From The Adviser Which May Become Subject To Recoupment [Line Items]                          
Yearly cumulative other expense     $ 678,333                    
Yearly expense limitation     392,955                    
Yearly cumulative expense reimbursement     285,378                    
Quarterly recoupable/ (recouped) amount     $ 124,667                    
Recoupment eligibility expiration     Sep. 30, 2025                    
June 30, 2025 [Member]                          
Fee Waivers And Expense Reimbursements Due From The Adviser Which May Become Subject To Recoupment [Line Items]                          
Yearly cumulative other expense       $ 434,019                  
Yearly expense limitation       273,308                  
Yearly cumulative expense reimbursement       160,711                  
Quarterly recoupable/ (recouped) amount       $ 98,950                  
Recoupment eligibility expiration       Jun. 30, 2025                  
March 31, 2025 [Member]                          
Fee Waivers And Expense Reimbursements Due From The Adviser Which May Become Subject To Recoupment [Line Items]                          
Yearly cumulative other expense         $ 211,896                
Yearly expense limitation         150,135                
Yearly cumulative expense reimbursement         61,761                
Quarterly recoupable/ (recouped) amount         $ 61,761                
Recoupment eligibility expiration         Mar. 31, 2025                
December 31, 2024 [Member]                          
Fee Waivers And Expense Reimbursements Due From The Adviser Which May Become Subject To Recoupment [Line Items]                          
Yearly cumulative other expense           $ 892,640              
Yearly expense limitation           597,379              
Yearly cumulative expense reimbursement           295,261              
Quarterly recoupable/ (recouped) amount           $ 94,762              
Recoupment eligibility expiration           Dec. 31, 2024              
September 30, 2024 [Member]                          
Fee Waivers And Expense Reimbursements Due From The Adviser Which May Become Subject To Recoupment [Line Items]                          
Yearly cumulative other expense             $ 664,052            
Yearly expense limitation             463,553            
Yearly cumulative expense reimbursement             200,499            
Quarterly recoupable/ (recouped) amount             $ 68,134            
Recoupment eligibility expiration             Sep. 30, 2024            
June 30, 2024 [Member]                          
Fee Waivers And Expense Reimbursements Due From The Adviser Which May Become Subject To Recoupment [Line Items]                          
Yearly cumulative other expense               $ 436,866          
Yearly expense limitation               304,501          
Yearly cumulative expense reimbursement               132,365          
Quarterly recoupable/ (recouped) amount               $ 68,919          
Recoupment eligibility expiration               Jun. 30, 2024          
March 31, 2024 [Member]                          
Fee Waivers And Expense Reimbursements Due From The Adviser Which May Become Subject To Recoupment [Line Items]                          
Yearly cumulative other expense                 $ 220,126        
Yearly expense limitation                 156,680        
Yearly cumulative expense reimbursement                 63,446        
Quarterly recoupable/ (recouped) amount                 $ 63,446        
Recoupment eligibility expiration                 Mar. 31, 2024        
December 31, 2023 [Member]                          
Fee Waivers And Expense Reimbursements Due From The Adviser Which May Become Subject To Recoupment [Line Items]                          
Yearly cumulative other expense                   $ 989,447      
Yearly expense limitation                   639,959      
Yearly cumulative expense reimbursement                   349,488      
Quarterly recoupable/ (recouped) amount                   $ 101,541      
Recoupment eligibility expiration                   Dec. 31, 2023      
September 30, 2023 [Member]                          
Fee Waivers And Expense Reimbursements Due From The Adviser Which May Become Subject To Recoupment [Line Items]                          
Yearly cumulative other expense                     $ 687,228    
Yearly expense limitation                     439,281    
Yearly cumulative expense reimbursement                     247,947    
Quarterly recoupable/ (recouped) amount                     $ 94,039    
Recoupment eligibility expiration                     Sep. 30, 2023    
June 30, 2023 [Member]                          
Fee Waivers And Expense Reimbursements Due From The Adviser Which May Become Subject To Recoupment [Line Items]                          
Yearly cumulative other expense                       $ 445,585  
Yearly expense limitation                       291,677  
Yearly cumulative expense reimbursement                       153,908  
Quarterly recoupable/ (recouped) amount                       $ (30,539)  
Recoupment eligibility expiration                       Jun. 30, 2023  
Expiration [Member]                          
Fee Waivers And Expense Reimbursements Due From The Adviser Which May Become Subject To Recoupment [Line Items]                          
Yearly cumulative other expense                         $ 257,226
Yearly expense limitation                         72,779
Yearly cumulative expense reimbursement                         184,447
Quarterly recoupable/ (recouped) amount                         $ 0
Recoupment eligibility expired                         Expired
XML 49 R40.htm IDEA: XBRL DOCUMENT v3.23.1
Related Party Transactions and Arrangements - Additional Information (Detail) - USD ($)
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Dec. 31, 2022
Related Party Transaction [Line Items]      
Base Management Fee Calculated Annual Rate Of Percentage Of Average Value Of Gross Assets 2.00%    
Investment Advisory Fee payable incurred during period $ 265,381 $ 299,270  
Maximum Recoupment Of Other Expenses Exceeds TheAnnual Rate Percentage Of Average Gross Assets 3.40%    
Expense reimbursements amount that are eligible for recoupment by the adviser expired $ 184,447    
Subordinated Incentive Fee On Income Is Determined And Payable Quarterly In Arrears Equals Percentage Of Pre Incentive Fee Net Investment Income 20.00%    
Hurdle Rate Expressed As Rate of Return ON Net Assets Equal To Percentage Per Quarter 1.875%    
Hurdle Rate 1.875%    
Pre Incentive Fee Net Investment Income For Quarter Equals Percentage Of Net Assets At The End Of Quarter 2.34375%    
Catch UP Fee Receive By The Adviser Percentage Of The Pre Incentive Fee Net Investment Income From The Quarter 20.00%    
Percentage Of Incentive Fee Capital Gains Is Determined And Payable In Arrears As At End Of Each Calender Year 20.00%    
Incentive fee incurred on capital gains $ 0 0  
Aggregate Accrued Incentive Fees On Capital Gains 0    
Payment Of Incentive fees With Respect TO Realized Gains To The Adviser $ 0    
Minimum Reimbursement Amount As A Percentage Of Average Gross Assets 0.40%    
Administration fees payable to related party incurred during period $ 52,321 59,601  
Annual Rate Percentage Of Average Gross Assets 3.40%    
Organization costs and offering costs are limited to percentage of total gross proceeds raised in the offering 1.00%    
Cumulative Aggregate Amount Of Organization And Offering Costs $ 5,327,574    
Adviser Forfeited The Right To Reimbursement of The Remaining Amount Of Costs Subsequent To Termination Of The Offering 4,305,091    
Annual Retainer Amount Payable IN Quarterly Installments To Related Party Oversees All Of The Portfolios In The Fund Complex 150,000    
Annual Retainer Amount Payable In Quarterly Installments To Related Party Who Does Not Oversees All Portfolios On Prorated Basis Of Who Oversees All Portfolios 150,000    
Additional Payment Amount Eligible To Receive By Related Party Payable In Quarterly Installments 10,000    
Directors Fee Expense 4,967 3,731  
Director Fee Expense Payable Amount 0    
Expense Limitation Agreement [Member]      
Related Party Transaction [Line Items]      
Receivable from advisor $ 81,858   $ 92,216
As Per Agreement Contractually Obligated To Waive Fees And If Necessary Pay Or Reimburse Certain Other Expenses To Percentage Of Quarter End Value Of The Gross Assets 1.00%    
As Per Agreement Obligation Renewal period one-year    
As Per Agreement Written Notice Period For Termination 60 days    
Cumulative Total Of Fees Waived By Adviser Under Agreement Which Are Recoupable $ 919,754    
Advisory Fees And Administration Fees [Member]      
Related Party Transaction [Line Items]      
Payable to Adviser 317,702   $ 314,993
Adviser [Member]      
Related Party Transaction [Line Items]      
Administration fees payable to related party incurred during period 52,321 59,601  
Voluntarily reimburse amount for unrealized losses 0 $ 0  
Cumulative committed amount to voluntarily reimburse the unrealized losses $ 2,275,000    
XML 50 R41.htm IDEA: XBRL DOCUMENT v3.23.1
U.S. Federal Income Tax Information - Additional Information (Detail)
3 Months Ended
Mar. 31, 2023
Income Tax Disclosure [Abstract]  
Percentage of Distribution to Shareholders,investment company taxable income 90.00%
Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent 98.00%
Effective Income Tax Rate Reconciliation, Disposition of Asset, Percent 98.20%
XML 51 R42.htm IDEA: XBRL DOCUMENT v3.23.1
Share Repurchase Program - Additional Information (Detail) - shares
3 Months Ended
Mar. 31, 2023
Dec. 31, 2022
Equity, Class of Treasury Stock [Line Items]    
Minimum limit of shares to be repurchased, percent 10.00% 2.50%
Percentage of shares tobe issued under ceiling limit of net asset value per share 2.50%  
Minimum notice period of shares to be suspend or terminate 30.00%  
Stock Repurchased During Period, Shares 0  
First Quarter Tender Offer [Member]    
Equity, Class of Treasury Stock [Line Items]    
Minimum limit of shares to be repurchased, percent 1.86%  
Percentage of share offered to purchase for cash 2.50%  
Stock Repurchase Program Expiration Date Mar. 24, 2023  
Stock Repurchased During Period, Shares 181,298  
XML 52 R43.htm IDEA: XBRL DOCUMENT v3.23.1
Economic Dependency and Commitments and Contingencies - Additional Information (Detail) - USD ($)
Mar. 31, 2023
Dec. 31, 2022
Other Commitments [Line Items]    
Commitments and Contingencies $ 0 $ 0
Unfunded Loan Commitment [Member]    
Other Commitments [Line Items]    
Commitments and Contingencies $ 0  
XML 53 R44.htm IDEA: XBRL DOCUMENT v3.23.1
Market and Other Risk Factors - Additional Information (Detail) - USD ($)
$ in Billions
1 Months Ended 3 Months Ended
Mar. 31, 2021
Mar. 31, 2023
Dec. 31, 2020
Stimulus Relief [Member]      
Unusual Risk or Uncertainty [Line Items]      
Off balance sheet asset face amount     $ 900
Coronavirus Aid, Relief, and Economic Security Act [Member]      
Unusual Risk or Uncertainty [Line Items]      
Funds alloted gto overcome the pandemic and economic distress   $ 2,200  
U.S. Federal Reserve [Member] | Coronavirus Aid, Relief, and Economic Security Act [Member]      
Unusual Risk or Uncertainty [Line Items]      
Funds alloted gto overcome the pandemic and economic distress   $ 1,500  
U.S. Federal Reserve [Member] | Coronavirus Aid, Relief, and Economic Security Act [Member] | American Rescue Plan Act [Member]      
Unusual Risk or Uncertainty [Line Items]      
Funds alloted gto overcome the pandemic and economic distress $ 1,900    
XML 54 R45.htm IDEA: XBRL DOCUMENT v3.23.1
Affiliated Investments - Summary of Affiliated Issuers of the Company (Detail)
3 Months Ended
Mar. 31, 2023
USD ($)
shares
Investments in and Advances to Affiliates [Line Items]  
Shares at the beginning period | shares 956,291
Fair value at the beginning period $ 10,273,001
Transfers in (out) (at cost) 0
Purchases 463,314
Sales 0
Realized gains (losses) 0
Change in unrealized appreciation (depreciation) 135,389
Affiliated Dividend income $ 111,456
Shares at the ending period | shares 1,070,232
Fair value at the ending period $ 10,871,704
NexPoint Residential Trust, Inc. [Member]  
Investments in and Advances to Affiliates [Line Items]  
Shares at the beginning period | shares 23,409
Fair value at the beginning period $ 1,018,779
Transfers in (out) (at cost) 0
Purchases 0
Sales 0
Realized gains (losses) 0
Change in unrealized appreciation (depreciation) 3,512
Affiliated Dividend income $ 9,832
Shares at the ending period | shares 23,409
Fair value at the ending period $ 1,022,291
NexPoint Capital REIT, LLC [Member]  
Investments in and Advances to Affiliates [Line Items]  
Shares at the beginning period | shares 100
Fair value at the beginning period $ 1,176,024
Transfers in (out) (at cost) 7,368,085
Purchases 463,314
Sales 0
Realized gains (losses) 0
Change in unrealized appreciation (depreciation) (1,639,454)
Affiliated Dividend income $ 0
Shares at the ending period | shares 464,041
Fair value at the ending period $ 7,367,969
NexPoint Real Estate Finance, Inc. [Member]  
Investments in and Advances to Affiliates [Line Items]  
Shares at the beginning period | shares 481,670
Fair value at the beginning period $ 7,653,730
Transfers in (out) (at cost) (7,368,085)
Purchases 0
Sales 0
Realized gains (losses) 0
Change in unrealized appreciation (depreciation) 1,777,618
Affiliated Dividend income $ 90,194
Shares at the ending period | shares 131,670
Fair value at the ending period $ 2,063,263
SFR WLIF III, LLC [Member]  
Investments in and Advances to Affiliates [Line Items]  
Shares at the beginning period | shares 451,112
Fair value at the beginning period $ 424,468
Transfers in (out) (at cost) 0
Purchases 0
Sales 0
Realized gains (losses) 0
Change in unrealized appreciation (depreciation) (6,287)
Affiliated Dividend income $ 11,430
Shares at the ending period | shares 451,112
Fair value at the ending period $ 418,181
XML 55 R46.htm IDEA: XBRL DOCUMENT v3.23.1
Financial Highlights - Summary of Share Outstanding (Detail)
3 Months Ended
Mar. 31, 2023
USD ($)
shares
$ / shares
Mar. 31, 2022
USD ($)
shares
$ / shares
Dec. 31, 2022
USD ($)
shares
Dec. 31, 2021
USD ($)
Investment Company, Financial Highlights [Line Items]        
Net asset value, beginning of period $ 5.55 $ 6.32    
Investment Company, Investment Income (Loss) from Operations, Per Share [Abstract]        
Net investment income(1) 0.04 0.05    
Net realized and unrealized gain (loss) (0.14) 0.07    
Total from investment operations $ (0.1) $ 0.12    
Less distribution declared to common shareholders:        
From net investment income (per share) | shares (0.09) (0.09)    
Total distributions declared to common shareholders $ (0.09) $ (0.09)    
Investment Company, Capital Share Transactions [Abstract]        
Issuance of common stock(2) (per share) | shares 0 0    
Shares tendered(1) (per share) | shares 0 0    
Net asset value, end of period $ 5.36 $ 6.35    
Net asset value total return(3)(4) (1.80%) 1.83%    
Investment Company, Financial Ratios [Abstract]        
Net assets, end of period (in 000's) | $ $ 51,159,305 $ 62,947,277 $ 53,694,167 $ 62,938,908
Shares outstanding, end of period | shares 9,548,899 9,918,671 9,677,593  
Ratios based on weighted average net assets of common shares:        
Gross operating expenses(5) 4.05% 3.72%    
Fees and expenses waived or reimbursed(5) (0.62%) (0.39%)    
Net operating expenses(5) 3.43% 3.33%    
Net investment income (loss) before fees waived or reimbursed(5) 2.14% 2.73%    
Net investment income (loss) after fees waived or reimbursed(5) 2.76% 3.12%    
Portfolio turnover rate(4) 1.00% 26.00%    
Asset coverage ratio 0.00% 0.00%    
Weighted average commission rate paid(6) 0.00% 0.00%    
XML 56 d421644d10q_htm.xml IDEA: XBRL DOCUMENT 0001588272 2023-01-01 2023-03-31 0001588272 2022-12-31 0001588272 2023-03-31 0001588272 2022-01-01 2022-03-31 0001588272 2022-03-31 0001588272 2021-12-31 0001588272 cik0001588272:AffiliatedInvestmentsMember 2022-12-31 0001588272 cik0001588272:NonControlledOrNonAffiliatedInvestmentsMember 2022-12-31 0001588272 cik0001588272:DecemberThirtyFirstTwoThousandAndTwentyFiveMember 2022-12-31 0001588272 cik0001588272:ExpenseLimitationAgreementMember 2022-12-31 0001588272 us-gaap:MoneyMarketFundsMember 2022-12-31 0001588272 cik0001588272:AdvisoryFeesAndAdministrationFeesMember 2022-12-31 0001588272 cik0001588272:FirstLienTermLoanMember cik0001588272:HealthcareAtTwentyFourPointFivePercentageMember cik0001588272:SeniorSecuredLoansAtTwentySixPointZeroFivePercentMember cik0001588272:AurisLuxembourgIiiS.a.r.l.Member 2022-12-31 0001588272 cik0001588272:FirstLienTermLoanMember cik0001588272:HealthcareAtTwentyFourPointFivePercentageMember cik0001588272:SeniorSecuredLoansAtTwentySixPointZeroFivePercentMember cik0001588272:CarestreamHealthIncMember 2022-12-31 0001588272 cik0001588272:FirstLienTermLoanMember cik0001588272:HealthcareAtTwentyFourPointFivePercentageMember cik0001588272:SeniorSecuredLoansAtTwentySixPointZeroFivePercentMember cik0001588272:CcsMedicalIncMember 2022-12-31 0001588272 cik0001588272:SecondLienTermLoanMember cik0001588272:HealthcareAtTwentyFourPointFivePercentageMember cik0001588272:SeniorSecuredLoansAtTwentySixPointZeroFivePercentMember cik0001588272:CntHoldingsICorpMember 2022-12-31 0001588272 cik0001588272:FirstLienDelayedDrawTermLoanMember cik0001588272:HealthcareAtTwentyFourPointFivePercentageMember cik0001588272:SeniorSecuredLoansAtTwentySixPointZeroFivePercentMember cik0001588272:CovenantSurgicalPartnersInc.Member 2022-12-31 0001588272 cik0001588272:FirstLienTermLoanMember cik0001588272:HealthcareAtTwentyFourPointFivePercentageMember cik0001588272:SeniorSecuredLoansAtTwentySixPointZeroFivePercentMember cik0001588272:CovenantSurgicalPartnersInc.Member 2022-12-31 0001588272 cik0001588272:FirstLienTermLoanMember cik0001588272:HealthcareAtTwentyFourPointFivePercentageMember cik0001588272:SeniorSecuredLoansAtTwentySixPointZeroFivePercentMember cik0001588272:EnvisionHealthcareCorp.Member 2022-12-31 0001588272 cik0001588272:FirstLienTermLoanMember cik0001588272:HealthcareAtTwentyFourPointFivePercentageMember cik0001588272:SeniorSecuredLoansAtTwentySixPointZeroFivePercentMember cik0001588272:RxbenefitsInc.Member 2022-12-31 0001588272 cik0001588272:SecondLienTermLoanMember cik0001588272:HealthcareAtTwentyFourPointFivePercentageMember cik0001588272:SeniorSecuredLoansAtTwentySixPointZeroFivePercentMember cik0001588272:SoundInpatientPhysiciansMember 2022-12-31 0001588272 cik0001588272:FirstLienTermLoanMember cik0001588272:HealthcareAtTwentyFourPointFivePercentageMember cik0001588272:SeniorSecuredLoansAtTwentySixPointZeroFivePercentMember cik0001588272:WellpathHoldingsInc.Member 2022-12-31 0001588272 cik0001588272:FirstLienTermLoanHMember cik0001588272:TeleCommunicationServicesAtTwoPointZeroPercentageMember cik0001588272:SeniorSecuredLoansAtTwentySixPointZeroFivePercentMember cik0001588272:TerrestarCorp.Member 2022-12-31 0001588272 cik0001588272:FirstLienTermLoanFMember cik0001588272:TeleCommunicationServicesAtTwoPointZeroPercentageMember cik0001588272:SeniorSecuredLoansAtTwentySixPointZeroFivePercentMember cik0001588272:TerrestarCorp.Member 2022-12-31 0001588272 cik0001588272:FirstLienTermLoanEMember cik0001588272:TeleCommunicationServicesAtTwoPointZeroPercentageMember cik0001588272:SeniorSecuredLoansAtTwentySixPointZeroFivePercentMember cik0001588272:TerrestarCorp.Member 2022-12-31 0001588272 cik0001588272:FirstLienTermLoanGMember cik0001588272:TeleCommunicationServicesAtTwoPointZeroPercentageMember cik0001588272:SeniorSecuredLoansAtTwentySixPointZeroFivePercentMember cik0001588272:TerrestarCorp.Member 2022-12-31 0001588272 cik0001588272:HealthcareAtFourPointFivePercentMember cik0001588272:CorporateBondsAtFivePointZeroPercentMember cik0001588272:HadrianMergerSubInc.Member 2022-12-31 0001588272 cik0001588272:InterestRateAtSixPointThreeEightPercentageMember cik0001588272:MediaAndTelecommunicationsAtZeroPointFivePercentMember cik0001588272:CorporateBondsAtFivePointZeroPercentMember cik0001588272:IheartcommunicationsInc.Member 2022-12-31 0001588272 cik0001588272:InterestRateAtEightPointThreeEightPercentageMember cik0001588272:MediaAndTelecommunicationsAtZeroPointFivePercentMember cik0001588272:CorporateBondsAtFivePointZeroPercentMember cik0001588272:IheartcommunicationsInc.Member 2022-12-31 0001588272 cik0001588272:FinancialsAtZeroPointZeroPercentMember cik0001588272:AssetBackedSecuritiesAtZeroPointZeroPercentMember cik0001588272:GraysonInvestorCorp.Member 2022-12-31 0001588272 cik0001588272:FinancialsAtZeroPointZeroPercentMember cik0001588272:AssetBackedSecuritiesAtZeroPointZeroPercentMember cik0001588272:PamcoClo19971abMember 2022-12-31 0001588272 cik0001588272:HealthcareAtTwentyFourPointFivePercentageMember cik0001588272:SeniorSecuredLoansAtTwentySixPointZeroFivePercentMember 2022-12-31 0001588272 cik0001588272:TeleCommunicationServicesAtTwoPointZeroPercentageMember cik0001588272:SeniorSecuredLoansAtTwentySixPointZeroFivePercentMember 2022-12-31 0001588272 cik0001588272:SeniorSecuredLoansAtTwentySixPointZeroFivePercentMember 2022-12-31 0001588272 cik0001588272:FinancialsAtZeroPointZeroPercentMember cik0001588272:AssetBackedSecuritiesAtZeroPointZeroPercentMember 2022-12-31 0001588272 cik0001588272:AssetBackedSecuritiesAtZeroPointZeroPercentMember 2022-12-31 0001588272 cik0001588272:MediaAndTelecommunicationsAtZeroPointFivePercentMember cik0001588272:CorporateBondsAtFivePointZeroPercentMember 2022-12-31 0001588272 cik0001588272:CorporateBondsAtFivePointZeroPercentMember 2022-12-31 0001588272 cik0001588272:RealEstateInvestmentTrustAtOnePointNinePercentageMember cik0001588272:CommonStocksAtThirtySixPointThreePercentMember cik0001588272:NexpointResidentialTrustInc.Member 2022-12-31 0001588272 cik0001588272:ServiceAtZeroPointZeroPercentageMember cik0001588272:CommonStocksAtThirtySixPointThreePercentMember cik0001588272:WayneServicesLegacyInc.Member 2022-12-31 0001588272 cik0001588272:TelecommunicationServicesAtNinePointFivePercentageMember cik0001588272:CommonStocksAtThirtySixPointThreePercentMember cik0001588272:TerrestarCorp..Member 2022-12-31 0001588272 cik0001588272:ConsumerProductsAtFivePointSevenPercentageMember cik0001588272:LLCInterestsAtEightPointSevenPercentMember cik0001588272:UsGamingLlcMember 2022-12-31 0001588272 cik0001588272:RealEstateAtThreePointZeroPercentageMember cik0001588272:LLCInterestsAtEightPointSevenPercentMember cik0001588272:SfrWlifIiiLlcMember 2022-12-31 0001588272 cik0001588272:RealEstateAtThreePointZeroPercentageMember cik0001588272:LLCInterestsAtEightPointSevenPercentMember cik0001588272:NexpointCapitalReitLlcSeniorLoansCommonStocksMember 2022-12-31 0001588272 cik0001588272:ChemicalsAtZeroPointOnePercentageMember cik0001588272:CommonStocksAtThirtySixPointThreePercentMember cik0001588272:MpmHoldingsIncMember 2022-12-31 0001588272 cik0001588272:EnergyAtThreePointZeroPercentageMember cik0001588272:CommonStocksAtThirtySixPointThreePercentMember cik0001588272:QuarternorthEnergyInc.Member 2022-12-31 0001588272 cik0001588272:FinancialsAtThreePointTwoPercentageMember cik0001588272:CommonStocksAtThirtySixPointThreePercentMember cik0001588272:AmericanBanknoteCorpMember 2022-12-31 0001588272 cik0001588272:RealEstateAtEighteenPointSixPercentageMember cik0001588272:CommonStocksAtThirtySixPointThreePercentMember cik0001588272:NexpointRealEstateFinanceInc.Member 2022-12-31 0001588272 cik0001588272:RealEstateAtEighteenPointSixPercentageMember cik0001588272:CommonStocksAtThirtySixPointThreePercentMember cik0001588272:IqhqIncMember 2022-12-31 0001588272 cik0001588272:CommonStocksAtThirtySixPointThreePercentMember 2022-12-31 0001588272 cik0001588272:RealEstateAtThreePointZeroPercentageMember cik0001588272:LLCInterestsAtEightPointSevenPercentMember 2022-12-31 0001588272 cik0001588272:LLCInterestsAtEightPointSevenPercentMember 2022-12-31 0001588272 cik0001588272:RealEstateAtEighteenPointSixPercentageMember cik0001588272:CommonStocksAtThirtySixPointThreePercentMember 2022-12-31 0001588272 cik0001588272:EnergyAtZeroPointThreePercentageMember cik0001588272:WarrantsAtZeroPointFourPercentMember cik0001588272:QuarternorthTranche1Member 2022-12-31 0001588272 cik0001588272:EnergyAtZeroPointThreePercentageMember cik0001588272:WarrantsAtZeroPointFourPercentMember cik0001588272:QuarternorthTranche2Member 2022-12-31 0001588272 cik0001588272:MediaAndTelecommunicationsAtZeroPointOnePercentageMember cik0001588272:WarrantsAtZeroPointFourPercentMember cik0001588272:IheartmediaInc.Member 2022-12-31 0001588272 cik0001588272:FinancialsAtTwoPointSevenPercentageMember cik0001588272:PreferredStocksAtTwentyTwoPointThreePercentMember cik0001588272:SevenHundredSeventySevenPartnersLlcMember 2022-12-31 0001588272 cik0001588272:FinancialsAtTwoPointSevenPercentageMember cik0001588272:PreferredStocksAtTwentyTwoPointThreePercentMember cik0001588272:UnitedFidelityBankFsbMember 2022-12-31 0001588272 cik0001588272:HealthcareAtNinteenPointSixPercentageMember cik0001588272:PreferredStocksAtTwentyTwoPointThreePercentMember cik0001588272:ApnimedInc.Member 2022-12-31 0001588272 cik0001588272:HealthcareAtNinteenPointSixPercentageMember cik0001588272:PreferredStocksAtTwentyTwoPointThreePercentMember cik0001588272:SeriesC2Member cik0001588272:ApnimedInc.Member 2022-12-31 0001588272 cik0001588272:HealthcareAtNinteenPointSixPercentageMember cik0001588272:PreferredStocksAtTwentyTwoPointThreePercentMember us-gaap:SeriesBPreferredStockMember cik0001588272:SapienceTherapeuticsInc.Member 2022-12-31 0001588272 cik0001588272:HealthcareAtNinteenPointSixPercentageMember cik0001588272:PreferredStocksAtTwentyTwoPointThreePercentMember cik0001588272:Seriesb1preferredSharesMember cik0001588272:SapienceTherapeuticsInc.Member 2022-12-31 0001588272 cik0001588272:FinancialsAtTwoPointSevenPercentageMember cik0001588272:PreferredStocksAtTwentyTwoPointThreePercentMember 2022-12-31 0001588272 cik0001588272:HealthcareAtNinteenPointSixPercentageMember cik0001588272:PreferredStocksAtTwentyTwoPointThreePercentMember 2022-12-31 0001588272 cik0001588272:PreferredStocksAtTwentyTwoPointThreePercentMember 2022-12-31 0001588272 cik0001588272:EnergyAtZeroPointThreePercentageMember cik0001588272:WarrantsAtZeroPointFourPercentMember 2022-12-31 0001588272 cik0001588272:WarrantsAtZeroPointFourPercentMember 2022-12-31 0001588272 cik0001588272:TotalInvestmentNinetyNinePointTwoMember 2022-12-31 0001588272 cik0001588272:CashEquivalentsAtTwoPointSevenPercentageMember 2022-12-31 0001588272 cik0001588272:OtherAssetsLiabilitiesNetAtOnePointEightPercentageMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel3Member us-gaap:AssetBackedSecuritiesMember cik0001588272:GraysonInvestorCorpMember cik0001588272:AssetBackedSecuritiesOneMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel3Member us-gaap:AssetBackedSecuritiesMember cik0001588272:PamcoCloNineteenNinetySevenOneABMember cik0001588272:AssetBackedSecuritiesOneMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel3Member us-gaap:CommonStockMember cik0001588272:AmericanBanknoteCorpMember cik0001588272:CommonStockOneMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel3Member us-gaap:CommonStockMember cik0001588272:IqhqMember cik0001588272:CommonStockOneMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel3Member us-gaap:CommonStockMember cik0001588272:TereeStarCorpMember cik0001588272:CommonStockOneMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel3Member us-gaap:CommonStockMember cik0001588272:WayneServicesLegacyIncMember cik0001588272:CommonStockOneMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel3Member cik0001588272:LlcInterestsMember cik0001588272:NexpointCapitalReitLlcSeniorLoansCommonStocksMember cik0001588272:LlcInterestsOneMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel3Member cik0001588272:LlcInterestsMember cik0001588272:SfrWlifThreeLlcMember cik0001588272:LlcInterestsOneMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel3Member cik0001588272:LlcInterestsMember cik0001588272:UsGamingLlcMember cik0001588272:LlcInterestsOneMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel3Member us-gaap:PreferredStockMember cik0001588272:AprimedIncMember cik0001588272:PreferredStockOneMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel3Member us-gaap:PreferredStockMember cik0001588272:AprimedIncMember cik0001588272:SeriesCTwoPreferredStockMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel3Member us-gaap:PreferredStockMember cik0001588272:SapienceTherapauticsIncMember us-gaap:SeriesBPreferredStockMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel3Member us-gaap:PreferredStockMember cik0001588272:SapienceTherapauticsIncMember cik0001588272:SeriesBOnePreferredStockMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel3Member cik0001588272:SeniorSecuredLoansMember cik0001588272:CcsMedicalIncMember cik0001588272:SeniorSecuredLoansOneMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel3Member cik0001588272:SeniorSecuredLoansMember cik0001588272:TerreStarCorpMember cik0001588272:SeniorSecuredLoansOneMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel3Member cik0001588272:SeniorSecuredLoansMember cik0001588272:TerreStarCorpMember cik0001588272:SeniorSecuredLoansTwoMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel3Member cik0001588272:SeniorSecuredLoansMember cik0001588272:TerreStarCorpMember cik0001588272:SeniorSecuredLoansThreeMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel3Member cik0001588272:SeniorSecuredLoansMember cik0001588272:TerreStarCorpMember cik0001588272:SeniorSecuredLoansFourMember 2022-12-31 0001588272 us-gaap:HealthCareMember 2022-12-31 0001588272 us-gaap:RealEstateMember 2022-12-31 0001588272 cik0001588272:TelecommunicationServicesMember 2022-12-31 0001588272 cik0001588272:ConsumerProductsMember 2022-12-31 0001588272 us-gaap:FinancialServiceMember 2022-12-31 0001588272 cik0001588272:EnergyMember 2022-12-31 0001588272 cik0001588272:RealEstateInvestmentTrustsMember 2022-12-31 0001588272 cik0001588272:MediaAndTelecommunicationsMember 2022-12-31 0001588272 cik0001588272:ChemicalsMember 2022-12-31 0001588272 us-gaap:ServiceMember 2022-12-31 0001588272 cik0001588272:SeniorSecuredLoansFirstLienMember 2022-12-31 0001588272 cik0001588272:SeniorSecuredLoansSecondLienMember 2022-12-31 0001588272 us-gaap:AssetBackedSecuritiesMember 2022-12-31 0001588272 us-gaap:CorporateBondSecuritiesMember 2022-12-31 0001588272 us-gaap:CommonStockMember 2022-12-31 0001588272 cik0001588272:LlcMemberInterestsMember 2022-12-31 0001588272 us-gaap:PreferredStockMember 2022-12-31 0001588272 us-gaap:WarrantMember 2022-12-31 0001588272 country:KY 2022-12-31 0001588272 country:LU 2022-12-31 0001588272 country:US 2022-12-31 0001588272 us-gaap:FairValueInputsLevel1Member cik0001588272:SeniorSecuredLoansMember us-gaap:HealthCareMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel2Member cik0001588272:SeniorSecuredLoansMember us-gaap:HealthCareMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel3Member cik0001588272:SeniorSecuredLoansMember us-gaap:HealthCareMember 2022-12-31 0001588272 cik0001588272:SeniorSecuredLoansMember us-gaap:HealthCareMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel1Member cik0001588272:SeniorSecuredLoansMember cik0001588272:TelcommunicationServicesMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel2Member cik0001588272:SeniorSecuredLoansMember cik0001588272:TelcommunicationServicesMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel3Member cik0001588272:SeniorSecuredLoansMember cik0001588272:TelcommunicationServicesMember 2022-12-31 0001588272 cik0001588272:SeniorSecuredLoansMember cik0001588272:TelcommunicationServicesMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel1Member cik0001588272:AssetBackedSecuritiesOneMember cik0001588272:FinancialsMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel2Member cik0001588272:AssetBackedSecuritiesOneMember cik0001588272:FinancialsMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel3Member cik0001588272:AssetBackedSecuritiesOneMember cik0001588272:FinancialsMember 2022-12-31 0001588272 cik0001588272:AssetBackedSecuritiesOneMember cik0001588272:FinancialsMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel1Member cik0001588272:CorporateBondsMember us-gaap:HealthCareMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel2Member cik0001588272:CorporateBondsMember us-gaap:HealthCareMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel3Member cik0001588272:CorporateBondsMember us-gaap:HealthCareMember 2022-12-31 0001588272 cik0001588272:CorporateBondsMember us-gaap:HealthCareMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel1Member cik0001588272:CorporateBondsMember cik0001588272:MediaAndTelecommunicationsMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel2Member cik0001588272:CorporateBondsMember cik0001588272:MediaAndTelecommunicationsMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel3Member cik0001588272:CorporateBondsMember cik0001588272:MediaAndTelecommunicationsMember 2022-12-31 0001588272 cik0001588272:CorporateBondsMember cik0001588272:MediaAndTelecommunicationsMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel1Member us-gaap:CommonStockMember cik0001588272:ChemicalsMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel2Member us-gaap:CommonStockMember cik0001588272:ChemicalsMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel3Member us-gaap:CommonStockMember cik0001588272:ChemicalsMember 2022-12-31 0001588272 us-gaap:CommonStockMember cik0001588272:ChemicalsMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel1Member us-gaap:CommonStockMember cik0001588272:EnergyMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel2Member us-gaap:CommonStockMember cik0001588272:EnergyMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel3Member us-gaap:CommonStockMember cik0001588272:EnergyMember 2022-12-31 0001588272 us-gaap:CommonStockMember cik0001588272:EnergyMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel1Member us-gaap:CommonStockMember cik0001588272:FinancialsMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel2Member us-gaap:CommonStockMember cik0001588272:FinancialsMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel3Member us-gaap:CommonStockMember cik0001588272:FinancialsMember 2022-12-31 0001588272 us-gaap:CommonStockMember cik0001588272:FinancialsMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel1Member us-gaap:CommonStockMember us-gaap:RealEstateMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel2Member us-gaap:CommonStockMember us-gaap:RealEstateMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel3Member us-gaap:CommonStockMember us-gaap:RealEstateMember 2022-12-31 0001588272 us-gaap:CommonStockMember us-gaap:RealEstateMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel1Member us-gaap:CommonStockMember cik0001588272:RealEstateInvestmentTrustsMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel2Member us-gaap:CommonStockMember cik0001588272:RealEstateInvestmentTrustsMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel3Member us-gaap:CommonStockMember cik0001588272:RealEstateInvestmentTrustsMember 2022-12-31 0001588272 us-gaap:CommonStockMember cik0001588272:RealEstateInvestmentTrustsMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel1Member us-gaap:CommonStockMember us-gaap:ServiceMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel2Member us-gaap:CommonStockMember us-gaap:ServiceMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel3Member us-gaap:CommonStockMember us-gaap:ServiceMember 2022-12-31 0001588272 us-gaap:CommonStockMember us-gaap:ServiceMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel1Member us-gaap:CommonStockMember cik0001588272:TelecommunicationServicesMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel2Member us-gaap:CommonStockMember cik0001588272:TelecommunicationServicesMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel3Member us-gaap:CommonStockMember cik0001588272:TelecommunicationServicesMember 2022-12-31 0001588272 us-gaap:CommonStockMember cik0001588272:TelecommunicationServicesMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel1Member cik0001588272:LlcInterestsMember cik0001588272:ConsumerProductsMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel2Member cik0001588272:LlcInterestsMember cik0001588272:ConsumerProductsMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel3Member cik0001588272:LlcInterestsMember cik0001588272:ConsumerProductsMember 2022-12-31 0001588272 cik0001588272:LlcInterestsMember cik0001588272:ConsumerProductsMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel1Member cik0001588272:LlcInterestsMember us-gaap:RealEstateMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel2Member cik0001588272:LlcInterestsMember us-gaap:RealEstateMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel3Member cik0001588272:LlcInterestsMember us-gaap:RealEstateMember 2022-12-31 0001588272 cik0001588272:LlcInterestsMember us-gaap:RealEstateMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel1Member us-gaap:PreferredStockMember cik0001588272:FinancialsMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel2Member us-gaap:PreferredStockMember cik0001588272:FinancialsMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel3Member us-gaap:PreferredStockMember cik0001588272:FinancialsMember 2022-12-31 0001588272 us-gaap:PreferredStockMember cik0001588272:FinancialsMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel1Member us-gaap:PreferredStockMember us-gaap:HealthCareMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel2Member us-gaap:PreferredStockMember us-gaap:HealthCareMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel3Member us-gaap:PreferredStockMember us-gaap:HealthCareMember 2022-12-31 0001588272 us-gaap:PreferredStockMember us-gaap:HealthCareMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel1Member us-gaap:WarrantMember cik0001588272:EnergyMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel2Member us-gaap:WarrantMember cik0001588272:EnergyMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel3Member us-gaap:WarrantMember cik0001588272:EnergyMember 2022-12-31 0001588272 us-gaap:WarrantMember cik0001588272:EnergyMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel1Member us-gaap:WarrantMember cik0001588272:MediaAndTelecommunicationsMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel2Member us-gaap:WarrantMember cik0001588272:MediaAndTelecommunicationsMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel3Member us-gaap:WarrantMember cik0001588272:MediaAndTelecommunicationsMember 2022-12-31 0001588272 us-gaap:WarrantMember cik0001588272:MediaAndTelecommunicationsMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel1Member 2022-12-31 0001588272 us-gaap:FairValueInputsLevel2Member 2022-12-31 0001588272 us-gaap:FairValueInputsLevel3Member 2022-12-31 0001588272 srt:MaximumMember cik0001588272:EquityMethodInvesteeControllingInvestmentMember 2022-12-31 0001588272 srt:MinimumMember cik0001588272:EquityMethodInvesteeAffiliatedInvestmentsMember 2022-12-31 0001588272 cik0001588272:BaseRateOf6MonthLiborMember 2022-12-31 0001588272 cik0001588272:BaseRateOf3MonthLiborMember 2022-12-31 0001588272 cik0001588272:BaseRateOf1MonthLiborMember 2022-12-31 0001588272 cik0001588272:BoardOfDirectorsMember 2022-12-31 0001588272 cik0001588272:RestrictedSecuritiesMember 2022-12-31 0001588272 srt:AffiliatedEntityMember 2022-12-31 0001588272 cik0001588272:LlcInterestsMember us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputDiscountRateMember 2022-12-31 0001588272 us-gaap:PreferredStockMember us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputOptionVolatilityMember 2022-12-31 0001588272 us-gaap:CommonStockMember us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputDiscountRateMember 2022-12-31 0001588272 cik0001588272:SeniorSecuredLoansMember us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputDiscountRateMember us-gaap:ValuationTechniqueDiscountedCashFlowMember 2022-12-31 0001588272 us-gaap:AssetBackedSecuritiesMember us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputDiscountRateMember us-gaap:ValuationTechniqueDiscountedCashFlowMember 2022-12-31 0001588272 srt:MinimumMember cik0001588272:LlcInterestsMember us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputDiscountRateMember us-gaap:ValuationTechniqueDiscountedCashFlowMember 2022-12-31 0001588272 srt:MaximumMember cik0001588272:LlcInterestsMember us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputDiscountRateMember us-gaap:ValuationTechniqueDiscountedCashFlowMember 2022-12-31 0001588272 srt:WeightedAverageMember cik0001588272:LlcInterestsMember us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputDiscountRateMember us-gaap:ValuationTechniqueDiscountedCashFlowMember 2022-12-31 0001588272 srt:MinimumMember cik0001588272:LlcInterestsMember us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputEbitdaMultipleMember cik0001588272:ValuationTechniqueMultipleAnalysisMember 2022-12-31 0001588272 srt:MaximumMember cik0001588272:LlcInterestsMember us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputEbitdaMultipleMember cik0001588272:ValuationTechniqueMultipleAnalysisMember 2022-12-31 0001588272 srt:WeightedAverageMember cik0001588272:LlcInterestsMember us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputEbitdaMultipleMember cik0001588272:ValuationTechniqueMultipleAnalysisMember 2022-12-31 0001588272 srt:MinimumMember us-gaap:PreferredStockMember us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputOptionVolatilityMember 2022-12-31 0001588272 srt:MaximumMember us-gaap:PreferredStockMember us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputOptionVolatilityMember 2022-12-31 0001588272 srt:WeightedAverageMember us-gaap:PreferredStockMember us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputOptionVolatilityMember 2022-12-31 0001588272 us-gaap:PreferredStockMember us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputCapRateMember 2022-12-31 0001588272 srt:MinimumMember us-gaap:CommonStockMember us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputDiscountRateMember 2022-12-31 0001588272 srt:MaximumMember us-gaap:CommonStockMember us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputDiscountRateMember 2022-12-31 0001588272 srt:WeightedAverageMember us-gaap:CommonStockMember us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputDiscountRateMember 2022-12-31 0001588272 srt:MinimumMember us-gaap:CommonStockMember us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputEbitdaMultipleMember 2022-12-31 0001588272 srt:MaximumMember us-gaap:CommonStockMember us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputEbitdaMultipleMember 2022-12-31 0001588272 srt:WeightedAverageMember us-gaap:CommonStockMember us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputEbitdaMultipleMember 2022-12-31 0001588272 srt:MinimumMember us-gaap:CommonStockMember us-gaap:FairValueInputsLevel3Member cik0001588272:MeasurementInputUnadjustedPriceMember 2022-12-31 0001588272 srt:MaximumMember us-gaap:CommonStockMember us-gaap:FairValueInputsLevel3Member cik0001588272:MeasurementInputUnadjustedPriceMember 2022-12-31 0001588272 srt:WeightedAverageMember us-gaap:CommonStockMember us-gaap:FairValueInputsLevel3Member cik0001588272:MeasurementInputUnadjustedPriceMember 2022-12-31 0001588272 srt:MinimumMember us-gaap:CommonStockMember us-gaap:FairValueInputsLevel3Member cik0001588272:MeasurementInputEnterpriseValueMember cik0001588272:ValuationTechniqueLiquidationAnalysisMember 2022-12-31 0001588272 srt:MaximumMember us-gaap:CommonStockMember us-gaap:FairValueInputsLevel3Member cik0001588272:MeasurementInputEnterpriseValueMember cik0001588272:ValuationTechniqueLiquidationAnalysisMember 2022-12-31 0001588272 srt:WeightedAverageMember us-gaap:CommonStockMember us-gaap:FairValueInputsLevel3Member cik0001588272:MeasurementInputEnterpriseValueMember cik0001588272:ValuationTechniqueLiquidationAnalysisMember 2022-12-31 0001588272 srt:MinimumMember us-gaap:CommonStockMember us-gaap:FairValueInputsLevel3Member cik0001588272:MeasurementInputRecoveryRateMember 2022-12-31 0001588272 srt:MaximumMember us-gaap:CommonStockMember us-gaap:FairValueInputsLevel3Member cik0001588272:MeasurementInputRecoveryRateMember 2022-12-31 0001588272 srt:WeightedAverageMember us-gaap:CommonStockMember us-gaap:FairValueInputsLevel3Member cik0001588272:MeasurementInputRecoveryRateMember 2022-12-31 0001588272 us-gaap:CommonStockMember us-gaap:FairValueInputsLevel3Member cik0001588272:MeasurementInputNavMultipleMember cik0001588272:ValuationTechniqueNetAssetValueMember 2022-12-31 0001588272 srt:MinimumMember cik0001588272:SeniorSecuredLoansMember us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputDiscountRateMember us-gaap:ValuationTechniqueDiscountedCashFlowMember 2022-12-31 0001588272 srt:MaximumMember cik0001588272:SeniorSecuredLoansMember us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputDiscountRateMember us-gaap:ValuationTechniqueDiscountedCashFlowMember 2022-12-31 0001588272 srt:WeightedAverageMember cik0001588272:SeniorSecuredLoansMember us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputDiscountRateMember us-gaap:ValuationTechniqueDiscountedCashFlowMember 2022-12-31 0001588272 cik0001588272:MarchThirtyFirstTwoThousandAndTwentyFiveMember 2022-03-31 0001588272 cik0001588272:FirstLienTermLoanMember cik0001588272:HealthcareAtTwentyFourPointFivePercentageMember cik0001588272:SeniorSecuredLoansAtTwentySixPointZeroFivePercentMember cik0001588272:AurisLuxembourgIiiS.a.r.l.Member 2022-01-01 2022-12-31 0001588272 cik0001588272:FirstLienTermLoanMember cik0001588272:HealthcareAtTwentyFourPointFivePercentageMember cik0001588272:SeniorSecuredLoansAtTwentySixPointZeroFivePercentMember cik0001588272:CarestreamHealthIncMember 2022-01-01 2022-12-31 0001588272 cik0001588272:FirstLienTermLoanMember cik0001588272:HealthcareAtTwentyFourPointFivePercentageMember cik0001588272:SeniorSecuredLoansAtTwentySixPointZeroFivePercentMember cik0001588272:CcsMedicalIncMember 2022-01-01 2022-12-31 0001588272 cik0001588272:SecondLienTermLoanMember cik0001588272:HealthcareAtTwentyFourPointFivePercentageMember cik0001588272:SeniorSecuredLoansAtTwentySixPointZeroFivePercentMember cik0001588272:CntHoldingsICorpMember 2022-01-01 2022-12-31 0001588272 cik0001588272:FirstLienDelayedDrawTermLoanMember cik0001588272:HealthcareAtTwentyFourPointFivePercentageMember cik0001588272:SeniorSecuredLoansAtTwentySixPointZeroFivePercentMember cik0001588272:CovenantSurgicalPartnersInc.Member 2022-01-01 2022-12-31 0001588272 cik0001588272:FirstLienTermLoanMember cik0001588272:HealthcareAtTwentyFourPointFivePercentageMember cik0001588272:SeniorSecuredLoansAtTwentySixPointZeroFivePercentMember cik0001588272:CovenantSurgicalPartnersInc.Member 2022-01-01 2022-12-31 0001588272 cik0001588272:FirstLienTermLoanMember cik0001588272:HealthcareAtTwentyFourPointFivePercentageMember cik0001588272:SeniorSecuredLoansAtTwentySixPointZeroFivePercentMember cik0001588272:EnvisionHealthcareCorp.Member 2022-01-01 2022-12-31 0001588272 cik0001588272:FirstLienTermLoanMember cik0001588272:HealthcareAtTwentyFourPointFivePercentageMember cik0001588272:SeniorSecuredLoansAtTwentySixPointZeroFivePercentMember cik0001588272:RxbenefitsInc.Member 2022-01-01 2022-12-31 0001588272 cik0001588272:SecondLienTermLoanMember cik0001588272:HealthcareAtTwentyFourPointFivePercentageMember cik0001588272:SeniorSecuredLoansAtTwentySixPointZeroFivePercentMember cik0001588272:SoundInpatientPhysiciansMember 2022-01-01 2022-12-31 0001588272 cik0001588272:FirstLienTermLoanMember cik0001588272:HealthcareAtTwentyFourPointFivePercentageMember cik0001588272:SeniorSecuredLoansAtTwentySixPointZeroFivePercentMember cik0001588272:WellpathHoldingsInc.Member 2022-01-01 2022-12-31 0001588272 cik0001588272:FirstLienTermLoanHMember cik0001588272:TeleCommunicationServicesAtTwoPointZeroPercentageMember cik0001588272:SeniorSecuredLoansAtTwentySixPointZeroFivePercentMember cik0001588272:TerrestarCorp.Member 2022-01-01 2022-12-31 0001588272 cik0001588272:FirstLienTermLoanFMember cik0001588272:TeleCommunicationServicesAtTwoPointZeroPercentageMember cik0001588272:SeniorSecuredLoansAtTwentySixPointZeroFivePercentMember cik0001588272:TerrestarCorp.Member 2022-01-01 2022-12-31 0001588272 cik0001588272:FirstLienTermLoanEMember cik0001588272:TeleCommunicationServicesAtTwoPointZeroPercentageMember cik0001588272:SeniorSecuredLoansAtTwentySixPointZeroFivePercentMember cik0001588272:TerrestarCorp.Member 2022-01-01 2022-12-31 0001588272 cik0001588272:FirstLienTermLoanGMember cik0001588272:TeleCommunicationServicesAtTwoPointZeroPercentageMember cik0001588272:SeniorSecuredLoansAtTwentySixPointZeroFivePercentMember cik0001588272:TerrestarCorp.Member 2022-01-01 2022-12-31 0001588272 cik0001588272:FinancialsAtZeroPointZeroPercentMember cik0001588272:AssetBackedSecuritiesAtZeroPointZeroPercentMember cik0001588272:GraysonInvestorCorp.Member 2022-01-01 2022-12-31 0001588272 cik0001588272:FinancialsAtZeroPointZeroPercentMember cik0001588272:AssetBackedSecuritiesAtZeroPointZeroPercentMember cik0001588272:PamcoClo19971abMember 2022-01-01 2022-12-31 0001588272 cik0001588272:HealthcareAtTwentyFourPointFivePercentageMember cik0001588272:CorporateBondsAtFivePointZeroPercentMember cik0001588272:HadrianMergerSubInc.Member 2022-01-01 2022-12-31 0001588272 cik0001588272:TeleCommunicationServicesAtZeroPointFivePercentageMember cik0001588272:CorporateBondsAtFivePointZeroPercentMember cik0001588272:IheartcommunicationsInc.Member 2022-01-01 2022-12-31 0001588272 cik0001588272:HealthcareAtFourPointFivePercentMember cik0001588272:CorporateBondsAtFivePointZeroPercentMember cik0001588272:HadrianMergerSubInc.Member 2022-01-01 2022-12-31 0001588272 cik0001588272:InterestRateAtSixPointThreeEightPercentageMember cik0001588272:MediaAndTelecommunicationsAtZeroPointFivePercentMember cik0001588272:CorporateBondsAtFivePointZeroPercentMember cik0001588272:IheartcommunicationsInc.Member 2022-01-01 2022-12-31 0001588272 cik0001588272:InterestRateAtEightPointThreeEightPercentageMember cik0001588272:MediaAndTelecommunicationsAtZeroPointFivePercentMember cik0001588272:CorporateBondsAtFivePointZeroPercentMember cik0001588272:IheartcommunicationsInc.Member 2022-01-01 2022-12-31 0001588272 cik0001588272:RealEstateInvestmentTrustAtOnePointNinePercentageMember cik0001588272:CommonStocksAtThirtySixPointThreePercentMember cik0001588272:NexpointResidentialTrustInc.Member 2022-01-01 2022-12-31 0001588272 cik0001588272:ServiceAtZeroPointZeroPercentageMember cik0001588272:CommonStocksAtThirtySixPointThreePercentMember cik0001588272:WayneServicesLegacyInc.Member 2022-01-01 2022-12-31 0001588272 cik0001588272:TelecommunicationServicesAtNinePointFivePercentageMember cik0001588272:CommonStocksAtThirtySixPointThreePercentMember cik0001588272:TerrestarCorp..Member 2022-01-01 2022-12-31 0001588272 cik0001588272:ConsumerProductsAtFivePointSevenPercentageMember cik0001588272:LLCInterestsAtEightPointSevenPercentMember cik0001588272:UsGamingLlcMember 2022-01-01 2022-12-31 0001588272 cik0001588272:RealEstateAtThreePointZeroPercentageMember cik0001588272:LLCInterestsAtEightPointSevenPercentMember cik0001588272:SfrWlifIiiLlcMember 2022-01-01 2022-12-31 0001588272 cik0001588272:RealEstateAtThreePointZeroPercentageMember cik0001588272:LLCInterestsAtEightPointSevenPercentMember cik0001588272:NexpointCapitalReitLlcSeniorLoansCommonStocksMember 2022-01-01 2022-12-31 0001588272 cik0001588272:ChemicalsAtZeroPointOnePercentageMember cik0001588272:CommonStocksAtThirtySixPointThreePercentMember cik0001588272:MpmHoldingsIncMember 2022-01-01 2022-12-31 0001588272 cik0001588272:EnergyAtThreePointZeroPercentageMember cik0001588272:CommonStocksAtThirtySixPointThreePercentMember cik0001588272:QuarternorthEnergyInc.Member 2022-01-01 2022-12-31 0001588272 cik0001588272:FinancialsAtThreePointTwoPercentageMember cik0001588272:CommonStocksAtThirtySixPointThreePercentMember cik0001588272:AmericanBanknoteCorpMember 2022-01-01 2022-12-31 0001588272 cik0001588272:RealEstateAtEighteenPointSixPercentageMember cik0001588272:CommonStocksAtThirtySixPointThreePercentMember cik0001588272:NexpointRealEstateFinanceInc.Member 2022-01-01 2022-12-31 0001588272 cik0001588272:RealEstateAtEighteenPointSixPercentageMember cik0001588272:CommonStocksAtThirtySixPointThreePercentMember cik0001588272:IqhqIncMember 2022-01-01 2022-12-31 0001588272 cik0001588272:FinancialsAtTwoPointSevenPercentageMember cik0001588272:PreferredStocksAtTwentyTwoPointThreePercentMember cik0001588272:SevenHundredSeventySevenPartnersLlcMember 2022-01-01 2022-12-31 0001588272 cik0001588272:FinancialsAtTwoPointSevenPercentageMember cik0001588272:PreferredStocksAtTwentyTwoPointThreePercentMember cik0001588272:UnitedFidelityBankFsbMember 2022-01-01 2022-12-31 0001588272 cik0001588272:HealthcareAtNinteenPointSixPercentageMember cik0001588272:PreferredStocksAtTwentyTwoPointThreePercentMember cik0001588272:ApnimedInc.Member 2022-01-01 2022-12-31 0001588272 cik0001588272:HealthcareAtNinteenPointSixPercentageMember cik0001588272:PreferredStocksAtTwentyTwoPointThreePercentMember cik0001588272:SeriesC2Member cik0001588272:ApnimedInc.Member 2022-01-01 2022-12-31 0001588272 cik0001588272:HealthcareAtNinteenPointSixPercentageMember cik0001588272:PreferredStocksAtTwentyTwoPointThreePercentMember us-gaap:SeriesBPreferredStockMember cik0001588272:SapienceTherapeuticsInc.Member 2022-01-01 2022-12-31 0001588272 cik0001588272:HealthcareAtNinteenPointSixPercentageMember cik0001588272:PreferredStocksAtTwentyTwoPointThreePercentMember cik0001588272:Seriesb1preferredSharesMember cik0001588272:SapienceTherapeuticsInc.Member 2022-01-01 2022-12-31 0001588272 cik0001588272:EnergyAtZeroPointThreePercentageMember cik0001588272:WarrantsAtZeroPointFourPercentMember cik0001588272:QuarternorthTranche1Member 2022-01-01 2022-12-31 0001588272 cik0001588272:EnergyAtZeroPointThreePercentageMember cik0001588272:WarrantsAtZeroPointFourPercentMember cik0001588272:QuarternorthTranche2Member 2022-01-01 2022-12-31 0001588272 cik0001588272:MediaAndTelecommunicationsAtZeroPointOnePercentageMember cik0001588272:WarrantsAtZeroPointFourPercentMember cik0001588272:IheartmediaInc.Member 2022-01-01 2022-12-31 0001588272 cik0001588272:TotalInvestmentNinetyNinePointTwoMember 2022-01-01 2022-12-31 0001588272 us-gaap:FairValueInputsLevel3Member us-gaap:AssetBackedSecuritiesMember cik0001588272:GraysonInvestorCorpMember cik0001588272:AssetBackedSecuritiesOneMember 2022-01-01 2022-12-31 0001588272 us-gaap:FairValueInputsLevel3Member us-gaap:AssetBackedSecuritiesMember cik0001588272:PamcoCloNineteenNinetySevenOneABMember cik0001588272:AssetBackedSecuritiesOneMember 2022-01-01 2022-12-31 0001588272 us-gaap:FairValueInputsLevel3Member us-gaap:CommonStockMember cik0001588272:AmericanBanknoteCorpMember cik0001588272:CommonStockOneMember 2022-01-01 2022-12-31 0001588272 us-gaap:FairValueInputsLevel3Member us-gaap:CommonStockMember cik0001588272:IqhqMember cik0001588272:CommonStockOneMember 2022-01-01 2022-12-31 0001588272 us-gaap:FairValueInputsLevel3Member us-gaap:CommonStockMember cik0001588272:TereeStarCorpMember cik0001588272:CommonStockOneMember 2022-01-01 2022-12-31 0001588272 us-gaap:FairValueInputsLevel3Member us-gaap:CommonStockMember cik0001588272:WayneServicesLegacyIncMember cik0001588272:CommonStockOneMember 2022-01-01 2022-12-31 0001588272 us-gaap:FairValueInputsLevel3Member cik0001588272:LlcInterestsMember cik0001588272:NexpointCapitalReitLlcSeniorLoansCommonStocksMember cik0001588272:LlcInterestsOneMember 2022-01-01 2022-12-31 0001588272 us-gaap:FairValueInputsLevel3Member cik0001588272:LlcInterestsMember cik0001588272:SfrWlifThreeLlcMember cik0001588272:LlcInterestsOneMember 2022-01-01 2022-12-31 0001588272 us-gaap:FairValueInputsLevel3Member cik0001588272:LlcInterestsMember cik0001588272:UsGamingLlcMember cik0001588272:LlcInterestsOneMember 2022-01-01 2022-12-31 0001588272 us-gaap:FairValueInputsLevel3Member us-gaap:PreferredStockMember cik0001588272:AprimedIncMember cik0001588272:PreferredStockOneMember 2022-01-01 2022-12-31 0001588272 us-gaap:FairValueInputsLevel3Member us-gaap:PreferredStockMember cik0001588272:AprimedIncMember cik0001588272:SeriesCTwoPreferredStockMember 2022-01-01 2022-12-31 0001588272 us-gaap:FairValueInputsLevel3Member us-gaap:PreferredStockMember cik0001588272:SapienceTherapauticsIncMember us-gaap:SeriesBPreferredStockMember 2022-01-01 2022-12-31 0001588272 us-gaap:FairValueInputsLevel3Member us-gaap:PreferredStockMember cik0001588272:SapienceTherapauticsIncMember cik0001588272:SeriesBOnePreferredStockMember 2022-01-01 2022-12-31 0001588272 us-gaap:FairValueInputsLevel3Member cik0001588272:SeniorSecuredLoansMember cik0001588272:CcsMedicalIncMember cik0001588272:SeniorSecuredLoansOneMember 2022-01-01 2022-12-31 0001588272 us-gaap:FairValueInputsLevel3Member cik0001588272:SeniorSecuredLoansMember cik0001588272:TerreStarCorpMember cik0001588272:SeniorSecuredLoansOneMember 2022-01-01 2022-12-31 0001588272 us-gaap:FairValueInputsLevel3Member cik0001588272:SeniorSecuredLoansMember cik0001588272:TerreStarCorpMember cik0001588272:SeniorSecuredLoansTwoMember 2022-01-01 2022-12-31 0001588272 us-gaap:FairValueInputsLevel3Member cik0001588272:SeniorSecuredLoansMember cik0001588272:TerreStarCorpMember cik0001588272:SeniorSecuredLoansThreeMember 2022-01-01 2022-12-31 0001588272 us-gaap:FairValueInputsLevel3Member cik0001588272:SeniorSecuredLoansMember cik0001588272:TerreStarCorpMember cik0001588272:SeniorSecuredLoansFourMember 2022-01-01 2022-12-31 0001588272 cik0001588272:LlcInterestsMember us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputDiscountRateMember 2022-01-01 2022-12-31 0001588272 cik0001588272:LlcInterestsMember us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputEbitdaMultipleMember cik0001588272:ValuationTechniqueMultipleAnalysisMember 2022-01-01 2022-12-31 0001588272 us-gaap:PreferredStockMember us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputOptionVolatilityMember 2022-01-01 2022-12-31 0001588272 us-gaap:PreferredStockMember us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputCapRateMember 2022-01-01 2022-12-31 0001588272 us-gaap:CommonStockMember us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputDiscountRateMember 2022-01-01 2022-12-31 0001588272 us-gaap:CommonStockMember us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputEbitdaMultipleMember 2022-01-01 2022-12-31 0001588272 us-gaap:CommonStockMember us-gaap:FairValueInputsLevel3Member cik0001588272:MeasurementInputEnterpriseValueMember cik0001588272:ValuationTechniqueLiquidationAnalysisMember 2022-01-01 2022-12-31 0001588272 us-gaap:CommonStockMember us-gaap:FairValueInputsLevel3Member cik0001588272:MeasurementInputRecoveryRateMember 2022-01-01 2022-12-31 0001588272 us-gaap:CommonStockMember us-gaap:FairValueInputsLevel3Member cik0001588272:MeasurementInputNavMultipleMember cik0001588272:ValuationTechniqueNetAssetValueMember 2022-01-01 2022-12-31 0001588272 cik0001588272:SeniorSecuredLoansMember us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputDiscountRateMember us-gaap:ValuationTechniqueDiscountedCashFlowMember 2022-01-01 2022-12-31 0001588272 us-gaap:AssetBackedSecuritiesMember us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputDiscountRateMember us-gaap:ValuationTechniqueDiscountedCashFlowMember 2022-01-01 2022-12-31 0001588272 us-gaap:CommonStockMember us-gaap:FairValueInputsLevel3Member cik0001588272:MeasurementInputUnadjustedPriceMember 2022-01-01 2022-12-31 0001588272 cik0001588272:AffiliatedInvestmentsMember 2022-01-01 2022-03-31 0001588272 cik0001588272:NonControlledOrNonAffiliatedInvestmentsMember 2022-01-01 2022-03-31 0001588272 us-gaap:RetainedEarningsMember 2022-01-01 2022-03-31 0001588272 us-gaap:CommonStockMember 2022-01-01 2022-03-31 0001588272 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-03-31 0001588272 cik0001588272:AdviserMember 2022-01-01 2022-03-31 0001588272 us-gaap:InvestmentsMember us-gaap:PreferredStockMember us-gaap:HealthCareMember 2022-01-01 2022-03-31 0001588272 us-gaap:InvestmentsMember cik0001588272:LlcInterestsMember us-gaap:RealEstateMember 2022-01-01 2022-03-31 0001588272 us-gaap:InvestmentsMember cik0001588272:LlcInterestsMember cik0001588272:ConsumerProductsMember 2022-01-01 2022-03-31 0001588272 us-gaap:InvestmentsMember us-gaap:CommonStockMember cik0001588272:TelecommunicationServicesMember 2022-01-01 2022-03-31 0001588272 us-gaap:InvestmentsMember us-gaap:CommonStockMember us-gaap:ServiceMember 2022-01-01 2022-03-31 0001588272 us-gaap:InvestmentsMember us-gaap:CommonStockMember us-gaap:RealEstateMember 2022-01-01 2022-03-31 0001588272 us-gaap:InvestmentsMember us-gaap:CommonStockMember cik0001588272:FinancialsMember 2022-01-01 2022-03-31 0001588272 us-gaap:InvestmentsMember cik0001588272:SeniorSecuredLoansMember cik0001588272:TelcommunicationServicesMember 2022-01-01 2022-03-31 0001588272 us-gaap:InvestmentsMember cik0001588272:SeniorSecuredLoansMember us-gaap:HealthCareMember 2022-01-01 2022-03-31 0001588272 us-gaap:InvestmentsMember cik0001588272:AssetBackedSecuritiesOneMember cik0001588272:FinancialsMember 2022-01-01 2022-03-31 0001588272 us-gaap:InvestmentsMember 2022-01-01 2022-03-31 0001588272 cik0001588272:AffiliatedInvestmentsMember 2023-03-31 0001588272 cik0001588272:NonControlledOrNonAffiliatedInvestmentsMember 2023-03-31 0001588272 cik0001588272:NextPointAdvisorsL.pMember 2023-03-31 0001588272 us-gaap:UnfundedLoanCommitmentMember 2023-03-31 0001588272 cik0001588272:FirstQuarterTenderOfferMember 2023-03-31 0001588272 cik0001588272:MarchThirtyOneTwoThousandTwentySixMember 2023-03-31 0001588272 cik0001588272:ExpenseLimitationAgreementMember 2023-03-31 0001588272 us-gaap:MoneyMarketFundsMember 2023-03-31 0001588272 cik0001588272:AdvisoryFeesAndAdministrationFeesMember 2023-03-31 0001588272 cik0001588272:AdviserMember 2023-03-31 0001588272 cik0001588272:FirstLienTermLoanMember cik0001588272:HealthcareAtSixteenPointFivePercentageMember cik0001588272:SeniorSecuredLoansAtNineteenPointSixPercentMember cik0001588272:AurisLuxembourgIiiS.a.r.l.Member 2023-03-31 0001588272 cik0001588272:FirstLienTermLoanMember cik0001588272:HealthcareAtSixteenPointFivePercentageMember cik0001588272:SeniorSecuredLoansAtNineteenPointSixPercentMember cik0001588272:CarestreamHealthIncMember 2023-03-31 0001588272 cik0001588272:FirstLienTermLoanMember cik0001588272:HealthcareAtSixteenPointFivePercentageMember cik0001588272:SeniorSecuredLoansAtNineteenPointSixPercentMember cik0001588272:CcsMedicalIncMember 2023-03-31 0001588272 cik0001588272:SecondLienTermLoanMember cik0001588272:HealthcareAtSixteenPointFivePercentageMember cik0001588272:SeniorSecuredLoansAtNineteenPointSixPercentMember cik0001588272:CntHoldingsICorpMember 2023-03-31 0001588272 cik0001588272:FirstLienDelayedDrawTermLoanMember cik0001588272:HealthcareAtSixteenPointFivePercentageMember cik0001588272:SeniorSecuredLoansAtNineteenPointSixPercentMember cik0001588272:CovenantSurgicalPartnersInc.Member 2023-03-31 0001588272 cik0001588272:FirstLienTermLoanMember cik0001588272:HealthcareAtSixteenPointFivePercentageMember cik0001588272:SeniorSecuredLoansAtNineteenPointSixPercentMember cik0001588272:CovenantSurgicalPartnersInc.Member 2023-03-31 0001588272 cik0001588272:FirstLienTermLoanMember cik0001588272:HealthcareAtSixteenPointFivePercentageMember cik0001588272:SeniorSecuredLoansAtNineteenPointSixPercentMember cik0001588272:EnvisionHealthcareCorp.Member 2023-03-31 0001588272 cik0001588272:SecondLienTermLoanMember cik0001588272:HealthcareAtSixteenPointFivePercentageMember cik0001588272:SeniorSecuredLoansAtNineteenPointSixPercentMember cik0001588272:SoundInpatientPhysiciansMember 2023-03-31 0001588272 cik0001588272:FirstLienTermLoanMember cik0001588272:HealthcareAtSixteenPointFivePercentageMember cik0001588272:SeniorSecuredLoansAtNineteenPointSixPercentMember cik0001588272:WellpathHoldingsInc.Member 2023-03-31 0001588272 cik0001588272:FirstLienTermLoanEMember cik0001588272:TeleCommunicationServicesAtTwoPointTwoPercentageMember cik0001588272:SeniorSecuredLoansAtNineteenPointSixPercentMember cik0001588272:TerrestarCorp.Member 2023-03-31 0001588272 cik0001588272:FirstLienTermLoanGMember cik0001588272:TeleCommunicationServicesAtTwoPointTwoPercentageMember cik0001588272:SeniorSecuredLoansAtNineteenPointSixPercentMember cik0001588272:TerrestarCorp.Member 2023-03-31 0001588272 cik0001588272:FirstLienTermLoanHMember cik0001588272:TeleCommunicationServicesAtTwoPointTwoPercentageMember cik0001588272:SeniorSecuredLoansAtNineteenPointSixPercentMember cik0001588272:TerrestarCorp.Member 2023-03-31 0001588272 cik0001588272:FirstLienTermLoanFMember cik0001588272:TeleCommunicationServicesAtTwoPointTwoPercentageMember cik0001588272:SeniorSecuredLoansAtNineteenPointSixPercentMember cik0001588272:TerrestarCorp.Member 2023-03-31 0001588272 cik0001588272:HealthcareAtFourPointFourPercentMember cik0001588272:CorporateBondsAtFourPointNinePercentMember cik0001588272:HadrianMergerSubInc.Member 2023-03-31 0001588272 cik0001588272:InterestRateAtSixPointThreeEightPercentageMember cik0001588272:MediaAndTelecommunicationsAtZeroPointFivePercentMember cik0001588272:CorporateBondsAtFourPointNinePercentMember cik0001588272:IheartcommunicationsInc.Member 2023-03-31 0001588272 cik0001588272:InterestRateAtEightPointThreeEightPercentageMember cik0001588272:MediaAndTelecommunicationsAtZeroPointFivePercentMember cik0001588272:CorporateBondsAtFourPointNinePercentMember cik0001588272:IheartcommunicationsInc.Member 2023-03-31 0001588272 cik0001588272:FirstLienTermLoanMember cik0001588272:RealEstateAtZeroPointNinePercentageMember cik0001588272:SeniorSecuredLoansAtNineteenPointSixPercentMember cik0001588272:NexpointCapitalReitLlcSeniorLoansCommonStocksMember 2023-03-31 0001588272 cik0001588272:FinancialsAtZeroPointZeroPercentMember cik0001588272:AssetBackedSecuritiesAtZeroPointZeroPercentMember cik0001588272:GraysonInvestorCorp.Member 2023-03-31 0001588272 cik0001588272:FinancialsAtZeroPointZeroPercentMember cik0001588272:AssetBackedSecuritiesAtZeroPointZeroPercentMember cik0001588272:PamcoClo19971abMember 2023-03-31 0001588272 cik0001588272:HealthcareAtSixteenPointFivePercentageMember cik0001588272:SeniorSecuredLoansAtNineteenPointSixPercentMember 2023-03-31 0001588272 cik0001588272:TeleCommunicationServicesAtTwoPointTwoPercentageMember cik0001588272:SeniorSecuredLoansAtNineteenPointSixPercentMember 2023-03-31 0001588272 cik0001588272:SeniorSecuredLoansAtNineteenPointSixPercentMember 2023-03-31 0001588272 cik0001588272:FinancialsAtZeroPointZeroPercentMember cik0001588272:AssetBackedSecuritiesAtZeroPointZeroPercentMember 2023-03-31 0001588272 cik0001588272:AssetBackedSecuritiesAtZeroPointZeroPercentMember 2023-03-31 0001588272 cik0001588272:MediaAndTelecommunicationsAtZeroPointFivePercentMember cik0001588272:CorporateBondsAtFourPointNinePercentMember 2023-03-31 0001588272 cik0001588272:CorporateBondsAtFourPointNinePercentMember 2023-03-31 0001588272 cik0001588272:ChemicalsAtZeroPointOnePercentageMember cik0001588272:CommonStocksAtTwentySevenPointTwoPercentMember cik0001588272:MpmHoldingsIncMember 2023-03-31 0001588272 cik0001588272:EnergyAtThreePointTwoPercentageMember cik0001588272:CommonStocksAtTwentySevenPointTwoPercentMember cik0001588272:QuarternorthEnergyInc.Member 2023-03-31 0001588272 cik0001588272:FinancialsAtThreePointFourPercentageMember cik0001588272:CommonStocksAtTwentySevenPointTwoPercentMember cik0001588272:AmericanBanknoteCorpMember 2023-03-31 0001588272 cik0001588272:RealEstateAtEightPointSevenPercentageMember cik0001588272:CommonStocksAtTwentySevenPointTwoPercentMember cik0001588272:NexpointRealEstateFinanceInc.Member 2023-03-31 0001588272 cik0001588272:RealEstateAtEightPointSevenPercentageMember cik0001588272:CommonStocksAtTwentySevenPointTwoPercentMember cik0001588272:IqhqIncMember 2023-03-31 0001588272 cik0001588272:RealEstateInvestmentTrustAtTwoPointZeroPercentageMember cik0001588272:CommonStocksAtTwentySevenPointTwoPercentMember cik0001588272:NexpointResidentialTrustInc.Member 2023-03-31 0001588272 cik0001588272:ServiceAtZeroPointZeroPercentageMember cik0001588272:CommonStocksAtTwentySevenPointTwoPercentMember cik0001588272:WayneServicesLegacyInc.Member 2023-03-31 0001588272 cik0001588272:TelecommunicationServicesAtNinePointEightPercentageMember cik0001588272:CommonStocksAtTwentySevenPointTwoPercentMember cik0001588272:TerrestarCorp..Member 2023-03-31 0001588272 cik0001588272:ConsumerProductsAtFivePointSixPercentageMember cik0001588272:LLCInterestsAtNineteenPointNinePercentMember cik0001588272:UsGamingLlcMember 2023-03-31 0001588272 cik0001588272:RealEstateAtFourteenPointThreePercentageMember cik0001588272:LLCInterestsAtNineteenPointNinePercentMember cik0001588272:SfrWlifIiiLlcMember 2023-03-31 0001588272 cik0001588272:RealEstateAtFourteenPointThreePercentageMember cik0001588272:LLCInterestsAtNineteenPointNinePercentMember cik0001588272:NexpointCapitalReitLlcSeniorLoansCommonStocksMember 2023-03-31 0001588272 cik0001588272:RealEstateAtEightPointSevenPercentageMember cik0001588272:CommonStocksAtTwentySevenPointTwoPercentMember 2023-03-31 0001588272 cik0001588272:CommonStocksAtTwentySevenPointTwoPercentMember 2023-03-31 0001588272 cik0001588272:RealEstateAtFourteenPointThreePercentageMember cik0001588272:LLCInterestsAtNineteenPointNinePercentMember 2023-03-31 0001588272 cik0001588272:LLCInterestsAtNineteenPointNinePercentMember 2023-03-31 0001588272 cik0001588272:FinancialsAtTwoPointSevenPercentageMember cik0001588272:PreferredStocksAtTwentyThreePointFourPercentMember cik0001588272:SevenHundredSeventySevenPartnersLlcMember 2023-03-31 0001588272 cik0001588272:FinancialsAtTwoPointSevenPercentageMember cik0001588272:PreferredStocksAtTwentyThreePointFourPercentMember cik0001588272:UnitedFidelityBankFsbMember 2023-03-31 0001588272 cik0001588272:HealthcareAtTwentyPointSevenPercentageMember cik0001588272:PreferredStocksAtTwentyThreePointFourPercentMember cik0001588272:ApnimedInc.Member 2023-03-31 0001588272 cik0001588272:HealthcareAtTwentyPointSevenPercentageMember cik0001588272:PreferredStocksAtTwentyThreePointFourPercentMember cik0001588272:SeriesC2Member cik0001588272:ApnimedInc.Member 2023-03-31 0001588272 cik0001588272:HealthcareAtTwentyPointSevenPercentageMember cik0001588272:PreferredStocksAtTwentyThreePointFourPercentMember us-gaap:SeriesBPreferredStockMember cik0001588272:SapienceTherapeuticsInc.Member 2023-03-31 0001588272 cik0001588272:HealthcareAtTwentyPointSevenPercentageMember cik0001588272:PreferredStocksAtTwentyThreePointFourPercentMember cik0001588272:Seriesb1preferredSharesMember cik0001588272:SapienceTherapeuticsInc.Member 2023-03-31 0001588272 cik0001588272:EnergyAtZeroPointThreePercentageMember cik0001588272:WarrantsAtZeroPointThreePercentMember cik0001588272:QuarternorthTranche1Member 2023-03-31 0001588272 cik0001588272:EnergyAtZeroPointThreePercentageMember cik0001588272:WarrantsAtZeroPointThreePercentMember cik0001588272:QuarternorthTranche2Member 2023-03-31 0001588272 cik0001588272:MediaAndTelecommunicationsAtZeroPointZeroPercentageMember cik0001588272:WarrantsAtZeroPointThreePercentMember cik0001588272:IheartmediaInc.Member 2023-03-31 0001588272 cik0001588272:FinancialsAtTwoPointSevenPercentageMember cik0001588272:PreferredStocksAtTwentyThreePointFourPercentMember 2023-03-31 0001588272 cik0001588272:HealthcareAtTwentyPointSevenPercentageMember cik0001588272:PreferredStocksAtTwentyThreePointFourPercentMember 2023-03-31 0001588272 cik0001588272:PreferredStocksAtTwentyThreePointFourPercentMember 2023-03-31 0001588272 cik0001588272:EnergyAtZeroPointThreePercentageMember cik0001588272:WarrantsAtZeroPointThreePercentMember 2023-03-31 0001588272 cik0001588272:WarrantsAtZeroPointThreePercentMember 2023-03-31 0001588272 cik0001588272:TotalInvestmentNinetyFivePointThreeMember 2023-03-31 0001588272 cik0001588272:CashEquivalentsAtOnePointFivePercentageMember 2023-03-31 0001588272 cik0001588272:OtherAssetsLiabilitiesNetAtThreePointTwoPercentageMember 2023-03-31 0001588272 us-gaap:FairValueInputsLevel3Member us-gaap:AssetBackedSecuritiesMember cik0001588272:GraysonInvestorCorpMember cik0001588272:AssetBackedSecuritiesOneMember 2023-03-31 0001588272 us-gaap:FairValueInputsLevel3Member us-gaap:AssetBackedSecuritiesMember cik0001588272:PamcoCloNineteenNinetySevenOneABMember cik0001588272:AssetBackedSecuritiesOneMember 2023-03-31 0001588272 us-gaap:FairValueInputsLevel3Member us-gaap:CommonStockMember cik0001588272:AmericanBanknoteCorpMember cik0001588272:CommonStockOneMember 2023-03-31 0001588272 us-gaap:FairValueInputsLevel3Member us-gaap:CommonStockMember cik0001588272:IqhqMember cik0001588272:CommonStockOneMember 2023-03-31 0001588272 us-gaap:FairValueInputsLevel3Member us-gaap:CommonStockMember cik0001588272:TereeStarCorpMember cik0001588272:CommonStockOneMember 2023-03-31 0001588272 us-gaap:FairValueInputsLevel3Member us-gaap:CommonStockMember cik0001588272:WayneServicesLegacyIncMember cik0001588272:CommonStockOneMember 2023-03-31 0001588272 us-gaap:FairValueInputsLevel3Member cik0001588272:LlcInterestsMember cik0001588272:NexpointCapitalReitLlcSeniorLoansCommonStocksMember cik0001588272:LlcInterestsOneMember 2023-03-31 0001588272 us-gaap:FairValueInputsLevel3Member cik0001588272:LlcInterestsMember cik0001588272:SfrWlifThreeLlcMember cik0001588272:LlcInterestsOneMember 2023-03-31 0001588272 us-gaap:FairValueInputsLevel3Member cik0001588272:LlcInterestsMember cik0001588272:UsGamingLlcMember cik0001588272:LlcInterestsOneMember 2023-03-31 0001588272 us-gaap:FairValueInputsLevel3Member us-gaap:PreferredStockMember cik0001588272:AprimedIncMember cik0001588272:PreferredStockOneMember 2023-03-31 0001588272 us-gaap:FairValueInputsLevel3Member us-gaap:PreferredStockMember cik0001588272:AprimedIncMember cik0001588272:SeriesCTwoPreferredStockMember 2023-03-31 0001588272 us-gaap:FairValueInputsLevel3Member us-gaap:PreferredStockMember cik0001588272:SapienceTherapauticsIncMember us-gaap:SeriesBPreferredStockMember 2023-03-31 0001588272 us-gaap:FairValueInputsLevel3Member us-gaap:PreferredStockMember cik0001588272:SapienceTherapauticsIncMember cik0001588272:SeriesBOnePreferredStockMember 2023-03-31 0001588272 us-gaap:FairValueInputsLevel3Member cik0001588272:SeniorSecuredLoansMember cik0001588272:CcsMedicalIncMember cik0001588272:SeniorSecuredLoansOneMember 2023-03-31 0001588272 us-gaap:FairValueInputsLevel3Member cik0001588272:SeniorSecuredLoansMember cik0001588272:TerreStarCorpMember cik0001588272:SeniorSecuredLoansOneMember 2023-03-31 0001588272 us-gaap:FairValueInputsLevel3Member cik0001588272:SeniorSecuredLoansMember cik0001588272:TerreStarCorpMember cik0001588272:SeniorSecuredLoansTwoMember 2023-03-31 0001588272 us-gaap:FairValueInputsLevel3Member cik0001588272:SeniorSecuredLoansMember cik0001588272:TerreStarCorpMember cik0001588272:SeniorSecuredLoansThreeMember 2023-03-31 0001588272 us-gaap:FairValueInputsLevel3Member cik0001588272:SeniorSecuredLoansMember cik0001588272:TerreStarCorpMember cik0001588272:SeniorSecuredLoansFourMember 2023-03-31 0001588272 us-gaap:FairValueInputsLevel3Member cik0001588272:SeniorSecuredLoansMember cik0001588272:NexpointCapitalReitLlc.Member cik0001588272:SeniorSecuredLoansOneMember 2023-03-31 0001588272 us-gaap:HealthCareMember 2023-03-31 0001588272 us-gaap:RealEstateMember 2023-03-31 0001588272 cik0001588272:TelecommunicationServicesMember 2023-03-31 0001588272 us-gaap:FinancialServiceMember 2023-03-31 0001588272 cik0001588272:ConsumerProductsMember 2023-03-31 0001588272 cik0001588272:EnergyMember 2023-03-31 0001588272 cik0001588272:RealEstateInvestmentTrustsMember 2023-03-31 0001588272 cik0001588272:MediaAndTelecommunicationsMember 2023-03-31 0001588272 cik0001588272:ChemicalsMember 2023-03-31 0001588272 us-gaap:ServiceMember 2023-03-31 0001588272 cik0001588272:SeniorSecuredLoansFirstLienMember 2023-03-31 0001588272 cik0001588272:SeniorSecuredLoansSecondLienMember 2023-03-31 0001588272 us-gaap:AssetBackedSecuritiesMember 2023-03-31 0001588272 us-gaap:CorporateBondSecuritiesMember 2023-03-31 0001588272 us-gaap:CommonStockMember 2023-03-31 0001588272 cik0001588272:LlcMemberInterestsMember 2023-03-31 0001588272 us-gaap:PreferredStockMember 2023-03-31 0001588272 us-gaap:WarrantMember 2023-03-31 0001588272 country:KY 2023-03-31 0001588272 country:LU 2023-03-31 0001588272 country:US 2023-03-31 0001588272 us-gaap:FairValueInputsLevel1Member cik0001588272:SeniorSecuredLoansMember us-gaap:HealthCareMember 2023-03-31 0001588272 us-gaap:FairValueInputsLevel2Member cik0001588272:SeniorSecuredLoansMember us-gaap:HealthCareMember 2023-03-31 0001588272 us-gaap:FairValueInputsLevel3Member cik0001588272:SeniorSecuredLoansMember us-gaap:HealthCareMember 2023-03-31 0001588272 cik0001588272:SeniorSecuredLoansMember us-gaap:HealthCareMember 2023-03-31 0001588272 us-gaap:FairValueInputsLevel1Member cik0001588272:SeniorSecuredLoansMember cik0001588272:TelcommunicationServicesMember 2023-03-31 0001588272 us-gaap:FairValueInputsLevel2Member cik0001588272:SeniorSecuredLoansMember cik0001588272:TelcommunicationServicesMember 2023-03-31 0001588272 us-gaap:FairValueInputsLevel3Member cik0001588272:SeniorSecuredLoansMember cik0001588272:TelcommunicationServicesMember 2023-03-31 0001588272 cik0001588272:SeniorSecuredLoansMember cik0001588272:TelcommunicationServicesMember 2023-03-31 0001588272 us-gaap:FairValueInputsLevel1Member cik0001588272:AssetBackedSecuritiesOneMember cik0001588272:FinancialsMember 2023-03-31 0001588272 us-gaap:FairValueInputsLevel2Member cik0001588272:AssetBackedSecuritiesOneMember cik0001588272:FinancialsMember 2023-03-31 0001588272 us-gaap:FairValueInputsLevel3Member cik0001588272:AssetBackedSecuritiesOneMember cik0001588272:FinancialsMember 2023-03-31 0001588272 cik0001588272:AssetBackedSecuritiesOneMember cik0001588272:FinancialsMember 2023-03-31 0001588272 us-gaap:FairValueInputsLevel1Member cik0001588272:CorporateBondsMember us-gaap:HealthCareMember 2023-03-31 0001588272 us-gaap:FairValueInputsLevel2Member cik0001588272:CorporateBondsMember us-gaap:HealthCareMember 2023-03-31 0001588272 us-gaap:FairValueInputsLevel3Member cik0001588272:CorporateBondsMember us-gaap:HealthCareMember 2023-03-31 0001588272 cik0001588272:CorporateBondsMember us-gaap:HealthCareMember 2023-03-31 0001588272 us-gaap:FairValueInputsLevel1Member cik0001588272:CorporateBondsMember cik0001588272:MediaAndTelecommunicationsMember 2023-03-31 0001588272 us-gaap:FairValueInputsLevel2Member cik0001588272:CorporateBondsMember cik0001588272:MediaAndTelecommunicationsMember 2023-03-31 0001588272 us-gaap:FairValueInputsLevel3Member cik0001588272:CorporateBondsMember cik0001588272:MediaAndTelecommunicationsMember 2023-03-31 0001588272 cik0001588272:CorporateBondsMember cik0001588272:MediaAndTelecommunicationsMember 2023-03-31 0001588272 us-gaap:FairValueInputsLevel1Member us-gaap:CommonStockMember cik0001588272:ChemicalsMember 2023-03-31 0001588272 us-gaap:FairValueInputsLevel2Member us-gaap:CommonStockMember cik0001588272:ChemicalsMember 2023-03-31 0001588272 us-gaap:FairValueInputsLevel3Member us-gaap:CommonStockMember cik0001588272:ChemicalsMember 2023-03-31 0001588272 us-gaap:CommonStockMember cik0001588272:ChemicalsMember 2023-03-31 0001588272 us-gaap:FairValueInputsLevel1Member us-gaap:CommonStockMember cik0001588272:EnergyMember 2023-03-31 0001588272 us-gaap:FairValueInputsLevel2Member us-gaap:CommonStockMember cik0001588272:EnergyMember 2023-03-31 0001588272 us-gaap:FairValueInputsLevel3Member us-gaap:CommonStockMember cik0001588272:EnergyMember 2023-03-31 0001588272 us-gaap:CommonStockMember cik0001588272:EnergyMember 2023-03-31 0001588272 us-gaap:FairValueInputsLevel1Member us-gaap:CommonStockMember cik0001588272:FinancialsMember 2023-03-31 0001588272 us-gaap:FairValueInputsLevel2Member us-gaap:CommonStockMember cik0001588272:FinancialsMember 2023-03-31 0001588272 us-gaap:FairValueInputsLevel3Member us-gaap:CommonStockMember cik0001588272:FinancialsMember 2023-03-31 0001588272 us-gaap:CommonStockMember cik0001588272:FinancialsMember 2023-03-31 0001588272 us-gaap:FairValueInputsLevel1Member us-gaap:CommonStockMember us-gaap:RealEstateMember 2023-03-31 0001588272 us-gaap:FairValueInputsLevel2Member us-gaap:CommonStockMember us-gaap:RealEstateMember 2023-03-31 0001588272 us-gaap:FairValueInputsLevel3Member us-gaap:CommonStockMember us-gaap:RealEstateMember 2023-03-31 0001588272 us-gaap:CommonStockMember us-gaap:RealEstateMember 2023-03-31 0001588272 us-gaap:FairValueInputsLevel1Member us-gaap:CommonStockMember cik0001588272:RealEstateInvestmentTrustsMember 2023-03-31 0001588272 us-gaap:FairValueInputsLevel2Member us-gaap:CommonStockMember cik0001588272:RealEstateInvestmentTrustsMember 2023-03-31 0001588272 us-gaap:FairValueInputsLevel3Member us-gaap:CommonStockMember cik0001588272:RealEstateInvestmentTrustsMember 2023-03-31 0001588272 us-gaap:CommonStockMember cik0001588272:RealEstateInvestmentTrustsMember 2023-03-31 0001588272 us-gaap:FairValueInputsLevel1Member us-gaap:CommonStockMember us-gaap:ServiceMember 2023-03-31 0001588272 us-gaap:FairValueInputsLevel2Member us-gaap:CommonStockMember us-gaap:ServiceMember 2023-03-31 0001588272 us-gaap:FairValueInputsLevel3Member us-gaap:CommonStockMember us-gaap:ServiceMember 2023-03-31 0001588272 us-gaap:CommonStockMember us-gaap:ServiceMember 2023-03-31 0001588272 us-gaap:FairValueInputsLevel1Member us-gaap:CommonStockMember cik0001588272:TelecommunicationServicesMember 2023-03-31 0001588272 us-gaap:FairValueInputsLevel2Member us-gaap:CommonStockMember cik0001588272:TelecommunicationServicesMember 2023-03-31 0001588272 us-gaap:FairValueInputsLevel3Member us-gaap:CommonStockMember cik0001588272:TelecommunicationServicesMember 2023-03-31 0001588272 us-gaap:CommonStockMember cik0001588272:TelecommunicationServicesMember 2023-03-31 0001588272 us-gaap:FairValueInputsLevel1Member cik0001588272:LlcInterestsMember cik0001588272:ConsumerProductsMember 2023-03-31 0001588272 us-gaap:FairValueInputsLevel2Member cik0001588272:LlcInterestsMember cik0001588272:ConsumerProductsMember 2023-03-31 0001588272 us-gaap:FairValueInputsLevel3Member cik0001588272:LlcInterestsMember cik0001588272:ConsumerProductsMember 2023-03-31 0001588272 cik0001588272:LlcInterestsMember cik0001588272:ConsumerProductsMember 2023-03-31 0001588272 us-gaap:FairValueInputsLevel1Member cik0001588272:LlcInterestsMember us-gaap:RealEstateMember 2023-03-31 0001588272 us-gaap:FairValueInputsLevel2Member cik0001588272:LlcInterestsMember us-gaap:RealEstateMember 2023-03-31 0001588272 us-gaap:FairValueInputsLevel3Member cik0001588272:LlcInterestsMember us-gaap:RealEstateMember 2023-03-31 0001588272 cik0001588272:LlcInterestsMember us-gaap:RealEstateMember 2023-03-31 0001588272 us-gaap:FairValueInputsLevel1Member us-gaap:PreferredStockMember cik0001588272:FinancialsMember 2023-03-31 0001588272 us-gaap:FairValueInputsLevel2Member us-gaap:PreferredStockMember cik0001588272:FinancialsMember 2023-03-31 0001588272 us-gaap:FairValueInputsLevel3Member us-gaap:PreferredStockMember cik0001588272:FinancialsMember 2023-03-31 0001588272 us-gaap:PreferredStockMember cik0001588272:FinancialsMember 2023-03-31 0001588272 us-gaap:FairValueInputsLevel1Member us-gaap:PreferredStockMember us-gaap:HealthCareMember 2023-03-31 0001588272 us-gaap:FairValueInputsLevel2Member us-gaap:PreferredStockMember us-gaap:HealthCareMember 2023-03-31 0001588272 us-gaap:FairValueInputsLevel3Member us-gaap:PreferredStockMember us-gaap:HealthCareMember 2023-03-31 0001588272 us-gaap:PreferredStockMember us-gaap:HealthCareMember 2023-03-31 0001588272 us-gaap:FairValueInputsLevel1Member us-gaap:WarrantMember cik0001588272:EnergyMember 2023-03-31 0001588272 us-gaap:FairValueInputsLevel2Member us-gaap:WarrantMember cik0001588272:EnergyMember 2023-03-31 0001588272 us-gaap:FairValueInputsLevel3Member us-gaap:WarrantMember cik0001588272:EnergyMember 2023-03-31 0001588272 us-gaap:WarrantMember cik0001588272:EnergyMember 2023-03-31 0001588272 us-gaap:FairValueInputsLevel1Member us-gaap:WarrantMember cik0001588272:MediaAndTelecommunicationsMember 2023-03-31 0001588272 us-gaap:FairValueInputsLevel2Member us-gaap:WarrantMember cik0001588272:MediaAndTelecommunicationsMember 2023-03-31 0001588272 us-gaap:FairValueInputsLevel3Member us-gaap:WarrantMember cik0001588272:MediaAndTelecommunicationsMember 2023-03-31 0001588272 us-gaap:WarrantMember cik0001588272:MediaAndTelecommunicationsMember 2023-03-31 0001588272 us-gaap:FairValueInputsLevel1Member 2023-03-31 0001588272 us-gaap:FairValueInputsLevel2Member 2023-03-31 0001588272 us-gaap:FairValueInputsLevel3Member 2023-03-31 0001588272 us-gaap:FairValueInputsLevel3Member cik0001588272:SeniorSecuredLoansMember us-gaap:RealEstateMember 2023-03-31 0001588272 cik0001588272:SeniorSecuredLoansMember us-gaap:RealEstateMember 2023-03-31 0001588272 srt:MinimumMember cik0001588272:EquityMethodInvesteeControllingInvestmentMember 2023-03-31 0001588272 srt:MaximumMember cik0001588272:EquityMethodInvesteeControllingInvestmentMember 2023-03-31 0001588272 cik0001588272:BaseRateOf3MonthLiborMember 2023-03-31 0001588272 cik0001588272:BaseRateOf3MonthSofrMember 2023-03-31 0001588272 cik0001588272:BoardOfDirectorsMember 2023-03-31 0001588272 srt:AffiliatedEntityMember 2023-03-31 0001588272 cik0001588272:LlcInterestsMember us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputDiscountRateMember us-gaap:ValuationTechniqueDiscountedCashFlowMember 2023-03-31 0001588272 us-gaap:PreferredStockMember us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputOptionVolatilityMember us-gaap:ValuationTechniqueOptionPricingModelMember 2023-03-31 0001588272 us-gaap:CommonStockMember us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputDiscountRateMember us-gaap:ValuationTechniqueDiscountedCashFlowMember 2023-03-31 0001588272 cik0001588272:SeniorSecuredLoansMember us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputDiscountRateMember us-gaap:ValuationTechniqueDiscountedCashFlowMember 2023-03-31 0001588272 us-gaap:AssetBackedSecuritiesMember us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputDiscountRateMember us-gaap:ValuationTechniqueDiscountedCashFlowMember 2023-03-31 0001588272 srt:MinimumMember cik0001588272:LlcInterestsMember us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputDiscountRateMember us-gaap:ValuationTechniqueDiscountedCashFlowMember 2023-03-31 0001588272 srt:MaximumMember cik0001588272:LlcInterestsMember us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputDiscountRateMember us-gaap:ValuationTechniqueDiscountedCashFlowMember 2023-03-31 0001588272 srt:WeightedAverageMember cik0001588272:LlcInterestsMember us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputDiscountRateMember us-gaap:ValuationTechniqueDiscountedCashFlowMember 2023-03-31 0001588272 srt:MinimumMember cik0001588272:LlcInterestsMember us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputEbitdaMultipleMember cik0001588272:ValuationTechniqueMultipleAnalysisMember 2023-03-31 0001588272 srt:MaximumMember cik0001588272:LlcInterestsMember us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputEbitdaMultipleMember cik0001588272:ValuationTechniqueMultipleAnalysisMember 2023-03-31 0001588272 srt:MinimumMember us-gaap:PreferredStockMember us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputOptionVolatilityMember us-gaap:ValuationTechniqueOptionPricingModelMember 2023-03-31 0001588272 srt:MaximumMember us-gaap:PreferredStockMember us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputOptionVolatilityMember us-gaap:ValuationTechniqueOptionPricingModelMember 2023-03-31 0001588272 srt:WeightedAverageMember us-gaap:PreferredStockMember us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputOptionVolatilityMember us-gaap:ValuationTechniqueOptionPricingModelMember 2023-03-31 0001588272 srt:MinimumMember us-gaap:CommonStockMember us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputDiscountRateMember us-gaap:ValuationTechniqueDiscountedCashFlowMember 2023-03-31 0001588272 srt:MaximumMember us-gaap:CommonStockMember us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputDiscountRateMember us-gaap:ValuationTechniqueDiscountedCashFlowMember 2023-03-31 0001588272 srt:WeightedAverageMember us-gaap:CommonStockMember us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputDiscountRateMember us-gaap:ValuationTechniqueDiscountedCashFlowMember 2023-03-31 0001588272 srt:MinimumMember us-gaap:CommonStockMember us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputEbitdaMultipleMember cik0001588272:ValuationTechniqueMultipleAnalysisMember 2023-03-31 0001588272 srt:MaximumMember us-gaap:CommonStockMember us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputEbitdaMultipleMember cik0001588272:ValuationTechniqueMultipleAnalysisMember 2023-03-31 0001588272 srt:WeightedAverageMember us-gaap:CommonStockMember us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputEbitdaMultipleMember cik0001588272:ValuationTechniqueMultipleAnalysisMember 2023-03-31 0001588272 srt:MinimumMember us-gaap:CommonStockMember us-gaap:FairValueInputsLevel3Member cik0001588272:MeasurementInputUnadjustedPriceMember 2023-03-31 0001588272 srt:MaximumMember us-gaap:CommonStockMember us-gaap:FairValueInputsLevel3Member cik0001588272:MeasurementInputUnadjustedPriceMember 2023-03-31 0001588272 srt:WeightedAverageMember us-gaap:CommonStockMember us-gaap:FairValueInputsLevel3Member cik0001588272:MeasurementInputUnadjustedPriceMember 2023-03-31 0001588272 us-gaap:CommonStockMember us-gaap:FairValueInputsLevel3Member cik0001588272:MeasurementInputEnterpriseValueMember cik0001588272:ValuationTechniqueTransactionIndicationOfValueMember 2023-03-31 0001588272 srt:MinimumMember us-gaap:CommonStockMember us-gaap:FairValueInputsLevel3Member cik0001588272:MeasurementInputRecoveryRateMember cik0001588272:ValuationTechniqueLiquidationAnalysisMember 2023-03-31 0001588272 srt:MaximumMember us-gaap:CommonStockMember us-gaap:FairValueInputsLevel3Member cik0001588272:MeasurementInputRecoveryRateMember cik0001588272:ValuationTechniqueLiquidationAnalysisMember 2023-03-31 0001588272 us-gaap:CommonStockMember us-gaap:FairValueInputsLevel3Member cik0001588272:MeasurementInputNavMultipleMember cik0001588272:ValuationTechniqueNetAssetValueMember 2023-03-31 0001588272 srt:MinimumMember cik0001588272:SeniorSecuredLoansMember us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputDiscountRateMember us-gaap:ValuationTechniqueDiscountedCashFlowMember 2023-03-31 0001588272 srt:MaximumMember cik0001588272:SeniorSecuredLoansMember us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputDiscountRateMember us-gaap:ValuationTechniqueDiscountedCashFlowMember 2023-03-31 0001588272 srt:WeightedAverageMember cik0001588272:SeniorSecuredLoansMember us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputDiscountRateMember us-gaap:ValuationTechniqueDiscountedCashFlowMember 2023-03-31 0001588272 srt:WeightedAverageMember cik0001588272:LlcInterestsMember us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputEbitdaMultipleMember cik0001588272:ValuationTechniqueMultipleAnalysisMember 2023-03-31 0001588272 cik0001588272:AffiliatedInvestmentsMember 2023-01-01 2023-03-31 0001588272 cik0001588272:NonControlledOrNonAffiliatedInvestmentsMember 2023-01-01 2023-03-31 0001588272 cik0001588272:NextPointAdvisorsL.pMember 2023-01-01 2023-03-31 0001588272 cik0001588272:NexpointResidentialTrustInc.Member 2023-01-01 2023-03-31 0001588272 cik0001588272:NexpointCapitalReitLlcSeniorLoansCommonStocksMember 2023-01-01 2023-03-31 0001588272 cik0001588272:NexpointRealEstateFinanceInc.Member 2023-01-01 2023-03-31 0001588272 cik0001588272:SfrWlifIiiLlcMember 2023-01-01 2023-03-31 0001588272 cik0001588272:CoronavirusAidReliefAndEconomicSecurityActMember 2023-01-01 2023-03-31 0001588272 cik0001588272:CoronavirusAidReliefAndEconomicSecurityActMember cik0001588272:U.s.FederalReserveMember 2023-01-01 2023-03-31 0001588272 cik0001588272:FirstQuarterTenderOfferMember 2023-01-01 2023-03-31 0001588272 us-gaap:RetainedEarningsMember 2023-01-01 2023-03-31 0001588272 us-gaap:CommonStockMember 2023-01-01 2023-03-31 0001588272 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-03-31 0001588272 cik0001588272:AdviserMember 2023-01-01 2023-03-31 0001588272 cik0001588272:ExpenseLimitationAgreementMember 2023-01-01 2023-03-31 0001588272 cik0001588272:FirstLienTermLoanMember cik0001588272:HealthcareAtSixteenPointFivePercentageMember cik0001588272:SeniorSecuredLoansAtNineteenPointSixPercentMember cik0001588272:AurisLuxembourgIiiS.a.r.l.Member 2023-01-01 2023-03-31 0001588272 cik0001588272:FirstLienTermLoanMember cik0001588272:HealthcareAtSixteenPointFivePercentageMember cik0001588272:SeniorSecuredLoansAtNineteenPointSixPercentMember cik0001588272:CarestreamHealthIncMember 2023-01-01 2023-03-31 0001588272 cik0001588272:FirstLienTermLoanMember cik0001588272:HealthcareAtSixteenPointFivePercentageMember cik0001588272:SeniorSecuredLoansAtNineteenPointSixPercentMember cik0001588272:CcsMedicalIncMember 2023-01-01 2023-03-31 0001588272 cik0001588272:SecondLienTermLoanMember cik0001588272:HealthcareAtSixteenPointFivePercentageMember cik0001588272:SeniorSecuredLoansAtNineteenPointSixPercentMember cik0001588272:CntHoldingsICorpMember 2023-01-01 2023-03-31 0001588272 cik0001588272:FirstLienDelayedDrawTermLoanMember cik0001588272:HealthcareAtSixteenPointFivePercentageMember cik0001588272:SeniorSecuredLoansAtNineteenPointSixPercentMember cik0001588272:CovenantSurgicalPartnersInc.Member 2023-01-01 2023-03-31 0001588272 cik0001588272:FirstLienTermLoanMember cik0001588272:HealthcareAtSixteenPointFivePercentageMember cik0001588272:SeniorSecuredLoansAtNineteenPointSixPercentMember cik0001588272:CovenantSurgicalPartnersInc.Member 2023-01-01 2023-03-31 0001588272 cik0001588272:FirstLienTermLoanMember cik0001588272:HealthcareAtSixteenPointFivePercentageMember cik0001588272:SeniorSecuredLoansAtNineteenPointSixPercentMember cik0001588272:EnvisionHealthcareCorp.Member 2023-01-01 2023-03-31 0001588272 cik0001588272:SecondLienTermLoanMember cik0001588272:HealthcareAtSixteenPointFivePercentageMember cik0001588272:SeniorSecuredLoansAtNineteenPointSixPercentMember cik0001588272:SoundInpatientPhysiciansMember 2023-01-01 2023-03-31 0001588272 cik0001588272:FirstLienTermLoanMember cik0001588272:HealthcareAtSixteenPointFivePercentageMember cik0001588272:SeniorSecuredLoansAtNineteenPointSixPercentMember cik0001588272:WellpathHoldingsInc.Member 2023-01-01 2023-03-31 0001588272 cik0001588272:FirstLienTermLoanMember cik0001588272:RealEstateAtZeroPointNinePercentageMember cik0001588272:SeniorSecuredLoansAtNineteenPointSixPercentMember cik0001588272:NexpointCapitalReitLlcSeniorLoansCommonStocksMember 2023-01-01 2023-03-31 0001588272 cik0001588272:FirstLienTermLoanEMember cik0001588272:TeleCommunicationServicesAtTwoPointTwoPercentageMember cik0001588272:SeniorSecuredLoansAtNineteenPointSixPercentMember cik0001588272:TerrestarCorp.Member 2023-01-01 2023-03-31 0001588272 cik0001588272:FirstLienTermLoanGMember cik0001588272:TeleCommunicationServicesAtTwoPointTwoPercentageMember cik0001588272:SeniorSecuredLoansAtNineteenPointSixPercentMember cik0001588272:TerrestarCorp.Member 2023-01-01 2023-03-31 0001588272 cik0001588272:FirstLienTermLoanHMember cik0001588272:TeleCommunicationServicesAtTwoPointTwoPercentageMember cik0001588272:SeniorSecuredLoansAtNineteenPointSixPercentMember cik0001588272:TerrestarCorp.Member 2023-01-01 2023-03-31 0001588272 cik0001588272:FirstLienTermLoanFMember cik0001588272:TeleCommunicationServicesAtTwoPointTwoPercentageMember cik0001588272:SeniorSecuredLoansAtNineteenPointSixPercentMember cik0001588272:TerrestarCorp.Member 2023-01-01 2023-03-31 0001588272 cik0001588272:FinancialsAtZeroPointZeroPercentMember cik0001588272:AssetBackedSecuritiesAtZeroPointZeroPercentMember cik0001588272:GraysonInvestorCorp.Member 2023-01-01 2023-03-31 0001588272 cik0001588272:FinancialsAtZeroPointZeroPercentMember cik0001588272:AssetBackedSecuritiesAtZeroPointZeroPercentMember cik0001588272:PamcoClo19971abMember 2023-01-01 2023-03-31 0001588272 cik0001588272:HealthcareAtFourPointFourPercentMember cik0001588272:CorporateBondsAtFourPointNinePercentMember cik0001588272:HadrianMergerSubInc.Member 2023-01-01 2023-03-31 0001588272 cik0001588272:InterestRateAtSixPointThreeEightPercentageMember cik0001588272:MediaAndTelecommunicationsAtZeroPointFivePercentMember cik0001588272:CorporateBondsAtFourPointNinePercentMember cik0001588272:IheartcommunicationsInc.Member 2023-01-01 2023-03-31 0001588272 cik0001588272:InterestRateAtEightPointThreeEightPercentageMember cik0001588272:MediaAndTelecommunicationsAtZeroPointFivePercentMember cik0001588272:CorporateBondsAtFourPointNinePercentMember cik0001588272:IheartcommunicationsInc.Member 2023-01-01 2023-03-31 0001588272 cik0001588272:FirstLienTermLoanMember cik0001588272:HealthcareAtSixteenPointFivePercentageMember cik0001588272:SeniorSecuredLoansAtNineteenPointSixPercentMember 2023-01-01 2023-03-31 0001588272 cik0001588272:ChemicalsAtZeroPointOnePercentageMember cik0001588272:CommonStocksAtTwentySevenPointTwoPercentMember cik0001588272:MpmHoldingsIncMember 2023-01-01 2023-03-31 0001588272 cik0001588272:EnergyAtThreePointTwoPercentageMember cik0001588272:CommonStocksAtTwentySevenPointTwoPercentMember cik0001588272:QuarternorthEnergyInc.Member 2023-01-01 2023-03-31 0001588272 cik0001588272:FinancialsAtThreePointFourPercentageMember cik0001588272:CommonStocksAtTwentySevenPointTwoPercentMember cik0001588272:AmericanBanknoteCorpMember 2023-01-01 2023-03-31 0001588272 cik0001588272:RealEstateAtEightPointSevenPercentageMember cik0001588272:CommonStocksAtTwentySevenPointTwoPercentMember cik0001588272:NexpointRealEstateFinanceInc.Member 2023-01-01 2023-03-31 0001588272 cik0001588272:RealEstateAtEightPointSevenPercentageMember cik0001588272:CommonStocksAtTwentySevenPointTwoPercentMember cik0001588272:IqhqIncMember 2023-01-01 2023-03-31 0001588272 cik0001588272:RealEstateInvestmentTrustAtTwoPointZeroPercentageMember cik0001588272:CommonStocksAtTwentySevenPointTwoPercentMember cik0001588272:NexpointResidentialTrustInc.Member 2023-01-01 2023-03-31 0001588272 cik0001588272:ServiceAtZeroPointZeroPercentageMember cik0001588272:CommonStocksAtTwentySevenPointTwoPercentMember cik0001588272:WayneServicesLegacyInc.Member 2023-01-01 2023-03-31 0001588272 cik0001588272:TelecommunicationServicesAtNinePointEightPercentageMember cik0001588272:CommonStocksAtTwentySevenPointTwoPercentMember cik0001588272:TerrestarCorp..Member 2023-01-01 2023-03-31 0001588272 cik0001588272:ConsumerProductsAtFivePointSixPercentageMember cik0001588272:LLCInterestsAtNineteenPointNinePercentMember cik0001588272:UsGamingLlcMember 2023-01-01 2023-03-31 0001588272 cik0001588272:RealEstateAtFourteenPointThreePercentageMember cik0001588272:LLCInterestsAtNineteenPointNinePercentMember cik0001588272:SfrWlifIiiLlcMember 2023-01-01 2023-03-31 0001588272 cik0001588272:RealEstateAtFourteenPointThreePercentageMember cik0001588272:LLCInterestsAtNineteenPointNinePercentMember cik0001588272:NexpointCapitalReitLlcSeniorLoansCommonStocksMember 2023-01-01 2023-03-31 0001588272 cik0001588272:FinancialsAtTwoPointSevenPercentageMember cik0001588272:PreferredStocksAtTwentyThreePointFourPercentMember cik0001588272:SevenHundredSeventySevenPartnersLlcMember 2023-01-01 2023-03-31 0001588272 cik0001588272:FinancialsAtTwoPointSevenPercentageMember cik0001588272:PreferredStocksAtTwentyThreePointFourPercentMember cik0001588272:UnitedFidelityBankFsbMember 2023-01-01 2023-03-31 0001588272 cik0001588272:HealthcareAtTwentyPointSevenPercentageMember cik0001588272:PreferredStocksAtTwentyThreePointFourPercentMember cik0001588272:ApnimedInc.Member 2023-01-01 2023-03-31 0001588272 cik0001588272:HealthcareAtTwentyPointSevenPercentageMember cik0001588272:PreferredStocksAtTwentyThreePointFourPercentMember cik0001588272:SeriesC2Member cik0001588272:ApnimedInc.Member 2023-01-01 2023-03-31 0001588272 cik0001588272:HealthcareAtTwentyPointSevenPercentageMember cik0001588272:PreferredStocksAtTwentyThreePointFourPercentMember us-gaap:SeriesBPreferredStockMember cik0001588272:SapienceTherapeuticsInc.Member 2023-01-01 2023-03-31 0001588272 cik0001588272:HealthcareAtTwentyPointSevenPercentageMember cik0001588272:PreferredStocksAtTwentyThreePointFourPercentMember cik0001588272:Seriesb1preferredSharesMember cik0001588272:SapienceTherapeuticsInc.Member 2023-01-01 2023-03-31 0001588272 cik0001588272:EnergyAtZeroPointThreePercentageMember cik0001588272:WarrantsAtZeroPointThreePercentMember cik0001588272:QuarternorthTranche1Member 2023-01-01 2023-03-31 0001588272 cik0001588272:EnergyAtZeroPointThreePercentageMember cik0001588272:WarrantsAtZeroPointThreePercentMember cik0001588272:QuarternorthTranche2Member 2023-01-01 2023-03-31 0001588272 cik0001588272:MediaAndTelecommunicationsAtZeroPointZeroPercentageMember cik0001588272:WarrantsAtZeroPointThreePercentMember cik0001588272:IheartmediaInc.Member 2023-01-01 2023-03-31 0001588272 cik0001588272:FinancialsAtTwoPointSevenPercentageMember cik0001588272:PreferredStocksAtTwentyTwoPointThreePercentMember cik0001588272:SevenHundredSeventySevenPartnersLlcMember 2023-01-01 2023-03-31 0001588272 cik0001588272:FinancialsAtTwoPointSevenPercentageMember cik0001588272:PreferredStocksAtTwentyTwoPointThreePercentMember cik0001588272:UnitedFidelityBankFsbMember 2023-01-01 2023-03-31 0001588272 cik0001588272:HealthcareAtNinteenPointSixPercentageMember cik0001588272:PreferredStocksAtTwentyTwoPointThreePercentMember cik0001588272:ApnimedInc.Member 2023-01-01 2023-03-31 0001588272 cik0001588272:HealthcareAtNinteenPointSixPercentageMember cik0001588272:PreferredStocksAtTwentyTwoPointThreePercentMember cik0001588272:SeriesC2Member cik0001588272:ApnimedInc.Member 2023-01-01 2023-03-31 0001588272 cik0001588272:HealthcareAtNinteenPointSixPercentageMember cik0001588272:PreferredStocksAtTwentyTwoPointThreePercentMember us-gaap:SeriesBPreferredStockMember cik0001588272:SapienceTherapeuticsInc.Member 2023-01-01 2023-03-31 0001588272 cik0001588272:TotalInvestmentNinetyFivePointThreeMember 2023-01-01 2023-03-31 0001588272 us-gaap:FairValueInputsLevel3Member us-gaap:AssetBackedSecuritiesMember cik0001588272:GraysonInvestorCorpMember cik0001588272:AssetBackedSecuritiesOneMember 2023-01-01 2023-03-31 0001588272 us-gaap:FairValueInputsLevel3Member us-gaap:AssetBackedSecuritiesMember cik0001588272:PamcoCloNineteenNinetySevenOneABMember cik0001588272:AssetBackedSecuritiesOneMember 2023-01-01 2023-03-31 0001588272 us-gaap:FairValueInputsLevel3Member us-gaap:CommonStockMember cik0001588272:AmericanBanknoteCorpMember cik0001588272:CommonStockOneMember 2023-01-01 2023-03-31 0001588272 us-gaap:FairValueInputsLevel3Member us-gaap:CommonStockMember cik0001588272:IqhqMember cik0001588272:CommonStockOneMember 2023-01-01 2023-03-31 0001588272 us-gaap:FairValueInputsLevel3Member us-gaap:CommonStockMember cik0001588272:TereeStarCorpMember cik0001588272:CommonStockOneMember 2023-01-01 2023-03-31 0001588272 us-gaap:FairValueInputsLevel3Member us-gaap:CommonStockMember cik0001588272:WayneServicesLegacyIncMember cik0001588272:CommonStockOneMember 2023-01-01 2023-03-31 0001588272 us-gaap:FairValueInputsLevel3Member cik0001588272:LlcInterestsMember cik0001588272:NexpointCapitalReitLlcSeniorLoansCommonStocksMember cik0001588272:LlcInterestsOneMember 2023-01-01 2023-03-31 0001588272 us-gaap:FairValueInputsLevel3Member cik0001588272:LlcInterestsMember cik0001588272:SfrWlifThreeLlcMember cik0001588272:LlcInterestsOneMember 2023-01-01 2023-03-31 0001588272 us-gaap:FairValueInputsLevel3Member cik0001588272:LlcInterestsMember cik0001588272:UsGamingLlcMember cik0001588272:LlcInterestsOneMember 2023-01-01 2023-03-31 0001588272 us-gaap:FairValueInputsLevel3Member us-gaap:PreferredStockMember cik0001588272:AprimedIncMember cik0001588272:PreferredStockOneMember 2023-01-01 2023-03-31 0001588272 us-gaap:FairValueInputsLevel3Member us-gaap:PreferredStockMember cik0001588272:AprimedIncMember cik0001588272:SeriesCTwoPreferredStockMember 2023-01-01 2023-03-31 0001588272 us-gaap:FairValueInputsLevel3Member us-gaap:PreferredStockMember cik0001588272:SapienceTherapauticsIncMember us-gaap:SeriesBPreferredStockMember 2023-01-01 2023-03-31 0001588272 us-gaap:FairValueInputsLevel3Member us-gaap:PreferredStockMember cik0001588272:SapienceTherapauticsIncMember cik0001588272:SeriesBOnePreferredStockMember 2023-01-01 2023-03-31 0001588272 us-gaap:FairValueInputsLevel3Member cik0001588272:SeniorSecuredLoansMember cik0001588272:CcsMedicalIncMember cik0001588272:SeniorSecuredLoansOneMember 2023-01-01 2023-03-31 0001588272 us-gaap:FairValueInputsLevel3Member cik0001588272:SeniorSecuredLoansMember cik0001588272:TerreStarCorpMember cik0001588272:SeniorSecuredLoansOneMember 2023-01-01 2023-03-31 0001588272 us-gaap:FairValueInputsLevel3Member cik0001588272:SeniorSecuredLoansMember cik0001588272:TerreStarCorpMember cik0001588272:SeniorSecuredLoansTwoMember 2023-01-01 2023-03-31 0001588272 us-gaap:FairValueInputsLevel3Member cik0001588272:SeniorSecuredLoansMember cik0001588272:TerreStarCorpMember cik0001588272:SeniorSecuredLoansThreeMember 2023-01-01 2023-03-31 0001588272 us-gaap:FairValueInputsLevel3Member cik0001588272:SeniorSecuredLoansMember cik0001588272:TerreStarCorpMember cik0001588272:SeniorSecuredLoansFourMember 2023-01-01 2023-03-31 0001588272 us-gaap:FairValueInputsLevel3Member cik0001588272:SeniorSecuredLoansMember cik0001588272:NexpointCapitalReitLlc.Member cik0001588272:SeniorSecuredLoansOneMember 2023-01-01 2023-03-31 0001588272 cik0001588272:InvestmentsByIndustryMember 2023-01-01 2023-03-31 0001588272 cik0001588272:TypeOfInvestmentDebtOrEquityMember 2023-01-01 2023-03-31 0001588272 cik0001588272:InvestmentsByGeographyMember 2023-01-01 2023-03-31 0001588272 us-gaap:InvestmentsMember cik0001588272:SeniorSecuredLoansMember cik0001588272:TelcommunicationServicesMember 2023-01-01 2023-03-31 0001588272 us-gaap:InvestmentsMember cik0001588272:SeniorSecuredLoansMember us-gaap:HealthCareMember 2023-01-01 2023-03-31 0001588272 us-gaap:InvestmentsMember cik0001588272:AssetBackedSecuritiesOneMember cik0001588272:FinancialsMember 2023-01-01 2023-03-31 0001588272 us-gaap:InvestmentsMember us-gaap:CommonStockMember cik0001588272:FinancialsMember 2023-01-01 2023-03-31 0001588272 us-gaap:InvestmentsMember us-gaap:CommonStockMember us-gaap:RealEstateMember 2023-01-01 2023-03-31 0001588272 us-gaap:InvestmentsMember us-gaap:CommonStockMember us-gaap:ServiceMember 2023-01-01 2023-03-31 0001588272 us-gaap:InvestmentsMember us-gaap:CommonStockMember cik0001588272:TelecommunicationServicesMember 2023-01-01 2023-03-31 0001588272 us-gaap:InvestmentsMember cik0001588272:LlcInterestsMember cik0001588272:ConsumerProductsMember 2023-01-01 2023-03-31 0001588272 us-gaap:InvestmentsMember cik0001588272:LlcInterestsMember us-gaap:RealEstateMember 2023-01-01 2023-03-31 0001588272 us-gaap:InvestmentsMember us-gaap:PreferredStockMember us-gaap:HealthCareMember 2023-01-01 2023-03-31 0001588272 us-gaap:InvestmentsMember 2023-01-01 2023-03-31 0001588272 us-gaap:InvestmentsMember cik0001588272:SeniorSecuredLoansMember us-gaap:RealEstateMember 2023-01-01 2023-03-31 0001588272 cik0001588272:LlcInterestsMember us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputDiscountRateMember us-gaap:ValuationTechniqueDiscountedCashFlowMember 2023-01-01 2023-03-31 0001588272 cik0001588272:LlcInterestsMember us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputEbitdaMultipleMember cik0001588272:ValuationTechniqueMultipleAnalysisMember 2023-01-01 2023-03-31 0001588272 us-gaap:PreferredStockMember us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputOptionVolatilityMember us-gaap:ValuationTechniqueOptionPricingModelMember 2023-01-01 2023-03-31 0001588272 us-gaap:CommonStockMember us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputDiscountRateMember us-gaap:ValuationTechniqueDiscountedCashFlowMember 2023-01-01 2023-03-31 0001588272 us-gaap:CommonStockMember us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputEbitdaMultipleMember cik0001588272:ValuationTechniqueMultipleAnalysisMember 2023-01-01 2023-03-31 0001588272 us-gaap:CommonStockMember us-gaap:FairValueInputsLevel3Member cik0001588272:MeasurementInputEnterpriseValueMember cik0001588272:ValuationTechniqueTransactionIndicationOfValueMember 2023-01-01 2023-03-31 0001588272 us-gaap:CommonStockMember us-gaap:FairValueInputsLevel3Member cik0001588272:MeasurementInputRecoveryRateMember cik0001588272:ValuationTechniqueLiquidationAnalysisMember 2023-01-01 2023-03-31 0001588272 us-gaap:CommonStockMember us-gaap:FairValueInputsLevel3Member cik0001588272:MeasurementInputNavMultipleMember cik0001588272:ValuationTechniqueNetAssetValueMember 2023-01-01 2023-03-31 0001588272 cik0001588272:SeniorSecuredLoansMember us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputDiscountRateMember us-gaap:ValuationTechniqueDiscountedCashFlowMember 2023-01-01 2023-03-31 0001588272 us-gaap:AssetBackedSecuritiesMember us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputDiscountRateMember us-gaap:ValuationTechniqueDiscountedCashFlowMember 2023-01-01 2023-03-31 0001588272 us-gaap:CommonStockMember us-gaap:FairValueInputsLevel3Member cik0001588272:MeasurementInputUnadjustedPriceMember 2023-01-01 2023-03-31 0001588272 cik0001588272:PromissoryNoteMember us-gaap:PreferredStockMember 2023-01-01 2023-03-31 0001588272 cik0001588272:DecemberThirtyFirstTwoThousandAndTwentyFourMember 2021-12-31 0001588272 cik0001588272:MarchThirtyFirstTwoThousandAndTwentyFiveMember 2022-03-31 2022-03-31 0001588272 cik0001588272:JuneThirtyTwoThousandAndTwentyFiveMember 2022-06-30 2022-06-30 0001588272 cik0001588272:JuneThirtyTwoThousandAndTwentyFiveMember 2022-06-30 0001588272 cik0001588272:SeptemberThirtyTwoThousandAndTwentyFiveMember 2022-09-30 2022-09-30 0001588272 cik0001588272:SeptemberThirtyTwoThousandAndTwentyFiveMember 2022-09-30 0001588272 cik0001588272:MarchThirtyFirstTwoThousandAndTwentyFourMember 2021-03-31 2021-03-31 0001588272 cik0001588272:MarchThirtyFirstTwoThousandAndTwentyFourMember 2021-03-31 0001588272 cik0001588272:JuneThirtyTwoThousandAndTwentyFourMember 2021-06-30 2021-06-30 0001588272 cik0001588272:JuneThirtyTwoThousandAndTwentyFourMember 2021-06-30 0001588272 cik0001588272:SeptemberThirtyTwoThousandAndTwentyFourMember 2021-09-30 2021-09-30 0001588272 cik0001588272:SeptemberThirtyTwoThousandAndTwentyFourMember 2021-09-30 0001588272 cik0001588272:DecemberThirtyFirstTwoThousandAndTwentyFourMember 2021-12-31 2021-12-31 0001588272 cik0001588272:ExpirationMember 2020-03-31 2020-03-31 0001588272 cik0001588272:ExpirationMember 2020-03-31 0001588272 cik0001588272:JuneThirtyTwoThousandAndTwentyThreeMember 2020-06-30 2020-06-30 0001588272 cik0001588272:JuneThirtyTwoThousandAndTwentyThreeMember 2020-06-30 0001588272 cik0001588272:SeptemberThirtyTwoThousandAndTwentyThreeMember 2020-09-30 2020-09-30 0001588272 cik0001588272:SeptemberThirtyTwoThousandAndTwentyThreeMember 2020-09-30 0001588272 cik0001588272:DecemberThirtyFirstTwoThousandAndTwentyThreeMember 2020-12-31 2020-12-31 0001588272 cik0001588272:DecemberThirtyFirstTwoThousandAndTwentyThreeMember 2020-12-31 0001588272 cik0001588272:StimulusReliefMember 2020-12-31 0001588272 cik0001588272:CoronavirusAidReliefAndEconomicSecurityActMember cik0001588272:AmericanRescuePlanActMember cik0001588272:U.s.FederalReserveMember 2021-03-01 2021-03-31 0001588272 cik0001588272:MarchThirtyOneTwoThousandTwentySixMember 2023-03-31 2023-03-31 0001588272 cik0001588272:DecemberThirtyFirstTwoThousandAndTwentyFiveMember 2022-12-31 2022-12-31 0001588272 us-gaap:CommonStockMember 2021-12-31 0001588272 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001588272 us-gaap:RetainedEarningsMember 2021-12-31 0001588272 us-gaap:InvestmentsMember cik0001588272:SeniorSecuredLoansMember cik0001588272:TelcommunicationServicesMember 2021-12-31 0001588272 us-gaap:InvestmentsMember cik0001588272:SeniorSecuredLoansMember us-gaap:HealthCareMember 2021-12-31 0001588272 us-gaap:InvestmentsMember cik0001588272:AssetBackedSecuritiesOneMember cik0001588272:FinancialsMember 2021-12-31 0001588272 us-gaap:InvestmentsMember 2021-12-31 0001588272 us-gaap:InvestmentsMember us-gaap:PreferredStockMember us-gaap:HealthCareMember 2021-12-31 0001588272 us-gaap:InvestmentsMember cik0001588272:LlcInterestsMember us-gaap:RealEstateMember 2021-12-31 0001588272 us-gaap:InvestmentsMember cik0001588272:LlcInterestsMember cik0001588272:ConsumerProductsMember 2021-12-31 0001588272 us-gaap:InvestmentsMember us-gaap:CommonStockMember cik0001588272:TelecommunicationServicesMember 2021-12-31 0001588272 us-gaap:InvestmentsMember us-gaap:CommonStockMember us-gaap:ServiceMember 2021-12-31 0001588272 us-gaap:InvestmentsMember us-gaap:CommonStockMember us-gaap:RealEstateMember 2021-12-31 0001588272 us-gaap:InvestmentsMember us-gaap:CommonStockMember cik0001588272:FinancialsMember 2021-12-31 0001588272 us-gaap:InvestmentsMember us-gaap:PreferredStockMember us-gaap:HealthCareMember 2022-03-31 0001588272 us-gaap:InvestmentsMember cik0001588272:LlcInterestsMember us-gaap:RealEstateMember 2022-03-31 0001588272 us-gaap:InvestmentsMember us-gaap:CommonStockMember cik0001588272:TelecommunicationServicesMember 2022-03-31 0001588272 us-gaap:InvestmentsMember cik0001588272:LlcInterestsMember cik0001588272:ConsumerProductsMember 2022-03-31 0001588272 us-gaap:InvestmentsMember 2022-03-31 0001588272 us-gaap:InvestmentsMember cik0001588272:SeniorSecuredLoansMember cik0001588272:TelcommunicationServicesMember 2022-03-31 0001588272 us-gaap:InvestmentsMember cik0001588272:SeniorSecuredLoansMember us-gaap:HealthCareMember 2022-03-31 0001588272 us-gaap:InvestmentsMember cik0001588272:AssetBackedSecuritiesOneMember cik0001588272:FinancialsMember 2022-03-31 0001588272 us-gaap:InvestmentsMember us-gaap:CommonStockMember cik0001588272:FinancialsMember 2022-03-31 0001588272 us-gaap:InvestmentsMember us-gaap:CommonStockMember us-gaap:RealEstateMember 2022-03-31 0001588272 us-gaap:InvestmentsMember us-gaap:CommonStockMember us-gaap:ServiceMember 2022-03-31 0001588272 us-gaap:CommonStockMember 2022-03-31 0001588272 us-gaap:AdditionalPaidInCapitalMember 2022-03-31 0001588272 us-gaap:RetainedEarningsMember 2022-03-31 0001588272 cik0001588272:NexpointResidentialTrustInc.Member 2022-12-31 0001588272 cik0001588272:NexpointCapitalReitLlcSeniorLoansCommonStocksMember 2022-12-31 0001588272 cik0001588272:NexpointRealEstateFinanceInc.Member 2022-12-31 0001588272 cik0001588272:SfrWlifIiiLlcMember 2022-12-31 0001588272 cik0001588272:NexpointResidentialTrustInc.Member 2023-03-31 0001588272 cik0001588272:NexpointCapitalReitLlcSeniorLoansCommonStocksMember 2023-03-31 0001588272 cik0001588272:NexpointRealEstateFinanceInc.Member 2023-03-31 0001588272 cik0001588272:SfrWlifIiiLlcMember 2023-03-31 0001588272 us-gaap:CommonStockMember 2022-12-31 0001588272 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001588272 us-gaap:RetainedEarningsMember 2022-12-31 0001588272 us-gaap:InvestmentsMember cik0001588272:SeniorSecuredLoansMember cik0001588272:TelcommunicationServicesMember 2022-12-31 0001588272 us-gaap:InvestmentsMember cik0001588272:SeniorSecuredLoansMember us-gaap:HealthCareMember 2022-12-31 0001588272 us-gaap:InvestmentsMember cik0001588272:AssetBackedSecuritiesOneMember cik0001588272:FinancialsMember 2022-12-31 0001588272 us-gaap:InvestmentsMember us-gaap:CommonStockMember cik0001588272:FinancialsMember 2022-12-31 0001588272 us-gaap:InvestmentsMember us-gaap:CommonStockMember us-gaap:RealEstateMember 2022-12-31 0001588272 us-gaap:InvestmentsMember us-gaap:CommonStockMember us-gaap:ServiceMember 2022-12-31 0001588272 us-gaap:InvestmentsMember us-gaap:CommonStockMember cik0001588272:TelecommunicationServicesMember 2022-12-31 0001588272 us-gaap:InvestmentsMember cik0001588272:LlcInterestsMember cik0001588272:ConsumerProductsMember 2022-12-31 0001588272 us-gaap:InvestmentsMember cik0001588272:LlcInterestsMember us-gaap:RealEstateMember 2022-12-31 0001588272 us-gaap:InvestmentsMember us-gaap:PreferredStockMember us-gaap:HealthCareMember 2022-12-31 0001588272 us-gaap:InvestmentsMember 2022-12-31 0001588272 us-gaap:InvestmentsMember cik0001588272:SeniorSecuredLoansMember us-gaap:RealEstateMember 2022-12-31 0001588272 us-gaap:InvestmentsMember cik0001588272:SeniorSecuredLoansMember us-gaap:RealEstateMember 2023-03-31 0001588272 us-gaap:InvestmentsMember 2023-03-31 0001588272 us-gaap:InvestmentsMember us-gaap:PreferredStockMember us-gaap:HealthCareMember 2023-03-31 0001588272 us-gaap:InvestmentsMember cik0001588272:SeniorSecuredLoansMember us-gaap:HealthCareMember 2023-03-31 0001588272 us-gaap:InvestmentsMember cik0001588272:AssetBackedSecuritiesOneMember cik0001588272:FinancialsMember 2023-03-31 0001588272 us-gaap:InvestmentsMember us-gaap:CommonStockMember cik0001588272:FinancialsMember 2023-03-31 0001588272 us-gaap:InvestmentsMember us-gaap:CommonStockMember us-gaap:RealEstateMember 2023-03-31 0001588272 us-gaap:InvestmentsMember us-gaap:CommonStockMember us-gaap:ServiceMember 2023-03-31 0001588272 us-gaap:InvestmentsMember us-gaap:CommonStockMember cik0001588272:TelecommunicationServicesMember 2023-03-31 0001588272 us-gaap:InvestmentsMember cik0001588272:LlcInterestsMember cik0001588272:ConsumerProductsMember 2023-03-31 0001588272 us-gaap:InvestmentsMember cik0001588272:LlcInterestsMember us-gaap:RealEstateMember 2023-03-31 0001588272 us-gaap:InvestmentsMember cik0001588272:SeniorSecuredLoansMember cik0001588272:TelcommunicationServicesMember 2023-03-31 0001588272 us-gaap:CommonStockMember 2023-03-31 0001588272 us-gaap:AdditionalPaidInCapitalMember 2023-03-31 0001588272 us-gaap:RetainedEarningsMember 2023-03-31 iso4217:USD shares pure utr:Day iso4217:USD shares 0 0 false Q1 --12-31 0001588272 10-Q true 2023-03-31 2023 false 814-01074 NexPoint Capital, Inc. DE 38-3926499 300 Crescent Court, Suite 700 Dallas TX 75201 972 628-4100 Common Stock, par value $0.001 per share Yes Yes Non-accelerated Filer false false false 9548899 38023138 41687079 37859825 43020714 12788205 12324892 10871704 10273001 1131784 1629846 3318593 0 312746 220194 81858 92216 14029 15905 53590539 55251876 991699 0 317702 314993 262432 371736 859401 870980 2431234 1557709 0.001 0.001 25000000 25000000 0 0 0 0 0.001 0.001 200000000 200000000 9548899 9548899 9677593 9677593 9549 9678 86251861 86949376 -35102105 -33264887 51159305 53694167 5.36 5.55 636822 562607 29847 106711 36707 95633 111456 249659 814832 1014610 265381 299270 75988 76747 52321 59601 41136 50183 40348 39474 25607 20230 18232 17795 9189 18218 4967 3731 533169 585249 81858 61761 451311 523488 363521 491122 20220 241708 0 -74604 -1496947 -1338064 135389 1824855 -1341338 653895 -977817 1145017 0.04 0.05 -0.1 -0.1 0.11 0.11 9699655 9699655 9990797 9990797 9677593 9678 86949376 -33264887 53694167 363521 363521 20220 20220 -1361558 -1361558 181298 181 991518 991699 52604 53 294002 294055 859401 859401 -128694 -128 -697516 -1837218 -2534862 9548899 9550 86251860 -35102105 51159305 0.09 0.09 9956228 9956 91135719 -28206767 62938908 491122 491122 167104 167104 486791 486791 85999 86 550034 550120 48442 49 306103 306152 892680 892680 -37557 -37 -243931 252337 8369 9918671 9919 90891788 -27954430 62947277 0.09 0.09 -977817 1145017 0 -6918805 29847 106711 3345666 5643969 20220 167104 -1361558 486791 -94971 -87336 -3318593 990537 92552 181211 -10358 -37082 -1876 -2558 991699 0 0 -301369 2709 -19351 -109304 57764 1070562 -391751 991699 550120 576925 589909 -1568624 -1140029 -498062 -1531780 1629846 2811171 1131784 1279391 29847 106711 294055 306152 41919 30187 Auris Luxembourg III S.a.r.l. L + 375 4.93 2026-02-27 1465094 1461589 1331038 Carestream Health, Inc. SOFR + 750 5.00 2027-09-30 668605 579387 398990 CCS Medical, Inc L + 1400 1.00 2026-04-07 3000000 2930985 3000000 CNT Holdings I Corp L + 675 4.63 2028-11-06 0 -783 0 Covenant Surgical Partners, Inc. 4% Fixed 2026-07-01 333333 333783 283057 Covenant Surgical Partners, Inc. L + 400 4.82 2026-07-01 1609272 1611581 1366545 Envision Healthcare Corp. L + 375 5.16 2025-10-10 4501911 3754602 348898 Sound Inpatient Physicians L + 675 4.83 2026-06-26 1555556 1486286 1070222 Wellpath Holdings, Inc. L + 550 4.83 2025-10-01 982051 978000 667265 8466015 NexPoint Capital REIT, LLC PRIME 8.00 2025-03-25 463314 463314 463314 TerreStar Corp. 11% PIK 11.00 2024-02-28 838322 838322 836016 TerreStar Corp. 11% PIK 0.00 2024-02-28 35457 35457 35360 TerreStar Corp. 11% PIK 0.00 2024-02-28 33082 33082 32991 TerreStar Corp. 11% PIK 0.00 2024-02-28 198467 198467 197921 1102288 10031617 Grayson Investor Corp. 800 218666 7267 PAMCO CLO 1997-1A B 295435 169875 13 7280 7280 Hadrian Merger Sub, Inc. 2026-05-01 2728000 2476999 2240779 iHeartCommunications, Inc. 2026-05-01 116808 313455 103192 iHeartCommunications, Inc. 2027-05-01 214073 584792 156274 259466 2500245 MPM Holdings, Inc. 8500 17000 42500 Quarternorth Energy, Inc. 11534 981428 1629178 American Banknote Corp. 750000 2062500 1732500 Nexpoint Real Estate Finance, Inc. 131670 2592506 2063263 IQHQ, Inc. 100000 1500000 2359000 4422263 NexPoint Residential Trust, Inc. 23409 698189 1022291 Wayne Services Legacy Inc. 237 253404 2268 TerreStar Corp. 14035 1599990 5032249 13883249 US Gaming, LLC 1700 1700000 2841603 SFR WLIF III, LLC 451112 451111 418181 NexPoint Capital REIT, LLC 727 8583085 6904655 7322836 10164439 777 Partners, LLC 0.10 750 750000 720000 United Fidelity Bank FSB 0.07 1000 1000000 680000 1400000 Apnimed, Inc. 0.08 135122 1199994 1499989 Apnimed, Inc. 0.08 72065 799993 799993 Sapience Therapeutics, Inc. 0.08 1619048 4080000 4581906 Sapience Therapeutics, Inc. 0.08 1111111 4000000 3700000 10581888 11981888 QuarterNorth Tranche 1 5738 16122 58815 QuarterNorth Tranche 2 11051 5175 93933 152748 iHeartMedia, Inc. 2875 52987 10063 162811 50811343 48731529 773826 1653950 51159305 0.25 0.05 0.049 0.0519 0.0451 34445226 0.673 10871704 0.213 2248059 0.044 Auris Luxembourg III S.a.r.l. L + 375 4.93% 2026-02-27 1468909 1465131 1318346 Carestream Health, Inc. L + 675 12.18% 2027-09-30 668605 576001 511483 CCS Medical, Inc 14% Fixed 2026-04-07 3000000 2926520 3000000 CNT Holdings I Corp L + 675 3.74% 2028-11-06 1500000 1494084 1422503 Covenant Surgical Partners, Inc. 4% Fixed 2026-07-01 333333 333817 282500 Covenant Surgical Partners, Inc. L + 400 4.41% 2026-07-01 1613305 1615775 1367276 Envision Healthcare Corp. L + 375 4.07% 2025-10-10 4518572 3709077 1354645 RxBenefits, Inc. L +450 2.11% 2027-12-20 1993177 1963107 1888535 Sound Inpatient Physicians L + 675 4.07% 2026-06-26 1555556 1481972 1229869 Wellpath Holdings, Inc. L + 550 4.41% 2025-10-01 984615 980197 783793 13158950 TerreStar Corp. 11%PIK 2024-02-28 32189 32189 32002 TerreStar Corp. 11%PIK 2024-02-28 193108 193108 191988 TerreStar Corp. 11%PIK 2024-02-28 815685 815684 810953 TerreStar Corp. 11%PIK 2024-02-28 34500 34500 34300 1069243 14228193 Grayson Investor Corp. 800 218666 7023 PAMCO CLO 1997-1A B 295435 169875 13 7036 7036 Hadrian Merger Sub, Inc. 8.500% 2026-05-01 2728000 2460536 2414839 iHeartCommunications, Inc. 6.375% 2026-05-01 116808 313455 107648 iHeartCommunications, Inc. 8.375% 2027-05-01 214073 584792 182430 290078 2704917 MPM Holdings, Inc. 8500 17000 42500 Quarternorth Energy, Inc. 11534 981428 1591692 American Banknote Corp. 750000 2062500 1732500 Nexpoint Real Estate Finance, Inc. 481670 9960591 7653730 IQHQ, Inc. 100000 1500000 2359000 10012730 NexPoint Residential Trust, Inc. 23409 698189 1018779 Wayne Services Legacy Inc. 237 253404 2269 TerreStar Corp. 14035 1599990 5114214 19514684 US Gaming, LLC 2000 2000000 3088750 SFR WLIF III, LLC 451112 451112 424468 NexPoint Capital REIT, LLC 100 1215000 1176024 1600492 4689242 777 Partners, LLC 0.10 750 750000 740625 United Fidelity Bank FSB 0.07 1000 1000000 700000 1440625 Apnimed, Inc. 0.08 135122 1199993 1499989 Apnimed, Inc. 0.08 72065 799994 799994 Sapience Therapeutics, Inc. 0.08 1619048 4080000 4549525 Sapience Therapeutics, Inc. 1111111 4000000 3677777 10527285 11967910 QuarterNorth Tranche 1 2029-08-27 5738 16122 64553 QuarterNorth Tranche 2 2029-08-27 11051 5175 96696 161249 iHeartMedia, Inc. 2039-05-01 2875 52987 20484 181733 54011971 53293715 1420428 -1019976 53694167 0.25 0.05 0.048 0.0514 0.0477 28500789 0.53 0.0439 2421875 0.045 10273001 0.191 <div style="margin-top: 12pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">Note 1 — Organization </div></div> <div style="text-indent: 9%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">NexPoint Capital, Inc. (the “Company”) is an externally managed, <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-diversified,</div> <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">closed-end</div> management investment company that has elected to be regulated as a business development company (“BDC”) under the 1940 Act. The Company follows the investment company accounting and reporting guidance of the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 946 <div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Financial Services—Investment Companies.</div></div> The Company’s investment objective is to generate current income and capital appreciation primarily through investments in middle-market healthcare companies, middle-market companies in <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-healthcare</div> sectors, syndicated floating rate debt of large public and nonpublic companies and collateralized loan obligations. The Company has elected to be treated for federal income tax purposes, and intends to qualify annually thereafter, as a regulated investment company (“RIC”), under Subchapter M of the Internal Revenue Code of 1986, as amended (the “Code”). In this report, “we,” “us” and “our” refer to NexPoint Capital, Inc. </div></div> <div style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The Company was formed in Delaware on September 30, 2013 and formally commenced operations on September 2, 2014 upon satisfying the minimum offering requirement by raising gross proceeds of $10.0 million in connection with a private placement with NexPoint Advisors, L.P. (the “Adviser”), our external advisor. In aggregate as of March 31, 2023, the Adviser controls 2,549,002 total shares of common stock (or 26.7%) of the Company, including reinvestment of dividends, for a net amount of approximately $13.7 million. </div> <div style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The Company has retained the Adviser to manage certain aspects of its affairs on a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">day-to-day</div></div> basis. NexPoint Securities, Inc. (the “Dealer Manager”), an entity under common ownership with the Adviser, served as the dealer manager of the Company’s continuous public offering prior to the termination of the offering. The Adviser and Dealer Manager are related parties and will receive fees and other compensation for services related to the investment and management of the Company’s assets and the continuous public offering. The Company’s continuous public offering ended on February 14, 2018. </div> 10000000 2549002 0.267 13700000 <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">Note 2 — Summary of Significant Accounting Policies </div></div> <div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Basis of Accounting </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The accompanying financial statements of the Company are prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”). Additionally, the accompanying financial statements of the Company and related financial information have been prepared pursuant to the requirements for reporting on Form <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">10-Q</div> and Article 10 of Regulation <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">S-X.</div> The current period’s results of operations will not necessarily be indicative of results that ultimately may be achieved for the fiscal year ending December 31, 2023. The interim financial data as of March 31, 2023 and for the three months ended March 31, 2023 and 2022 is unaudited. In the opinion of management, the interim financial data includes all adjustments, consisting only of the normal recurring adjustments, necessary to a fair statement of the results for the interim periods. </div> <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Use of Estimates </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of increases and decreases in net assets from operations during the reporting period. Actual results could differ from those estimates. </div> <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Statements of Cash Flows </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Information on financial transactions which have been settled through the receipt or disbursement of cash is presented in the Statements of Cash Flows. The cash amount shown in the Statements of Cash Flows is the amount included within the Company’s Statements of Assets and Liabilities and includes cash on hand at its custodian bank. </div> <div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;"> </div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"> </div> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Cash and Cash Equivalents </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The Company considers liquid assets deposited with a bank, money market funds, and certain short-term debt instruments with original maturities of three months or less to be cash equivalents. These investments represent amounts held with financial institutions that are readily accessible to pay Company expenses or purchase investments. Cash and cash equivalents are valued at cost plus accrued interest, which approximates fair value. The value of cash equivalents denominated in foreign currencies, if any, is determined by converting to U.S. dollars on the date of the Statements of Assets and Liabilities. As of March 31, 2023 and December 31, 2022, the Company had cash and cash equivalents of $1,131,784 and $1,629,846, respectively. As of March 31, 2023 and December 31, 2022, $773,826 and $1,420,428 was held in the State Street U.S. Government Money Market Fund, and $357,958 and $209,418 was held in a custodial account with State Street Bank and Trust Company, respectively. </div> <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Securities Sold Short and Restricted Cash </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The Company may sell securities short. A security sold short is a transaction in which the Company sells a security it does not own in anticipation that the market price of that security will decline. When the Company sells a security short, it must borrow the security sold short from a broker-dealer and deliver it to the buyer upon conclusion of the transaction. The Company may have to pay a fee to borrow particular securities and is often obligated to pay over any dividends or other payments received on such borrowed securities. Cash held as collateral for securities sold short is classified as restricted cash on the Statements of Assets and Liabilities, when applicable. Securities held as collateral for securities sold short are shown on the Schedules of Investments for the Company, as applicable. As of March 31, 2023 and December 31, 2022, the Company did not have any securities sold short. </div> <div style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">When securities are sold short, the Company intends to limit exposure to a possible market decline in the value of its portfolio companies through short sales of securities that the Adviser believes possess volatility characteristics similar to those being hedged. In addition, the Company may use short sales for <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-hedging</div> purposes to pursue its investment objective. Subject to the requirements of the 1940 Act and the Code, the Company will not make a short sale if, after giving effect to such sale, the market value of all securities sold short by the Company exceeds 25% of the value of its total assets. </div> <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Other Fee Income </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Fee income may consist of origination/closing fees, amendment fees, administrative agent fees, transaction <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">break-up</div> fees and other miscellaneous fees. Origination fees, amendment fees, and other similar fees are <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-recurring</div> fee sources. Such fees are received on a transaction by transaction basis and do not constitute a regular stream of income. For the three months ended March 31, 2023 and March 31, 2022, the Company recognized $0 and $0 of fee income, respectively. </div> <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Fair Value of Financial Instruments </div></div></div></div> <div style="text-indent: 9%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="display:inline;">It is the Company’s policy to hold the investments at fair value. ASC Topic 820, <div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Fair Value Measurements and Disclosure</div></div> (“ASC Topic 820”) defines fair value as the price that would be received from the sale of an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. ASC Topic 820 also establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. These tiers include: Level 1, defined as observable inputs such as quoted prices in active markets; Level 2, which includes inputs such as quoted prices for similar securities in active markets and quoted prices for identical securities where there is little or no activity in the market; and Level 3, defined as unobservable inputs for which little or no market data exists, therefore requiring an entity to develop its own assumptions. </div></div> <div style="text-indent: 9%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">Pursuant to Rule <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2a-5</div> under the 1940 Act, the Board has designated the Adviser as the Company’s valuation designee to perform the fair valuation determination for securities and other assets held by the Company. The Company determines the net asset value of its investment portfolio each quarter, or more frequently as needed. Securities that are publicly-traded are valued at the reported closing price on the valuation date. Securities that are not publicly-traded are valued at fair value as determined in good faith by the Adviser as valuation designee, pursuant to board-approved policies and procedures. In connection with that determination, the Adviser will consider portfolio company valuations based on relevant inputs, including indicative dealer quotes, values of like securities, recent portfolio company financial statements and forecasts, and valuations prepared by third-party valuation services. Rule <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2a-5</div> states that a market quotation is readily available only when that quotation is a quoted price (unadjusted) in active markets for identical investments that the Company can access at the measurement date, provided that a quotation will not be readily available if it is not reliable. Market quotations may also not be “readily available” if a significant event occurs that causes the Adviser to believe that the market price of a security no longer represents the security’s current value at the time of the Company’s net asset value (“NAV”) determination. </div></div> <div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;"> </div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"> </div> <div/><div> <div style="background-color:white;display: inline;"> </div> </div> <div style="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">With respect to investments for which market quotations are not readily available, the Adviser undertakes a multi-step valuation process each quarter, as described below: </div> <div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:10%"> </td> <td style="width:2%;vertical-align:top;text-align:left;">•</td> <td style="width:1%;vertical-align:top"> </td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-align: left; line-height: normal;">The valuation process begins with each portfolio company or investment being initially valued by investment professionals of the Adviser responsible for credit monitoring or independent third party valuation firms. </div> </td> </tr> </table> <div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:10%"> </td> <td style="width:2%;vertical-align:top;text-align:left;">•</td> <td style="width:1%;vertical-align:top"> </td> <td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;">Preliminary valuation conclusions are then documented and discussed with a committee comprised of certain senior management employees of the Adviser (the “Valuation Committee”) established by the Adviser to assist the Adviser in discharging its responsibilities as valuation designee. </div> </td> </tr> </table> <div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:10%"> </td> <td style="width:2%;vertical-align:top;text-align:left;">•</td> <td style="width:1%;vertical-align:top"> </td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-align: left; line-height: normal;">At least once each quarter, the valuations for approximately one quarter of the portfolio investments that have been fair valued are reviewed by an independent valuation firm such that, over the course of a year, each material portfolio investment that has been fair valued shall have been reviewed by an independent valuation firm at least once. </div> </td> </tr> </table> <div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:10%"> </td> <td style="width:2%;vertical-align:top;text-align:left;">•</td> <td style="width:1%;vertical-align:top"> </td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-align: left; line-height: normal;">Based on this information, the Adviser discusses valuations and determines the fair value of each investment in the portfolio in good faith pursuant to board-approved policies and procedures. </div> </td> </tr> </table> <div style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">As of March 31, 2023, the Company held the following investments for which a sufficient level of current, reliable market quotations were not available: </div> <div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:76%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:61%"/> <td style="vertical-align:bottom;width:5%"/> <td style="width:23%"/> <td style="vertical-align:bottom;width:5%"/> <td/> <td/> <td/> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Instrument</div></div> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"> <div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;">Type</div></div> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Fair value</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Grayson Investor Corp.</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Asset-Backed Securities</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"> 7,267</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">PAMCO CLO <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">1997-1A</div> B</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">Asset-Backed Securities</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">13</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">American Banknote Corp.</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">Common Stocks</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,732,500</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">IQHQ, Inc.</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">Common Stocks</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,359,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">TerreStar Corp.</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">Common Stocks</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,032,249</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Wayne Services Legacy, Inc.</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">Common Stocks</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,268</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">NexPoint Capital REIT, LLC</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">LLC Interests</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">6,904,655</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">SFR WLIF III, LLC</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">LLC Interests</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">418,181</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">US Gaming, LLC</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">LLC Interests</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,841,603</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Apnimed, Inc.</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">Preferred Stocks</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,499,989</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Apnimed, Inc.</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">Preferred Stocks</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">799,993</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Sapience Therapeutics, Inc.</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">Preferred Stocks</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,581,906</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Sapience Therapeutics, Inc.</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">Preferred Stocks</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,700,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">CCS Medical, Inc.</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">Senior Secured Loans</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,000,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">NexPoint Capital REIT<div style="letter-spacing: 0px; top: 0px;;display:inline;">,</div> <div style="letter-spacing: 0px; top: 0px;;display:inline;">LLC</div></div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">Senior Secured Loans</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">463,314</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">TerreStar Corp.</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">Senior Secured Loans</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">836,016</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">TerreStar Corp.</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">Senior Secured Loans</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">197,921</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">TerreStar Corp.</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">Senior Secured Loans</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">35,360</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">TerreStar Corp.</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">Senior Secured Loans</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">32,991</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> </table> <div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"> </div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"/> <div style="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">As of December 31, 2022, the Company held the following investments for which a sufficient level of current, reliable market quotations were not available: </div> <div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:76%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:61%"/> <td style="vertical-align:bottom;width:5%"/> <td style="width:23%"/> <td style="vertical-align:bottom;width:5%"/> <td/> <td/> <td/> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Instrument</div></div> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"> <div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;">Type</div></div> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Fair value</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Grayson Investor Corp.</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Asset-Backed Securities</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"> 7,023</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">PAMCO CLO <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">1997-1A</div> B</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">Asset-Backed Securities</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">13</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">American Banknote Corp.</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">Common Stocks</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,732,500</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">IQHQ, Inc.</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">Common Stocks</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,359,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">TerreStar Corp.</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">Common Stocks</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,114,214</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Wayne Services Legacy, Inc.</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">Common Stocks</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,269</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">NexPoint Capital REIT, LLC</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">LLC Interests</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,176,024</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">SFR WLIF III, LLC</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">LLC Interests</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">424,468</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">US Gaming, LLC</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">LLC Interests</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,088,750</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Apnimed, Inc.</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">Preferred Stocks</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,499,989</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Apnimed, Inc.</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">Preferred Stocks</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">799,994</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Sapience Therapeutics, Inc.</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">Preferred Stocks</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,549,525</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Sapience Therapeutics, Inc.</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">Preferred Stocks</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,677,777</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">CCS Medical, Inc.</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">Senior Secured Loans</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,000,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">TerreStar Corp.</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">Senior Secured Loans</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">810,953</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">TerreStar Corp.</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">Senior Secured Loans</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">191,988</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">TerreStar Corp.</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">Senior Secured Loans</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">34,300</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">TerreStar Corp.</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">Senior Secured Loans</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">32,002</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> </table> <div style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Determination of fair value involves subjective judgments and estimates. Accordingly, the notes to the Company’s financial statements will refer to the uncertainty with respect to the possible effect of such valuations, and any change in such valuations, in the Company’s financial statements. Below is a description of factors that the Adviser and the Valuation Committee may consider when valuing the Company’s debt and equity investments. </div> <div style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Valuation of fixed income investments, such as loans and debt securities, depends upon a number of factors, including prevailing interest rates for like securities, expected volatility in future interest rates, call features, put features and other relevant terms of the debt. For investments without readily available market prices, the Company may incorporate these factors into discounted cash flow models to arrive at fair value. Other factors that the Adviser and the Valuation Committee may consider include the borrower’s ability to adequately service its debt, the fair market value of the portfolio company in relation to the face amount of its outstanding debt and the quality of collateral securing the Company’s debt investments. </div> <div style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The Company’s equity investments in portfolio companies for which there is no liquid public market will be valued at fair value. The Adviser and the Valuation Committee, in its analysis of fair value, may consider various factors, such as multiples of earnings before interest, taxes, depreciation and amortization (“EBITDA”), cash flows, net income, revenues or, in limited instances, book value or liquidation value. All of these factors may be subject to adjustments based upon the particular circumstances of a portfolio company or the Company’s actual investment position. For example, adjustments to EBITDA may take into account compensation to previous owners or acquisition, recapitalization, restructuring or other related items. </div> <div style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The Adviser and the Valuation Committee may also look to private merger and acquisition statistics, public trading multiples discounted for illiquidity and other factors, valuations implied by third-party investments in the portfolio companies or industry practices in determining fair value. The Adviser and the Valuation Committee may also consider the size and scope of a portfolio company and its specific strengths and weaknesses, as well as any other factors it deems relevant in assessing the value. Generally, the value of the Company’s equity interests in public companies for which market quotations are readily available will be based upon the most recent closing public market price. </div> <div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"> </div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"/> <div style="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">If the Company receives warrants or other equity-linked securities at nominal or no additional cost in connection with an investment in a debt security, the Company will allocate the cost basis in the investment between the debt securities and any such warrants or other equity-linked securities received at the time of origination. The Adviser and the Valuation Committee will subsequently value these warrants or other equity-linked securities received at fair value. </div><div style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">As applicable, the Company values its Level 2 assets by using the midpoint of the prevailing bid and ask prices from dealers on the date of the relevant period end, which is provided by an independent third-party pricing service and screened for validity by such service. For investments for which the third-party pricing service is unable to obtain quoted prices, the Company obtains bid and ask prices directly from dealers who make a market in such investments. </div><div style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">To the extent that the Company holds investments for which no active secondary market exists and, therefore, no bid and ask prices can be readily obtained, the Adviser and the Valuation Committee utilize an independent third-party valuation service to value such investments in a manner consistent with the Company’s multistep valuation process previously described. </div><div style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The Company periodically benchmarks the bid and ask prices received from the third-party pricing service and/or dealers, as applicable, and valuations received from the third-party valuation service against the actual prices at which it purchases and sells its investments. The Company believes that these prices are reliable indicators of fair value. The Adviser and the Valuation Committee review and approve the valuation determinations made with respect to these investments in a manner consistent with the Company’s valuation procedures. </div><div style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">As of March 31, 2023, the Company’s investments consisted of senior secured loans, asset-backed securities, common stocks, LLC interests, preferred stocks, corporate bonds, and warrants, which may be purchased for a fraction of the price of the underlying securities. The fair value of the Company’s loans, bonds and asset-backed securities are generally based on quotes received from brokers or independent pricing services. Loans, bonds and asset-backed securities with quotes that are based on actual trades with a sufficient level of activity on or near the measurement date are classified as Level 2 assets. Loans, bonds and asset-backed securities that are priced using quotes derived from implied values, indicative bids or a limited number of actual trades are classified as Level 3 assets because the inputs used by the brokers and pricing services to derive the values are not readily observable. </div><div style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The fair value of the Company’s common stocks and options that are not actively traded on national exchanges are generally priced using quotes derived from implied values, indicative bids, or a limited amount of actual trades and are classified as Level 3 assets because the inputs used by the brokers and pricing services to derive the values are not readily observable. Exchange traded options are valued based on the last trade price on the primary exchange on which they trade. If an option does not trade, the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">mid-price</div> is utilized to value the option. </div><div style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">At the end of each calendar quarter, the Adviser evaluates the Level 2 and 3 investments for changes in liquidity, including: whether a broker is willing to execute at the quoted price, the depth and consistency of prices from third party services, and the existence of contemporaneous, observable trades in the market. Additionally, management evaluates the Level 1 and 2 assets and liabilities on a quarterly basis for changes in listings or delistings on national exchanges. </div><div style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Due to the inherent uncertainty of determining the fair value of investments that do not have a readily available market price, the fair value of the Company’s investments may fluctuate from period to period. Additionally, the fair value of investments may differ significantly from the values that would have been used had a ready market existed for such investments and may differ materially from the values the Company may ultimately realize. Further, such investments may be subject to legal and other restrictions on resale or otherwise less liquid than publicly traded securities. </div><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"> </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"/><div style="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The inputs or methodology used for valuing investments are not necessarily an indication of the risk associated with investing in those investments. The following are summaries of the Company’s investments categorized within the fair value hierarchy as of March 31, 2023 and December 31, 2022: </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:92%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:53%"/> <td style="vertical-align:bottom;width:3%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:3%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:3%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:3%"/> <td/> <td/> <td/></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="14" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">March 31, 2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Investments</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level 1</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level 2</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level 3</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Total</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:1pt"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td colspan="16" style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Assets</div></div></td> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0em; text-indent: 0em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;"> </div></div></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td colspan="16" style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Senior Secured Loans</div></td> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0em; text-indent: 0em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"> </div></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Healthcare</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,466,015</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,000,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">8,466,015</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Real Estate</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">463,314</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">463,314</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Telecommunication Services</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,102,288</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,102,288</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td colspan="16" style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Asset-Backed Securities</div></td> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0em; text-indent: 0em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"> </div></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Financials</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">7,280</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">7,280</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td colspan="16" style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Corporate Bonds</div></td> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0em; text-indent: 0em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"> </div></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Healthcare</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,240,779</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,240,779</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Media/Telecommunications</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">259,466</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">259,466</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td colspan="16" style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Common Stocks</div></td> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0em; text-indent: 0em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"> </div></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Chemicals</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">42,500</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">42,500</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Energy</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,629,178</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,629,178</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Financials</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,732,500</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,732,500</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Real Estate</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,063,263</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,359,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,422,263</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Real Estate Investment Trusts (REITs)</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,022,291</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,022,291</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Service</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,268</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,268</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Telecommunication Services</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,032,249</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,032,249</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td colspan="16" style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">LLC Interests</div></td> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0em; text-indent: 0em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"> </div></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Consumer Products</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,841,603</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,841,603</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Real Estate</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">7,322,836</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">7,322,836</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td colspan="16" style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Preferred Stocks</div></td> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0em; text-indent: 0em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"> </div></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Financials</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,400,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,400,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Healthcare</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">10,581,888</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">10,581,888</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td colspan="16" style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Warrants</div></td> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0em; text-indent: 0em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"> </div></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Energy</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">152,748</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">152,748</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Media/Telecommunications</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">10,063</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">10,063</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Total Assets</div></div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">3,085,554</div></div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">11,200,749</div></div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">34,445,226</div></div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">48,731,529</div></div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Total Investments</div></div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">3,085,554</div></div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">11,200,749</div></div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">34,445,226</div></div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">48,731,529</div></div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"> </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"/> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 92%; border: 0px; margin: 0px auto; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width:53%"><br/></td> <td style="vertical-align:bottom;width:3%"><br/></td> <td><br/></td> <td><br/></td> <td><br/></td> <td style="vertical-align:bottom;width:3%"><br/></td> <td><br/></td> <td><br/></td> <td><br/></td> <td style="vertical-align:bottom;width:3%"><br/></td> <td><br/></td> <td><br/></td> <td><br/></td> <td style="vertical-align:bottom;width:3%"><br/></td> <td><br/></td> <td><br/></td> <td><br/></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="14" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December 31, 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Investments</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level 1</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level 2</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level 3</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Total</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:1pt"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td colspan="16" style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Assets</div></div></td> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0em; text-indent: 0em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;"> </div></div></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td colspan="16" style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Senior Secured Loans</div></td> <td style="vertical-align:top"><div style="margin-top: 0px; margin-bottom: 0px; margin-left: 0em; text-indent: 0em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"> </div></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Healthcare</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">10,158,950</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,000,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">13,158,950</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Telecommunication Services</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,069,243</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,069,243</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td colspan="16" style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Asset-Backed Securities</div></td> <td style="vertical-align:top"><div style="margin-top: 0px; margin-bottom: 0px; margin-left: 0em; text-indent: 0em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"> </div></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Financials</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">7,036</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">7,036</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td colspan="16" style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Corporate Bonds</div></td> <td style="vertical-align:top"><div style="margin-top: 0px; margin-bottom: 0px; margin-left: 0em; text-indent: 0em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"> </div></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Healthcare</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,414,839</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,414,839</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Media/Telecommunications</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">290,078</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">290,078</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td colspan="16" style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Common Stocks</div></td> <td style="vertical-align:top"><div style="margin-top: 0px; margin-bottom: 0px; margin-left: 0em; text-indent: 0em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"> </div></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Chemicals</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">42,500</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">42,500</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Energy</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,591,692</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,591,692</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Financials</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,732,500</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,732,500</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Real Estate</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">7,653,730</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,359,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">10,012,730</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Real Estate Investment Trusts (REITs)</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,018,779</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,018,779</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Service</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,269</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,269</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Telecommunication Services</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,114,214</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,114,214</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td colspan="16" style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">LLC Interests</div></td> <td style="vertical-align:top"><div style="margin-top: 0px; margin-bottom: 0px; margin-left: 0em; text-indent: 0em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"> </div></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Consumer Products</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,088,750</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,088,750</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Real Estate</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,600,492</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,600,492</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td colspan="16" style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Preferred Stocks</div></td> <td style="vertical-align:top"><div style="margin-top: 0px; margin-bottom: 0px; margin-left: 0em; text-indent: 0em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"> </div></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Financials</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,440,625</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,440,625</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Healthcare</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">10,527,285</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">10,527,285</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td colspan="16" style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Warrants</div></td> <td style="vertical-align:top"><div style="margin-top: 0px; margin-bottom: 0px; margin-left: 0em; text-indent: 0em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"> </div></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Energy</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">161,249</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">161,249</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Media/Telecommunications</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">20,484</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">20,484</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Total Assets</div></div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">8,672,509</div></div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">16,120,417</div></div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">28,500,789</div></div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">53,293,715</div></div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Total Investments</div></div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">8,672,509</div></div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">16,120,417</div></div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">28,500,789</div></div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">53,293,715</div></div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table> <div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;"> </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"/><div/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"/><div style="letter-spacing: 0px; top: 0px;;display:inline;"/><div style="text-indent: 9%; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The table below sets forth a summary of changes in the Company’s Level 3 investments (measured at fair value using significant unobservable inputs) for the three months ended March 31, 2023. The table below includes noncash transactions for the three months ended March 31, 2023. </div></div></div><div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 8pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="font-size: 0px;"> <td style="width: 31%;"><br/></td> <td style="width: 2%; vertical-align: bottom;"><br/></td> <td><br/></td> <td><br/></td> <td><br/></td> <td style="width: 2%; vertical-align: bottom;"><br/></td> <td><br/></td> <td><br/></td> <td><br/></td> <td style="width: 2%; vertical-align: bottom;"><br/></td> <td><br/></td> <td><br/></td> <td><br/></td> <td style="width: 2%; vertical-align: bottom;"><br/></td> <td><br/></td> <td><br/></td> <td><br/></td> <td style="width: 2%; vertical-align: bottom;"><br/></td> <td><br/></td> <td><br/></td> <td><br/></td> <td style="width: 2%; vertical-align: bottom;"><br/></td> <td><br/></td> <td><br/></td> <td><br/></td> <td style="width: 2%; vertical-align: bottom;"><br/></td> <td><br/></td> <td><br/></td> <td><br/></td> <td style="width: 2%; vertical-align: bottom;"><br/></td> <td><br/></td> <td><br/></td> <td><br/></td> <td><br/></td> <td style="width: 2%; vertical-align: bottom;"><br/></td> <td><br/></td> <td><br/></td> <td><br/></td> <td style="width: 2%; vertical-align: bottom;"><br/></td> <td><br/></td> <td><br/></td> <td><br/></td> <td style="width: 2%; vertical-align: bottom;"><br/></td> <td><br/></td> <td><br/></td> <td><br/></td></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Investments:</div></div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Balance as of<br/>December 31,<br/>2022</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Transfers<br/>into<br/>Level 3</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Transfer<br/>s out of<br/>Level 3</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Net<br/>amortization<br/>(accretion) of<br/>premium/<br/>(discount)</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Distribution<br/>to Return<br/>Capital</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Net realized<br/>gains/<br/>(losses)</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Net</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">change in<br/>unrealized<br/>gains/<br/>(losses)</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Purchases/<br/>PIK</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding: 0px;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(Sales<br/>and<br/>redemptions)</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Balance as of<br/>March 31,<br/>2023</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Change in<br/>unrealized<br/>gain/(loss)<br/>on Level 3<br/>securities still<br/>held at period<br/>end</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Assets</div></div></div></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/><br/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/><br/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/><br/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/><br/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/><br/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/><br/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/><br/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/><br/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/><br/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/><br/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/><br/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/><br/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/><br/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/><br/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/><br/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/><br/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/><br/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/><br/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/><br/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/><br/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/><br/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/><br/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/><br/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/><br/></td> <td style="vertical-align: bottom; padding: 0px;"> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/><br/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/><br/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/><br/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/><br/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/><br/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/><br/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/><br/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/><br/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/><br/></td></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Senior Secured Loans</div></div></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/><br/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/><br/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/><br/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/><br/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/><br/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/><br/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/><br/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/><br/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/><br/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/><br/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/><br/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/><br/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/><br/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/><br/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/><br/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/><br/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/><br/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/><br/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/><br/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/><br/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/><br/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/><br/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/><br/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/><br/></td> <td style="vertical-align: bottom; padding: 0px;"> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/><br/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/><br/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/><br/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/><br/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/><br/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/><br/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/><br/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/><br/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/><br/></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Telecommunication Services</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,069,243</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"> —  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"> 3,198</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"> 29,847</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space: nowrap; vertical-align: bottom; padding: 0px;"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"> —  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align: bottom; padding: 0px;"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"> 1,102,288</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"> 3,198</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Healthcare</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,000,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,465</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(4,465</td> <td style="white-space:nowrap;vertical-align:bottom">)<div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space: nowrap; vertical-align: bottom; padding: 0px;"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align: bottom; padding: 0px;"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,000,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(4,465</td> <td style="white-space:nowrap;vertical-align:bottom">)</td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Real Estate</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">463,314</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space: nowrap; vertical-align: bottom; padding: 0px;"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align: bottom; padding: 0px;"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">463,314</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Asset-Backed Securities</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align: bottom; padding: 0px;"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align: bottom; padding: 0px;"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Financials</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">7,036</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">244</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space: nowrap; vertical-align: bottom; padding: 0px;"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align: bottom; padding: 0px;"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">7,280</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">244</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Common Stocks</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align: bottom; padding: 0px;"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align: bottom; padding: 0px;"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Financials</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,732,500</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space: nowrap; vertical-align: bottom; padding: 0px;"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align: bottom; padding: 0px;"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,732,500</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Real Estate</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,359,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space: nowrap; vertical-align: bottom; padding: 0px;"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align: bottom; padding: 0px;"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,359,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Service</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,269</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space: nowrap; vertical-align: bottom; padding: 0px;"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align: bottom; padding: 0px;"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,268</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Telecommunication Services</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,114,214</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(81,965</td> <td style="white-space:nowrap;vertical-align:bottom">)</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space: nowrap; vertical-align: bottom; padding: 0px;"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align: bottom; padding: 0px;"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,032,249</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(81,965</td> <td style="white-space:nowrap;vertical-align:bottom">)</td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">LLC Interests</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align: bottom; padding: 0px;"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align: bottom; padding: 0px;"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Consumer Products</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,088,750</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">163,314</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">52,853</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space: nowrap; vertical-align: bottom; padding: 0px;"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(463,314</td> <td style="white-space:nowrap;vertical-align:bottom">)</td> <td style="vertical-align: bottom; padding: 0px;"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,841,603</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">52,853</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Real Estate</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,600,492</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(1,645,741</td> <td style="white-space:nowrap;vertical-align:bottom">)</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">7,368,085</td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-size:75%; vertical-align:top;display:inline;;font-size:6.6px">(1)</div> </td> <td style="white-space: nowrap; vertical-align: bottom; padding: 0px;"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align: bottom; padding: 0px;"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">7,322,836</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(1,645,741</td> <td style="white-space:nowrap;vertical-align:bottom">)</td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Preferred Stocks</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align: bottom; padding: 0px;"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align: bottom; padding: 0px;"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Healthcare</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">10,527,285</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">54,603</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space: nowrap; vertical-align: bottom; padding: 0px;"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align: bottom; padding: 0px;"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">10,581,888</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">54,603</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="padding: 0px;"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align: bottom; padding: 0px;"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">28,500,789</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,465</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">163,314</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(1,621,273</td> <td style="white-space:nowrap;vertical-align:bottom">)</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">7,861,246</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space: nowrap; vertical-align: bottom; padding: 0px;"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(463,314</td> <td style="white-space:nowrap;vertical-align:bottom">)<div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding: 0px;"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">34,445,226</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(1,621,273</td> <td style="white-space:nowrap;vertical-align:bottom">)<div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="padding: 0px;"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align: bottom; padding: 0px;"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table><div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%; vertical-align: top;;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 75%; vertical-align: top;;display:inline;;font-size:8.3px">(1)</div> </div></td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Represents an in-kind transfer to the subreit. </div></div></div></td></tr></table><div style="clear:both;max-height:0pt;;text-indent: 0px;"/><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The table below sets forth a summary of changes in the Company’s Level 3 investments (measured at fair value using significant unobservable inputs) for the three months ended March 31, 2022.</div></div><div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; font-family: &quot;Times New Roman&quot;; font-size: 8pt; width: 100%; border: 0px; margin: 0px auto; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width:29%"><br/></td> <td style="vertical-align:bottom;width:2%"><br/></td> <td><br/></td> <td><br/></td> <td><br/></td> <td style="vertical-align:bottom;width:2%"><br/></td> <td><br/></td> <td><br/></td> <td><br/></td> <td style="vertical-align:bottom;width:2%"><br/></td> <td><br/></td> <td><br/></td> <td><br/></td> <td style="vertical-align:bottom;width:2%"><br/></td> <td><br/></td> <td><br/></td> <td><br/></td> <td style="vertical-align:bottom;width:2%"><br/></td> <td><br/></td> <td><br/></td> <td><br/></td> <td style="vertical-align:bottom;width:2%"><br/></td> <td><br/></td> <td><br/></td> <td><br/></td> <td style="vertical-align:bottom;width:2%"><br/></td> <td><br/></td> <td><br/></td> <td><br/></td> <td style="vertical-align:bottom;width:2%"><br/></td> <td><br/></td> <td><br/></td> <td><br/></td> <td style="vertical-align:bottom;width:2%"><br/></td> <td><br/></td> <td><br/></td> <td><br/></td> <td style="vertical-align:bottom;width:2%"><br/></td> <td><br/></td> <td><br/></td> <td><br/></td> <td style="vertical-align:bottom;width:2%"><br/></td> <td><br/></td> <td><br/></td> <td><br/></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Investments:</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Balance as of<br/> December 31,<br/> 2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Transfers<br/> into<br/> Level 3</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Transfer<br/> out of<br/> Level 3</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Net<br/> amortization<br/> (accretion) of<br/> premium/<br/> (discount)</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Distribution<br/> to Return<br/> Capital</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Net realized<br/> gains/<br/> (losses)</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Net</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">change in<br/> unrealized<br/> gains/<br/> (losses)</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Purchases/<br/> PIK</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(Sales<br/> and<br/> redemptions)</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Balance as of<br/> March 31,<br/> 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Change in<br/> unrealized<br/> gain/(loss)<br/> on Level 3<br/> securities still<br/> held at period<br/> end</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:1pt"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td colspan="2" style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td colspan="2" style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td colspan="2" style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td colspan="2" style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Assets</div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Senior Secured Loans</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Telecommunication Services</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">962,478</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">26,711</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">989,189</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Healthcare</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,000,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,809</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">86,191</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,990,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(4,080,000</td> <td style="white-space:nowrap;vertical-align:bottom">)(a) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,000,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">86,191</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Asset-Backed Securities</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Financials</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">405,040</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">11,787</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(16,979</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">399,848</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">11,787</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Common Stocks</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Financials</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,208,750</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(603,450</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,605,300</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(603,450</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Real Estate</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,823,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">141,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,964,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">141,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Service</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,172</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,172</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Telecommunication Services</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,706,357</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(94,456</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,611,901</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(94,456</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">LLC Interests</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Consumer Products</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,812,212</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">169,426</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,981,638</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">169,426</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Real Estate</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,760,162</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(74,603</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">139,367</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(3,274,285</td> <td style="white-space:nowrap;vertical-align:bottom">)(b) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,550,641</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(13,275</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Preferred Stocks</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Healthcare</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">8,080,000</td> <td style="white-space:nowrap;vertical-align:bottom">(a) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">8,080,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">21,683,171</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"> —  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,809</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"> —  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(74,603</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(150,135</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">11,096,711</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(7,371,264</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">25,187,689</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(302,777</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table><div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border: 0px; width: 100%; border-spacing: 0px;"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;"><div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(a)</div> </td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Denotes Sapience’s $4,080,000 promissory notes and paid in kind interest conversion to preferred stock. </div></td></tr></table> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border: 0px; width: 100%; border-spacing: 0px;"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;"><div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(b)</div> </td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Denotes SFR II’s LLC Interests conversion into NREF common shares. </div></td></tr></table> <div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;"> </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"/><div/><div><div style="background-color:white;display: inline;"/></div> <div style="text-indent: 9%; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Investments designated as Level 3 may include investments valued using quotes or indications furnished by brokers which are based on models or estimates and may not be executable prices. In light of the developing market conditions, the Adviser continues to search for observable data points and evaluate broker quotes and indications received for investments. Determination of fair values is uncertain because it involves subjective judgments and estimates that are unobservable. Transfers from Level 2 to Level 3 are due to a decrease in market activity (e.g. frequency of trades), which resulted in a decrease of available market inputs to determine price. For the three months ended March 31, 2023, there were no transfers from Level 2 to Level 3. For the three months ended March 31, 2022, there were no transfers from Level 2 to Level 3. Transfers from Level 3 to Level 2 and from Level 2 to Level 1 are due to an increase in market activity (e.g. frequency of trades), which resulted in an increase of available market inputs to determine price. </div></div></div> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; margin-top: 12pt; margin-bottom: 0pt; text-indent: 9%; font-size: 10pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The following are summaries of significant unobservable inputs used in the fair valuations of investments categorized within Level 3 of the fair value hierarchy as of March 31, 2023 and December 31, 2022:</div></div> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 12pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="font-family: &quot;Times New Roman&quot;; letter-spacing: normal; orphans: 2; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; border-collapse: collapse; font-size: 10pt; width: 750.719px; border: 0px; margin: 0px auto; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width: 150.141px; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="font-family: &quot;Times New Roman&quot;;"/> <td style="font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; width: 7.5px; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="width: 167.719px; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="width: 157.641px; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="font-family: &quot;Times New Roman&quot;;"/> <td style="font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; width: 7.5px; font-family: &quot;Times New Roman&quot;;"/> </tr> <tr style="break-inside: avoid; font-family: 'Times New Roman'; font-size: 8pt;"> <td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Investment</div></div></div> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="border-bottom: 1pt solid rgb(0, 0, 0); vertical-align: bottom;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Fair value at</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">March 31, 2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="border-bottom: 1pt solid rgb(0, 0, 0); vertical-align: bottom;;text-align:center;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Valuation</div></div></div> <div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">technique</div></div></div> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="border-bottom: 1pt solid rgb(0, 0, 0); vertical-align: bottom;;text-align:center;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Unobservable</div></div></div> <div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">inputs</div></div></div> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="border-bottom: 1pt solid rgb(0, 0, 0); vertical-align: bottom;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Range of input value(s)</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(weighted average)</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> </tr> <tr style="break-inside: avoid; font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">LLC Interest</div></div> </td> <td style="vertical-align: bottom;"> </td> <td style="white-space: nowrap; vertical-align: top;">$</td> <td style="white-space: nowrap; vertical-align: top;;text-align:right;">10,164,438</td> <td style="white-space: nowrap; vertical-align: top;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: top; white-space: nowrap;;text-align:center;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Discounted Cash Flow</div></div> <div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Multiples Analysis</div></div> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: top; white-space: nowrap;;text-align:center;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Discount Rate</div></div> <div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Multiple of EBITDA</div></div> </td> <td style="vertical-align: bottom;"> </td> <td style="white-space: nowrap; vertical-align: top;"> <br/> <div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"/> </td> <td style="white-space: nowrap; vertical-align: top;;text-align:center;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">4.98% - 9.18% (7.08%)</div><br/> <div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">5.60x - 9.95x (<div style="letter-spacing: 0px; top: 0px;;display:inline;">7.70</div>x)</div></div> </td> <td style="white-space: nowrap; vertical-align: top;"> <br/> <div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> </tr> <tr style="break-inside: avoid; font-family: 'Times New Roman'; font-size: 10pt;"> <td style="vertical-align: top;"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Preferred Stock</div></div> </td> <td style="vertical-align: bottom;"> </td> <td style="white-space: nowrap; vertical-align: top;"> </td> <td style="white-space: nowrap; vertical-align: top;;text-align:right;">10,581,888</td> <td style="white-space: nowrap; vertical-align: top;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: top; white-space: nowrap;;text-align:center;">Option Pricing Model</td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: top; white-space: nowrap;;text-align:center;">Volatility</td> <td style="vertical-align: bottom;"> </td> <td style="white-space: nowrap; vertical-align: top;"> </td> <td style="white-space: nowrap; vertical-align: top;;text-align:center;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">40% - 90% (65%)</div></td> <td style="white-space: nowrap; vertical-align: top; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> </tr> <tr style="break-inside: avoid; font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Common Stock</div></div> </td> <td style="vertical-align: bottom;"> </td> <td style="white-space: nowrap; vertical-align: top;"> </td> <td style="white-space: nowrap; vertical-align: top;;text-align:right;">9,126,018</td> <td style="white-space: nowrap; vertical-align: top;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: top; white-space: nowrap;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Discounted Cash Flow</div></div> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Multiples Analysis</div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt; text-align: left; line-height: normal;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Transaction Indication of Value</div></div> <div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Liquidation Analysis<br/>Net Asset Value</div></div> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: top; white-space: nowrap;;text-align:center;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Discount Rate</div></div> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Multiple of EBITDA</div></div> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Unadjusted<div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Price/MHz-PoP</div><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"/></div> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Enterprise Value ($mm)</div></div> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Recovery Rate</div></div> <div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">N/A</div></div> </td> <td style="vertical-align: bottom;"> </td> <td style="white-space: nowrap; vertical-align: top;"> <br/> <div style="margin-bottom: 0pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"/> <div style="margin-bottom: 0pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"/> <div style="margin-bottom: 0pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"/> <div style="margin-bottom: 0pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"/> <div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"/> </td> <td style="white-space: nowrap; vertical-align: top;;text-align:center;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">11.0% - 13.0% (12.0%)</div><br/> <div style="margin-bottom: 0pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">3.25x - 4.25x (<div style="letter-spacing: 0px; top: 0px;;display:inline;"/>3.75x)  </div></div> <div style="margin-bottom: 0pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">$0.09 - $0.95 ($0.52)</div></div> <div style="margin-bottom: 0pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">$921.5</div></div> <div style="margin-bottom: 0pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">40% - 100%</div></div> <div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">$28</div></div> </td> <td style="white-space: nowrap; vertical-align: top;"> <br/> <div style="margin-bottom: 0pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <div style="margin-bottom: 0pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <div style="margin-bottom: 0pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"/> <div style="margin-bottom: 0pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> </tr> <tr style="break-inside: avoid; font-family: 'Times New Roman'; font-size: 10pt;"> <td style="vertical-align: top;"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Senior Secured Loans</div></div> </td> <td style="vertical-align: bottom;"> </td> <td style="white-space: nowrap; vertical-align: top;"> </td> <td style="white-space: nowrap; vertical-align: top;;text-align:right;">4,565,602</td> <td style="white-space: nowrap; vertical-align: top;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: top; white-space: nowrap;;text-align:center;">Discounted Cash Flow</td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: top; white-space: nowrap;;text-align:center;">Discount Rate</td> <td style="vertical-align: bottom;"> </td> <td style="white-space: nowrap; vertical-align: top;"> </td> <td style="white-space: nowrap; vertical-align: top;;text-align:center;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">10.25% - 13.06% (11.40%)</div></td> <td style="white-space: nowrap; vertical-align: top;"> </td> </tr> <tr style="break-inside: avoid; font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Asset-Backed Securities</div></div> </td> <td style="vertical-align: bottom;"> </td> <td style="white-space: nowrap; vertical-align: top;"> </td> <td style="white-space: nowrap; vertical-align: top;;text-align:right;">7,280</td> <td style="white-space: nowrap; vertical-align: top;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: top; white-space: nowrap;;text-align:center;">NAV Approach</td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: top; white-space: nowrap;;text-align:center;">Discount Rate</td> <td style="vertical-align: bottom;"> </td> <td style="white-space: nowrap; vertical-align: top;"> </td> <td style="white-space: nowrap; vertical-align: top;;text-align:center;">70.00%</td> <td style="white-space: nowrap; vertical-align: top;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> </tr> <tr style="break-inside: avoid; font-family: 'Times New Roman'; font-size: 10pt;"> <td style="vertical-align: top;"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total</div></div></div> </td> <td style="vertical-align: bottom;"> </td> <td style="white-space: nowrap; vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="white-space: nowrap; vertical-align: bottom;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">       34,445,226</div></div></td> <td style="white-space: nowrap; vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> </tr> </table> <div style="clear:both;max-height:0pt;"/> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 12pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="font-family: &quot;Times New Roman&quot;; letter-spacing: normal; orphans: 2; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; border-collapse: collapse; font-size: 10pt; width: 750.719px; border: 0px; margin: 0px auto; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width: 160.484px; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="font-family: &quot;Times New Roman&quot;;"/> <td style="font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; width: 7.09375px; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="width: 167.719px; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="width: 149.984px; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="font-family: &quot;Times New Roman&quot;;"/> </tr> <tr style="break-inside: avoid; font-family: 'Times New Roman'; font-size: 8pt;"> <td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Investment</div></div></div> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="border-bottom: 1pt solid rgb(0, 0, 0); vertical-align: bottom; width: 11%; padding: 0pt 0pt 0pt 2pt;;text-align:center;"><div style="letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"><div style="font-weight:bold;display:inline;">Fair value at</div></div><br/><div style="letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"><div style="font-weight:bold;display:inline;">December 31, 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="border-bottom: 1pt solid rgb(0, 0, 0); vertical-align: bottom;;text-align:center;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Valuation</div></div></div> <div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">technique</div></div></div> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="border-bottom: 1pt solid rgb(0, 0, 0); vertical-align: bottom;;text-align:center;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Unobservable</div></div></div> <div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">inputs</div></div></div> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="border-bottom: 1pt solid rgb(0, 0, 0); vertical-align: bottom;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Range of input value(s)</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(weighted average)</div></div></td> </tr> <tr style="break-inside: avoid; font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">LLC Interest</div></div> </td> <td style="vertical-align: bottom;"> </td> <td style="white-space: nowrap; vertical-align: top; padding: 0pt 2pt 0pt 0pt;">$</td> <td style="white-space: nowrap; vertical-align: top; padding: 0pt 2pt 0pt 0pt;;text-align:right;">4,689,242</td> <td style="white-space: nowrap; vertical-align: top; padding: 0px;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: top; white-space: nowrap;;text-align:center;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Discounted Cash Flow</div></div> <div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Multiples Analysis</div></div> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: top; white-space: nowrap;;text-align:center;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Discount Rate</div></div> <div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Multiple of EBITDA</div></div> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: top; white-space: nowrap;;text-align:center;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">4.73% - 8.93% (6.83%)</div><br/> <div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">5.55x - 9.85x (7.70x)</div></div> </td> </tr> <tr style="break-inside: avoid; font-family: 'Times New Roman'; font-size: 10pt;"> <td style="vertical-align: top;"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Preferred Stock</div></div> </td> <td style="vertical-align: bottom;"> </td> <td style="white-space: nowrap; vertical-align: top;"> </td> <td style="white-space: nowrap; vertical-align: top; width: 10%; padding: 0pt 0pt 0pt 2pt;;text-align:right;">10,527,285</td> <td style="white-space: nowrap; vertical-align: top; padding: 0px;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: top; white-space: nowrap;;text-align:center;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Option Pricing Model</div></div> <div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Transaction Indication of Value</div></div> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: top; white-space: nowrap;;text-align:center;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Volatility</div></div> <div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Recap Price</div></div> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: top; white-space: nowrap;;text-align:center;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">40% - 60% (50%)</div><br/> <div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">$11.10</div></div> </td> </tr> <tr style="break-inside: avoid; font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Common Stock</div></div> </td> <td style="vertical-align: bottom;"> </td> <td style="white-space: nowrap; vertical-align: top;"> </td> <td style="white-space: nowrap; vertical-align: top; width: 10%; padding: 0pt 0pt 0pt 2pt;;text-align:right;">9,207,983</td> <td style="white-space: nowrap; vertical-align: top; padding: 0px;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: top; white-space: nowrap;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Discounted Cash Flow</div></div> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Multiples Analysis</div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt; text-align: left; line-height: normal;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Transaction Indication of Value</div></div> <div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Liquidation Analysis<br/>Net Asset Value</div></div> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: top; white-space: nowrap;;text-align:center;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Discount Rate</div></div> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Multiple of EBITDA</div></div> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Unadjusted Price/MHz-PoP</div></div> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Enterprise Value ($mm)</div></div> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Recovery Rate</div></div> <div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">N/A</div></div> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: top; white-space: nowrap;;text-align:center;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">13.50% - 15.50% (14.50%)</div><br/> <div style="margin-bottom: 0pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">3.25x - 4.25x (3.75x)</div></div> <div style="margin-bottom: 0pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">$0.09 - $0.95 ($0.52)  </div></div> <div style="margin-bottom: 0pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">$872 - $969 ($920.5)  </div></div> <div style="margin-bottom: 0pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">40% - 100% (70%)</div></div> <div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">$28</div></div> </td> </tr> <tr style="break-inside: avoid; font-family: 'Times New Roman'; font-size: 10pt;"> <td style="vertical-align: top;"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Senior Secured Loans</div></div> </td> <td style="vertical-align: bottom;"> </td> <td style="white-space: nowrap; vertical-align: top;"> </td> <td style="white-space: nowrap; vertical-align: top; width: 10%; padding: 0pt 0pt 0pt 2pt;;text-align:right;">4,069,243</td> <td style="white-space: nowrap; vertical-align: top; padding: 0px;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: top; white-space: nowrap;;text-align:center;">Discounted Cash Flow</td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: top; white-space: nowrap;;text-align:center;">Discount Rate</td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: top; white-space: nowrap;;text-align:center;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">   10.25% - 13.08% (11.67%)   </div></td> </tr> <tr style="break-inside: avoid; font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Asset-Backed Securities</div></div> </td> <td style="vertical-align: bottom;"> </td> <td style="white-space: nowrap; vertical-align: top;"> </td> <td style="white-space: nowrap; vertical-align: top; width: 10%; padding: 0pt 0pt 0pt 2pt;;text-align:right;">7,036</td> <td style="white-space: nowrap; vertical-align: top; padding: 0px;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: top; white-space: nowrap;;text-align:center;">NAV Approach</td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: top; white-space: nowrap;;text-align:center;">Discount Rate</td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: top; white-space: nowrap;;text-align:center;">70.00%</td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> </tr> <tr style="break-inside: avoid; font-family: 'Times New Roman'; font-size: 10pt;"> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total</div></div></div> </td> <td style="vertical-align: bottom;"> </td> <td style="white-space: nowrap; vertical-align: bottom; padding: 0pt 0pt 0pt 2pt;"><div style="letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="white-space: nowrap; vertical-align: bottom; padding: 0pt 0pt 0pt 2pt;;text-align:right;"><div style="letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"><div style="font-weight:bold;display:inline;">28,500,789</div></div></td> <td style="white-space: nowrap; vertical-align: bottom; padding: 0px;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> </tr> </table> <div style="clear:both;max-height:0pt;"/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"/> <div style="text-indent: 9%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">The significant unobservable inputs used in the fair value measurement of the Company’s LLC interests are: discount rate and multiples of EBITDA. Significant increases (decreases) in those inputs in isolation could result in a significantly lower (higher) fair value measurement. The significant unobservable inputs used in the fair value measurement of the Company’s common equity securities are: multiple of EBITDA, <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">price/MHz-PoP</div> multiple, liquidity discount, discount rate, enterprise value, and transaction price. Significant increases (decreases) in any of those inputs in isolation could result in a significantly lower (higher) fair value measurement. The significant unobservable inputs used in the fair value measurement of the Company’s preferred stock are: option pricing model. Significant increases (decreases) in any of those inputs in isolation could result in a significantly lower (higher) fair value measurement. The significant unobservable inputs used in the fair value measurement of the Company’s senior secured loans are: discount rate and spread adjustment. Significant increases (decreases) in either of those inputs in isolation could result in a significantly lower (higher) fair value measurement. </div></div> <div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/></div></div> <div style="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The significant unobservable inputs used in the fair value measurement of the Company’s asset-backed securities are: discount rate and broker quote indication of value. Significant increases (decreases) in either of those inputs in isolation could result in a significantly lower (higher) fair value measurement. The significant unobservable input used in the fair value measurement of the Company’s warrant securities is: volatility assumption. Significant increases (decreases) in this input in isolation could result in a significantly lower (higher) fair value measurement.</div> <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Derivative Transactions </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The Company is subject to equity price risk, interest rate risk and foreign currency exchange rate risk in the normal course of pursuing its investment objective. The Company may invest without limitation in warrants and may also use derivatives, primarily swaps (including equity, variance and volatility swaps), options and futures contracts on securities, interest rates, commodities and/or currencies, as substitutes for direct investments the Company can make. The Company may also use derivatives such as swaps, options (including options on futures), futures, and foreign currency transactions (e.g., foreign currency swaps, futures and forwards) to any extent deemed by the Adviser to be in the best interest of the Company, and to the extent permitted by the 1940 Act, to hedge various investments for risk management and speculative purposes. </div> <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Options </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The Company purchases options, subject to certain limitations. The Company may invest in options contracts to manage its exposure to the stock and bond markets and fluctuations in foreign currency values. Writing puts and buying calls tend to increase the Company’s exposure to the underlying instrument while buying puts and writing calls tend to decrease the Company’s exposure to the underlying instrument, or economically hedge other Company investments. The Company’s risks in using these contracts include changes in the value of the underlying instruments, nonperformance of the counterparties under the contracts’ terms and changes in the liquidity of the secondary market for the contracts. Options are valued at the last sale price, or if no sales occurred on that day, at the last quoted bid price. As of and during the three months ended March 31, 2023 and 2022, the Company did not hold options. </div> <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Investment Transactions </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Investment transactions are accounted for on trade date. Realized gains (losses) on investments sold are recorded on the basis of specific identification method for both financial statement and U.S. federal income tax purposes. Payable for investments purchased and receivable for investments sold on the Statements of Assets and Liabilities, if any, represents the cost of purchases and proceeds from sales of investment securities, respectively, for trades that have been executed but not yet settled. </div> <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Income Recognition </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Corporate actions (including cash dividends from common stock and equity tranches of asset-backed securities) are recorded on the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">ex-dividend</div> date, net of applicable withholding taxes, except for certain foreign corporate actions, which are recorded as soon after the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">ex-dividend</div> date as such information becomes available. Interest income is recorded on the accrual basis. The Company does not accrue as a receivable for interest or dividends on loans, asset-backed securities and other securities if there is a reason to doubt the Company’s ability to collect such income. For loans with contractual PIK <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">(payment-in-kind)</div></div> interest income, which represents contractual interest accrued and added to the loan balance that generally becomes due at maturity, we will not accrue PIK interest if we believe that the PIK interest is no longer collectible. Loan origination fees, original issue discount and market discount are capitalized and such amounts are amortized as interest income over the respective term of the loan or security. Upon the prepayment of a loan or security, any unamortized loan origination fees and original issue discount are recorded as interest income. </div> <div style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Accretion of discounts and amortization of premiums on taxable bonds, loans and asset-backed securities are computed to the call or maturity date, whichever is shorter, using the effective yield method. Withholding taxes on foreign dividends have been provided for in accordance with the Company’s understanding of the applicable country’s tax rules and rates. </div> <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Organization and Offering Costs </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Organization costs are paid by the Adviser and include the cost of incorporating, such as the cost of legal services and other fees pertaining to our organization. Offering costs include legal fees, promotional costs and other costs pertaining to the public offering of our shares of common stock and are also paid by the Adviser. Prior to the termination of the offering, as we raised proceeds, these organization and offering costs were expensed and became payable to the Adviser. Organization and offering costs are limited to 1% of total gross proceeds raised and are not due and payable to the Adviser to the extent they exceed that amount. Please refer to Note 4 for additional information on Organization and Offering Costs. </div> <div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;"> </div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"/> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Paid-in</div> Capital </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The proceeds from the issuance of common stock as presented on the Company’s Statements of Changes in Net Assets is presented net of selling commissions and fees for the three months ended March 31, 2023 and March 31, 2022. Selling commissions and fees of $0 and $0 were paid for the three months ended March 31, 2023 and March 31, 2022, respectively. </div><div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Earnings Per Share </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">In accordance with the provisions of ASC Topic 260—<div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Earnings per Share</div></div> (“ASC Topic 260”), basic earnings per share is computed by dividing earnings available to common stockholders by the weighted average number of shares outstanding during the period. Other potentially dilutive common shares, and the related impact to earnings, are considered when calculating earnings per share on a diluted basis. </div><div style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The following table sets forth the computation of the weighted average basic and diluted net increase in net assets per share from operations:</div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:76%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:73%"/> <td style="vertical-align:bottom;width:5%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:4%"/> <td/> <td/> <td/></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">For the three months ended<br/> March 31,</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net increase (decrease) in net assets resulting from operations</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(977,817</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,145,017</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Weighted average common shares outstanding</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">9,699,655</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">9,990,797</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Earnings (loss) per common share-basic and diluted</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(0.10</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.11</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr></table><div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Distributions </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Distributions to the Company’s stockholders will be recorded as of the record date. Subject to the discretion of the Board and applicable legal restrictions, the Company intends to authorize and declare ordinary cash distributions on a weekly basis and pay such distributions on a quarterly basis. Net realized capital gains, if any, will generally be distributed or deemed distributed at least every <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">12-month</div> period. </div><div style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">On June 24, 2020, the Board approved a change in its dividend and capital gains distribution schedule from monthly distributions to quarterly distributions, effective immediately. The first quarterly distribution was paid on October 12, 2020 to shareholders of record as of September 30, 2020. The dividends are expected to be declared in the amount of $0.09 per share of the Company’s common stock to the stockholders of record at each quarter end. </div><div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Recent Accounting Pronouncements </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">In March 2020, the FASB issued Accounting Standards Update (“ASU”) <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">No. 2020-04,</div> “Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting” which provides optional exceptions for applying GAAP to contract modifications, hedging relationships and other transactions affected by reference rate reform if certain criteria are met. ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">No. 2020-04</div> is elective and effective for all entities as of March 12, 2020 through December 31, 2022. The Company is currently evaluating the impact of ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">No. 2020-04.</div> Please refer to Note 8 for additional information. </div> <div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Basis of Accounting </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The accompanying financial statements of the Company are prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”). Additionally, the accompanying financial statements of the Company and related financial information have been prepared pursuant to the requirements for reporting on Form <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">10-Q</div> and Article 10 of Regulation <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">S-X.</div> The current period’s results of operations will not necessarily be indicative of results that ultimately may be achieved for the fiscal year ending December 31, 2023. The interim financial data as of March 31, 2023 and for the three months ended March 31, 2023 and 2022 is unaudited. In the opinion of management, the interim financial data includes all adjustments, consisting only of the normal recurring adjustments, necessary to a fair statement of the results for the interim periods. </div> <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Use of Estimates </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of increases and decreases in net assets from operations during the reporting period. Actual results could differ from those estimates. </div> <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Statements of Cash Flows </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Information on financial transactions which have been settled through the receipt or disbursement of cash is presented in the Statements of Cash Flows. The cash amount shown in the Statements of Cash Flows is the amount included within the Company’s Statements of Assets and Liabilities and includes cash on hand at its custodian bank. </div> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Cash and Cash Equivalents </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The Company considers liquid assets deposited with a bank, money market funds, and certain short-term debt instruments with original maturities of three months or less to be cash equivalents. These investments represent amounts held with financial institutions that are readily accessible to pay Company expenses or purchase investments. Cash and cash equivalents are valued at cost plus accrued interest, which approximates fair value. The value of cash equivalents denominated in foreign currencies, if any, is determined by converting to U.S. dollars on the date of the Statements of Assets and Liabilities. As of March 31, 2023 and December 31, 2022, the Company had cash and cash equivalents of $1,131,784 and $1,629,846, respectively. As of March 31, 2023 and December 31, 2022, $773,826 and $1,420,428 was held in the State Street U.S. Government Money Market Fund, and $357,958 and $209,418 was held in a custodial account with State Street Bank and Trust Company, respectively. </div> 1131784 1629846 773826 1420428 357958 209418 <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Securities Sold Short and Restricted Cash </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The Company may sell securities short. A security sold short is a transaction in which the Company sells a security it does not own in anticipation that the market price of that security will decline. When the Company sells a security short, it must borrow the security sold short from a broker-dealer and deliver it to the buyer upon conclusion of the transaction. The Company may have to pay a fee to borrow particular securities and is often obligated to pay over any dividends or other payments received on such borrowed securities. Cash held as collateral for securities sold short is classified as restricted cash on the Statements of Assets and Liabilities, when applicable. Securities held as collateral for securities sold short are shown on the Schedules of Investments for the Company, as applicable. As of March 31, 2023 and December 31, 2022, the Company did not have any securities sold short. </div> <div style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">When securities are sold short, the Company intends to limit exposure to a possible market decline in the value of its portfolio companies through short sales of securities that the Adviser believes possess volatility characteristics similar to those being hedged. In addition, the Company may use short sales for <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-hedging</div> purposes to pursue its investment objective. Subject to the requirements of the 1940 Act and the Code, the Company will not make a short sale if, after giving effect to such sale, the market value of all securities sold short by the Company exceeds 25% of the value of its total assets. </div> 0 0 0.25 0.25 <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Other Fee Income </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Fee income may consist of origination/closing fees, amendment fees, administrative agent fees, transaction <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">break-up</div> fees and other miscellaneous fees. Origination fees, amendment fees, and other similar fees are <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-recurring</div> fee sources. Such fees are received on a transaction by transaction basis and do not constitute a regular stream of income. For the three months ended March 31, 2023 and March 31, 2022, the Company recognized $0 and $0 of fee income, respectively. </div> 0 0 <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Fair Value of Financial Instruments </div></div></div></div> <div style="text-indent: 9%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="display:inline;">It is the Company’s policy to hold the investments at fair value. ASC Topic 820, <div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Fair Value Measurements and Disclosure</div></div> (“ASC Topic 820”) defines fair value as the price that would be received from the sale of an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. ASC Topic 820 also establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. These tiers include: Level 1, defined as observable inputs such as quoted prices in active markets; Level 2, which includes inputs such as quoted prices for similar securities in active markets and quoted prices for identical securities where there is little or no activity in the market; and Level 3, defined as unobservable inputs for which little or no market data exists, therefore requiring an entity to develop its own assumptions. </div></div> <div style="text-indent: 9%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">Pursuant to Rule <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2a-5</div> under the 1940 Act, the Board has designated the Adviser as the Company’s valuation designee to perform the fair valuation determination for securities and other assets held by the Company. The Company determines the net asset value of its investment portfolio each quarter, or more frequently as needed. Securities that are publicly-traded are valued at the reported closing price on the valuation date. Securities that are not publicly-traded are valued at fair value as determined in good faith by the Adviser as valuation designee, pursuant to board-approved policies and procedures. In connection with that determination, the Adviser will consider portfolio company valuations based on relevant inputs, including indicative dealer quotes, values of like securities, recent portfolio company financial statements and forecasts, and valuations prepared by third-party valuation services. Rule <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2a-5</div> states that a market quotation is readily available only when that quotation is a quoted price (unadjusted) in active markets for identical investments that the Company can access at the measurement date, provided that a quotation will not be readily available if it is not reliable. Market quotations may also not be “readily available” if a significant event occurs that causes the Adviser to believe that the market price of a security no longer represents the security’s current value at the time of the Company’s net asset value (“NAV”) determination. </div></div> <div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;"> </div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"> </div> <div/><div> <div style="background-color:white;display: inline;"> </div> </div> <div style="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">With respect to investments for which market quotations are not readily available, the Adviser undertakes a multi-step valuation process each quarter, as described below: </div> <div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:10%"> </td> <td style="width:2%;vertical-align:top;text-align:left;">•</td> <td style="width:1%;vertical-align:top"> </td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-align: left; line-height: normal;">The valuation process begins with each portfolio company or investment being initially valued by investment professionals of the Adviser responsible for credit monitoring or independent third party valuation firms. </div> </td> </tr> </table> <div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:10%"> </td> <td style="width:2%;vertical-align:top;text-align:left;">•</td> <td style="width:1%;vertical-align:top"> </td> <td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;">Preliminary valuation conclusions are then documented and discussed with a committee comprised of certain senior management employees of the Adviser (the “Valuation Committee”) established by the Adviser to assist the Adviser in discharging its responsibilities as valuation designee. </div> </td> </tr> </table> <div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:10%"> </td> <td style="width:2%;vertical-align:top;text-align:left;">•</td> <td style="width:1%;vertical-align:top"> </td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-align: left; line-height: normal;">At least once each quarter, the valuations for approximately one quarter of the portfolio investments that have been fair valued are reviewed by an independent valuation firm such that, over the course of a year, each material portfolio investment that has been fair valued shall have been reviewed by an independent valuation firm at least once. </div> </td> </tr> </table> <div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:10%"> </td> <td style="width:2%;vertical-align:top;text-align:left;">•</td> <td style="width:1%;vertical-align:top"> </td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-align: left; line-height: normal;">Based on this information, the Adviser discusses valuations and determines the fair value of each investment in the portfolio in good faith pursuant to board-approved policies and procedures. </div> </td> </tr> </table> <div style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">As of March 31, 2023, the Company held the following investments for which a sufficient level of current, reliable market quotations were not available: </div> <div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:76%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:61%"/> <td style="vertical-align:bottom;width:5%"/> <td style="width:23%"/> <td style="vertical-align:bottom;width:5%"/> <td/> <td/> <td/> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Instrument</div></div> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"> <div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;">Type</div></div> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Fair value</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Grayson Investor Corp.</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Asset-Backed Securities</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"> 7,267</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">PAMCO CLO <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">1997-1A</div> B</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">Asset-Backed Securities</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">13</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">American Banknote Corp.</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">Common Stocks</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,732,500</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">IQHQ, Inc.</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">Common Stocks</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,359,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">TerreStar Corp.</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">Common Stocks</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,032,249</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Wayne Services Legacy, Inc.</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">Common Stocks</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,268</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">NexPoint Capital REIT, LLC</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">LLC Interests</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">6,904,655</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">SFR WLIF III, LLC</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">LLC Interests</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">418,181</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">US Gaming, LLC</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">LLC Interests</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,841,603</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Apnimed, Inc.</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">Preferred Stocks</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,499,989</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Apnimed, Inc.</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">Preferred Stocks</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">799,993</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Sapience Therapeutics, Inc.</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">Preferred Stocks</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,581,906</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Sapience Therapeutics, Inc.</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">Preferred Stocks</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,700,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">CCS Medical, Inc.</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">Senior Secured Loans</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,000,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">NexPoint Capital REIT<div style="letter-spacing: 0px; top: 0px;;display:inline;">,</div> <div style="letter-spacing: 0px; top: 0px;;display:inline;">LLC</div></div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">Senior Secured Loans</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">463,314</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">TerreStar Corp.</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">Senior Secured Loans</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">836,016</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">TerreStar Corp.</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">Senior Secured Loans</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">197,921</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">TerreStar Corp.</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">Senior Secured Loans</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">35,360</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">TerreStar Corp.</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">Senior Secured Loans</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">32,991</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> </table> <div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"> </div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"/> <div style="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">As of December 31, 2022, the Company held the following investments for which a sufficient level of current, reliable market quotations were not available: </div> <div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:76%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:61%"/> <td style="vertical-align:bottom;width:5%"/> <td style="width:23%"/> <td style="vertical-align:bottom;width:5%"/> <td/> <td/> <td/> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Instrument</div></div> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"> <div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;">Type</div></div> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Fair value</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Grayson Investor Corp.</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Asset-Backed Securities</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"> 7,023</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">PAMCO CLO <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">1997-1A</div> B</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">Asset-Backed Securities</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">13</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">American Banknote Corp.</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">Common Stocks</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,732,500</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">IQHQ, Inc.</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">Common Stocks</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,359,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">TerreStar Corp.</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">Common Stocks</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,114,214</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Wayne Services Legacy, Inc.</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">Common Stocks</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,269</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">NexPoint Capital REIT, LLC</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">LLC Interests</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,176,024</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">SFR WLIF III, LLC</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">LLC Interests</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">424,468</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">US Gaming, LLC</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">LLC Interests</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,088,750</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Apnimed, Inc.</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">Preferred Stocks</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,499,989</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Apnimed, Inc.</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">Preferred Stocks</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">799,994</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Sapience Therapeutics, Inc.</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">Preferred Stocks</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,549,525</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Sapience Therapeutics, Inc.</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">Preferred Stocks</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,677,777</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">CCS Medical, Inc.</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">Senior Secured Loans</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,000,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">TerreStar Corp.</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">Senior Secured Loans</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">810,953</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">TerreStar Corp.</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">Senior Secured Loans</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">191,988</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">TerreStar Corp.</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">Senior Secured Loans</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">34,300</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">TerreStar Corp.</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">Senior Secured Loans</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">32,002</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> </table> <div style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Determination of fair value involves subjective judgments and estimates. Accordingly, the notes to the Company’s financial statements will refer to the uncertainty with respect to the possible effect of such valuations, and any change in such valuations, in the Company’s financial statements. Below is a description of factors that the Adviser and the Valuation Committee may consider when valuing the Company’s debt and equity investments. </div> <div style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Valuation of fixed income investments, such as loans and debt securities, depends upon a number of factors, including prevailing interest rates for like securities, expected volatility in future interest rates, call features, put features and other relevant terms of the debt. For investments without readily available market prices, the Company may incorporate these factors into discounted cash flow models to arrive at fair value. Other factors that the Adviser and the Valuation Committee may consider include the borrower’s ability to adequately service its debt, the fair market value of the portfolio company in relation to the face amount of its outstanding debt and the quality of collateral securing the Company’s debt investments. </div> <div style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The Company’s equity investments in portfolio companies for which there is no liquid public market will be valued at fair value. The Adviser and the Valuation Committee, in its analysis of fair value, may consider various factors, such as multiples of earnings before interest, taxes, depreciation and amortization (“EBITDA”), cash flows, net income, revenues or, in limited instances, book value or liquidation value. All of these factors may be subject to adjustments based upon the particular circumstances of a portfolio company or the Company’s actual investment position. For example, adjustments to EBITDA may take into account compensation to previous owners or acquisition, recapitalization, restructuring or other related items. </div> <div style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The Adviser and the Valuation Committee may also look to private merger and acquisition statistics, public trading multiples discounted for illiquidity and other factors, valuations implied by third-party investments in the portfolio companies or industry practices in determining fair value. The Adviser and the Valuation Committee may also consider the size and scope of a portfolio company and its specific strengths and weaknesses, as well as any other factors it deems relevant in assessing the value. Generally, the value of the Company’s equity interests in public companies for which market quotations are readily available will be based upon the most recent closing public market price. </div> <div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"> </div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"/> <div style="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">If the Company receives warrants or other equity-linked securities at nominal or no additional cost in connection with an investment in a debt security, the Company will allocate the cost basis in the investment between the debt securities and any such warrants or other equity-linked securities received at the time of origination. The Adviser and the Valuation Committee will subsequently value these warrants or other equity-linked securities received at fair value. </div><div style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">As applicable, the Company values its Level 2 assets by using the midpoint of the prevailing bid and ask prices from dealers on the date of the relevant period end, which is provided by an independent third-party pricing service and screened for validity by such service. For investments for which the third-party pricing service is unable to obtain quoted prices, the Company obtains bid and ask prices directly from dealers who make a market in such investments. </div><div style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">To the extent that the Company holds investments for which no active secondary market exists and, therefore, no bid and ask prices can be readily obtained, the Adviser and the Valuation Committee utilize an independent third-party valuation service to value such investments in a manner consistent with the Company’s multistep valuation process previously described. </div><div style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The Company periodically benchmarks the bid and ask prices received from the third-party pricing service and/or dealers, as applicable, and valuations received from the third-party valuation service against the actual prices at which it purchases and sells its investments. The Company believes that these prices are reliable indicators of fair value. The Adviser and the Valuation Committee review and approve the valuation determinations made with respect to these investments in a manner consistent with the Company’s valuation procedures. </div><div style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">As of March 31, 2023, the Company’s investments consisted of senior secured loans, asset-backed securities, common stocks, LLC interests, preferred stocks, corporate bonds, and warrants, which may be purchased for a fraction of the price of the underlying securities. The fair value of the Company’s loans, bonds and asset-backed securities are generally based on quotes received from brokers or independent pricing services. Loans, bonds and asset-backed securities with quotes that are based on actual trades with a sufficient level of activity on or near the measurement date are classified as Level 2 assets. Loans, bonds and asset-backed securities that are priced using quotes derived from implied values, indicative bids or a limited number of actual trades are classified as Level 3 assets because the inputs used by the brokers and pricing services to derive the values are not readily observable. </div><div style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The fair value of the Company’s common stocks and options that are not actively traded on national exchanges are generally priced using quotes derived from implied values, indicative bids, or a limited amount of actual trades and are classified as Level 3 assets because the inputs used by the brokers and pricing services to derive the values are not readily observable. Exchange traded options are valued based on the last trade price on the primary exchange on which they trade. If an option does not trade, the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">mid-price</div> is utilized to value the option. </div><div style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">At the end of each calendar quarter, the Adviser evaluates the Level 2 and 3 investments for changes in liquidity, including: whether a broker is willing to execute at the quoted price, the depth and consistency of prices from third party services, and the existence of contemporaneous, observable trades in the market. Additionally, management evaluates the Level 1 and 2 assets and liabilities on a quarterly basis for changes in listings or delistings on national exchanges. </div><div style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Due to the inherent uncertainty of determining the fair value of investments that do not have a readily available market price, the fair value of the Company’s investments may fluctuate from period to period. Additionally, the fair value of investments may differ significantly from the values that would have been used had a ready market existed for such investments and may differ materially from the values the Company may ultimately realize. Further, such investments may be subject to legal and other restrictions on resale or otherwise less liquid than publicly traded securities. </div><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"> </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"/><div style="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The inputs or methodology used for valuing investments are not necessarily an indication of the risk associated with investing in those investments. The following are summaries of the Company’s investments categorized within the fair value hierarchy as of March 31, 2023 and December 31, 2022: </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:92%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:53%"/> <td style="vertical-align:bottom;width:3%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:3%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:3%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:3%"/> <td/> <td/> <td/></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="14" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">March 31, 2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Investments</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level 1</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level 2</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level 3</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Total</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:1pt"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td colspan="16" style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Assets</div></div></td> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0em; text-indent: 0em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;"> </div></div></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td colspan="16" style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Senior Secured Loans</div></td> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0em; text-indent: 0em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"> </div></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Healthcare</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,466,015</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,000,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">8,466,015</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Real Estate</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">463,314</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">463,314</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Telecommunication Services</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,102,288</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,102,288</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td colspan="16" style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Asset-Backed Securities</div></td> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0em; text-indent: 0em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"> </div></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Financials</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">7,280</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">7,280</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td colspan="16" style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Corporate Bonds</div></td> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0em; text-indent: 0em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"> </div></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Healthcare</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,240,779</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,240,779</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Media/Telecommunications</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">259,466</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">259,466</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td colspan="16" style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Common Stocks</div></td> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0em; text-indent: 0em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"> </div></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Chemicals</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">42,500</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">42,500</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Energy</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,629,178</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,629,178</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Financials</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,732,500</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,732,500</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Real Estate</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,063,263</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,359,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,422,263</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Real Estate Investment Trusts (REITs)</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,022,291</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,022,291</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Service</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,268</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,268</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Telecommunication Services</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,032,249</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,032,249</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td colspan="16" style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">LLC Interests</div></td> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0em; text-indent: 0em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"> </div></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Consumer Products</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,841,603</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,841,603</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Real Estate</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">7,322,836</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">7,322,836</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td colspan="16" style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Preferred Stocks</div></td> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0em; text-indent: 0em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"> </div></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Financials</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,400,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,400,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Healthcare</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">10,581,888</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">10,581,888</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td colspan="16" style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Warrants</div></td> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0em; text-indent: 0em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"> </div></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Energy</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">152,748</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">152,748</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Media/Telecommunications</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">10,063</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">10,063</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Total Assets</div></div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">3,085,554</div></div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">11,200,749</div></div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">34,445,226</div></div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">48,731,529</div></div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Total Investments</div></div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">3,085,554</div></div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">11,200,749</div></div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">34,445,226</div></div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">48,731,529</div></div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"> </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"/> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 92%; border: 0px; margin: 0px auto; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width:53%"><br/></td> <td style="vertical-align:bottom;width:3%"><br/></td> <td><br/></td> <td><br/></td> <td><br/></td> <td style="vertical-align:bottom;width:3%"><br/></td> <td><br/></td> <td><br/></td> <td><br/></td> <td style="vertical-align:bottom;width:3%"><br/></td> <td><br/></td> <td><br/></td> <td><br/></td> <td style="vertical-align:bottom;width:3%"><br/></td> <td><br/></td> <td><br/></td> <td><br/></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="14" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December 31, 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Investments</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level 1</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level 2</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level 3</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Total</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:1pt"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td colspan="16" style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Assets</div></div></td> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0em; text-indent: 0em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;"> </div></div></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td colspan="16" style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Senior Secured Loans</div></td> <td style="vertical-align:top"><div style="margin-top: 0px; margin-bottom: 0px; margin-left: 0em; text-indent: 0em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"> </div></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Healthcare</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">10,158,950</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,000,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">13,158,950</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Telecommunication Services</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,069,243</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,069,243</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td colspan="16" style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Asset-Backed Securities</div></td> <td style="vertical-align:top"><div style="margin-top: 0px; margin-bottom: 0px; margin-left: 0em; text-indent: 0em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"> </div></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Financials</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">7,036</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">7,036</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td colspan="16" style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Corporate Bonds</div></td> <td style="vertical-align:top"><div style="margin-top: 0px; margin-bottom: 0px; margin-left: 0em; text-indent: 0em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"> </div></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Healthcare</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,414,839</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,414,839</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Media/Telecommunications</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">290,078</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">290,078</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td colspan="16" style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Common Stocks</div></td> <td style="vertical-align:top"><div style="margin-top: 0px; margin-bottom: 0px; margin-left: 0em; text-indent: 0em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"> </div></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Chemicals</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">42,500</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">42,500</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Energy</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,591,692</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,591,692</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Financials</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,732,500</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,732,500</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Real Estate</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">7,653,730</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,359,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">10,012,730</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Real Estate Investment Trusts (REITs)</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,018,779</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,018,779</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Service</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,269</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,269</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Telecommunication Services</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,114,214</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,114,214</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td colspan="16" style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">LLC Interests</div></td> <td style="vertical-align:top"><div style="margin-top: 0px; margin-bottom: 0px; margin-left: 0em; text-indent: 0em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"> </div></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Consumer Products</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,088,750</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,088,750</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Real Estate</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,600,492</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,600,492</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td colspan="16" style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Preferred Stocks</div></td> <td style="vertical-align:top"><div style="margin-top: 0px; margin-bottom: 0px; margin-left: 0em; text-indent: 0em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"> </div></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Financials</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,440,625</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,440,625</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Healthcare</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">10,527,285</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">10,527,285</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td colspan="16" style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Warrants</div></td> <td style="vertical-align:top"><div style="margin-top: 0px; margin-bottom: 0px; margin-left: 0em; text-indent: 0em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"> </div></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Energy</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">161,249</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">161,249</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Media/Telecommunications</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">20,484</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">20,484</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Total Assets</div></div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">8,672,509</div></div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">16,120,417</div></div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">28,500,789</div></div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">53,293,715</div></div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Total Investments</div></div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">8,672,509</div></div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">16,120,417</div></div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">28,500,789</div></div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">53,293,715</div></div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table> <div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;"> </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"/><div/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"/><div style="letter-spacing: 0px; top: 0px;;display:inline;"/><div style="text-indent: 9%; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The table below sets forth a summary of changes in the Company’s Level 3 investments (measured at fair value using significant unobservable inputs) for the three months ended March 31, 2023. The table below includes noncash transactions for the three months ended March 31, 2023. </div></div></div><div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 8pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="font-size: 0px;"> <td style="width: 31%;"><br/></td> <td style="width: 2%; vertical-align: bottom;"><br/></td> <td><br/></td> <td><br/></td> <td><br/></td> <td style="width: 2%; vertical-align: bottom;"><br/></td> <td><br/></td> <td><br/></td> <td><br/></td> <td style="width: 2%; vertical-align: bottom;"><br/></td> <td><br/></td> <td><br/></td> <td><br/></td> <td style="width: 2%; vertical-align: bottom;"><br/></td> <td><br/></td> <td><br/></td> <td><br/></td> <td style="width: 2%; vertical-align: bottom;"><br/></td> <td><br/></td> <td><br/></td> <td><br/></td> <td style="width: 2%; vertical-align: bottom;"><br/></td> <td><br/></td> <td><br/></td> <td><br/></td> <td style="width: 2%; vertical-align: bottom;"><br/></td> <td><br/></td> <td><br/></td> <td><br/></td> <td style="width: 2%; vertical-align: bottom;"><br/></td> <td><br/></td> <td><br/></td> <td><br/></td> <td><br/></td> <td style="width: 2%; vertical-align: bottom;"><br/></td> <td><br/></td> <td><br/></td> <td><br/></td> <td style="width: 2%; vertical-align: bottom;"><br/></td> <td><br/></td> <td><br/></td> <td><br/></td> <td style="width: 2%; vertical-align: bottom;"><br/></td> <td><br/></td> <td><br/></td> <td><br/></td></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Investments:</div></div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Balance as of<br/>December 31,<br/>2022</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Transfers<br/>into<br/>Level 3</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Transfer<br/>s out of<br/>Level 3</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Net<br/>amortization<br/>(accretion) of<br/>premium/<br/>(discount)</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Distribution<br/>to Return<br/>Capital</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Net realized<br/>gains/<br/>(losses)</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Net</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">change in<br/>unrealized<br/>gains/<br/>(losses)</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Purchases/<br/>PIK</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding: 0px;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(Sales<br/>and<br/>redemptions)</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Balance as of<br/>March 31,<br/>2023</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Change in<br/>unrealized<br/>gain/(loss)<br/>on Level 3<br/>securities still<br/>held at period<br/>end</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Assets</div></div></div></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/><br/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/><br/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/><br/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/><br/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/><br/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/><br/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/><br/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/><br/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/><br/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/><br/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/><br/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/><br/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/><br/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/><br/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/><br/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/><br/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/><br/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/><br/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/><br/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/><br/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/><br/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/><br/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/><br/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/><br/></td> <td style="vertical-align: bottom; padding: 0px;"> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/><br/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/><br/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/><br/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/><br/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/><br/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/><br/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/><br/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/><br/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/><br/></td></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Senior Secured Loans</div></div></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/><br/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/><br/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/><br/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/><br/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/><br/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/><br/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/><br/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/><br/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/><br/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/><br/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/><br/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/><br/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/><br/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/><br/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/><br/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/><br/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/><br/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/><br/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/><br/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/><br/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/><br/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/><br/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/><br/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/><br/></td> <td style="vertical-align: bottom; padding: 0px;"> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/><br/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/><br/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/><br/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/><br/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/><br/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/><br/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/><br/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/><br/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/><br/></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Telecommunication Services</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,069,243</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"> —  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"> 3,198</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"> 29,847</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space: nowrap; vertical-align: bottom; padding: 0px;"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"> —  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align: bottom; padding: 0px;"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"> 1,102,288</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"> 3,198</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Healthcare</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,000,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,465</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(4,465</td> <td style="white-space:nowrap;vertical-align:bottom">)<div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space: nowrap; vertical-align: bottom; padding: 0px;"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align: bottom; padding: 0px;"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,000,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(4,465</td> <td style="white-space:nowrap;vertical-align:bottom">)</td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Real Estate</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">463,314</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space: nowrap; vertical-align: bottom; padding: 0px;"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align: bottom; padding: 0px;"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">463,314</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Asset-Backed Securities</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align: bottom; padding: 0px;"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align: bottom; padding: 0px;"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Financials</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">7,036</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">244</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space: nowrap; vertical-align: bottom; padding: 0px;"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align: bottom; padding: 0px;"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">7,280</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">244</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Common Stocks</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align: bottom; padding: 0px;"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align: bottom; padding: 0px;"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Financials</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,732,500</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space: nowrap; vertical-align: bottom; padding: 0px;"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align: bottom; padding: 0px;"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,732,500</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Real Estate</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,359,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space: nowrap; vertical-align: bottom; padding: 0px;"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align: bottom; padding: 0px;"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,359,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Service</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,269</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space: nowrap; vertical-align: bottom; padding: 0px;"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align: bottom; padding: 0px;"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,268</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Telecommunication Services</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,114,214</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(81,965</td> <td style="white-space:nowrap;vertical-align:bottom">)</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space: nowrap; vertical-align: bottom; padding: 0px;"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align: bottom; padding: 0px;"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,032,249</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(81,965</td> <td style="white-space:nowrap;vertical-align:bottom">)</td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">LLC Interests</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align: bottom; padding: 0px;"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align: bottom; padding: 0px;"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Consumer Products</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,088,750</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">163,314</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">52,853</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space: nowrap; vertical-align: bottom; padding: 0px;"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(463,314</td> <td style="white-space:nowrap;vertical-align:bottom">)</td> <td style="vertical-align: bottom; padding: 0px;"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,841,603</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">52,853</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Real Estate</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,600,492</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(1,645,741</td> <td style="white-space:nowrap;vertical-align:bottom">)</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">7,368,085</td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-size:75%; vertical-align:top;display:inline;;font-size:6.6px">(1)</div> </td> <td style="white-space: nowrap; vertical-align: bottom; padding: 0px;"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align: bottom; padding: 0px;"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">7,322,836</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(1,645,741</td> <td style="white-space:nowrap;vertical-align:bottom">)</td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Preferred Stocks</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align: bottom; padding: 0px;"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align: bottom; padding: 0px;"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Healthcare</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">10,527,285</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">54,603</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space: nowrap; vertical-align: bottom; padding: 0px;"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align: bottom; padding: 0px;"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">10,581,888</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">54,603</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="padding: 0px;"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align: bottom; padding: 0px;"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">28,500,789</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,465</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">163,314</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(1,621,273</td> <td style="white-space:nowrap;vertical-align:bottom">)</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">7,861,246</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space: nowrap; vertical-align: bottom; padding: 0px;"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(463,314</td> <td style="white-space:nowrap;vertical-align:bottom">)<div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding: 0px;"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">34,445,226</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(1,621,273</td> <td style="white-space:nowrap;vertical-align:bottom">)<div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="padding: 0px;"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align: bottom; padding: 0px;"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table><div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%; vertical-align: top;;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 75%; vertical-align: top;;display:inline;;font-size:8.3px">(1)</div> </div></td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Represents an in-kind transfer to the subreit. </div></div></div></td></tr></table><div style="clear:both;max-height:0pt;;text-indent: 0px;"/><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The table below sets forth a summary of changes in the Company’s Level 3 investments (measured at fair value using significant unobservable inputs) for the three months ended March 31, 2022.</div></div><div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; font-family: &quot;Times New Roman&quot;; font-size: 8pt; width: 100%; border: 0px; margin: 0px auto; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width:29%"><br/></td> <td style="vertical-align:bottom;width:2%"><br/></td> <td><br/></td> <td><br/></td> <td><br/></td> <td style="vertical-align:bottom;width:2%"><br/></td> <td><br/></td> <td><br/></td> <td><br/></td> <td style="vertical-align:bottom;width:2%"><br/></td> <td><br/></td> <td><br/></td> <td><br/></td> <td style="vertical-align:bottom;width:2%"><br/></td> <td><br/></td> <td><br/></td> <td><br/></td> <td style="vertical-align:bottom;width:2%"><br/></td> <td><br/></td> <td><br/></td> <td><br/></td> <td style="vertical-align:bottom;width:2%"><br/></td> <td><br/></td> <td><br/></td> <td><br/></td> <td style="vertical-align:bottom;width:2%"><br/></td> <td><br/></td> <td><br/></td> <td><br/></td> <td style="vertical-align:bottom;width:2%"><br/></td> <td><br/></td> <td><br/></td> <td><br/></td> <td style="vertical-align:bottom;width:2%"><br/></td> <td><br/></td> <td><br/></td> <td><br/></td> <td style="vertical-align:bottom;width:2%"><br/></td> <td><br/></td> <td><br/></td> <td><br/></td> <td style="vertical-align:bottom;width:2%"><br/></td> <td><br/></td> <td><br/></td> <td><br/></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Investments:</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Balance as of<br/> December 31,<br/> 2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Transfers<br/> into<br/> Level 3</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Transfer<br/> out of<br/> Level 3</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Net<br/> amortization<br/> (accretion) of<br/> premium/<br/> (discount)</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Distribution<br/> to Return<br/> Capital</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Net realized<br/> gains/<br/> (losses)</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Net</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">change in<br/> unrealized<br/> gains/<br/> (losses)</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Purchases/<br/> PIK</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(Sales<br/> and<br/> redemptions)</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Balance as of<br/> March 31,<br/> 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Change in<br/> unrealized<br/> gain/(loss)<br/> on Level 3<br/> securities still<br/> held at period<br/> end</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:1pt"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td colspan="2" style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td colspan="2" style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td colspan="2" style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td colspan="2" style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Assets</div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Senior Secured Loans</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Telecommunication Services</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">962,478</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">26,711</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">989,189</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Healthcare</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,000,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,809</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">86,191</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,990,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(4,080,000</td> <td style="white-space:nowrap;vertical-align:bottom">)(a) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,000,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">86,191</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Asset-Backed Securities</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Financials</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">405,040</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">11,787</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(16,979</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">399,848</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">11,787</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Common Stocks</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Financials</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,208,750</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(603,450</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,605,300</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(603,450</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Real Estate</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,823,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">141,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,964,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">141,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Service</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,172</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,172</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Telecommunication Services</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,706,357</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(94,456</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,611,901</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(94,456</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">LLC Interests</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Consumer Products</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,812,212</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">169,426</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,981,638</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">169,426</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Real Estate</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,760,162</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(74,603</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">139,367</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(3,274,285</td> <td style="white-space:nowrap;vertical-align:bottom">)(b) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,550,641</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(13,275</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Preferred Stocks</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Healthcare</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">8,080,000</td> <td style="white-space:nowrap;vertical-align:bottom">(a) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">8,080,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">21,683,171</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"> —  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,809</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"> —  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(74,603</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(150,135</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">11,096,711</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(7,371,264</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">25,187,689</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(302,777</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table><div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border: 0px; width: 100%; border-spacing: 0px;"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;"><div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(a)</div> </td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Denotes Sapience’s $4,080,000 promissory notes and paid in kind interest conversion to preferred stock. </div></td></tr></table> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border: 0px; width: 100%; border-spacing: 0px;"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;"><div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(b)</div> </td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Denotes SFR II’s LLC Interests conversion into NREF common shares. </div></td></tr></table> <div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;"> </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"/><div/><div><div style="background-color:white;display: inline;"/></div> <div style="text-indent: 9%; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Investments designated as Level 3 may include investments valued using quotes or indications furnished by brokers which are based on models or estimates and may not be executable prices. In light of the developing market conditions, the Adviser continues to search for observable data points and evaluate broker quotes and indications received for investments. Determination of fair values is uncertain because it involves subjective judgments and estimates that are unobservable. Transfers from Level 2 to Level 3 are due to a decrease in market activity (e.g. frequency of trades), which resulted in a decrease of available market inputs to determine price. For the three months ended March 31, 2023, there were no transfers from Level 2 to Level 3. For the three months ended March 31, 2022, there were no transfers from Level 2 to Level 3. Transfers from Level 3 to Level 2 and from Level 2 to Level 1 are due to an increase in market activity (e.g. frequency of trades), which resulted in an increase of available market inputs to determine price. </div></div></div> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; margin-top: 12pt; margin-bottom: 0pt; text-indent: 9%; font-size: 10pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The following are summaries of significant unobservable inputs used in the fair valuations of investments categorized within Level 3 of the fair value hierarchy as of March 31, 2023 and December 31, 2022:</div></div> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 12pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="font-family: &quot;Times New Roman&quot;; letter-spacing: normal; orphans: 2; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; border-collapse: collapse; font-size: 10pt; width: 750.719px; border: 0px; margin: 0px auto; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width: 150.141px; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="font-family: &quot;Times New Roman&quot;;"/> <td style="font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; width: 7.5px; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="width: 167.719px; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="width: 157.641px; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="font-family: &quot;Times New Roman&quot;;"/> <td style="font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; width: 7.5px; font-family: &quot;Times New Roman&quot;;"/> </tr> <tr style="break-inside: avoid; font-family: 'Times New Roman'; font-size: 8pt;"> <td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Investment</div></div></div> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="border-bottom: 1pt solid rgb(0, 0, 0); vertical-align: bottom;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Fair value at</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">March 31, 2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="border-bottom: 1pt solid rgb(0, 0, 0); vertical-align: bottom;;text-align:center;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Valuation</div></div></div> <div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">technique</div></div></div> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="border-bottom: 1pt solid rgb(0, 0, 0); vertical-align: bottom;;text-align:center;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Unobservable</div></div></div> <div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">inputs</div></div></div> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="border-bottom: 1pt solid rgb(0, 0, 0); vertical-align: bottom;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Range of input value(s)</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(weighted average)</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> </tr> <tr style="break-inside: avoid; font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">LLC Interest</div></div> </td> <td style="vertical-align: bottom;"> </td> <td style="white-space: nowrap; vertical-align: top;">$</td> <td style="white-space: nowrap; vertical-align: top;;text-align:right;">10,164,438</td> <td style="white-space: nowrap; vertical-align: top;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: top; white-space: nowrap;;text-align:center;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Discounted Cash Flow</div></div> <div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Multiples Analysis</div></div> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: top; white-space: nowrap;;text-align:center;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Discount Rate</div></div> <div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Multiple of EBITDA</div></div> </td> <td style="vertical-align: bottom;"> </td> <td style="white-space: nowrap; vertical-align: top;"> <br/> <div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"/> </td> <td style="white-space: nowrap; vertical-align: top;;text-align:center;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">4.98% - 9.18% (7.08%)</div><br/> <div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">5.60x - 9.95x (<div style="letter-spacing: 0px; top: 0px;;display:inline;">7.70</div>x)</div></div> </td> <td style="white-space: nowrap; vertical-align: top;"> <br/> <div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> </tr> <tr style="break-inside: avoid; font-family: 'Times New Roman'; font-size: 10pt;"> <td style="vertical-align: top;"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Preferred Stock</div></div> </td> <td style="vertical-align: bottom;"> </td> <td style="white-space: nowrap; vertical-align: top;"> </td> <td style="white-space: nowrap; vertical-align: top;;text-align:right;">10,581,888</td> <td style="white-space: nowrap; vertical-align: top;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: top; white-space: nowrap;;text-align:center;">Option Pricing Model</td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: top; white-space: nowrap;;text-align:center;">Volatility</td> <td style="vertical-align: bottom;"> </td> <td style="white-space: nowrap; vertical-align: top;"> </td> <td style="white-space: nowrap; vertical-align: top;;text-align:center;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">40% - 90% (65%)</div></td> <td style="white-space: nowrap; vertical-align: top; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> </tr> <tr style="break-inside: avoid; font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Common Stock</div></div> </td> <td style="vertical-align: bottom;"> </td> <td style="white-space: nowrap; vertical-align: top;"> </td> <td style="white-space: nowrap; vertical-align: top;;text-align:right;">9,126,018</td> <td style="white-space: nowrap; vertical-align: top;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: top; white-space: nowrap;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Discounted Cash Flow</div></div> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Multiples Analysis</div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt; text-align: left; line-height: normal;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Transaction Indication of Value</div></div> <div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Liquidation Analysis<br/>Net Asset Value</div></div> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: top; white-space: nowrap;;text-align:center;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Discount Rate</div></div> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Multiple of EBITDA</div></div> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Unadjusted<div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Price/MHz-PoP</div><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"/></div> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Enterprise Value ($mm)</div></div> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Recovery Rate</div></div> <div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">N/A</div></div> </td> <td style="vertical-align: bottom;"> </td> <td style="white-space: nowrap; vertical-align: top;"> <br/> <div style="margin-bottom: 0pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"/> <div style="margin-bottom: 0pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"/> <div style="margin-bottom: 0pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"/> <div style="margin-bottom: 0pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"/> <div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"/> </td> <td style="white-space: nowrap; vertical-align: top;;text-align:center;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">11.0% - 13.0% (12.0%)</div><br/> <div style="margin-bottom: 0pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">3.25x - 4.25x (<div style="letter-spacing: 0px; top: 0px;;display:inline;"/>3.75x)  </div></div> <div style="margin-bottom: 0pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">$0.09 - $0.95 ($0.52)</div></div> <div style="margin-bottom: 0pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">$921.5</div></div> <div style="margin-bottom: 0pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">40% - 100%</div></div> <div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">$28</div></div> </td> <td style="white-space: nowrap; vertical-align: top;"> <br/> <div style="margin-bottom: 0pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <div style="margin-bottom: 0pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <div style="margin-bottom: 0pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"/> <div style="margin-bottom: 0pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> </tr> <tr style="break-inside: avoid; font-family: 'Times New Roman'; font-size: 10pt;"> <td style="vertical-align: top;"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Senior Secured Loans</div></div> </td> <td style="vertical-align: bottom;"> </td> <td style="white-space: nowrap; vertical-align: top;"> </td> <td style="white-space: nowrap; vertical-align: top;;text-align:right;">4,565,602</td> <td style="white-space: nowrap; vertical-align: top;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: top; white-space: nowrap;;text-align:center;">Discounted Cash Flow</td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: top; white-space: nowrap;;text-align:center;">Discount Rate</td> <td style="vertical-align: bottom;"> </td> <td style="white-space: nowrap; vertical-align: top;"> </td> <td style="white-space: nowrap; vertical-align: top;;text-align:center;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">10.25% - 13.06% (11.40%)</div></td> <td style="white-space: nowrap; vertical-align: top;"> </td> </tr> <tr style="break-inside: avoid; font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Asset-Backed Securities</div></div> </td> <td style="vertical-align: bottom;"> </td> <td style="white-space: nowrap; vertical-align: top;"> </td> <td style="white-space: nowrap; vertical-align: top;;text-align:right;">7,280</td> <td style="white-space: nowrap; vertical-align: top;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: top; white-space: nowrap;;text-align:center;">NAV Approach</td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: top; white-space: nowrap;;text-align:center;">Discount Rate</td> <td style="vertical-align: bottom;"> </td> <td style="white-space: nowrap; vertical-align: top;"> </td> <td style="white-space: nowrap; vertical-align: top;;text-align:center;">70.00%</td> <td style="white-space: nowrap; vertical-align: top;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> </tr> <tr style="break-inside: avoid; font-family: 'Times New Roman'; font-size: 10pt;"> <td style="vertical-align: top;"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total</div></div></div> </td> <td style="vertical-align: bottom;"> </td> <td style="white-space: nowrap; vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="white-space: nowrap; vertical-align: bottom;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">       34,445,226</div></div></td> <td style="white-space: nowrap; vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> </tr> </table> <div style="clear:both;max-height:0pt;"/> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 12pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="font-family: &quot;Times New Roman&quot;; letter-spacing: normal; orphans: 2; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; border-collapse: collapse; font-size: 10pt; width: 750.719px; border: 0px; margin: 0px auto; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width: 160.484px; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="font-family: &quot;Times New Roman&quot;;"/> <td style="font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; width: 7.09375px; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="width: 167.719px; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="width: 149.984px; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="font-family: &quot;Times New Roman&quot;;"/> </tr> <tr style="break-inside: avoid; font-family: 'Times New Roman'; font-size: 8pt;"> <td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Investment</div></div></div> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="border-bottom: 1pt solid rgb(0, 0, 0); vertical-align: bottom; width: 11%; padding: 0pt 0pt 0pt 2pt;;text-align:center;"><div style="letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"><div style="font-weight:bold;display:inline;">Fair value at</div></div><br/><div style="letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"><div style="font-weight:bold;display:inline;">December 31, 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="border-bottom: 1pt solid rgb(0, 0, 0); vertical-align: bottom;;text-align:center;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Valuation</div></div></div> <div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">technique</div></div></div> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="border-bottom: 1pt solid rgb(0, 0, 0); vertical-align: bottom;;text-align:center;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Unobservable</div></div></div> <div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">inputs</div></div></div> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="border-bottom: 1pt solid rgb(0, 0, 0); vertical-align: bottom;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Range of input value(s)</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(weighted average)</div></div></td> </tr> <tr style="break-inside: avoid; font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">LLC Interest</div></div> </td> <td style="vertical-align: bottom;"> </td> <td style="white-space: nowrap; vertical-align: top; padding: 0pt 2pt 0pt 0pt;">$</td> <td style="white-space: nowrap; vertical-align: top; padding: 0pt 2pt 0pt 0pt;;text-align:right;">4,689,242</td> <td style="white-space: nowrap; vertical-align: top; padding: 0px;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: top; white-space: nowrap;;text-align:center;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Discounted Cash Flow</div></div> <div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Multiples Analysis</div></div> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: top; white-space: nowrap;;text-align:center;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Discount Rate</div></div> <div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Multiple of EBITDA</div></div> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: top; white-space: nowrap;;text-align:center;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">4.73% - 8.93% (6.83%)</div><br/> <div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">5.55x - 9.85x (7.70x)</div></div> </td> </tr> <tr style="break-inside: avoid; font-family: 'Times New Roman'; font-size: 10pt;"> <td style="vertical-align: top;"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Preferred Stock</div></div> </td> <td style="vertical-align: bottom;"> </td> <td style="white-space: nowrap; vertical-align: top;"> </td> <td style="white-space: nowrap; vertical-align: top; width: 10%; padding: 0pt 0pt 0pt 2pt;;text-align:right;">10,527,285</td> <td style="white-space: nowrap; vertical-align: top; padding: 0px;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: top; white-space: nowrap;;text-align:center;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Option Pricing Model</div></div> <div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Transaction Indication of Value</div></div> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: top; white-space: nowrap;;text-align:center;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Volatility</div></div> <div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Recap Price</div></div> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: top; white-space: nowrap;;text-align:center;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">40% - 60% (50%)</div><br/> <div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">$11.10</div></div> </td> </tr> <tr style="break-inside: avoid; font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Common Stock</div></div> </td> <td style="vertical-align: bottom;"> </td> <td style="white-space: nowrap; vertical-align: top;"> </td> <td style="white-space: nowrap; vertical-align: top; width: 10%; padding: 0pt 0pt 0pt 2pt;;text-align:right;">9,207,983</td> <td style="white-space: nowrap; vertical-align: top; padding: 0px;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: top; white-space: nowrap;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Discounted Cash Flow</div></div> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Multiples Analysis</div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt; text-align: left; line-height: normal;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Transaction Indication of Value</div></div> <div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Liquidation Analysis<br/>Net Asset Value</div></div> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: top; white-space: nowrap;;text-align:center;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Discount Rate</div></div> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Multiple of EBITDA</div></div> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Unadjusted Price/MHz-PoP</div></div> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Enterprise Value ($mm)</div></div> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Recovery Rate</div></div> <div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">N/A</div></div> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: top; white-space: nowrap;;text-align:center;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">13.50% - 15.50% (14.50%)</div><br/> <div style="margin-bottom: 0pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">3.25x - 4.25x (3.75x)</div></div> <div style="margin-bottom: 0pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">$0.09 - $0.95 ($0.52)  </div></div> <div style="margin-bottom: 0pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">$872 - $969 ($920.5)  </div></div> <div style="margin-bottom: 0pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">40% - 100% (70%)</div></div> <div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">$28</div></div> </td> </tr> <tr style="break-inside: avoid; font-family: 'Times New Roman'; font-size: 10pt;"> <td style="vertical-align: top;"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Senior Secured Loans</div></div> </td> <td style="vertical-align: bottom;"> </td> <td style="white-space: nowrap; vertical-align: top;"> </td> <td style="white-space: nowrap; vertical-align: top; width: 10%; padding: 0pt 0pt 0pt 2pt;;text-align:right;">4,069,243</td> <td style="white-space: nowrap; vertical-align: top; padding: 0px;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: top; white-space: nowrap;;text-align:center;">Discounted Cash Flow</td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: top; white-space: nowrap;;text-align:center;">Discount Rate</td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: top; white-space: nowrap;;text-align:center;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">   10.25% - 13.08% (11.67%)   </div></td> </tr> <tr style="break-inside: avoid; font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Asset-Backed Securities</div></div> </td> <td style="vertical-align: bottom;"> </td> <td style="white-space: nowrap; vertical-align: top;"> </td> <td style="white-space: nowrap; vertical-align: top; width: 10%; padding: 0pt 0pt 0pt 2pt;;text-align:right;">7,036</td> <td style="white-space: nowrap; vertical-align: top; padding: 0px;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: top; white-space: nowrap;;text-align:center;">NAV Approach</td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: top; white-space: nowrap;;text-align:center;">Discount Rate</td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: top; white-space: nowrap;;text-align:center;">70.00%</td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> </tr> <tr style="break-inside: avoid; font-family: 'Times New Roman'; font-size: 10pt;"> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total</div></div></div> </td> <td style="vertical-align: bottom;"> </td> <td style="white-space: nowrap; vertical-align: bottom; padding: 0pt 0pt 0pt 2pt;"><div style="letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="white-space: nowrap; vertical-align: bottom; padding: 0pt 0pt 0pt 2pt;;text-align:right;"><div style="letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"><div style="font-weight:bold;display:inline;">28,500,789</div></div></td> <td style="white-space: nowrap; vertical-align: bottom; padding: 0px;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> </tr> </table> <div style="clear:both;max-height:0pt;"/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"/> <div style="text-indent: 9%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">The significant unobservable inputs used in the fair value measurement of the Company’s LLC interests are: discount rate and multiples of EBITDA. Significant increases (decreases) in those inputs in isolation could result in a significantly lower (higher) fair value measurement. The significant unobservable inputs used in the fair value measurement of the Company’s common equity securities are: multiple of EBITDA, <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">price/MHz-PoP</div> multiple, liquidity discount, discount rate, enterprise value, and transaction price. Significant increases (decreases) in any of those inputs in isolation could result in a significantly lower (higher) fair value measurement. The significant unobservable inputs used in the fair value measurement of the Company’s preferred stock are: option pricing model. Significant increases (decreases) in any of those inputs in isolation could result in a significantly lower (higher) fair value measurement. The significant unobservable inputs used in the fair value measurement of the Company’s senior secured loans are: discount rate and spread adjustment. Significant increases (decreases) in either of those inputs in isolation could result in a significantly lower (higher) fair value measurement. </div></div> <div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/></div></div> <div style="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The significant unobservable inputs used in the fair value measurement of the Company’s asset-backed securities are: discount rate and broker quote indication of value. Significant increases (decreases) in either of those inputs in isolation could result in a significantly lower (higher) fair value measurement. The significant unobservable input used in the fair value measurement of the Company’s warrant securities is: volatility assumption. Significant increases (decreases) in this input in isolation could result in a significantly lower (higher) fair value measurement.</div> <div style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">As of March 31, 2023, the Company held the following investments for which a sufficient level of current, reliable market quotations were not available: </div> <div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:76%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:61%"/> <td style="vertical-align:bottom;width:5%"/> <td style="width:23%"/> <td style="vertical-align:bottom;width:5%"/> <td/> <td/> <td/> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Instrument</div></div> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"> <div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;">Type</div></div> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Fair value</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Grayson Investor Corp.</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Asset-Backed Securities</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"> 7,267</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">PAMCO CLO <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">1997-1A</div> B</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">Asset-Backed Securities</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">13</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">American Banknote Corp.</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">Common Stocks</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,732,500</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">IQHQ, Inc.</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">Common Stocks</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,359,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">TerreStar Corp.</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">Common Stocks</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,032,249</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Wayne Services Legacy, Inc.</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">Common Stocks</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,268</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">NexPoint Capital REIT, LLC</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">LLC Interests</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">6,904,655</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">SFR WLIF III, LLC</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">LLC Interests</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">418,181</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">US Gaming, LLC</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">LLC Interests</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,841,603</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Apnimed, Inc.</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">Preferred Stocks</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,499,989</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Apnimed, Inc.</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">Preferred Stocks</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">799,993</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Sapience Therapeutics, Inc.</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">Preferred Stocks</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,581,906</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Sapience Therapeutics, Inc.</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">Preferred Stocks</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,700,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">CCS Medical, Inc.</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">Senior Secured Loans</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,000,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">NexPoint Capital REIT<div style="letter-spacing: 0px; top: 0px;;display:inline;">,</div> <div style="letter-spacing: 0px; top: 0px;;display:inline;">LLC</div></div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">Senior Secured Loans</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">463,314</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">TerreStar Corp.</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">Senior Secured Loans</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">836,016</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">TerreStar Corp.</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">Senior Secured Loans</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">197,921</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">TerreStar Corp.</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">Senior Secured Loans</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">35,360</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">TerreStar Corp.</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">Senior Secured Loans</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">32,991</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> </table> <div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"> </div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"/> <div style="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">As of December 31, 2022, the Company held the following investments for which a sufficient level of current, reliable market quotations were not available: </div> <div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:76%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:61%"/> <td style="vertical-align:bottom;width:5%"/> <td style="width:23%"/> <td style="vertical-align:bottom;width:5%"/> <td/> <td/> <td/> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Instrument</div></div> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"> <div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;">Type</div></div> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Fair value</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Grayson Investor Corp.</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Asset-Backed Securities</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"> 7,023</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">PAMCO CLO <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">1997-1A</div> B</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">Asset-Backed Securities</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">13</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">American Banknote Corp.</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">Common Stocks</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,732,500</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">IQHQ, Inc.</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">Common Stocks</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,359,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">TerreStar Corp.</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">Common Stocks</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,114,214</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Wayne Services Legacy, Inc.</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">Common Stocks</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,269</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">NexPoint Capital REIT, LLC</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">LLC Interests</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,176,024</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">SFR WLIF III, LLC</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">LLC Interests</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">424,468</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">US Gaming, LLC</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">LLC Interests</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,088,750</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Apnimed, Inc.</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">Preferred Stocks</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,499,989</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Apnimed, Inc.</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">Preferred Stocks</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">799,994</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Sapience Therapeutics, Inc.</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">Preferred Stocks</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,549,525</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Sapience Therapeutics, Inc.</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">Preferred Stocks</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,677,777</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">CCS Medical, Inc.</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">Senior Secured Loans</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,000,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">TerreStar Corp.</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">Senior Secured Loans</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">810,953</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">TerreStar Corp.</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">Senior Secured Loans</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">191,988</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">TerreStar Corp.</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">Senior Secured Loans</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">34,300</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">TerreStar Corp.</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">Senior Secured Loans</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">32,002</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> </table> Asset-Backed Securities 7267 Asset-Backed Securities 13 Common Stocks 1732500 Common Stocks 2359000 Common Stocks 5032249 Common Stocks 2268 LLC Interests 6904655 LLC Interests 418181 LLC Interests 2841603 Preferred Stocks 1499989 Preferred Stocks 799993 Preferred Stocks 4581906 Preferred Stocks 3700000 Senior Secured Loans 3000000 Senior Secured Loans 463314 Senior Secured Loans 836016 Senior Secured Loans 197921 Senior Secured Loans 35360 Senior Secured Loans 32991 Asset-Backed Securities 7023 Asset-Backed Securities 13 Common Stocks 1732500 Common Stocks 2359000 Common Stocks 5114214 Common Stocks 2269 LLC Interests 1176024 LLC Interests 424468 LLC Interests 3088750 Preferred Stocks 1499989 Preferred Stocks 799994 Preferred Stocks 4549525 Preferred Stocks 3677777 Senior Secured Loans 3000000 Senior Secured Loans 810953 Senior Secured Loans 191988 Senior Secured Loans 34300 Senior Secured Loans 32002 <div style="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The inputs or methodology used for valuing investments are not necessarily an indication of the risk associated with investing in those investments. The following are summaries of the Company’s investments categorized within the fair value hierarchy as of March 31, 2023 and December 31, 2022: </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:92%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:53%"/> <td style="vertical-align:bottom;width:3%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:3%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:3%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:3%"/> <td/> <td/> <td/></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="14" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">March 31, 2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Investments</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level 1</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level 2</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level 3</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Total</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:1pt"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td colspan="16" style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Assets</div></div></td> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0em; text-indent: 0em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;"> </div></div></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td colspan="16" style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Senior Secured Loans</div></td> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0em; text-indent: 0em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"> </div></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Healthcare</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,466,015</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,000,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">8,466,015</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Real Estate</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">463,314</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">463,314</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Telecommunication Services</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,102,288</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,102,288</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td colspan="16" style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Asset-Backed Securities</div></td> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0em; text-indent: 0em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"> </div></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Financials</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">7,280</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">7,280</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td colspan="16" style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Corporate Bonds</div></td> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0em; text-indent: 0em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"> </div></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Healthcare</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,240,779</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,240,779</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Media/Telecommunications</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">259,466</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">259,466</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td colspan="16" style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Common Stocks</div></td> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0em; text-indent: 0em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"> </div></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Chemicals</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">42,500</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">42,500</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Energy</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,629,178</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,629,178</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Financials</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,732,500</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,732,500</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Real Estate</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,063,263</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,359,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,422,263</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Real Estate Investment Trusts (REITs)</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,022,291</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,022,291</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Service</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,268</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,268</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Telecommunication Services</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,032,249</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,032,249</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td colspan="16" style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">LLC Interests</div></td> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0em; text-indent: 0em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"> </div></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Consumer Products</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,841,603</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,841,603</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Real Estate</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">7,322,836</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">7,322,836</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td colspan="16" style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Preferred Stocks</div></td> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0em; text-indent: 0em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"> </div></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Financials</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,400,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,400,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Healthcare</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">10,581,888</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">10,581,888</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td colspan="16" style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Warrants</div></td> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0em; text-indent: 0em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"> </div></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Energy</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">152,748</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">152,748</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Media/Telecommunications</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">10,063</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">10,063</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Total Assets</div></div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">3,085,554</div></div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">11,200,749</div></div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">34,445,226</div></div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">48,731,529</div></div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Total Investments</div></div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">3,085,554</div></div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">11,200,749</div></div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">34,445,226</div></div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">48,731,529</div></div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"> </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"/> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 92%; border: 0px; margin: 0px auto; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width:53%"><br/></td> <td style="vertical-align:bottom;width:3%"><br/></td> <td><br/></td> <td><br/></td> <td><br/></td> <td style="vertical-align:bottom;width:3%"><br/></td> <td><br/></td> <td><br/></td> <td><br/></td> <td style="vertical-align:bottom;width:3%"><br/></td> <td><br/></td> <td><br/></td> <td><br/></td> <td style="vertical-align:bottom;width:3%"><br/></td> <td><br/></td> <td><br/></td> <td><br/></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="14" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December 31, 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Investments</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level 1</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level 2</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level 3</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Total</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:1pt"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td colspan="16" style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Assets</div></div></td> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0em; text-indent: 0em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;"> </div></div></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td colspan="16" style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Senior Secured Loans</div></td> <td style="vertical-align:top"><div style="margin-top: 0px; margin-bottom: 0px; margin-left: 0em; text-indent: 0em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"> </div></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Healthcare</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">10,158,950</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,000,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">13,158,950</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Telecommunication Services</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,069,243</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,069,243</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td colspan="16" style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Asset-Backed Securities</div></td> <td style="vertical-align:top"><div style="margin-top: 0px; margin-bottom: 0px; margin-left: 0em; text-indent: 0em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"> </div></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Financials</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">7,036</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">7,036</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td colspan="16" style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Corporate Bonds</div></td> <td style="vertical-align:top"><div style="margin-top: 0px; margin-bottom: 0px; margin-left: 0em; text-indent: 0em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"> </div></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Healthcare</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,414,839</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,414,839</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Media/Telecommunications</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">290,078</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">290,078</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td colspan="16" style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Common Stocks</div></td> <td style="vertical-align:top"><div style="margin-top: 0px; margin-bottom: 0px; margin-left: 0em; text-indent: 0em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"> </div></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Chemicals</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">42,500</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">42,500</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Energy</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,591,692</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,591,692</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Financials</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,732,500</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,732,500</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Real Estate</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">7,653,730</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,359,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">10,012,730</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Real Estate Investment Trusts (REITs)</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,018,779</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,018,779</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Service</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,269</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,269</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Telecommunication Services</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,114,214</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,114,214</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td colspan="16" style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">LLC Interests</div></td> <td style="vertical-align:top"><div style="margin-top: 0px; margin-bottom: 0px; margin-left: 0em; text-indent: 0em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"> </div></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Consumer Products</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,088,750</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,088,750</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Real Estate</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,600,492</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,600,492</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td colspan="16" style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Preferred Stocks</div></td> <td style="vertical-align:top"><div style="margin-top: 0px; margin-bottom: 0px; margin-left: 0em; text-indent: 0em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"> </div></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Financials</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,440,625</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,440,625</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Healthcare</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">10,527,285</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">10,527,285</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td colspan="16" style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Warrants</div></td> <td style="vertical-align:top"><div style="margin-top: 0px; margin-bottom: 0px; margin-left: 0em; text-indent: 0em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"> </div></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Energy</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">161,249</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">161,249</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Media/Telecommunications</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">20,484</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">20,484</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Total Assets</div></div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">8,672,509</div></div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">16,120,417</div></div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">28,500,789</div></div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">53,293,715</div></div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Total Investments</div></div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">8,672,509</div></div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">16,120,417</div></div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">28,500,789</div></div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">53,293,715</div></div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table> 0 5466015 3000000 8466015 463314 463314 0 0 1102288 1102288 0 0 7280 7280 0 2240779 0 2240779 0 259466 0 259466 0 42500 0 42500 0 1629178 0 1629178 0 0 1732500 1732500 2063263 0 2359000 4422263 1022291 0 0 1022291 0 0 2268 2268 0 0 5032249 5032249 0 0 2841603 2841603 0 0 7322836 7322836 0 1400000 0 1400000 0 0 10581888 10581888 0 152748 0 152748 0 10063 0 10063 3085554 11200749 34445226 48731529 3085554 11200749 34445226 48731529 0 10158950 3000000 13158950 0 0 1069243 1069243 0 0 7036 7036 0 2414839 0 2414839 0 290078 0 290078 0 42500 0 42500 0 1591692 0 1591692 0 0 1732500 1732500 7653730 0 2359000 10012730 1018779 0 0 1018779 0 0 2269 2269 0 0 5114214 5114214 0 0 3088750 3088750 0 0 1600492 1600492 0 1440625 0 1440625 0 0 10527285 10527285 0 161249 0 161249 0 20484 0 20484 8672509 16120417 28500789 53293715 8672509 16120417 28500789 53293715 <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"/><div style="letter-spacing: 0px; top: 0px;;display:inline;"/><div style="text-indent: 9%; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The table below sets forth a summary of changes in the Company’s Level 3 investments (measured at fair value using significant unobservable inputs) for the three months ended March 31, 2023. The table below includes noncash transactions for the three months ended March 31, 2023. </div></div></div><div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 8pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="font-size: 0px;"> <td style="width: 31%;"><br/></td> <td style="width: 2%; vertical-align: bottom;"><br/></td> <td><br/></td> <td><br/></td> <td><br/></td> <td style="width: 2%; vertical-align: bottom;"><br/></td> <td><br/></td> <td><br/></td> <td><br/></td> <td style="width: 2%; vertical-align: bottom;"><br/></td> <td><br/></td> <td><br/></td> <td><br/></td> <td style="width: 2%; vertical-align: bottom;"><br/></td> <td><br/></td> <td><br/></td> <td><br/></td> <td style="width: 2%; vertical-align: bottom;"><br/></td> <td><br/></td> <td><br/></td> <td><br/></td> <td style="width: 2%; vertical-align: bottom;"><br/></td> <td><br/></td> <td><br/></td> <td><br/></td> <td style="width: 2%; vertical-align: bottom;"><br/></td> <td><br/></td> <td><br/></td> <td><br/></td> <td style="width: 2%; vertical-align: bottom;"><br/></td> <td><br/></td> <td><br/></td> <td><br/></td> <td><br/></td> <td style="width: 2%; vertical-align: bottom;"><br/></td> <td><br/></td> <td><br/></td> <td><br/></td> <td style="width: 2%; vertical-align: bottom;"><br/></td> <td><br/></td> <td><br/></td> <td><br/></td> <td style="width: 2%; vertical-align: bottom;"><br/></td> <td><br/></td> <td><br/></td> <td><br/></td></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Investments:</div></div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Balance as of<br/>December 31,<br/>2022</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Transfers<br/>into<br/>Level 3</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Transfer<br/>s out of<br/>Level 3</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Net<br/>amortization<br/>(accretion) of<br/>premium/<br/>(discount)</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Distribution<br/>to Return<br/>Capital</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Net realized<br/>gains/<br/>(losses)</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Net</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">change in<br/>unrealized<br/>gains/<br/>(losses)</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Purchases/<br/>PIK</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding: 0px;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(Sales<br/>and<br/>redemptions)</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Balance as of<br/>March 31,<br/>2023</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Change in<br/>unrealized<br/>gain/(loss)<br/>on Level 3<br/>securities still<br/>held at period<br/>end</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Assets</div></div></div></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/><br/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/><br/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/><br/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/><br/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/><br/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/><br/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/><br/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/><br/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/><br/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/><br/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/><br/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/><br/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/><br/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/><br/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/><br/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/><br/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/><br/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/><br/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/><br/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/><br/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/><br/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/><br/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/><br/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/><br/></td> <td style="vertical-align: bottom; padding: 0px;"> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/><br/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/><br/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/><br/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/><br/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/><br/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/><br/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/><br/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/><br/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/><br/></td></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Senior Secured Loans</div></div></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/><br/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/><br/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/><br/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/><br/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/><br/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/><br/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/><br/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/><br/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/><br/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/><br/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/><br/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/><br/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/><br/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/><br/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/><br/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/><br/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/><br/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/><br/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/><br/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/><br/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/><br/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/><br/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/><br/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/><br/></td> <td style="vertical-align: bottom; padding: 0px;"> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/><br/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/><br/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/><br/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/><br/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/><br/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/><br/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/><br/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/><br/></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/><br/></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Telecommunication Services</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,069,243</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"> —  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"> 3,198</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"> 29,847</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space: nowrap; vertical-align: bottom; padding: 0px;"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"> —  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align: bottom; padding: 0px;"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"> 1,102,288</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"> 3,198</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Healthcare</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,000,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,465</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(4,465</td> <td style="white-space:nowrap;vertical-align:bottom">)<div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space: nowrap; vertical-align: bottom; padding: 0px;"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align: bottom; padding: 0px;"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,000,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(4,465</td> <td style="white-space:nowrap;vertical-align:bottom">)</td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Real Estate</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">463,314</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space: nowrap; vertical-align: bottom; padding: 0px;"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align: bottom; padding: 0px;"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">463,314</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Asset-Backed Securities</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align: bottom; padding: 0px;"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align: bottom; padding: 0px;"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Financials</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">7,036</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">244</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space: nowrap; vertical-align: bottom; padding: 0px;"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align: bottom; padding: 0px;"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">7,280</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">244</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Common Stocks</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align: bottom; padding: 0px;"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align: bottom; padding: 0px;"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Financials</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,732,500</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space: nowrap; vertical-align: bottom; padding: 0px;"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align: bottom; padding: 0px;"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,732,500</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Real Estate</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,359,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space: nowrap; vertical-align: bottom; padding: 0px;"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align: bottom; padding: 0px;"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,359,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Service</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,269</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space: nowrap; vertical-align: bottom; padding: 0px;"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align: bottom; padding: 0px;"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,268</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Telecommunication Services</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,114,214</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(81,965</td> <td style="white-space:nowrap;vertical-align:bottom">)</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space: nowrap; vertical-align: bottom; padding: 0px;"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align: bottom; padding: 0px;"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,032,249</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(81,965</td> <td style="white-space:nowrap;vertical-align:bottom">)</td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">LLC Interests</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align: bottom; padding: 0px;"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align: bottom; padding: 0px;"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Consumer Products</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,088,750</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">163,314</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">52,853</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space: nowrap; vertical-align: bottom; padding: 0px;"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(463,314</td> <td style="white-space:nowrap;vertical-align:bottom">)</td> <td style="vertical-align: bottom; padding: 0px;"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,841,603</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">52,853</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Real Estate</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,600,492</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(1,645,741</td> <td style="white-space:nowrap;vertical-align:bottom">)</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">7,368,085</td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-size:75%; vertical-align:top;display:inline;;font-size:6.6px">(1)</div> </td> <td style="white-space: nowrap; vertical-align: bottom; padding: 0px;"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align: bottom; padding: 0px;"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">7,322,836</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(1,645,741</td> <td style="white-space:nowrap;vertical-align:bottom">)</td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Preferred Stocks</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align: bottom; padding: 0px;"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align: bottom; padding: 0px;"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Healthcare</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">10,527,285</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">54,603</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space: nowrap; vertical-align: bottom; padding: 0px;"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align: bottom; padding: 0px;"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">10,581,888</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">54,603</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="padding: 0px;"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align: bottom; padding: 0px;"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">28,500,789</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,465</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">163,314</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(1,621,273</td> <td style="white-space:nowrap;vertical-align:bottom">)</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">7,861,246</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space: nowrap; vertical-align: bottom; padding: 0px;"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(463,314</td> <td style="white-space:nowrap;vertical-align:bottom">)<div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding: 0px;"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">34,445,226</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(1,621,273</td> <td style="white-space:nowrap;vertical-align:bottom">)<div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="padding: 0px;"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align: bottom; padding: 0px;"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table><div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%; vertical-align: top;;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 75%; vertical-align: top;;display:inline;;font-size:8.3px">(1)</div> </div></td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Represents an in-kind transfer to the subreit. </div></div></div></td></tr></table><div style="clear:both;max-height:0pt;;text-indent: 0px;"/><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The table below sets forth a summary of changes in the Company’s Level 3 investments (measured at fair value using significant unobservable inputs) for the three months ended March 31, 2022.</div></div><div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; font-family: &quot;Times New Roman&quot;; font-size: 8pt; width: 100%; border: 0px; margin: 0px auto; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width:29%"><br/></td> <td style="vertical-align:bottom;width:2%"><br/></td> <td><br/></td> <td><br/></td> <td><br/></td> <td style="vertical-align:bottom;width:2%"><br/></td> <td><br/></td> <td><br/></td> <td><br/></td> <td style="vertical-align:bottom;width:2%"><br/></td> <td><br/></td> <td><br/></td> <td><br/></td> <td style="vertical-align:bottom;width:2%"><br/></td> <td><br/></td> <td><br/></td> <td><br/></td> <td style="vertical-align:bottom;width:2%"><br/></td> <td><br/></td> <td><br/></td> <td><br/></td> <td style="vertical-align:bottom;width:2%"><br/></td> <td><br/></td> <td><br/></td> <td><br/></td> <td style="vertical-align:bottom;width:2%"><br/></td> <td><br/></td> <td><br/></td> <td><br/></td> <td style="vertical-align:bottom;width:2%"><br/></td> <td><br/></td> <td><br/></td> <td><br/></td> <td style="vertical-align:bottom;width:2%"><br/></td> <td><br/></td> <td><br/></td> <td><br/></td> <td style="vertical-align:bottom;width:2%"><br/></td> <td><br/></td> <td><br/></td> <td><br/></td> <td style="vertical-align:bottom;width:2%"><br/></td> <td><br/></td> <td><br/></td> <td><br/></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Investments:</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Balance as of<br/> December 31,<br/> 2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Transfers<br/> into<br/> Level 3</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Transfer<br/> out of<br/> Level 3</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Net<br/> amortization<br/> (accretion) of<br/> premium/<br/> (discount)</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Distribution<br/> to Return<br/> Capital</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Net realized<br/> gains/<br/> (losses)</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Net</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">change in<br/> unrealized<br/> gains/<br/> (losses)</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Purchases/<br/> PIK</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(Sales<br/> and<br/> redemptions)</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Balance as of<br/> March 31,<br/> 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Change in<br/> unrealized<br/> gain/(loss)<br/> on Level 3<br/> securities still<br/> held at period<br/> end</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:1pt"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td colspan="2" style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td colspan="2" style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td colspan="2" style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td colspan="2" style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Assets</div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Senior Secured Loans</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Telecommunication Services</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">962,478</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">26,711</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">989,189</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Healthcare</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,000,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,809</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">86,191</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,990,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(4,080,000</td> <td style="white-space:nowrap;vertical-align:bottom">)(a) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,000,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">86,191</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Asset-Backed Securities</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Financials</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">405,040</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">11,787</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(16,979</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">399,848</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">11,787</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Common Stocks</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Financials</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,208,750</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(603,450</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,605,300</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(603,450</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Real Estate</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,823,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">141,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,964,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">141,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Service</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,172</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,172</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Telecommunication Services</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,706,357</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(94,456</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,611,901</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(94,456</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">LLC Interests</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Consumer Products</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,812,212</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">169,426</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,981,638</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">169,426</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Real Estate</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,760,162</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(74,603</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">139,367</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(3,274,285</td> <td style="white-space:nowrap;vertical-align:bottom">)(b) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,550,641</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(13,275</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Preferred Stocks</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Healthcare</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">8,080,000</td> <td style="white-space:nowrap;vertical-align:bottom">(a) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">8,080,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">21,683,171</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"> —  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,809</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"> —  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(74,603</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(150,135</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">11,096,711</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(7,371,264</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">25,187,689</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(302,777</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table><div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border: 0px; width: 100%; border-spacing: 0px;"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;"><div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(a)</div> </td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Denotes Sapience’s $4,080,000 promissory notes and paid in kind interest conversion to preferred stock. </div></td></tr></table> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border: 0px; width: 100%; border-spacing: 0px;"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;"><div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(b)</div> </td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Denotes SFR II’s LLC Interests conversion into NREF common shares. </div></td></tr></table> 1069243 0 0 0 0 0 3198 29847 0 1102288 3198 3000000 0 0 4465 0 0 -4465 0 0 3000000 -4465 0 0 0 0 0 0 0 463314 0 463314 0 7036 0 0 0 0 0 244 0 0 7280 244 1732500 0 0 0 0 0 0 0 0 1732500 0 2359000 0 0 0 0 0 0 0 0 2359000 0 2269 0 0 0 0 0 0 0 0 2268 0 5114214 0 0 0 0 0 -81965 0 0 5032249 -81965 3088750 0 0 0 0 163314 52853 0 -463314 2841603 52853 1600492 0 0 0 0 0 -1645741 7368085 0 7322836 -1645741 10527285 0 0 0 0 0 54603 0 0 10581888 54603 28500789 0 0 4465 0 163314 -1621273 7861246 -463314 34445226 -1621273 962478 0 0 0 0 0 0 26711 0 989189 0 4000000 0 0 3809 0 0 86191 2990000 -4080000 3000000 86191 405040 0 0 0 0 0 11787 0 -16979 399848 11787 2208750 0 0 0 0 0 -603450 0 0 1605300 -603450 1823000 0 0 0 0 0 141000 0 0 1964000 141000 5172 0 0 0 0 0 0 0 0 5172 0 4706357 0 0 0 0 0 -94456 0 0 4611901 -94456 2812212 0 0 0 0 0 169426 0 0 2981638 169426 4760162 0 0 0 0 -74603 139367 0 -3274285 1550641 -13275 0 0 0 0 0 0 0 8080000 0 8080000 0 21683171 0 0 3809 0 -74603 -150135 11096711 -7371264 25187689 -302777 4080000 <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; margin-top: 12pt; margin-bottom: 0pt; text-indent: 9%; font-size: 10pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The following are summaries of significant unobservable inputs used in the fair valuations of investments categorized within Level 3 of the fair value hierarchy as of March 31, 2023 and December 31, 2022:</div></div> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 12pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="font-family: &quot;Times New Roman&quot;; letter-spacing: normal; orphans: 2; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; border-collapse: collapse; font-size: 10pt; width: 750.719px; border: 0px; margin: 0px auto; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width: 150.141px; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="font-family: &quot;Times New Roman&quot;;"/> <td style="font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; width: 7.5px; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="width: 167.719px; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="width: 157.641px; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="font-family: &quot;Times New Roman&quot;;"/> <td style="font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; width: 7.5px; font-family: &quot;Times New Roman&quot;;"/> </tr> <tr style="break-inside: avoid; font-family: 'Times New Roman'; font-size: 8pt;"> <td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Investment</div></div></div> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="border-bottom: 1pt solid rgb(0, 0, 0); vertical-align: bottom;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Fair value at</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">March 31, 2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="border-bottom: 1pt solid rgb(0, 0, 0); vertical-align: bottom;;text-align:center;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Valuation</div></div></div> <div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">technique</div></div></div> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="border-bottom: 1pt solid rgb(0, 0, 0); vertical-align: bottom;;text-align:center;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Unobservable</div></div></div> <div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">inputs</div></div></div> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="border-bottom: 1pt solid rgb(0, 0, 0); vertical-align: bottom;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Range of input value(s)</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(weighted average)</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> </tr> <tr style="break-inside: avoid; font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">LLC Interest</div></div> </td> <td style="vertical-align: bottom;"> </td> <td style="white-space: nowrap; vertical-align: top;">$</td> <td style="white-space: nowrap; vertical-align: top;;text-align:right;">10,164,438</td> <td style="white-space: nowrap; vertical-align: top;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: top; white-space: nowrap;;text-align:center;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Discounted Cash Flow</div></div> <div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Multiples Analysis</div></div> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: top; white-space: nowrap;;text-align:center;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Discount Rate</div></div> <div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Multiple of EBITDA</div></div> </td> <td style="vertical-align: bottom;"> </td> <td style="white-space: nowrap; vertical-align: top;"> <br/> <div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"/> </td> <td style="white-space: nowrap; vertical-align: top;;text-align:center;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">4.98% - 9.18% (7.08%)</div><br/> <div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">5.60x - 9.95x (<div style="letter-spacing: 0px; top: 0px;;display:inline;">7.70</div>x)</div></div> </td> <td style="white-space: nowrap; vertical-align: top;"> <br/> <div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> </tr> <tr style="break-inside: avoid; font-family: 'Times New Roman'; font-size: 10pt;"> <td style="vertical-align: top;"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Preferred Stock</div></div> </td> <td style="vertical-align: bottom;"> </td> <td style="white-space: nowrap; vertical-align: top;"> </td> <td style="white-space: nowrap; vertical-align: top;;text-align:right;">10,581,888</td> <td style="white-space: nowrap; vertical-align: top;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: top; white-space: nowrap;;text-align:center;">Option Pricing Model</td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: top; white-space: nowrap;;text-align:center;">Volatility</td> <td style="vertical-align: bottom;"> </td> <td style="white-space: nowrap; vertical-align: top;"> </td> <td style="white-space: nowrap; vertical-align: top;;text-align:center;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">40% - 90% (65%)</div></td> <td style="white-space: nowrap; vertical-align: top; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> </tr> <tr style="break-inside: avoid; font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Common Stock</div></div> </td> <td style="vertical-align: bottom;"> </td> <td style="white-space: nowrap; vertical-align: top;"> </td> <td style="white-space: nowrap; vertical-align: top;;text-align:right;">9,126,018</td> <td style="white-space: nowrap; vertical-align: top;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: top; white-space: nowrap;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Discounted Cash Flow</div></div> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Multiples Analysis</div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt; text-align: left; line-height: normal;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Transaction Indication of Value</div></div> <div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Liquidation Analysis<br/>Net Asset Value</div></div> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: top; white-space: nowrap;;text-align:center;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Discount Rate</div></div> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Multiple of EBITDA</div></div> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Unadjusted<div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Price/MHz-PoP</div><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"/></div> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Enterprise Value ($mm)</div></div> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Recovery Rate</div></div> <div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">N/A</div></div> </td> <td style="vertical-align: bottom;"> </td> <td style="white-space: nowrap; vertical-align: top;"> <br/> <div style="margin-bottom: 0pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"/> <div style="margin-bottom: 0pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"/> <div style="margin-bottom: 0pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"/> <div style="margin-bottom: 0pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"/> <div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"/> </td> <td style="white-space: nowrap; vertical-align: top;;text-align:center;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">11.0% - 13.0% (12.0%)</div><br/> <div style="margin-bottom: 0pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">3.25x - 4.25x (<div style="letter-spacing: 0px; top: 0px;;display:inline;"/>3.75x)  </div></div> <div style="margin-bottom: 0pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">$0.09 - $0.95 ($0.52)</div></div> <div style="margin-bottom: 0pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">$921.5</div></div> <div style="margin-bottom: 0pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">40% - 100%</div></div> <div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">$28</div></div> </td> <td style="white-space: nowrap; vertical-align: top;"> <br/> <div style="margin-bottom: 0pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <div style="margin-bottom: 0pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <div style="margin-bottom: 0pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"/> <div style="margin-bottom: 0pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> </tr> <tr style="break-inside: avoid; font-family: 'Times New Roman'; font-size: 10pt;"> <td style="vertical-align: top;"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Senior Secured Loans</div></div> </td> <td style="vertical-align: bottom;"> </td> <td style="white-space: nowrap; vertical-align: top;"> </td> <td style="white-space: nowrap; vertical-align: top;;text-align:right;">4,565,602</td> <td style="white-space: nowrap; vertical-align: top;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: top; white-space: nowrap;;text-align:center;">Discounted Cash Flow</td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: top; white-space: nowrap;;text-align:center;">Discount Rate</td> <td style="vertical-align: bottom;"> </td> <td style="white-space: nowrap; vertical-align: top;"> </td> <td style="white-space: nowrap; vertical-align: top;;text-align:center;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">10.25% - 13.06% (11.40%)</div></td> <td style="white-space: nowrap; vertical-align: top;"> </td> </tr> <tr style="break-inside: avoid; font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Asset-Backed Securities</div></div> </td> <td style="vertical-align: bottom;"> </td> <td style="white-space: nowrap; vertical-align: top;"> </td> <td style="white-space: nowrap; vertical-align: top;;text-align:right;">7,280</td> <td style="white-space: nowrap; vertical-align: top;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: top; white-space: nowrap;;text-align:center;">NAV Approach</td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: top; white-space: nowrap;;text-align:center;">Discount Rate</td> <td style="vertical-align: bottom;"> </td> <td style="white-space: nowrap; vertical-align: top;"> </td> <td style="white-space: nowrap; vertical-align: top;;text-align:center;">70.00%</td> <td style="white-space: nowrap; vertical-align: top;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> </tr> <tr style="break-inside: avoid; font-family: 'Times New Roman'; font-size: 10pt;"> <td style="vertical-align: top;"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total</div></div></div> </td> <td style="vertical-align: bottom;"> </td> <td style="white-space: nowrap; vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="white-space: nowrap; vertical-align: bottom;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">       34,445,226</div></div></td> <td style="white-space: nowrap; vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> </tr> </table> <div style="clear:both;max-height:0pt;"/> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 12pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="font-family: &quot;Times New Roman&quot;; letter-spacing: normal; orphans: 2; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; border-collapse: collapse; font-size: 10pt; width: 750.719px; border: 0px; margin: 0px auto; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width: 160.484px; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="font-family: &quot;Times New Roman&quot;;"/> <td style="font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; width: 7.09375px; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="width: 167.719px; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="width: 149.984px; font-family: &quot;Times New Roman&quot;;"/> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="font-family: &quot;Times New Roman&quot;;"/> </tr> <tr style="break-inside: avoid; font-family: 'Times New Roman'; font-size: 8pt;"> <td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Investment</div></div></div> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="border-bottom: 1pt solid rgb(0, 0, 0); vertical-align: bottom; width: 11%; padding: 0pt 0pt 0pt 2pt;;text-align:center;"><div style="letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"><div style="font-weight:bold;display:inline;">Fair value at</div></div><br/><div style="letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"><div style="font-weight:bold;display:inline;">December 31, 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="border-bottom: 1pt solid rgb(0, 0, 0); vertical-align: bottom;;text-align:center;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Valuation</div></div></div> <div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">technique</div></div></div> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="border-bottom: 1pt solid rgb(0, 0, 0); vertical-align: bottom;;text-align:center;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Unobservable</div></div></div> <div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">inputs</div></div></div> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="border-bottom: 1pt solid rgb(0, 0, 0); vertical-align: bottom;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Range of input value(s)</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(weighted average)</div></div></td> </tr> <tr style="break-inside: avoid; font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">LLC Interest</div></div> </td> <td style="vertical-align: bottom;"> </td> <td style="white-space: nowrap; vertical-align: top; padding: 0pt 2pt 0pt 0pt;">$</td> <td style="white-space: nowrap; vertical-align: top; padding: 0pt 2pt 0pt 0pt;;text-align:right;">4,689,242</td> <td style="white-space: nowrap; vertical-align: top; padding: 0px;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: top; white-space: nowrap;;text-align:center;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Discounted Cash Flow</div></div> <div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Multiples Analysis</div></div> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: top; white-space: nowrap;;text-align:center;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Discount Rate</div></div> <div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Multiple of EBITDA</div></div> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: top; white-space: nowrap;;text-align:center;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">4.73% - 8.93% (6.83%)</div><br/> <div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">5.55x - 9.85x (7.70x)</div></div> </td> </tr> <tr style="break-inside: avoid; font-family: 'Times New Roman'; font-size: 10pt;"> <td style="vertical-align: top;"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Preferred Stock</div></div> </td> <td style="vertical-align: bottom;"> </td> <td style="white-space: nowrap; vertical-align: top;"> </td> <td style="white-space: nowrap; vertical-align: top; width: 10%; padding: 0pt 0pt 0pt 2pt;;text-align:right;">10,527,285</td> <td style="white-space: nowrap; vertical-align: top; padding: 0px;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: top; white-space: nowrap;;text-align:center;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Option Pricing Model</div></div> <div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Transaction Indication of Value</div></div> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: top; white-space: nowrap;;text-align:center;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Volatility</div></div> <div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Recap Price</div></div> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: top; white-space: nowrap;;text-align:center;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">40% - 60% (50%)</div><br/> <div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">$11.10</div></div> </td> </tr> <tr style="break-inside: avoid; font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Common Stock</div></div> </td> <td style="vertical-align: bottom;"> </td> <td style="white-space: nowrap; vertical-align: top;"> </td> <td style="white-space: nowrap; vertical-align: top; width: 10%; padding: 0pt 0pt 0pt 2pt;;text-align:right;">9,207,983</td> <td style="white-space: nowrap; vertical-align: top; padding: 0px;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: top; white-space: nowrap;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Discounted Cash Flow</div></div> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Multiples Analysis</div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt; text-align: left; line-height: normal;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Transaction Indication of Value</div></div> <div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Liquidation Analysis<br/>Net Asset Value</div></div> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: top; white-space: nowrap;;text-align:center;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Discount Rate</div></div> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Multiple of EBITDA</div></div> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Unadjusted Price/MHz-PoP</div></div> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Enterprise Value ($mm)</div></div> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Recovery Rate</div></div> <div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">N/A</div></div> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: top; white-space: nowrap;;text-align:center;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">13.50% - 15.50% (14.50%)</div><br/> <div style="margin-bottom: 0pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">3.25x - 4.25x (3.75x)</div></div> <div style="margin-bottom: 0pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">$0.09 - $0.95 ($0.52)  </div></div> <div style="margin-bottom: 0pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">$872 - $969 ($920.5)  </div></div> <div style="margin-bottom: 0pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">40% - 100% (70%)</div></div> <div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">$28</div></div> </td> </tr> <tr style="break-inside: avoid; font-family: 'Times New Roman'; font-size: 10pt;"> <td style="vertical-align: top;"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Senior Secured Loans</div></div> </td> <td style="vertical-align: bottom;"> </td> <td style="white-space: nowrap; vertical-align: top;"> </td> <td style="white-space: nowrap; vertical-align: top; width: 10%; padding: 0pt 0pt 0pt 2pt;;text-align:right;">4,069,243</td> <td style="white-space: nowrap; vertical-align: top; padding: 0px;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: top; white-space: nowrap;;text-align:center;">Discounted Cash Flow</td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: top; white-space: nowrap;;text-align:center;">Discount Rate</td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: top; white-space: nowrap;;text-align:center;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">   10.25% - 13.08% (11.67%)   </div></td> </tr> <tr style="break-inside: avoid; font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Asset-Backed Securities</div></div> </td> <td style="vertical-align: bottom;"> </td> <td style="white-space: nowrap; vertical-align: top;"> </td> <td style="white-space: nowrap; vertical-align: top; width: 10%; padding: 0pt 0pt 0pt 2pt;;text-align:right;">7,036</td> <td style="white-space: nowrap; vertical-align: top; padding: 0px;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: top; white-space: nowrap;;text-align:center;">NAV Approach</td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: top; white-space: nowrap;;text-align:center;">Discount Rate</td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: top; white-space: nowrap;;text-align:center;">70.00%</td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> </tr> <tr style="break-inside: avoid; font-family: 'Times New Roman'; font-size: 10pt;"> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total</div></div></div> </td> <td style="vertical-align: bottom;"> </td> <td style="white-space: nowrap; vertical-align: bottom; padding: 0pt 0pt 0pt 2pt;"><div style="letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="white-space: nowrap; vertical-align: bottom; padding: 0pt 0pt 0pt 2pt;;text-align:right;"><div style="letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"><div style="font-weight:bold;display:inline;">28,500,789</div></div></td> <td style="white-space: nowrap; vertical-align: bottom; padding: 0px;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> </tr> </table> 10164438 Discounted Cash Flow Multiples Analysis Discount Rate Multiple of EBITDA 4.98 9.18 7.08 5.6 9.95 7.7 10581888 Option Pricing Model Volatility 40 90 65 9126018 Discounted Cash Flow Multiples Analysis Transaction Indication of Value Liquidation Analysis Net Asset Value Discount Rate Multiple of EBITDA Unadjusted Price/MHz-PoP Enterprise Value ($mm) Recovery Rate 11 13 12 3.25 4.25 3.75 0.09 0.95 0.52 921.5 40 100 28 4565602 Discounted Cash Flow Discount Rate 10.25 13.06 11.4 7280 NAV Approach Discount Rate 70 34445226 4689242 Discounted Cash Flow Multiples Analysis Discount Rate Multiple of EBITDA 4.73 8.93 6.83 5.55 9.85 7.7 10527285 Option Pricing Model Transaction Indication of Value Volatility Recap Price 40 60 50 11.1 9207983 Discounted Cash Flow Multiples Analysis Transaction Indication of Value Liquidation Analysis Net Asset Value Discount Rate Multiple of EBITDA Unadjusted Price/MHz-PoP Enterprise Value ($mm) Recovery Rate 13.5 15.5 14.5 3.25 4.25 3.75 0.09 0.95 0.52 872 969 920.5 40 100 70 28 4069243 Discounted Cash Flow Discount Rate 10.25 13.08 11.67 7036 NAV Approach Discount Rate 70 28500789 <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Derivative Transactions </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The Company is subject to equity price risk, interest rate risk and foreign currency exchange rate risk in the normal course of pursuing its investment objective. The Company may invest without limitation in warrants and may also use derivatives, primarily swaps (including equity, variance and volatility swaps), options and futures contracts on securities, interest rates, commodities and/or currencies, as substitutes for direct investments the Company can make. The Company may also use derivatives such as swaps, options (including options on futures), futures, and foreign currency transactions (e.g., foreign currency swaps, futures and forwards) to any extent deemed by the Adviser to be in the best interest of the Company, and to the extent permitted by the 1940 Act, to hedge various investments for risk management and speculative purposes. </div> <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Options </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The Company purchases options, subject to certain limitations. The Company may invest in options contracts to manage its exposure to the stock and bond markets and fluctuations in foreign currency values. Writing puts and buying calls tend to increase the Company’s exposure to the underlying instrument while buying puts and writing calls tend to decrease the Company’s exposure to the underlying instrument, or economically hedge other Company investments. The Company’s risks in using these contracts include changes in the value of the underlying instruments, nonperformance of the counterparties under the contracts’ terms and changes in the liquidity of the secondary market for the contracts. Options are valued at the last sale price, or if no sales occurred on that day, at the last quoted bid price. As of and during the three months ended March 31, 2023 and 2022, the Company did not hold options. </div> 0 0 <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Investment Transactions </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Investment transactions are accounted for on trade date. Realized gains (losses) on investments sold are recorded on the basis of specific identification method for both financial statement and U.S. federal income tax purposes. Payable for investments purchased and receivable for investments sold on the Statements of Assets and Liabilities, if any, represents the cost of purchases and proceeds from sales of investment securities, respectively, for trades that have been executed but not yet settled. </div> <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Income Recognition </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Corporate actions (including cash dividends from common stock and equity tranches of asset-backed securities) are recorded on the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">ex-dividend</div> date, net of applicable withholding taxes, except for certain foreign corporate actions, which are recorded as soon after the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">ex-dividend</div> date as such information becomes available. Interest income is recorded on the accrual basis. The Company does not accrue as a receivable for interest or dividends on loans, asset-backed securities and other securities if there is a reason to doubt the Company’s ability to collect such income. For loans with contractual PIK <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">(payment-in-kind)</div></div> interest income, which represents contractual interest accrued and added to the loan balance that generally becomes due at maturity, we will not accrue PIK interest if we believe that the PIK interest is no longer collectible. Loan origination fees, original issue discount and market discount are capitalized and such amounts are amortized as interest income over the respective term of the loan or security. Upon the prepayment of a loan or security, any unamortized loan origination fees and original issue discount are recorded as interest income. </div> <div style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Accretion of discounts and amortization of premiums on taxable bonds, loans and asset-backed securities are computed to the call or maturity date, whichever is shorter, using the effective yield method. Withholding taxes on foreign dividends have been provided for in accordance with the Company’s understanding of the applicable country’s tax rules and rates. </div> <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Organization and Offering Costs </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Organization costs are paid by the Adviser and include the cost of incorporating, such as the cost of legal services and other fees pertaining to our organization. Offering costs include legal fees, promotional costs and other costs pertaining to the public offering of our shares of common stock and are also paid by the Adviser. Prior to the termination of the offering, as we raised proceeds, these organization and offering costs were expensed and became payable to the Adviser. Organization and offering costs are limited to 1% of total gross proceeds raised and are not due and payable to the Adviser to the extent they exceed that amount. Please refer to Note 4 for additional information on Organization and Offering Costs. </div> 0.01 0.01 <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Paid-in</div> Capital </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The proceeds from the issuance of common stock as presented on the Company’s Statements of Changes in Net Assets is presented net of selling commissions and fees for the three months ended March 31, 2023 and March 31, 2022. Selling commissions and fees of $0 and $0 were paid for the three months ended March 31, 2023 and March 31, 2022, respectively. </div> 0 0 <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Earnings Per Share </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">In accordance with the provisions of ASC Topic 260—<div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Earnings per Share</div></div> (“ASC Topic 260”), basic earnings per share is computed by dividing earnings available to common stockholders by the weighted average number of shares outstanding during the period. Other potentially dilutive common shares, and the related impact to earnings, are considered when calculating earnings per share on a diluted basis. </div><div style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The following table sets forth the computation of the weighted average basic and diluted net increase in net assets per share from operations:</div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:76%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:73%"/> <td style="vertical-align:bottom;width:5%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:4%"/> <td/> <td/> <td/></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">For the three months ended<br/> March 31,</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net increase (decrease) in net assets resulting from operations</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(977,817</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,145,017</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Weighted average common shares outstanding</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">9,699,655</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">9,990,797</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Earnings (loss) per common share-basic and diluted</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(0.10</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.11</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr></table> <div style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The following table sets forth the computation of the weighted average basic and diluted net increase in net assets per share from operations:</div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:76%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:73%"/> <td style="vertical-align:bottom;width:5%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:4%"/> <td/> <td/> <td/></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">For the three months ended<br/> March 31,</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net increase (decrease) in net assets resulting from operations</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(977,817</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,145,017</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Weighted average common shares outstanding</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">9,699,655</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">9,990,797</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Earnings (loss) per common share-basic and diluted</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(0.10</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.11</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr></table> -977817 1145017 9699655 9699655 9990797 9990797 -0.1 -0.1 0.11 0.11 <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Distributions </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Distributions to the Company’s stockholders will be recorded as of the record date. Subject to the discretion of the Board and applicable legal restrictions, the Company intends to authorize and declare ordinary cash distributions on a weekly basis and pay such distributions on a quarterly basis. Net realized capital gains, if any, will generally be distributed or deemed distributed at least every <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">12-month</div> period. </div><div style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">On June 24, 2020, the Board approved a change in its dividend and capital gains distribution schedule from monthly distributions to quarterly distributions, effective immediately. The first quarterly distribution was paid on October 12, 2020 to shareholders of record as of September 30, 2020. The dividends are expected to be declared in the amount of $0.09 per share of the Company’s common stock to the stockholders of record at each quarter end. </div> 0.09 0.09 <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Recent Accounting Pronouncements </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">In March 2020, the FASB issued Accounting Standards Update (“ASU”) <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">No. 2020-04,</div> “Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting” which provides optional exceptions for applying GAAP to contract modifications, hedging relationships and other transactions affected by reference rate reform if certain criteria are met. ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">No. 2020-04</div> is elective and effective for all entities as of March 12, 2020 through December 31, 2022. The Company is currently evaluating the impact of ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">No. 2020-04.</div> Please refer to Note 8 for additional information. </div> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">Note 3 — Investment Portfolio </div></div><div style="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The following table shows the composition of the Company’s invested assets by industry classification at fair value at March 31, 2023: </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:76%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:75%"/> <td style="vertical-align:bottom;width:5%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:5%"/> <td/> <td/> <td/></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Fair value</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Percentage</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Assets</div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Healthcare</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">21,288,682</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">43.7</td> <td style="white-space:nowrap;vertical-align:bottom">% </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Real Estate</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">12,208,413</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">25.0</td> <td style="white-space:nowrap;vertical-align:bottom">% </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Telecommunication Services</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">6,134,537</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">12.6</td> <td style="white-space:nowrap;vertical-align:bottom">% </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Financials</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,139,780</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">6.4</td> <td style="white-space:nowrap;vertical-align:bottom">% </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Consumer Products</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,841,603</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5.8</td> <td style="white-space:nowrap;vertical-align:bottom">% </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Energy</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,781,926</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3.7</td> <td style="white-space:nowrap;vertical-align:bottom">% </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Real Estate Investment Trusts (REITs)</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,022,291</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2.1</td> <td style="white-space:nowrap;vertical-align:bottom">% </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Media/Telecommunications</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">269,529</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.6</td> <td style="white-space:nowrap;vertical-align:bottom">% </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Chemicals</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">42,500</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.1</td> <td style="white-space:nowrap;vertical-align:bottom">% </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Service</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,268</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.0</td> <td style="white-space:nowrap;vertical-align:bottom">% </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Total Assets</div></div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">48,731,529</div></div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">100.0</div></div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">% </div></div></td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table><div style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The following table shows the composition of the Company’s invested assets by industry classification at fair value at December 31, 2022: </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:76%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:75%"/> <td style="vertical-align:bottom;width:5%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:5%"/> <td/> <td/> <td/></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Fair value</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Percentage</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Assets</div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Healthcare</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">26,101,074</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">49.0</td> <td style="white-space:nowrap;vertical-align:bottom">% </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Real Estate</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">11,613,222</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">21.7</td> <td style="white-space:nowrap;vertical-align:bottom">% </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Telecommunication Services</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">6,183,457</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">11.6</td> <td style="white-space:nowrap;vertical-align:bottom">% </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Consumer Products</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,088,750</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5.8</td> <td style="white-space:nowrap;vertical-align:bottom">% </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Financials</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,180,161</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">6.0</td> <td style="white-space:nowrap;vertical-align:bottom">% </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Energy</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,752,941</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3.3</td> <td style="white-space:nowrap;vertical-align:bottom">% </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Real Estate Investment Trusts (REITs)</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,018,779</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1.9</td> <td style="white-space:nowrap;vertical-align:bottom">% </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Media/Telecommunications</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">310,562</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.6</td> <td style="white-space:nowrap;vertical-align:bottom">% </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Chemicals</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">42,500</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.1</td> <td style="white-space:nowrap;vertical-align:bottom">% </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Service</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,269</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.0</td> <td style="white-space:nowrap;vertical-align:bottom">% </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Total Assets</div></div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">53,293,715</div></div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">100.0</div></div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">% </div></div></td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"> </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"> </div> <div style="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The following table summarizes the amortized cost and the fair value of the Company’s invested assets by class of financial asset as of March 31, 2023: </div> <div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:84%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:61%"/> <td style="vertical-align:bottom;width:5%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:5%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:5%"/> <td/> <td/> <td/></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Amortized Cost</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Fair value</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Percentage of<br/> Portfolio<br/> (at Fair Value)</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td colspan="8" style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Assets</div></div></td> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0em; text-indent: 0em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Senior Secured Loans - First Lien</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">13,218,569</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">8,961,395</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">18.4</td> <td style="white-space:nowrap;vertical-align:bottom">% </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Senior Secured Loans - Second Lien</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,485,503</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,070,222</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2.2</td> <td style="white-space:nowrap;vertical-align:bottom">% </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Asset-Backed Securities</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">388,541</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">7,280</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.0</td> <td style="white-space:nowrap;vertical-align:bottom">% </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Corporate Bonds</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,375,246</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,500,245</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5.1</td> <td style="white-space:nowrap;vertical-align:bottom">% </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Common Stocks</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">9,705,017</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">13,883,249</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">28.5</td> <td style="white-space:nowrap;vertical-align:bottom">% </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">LLC Interests</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">10,734,196</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">10,164,439</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">20.9</td> <td style="white-space:nowrap;vertical-align:bottom">% </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Preferred Stocks</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">11,829,987</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">11,981,888</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">24.6</td> <td style="white-space:nowrap;vertical-align:bottom">% </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Warrants</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">74,284</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">162,811</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.3</td> <td style="white-space:nowrap;vertical-align:bottom">% </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Total Assets</div></div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">50,811,343</div></div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">48,731,529</div></div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">100.0</div></div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">% </div></div></td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table> <div style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The following table summarizes the amortized cost and the fair value of the Company’s invested assets by class of financial asset as of December 31, 2022: </div> <div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:84%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:61%"/> <td style="vertical-align:bottom;width:5%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:5%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:5%"/> <td/> <td/> <td/></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Amortized Cost</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Fair value</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Percentage of<br/> Portfolio<br/> (at Fair Value)</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td colspan="8" style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Assets</div></div></td> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0em; text-indent: 0em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Senior Secured Loans - First Lien</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">14,645,106</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">11,575,821</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">21.7</td> <td style="white-space:nowrap;vertical-align:bottom">% </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Senior Secured Loans - Second Lien</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,976,056</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,652,372</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5.0</td> <td style="white-space:nowrap;vertical-align:bottom">% </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Asset-Backed Securities</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">388,541</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">7,036</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.0</td> <td style="white-space:nowrap;vertical-align:bottom">% </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Corporate Bonds</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,358,783</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,704,917</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5.1</td> <td style="white-space:nowrap;vertical-align:bottom">% </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Common Stocks</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">17,073,102</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">19,514,684</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">36.6</td> <td style="white-space:nowrap;vertical-align:bottom">% </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">LLC Interests</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,666,112</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,689,242</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">8.8</td> <td style="white-space:nowrap;vertical-align:bottom">% </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Preferred Stocks</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">11,829,987</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">11,967,910</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">22.5</td> <td style="white-space:nowrap;vertical-align:bottom">% </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Warrants</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">74,284</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">181,733</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.3</td> <td style="white-space:nowrap;vertical-align:bottom">% </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Total Assets</div></div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">54,011,971</div></div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">53,293,715</div></div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">100.0</div></div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">% </div></div></td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table> <div style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The following table shows the composition of the Company’s invested assets by geographic classification at March 31, 2023: </div> <div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:76%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:75%"/> <td style="vertical-align:bottom;width:5%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:5%"/> <td/> <td/> <td/></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Geography</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Fair value</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Percentage</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td colspan="8" style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Assets</div></div></td> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0em; text-indent: 0em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;"> </div></div></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Cayman Islands<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(1)</div></div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">7,280</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.0</td> <td style="white-space:nowrap;vertical-align:bottom">% </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Luxembourg<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(1)</div></div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,331,038</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2.7</td> <td style="white-space:nowrap;vertical-align:bottom">% </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">United States</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">47,393,211</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">97.3</td> <td style="white-space:nowrap;vertical-align:bottom">% </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Total Assets</div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">48,731,529</div></div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">100.0</div></div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">% </div></div></td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table> <div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;"><div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(1)</div> </td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Investment denominated in USD<div style="display:inline;">.</div></div></td></tr></table> <div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"> </div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"/> <div/><div style="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The following table shows the composition of the Company’s invested assets by geographic classification at December 31, 2022: </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:76%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:75%"/> <td style="vertical-align:bottom;width:5%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:5%"/> <td/> <td/> <td/></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Geography</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Fair value</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Percentage</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td colspan="8" style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Assets</div></div></td> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0em; text-indent: 0em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;"> </div></div></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Cayman Islands<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(1)</div></div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">7,036</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.0</td> <td style="white-space:nowrap;vertical-align:bottom">% </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Luxembourg<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(1)</div></div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,318,346</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2.5</td> <td style="white-space:nowrap;vertical-align:bottom">% </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">United States</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">51,968,333</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">97.5</td> <td style="white-space:nowrap;vertical-align:bottom">% </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Total Assets</div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">53,293,715</div></div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">100.0</div></div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">% </div></div></td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;"><div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(1)</div> </td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Investment denominated in USD. </div></td></tr></table> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The following table shows the composition of the Company’s invested assets by industry classification at fair value at March 31, 2023: </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:76%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:75%"/> <td style="vertical-align:bottom;width:5%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:5%"/> <td/> <td/> <td/></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Fair value</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Percentage</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Assets</div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Healthcare</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">21,288,682</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">43.7</td> <td style="white-space:nowrap;vertical-align:bottom">% </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Real Estate</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">12,208,413</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">25.0</td> <td style="white-space:nowrap;vertical-align:bottom">% </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Telecommunication Services</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">6,134,537</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">12.6</td> <td style="white-space:nowrap;vertical-align:bottom">% </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Financials</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,139,780</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">6.4</td> <td style="white-space:nowrap;vertical-align:bottom">% </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Consumer Products</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,841,603</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5.8</td> <td style="white-space:nowrap;vertical-align:bottom">% </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Energy</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,781,926</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3.7</td> <td style="white-space:nowrap;vertical-align:bottom">% </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Real Estate Investment Trusts (REITs)</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,022,291</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2.1</td> <td style="white-space:nowrap;vertical-align:bottom">% </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Media/Telecommunications</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">269,529</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.6</td> <td style="white-space:nowrap;vertical-align:bottom">% </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Chemicals</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">42,500</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.1</td> <td style="white-space:nowrap;vertical-align:bottom">% </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Service</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,268</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.0</td> <td style="white-space:nowrap;vertical-align:bottom">% </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Total Assets</div></div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">48,731,529</div></div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">100.0</div></div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">% </div></div></td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table><div style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The following table shows the composition of the Company’s invested assets by industry classification at fair value at December 31, 2022: </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:76%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:75%"/> <td style="vertical-align:bottom;width:5%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:5%"/> <td/> <td/> <td/></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Fair value</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Percentage</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Assets</div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Healthcare</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">26,101,074</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">49.0</td> <td style="white-space:nowrap;vertical-align:bottom">% </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Real Estate</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">11,613,222</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">21.7</td> <td style="white-space:nowrap;vertical-align:bottom">% </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Telecommunication Services</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">6,183,457</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">11.6</td> <td style="white-space:nowrap;vertical-align:bottom">% </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Consumer Products</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,088,750</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5.8</td> <td style="white-space:nowrap;vertical-align:bottom">% </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Financials</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,180,161</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">6.0</td> <td style="white-space:nowrap;vertical-align:bottom">% </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Energy</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,752,941</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3.3</td> <td style="white-space:nowrap;vertical-align:bottom">% </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Real Estate Investment Trusts (REITs)</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,018,779</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1.9</td> <td style="white-space:nowrap;vertical-align:bottom">% </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Media/Telecommunications</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">310,562</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.6</td> <td style="white-space:nowrap;vertical-align:bottom">% </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Chemicals</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">42,500</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.1</td> <td style="white-space:nowrap;vertical-align:bottom">% </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Service</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,269</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.0</td> <td style="white-space:nowrap;vertical-align:bottom">% </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Total Assets</div></div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">53,293,715</div></div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">100.0</div></div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">% </div></div></td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table> 21288682 0.437 12208413 0.25 6134537 0.126 3139780 0.064 2841603 0.058 1781926 0.037 1022291 0.021 269529 0.006 42500 0.001 2268 0 48731529 1 26101074 0.49 11613222 0.217 6183457 0.116 3088750 0.058 3180161 0.06 1752941 0.033 1018779 0.019 310562 0.006 42500 0.001 2269 0 53293715 1 <div style="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The following table summarizes the amortized cost and the fair value of the Company’s invested assets by class of financial asset as of March 31, 2023: </div> <div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:84%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:61%"/> <td style="vertical-align:bottom;width:5%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:5%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:5%"/> <td/> <td/> <td/></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Amortized Cost</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Fair value</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Percentage of<br/> Portfolio<br/> (at Fair Value)</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td colspan="8" style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Assets</div></div></td> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0em; text-indent: 0em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Senior Secured Loans - First Lien</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">13,218,569</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">8,961,395</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">18.4</td> <td style="white-space:nowrap;vertical-align:bottom">% </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Senior Secured Loans - Second Lien</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,485,503</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,070,222</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2.2</td> <td style="white-space:nowrap;vertical-align:bottom">% </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Asset-Backed Securities</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">388,541</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">7,280</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.0</td> <td style="white-space:nowrap;vertical-align:bottom">% </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Corporate Bonds</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,375,246</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,500,245</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5.1</td> <td style="white-space:nowrap;vertical-align:bottom">% </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Common Stocks</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">9,705,017</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">13,883,249</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">28.5</td> <td style="white-space:nowrap;vertical-align:bottom">% </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">LLC Interests</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">10,734,196</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">10,164,439</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">20.9</td> <td style="white-space:nowrap;vertical-align:bottom">% </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Preferred Stocks</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">11,829,987</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">11,981,888</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">24.6</td> <td style="white-space:nowrap;vertical-align:bottom">% </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Warrants</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">74,284</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">162,811</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.3</td> <td style="white-space:nowrap;vertical-align:bottom">% </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Total Assets</div></div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">50,811,343</div></div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">48,731,529</div></div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">100.0</div></div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">% </div></div></td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table> <div style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The following table summarizes the amortized cost and the fair value of the Company’s invested assets by class of financial asset as of December 31, 2022: </div> <div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:84%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:61%"/> <td style="vertical-align:bottom;width:5%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:5%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:5%"/> <td/> <td/> <td/></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Amortized Cost</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Fair value</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Percentage of<br/> Portfolio<br/> (at Fair Value)</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td colspan="8" style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Assets</div></div></td> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0em; text-indent: 0em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Senior Secured Loans - First Lien</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">14,645,106</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">11,575,821</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">21.7</td> <td style="white-space:nowrap;vertical-align:bottom">% </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Senior Secured Loans - Second Lien</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,976,056</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,652,372</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5.0</td> <td style="white-space:nowrap;vertical-align:bottom">% </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Asset-Backed Securities</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">388,541</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">7,036</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.0</td> <td style="white-space:nowrap;vertical-align:bottom">% </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Corporate Bonds</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,358,783</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,704,917</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5.1</td> <td style="white-space:nowrap;vertical-align:bottom">% </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Common Stocks</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">17,073,102</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">19,514,684</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">36.6</td> <td style="white-space:nowrap;vertical-align:bottom">% </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">LLC Interests</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,666,112</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,689,242</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">8.8</td> <td style="white-space:nowrap;vertical-align:bottom">% </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Preferred Stocks</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">11,829,987</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">11,967,910</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">22.5</td> <td style="white-space:nowrap;vertical-align:bottom">% </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Warrants</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">74,284</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">181,733</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.3</td> <td style="white-space:nowrap;vertical-align:bottom">% </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Total Assets</div></div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">54,011,971</div></div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">53,293,715</div></div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">100.0</div></div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">% </div></div></td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table> 13218569 8961395 0.184 1485503 1070222 0.022 388541 7280 0 3375246 2500245 0.051 9705017 13883249 0.285 10734196 10164439 0.209 11829987 11981888 0.246 74284 162811 0.003 50811343 48731529 1 14645106 11575821 0.217 2976056 2652372 0.05 388541 7036 0 3358783 2704917 0.051 17073102 19514684 0.366 3666112 4689242 0.088 11829987 11967910 0.225 74284 181733 0.003 54011971 53293715 1 <div style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The following table shows the composition of the Company’s invested assets by geographic classification at March 31, 2023: </div> <div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:76%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:75%"/> <td style="vertical-align:bottom;width:5%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:5%"/> <td/> <td/> <td/></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Geography</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Fair value</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Percentage</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td colspan="8" style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Assets</div></div></td> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0em; text-indent: 0em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;"> </div></div></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Cayman Islands<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(1)</div></div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">7,280</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.0</td> <td style="white-space:nowrap;vertical-align:bottom">% </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Luxembourg<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(1)</div></div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,331,038</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2.7</td> <td style="white-space:nowrap;vertical-align:bottom">% </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">United States</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">47,393,211</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">97.3</td> <td style="white-space:nowrap;vertical-align:bottom">% </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Total Assets</div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">48,731,529</div></div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">100.0</div></div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">% </div></div></td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table> <div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;"><div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(1)</div> </td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Investment denominated in USD<div style="display:inline;">.</div></div></td></tr></table> <div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"> </div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"/> <div/> <div style="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The following table shows the composition of the Company’s invested assets by geographic classification at December 31, 2022: </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:76%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:75%"/> <td style="vertical-align:bottom;width:5%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:5%"/> <td/> <td/> <td/></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Geography</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Fair value</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Percentage</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td colspan="8" style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Assets</div></div></td> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0em; text-indent: 0em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;"> </div></div></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Cayman Islands<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(1)</div></div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">7,036</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.0</td> <td style="white-space:nowrap;vertical-align:bottom">% </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Luxembourg<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(1)</div></div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,318,346</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2.5</td> <td style="white-space:nowrap;vertical-align:bottom">% </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">United States</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">51,968,333</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">97.5</td> <td style="white-space:nowrap;vertical-align:bottom">% </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Total Assets</div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">53,293,715</div></div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">100.0</div></div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">% </div></div></td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;"><div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(1)</div> </td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Investment denominated in USD. </div></td></tr></table> 7280 0 1331038 0.027 47393211 0.973 48731529 1 7036 0 1318346 0.025 51968333 0.975 53293715 1 <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">Note 4 — Related Party Transactions and Arrangements </div></div> <div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Investment Advisory Fee </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Payments for investment advisory services under the Company’s investment advisory agreement (the “Investment Advisory Agreement”) and administrative services agreement (the “Administration Agreement”) are equal to (a) a base management fee calculated at an annual rate of 2.0% of the average value of the Company’s gross assets at the end of the two most recently completed calendar quarters and (b) an incentive fee based on the Company’s performance. Effective June 5, 2017, the Investment Advisory Agreement and the Administration Agreement were amended to exclude cash and cash equivalents from the calculation of gross assets for the purpose of calculating investment advisory and administration fees. </div> <div style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">For the three months ended March 31, 2023 and March 31, 2022, the Company incurred investment advisory fees payable to the Adviser of $265,381 and $299,270, respectively. Amounts waived for investment advisory fees or administrative fees pertaining to periods prior to June 10, 2016 are not recoupable, but amounts waived for investment advisory fees or administrative fees pertaining to periods from and after June 10, 2016 are subject to recoupment by the Adviser within three years from the date that such fees were otherwise payable, provided that the recoupment will be limited to the amount of such voluntarily waived fees from and after June 10, 2016 and will not cause the sum of the Company’s investment advisory fees, administration fees, Other Expenses (as defined under “Expense Limits and Reimbursements” below), and any recoupment to exceed the annual rate of 3.40% of average gross assets. Effective December 20, 2017, the Adviser ended its voluntary waiver of advisory fees. </div> <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Incentive Fee </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The incentive fee consists of two parts. The first part, which is referred to as the subordinated incentive fee on income, is calculated and payable quarterly in arrears, and equals 20.0% of <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">“pre-incentive</div> fee net investment income” for the immediately preceding quarter and is subject to a hurdle rate, expressed as a rate of return on the Company’s net assets, as defined in the Investment Advisory Agreement, equal to 1.875% per quarter. As a result, the Adviser will not earn this incentive fee for any quarter until the Company’s <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">pre-incentive</div> fee net investment income for such quarter exceeds the hurdle rate of 1.875%. Once the Company’s <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">pre-incentive</div> fee net investment income in any quarter exceeds the hurdle rate, the Adviser will be entitled to a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">“catch-up”</div> fee equal to the amount of the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">pre-incentive</div> fee net investment income in excess of the hurdle rate, until the Company’s <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">pre-incentive</div> fee net investment income for such quarter equals 2.34375% of the Company’s net assets at the end of such quarter. This <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">“catch-up”</div> feature allows the Adviser to recoup the fees foregone as a result of the existence of the hurdle rate in that quarter. Thereafter, the Adviser will receive 20.0% of the Company’s <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">pre-incentive</div> fee net investment income from the quarter. </div> <div style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The second part of the incentive fee, which is referred to as the incentive fee on capital gains, is determined and payable in arrears as of the end of each calendar year (or upon termination of the Investment Advisory Agreement). This fee equals 20.0% of the Company’s incentive fee capital gains, which will equal the Company’s realized capital gains on a cumulative basis from formation, calculated as of the end of the applicable period, computed net of all realized capital losses (proceeds less amortized cost) and unrealized capital depreciation on a cumulative basis, less the aggregate amount of any previously paid capital gains incentive fees. The Company will accrue for the capital gains incentive fee, which, if earned, will be paid annually. The Company will accrue for the capital gains incentive fee based on net realized and unrealized gains; however, under the terms of the Investment Advisory Agreement, the fee payable to the Adviser will be based on realized gains and no such fee will be payable with respect to unrealized gains unless and until such gains are actually realized. </div> <div style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">For the three months ended March 31, 2023 and March 31, 2022, the Company incurred $0 and recognized a reduction $0 of incentive fees on capital gains, respectively. Since inception, the Company has accrued $0 of incentive fees on capital gains in aggregate. Effective December 20, 2017, the Adviser ended its voluntary waiver of incentive fees. No such fees have been paid with respect to realized gains to the Adviser as of March 31, 2023. </div> <div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"> </div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"/> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Administration Fee </div></div></div></div><div style="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Pursuant to the Administration Agreement with the Adviser, the Company also reimburses the Adviser for expenses necessary for its performance of services related to the Company’s administration and operations. The amount of the reimbursement will be the lesser of (1) the Company’s allocable portion of overhead and other expenses incurred by the Adviser in performing its obligations under the Administration Agreement and (2) 0.40% of the Company’s average gross assets, (excluding cash and cash equivalents). The Adviser is required to allocate the cost of such services to the Company based on objective factors such as assets, revenues, time allocations and/or other reasonable metrics. The Board assesses the reasonableness of such reimbursements based on the breadth, depth and quality of such services as compared to the estimated cost to the Company of obtaining similar services from third-party service providers known to be available. In addition, the Board will consider whether any single third-party service provider would be capable of providing all such services at comparable cost and quality. Finally, the Board will compare the total amount paid to the Adviser for such services as a percentage of the Company’s net assets to the same ratio as reported by other comparable BDCs. </div><div style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">For the three months ended March 31, 2023 and March 31, 2022, the Company incurred administration fees payable to the Adviser of $52,321 and $59,601, respectively. Amounts waived for management fees or administrative services expenses pertaining to periods prior to June 10, 2016 are not recoupable, but amounts waived for management fees or administrative services, expenses pertaining to periods from and after June 10, 2016 are subject to recoupment by the Adviser within three years from the date that such fees were otherwise payable, provided that the recoupment will be limited to the amount of such voluntarily waived fees from and after June 10, 2016 and will not cause the sum of the Company’s advisory fees, administration fees, Other Expenses, and any recoupment to exceed the annual rate of 3.40% of average gross assets. Effective December 20, 2017, the Adviser ended its voluntary waiver of administration fees. </div><div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Organization and Offering Costs </div></div></div></div><div style="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Organization costs include the cost of incorporating, such as the cost of legal services and other fees pertaining to our organization, and are paid by the Adviser. For the three months ended March 31, 2023 and March 31, 2022, the Adviser did not incur or pay organization costs on our behalf. </div><div style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Offering costs include legal fees, promotional costs and other costs pertaining to the public offering of our shares of common stock, and are capitalized and amortized to expense over one year. The Company’s continuous public offering ended on February 14, 2018. </div><div style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Organization costs and offering costs are limited to 1% of total gross proceeds raised in the offering and are not due and payable to the Adviser to the extent they exceed that amount. As of March 31, 2023, the cumulative aggregate amount of $5,327,574 of organization and offering costs exceeds 1% of total proceeds raised. Subsequent to the termination of the offering, the Adviser forfeited the right to reimbursement of the remaining $4,305,091 of these costs. </div><div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Fees Paid to Officers and Directors </div></div></div></div><div style="text-indent: 9%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">Each director who oversees all of the portfolios in the Fund Complex (as defined below) receives an annual retainer of $</div>150,000 payable in quarterly installments and allocated among each portfolio in the Fund Complex based on relative net assets. The annual retainer for a director who does not oversee all of the portfolios in the Fund Complex is prorated based on the portion of the $150,000 annual retainer allocable to the portfolios overseen by such director. Directors are reimbursed for actual <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">out-of-pocket</div></div> expenses relating to attendance at meetings. In addition, the Chairman of the Board and the Chairman of the Audit and Qualified Legal Committee each receive an additional payment of $10,000 payable in quarterly installments and allocated among each portfolio in the Fund Complex based on relative net assets. The Directors do not receive any separate compensation in connection with service on Committees or for attending Board or Committee Meetings. They do not have any pension or retirement plan. The “Fund Complex” consists of all of the RICs advised by the Adviser and any affiliates as of the period covered by this report. The Company pays no compensation to any of its officers, all of whom are employed by the Adviser, its affiliates or Skyview Group, Inc. (“Skyview”). </div><div style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">For the three months ended March 31, 2023 and March 31, 2022, the Company recorded an expense relating to director fees of $4,967 and $3,731, respectively, which represents the allocation of the director fees to the Company. As of March 31, 2023, there was no expenses payable relating to director fees. </div><div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;"> </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"> </div><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Expense Limits and Reimbursements </div></div></div></div><div style="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Pursuant to an expense limitation agreement, the Adviser is contractually obligated to waive fees and, if necessary, pay or reimburse certain other expenses to limit the ordinary “Other Expenses” to 1.0% of the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">quarter-end</div> value of the Company’s gross assets through the one year anniversary of the effective date of the registration statement (the “Expense Limitation Agreement”). Under the Expense Limitation Agreement, “Other Expenses” are all expenses with the exception of advisor and administration fees, organization and offering costs and the following: (i) interest, taxes, dividends tied to short sales, brokerage commissions, and other expenditures which are capitalized in accordance with GAAP; (ii) expenses incurred indirectly as a result of investments in other investment companies and pooled investment vehicles; (iii) other expenses attributable to, and incurred as a result of, our investments; (iv) expenses payable to the Adviser, as administrator, for providing significant managerial assistance to our portfolio companies; and (v) other extraordinary expenses (including litigation expenses) not incurred in the ordinary course of our business. The obligation will automatically renew for <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">one-year</div> terms unless it is terminated by the Company or the Adviser upon written notice within 60 days of the end of the current term or upon termination of the Investment Advisory Agreement. The Expense Limitation Agreement will continue through at least April 30, 202<div style="letter-spacing: 0px; top: 0px;;display:inline;">4</div>. </div><div style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Any expenses waived or reimbursed by the Adviser pursuant to the Expense Limitation Agreement are subject to possible recoupment by the Adviser within three years from the date of the waiver or reimbursement. The recoupment by the Adviser will be limited to the amount of previously waived or reimbursed expenses and cannot cause the Company’s expenses to exceed any expense limitation in place at the time of recoupment or waiver. </div><div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Reimbursable Expenses Table </div></div></div></div><div style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The cumulative total of fees waived by the Adviser under the Expense Limitation Agreement, which are recoupable as of March 31, 2023 is $919,754. This balance, and the balances in the tables below, only include amounts pertaining to the Expense Limitation Agreement, and do not include waived advisory and administration fees subject to recoupment discussed earlier in Note 4. The following table reflects the fee waivers and expense reimbursements due from the Adviser as of March 31, 2023, which may become subject to recoupment by the Adviser.</div><div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 8pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="font-size: 0px;"> <td style="width: 86%;"/> <td style="width: 1%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 1%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 1%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 1%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 1%; vertical-align: bottom;"/> <td/> <td/> <td/></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Period ended</div></div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> Yearly cumulative </div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">other expense</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Yearly expense</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">limitation</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Yearly cumulative<br/>expense<br/>reimbursement</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Quarterly<br/>    recoupable/    <br/>(recouped)<br/>amount</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">    Recoupment    </div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">eligibility<br/>expiration</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">March 31, 2023</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">208,486</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">126,628</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">81,858</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">81,858</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">       March 31, 2026</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr></table><div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 100%; border: 0px; margin: 0px auto; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width:86%"/> <td style="vertical-align:bottom;width:1%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:1%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:1%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:1%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:1%"/> <td/> <td/> <td/></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Period ended</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> Yearly cumulative </div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">other expense</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Yearly expense<br/> limitation</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Yearly cumulative<br/> expense<br/> reimbursement</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Quarterly<br/>     recoupable/    <br/> (recouped)<br/> amount</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Recoupment<br/> eligibility<br/> expiration</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">December 31, 2022</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">913,273</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">535,679</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">377,594</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">92,216</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">December 31, 2025</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">September 30, 2022</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">678,333</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">392,955</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">285,378</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">124,667</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">September 30, 2025</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">June 30, 2022</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">434,019</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">273,308</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">160,711</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">98,950</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">June 30, 2025</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">March 31, 2022</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">211,896</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">150,135</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">61,761</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">61,761</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">March 31, 2025</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr></table><div style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The following table reflects the fee waivers and expense reimbursements due from the Adviser as of December 31, 2021, September 30, 2021, June 30, 2021 and March 31, 2021, which may become subject to recoupment by the Adviser. </div><div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 100%; border: 0px; margin: 0px auto; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width:86%"/> <td style="vertical-align:bottom;width:1%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:1%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:1%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:1%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:1%"/> <td/> <td/> <td/></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Period ended</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> Yearly cumulative </div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">other expense</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Yearly expense<br/> limitation</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Yearly cumulative<br/> expense<br/> reimbursement</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Quarterly<br/>     recoupable/    <br/> (recouped)<br/> amount</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Recoupment<br/> eligibility<br/> expiration</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">December 31, 2021</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">892,640</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">597,379</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">295,261</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">94,762</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">December 31, 2024</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">September 30, 2021</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">664,052</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">463,553</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">200,499</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">68,134</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">September 30, 2024</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">June 30, 2021</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">436,866</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">304,501</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">132,365</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">68,919</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">June 30, 2024</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">March 31, 2021</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">220,126</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">156,680</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">63,446</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">63,446</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">March 31, 2024</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr></table><div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;"> </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"> </div><div style="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The following table reflects the fee waivers and expense reimbursements due from the Adviser as of December 31, 2020, September 30, 2020, June 30, 2020 and March 31, 2020, which may become subject to recoupment by the Adviser. </div><div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:41%"/> <td style="vertical-align:bottom;width:4%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:4%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:4%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:4%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:4%"/> <td/> <td/> <td/></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Period ended</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Yearly cumulative<br/> other expense</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Yearly expense<br/> limitation</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Yearly cumulative<br/> expense<br/> reimbursement</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Quarterly<br/> recoupable/<br/> (recouped)<br/> amount</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Recoupment<br/> eligibility<br/> expiration</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">December 31, 2020</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">989,447</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">639,959</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">349,488</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">101,541</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">December 31, 2023</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">September 30, 2020</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">687,228</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">439,281</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">247,947</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">94,039</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">September 30, 2023</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">June 30, 2020</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">445,585</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">291,677</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">153,908</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(30,539</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">June 30, 2023</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">March 31, 2020</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">257,226</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">72,779</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">184,447</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">Expired</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr></table> <div style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">During the three months ended March 31, 2023, $184,447 of expense reimbursements that were eligible for recoupment by the Adviser expired. </div> <div style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">There can be no assurance that the Expense Limitation Agreement will remain in effect or that the Adviser will reimburse any portion of the Company’s expenses in future quarters not covered by the Expense Limitation Agreement. Amounts shown do not include the amounts committed by the Adviser to voluntarily reimburse the Company for unrealized losses, all of which are not recoupable. </div> <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Net Increase from Amounts Committed by Affiliates </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">For the three months ended March 31, 2023 and March 31, 2022, the Adviser did not voluntarily reimburse the Company for unrealized losses sustained. Cumulatively since inception, the Adviser has committed $2,275,000 <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">to voluntarily reimburse the Company for such losses. Had these commitments not been made, since inception, the NAV as of March 31, 2023 would have been lower by approximately this amount. </div></div></div> <div style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Amounts committed and paid by the Adviser to reimburse for unrealized losses are nonrecurring, and investors should not expect the Adviser to make similar commitments or payments in the future. </div> <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Receivable from Adviser / Payable to Adviser </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">As of March 31, 2023 and December 31, 2022, $81,858 and $92,216 were owed from the Adviser to the Company, respectively, largely related to the expense limitation agreement. </div> <div style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">As of March 31, 2023 and December 31, 2022, the Company owed $317,702 and $314,993, respectively, to the Adviser, largely related to advisory fees, and administration fees. </div> <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Indemnification </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Under the Company’s organizational documents, the officers and Directors have been granted certain indemnification rights against certain liabilities that may arise out of performance of their duties to the Company. Additionally, in the normal course of business, the Company may enter into contracts with service providers that contain a variety of indemnification clauses. The Company’s maximum exposure under these arrangements is dependent on future claims that may be made against the Company and, therefore, cannot be estimated. </div> 0.02 265381 299270 0.034 0.20 0.01875 0.01875 0.0234375 0.20 0.20 0 0 0 0 0.004 52321 59601 0.034 0.01 5327574 0.01 4305091 150000 150000 10000 4967 3731 0 0.01 one-year P60D 919754 The following table reflects the fee waivers and expense reimbursements due from the Adviser as of March 31, 2023, which may become subject to recoupment by the Adviser.<div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 8pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="font-size: 0px;"> <td style="width: 86%;"/> <td style="width: 1%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 1%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 1%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 1%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 1%; vertical-align: bottom;"/> <td/> <td/> <td/></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Period ended</div></div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> Yearly cumulative </div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">other expense</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Yearly expense</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">limitation</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Yearly cumulative<br/>expense<br/>reimbursement</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Quarterly<br/>    recoupable/    <br/>(recouped)<br/>amount</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">    Recoupment    </div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">eligibility<br/>expiration</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">March 31, 2023</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">208,486</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">126,628</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">81,858</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">81,858</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">       March 31, 2026</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr></table><div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 100%; border: 0px; margin: 0px auto; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width:86%"/> <td style="vertical-align:bottom;width:1%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:1%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:1%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:1%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:1%"/> <td/> <td/> <td/></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Period ended</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> Yearly cumulative </div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">other expense</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Yearly expense<br/> limitation</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Yearly cumulative<br/> expense<br/> reimbursement</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Quarterly<br/>     recoupable/    <br/> (recouped)<br/> amount</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Recoupment<br/> eligibility<br/> expiration</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">December 31, 2022</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">913,273</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">535,679</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">377,594</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">92,216</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">December 31, 2025</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">September 30, 2022</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">678,333</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">392,955</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">285,378</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">124,667</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">September 30, 2025</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">June 30, 2022</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">434,019</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">273,308</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">160,711</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">98,950</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">June 30, 2025</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">March 31, 2022</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">211,896</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">150,135</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">61,761</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">61,761</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">March 31, 2025</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr></table><div style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The following table reflects the fee waivers and expense reimbursements due from the Adviser as of December 31, 2021, September 30, 2021, June 30, 2021 and March 31, 2021, which may become subject to recoupment by the Adviser. </div><div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 100%; border: 0px; margin: 0px auto; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width:86%"/> <td style="vertical-align:bottom;width:1%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:1%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:1%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:1%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:1%"/> <td/> <td/> <td/></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Period ended</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> Yearly cumulative </div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">other expense</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Yearly expense<br/> limitation</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Yearly cumulative<br/> expense<br/> reimbursement</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Quarterly<br/>     recoupable/    <br/> (recouped)<br/> amount</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Recoupment<br/> eligibility<br/> expiration</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">December 31, 2021</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">892,640</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">597,379</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">295,261</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">94,762</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">December 31, 2024</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">September 30, 2021</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">664,052</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">463,553</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">200,499</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">68,134</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">September 30, 2024</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">June 30, 2021</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">436,866</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">304,501</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">132,365</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">68,919</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">June 30, 2024</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">March 31, 2021</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">220,126</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">156,680</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">63,446</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">63,446</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">March 31, 2024</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr></table><div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;"> </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"> </div> <div style="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The following table reflects the fee waivers and expense reimbursements due from the Adviser as of December 31, 2020, September 30, 2020, June 30, 2020 and March 31, 2020, which may become subject to recoupment by the Adviser. </div><div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:41%"/> <td style="vertical-align:bottom;width:4%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:4%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:4%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:4%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:4%"/> <td/> <td/> <td/></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Period ended</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Yearly cumulative<br/> other expense</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Yearly expense<br/> limitation</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Yearly cumulative<br/> expense<br/> reimbursement</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Quarterly<br/> recoupable/<br/> (recouped)<br/> amount</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Recoupment<br/> eligibility<br/> expiration</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">December 31, 2020</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">989,447</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">639,959</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">349,488</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">101,541</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">December 31, 2023</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">September 30, 2020</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">687,228</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">439,281</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">247,947</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">94,039</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">September 30, 2023</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">June 30, 2020</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">445,585</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">291,677</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">153,908</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(30,539</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">June 30, 2023</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">March 31, 2020</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">257,226</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">72,779</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">184,447</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">Expired</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr></table> 208486 126628 81858 81858 2026-03-31 913273 535679 377594 92216 2025-12-31 678333 392955 285378 124667 2025-09-30 434019 273308 160711 98950 2025-06-30 211896 150135 61761 61761 2025-03-31 892640 597379 295261 94762 2024-12-31 664052 463553 200499 68134 2024-09-30 436866 304501 132365 68919 2024-06-30 220126 156680 63446 63446 2024-03-31 989447 639959 349488 101541 2023-12-31 687228 439281 247947 94039 2023-09-30 445585 291677 153908 -30539 2023-06-30 257226 72779 184447 0 Expired 184447 0 0 2275000 81858 92216 317702 314993 <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">Note 5 — U.S. Federal Income Tax Information </div></div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The Company has elected to be treated for federal income tax purposes, and intends to qualify annually, as a RIC under Subchapter M of the Code. To maintain its qualification as a RIC, the Company must, among other things, meet certain <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">source-of-income</div></div> and asset diversification requirements and distribute to its stockholders, for each taxable year, at least 90% of its “investment company taxable income,” which is generally the Company’s net ordinary income plus the excess, if any, of realized net short-term capital gains over realized net long-term capital losses. As a RIC, the Company will not be subject to corporate-level federal income taxes on any income that it timely distributes to its stockholders. The Company intends to make distributions in an amount sufficient to maintain its RIC status each year and to avoid any federal income taxes on income so distributed. The Company will also be subject to nondeductible federal excise taxes if it does not distribute at least 98% of net ordinary income, 98.2% of any capital gain net income, if any, and any recognized and undistributed income from prior years on which it paid no federal income taxes. </div> <div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;"> </div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"> </div> <div style="font-size: .83em;margin-top : 1.67em;margin-bottom : 1.67em;font-weight: bold;"/><div style="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The character of income and capital gains to be distributed is determined in accordance with the Code, U.S. Treasury regulations, and other applicable authority, which may differ from GAAP. These differences include (but are not limited to) investments organized as partnerships for tax purposes, total return swaps, loan investments, and losses deferred due to wash sale transactions. Reclassifications are made to the Company’s capital accounts to reflect income and gains available for distribution (or available capital loss carryovers) under the Code, U.S. Treasury regulations, and other applicable authority. These reclassifications have no impact on net investment income, realized gains or losses, or net asset value of the Company. The calculation of net investment income per share in the Financial Highlights table excludes these adjustments. </div><div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Uncertainty in Income Taxes </div></div></div></div><div style="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The Company will evaluate its tax positions to determine if the tax positions taken meet the minimum recognition threshold in connection with accounting for uncertainties in income tax positions taken or expected to be taken for the purposes of measuring and recognizing tax benefits or liabilities in the financial statements. Recognition of a tax benefit or liability with respect to an uncertain tax position is required only when the position is “more likely than not” to be sustained assuming examination by taxing authorities. The Company’s tax returns are subject to examination by the Internal Revenue Service for a period of three fiscal years after they are filed. The Company recognizes interest and penalties, if any, related to unrecognized tax liabilities as income tax expense in the Statements of Operations. During the three months ended March 31, 2023 and March 31, 2022, the Company did not incur any interest or penalties. Furthermore, management of the Company is also not aware of any tax positions for which it is reasonably possible that the total amounts of unrecognized tax benefits will significantly change in the next 12 months. </div> 0.90 0.98 0.982 <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">Note 6 — Share Repurchase Program </div></div> <div style="text-indent: 9%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">On a quarterly basis, the Company intends to offer to repurchase shares of common stock on such terms as may be determined by the Board in its complete and absolute discretion unless, in the judgment of directors who are not “interested persons” of the Company (as defined in the 1940 Act), such repurchases would not be in the best interests of the Company’s stockholders or would violate applicable law. The Company will conduct such repurchase offers in accordance with the requirements of Rule <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">13e-4</div> of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and the 1940 Act. Any offer to repurchase shares of common stock will be conducted solely through tender offer materials furnished to each stockholder. </div></div> <div style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The Company currently intends to limit the number of shares of common stock to be repurchased during any calendar year to the number of shares of common stock it can repurchase with the proceeds it receives from the sale of shares of common stock under its distribution reinvestment plan. At the discretion of the Board, the Company may also use cash on hand, cash available from borrowings and cash from liquidation of securities investments as of the end of the applicable period to repurchase shares of common stock. In addition, the Company will limit the number of shares of common stock to be repurchased in any calendar year to 10.0% of the weighted average number of shares of common stock outstanding in the prior calendar year, or 2.5% in each quarter, though the actual number of shares of common stock that the Company offers to repurchase may be less in light of the limitations noted above. The Company intends to offer to repurchase such shares of common stock at a price (i) not less than the net asset value per share (the “NAV Per Share”) of the Company’s common stock next calculated following the Expiration Date, and (ii) not more than 2.5% greater than the NAV Per Share as of such date. The Board may amend, suspend or terminate the share repurchase program at any time, upon 30 days’ notice. </div> <div style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The Company conducted its quarterly tender offer for the first quarter of 2023 from February 23, 2023, until expiration of March 24 2023<div style="letter-spacing: 0px; top: 0px;;display:inline;">,</div> at 4:00 p.m. New York City time, during which the Company offered to purchase for cash up to 2.5% of its outstanding shares of common stock. During the first quarter tender offer, 181,298 shares of the Company were tendered for repurchase, constituting approximately 1.86% of the Company’s outstanding shares. </div> <div style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">For the three months ended March 31, 2023, the Company repurchased 0 shares as part of its death and disability repurchase program. </div> 0.10 0.025 0.025 0.30 2023-03-24 0.025 181298 0.0186 0 <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Note 7 — Economic Dependency and Commitments and Contingencies </div></div></div></div> <div style="font-weight:bold;display:inline;"> </div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The Adviser has entered into a Services Agreement with Skyview, effective February 25, 2021, pursuant to which the Adviser will receive administrative and operational support services to enable it to provide the required advisory services to the Company. The Adviser, and not the Company, will compensate all Adviser and Skyview personnel who provide services to the Company. </div> <div style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">From time to time, the Company may be involved in legal proceedings in the normal course of its business. Although the outcome of such litigation cannot be predicted with any clarity, management is of the opinion, bas<div style="letter-spacing: 0px; top: 0px;;display:inline;">ed on</div> the advice of legal counsel, that final dispositions of any litigation should not have a material adverse effect on the financial position of the Company as of March 31, 2023. </div> <div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;"> </div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"> </div> <div style="font-size: .83em;margin-top : 1.67em;margin-bottom : 1.67em;font-weight: bold;"/> <div style="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Unfunded commitments to provide funds to portfolio companies are not recorded in the Company’s Statements of Assets and Liabilities. Since these commitments may expire without being drawn upon, the total commitment amount does not necessarily represent future cash requirements. The Company has sufficient liquidity to fund these commitments. As of March 31, 2023, the Company had no unfunded debt commitments. </div><div style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">In the normal course of business, the Company enters into contracts and agreements that contain a variety of representations and warranties that provide general indemnification. The Company’s maximum exposure under these agreements is unknown, as this would involve future claims that may be made against the Company that have not occurred. The Company believes the risk of material obligations under these indemnities to be low.</div> 0 <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Note 8 — Market and Other Risk Factors </div></div></div></div><div style="font-weight:bold;display:inline;"> </div><div style="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The primary risks of investing in the Company are described below in alphabetical order: </div><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Conflict of Interest Risk </div></div></div></div></div><div style="text-indent: 9%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Adviser or its affiliates may have other clients with similar, different or competing investment objectives. In serving in these multiple capacities, they may have obligations to other clients or investors in those other entities, the fulfillment of which may not be in the best interests of us or our stockholders. For example, our Adviser and its affiliates manage or sponsor other investment funds, accounts or other investment vehicles. Our investment objective may overlap with the investment objectives of such affiliated investment funds, accounts or other investment vehicles. As a result, our Adviser may face conflicts of interest in the allocation of investment opportunities among us and other investment funds, accounts or other investment vehicles advised by or affiliated with our Adviser. Our Adviser will seek to allocate investment opportunities among eligible accounts in a manner that is fair and equitable over time and consistent with its allocation policy. However, we can offer no assurance that such opportunities will be allocated to us fairly or equitably in the short-term or over time. Where we are able to co- invest consistent with the requirements of the 1940 Act and SEC exemptive relief, if sufficient securities or loan amounts are available to satisfy our and each such account’s proposed demand, the opportunity will be allocated in accordance with our Adviser’s pre-transaction determination and the requirements of the exemptive relief. If there is an insufficient amount of an investment opportunity to satisfy our demand and that of other accounts sponsored or managed by our Adviser or its affiliates, the allocation policy and exemptive relief further provides that allocations among us and such other accounts will generally be made pro rata based on the amount that each such party would have invested if sufficient loan amounts were available. However, there can be no assurance that we will be able to participate in all suitable investment opportunities. </div></div></div><div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Concentration Risk </div></div></div></div><div style="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The Company is classified as a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-diversified</div> investment company within the meaning of the 1940 Act, which means that it is not limited by the 1940 Act with respect to the proportion of the Company’s assets that it may invest in securities of a single issuer. To the extent that the Company assumes large positions in the securities of a small number of issuers, the Company’s net asset value may fluctuate to a greater extent than that of a diversified investment company as a result of changes in the financial condition or the market’s assessment of the issuer. The Company may also be more susceptible to any single economic or regulatory occurrence than a diversified investment company. Beyond the asset diversification requirements associated with the Company’s qualification as a RIC under the Code and certain contractual diversification requirements under a credit facility or other agreements, the Company does not have fixed guidelines for diversification, and its investments could be concentrated in relatively few portfolio companies. As a result, the aggregate returns the Company realizes may be significantly adversely affected if a small number of investments perform poorly or if the Company needs to write down the value of any one investment. Additionally, the Company’s investments may be concentrated in relatively few industries. As a result, a downturn in any particular industry in which the Company is invested could also significantly impact the aggregate returns realized. </div><div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Covenant-Lite Loans Risk </div></div></div></div><div style="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Loans in which the Company invests include covenant-lite loans, which carry more risk to the lender than traditional loans as they may contain fewer or less restrictive covenants on the borrower than traditionally included in loan documentation or may contain other borrower friendly characteristics. The Company may experience relatively greater difficulty or delays in enforcing its rights on its holdings of certain covenant-lite loans and debt securities than its holdings of loans or securities with the usual covenants. </div><div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Counterparty Credit Risk </div></div></div></div><div style="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Counterparty credit risk is the potential loss the Company may incur as a result of the failure of a counterparty or an issuer to make payments according to the terms of a contract. Counterparty credit risk is measured as the loss the Company would record if its counterparties failed to perform pursuant to the terms of their obligations to the Company. Because the Company may enter into <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">over-the-counter</div></div> forwards, options, swaps and other derivative financial instruments, the Company may be exposed to the credit risk of its counterparties. To limit the counterparty credit risk associated with such transactions, the Company conducts business only with financial institutions judged by the Adviser to present acceptable credit risk. </div><div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Credit Risk </div></div></div></div><div style="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Debt securities are subject to the risk of <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-payment</div> of scheduled interest and/or principal. <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Non-payment</div> would result in a reduction of income to the Company, a reduction in the value of the obligation experiencing <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-payment</div> and a potential decrease in the Company’s net asset value. </div><div style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Investments rated below investment grade are commonly referred to as high-yield, high risk or “junk debt.” They are regarded as predominantly speculative with respect to the issuing company’s continuing ability to meet principal and/or interest payments. Investments in high yield debt and high yield senior loans may result in greater net asset value fluctuation than if the Company did not make such investments. Corporate debt obligations, including senior loans, are subject to the risk of <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-payment</div> of scheduled interest and/or principal. </div><div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;"> </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"/><div style="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Non-payment</div> would result in a reduction of income to the Company, a reduction in the value of the corporate debt obligation experiencing <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-payment</div> and a potential decrease in the net asset value of the Company. Some of the loans the Company makes or acquires may provide for the payment by borrowers of <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Payment-In-Kind</div></div> (“PIK”) interest or accreted original issue discount at maturity. Such loans have the effect of deferring a borrower’s payment obligation until the end of the term of the loan, which may make it difficult for the Company to identify and address developing problems with borrowers in terms of their ability to repay debt. Particularly in a rising interest rate environment, loans containing PIK and original issue discount provisions can give rise to negative amortization on a loan, resulting in a borrower owing more at the end of the term of a loan than what it owed when the loan was originated. Any such developments may increase the risk of default on the Company’s loans by borrowers. </div><div style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Because loans are not ordinarily registered with the SEC or any state securities commission or listed on any securities exchange, there is usually less publicly available information about such instruments. In addition, loans may not be considered “securities” for purposes of the anti-fraud protections of the federal securities laws and, as a result, as a purchaser of these instruments, the Company may not be entitled to the anti-fraud protections of the federal securities laws. In the course of investing in such instruments, the Company may come into possession of material nonpublic information and, because of prohibitions on trading in securities of issuers while in possession of such information, the Company may be unable to enter into a transaction in a publicly-traded security of that issuer when it would otherwise be advantageous for us to do so. Alternatively, the Company may choose not to receive material nonpublic information about an issuer of such loans, with the result that the Company may have less information about such issuers than other investors who transact in such assets. </div><div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Foreign Securities Risk </div></div></div></div><div style="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Investments in foreign securities involve certain factors not typically associated with investing in U.S. securities, such as risks relating to (i) currency exchange matters, including fluctuations in the rate of exchange between the U.S. dollar (the currency in which the books of the Company are maintained) and the various foreign currencies in which the Company’s portfolio securities will be denominated and costs associated with conversion of investment principal and income from one currency into another; (ii) differences between the U.S. and foreign securities markets, including the absence of uniform accounting, auditing and financial reporting standards and practices and disclosure requirements, and less government supervision and regulation; (iii) political, social or economic instability; and (iv) the extension of credit, especially in the case of sovereign debt. </div><div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Illiquid Securities Risk </div></div></div></div><div style="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The Company will generally make investments in private companies. Substantially all of these investments will be subject to legal and other restrictions on resale or will otherwise be less liquid than publicly traded securities. The illiquidity of the Company’s investments may make it difficult for the Company to sell such investments if the need arises. In addition, if it is required to liquidate all or a portion of its portfolio quickly, the Company may realize significantly less than the value at which it has previously recorded its investments. In addition, it may face other restrictions on its ability to liquidate an investment in a portfolio company to the extent that it has material <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-public</div> information regarding such portfolio company or if an investment is held by one of its subsidiaries and is subject to contractual limitations on sale, such as the limitations on transfer of assets under certain circumstances under a credit facility. </div><div style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The Company may seek to address its short-term liquidity needs by carefully managing the settlements of its portfolio transactions, including transactions in loans, by maintaining short-term liquid assets sufficient to meet reasonably anticipated obligations, and by maintaining a credit facility. </div><div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Interest Rate Risk </div></div></div></div><div style="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Interest Rate risk is the risk that fixed income securities will decline in value because of changes in interest rates. When interest rates decline, the value of fixed rate securities already held by the Company can be expected to rise. Conversely, when interest rates rise, the value of existing fixed rate portfolio securities can be expected to decline. A company with a longer average portfolio duration will be more sensitive to changes in interest rates than a fund with a shorter average portfolio duration Recent and potential future changes in government monetary policy may affect the level of interest rates. </div><div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;"> </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"/><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Investments in Foreign Markets Risk </div></div></div></div><div style="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Investments in foreign markets involve special risks and considerations not typically associated with investing in the United States. These risks include revaluation of currencies, high rates of inflation, restrictions on repatriation of income and capital, and adverse political and economic developments. Moreover, securities issued in these markets may be less liquid, subject to government ownership controls, tariffs and taxes, subject to delays in settlements, and their prices may be more volatile. The Company may be subject to capital gains and repatriation taxes imposed by certain countries in which they invest. Such taxes are generally based on income and/or capital gains earned or repatriated. Taxes are accrued based upon net investment income, net realized gains and net unrealized appreciation as income and/or capital gains are earned. </div><div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Leverage Risk </div></div></div></div><div style="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The Company may use leverage in its investment program, including the use of borrowed funds and investments in certain types of options, such as puts, calls and warrants, which may be purchased for a fraction of the price of the underlying securities. While such strategies and techniques increase the opportunity to achieve higher returns on the amounts invested, they also increase the risk of loss. To the extent the Company purchases securities with borrowed funds, its net assets will tend to increase or decrease at a greater rate than if borrowed funds are not used. If the interest expense on borrowings were to exceed the net return on the portfolio securities purchased with borrowed funds, the Company’s use of leverage would result in a lower rate of return than if the Company were not leveraged. </div><div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">LIBOR Transition and Associated Risk </div></div></div></div><div style="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">LIBOR is the average offered rate for various maturities of short-term loans between major international banks who are members of the British Bankers Association. LIBOR is the most common benchmark interest rate index used to make adjustments to variable-rate loans. It is used throughout global banking and financial industries to determine interest rates for a variety of financial instruments (such as debt instruments and derivatives) and borrowing arrangements. </div><div style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Due to manipulation allegations in 2012 and reduced activity in the financial markets that it measures, in July 2017, the Financial Conduct Authority (the “FCA”), the United Kingdom financial regulatory body, announced a desire to phase out the use of LIBOR by the end of 2021 and that it will stop encouraging banks to provide the quotations needed to sustain LIBOR. The ICE Benchmark Administration Limited, the administrator of LIBOR, ceased publishing most LIBOR maturities, including some US LIBOR maturities, on December 31, 2021, and is expected to cease publishing the remaining and most liquid US LIBOR maturities on June 30, 2023. It is expected that market participants have or will transition to the use of alternative reference or benchmark rates prior to the applicable LIBOR publication cessation date. Additionally, although regulators have encouraged the development and adoption of alternative rates, such as the Secured Overnight Financing Rate (“SOFR”), the future utilization of LIBOR or of any particular replacement rate remains uncertain. </div><div style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Although the transition process away from LIBOR has become increasingly well defined in advance of the anticipated discontinuation dates, the impact on certain debt securities, derivatives and other financial instruments remains uncertain. It is expected that market participants will adopt alternative rates such as SOFR or otherwise amend financial instruments referencing LIBOR to include fallback provisions and other measures that contemplate the discontinuation of LIBOR or other similar market disruption events, but neither the effect of the transition process nor the viability of such measures is known. Further, uncertainty and risk remain regarding the willingness and ability of issuers and lenders to include alternative rates and revised provisions in new and existing contracts or instruments. To facilitate the transition of legacy derivatives contracts referencing LIBOR, the International Swaps and Derivatives Association, Inc. launched a protocol to incorporate fallback provisions. While the transition process away from LIBOR has become increasingly well defined in advance of the expected LIBOR cessation dates, there are obstacles to converting certain longer term securities and transactions to a new benchmark or benchmarks and the effectiveness of one alternative reference rate versus multiple alternative reference rates in new or existing financial instruments and products has not been determined. Furthermore, the risks associated with the cessation of LIBOR and transition to replacement rates may be exacerbated if an orderly transition to alternative reference rates is not completed in a timely manner. Certain proposed replacement rates to LIBOR, such as SOFR, which is a broad measure of secured overnight US Treasury repo rates, are materially different from LIBOR, and changes in the applicable spread for financial instruments transitioning away from LIBOR will need to be made to accommodate the differences. Furthermore, the risks associated with the expected discontinuation of LIBOR and transition to replacement rates may be exacerbated if an orderly transition to an alternative reference rate is not completed in a timely manner. As market participants transition away from LIBOR, LIBOR’s usefulness may deteriorate and the effects could be experienced until the permanent cessation of the majority of U.S. LIBOR rates in 2023. The transition process may lead to increased volatility and illiquidity in markets that currently rely on LIBOR to determine interest rates. LIBOR’s deterioration may adversely affect the liquidity and/or market value of securities that use LIBOR as a benchmark interest rate. </div><div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;"> </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"> </div><div style="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Alteration of the terms of a debt instrument or a modification of the terms of other types of contracts to replace LIBOR or another interbank offered rate (“IBOR”) with a new reference rate could result in a taxable exchange and the realization of income and gain/loss for U.S. federal income tax purposes. The Internal Revenue Service (“IRS”) has issued final regulations regarding the tax consequences of the transition from IBOR to a new reference rate in debt instruments and <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-debt</div> contracts. Under the final regulations, alteration or modification of the terms of a debt instrument to replace an operative rate that uses a discontinued IBOR with a qualified rate (as defined in the final regulations) including true up payments equalizing the fair market value of contracts before and after such IBOR transition, to add a qualified rate as a fallback rate to a contract whose operative rate uses a discontinued IBOR or to replace a fallback rate that uses a discontinued IBOR with a qualified rate would not be taxable. The IRS may provide additional guidance, with potential retroactive effect. </div><div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Operational and Technology Risk </div></div></div></div><div style="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The risk that cyber-attacks, disruptions, or failures that affect the Funds’ service providers, counterparties, market participants, or issuers of securities held by the Funds may adversely affect the Funds and its shareholders, including by causing losses for the Funds or impairing Fund operations. </div><div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Options Risk </div></div></div></div><div style="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">There are several risks associated with transactions in options on securities. For example, there are significant differences between the securities and options markets that could result in an imperfect correlation between these markets, causing a given transaction not to achieve its objectives. A transaction in options or securities may be unsuccessful to some degree because of market behavior or unexpected events. </div><div style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">When the Company writes a covered call option, the Company forgoes, during the option’s life, the opportunity to profit from increases in the market value of the security covering the call option above the sum of the premium and the strike price of the call, but retains the risk of loss should the price of the underlying security decline. The writer of an option has no control over the time when it may be required to fulfill its obligation and once an option writer has received an exercise notice, it must deliver the underlying security in exchange for the strike price. </div><div style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">When the Company writes a covered put option, the Company bears the risk of loss if the value of the underlying stock declines below the exercise price minus the put premium. If the option is exercised, the Company could incur a loss if it is required to purchase the stock underlying the put option at a price greater than the market price of the stock at the time of exercise plus the put premium the Company received when it wrote the option. While the Company’s potential gain in writing a covered put option is limited to distributions earned on the liquid assets securing the put option plus the premium received from the purchaser of the put option, the Company risks a loss equal to the entire exercise price of the option minus the put premium. </div><div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Pandemics and Associated Economic Disruption Risk </div></div></div></div><div style="text-indent: 9%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="display:inline;">An outbreak of respiratory disease caused by a novel coronavirus was first detected in China in late 2019 and subsequently spread globally (“COVID-19”). This coronavirus has resulted in and may continue to result in the closing of borders, enhanced health screenings, healthcare service preparation and delivery, quarantines, cancellations, disruptions to supply chains and customer activity, as well as general anxiety and economic uncertainty. The impact of this has resulted in a substantial economic volatility. Health crises caused by outbreaks of disease, such as the coronavirus, may exacerbate other <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">pre-existing</div> political, social and economic risks. The impact of this outbreak, and other epidemics and pandemics that may arise in the future, could continue to negatively affect the global economy, as well as the economies of individual countries, individual companies and the market in general in significant and unforeseen ways. For example, a widespread health crisis such as a global pandemic could cause substantial market volatility, exchange trading suspensions and closures, impact the Company’s ability to complete tender offer requests, and affect Company performance. Any such impact could adversely affect the Company’s performance, the performance of the issuers in which the Company invests, lines of credit available to the Company and may lead to losses on your investment in the Company. In addition, the increasing interconnectedness of markets around the world may result in many markets being affected by events or conditions in a single country or region or events affecting a single or small number of issuers. </div></div><div style="text-indent: 9%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;text-indent: 0px;;display:inline;">The United States responded to the COVID-19 outbreak and resulting economic distress with fiscal and monetary stimulus packages, including the Coronavirus Aid, Relief, and Economic Security Act (the “CARES Act”) passed in late March 2020. The CARES Act provides for over $</div></div>2.2<div style="null;text-indent: 0px;;display:inline;"> trillion in resources to small businesses, state and local governments, and individuals adversely impacted by the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">COVID-19</div> pandemic. Further, in March 2021, the government passed the American Rescue Plan Act of 2021, a $</div>1.9<div style="display:inline;"> trillion stimulus bill to accelerate the United States’ recovery from the economic and health effects of the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">COVID-19</div> pandemic. In late December 2020, the government also passed a spending bill that included $900 billion in stimulus relief for the COVID-19 pandemic. In addition, in <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">mid-March</div> 2020, the Fed cut interest rates to historically low levels and announced a new round of quantitative easing, including purchases of corporate and municipal government bonds. The Fed also enacted various programs to support liquidity operations and funding in the financial markets, including expanding its reverse </div></div><div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;"> </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"> </div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">repurchase agreement operations, which added $1.5 <div style="letter-spacing: 0px; top: 0px;;display:inline;">trillion of liquidity to the banking system; establishing swap lines with other major central banks to provide dollar funding; establishing a program to support money market funds; easing various bank capital buffers; providing funding backstops for businesses to provide bridging loans for up to four years; and providing funding to help credit flow in asset-backed securities markets. In addition, the Fed extended credit to small- and <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">medium-sized</div> businesses. As the Fed “tapers” or reduces the amount of securities it purchases pursuant to quantitative easing, and/or if the Fed raises the federal funds rate, there is a risk that interest rates will rise, which could expose fixed-income and related markets to heightened volatility and could cause the value of the Company’s investments, and the Company’s NAV, to decline, potentially suddenly and significantly. As a result, the Company may experience high redemptions and, as a result, increased portfolio turnover, which could increase the costs that the Company incurs and may negatively impact the Company’s performance. There is no assurance that the U.S. government’s support in response to <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">COVID-19</div> economic distress will offset the adverse impact to securities in which the Company may invest and future governmental support is not guaranteed. </div></div> <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Senior Loans Risk </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The risk that the issuer of a senior loan may fail to pay interest or principal when due, and changes in market interest rates may reduce the value of the senior loan or reduce the Company’s returns. The risks associated with senior loans are similar to the risks of high yield debt securities. Senior loans and other debt securities are also subject to the risk of price declines and to increases in interest rates, particularly long-term rates. Senior loans are also subject to the risk that, as interest rates rise, the cost of borrowing increases, which may increase the risk of default. In addition, the interest rates of floating rate loans typically only adjust to changes in short-term interest rates; long-term interest rates can vary dramatically from short-term interest rates. Therefore, senior loans may not mitigate price declines in a long-term interest rate environment. The Company’s investments in senior loans are typically below investment grade and are considered speculative because of the credit risk of their issuers. </div> <div style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">LIBOR is the average offered rate for various maturities of short-term loans between major international banks who are members of the British Bankers Association. LIBOR is the most common benchmark interest rate index used to make adjustments to variable-rate loans. It is used throughout global banking and financial industries to determine interest rates for a variety of financial instruments (such as debt instruments and derivatives) and borrowing arrangements. Due to manipulation allegations in 2012 and reduced activity in the financial markets that it measures, in July 2017, the Financial Conduct Authority, the United Kingdom financial regulatory body, announced a desire to phase out the use of LIBOR by the end of 2021. Please refer to “LIBOR Transition and Associated Risk” for more information. </div> <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Structured Finance Securities Risk </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">A portion of the Company’s investments may consist of equipment trust certificates, collateralized mortgage obligations, collateralized bond obligations, collateralized loan obligations (“CLO”) or similar instruments. Such structured finance securities are generally backed by an asset or a pool of assets, which serve as collateral. Depending on the type of security, the collateral may take the form of a portfolio of mortgage loans or bonds or other assets. The Company and other investors in structured finance securities ultimately bear the credit risk of the underlying collateral. In some instances, the structured finance securities are issued in multiple tranches, offering investors various maturity and credit risk characteristics, often categorized as senior, mezzanine and subordinated/equity according to their degree of risk. The riskiest securities are the equity tranche, which bears the bulk of defaults from the bonds or loans serving as collateral, and thus may protect the other, more senior tranches from default. If there are defaults or the relevant collateral otherwise underperforms, scheduled payments to senior tranches of such securities take precedence over those of mezzanine tranches, and scheduled payments to mezzanine tranches take precedence over those to subordinated/equity tranches. A senior tranche typically has higher ratings and lower yields than the underlying securities, and may be rated investment grade. Despite the protection from the equity tranche, other tranches can experience substantial losses due to actual defaults, increased sensitivity to defaults due to previous defaults and the disappearance of protecting tranches, market anticipation of defaults and aversion to certain structured finance securities as a class. </div> <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Short-Selling Risk </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Short sales by the Company that are not made where there is an offsetting long position in the asset that it is being sold short theoretically involve unlimited loss potential since the market price of securities sold short may continuously increase. Short selling allows the Company to profit from declines in market prices to the extent such decline exceeds the transaction costs and costs of borrowing the securities. However, since the borrowed securities must be replaced by purchases at market prices in order to close out the short position, any appreciation in the price of the borrowed securities would result in a loss. Purchasing securities to close out the short position can itself cause the price of securities to rise further, thereby exacerbating the loss. The Company may mitigate such losses by replacing the securities sold short before the market price has increased significantly. Under adverse market conditions, the Company might have difficulty purchasing securities to meet margin calls on its short sale delivery obligations, and might have to sell portfolio securities to raise the capital necessary to meet its short sale obligations at a time when fundamental investment considerations would not favor such sales. Further, if other short positions of the same security are closed out at the same time, a “short squeeze” can occur where demand exceeds the supply for the security sold short. A short squeeze makes it more likely that the Adviser will need to replace the borrowed security at an unfavorable price. </div> <div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;"> </div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"> </div> <div/> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Valuation Risk </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Certain of the Company’s assets are fair valued, including the Company’s investment in equity issued by TerreStar Corporation (“TerreStar”). TerreStar does not currently generate revenue and primarily derives its value from holding licenses of two wireless spectrum assets. The license with respect to one such spectrum asset was previously terminated by the FCC and subsequently restored on April 30, 2020 on a limited conditional basis. The restoration of such license requires TerreStar to meet certain deployment milestones for wireless medical telemetry service (“WMTS”) during a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">39-month</div> period. Upon satisfaction of the deployment milestones, TerreStar will be able use such spectrum for other services besides WMTS as long as those services do not interfere with WMTS and TerreStar continues to provide WMTS. </div> <div style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">If TerreStar is unsuccessful in satisfying such deployment milestones, or if other services cannot be implemented in a manner that does not interfere with WMTS, the value of the TerreStar equity would likely be materially negatively impacted. In determining the fair value of TerreStar, the Adviser has assigned a high probability of success on both conditions based on consultation with the company and its consultants.</div> 2200000000000 1900000000000 900000000000 1500000000000 <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Note 9 — Affiliated Investments </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Under Section 2(a)(3) of the 1940 Act, a portfolio company is defined as “aff<div style="letter-spacing: 0px; top: 0px;;text-indent: 0px;;display:inline;">iliated” if a</div> fund owns five percent or more of its outstanding voting securities or if the portfolio company is under common control.<div style="text-indent: 0px; letter-spacing: 0px; top: 0px;;display:inline;"> The table below includes non-cash transactions for the three months ended March 31, 2023.</div> The table below shows affiliated issuers of the Company as of March 31, 2023: </div> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"/></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="font-size: 0px;"> <td style="width: 24%;"/> <td style="width: 2%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 2%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 2%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 2%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 2%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 2%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 2%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 2%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 2%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 2%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"> <div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; line-height: normal;"><div style="display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Affiliated investments</div></div></div></div> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Shares</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">at</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December 31,</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Fair value</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">as of</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December 31,</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Transfers<br/>in (out)<br/>(at cost)</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;"> </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Purchases</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Sales</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Realized<br/>gains<br/>(losses)</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Change in<br/>unrealized<br/>appreciation<br/>(depreciation)</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;"> </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Fair value</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">as of</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">March 31,</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2023</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Shares</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">at</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">March 31,</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2023</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Affiliated<br/>Dividend<br/>income</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;"> </div></td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">NexPoint Residential Trust, Inc.</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">23,409</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,018,779</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space: nowrap;vertical-align: bottom;width: 3%;padding: 0pt 0pt 0pt 0pt;;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,512</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,022,291</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">23,409</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">9,832</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align: top; white-space: nowrap;"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal; white-space: nowrap;">NexPoint Capital <br/>REIT, LLC<div style="letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> (Senior <br/>Loans &amp; Common <br/>Stocks)<br/></div></div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">100</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,176,024</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">7,368,085</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">463,314</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space: nowrap;vertical-align: bottom;width: 4%;padding: 0pt 0pt 0pt 0pt;;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(1,639,454</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">7,367,969</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">464,041</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space: nowrap; vertical-align: bottom; width: 5%; padding: 0pt 5pt 0pt 0pt;;text-align:right;">—</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">NexPoint Real Estate Finance, Inc.</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">481,670</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">7,653,730</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(7,368,085</td> <td style="white-space:nowrap;vertical-align:bottom">)</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space: nowrap; vertical-align: bottom; width: 3%; padding: 0pt 5pt 0pt 0pt;;text-align:right;">—</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,777,618</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,063,263</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">131,670</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">90,194</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">SFR WLIF III, LLC</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">451,112</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">424,468</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(6,287</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">418,181</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">451,112</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">11,430</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Total affiliated investments</div></div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">956,291</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">10,273,001</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">463,314</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space: nowrap; vertical-align: bottom; width: 4%; padding: 0pt 5pt 0pt 0pt;;text-align:right;">—</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">135,389</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">10,871,704</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,070,232</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">111,456</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> </table> The table below shows affiliated issuers of the Company as of March 31, 2023: <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"/></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="font-size: 0px;"> <td style="width: 24%;"/> <td style="width: 2%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 2%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 2%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 2%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 2%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 2%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 2%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 2%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 2%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 2%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"> <div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; line-height: normal;"><div style="display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Affiliated investments</div></div></div></div> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Shares</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">at</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December 31,</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Fair value</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">as of</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December 31,</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Transfers<br/>in (out)<br/>(at cost)</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;"> </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Purchases</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Sales</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Realized<br/>gains<br/>(losses)</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Change in<br/>unrealized<br/>appreciation<br/>(depreciation)</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;"> </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Fair value</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">as of</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">March 31,</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2023</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Shares</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">at</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">March 31,</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2023</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Affiliated<br/>Dividend<br/>income</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;"> </div></td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">NexPoint Residential Trust, Inc.</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">23,409</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,018,779</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space: nowrap;vertical-align: bottom;width: 3%;padding: 0pt 0pt 0pt 0pt;;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,512</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,022,291</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">23,409</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">9,832</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align: top; white-space: nowrap;"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal; white-space: nowrap;">NexPoint Capital <br/>REIT, LLC<div style="letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;"> (Senior <br/>Loans &amp; Common <br/>Stocks)<br/></div></div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">100</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,176,024</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">7,368,085</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">463,314</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space: nowrap;vertical-align: bottom;width: 4%;padding: 0pt 0pt 0pt 0pt;;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(1,639,454</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">7,367,969</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">464,041</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space: nowrap; vertical-align: bottom; width: 5%; padding: 0pt 5pt 0pt 0pt;;text-align:right;">—</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">NexPoint Real Estate Finance, Inc.</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">481,670</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">7,653,730</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(7,368,085</td> <td style="white-space:nowrap;vertical-align:bottom">)</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space: nowrap; vertical-align: bottom; width: 3%; padding: 0pt 5pt 0pt 0pt;;text-align:right;">—</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,777,618</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,063,263</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">131,670</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">90,194</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">SFR WLIF III, LLC</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">451,112</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">424,468</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(6,287</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">418,181</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">451,112</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">11,430</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Total affiliated investments</div></div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">956,291</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">10,273,001</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">463,314</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space: nowrap; vertical-align: bottom; width: 4%; padding: 0pt 5pt 0pt 0pt;;text-align:right;">—</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">135,389</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">10,871,704</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,070,232</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">111,456</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> </table> 23409 1018779 0 0 0 0 3512 1022291 23409 9832 100 1176024 7368085 463314 0 0 -1639454 7367969 464041 0 481670 7653730 -7368085 0 0 0 1777618 2063263 131670 90194 451112 424468 0 0 0 0 -6287 418181 451112 11430 956291 10273001 0 463314 0 0 135389 10871704 1070232 111456 <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Note 10 — Financial Highlights </div></div></div></div> <div style="font-weight:bold;display:inline;"> </div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Selected data for a share outstanding throughout the three months ended March 31, 2023 and March 31, 2022 is as follows: </div> <div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:76%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:59%"/> <td style="vertical-align:bottom;width:16%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:15%"/> <td/> <td/> <td/> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom;text-align:center;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;">For the Three Months</div></div> <div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;">Ended</div></div> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">For the Three Months<br/> Ended</div></div></td> <td style="vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">March 31, 2023<br/> (Unaudited)</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">March 31, 2022<br/> (Unaudited)</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td colspan="8" style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Common shares per share operating performance:</div> </td> <td style="vertical-align:top"> <div style="margin-top: 0px; margin-bottom: 0px; margin-left: 0em; text-indent: 0em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"> </div> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Net asset value, beginning of period</div></div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5.55</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">6.32</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td colspan="8" style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Income from investment operations:</div></div> </td> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0em; text-indent: 0em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;"> </div></div> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net investment income<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(1)</div></div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.04</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.05</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net realized and unrealized gain (loss)</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(0.14</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.07</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total from investment operations</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(0.10</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.12</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td colspan="8" style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Less distribution declared to common shareholders:</div></div> </td> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0em; text-indent: 0em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;"> </div></div> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">From net investment income</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(0.09</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(0.09</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total distributions declared to common shareholders</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(0.09</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(0.09</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td colspan="8" style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Capital share transaction</div></div> </td> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0em; text-indent: 0em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;"> </div></div> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Issuance of common stock<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(2)</div></div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Shares tendered<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(1)</div></div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Net asset value, end of period</div></div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5.36</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">6.35</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net asset value total return<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(3)(4)</div></div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(1.80</td> <td style="white-space:nowrap;vertical-align:bottom">)%</td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1.83</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td colspan="8" style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Ratio and supplemental data:</div></div> </td> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0em; text-indent: 0em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;"> </div></div> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net assets, end of period (in 000’s)</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">51,159</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">62,947</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Shares outstanding, end of period</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">9,548,899</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">9,918,671</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td colspan="8" style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Common share information at end of period:</div></div> </td> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0em; text-indent: 0em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;"> </div></div> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td colspan="8" style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Ratios based on weighted average net assets of common shares:</div></div> </td> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0em; text-indent: 0em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;"> </div></div> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Gross operating expenses<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(5)</div></div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4.05</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3.72</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fees and expenses waived or reimbursed<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(5)</div></div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(0.62</td> <td style="white-space:nowrap;vertical-align:bottom">)% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(0.39</td> <td style="white-space:nowrap;vertical-align:bottom">)% </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net operating expenses<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(5)</div></div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3.43</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3.33</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align: top; white-space: nowrap;"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal; white-space: nowrap;">Net investment income (loss) before fees <br/>waived or reimbursed<div style="font-size: 75%; vertical-align: top; white-space: nowrap;;display:inline;;font-size:8.3px">(5)</div></div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2.14</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2.73</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net investment income (loss) after fees <br/>waived or reimbursed<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(5)</div></div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2.76</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3.12</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Portfolio turnover rate<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(4)</div></div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space: nowrap; vertical-align: bottom; width: 10%; padding: 0pt;;text-align:right;">1</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">26</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Asset coverage ratio</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom">% </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Weighted average commission rate paid<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(6)</div></div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> </table> <div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;"><div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(1)</div></td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Per share data was calculated using weighted average shares outstanding during the period. </div> </td> </tr> </table> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;"><div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(2)</div></td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">The continuous issuance of common stock may cause an incremental increase in net asset value per share due to the sale of shares at the then prevailing public offering price and the receipt of net proceeds per share by the Company in excess of net asset value per share on each subscription closing date. The per share data was derived by computing (i) the sum of (A) the number of shares issued in connection with subscriptions and/or distribution reinvestment on each share transaction date times (B) the differences between the net proceeds per share and the net asset value per share on each share transaction date, divided by (ii) the total shares outstanding at the end of the period. The Company’s continuous public offering ended on February 14, 2018. </div> </td> </tr> </table> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;"><div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(3)</div></td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Total returns are historical and assume changes in share price and reinvestment of dividends and capital gains distributions, and assume no sales charge. Distributions, if any, are assumed for purposes of this calculation to be reinvested at prices obtained under the Company’s Dividend Reinvestment Plan. Had the Adviser not absorbed a portion of expenses, total returns would have been lower. </div> </td> </tr> </table> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;"><div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(4)</div></td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Not annualized. </div> </td> </tr> </table> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;"><div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(5)</div></td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Annualized. </div> </td> </tr> </table> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;"><div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(6)</div></td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Represents the total dollar amount of commissions paid on portfolio transactions divided by total number of portfolio shares purchased and sold for which commissions were charged. </div> </td> </tr> </table> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Selected data for a share outstanding throughout the three months ended March 31, 2023 and March 31, 2022 is as follows: </div> <div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:76%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:59%"/> <td style="vertical-align:bottom;width:16%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:15%"/> <td/> <td/> <td/> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom;text-align:center;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;">For the Three Months</div></div> <div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;">Ended</div></div> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">For the Three Months<br/> Ended</div></div></td> <td style="vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">March 31, 2023<br/> (Unaudited)</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">March 31, 2022<br/> (Unaudited)</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td colspan="8" style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Common shares per share operating performance:</div> </td> <td style="vertical-align:top"> <div style="margin-top: 0px; margin-bottom: 0px; margin-left: 0em; text-indent: 0em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"> </div> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Net asset value, beginning of period</div></div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5.55</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">6.32</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td colspan="8" style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Income from investment operations:</div></div> </td> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0em; text-indent: 0em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;"> </div></div> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net investment income<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(1)</div></div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.04</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.05</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net realized and unrealized gain (loss)</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(0.14</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.07</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total from investment operations</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(0.10</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.12</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td colspan="8" style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Less distribution declared to common shareholders:</div></div> </td> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0em; text-indent: 0em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;"> </div></div> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">From net investment income</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(0.09</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(0.09</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total distributions declared to common shareholders</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(0.09</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(0.09</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td colspan="8" style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Capital share transaction</div></div> </td> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0em; text-indent: 0em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;"> </div></div> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Issuance of common stock<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(2)</div></div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Shares tendered<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(1)</div></div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Net asset value, end of period</div></div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5.36</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">6.35</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net asset value total return<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(3)(4)</div></div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(1.80</td> <td style="white-space:nowrap;vertical-align:bottom">)%</td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1.83</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td colspan="8" style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Ratio and supplemental data:</div></div> </td> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0em; text-indent: 0em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;"> </div></div> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net assets, end of period (in 000’s)</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">51,159</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">62,947</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Shares outstanding, end of period</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">9,548,899</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">9,918,671</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td colspan="8" style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Common share information at end of period:</div></div> </td> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0em; text-indent: 0em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;"> </div></div> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td colspan="8" style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Ratios based on weighted average net assets of common shares:</div></div> </td> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0em; text-indent: 0em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;"> </div></div> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Gross operating expenses<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(5)</div></div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4.05</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3.72</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fees and expenses waived or reimbursed<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(5)</div></div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(0.62</td> <td style="white-space:nowrap;vertical-align:bottom">)% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(0.39</td> <td style="white-space:nowrap;vertical-align:bottom">)% </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net operating expenses<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(5)</div></div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3.43</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3.33</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align: top; white-space: nowrap;"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal; white-space: nowrap;">Net investment income (loss) before fees <br/>waived or reimbursed<div style="font-size: 75%; vertical-align: top; white-space: nowrap;;display:inline;;font-size:8.3px">(5)</div></div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2.14</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2.73</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net investment income (loss) after fees <br/>waived or reimbursed<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(5)</div></div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2.76</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3.12</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Portfolio turnover rate<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(4)</div></div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space: nowrap; vertical-align: bottom; width: 10%; padding: 0pt;;text-align:right;">1</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">26</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Asset coverage ratio</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom">% </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Weighted average commission rate paid<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(6)</div></div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> </table> <div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;"><div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(1)</div></td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Per share data was calculated using weighted average shares outstanding during the period. </div> </td> </tr> </table> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;"><div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(2)</div></td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">The continuous issuance of common stock may cause an incremental increase in net asset value per share due to the sale of shares at the then prevailing public offering price and the receipt of net proceeds per share by the Company in excess of net asset value per share on each subscription closing date. The per share data was derived by computing (i) the sum of (A) the number of shares issued in connection with subscriptions and/or distribution reinvestment on each share transaction date times (B) the differences between the net proceeds per share and the net asset value per share on each share transaction date, divided by (ii) the total shares outstanding at the end of the period. The Company’s continuous public offering ended on February 14, 2018. </div> </td> </tr> </table> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;"><div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(3)</div></td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Total returns are historical and assume changes in share price and reinvestment of dividends and capital gains distributions, and assume no sales charge. Distributions, if any, are assumed for purposes of this calculation to be reinvested at prices obtained under the Company’s Dividend Reinvestment Plan. Had the Adviser not absorbed a portion of expenses, total returns would have been lower. </div> </td> </tr> </table> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;"><div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(4)</div></td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Not annualized. </div> </td> </tr> </table> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;"><div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(5)</div></td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Annualized. </div> </td> </tr> </table> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;"><div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(6)</div></td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Represents the total dollar amount of commissions paid on portfolio transactions divided by total number of portfolio shares purchased and sold for which commissions were charged. </div> </td> </tr> </table> 5.55 6.32 0.04 0.05 -0.14 0.07 -0.1 0.12 -0.09 -0.09 0.09 0.09 0 0 0 0 5.36 6.35 -0.018 0.0183 51159000 62947000 9548899 9918671 0.0405 0.0372 0.0062 0.0039 0.0343 0.0333 0.0214 0.0273 0.0276 0.0312 0.01 0.26 0 0 0 0 <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Note 11 — Subsequent Events </div></div></div></div> <div style="font-weight:bold;display:inline;"> </div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The Company has evaluated subsequent events through the date on which these financial statements were issued. </div> <div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;"> </div> The investment is not a qualifying asset under Section 55 of the 1940 Act. A business development company (“BDC”), such as the Company, may not acquire any asset other than a qualifying asset, unless at the time the acquisition is made, qualifying assets represent at least 70% of the business development company’s total assets. Non-qualifying assets represented 4.8% of the Company’s total assets as of December 31, 2022. The interest rate on these investments is subject to a base rate of 6-Month LIBOR, which at December 31, 2022 was 5.14%. The LIBOR rate used to calculate interest is the higher of the prevailing 6 month LIBOR rate in effect on the date of the semiannual reset, or the LIBOR base rate floor shown. The interest rate on these investments is subject to a base rate of 3-Month LIBOR, which at December 31, 2022 was 4.77%. The LIBOR rate used to calculate interest is the higher of the prevailing 3 month LIBOR rate in effect on the date of the quarterly reset, or the LIBOR base rate floor shown. Represents fair value as determined by the Adviser pursuant to the policies and procedures approved by the Board of Trustees (the “Board”). The Board has designated the Adviser as “valuation designee” for the Company pursuant to Rule 2a-5 of the 1940 Act. The Adviser considers fair valued securities to be securities for which market quotations are not readily available and these securities may be valued using a combination of observable and unobservable inputs. Securities with a total aggregate value of $28,500,789 or 53.0% of net assets were fair valued under the Company’s valuation procedures as of December 31, 2022. Classified as Level 3 within the three-tier fair value hierarchy. Please see Note 2 for an explanation of this hierarchy, as well as a list of unobservable inputs used in the valuation of these instruments. The interest rate on these investments is subject to a base rate of 1-Month LIBOR, which at December 31, 2022 was 4.39%. The LIBOR rate used to calculate interest is the higher of the prevailing 1 month LIBOR rate in effect on the date of the monthly reset, or the LIBOR base rate floor shown. Securities of collateralized loan obligations where an affiliate of the Adviser serves as collateral manager. The investment is considered to be the equity tranche of the issuer. Securities exempt from registration under Rule 144A of the Securities Act. These securities may only be resold in transactions exempt from registration to qualified institutional buyers. As of December 31, 2022, these securities amounted to $2,421,875, or 4.5% of net assets. The issuer is in default of its payment obligation, or is in danger of default. The interest rate on these investments is subject to a base rate of 3-Month LIBOR, which at March 31, 2023 was 5.19%. The LIBOR rate used to calculate interest is the higher of the prevailing 3 month LIBOR rate in effect on the date of the quarterly reset, or the LIBOR base rate floor shown. The investment is not a qualifying asset under Section 55 of the 1940 Act. A business development company (“BDC”), such as the Company, may not acquire any asset other than a qualifying asset, unless at the time the acquisition is made, qualifying assets represent at least 70% of the business development company’s total assets. Non-qualifying assets represented 4.9% of the Company’s total assets as of March 31, 2023. The interest rate on these investments is subject to a base rate of 3-Month SOFR, which at March 31, 2023 was 4.51% Represents fair value as determined by the Adviser (as defined in Note 1) pursuant to the policies and procedures approved by the Board of Directors (the “Board”). The Board has designated the Adviser as “valuation designee” for the Company pursuant to Rule 2a-5 of the 1940 Act. The Adviser considers fair valued securities to be securities for which market quotations are not readily available and these securities may be valued using a combination of observable and unobservable inputs. Securities with a total aggregate value of $34,445,226 or 67.3% of net assets were fair valued under the Company’s valuation procedures as of March 31, 2023. Represents an affiliated issuer. Assets with a total aggregate market value of $10,871,704, or 21.3% of net assets, were affiliated with the Company as of March 31, 2023. See Note 9. Securities exempt from registration under Rule 144A of the 1933 Act. These securities may only be resold in transactions exempt from registration to qualified institutional buyers. As of March 31, 2023, these securities amounted to $2,248,059, or 4.4% of net assets. Amortized cost represents the original cost adjusted for the amortization of premiums and/or accretion of discounts, as applicable, on investments. Non-income producing security. Represents an affiliated issuer. Assets with a total aggregate market value of $10,273,001, or 19.1% of net assets, were affiliated with the Company as of December 31, 2022. See Note 10. Unless otherwise noted, the Company did not “control” and was not an “affiliated person” of any of its portfolio companies, each as defined in the Investment Company Act of 1940, as amended (the “1940 Act”). In general, under the 1940 Act, the Company would be presumed to “control” a portfolio company if it owned 25% or more of its voting securities or had the power to exercise control over the management or policies of such portfolio company, and would be an “affiliated person” of a portfolio company if it owned 5% or more of its voting securities. Additionally, companies under common control (e.g., companies with a common owner of greater than 25% of their respective voting securities) are affiliates under the 1940 Act. All investments are denominated in United States Dollars. State Street U.S. Government Money Market Fund. Investment denominated in USD. Represents an in-kind transfer to the subreit. Denotes Sapience’s $4,080,000 promissory notes and paid in kind interest conversion to preferred stock. Denotes SFR II’s LLC Interests conversion into NREF common shares. EXCEL 57 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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

9^)5SU%!:T1]&;MMQN[UF!%: M9!8*ZDD9W@<6%MK?T8>U(8LB>B+=POQ<-I"]QWE/'9C=.9_?I\DO-)VF:_;L MT^5V(:"\S.[/HX85='N8Y;:<[_%M6'EIZQZF*R>^& M+M#]-J=U/6>5_HG$Z::$K*/]4_64YE>7=2T^W3WA,!=KZRFM$"^[4BR^;B/F M);7>%:)LX;M(=8O(VD'9#X1%B5=0IK/KY1A.7CXYYN Z7-(^JVV=\ZZ3 <0D MI!VF9]2/0^H;\P=[KZD;:4'[VAW>#+'@2VY#:YT]"_8WN)1@L1#1RVB72<-E MX5/VKKXUN_/^_?B^\^/SISR^*[(HQV_U$S1GE)A9J%MDMXS\L(2.ZU9FRTM_3;G^8O=74"D MD:#?Y$6VK5)_\/D/SD"$\I:9D'9SZS(9WK^48!?+)YH1,O13,T^67N"?T6:; MY=N0/B>:/G:YI$H-K/^GW=F"++=L*9Y2D8QFDSWL/ VS91EP6OT619KEC5Q: M?LT3Z<>]Q:HL1AX][AB'6$+Z367- ["[E) ZR]2DJLZZ8O'_V-)PFN$O/>WN MHW ;FCORB#94,71+,;-2J'LB?L!N^KR*:#-<[_C4URVM>#N=5I8A6$.D"689 MQ;01/H517#Y8%L#=PQ.@6+N])_5-67MYW*6K^XA7(J%V,)">ZC)CO4R-6>6\ MJC$\TESWR(CAKDY0N+]9]JEM.Z>FZ;+\ZWHSJVQ1"?6D:CN4/Y!&.'BF:[BID-QGT M#1//\A4=05V%17C^9DVR1W))>^P.PMR=L2G/_*8WJ QLROIJ;)V>=SR_Q MJRO<\_DU?G73]_FE^>JJ#^?:?'73]SD=JEJOKMEPMO<[FWUGL^_.N!OG;S:4 M^-.628>H.4W9#]0E8\:4K^FH=;7_HT@W=%1\@N[3HDC7Y:\K6H%(QBZ@WS^D M-%]4?[ ;/*?9ES)LY_\'4$L#!!0 ( +6)KU:-XG_'G04 &@F 9 M>&PO=V]R:W-H965TF.\6]B3:D$=UF:B^/!6LK-V^%0+-8T(^*(;6BNSJP8SXA4N_QF*#:'W)S1EN^,!'#P15H0BC;=@J2C^@UW9-@X'8+$5DF55L!I! MEN3E+[FK$M$(@%T!J I SPW 50 NB)8C*VB=$4EF4\YV@.O6"DUO%+DIHA6; M)->7\4IR=391<7)VI>IBN4TI8"MPGM]2(=4UD@*\NB!<;:S57[(@Z6OP&_AR M=09>_?QZ.I2J7QT]7%1]G)1]H(X^YH0? 0S? !0@; D_=8>?T44=CMKA0\6V MIHQJRJC PUV4RXIM,P8?6;I,\AL!OGY2[<&YI)GXQ\:U! _MX%IU;\6&+.CQ M0,E*4'Y+![-??H*CX'<;I> MI0&\$T+-(>K8*2D[@V76]>QQ.PN.@G R'=XV&7F6%-/&AK.%*GA.;11"^]C"/0K.H;SP MHD4UT*_.K)/DI-'DH3!.(9QL#_)V!JB& =!QVAA M8.[X@7.\EVI\/%EHQ5W1Q98G,J'"J3HWX*'EY@NM3;]A>&"?RJO0?>7"$UH[ M%\8)0:?!\*0^=R<'IP39[\)11]T;NP/=?N<@G;JQ#N:$']^)0P3'<19>*5A]."!HK!*->E>S)]E2YZ,-$0>.BH-M& M>5+RR*:]4;Q_(WUHAUKM(MQ1S<840:?7.%"B\2-1X3 ,(X1&^\-]W!*-HR"( MQY..$1O[ MW^Y80("BZ5?=5I'X$Y4\_,X-/YR>=+MPZ=J ?7GB>T=@Z,_X&3 M7G7HM%<'Y\(36GMIP9@KY#97C02P7:XLUIOS7%+5DRRJQ%K(;LB#EQ0"Z_TS M@J&]UI%Q3LCI1MJUCI]=ZV[4@^GUX9A08^VHW\4COZM'?2P?(6.HD-M0O:C6 M[>L_$=Q?D^AH&,9Q1QD;RX2>L$S-,H;/+V.OULD76CL'QCJA7JT3\FJ=?*&U M5L=>%*&2U74&(.^P),H8*N0V5=.\L-MYSVX3- MD[S'LO>Z"N8+K9TIX_MPV&O9>_5_OM#:N3#^#S_K->)_*?OHB7JN>/;A[;#Q M=MCM[9ZOCL9[R.9W$$YU>#6!OM#:F3).$??Z0A)[M8R^T-JY,)81NQ?U/*C# MJVNLT+IO,27/8>,S(/T-UISPFR07(*4K%18,8# #^ M!P &0 'AL+W=O'Q3[0XD@B0I$J2?FR7]\A)2L.D/7VQ3*'0(U, M\C2]2!HF5+2Z+*(L.AJ^BJITW),MYRRI\ M0/='NS*T2L8H7#2HK- *#):+Z":[NIUY_^#PI\"M/?H//I.UUH]^<<\74>H) MH<3"^0B,/AN\0RE](*+Q;8@9C4=ZX/'_0_2/(7?*9G*%=03BW_&(JIL2_S$LT3QQ%]/:D M&-"W/3K_#_04/FGE:@N_*([\.3XA)B.=_$#G-C\9\!,S,4RS">1I/CT1;SJF M-PWQIC^0W@3NM+):"L[ZAE <5@8M*M<;= D?A6*J$$S" QF1NL]9^/MF;9VA M_OGG)85Z K.7"?@[=65;5N B:OU99H/1\LVK["*]/I'>;$QO=BKZ_U;O)/IE M;O!9.X0,WKQZGV?Y-1P? 9]QM])".;ACK7!,3N!>%3&\=34&0)Y>W^FF96H? M5MGU.Q"6A ;<.32*2;FGYE5TV_D$E%9GG*ZDL:(4WE!(;9&?(=7EJ Y$2Q1H M!S[W:H/6^;I ?Y) &X=0-3+IZH(9A-^)SL #MLR"GUW(02CX@))MO0LE\X M M57B-!J:I;[AL&EHB##I/M- -G5,0D$:@"0+8Y[@\P&;0M62VY&'+O5 5>#GH MKHJF:ZBI2C3>:/!;)TQH*5COP3!AO;DRVEIHC2X0N?4]^#I+XY3P4GK)B72A ME1J&V%:X&ABYBPVU)[22JA M8#TPIKH"JRJ#E3^&!5YT-XMZO)R3D.40S5-TAD8127(^^WF2ICDX30T"MB:U M ]S+Z65RNGB$MYK4NX@O?WKGM]Q3O2:4<"$[WBLFGJI-;M0L@E-W4%I4)))! MT:/%&MWUVZPE%7>")C52]5YGT_CRH&+\K"5JRL>@HQ>+:GN5Y!*9_;?J%TVV8\&OMZ+T(?^DV<#3>@?9+37=Z M6/@#QB=_^1U02P,$% @ M8FO5DNU<.9?) 7GL !D !X;"]W;W)K M&ULW3UI;]M(EM_U*XB,>R #M$Q2E"BE#\!QDFXO M M5BLA:N=AG>75SR]6=;UY>7I:+5=B'5>C8B-R^.6Z*-=Q#5_+F]-J4XHXH4[K M[#3PO.GI.D[S%[_\1,\NRU]^*IHZ2W-Q63I5LU['Y?:5R(K[GU_X+]2#3^G- MJL8'I[_\M(EOQ)6HOVPN2_AVJD=)TK7(J[3(G5)<__SBS'_Y*L3VU.#W5-Q7 MUF<'=[(HBEO\W/:O2W MM'?8RR*NQ'F1?4V3>O7SB]D+)Q'7<9/5GXK[WX3#H'L$-"Z>2):Y>NXCG_YJ2SNG1);PVCX M@;9*O6%Q:8Z'I?KO@PG.+:N4IO\O0Z7<9Y[9PMET63UVE^XUP6 M6;I,1?73:0WS8:_3I1S[%8\=[!E[[+PO\GI5.6_R1"3M_J>P3KW80"WV5?#H M@._C,U[/+IW_.EM4=0G(\M]]&^;QPO[QD(!> M5IMX*7Y^ 112B?).O/CEKW_QI]Z/CZPVU*L-'QO].X_JT;'[5^Y\*&KA!,Y? M_S(+_.!'Y_ %.*_B*JVPH?7CYY4 (EP6ZTV<;_'!=9K'^3*-,Z>JXUH J=?4 MIX:&Y]S,B4OAP(HV\#=QTIP&*!/H)H!0ZA5]E^-ORA1&VV0P_8W(11EGV19_ M%YN:^^*X7_(4OUWAA+S M2AA'\X0=QEX/_YZ=G9)'_T?CT?.69*DR#UP+)<& M>/X.\@2X5Q;CM*9]FC-#1A>4+XL7?E *-E00M+ MZRW#%\&A9J^ \>3 J;$Q+FP=WPI'Z%EPHW$%W'V#DU2P[KAVXNMKX+]R#[AD MV%R\QB,C0$%[47/7+(T7:0;0ED,E:;7,BJHI:3.P+MPMSKRO#\^2P%K4$?1N M$OOM6PX@$$BV2JU J&\ F%SHF:_+8NV 6&1H5D[2E'@09E#"1D"K(@$,6M8- M+ "@!W*B@GTT&>X-P%+R0/6JJ"PPCA@W-2J=Q]7*>0NRLW(N+)R!_\SN@%_E M5;SDU=ROTN7*PBE8U X@$8%X LO&A(J!Q/J!=8@.Y M13G[EC4B]*)N#$FG6A7W^5/=< ZB)^X#D,\:D!*$=;*KI"!B/]&/56>H,X,& M[SJH(P>K>%5$88B;, N> K5)(USD.;Y[8B7A+_3AS> Z7=Q1I-\MJ@8\*]* M$U%6@'/0)%&XD,"!5\12F!W1H*ZS+G*Q!0(I;P%MKIL\J5R:8RG*&C0E!%%9 MG]0"Z#81"]P^")V&]T8#%65Z ^>;P1@UH!=MC;"Z% )'1[$*IP?,KD)27,@3 M$&;Y="Z 66E^!\C%0P-Z\K%JI%^)3"[=YDV C'5C4W&).!,GJ>2H594N,H$3 M;^*MAI%X %41R046!@QLN8K;TUNP[BZ69H#/C:!S6A95[6RRIL+9RH:0$( % M [D2O^/-IBP>).>YCM.2>S,RTD>-S/8TB<@+T*)BB== 3Z"V ==KRE+D*+E< M)P6NE .S3[$UGA"(RL19$ K<"29NV/B7T=7(28HLBP$GBGR']QR"K, =Z%?0 M:V!+2K&A5J^!0M<+X!'R:>"VA,HJEC#L!28,>>2[/G2-9B$U@:_38.[.PJF+ MK&@C2!G.ML];P5$4C=U9,%5#AH$'_\^<^U@BDDWS\&^)MPH"U*\%@"XG'O.> M2.,]D\9;( VFC*/Q)'+GDQE_";RY&_KMD6--NID2^XRYK>E> ?W1&)]+:*T MUMWUE5@JJKHJ8/@KI$?J]@F0#!0"1!#"5IL)K '9X4(!XL1T)TH&,*IGT (' MI,>(0['-G7$;C+_V8>*0V%"/D-: 63!V7@!+9E8*N@!H5AMF_D23.()D,*#Y M+"7BP0]ZF/L4E@I"#)6]D?-U)?+'IZ4UNSC[&D&W*$K44+%+W]Y(> &_*XM; M49XD G"OE&(S RB7.([47A;-%KXWFX+T"^#-E=1"\$<+/*,=:),8DVPF=JX% M?9$+ W4&8-( =KG0?P?<;J&[1:+++TA8I=C(!HB>8/8NP-V#GP9F54!ZRCQ M=\4E03K>02=89-7 8?&$\,#,(WD9X6:,8CU##0]T3M+.;/QH8<,R [D!BK.@ M7J7!-26I#F4=R =A@\ &0>..@1FWWM,%!AXO'#P60KZ+$HGUB;A M2>S 9Y9ADH0DF2@.IB4(:@RHTEW#S:9P6/7'J94VQ2"L8@DM:W&:2,^2NQ1N M5""CLU0 ,&ENE-MW!1P.GB?(EE6,=T[0&4'T+F'7L&1$;"(@U \7 N4.G,N- M *7R DY>WDS:NT:::2K16A:>6E[D)]@9!_E(V/X6:.DBAPT)^ICR1^Q/JDY% MRJ#40G">4U3&ZW*,!_5S!_JS61"TLMNJB5RMC5"S=XZ]PBK%:(#-C$5GK@&&P%X>SJ MW/E<;-*E,P/Q94_]'I3]IK2N":_-%>32NI!] MIP@OADPO]\11DDQ0O^G'8H MAAF^Q+,_FJ*6UP;$7L1ZK5C=Q7#F@)-N"VU 0J+2>(OX#HPYJ].3JA8;V@Z+ M ]"$4"5S1 SS_-$ 6Q0ET2:HP,LR7:#Z@M:WEP.ZV$Y_U$I2N_]"P&%+_9/& MZB+^%IFEV9Y$2CCW.J7+ME3@%EN[$8Q^C0HC7J+UY5AM#L&&Z(:4B+"""U>" M\J> ,0M"#9H1M&Q -[IVKM(R(=:_M79PG9;K:J2W=PGW[135O-)N9$0/P[Y& M;I(42\(O9,CRTMD =6IU'C8.S*,&"D$0 'FB6+@V>KS(4UBA=2\6ZTU6;(78 MV>H0OT@CP^]Z4>=J?&5SP)L@($%:K1B2]A#(N2JB3?LI+ .7#1R$R#LE"2;! MJF]%E04(0 M0>H4P #NKX281(\VC8:6-1[6-*XS1EO(-IP[ZG&JM]FP0QR8& MXHCF8FJ(,I$7C+M4W/.NX[QUZNV39J&,H[DLT'%*T =+MGO$SE;$L'#:!JZQ M1%;2MR2UHFIW0=4*,-I:[.&+BVU8&A"_BBO6* "#*]O\TZ9VA8"5#7/6JN1= MA'F@62MNF;9J[4M*,7O/SDU1)-@-T-JV+BV*N$Q.Z$11Y=DH"Q[.28PA ?:W MYZ;2N9,(R7QA2N VS!KZ6"&HG,WU-4Z3(ZQ (R>2HCM8C9HZFG6,:+98YKV0 M/%/SRI<#(R.OXN4M6@*-Q#YR M(C>81H/+L_?G'YWS=Q\=?SZ/3ORSO3W\\4#:#W.Z>.1H,.5)D+!AZJNZ6-Y" M0S<:!^[$\P87?_OM;RY*WFZ3P!U/YJX'33X+@ 0H@67O4!/7@Z&"<#[X&F^! M]*Y$>0?J?^6\$S?Q M"?=/#X"UR=.U2.0:@4U?XU83 Z5P/G?GL_E3#2-L-A\/KF C ED6"+0RWH@& ME:=]G4)W,O-A9]/G=1N[D>?1N9R?7X&.D,!I9[+Q%;-_P@CH\:X 30+)# M+\ =!E%OUW Z=L=^N(,!O8UGXZGK^=/#&OMSN%T'_F&-QQ-W/-W%P_ZV 9R$ M+]G#4U:+_P\< OC>OSR'\/W0#0"/GL91# M ,G,9FXT\?[)'")\-H<(Y^XDF#R70TRCR(VBZ/D'K@*PT_,"(''60XPGR6@B0,Q%AC?WA[!=9:HME\+=)K@UTU3ZV^T,.F]8=$&:/MJPE?'O&K%D720B M(R*(RY(,*6WC!=MNOA]OI(>,K;-LW2PUSK"1D0PJ<0)XP]>\BJ4(W2\14JZY MATA Z.M(^^ZQU!8Y]H.3!;N0O9?: RB-;0!J()Z<,$4C+[:%=="JR!FLS9J, M*8\A?POC/_>TVJ4,7&J?T<\H*'@, FDZ+Y1#<-/ K7VI8$&L:6'[M+I.J@/. MC!A-2JPSSK8RHL*,X[;/]"XNTZ*I#,DINB6CT49:*.%JG .\\,J+WB_+L5;' M#Y*42P%,C(.FO+KX_/I,&2U<@\(P KK*F8^@JG8G\H9\ M@K0;LL42G\%3)KK!D"V%.Z6$)D^F+'99)K'*HB'<.L!72AK&U;\WZ@ 7=-LF M;D3(:%P%R[1<-FLY.9L+>LU5,WDD+KL1FF7= M*(.99G+LYP1)5!V,<[3*.*L K_%<:$'I'?(P4&-O9%]K023JV&KM*AJHRYCH MUR">Q>R0B( XZ)B1[@Q7UHAKF3Y2 &BJ+&%IF9RPZ:]#K'T,)V5'=)HG;("_E8^QAAOUE[5U8J?M@AS#4Z^M'?AH0@'0QM1DK2=>1< MM(.JI(L.P -R,B9/F4)[WL )Z!>W+8\=\F!V_F<.>42T"P4>4, !AS_E,EZ4 M#=T'!G026U^2Q M#,HI%N2<0*)$DVZ/?LHMJCX8)2F<%IYU"UCW*QGO%RO"5/>BMG[%>IUXJ+5Y MO64 *K*DVK-#)$B^,@+B%'F"SALYE7A(*[Y NJQYH>;B8H^>]:.E96%8$.]4 M)&TS^V-8W^ E@QCYWB,V)G\%?X ZTT87)LPTUC'PE5*Y5H6*7.ECP"0T]WCX ME&X ^]*^O7;0!",N&B RU(_RY0IAR#Z#'F!IPI2AB(\C&70^Q9!!QHF.^Y\O MSI;H?GSL71#&-XB2C#!2TY*K!"R21%CKP#)FD1S#DM;57C7?N-T5-E9"CTNB M2MH2X:QA(R196UKVX>R2?40,8O:GM)UG6NN0 %K#[:K/2M$)VGLN G70YE#_ MC>YOSZWF2SBX@T)!7BW+=?0B83=[Y0[CYBPEUBX*"IJNO<[M ;K/'=H;,3-LBY=,BF7H0D M)]3+5=M^$SMQ8+IEYZ0DB9@UV[4)C6"!B<.W@YG:4OH92]?+I4-+I'"7>X&3 M,V!3EP'6#5Q%LB@S@+?Q54G?,(T-JKW[?2L?:_T"+E@80\/:VJ:!1TUEG/'J M[-A!VCXP)&!>L5&T=P,]B@6VYY"IPY"P14I\8VH%V2N?AXQOY*W2R3.O@=V+ M![9G=A'U>X'NMJ%NC#D=J.?)OQCDWTB :&!MS/U%!;(8G[UP,O3I4UO%77+% M:B@K1@$8GVN=31X%W5] G^ Y3' G_>@J1?:$QSUC$2CR1+OVEQC8"QI1.RI# MR23!'%]&!F@ZA/[C'5U+(0&98N05W#+.OD2+,NGR*K(3-4N\!\BP9_$ A%L+ M=;VP54Q77F0VM0Q+5K)J248[6P6WHWC4";I:MI*Z1]X7F?@AUB@8<@&:CVN= MH<(M>;-B9;&;LV.'YO3 R:=9@WU))63-ED!GKI[VP+&JR:)&JI'YUD=\(^=U M(Y3U,\U1EX6%V5X+V+)MG-B-]=B)J$D**WCR"3.UVS/@4SH BMSK#.U+R/CI M_.3U"(U#*LUE)U%J_ZIQ0)D!4YD\,G7CL,B7MG=/&3,F$H8#B\&<$UK2J01=W>>7:MD)FXP7MUR/7#, M+_$:2FS%*$U]A[X'BN:L#FE6!A@H XQA[%TU1C)+C$0#ZBV2(BMNM@PI>>%L MNLYVQ1IS@3>+N"2.1,WG&* Q@0^:XK[_I>X :SF?DTV!.>,-"AMKO#1-#1 MXW\'YUHU?X7JG+UEU1Q#DCPWBN:[3P;H$H]/=[9@Y@PF*'?09!*X43CK?G\:>6%LS\("_CH@ MOJ&2-X@#S";N9!+"9]]W UA]!+ _PA",,)RX03"%+^$,4,UW)\%<]KQ\B\Z1P0A/QW* MR4 F3H/)[I.G.%F HGAB?=S/R:8^,?;.]P.P%S8R"SM?NYQLYDXC1"+D._[4 M];&5'\&78(:HY48S_ 4P*I@#5H&:T\?)GC\(FH_I.D.I+ XGXA>EM&3IPA36 MO:Q/R50LSE8VA]*XU?%.29.(=4.!>YIU^62=^U@GQ;52L]&@EW244M:*[4WH M//6\R"F HI7(?_C -E=_Z;R*,ZJ/P8KQ9QSR<FZI/S 6Y+KS%7*UU0DC<] MD)>;A+Z8T+=+96X_=897E$[6'OYY1R'_E47@#W?#Q&$+/@. MG3 (PYUG? > 7SH"S)K$2)=OW>FNG%)[;*O;2B9][SP[(VF!Q +H^\='A5R- M_0CJ&\%UZ-!#3&#HQ4*CSNLV3PI!(_2>/!J)?* 2SR9&U1TJI#RVK@+O%'H @IM%/HP-EP6IC-4?>&QV;FY3-B-=Z6P1?.6&#UT(9.0-O7(U8); M2"G7$6!]#(N91(M/22@>T4X"$-;1&+:-R08S$MVHU5NP[NC[=J;M\< 9ZVMQW,-]'RSMOQA^/A_&Q)0FYZ2$R*O2 M;-D]*+>#Y<".%[H>#%-3+,-C5A "3@8=/QS/5 MHG5TL,^IY_K3I^<91BPDX/8[GH.LLM 3+C#P(PJ3"5SV0% -??QI M\H3 ^M;#G&G"1+K:<%R9-C,IBS6 M:545()"X,;F"XY3J Y&4T_D@7*VI,D'5=K3):("GH6=\^\FYN#""K)6:9HU# M8=L?/KUYJ_WQJYAB:^R[+2?7DZ?$A9".F])Q+(WEBJ)9%BXU.3 P(*+#45O MLU\-8_%2F?=D>YVY(E_#KO=*D#Q&@6W)\22N,0 ZU=E?T@&K7,MRPURRS>S8 MQ,JTPR%'CR6?51P"J0HSJ%""M'Y.5IH)I[#UD9&E0I"[4!E,8>,Z@@'Z)(TL M+J,*!R)62BCJP)JA&-V,8!@*J67/.+NQCU6($Y<*%(D*-Y9C84A%UZ'6@]D2*7*G-5ZXMZ]'CYV\ UC]X)Z;)IP8$-_=[]U#$BP_[1S ML 9[YD$\X0I]0@EF)V[7_RD)I>-7[_&:*O"I@IC?ZT"U#+\FBQJ5^TYW$QY9 MB^4J3P'(SI>>W7WBB)EK_L[##4'S']Y3.65DHL!]XQO1U@NDKP$4HA"D]VN3 M7*+K2SKO=>[)F4J>4NU@5N!!J@&52N4$G7 TG_W@G#CSD0]_A]'(F_UP[$Q& M4^^!GLXG#\[0B4:1UY7:]H7P(P?Y7,H(I??(EYW?3?)BZ-$<\.]P.OGAN*6J M.J"O!^@=/GQ7GZWR2ARX$7'Z_K=_G%P6E\X; M/ (JA"/''QZMUWCG7&(IEBT/^.'T#/2 $6W4'^/?H1_ 'U#31\$$@1G2WZ%S MY(U L3C!OW.XW\.?20":PCSP1Q,)*=^#/T?!K/=BA3G;TPEH(D$_P-H;]3V8 M5BUJBJOR1S#)\;Z;BC2 ?3C[W3G#B%Z,Q6J/&,'ZO1^T(F4NYOM)98>L_A>H M)42=RPW"/5#Z-F*)Q@C*V6@^1E0>S<9$+),)$\L,SQ=IY6%'Q[4-,;W4\A1. M6]3T"=/A&$^S[5ZUJ0CY1$"#=?60&L YN!03*N=!;13H .90Z*37#&?S*Z^'=-)K,GN<4V;B+KCZ *"+(M!FS%XL,*A'A2HR@GN6G]S^8V_Y[>EF MZ>XVDC,JB,F!X-@2H .ZL&Y5XB3F=8N^\H\+7:%V(2AC60*W3:TRE+Z5B[G! M6VE=FU']>>CAVPE<*IR*A65U!8ENT@#AL15(3YEW&X$%%8BN )4WP-2JD=3F MVL1E,O8D9%V;V)3!QB!SM1?QTUP?CL$W>A$%+HT(R:[R2UXN4OJ(D1=$%WA= ME\"7,>U<9V"G&+Q*01XY7Q&7*3%=]EPTE$R&298POV!8:_M ;U9]9UE62IHI M_8]VATRHT?5L]W+Z]G3:+O3-TU'F#J;:%FN9+\I8P''JIH[R$^53$#D(?CHI MNQ+6\2BK9\=[V,H^Z%T>%A(IW52?D&/NI!PKUZ,>T^!V^U4%.C6(POAED@7:+:_1X"4+0R\)IV0J$:9L MQ$BC5F>91X,9NM)LQ/F:5&S)%+AYTIC'V2S["VQC?61)0J-V%)_%P*SG+<:& M&Y=52Z1Q%O=#&5&8$SAR/BD/*F7R.L.,"ET?.T7>8BE4LIMS;[$$F$FQ6JBW M!NG2&%BCO2:13V*.LQMHZD71>F>%+KA%$*!W#ER+A$H$R9)6=?Q@,:K+>!NK MHL/VVDQB*;^W!RW1O0UI$\\JV*Y>+%$:]WRM2D2P/F E-E/JKDBD%537%[?T M!%O(VB\W>G/K@9^W(L3XN%$3='Z/)3E^D]D?,,Q%I0K MA=+-E2)?[98PHEPTL4Z;-=> B!\X^(&3CDV1L\<2?;$42B/?*T"'B&7'J!!T MS2]*0(*0AF1QQUET5),=LX9,]0JN0HH3$L0X=:TMR0A-/C_SV=*T1P(JZ;4 1!I]C>1/G M"K+X_",F6.& YP7>C5N_+PMY76:?74>]L=[-JDV)%>_ODJY&O\F$NB+ZT-9[95A48::UK!P4Z ^*N5'HP]/5_H 63R>:F M+*BJA>1UE$6#E7CPV-;QSR^-4]'F,0 MH?#WS-A]9<\;5;CN$L[P"HF(7H/1P^B(&5;*0V;>]Q!,/16_H ?;Z,':?CKV MDENA<,QND.NWB*YK>2<=9BG?)9 UZFAL3Z3U)CF/.+&Q"H5)GG3?7'3G#>12Y,S_BT W7#R>NYT>#K]UMM2(>6D4: MY^YT/L=BX330X"45\)CV:8]PL@LE6(HW\CU:!WSP6_%Y5>?;GB*Q M1%\H-RE$0E8R%N=2+R1B_*4)L0)2%R4,$%H_N9::E:[7 MF 13$T. MLI_/XRX\HU'?8BEHEU(RX@$P=FCCK"FGP>X;PS .J!32LH'T++-NO>D#F0M> MX:@6G_U.U[+("PRLD:_AR26?-J?\]NSJ%8D[6+?5\0HY!%JWG"\;JAFC:H>> M77VA3_BVDP_%B$8Z\0!QK"_VYU'?RW-/K7<>4V7*?D]O3JD L:^AJS>*)B^-*P/VJQ ;P M^W4!^H3\@A/H5VK_\C]02P,$% @ M8FO5B>J)KGG!0 >A !D !X M;"]W;W)K&ULQ9A;3QLY%,??^116VEVUTC3Q9:X4 MD""%+1)=(:#;A]4^F(F3C)@99VT'RG[Z_=N3!"@A!5557Q+?SO&Y_'P<9^=& MFRL[5U+G9]F!@RZEJI.WKF6HQ,]:FD0Y=,QG8F5%R%(2:>L I M30>-K-K>WDX8.S5[.WKNZJI5IX;8>=-(FWA/+K6^\IWC MT6Z/>H-4K4KG-4A\7:NAJFNO"&;\N]#96VWI!>^WE]J/@N_PY5):-=3UEVKD MIKN]O$=&:BSGM3O3-Q_5PI_$ZRMU;<,GN>G6BJ1'RKEUNED(PX*F:KMO^741 MAWL".7U"@"\$>+"[VRA8^4$ZN;=C] TQ?C6T^49P-4C#N*KU23EW!K,5Y-S> M<7NMK$.4'3G5QHUU7>F=@8-F/S\H%UH..BW\"2V"?-*MFUIRV([4Z*'\ !:M MS.)+LP[X1H6?I.D3P2+"*1<;](F5FR+H$T_H.P?,HWFMB!Z3.Y[)N)W(Q500MG-FJG1 G+Q$[.]4WECC,E+J9:5N%)Y':LRBE@B3]'"L. M6V4FMX1!B$4%3\ECZ^[EX<(@4):\.3L\OK!O(44Y3"\8X7T&J4]J5,G!(]NQ M:UI$"2\(#08/4< Q!7MC'B648MA++SR$B3S-,1;BH!T,Z2**,,9YE"'\7A6C MBQ6_$H@/JE3-)>*[8(*_B EDDB*$64SB(OCR@ EDB8F(%3$#$^(E3##LDR%#_6(3$X+1 M*$GY\YDHUC.1($B%B#*6;&8BW.[5?ZH#0S8H*>B-@(AU1+:C,'POO<_')5#B MUX^7,>TF\>E'OZT:^ZNMAW[KM.'%4&PB>5 M:A$##PJBGB!&KTD>%2F+1(%XY*$*/*$!?0VW@PH6Q7F"N N?OXQVV/4YA(,5 M[PYD>071H *G"4$4H"D!&QD*&UUD9JC-3!O/QP$T>[!$ED0\3DG(*5H)Z&-A M9=-X@)TNKRQ!R:()N,F\(SE(YG%!>-Y/L/+D9 C:G,(M@6B#F0S5CQ6I;[(T MCF*!I32@=HH?3LIX%Q=Z<89R7D1%[L\%OM#-<\+C0-P7:8ST=VT6PX68L!2U MD3&X(M9 1OU<)&+Q@BKTRXA;4Y9^!G1QE,8):ECJ.X@'<@V3E^7J&=2ANF1I M1!//1XI:(S).NOOO^]11D3Y-78(,Y;A,P54<%>!J'74,2C+4/LH)P_7DW0$& M(@UT/,1.1&F*&LMP>V-1 3XYR4,9_1YS:8;]*>$\P/R(.2"9"?$$FXF81+'#'M0@9,:0/K<5B[$%RG&]9"AM/ERQTB1K0O;FM/IM=Z[ ML4:JU7BR2*^U:LGG\P^D_U-^6&Z,YII#^F,!O3L1CP.*RT'X,APH?!C0Q%.* M:6"(@";/NF"_&] ^6??4&-Q[#^+'R22\>BV".V]=]S1UOO=>_)N>?%U>:H>W:FA.E1PIXQ=@?JSQVEAT_ :K MOQOV_@=02P,$% @ M8FO5J$J1;].$ I#8 !D !X;"]W;W)K&UL[5O;DMLXDGWW5R!J:B?L"%I%4M2M?8DHV]TQO;'3 M[7'WS,3&QCY (E3BFB0T %ER[=?OR01X%4MV7[RS#_MB2Q202!QDGKR ]?*D MS4=[4*H2GXJ\M*^N#E5U_.;FQNX.JI!VIH^JQ"][;0I9X:NYN[%'HV3*DXK\ M)@[#Y4TAL_+J]4M^]MZ\?JGK*L]*]=X(6Q>%- ]O5*Y/KZZBJ^;!A^SN4-&# MF]9T$[ MV6K]D;Y\G[ZZ"DDAE:M=11(D_KM7;U6>DR"H\0\O\ZI=DB;V/S?2O^.]8R]; M:=5;G?\]2ZO#JZOUE4C57M9Y]4&?_J3\?A8D;Z=SR_^*DQN;)%=B5]M*%WXR M-"BRTOTO/WD<>A/6X2,38C\A9KW=0JSE.UG)UR^-/@E#HR&-/O!6>3:4RTHZ ME)\J@U\SS*M>?U"YK%0JWDM3/8B?C2RM9+RLD&4J;@V>W"F<0F5?WE18D*;= M[+SP-TYX_(CPN?BS+JN#%=^6J4J'\V^@:*MMW&C[)KXH\,_2S,0\"D0[4JRMXBE7F7EV]_N,? MHF7XXH+22:MTL?(RA9=E=/1$%YT6TW)O>Z/!,1,BC1+J M'[7,1:7%4XD'3")PX5(ZB,0>:.QDOJL=J!*; 5N5)4V"7"7T7L2S\%_H?UI: MWBN#N>)>YK5J'HZAN3/:0FEK%2"&2!JCL#T_O#II46A;@5=WT"%_$#L(R!4I M %TP4AH!M4VEC#O4IUO"!Y#3>$*&U*:M0&8YJ<)1&0X:F#$3W^[WB@E8_&M= M*K$@%XY6 4^\>#B\.(UZ#&IQ4L!8XB,XAE!6GW9YG1*F]L"S^0,.(;NGG9') M&5VPS 9V$@AD!J"17=*88VV.VC+0[?#R;MKV1O8#J4#)SL1W7E9U@-( GDG1 M*0Q*VQU:3F,1@T=QT >7\*^-P;RI]6DQ<90/QCWA#:VWOX7 M\* Y3BE>L] ?ZH*3I655*3EL=X'6VQD&R+FRD&K^:$^8WAQ0 M%7V?L>$>O)?VUCQE>2ZV2N19D57.N)D &!HZ499_KW-\E2:#%S=HT9*7-XKG M+)ZPW\G:*A:-W.PQ1GD,_6#*Y /Q(^U5?/L)V:.%,D^EI60)T2;UA.X9U(\0 M_T9[=%3S067%MC;611!/I< !">2SP.T(GM##R3F]4HXH1M0YGR6..QO>['MY MGYC>@0J++32+PSX[-2?NW)5T; #W<+-O#2"9@=(:FJ18]S/$#(ESAU@)Q"R# M#2X^@FDQC0;N,P->I@>!.!TR''!F*?U5[/;8*I!T1[75)LU*#AI#Z9IY6A>P M+\SMQQ9@U_"#9_><. 5V;\B&';H?=.I>^^0D[6>T.S^MC M0K!8W'LO M3-98ZV/QET,YPVLEC5L%:[D 4EN%*$01-P8;:AZL#B63Y ME7U$51(+MF&3V$ \!2?51XJ,+*P-,9^-=\_("J &Z3<^B&FW'-C5<#L."O9S MGX1,2,"F\NR_.?#W)A,X$A5(P0'OGF-]YDG%U8+843 PKC$L[(S'8Y[M&$%' MP %G&C5-*!4?H81V9SKD\%&B#? C.;85N2*G+;2IW#@D+RYAJ\NSR:F"W>PR M#_K4/@(GCS6\ _1W1!8=KQ*_0,1]IFL+!SG*;(S. ';ON4V,9KSE;F>0GC59 MQ(79_IA@?&1)!H87M,S/*SM"H^#\&U;IZNRW(GR MPBE9W%4,:+OP5\G0KD,>2W'JKG1@XTM:NW8$?@680S.:(*1A=)1^=^ M_84/<$!G#^F726=.:ZS_=XN$8\_X0??2H(,D#U2J=)8]/LG1.8[LQA',\#AF MX[J :TLD#[5TB<'ETH'6[RTQ!!3<2RKY9,0.="&/4TUR4P(O:PD&3E.K0>W# M>5I311I?.7O%QE0\RJ3(?#1$\3=/,AU)N62QERJUCD*_D >X WD:/9M>+,^U M9V9B51>?-$[QH*0C!LY7NVVVECW*A6%&?K]<&%%6L\VS.Z=UCT(>/0:N+^-G M(FQ2M4EU)]*W0#QUU1XM_&B]]\PAUZI+QX!?F\R 8:@<:A16VL2Z/;7A:76\ MI;E08%,'I6BD!CQ/=NHAAJBRIGRXR@K5K-5T2FY@+0YC&+[5)1]&H2J3[?QI MO]'2I"S--A;8#2V)Y!IE!Y9@AY7YEMJU%2(, F/E,*)L(*L>SO<*Y2E 2]-9 M*:@^*]AL&9X1&F0TVZ;.LLCBP8!OG])G,ZG10C!\I8J$ !9L+BXF3KO.4%@(1,MK0 MWOU(VE,F,D*C\FCP8-Y^#SV$#:1V""03"C*$+J1H8ESOMTQ[(UXCTC@[!$D^ M14Q*-O^(2U D]]T*+])*6!G[%\DPBCS;.:RSL]YFWKQ[^W4Z$Q/EX*6FQ"(. MYK'O22PVP3*,OJ E,6R?374 6BQ;^OI:;8DOUR7XG#+_WYOX=;V)7]Z0^+_; M1YAH'_YH[B0RR"XI^!&+&;*=MYJ:"(/?=_P(WLA-T'Y0HYZ 2-P S-H8U5_ M2(Y<,._Q4)L$3#34= V->RM[2(VO6H9&^7LP38-@FJ5L&LPXY&ZPV($F'@.* MT!BP50>9[V<=:$.$W):=C<#B"TT29.Y'=0BX[T,(7'\8RF\>%#^M::/4(CCK%&HGFGB MP.6<>&MJLK,H88MBHC&)!DVQ\JM@5#^JA;@(PDWD?[/.=2F0DX.^]]D%3!W^ZV]NWB'3==GIM]2G2OU7Y$Z: M#@)3E]\LYB+M-RA[4^@R76-X_V[VZP+PG #?+E4LVYL%J/LHUFHZ9 M47SY28&>(T&;MC<8#04/,^(+-@I/. &^4O<2 >\-CZH]$Y]MD0\*WAX4[+K> MQ(?=F5XM1 1BVHZ(K]RASU!0; MGA6EPW3K"+K+W$']ZKS+;Z>)]F;H[H[?+XG_3,;5ZUA.HM%BY8KDC0-+ M__P\$F0^U2^LF.$OG$]2;:!*M%XGOQ6YE3)R=H[Z+]@Y8@ M*Y)F'1T&,%&^5''I15,PG"<.E_6EI5+=Y#DLR@/PN>OF1XJ$-+.[VK(=2)-G MKF_C7NSP%T\:-'=B!3TC[>G=*=NV<]T).O/IV'9 1!3C6YN_U+=K#J0 B6P5 MW55]46TS>_*>2R4?+OZ=MO+0-YD!]S2_3]CL^]#X,)BU_D_9?IO*3MOQH0B:4V43S(%Z1 MSHOY(EBN-O@T7R$9VB3T:QS$*+O&$Q=/?E+'RC\*6UG+U3J8STG6'!,WBP4A ML49RM5HS$DFP1(0]F[IXPD5>3U R3X(P(E6@&O(:GKX,@U44D5)KR Y%?])B M> 0D(XX \X:/8!$&T9R464;!:AEU'P:3%O\;ICY&$O^>X8%G_;U%Y[E.]$_Q MD5]I983W&O:P3$*RLLT*]L!'NUD$,9_&)L%IQ&?8).=6QF>WA'$LV$R6\V"Q M;$!<3S%B 0'/!G#/AZ84BGA!RR_% M*@Y6\(YHG?#&FM):[&^/' M4TWE-.&\@'L5)26>)365;6WX5JOM"5Y,HCEG=?4KI1N*FV2"ZS\_?9#==K4$ MW\!WUU(7$U0(WM=5;53WQB*GME3<=@GC)3V['K,]T&7$*/'JTFR^','\ZCP1 MA;?TNYW=5OH%*\'>NZYV;SD$3?7=Y:C#UO-,_("R^?MR1W<_GA :A=_V];E% MW9]G*#7L5VBW_ MC?[$-V8YF4AFN^;5F1&YAMA9NW30"WH$5V$SW+MQ@(F'N-3V^BSRPAK1) MV/7Q\6U5-UG7^$X!Z/JC5H]',^<&7IQ-_1"=]/6:QY.]4%< M2VJ#V/5L$JC'UK*4J"S68^5FO8\9Q4^+_771U^2 M[W@>[[Z]ZNU9MD2;.I3\\^ A';&AZL MK!T>#RV,_7*]"[E-N\NZES_.KZ-96QI%VY#B'DHK=U$^WOHNI^:)G>[+%Q(4 M4!=D<]I2;&H;%13=^G\AP>\<'HF:J5'2QC)(SXH>>%O%--4BW=\C=^>XOPA( M5= T=[:]N_N9F/K3DYO>7PX5"M9(?Q]%_ 2:.7MK)U1Y3P]EJ<>6,H_E2Z2/_'=)65Y4N^".]::(,#<#O>ZVKY@LMT/YA MVNO_ 5!+ P04 " "UB:]6$+JTE7]\S)%?6.HY1%'VP5R*'PW/.7$@=KZR[\S51$.M&&W\R MJD-HWT\FOJBID7YL6S*8J:QK9,"K6TQ\ZTB6<5&C)[/I],VDDD[>IDM#_:#ERK11UX8')ZW,H%W5#XTEXYO$UZ+Z5J MR'AEC7!4G8S.]M^?'[)]-/A#TC<2)56RT^':KCY1YO.: M_156^_A?K)+MP9N1*#H?;),7 T&C3/J5ZZS#8,&[Z4\6S/*"6<2=-HHH/\@@ M3X^=70G'UO#&#Y%J7 UPRG!0;H+#K,*Z7(Z^XG3 _'9FE![\8LIJ=Q=/P' 'N5LB_)\]J3#S]*- MQ<'^GIA-9P=/^#OH61]$?P<_\3<@^D'Y0EO?.1)_G/NZ1 M:^>];V5!)R,4AR>WI-'I\V?[;Z9'3^ ][/$>/N7]OT;I2:>/0Q:_V4#BM7C^ M[-UL?W8D_L7.XK8F<6&;5IJ-J*47L>2H%,&*.8F 7L%OL!=5=J22HP!';>=: MZ\GO"6E*3 0RI>>EWSJI5;7!L,&3WL# "RFN+R]$A[1RXJ:;%[5L QX_"UN) M$&&4-!:W5G _"O@3*OCL2A4)[M;-7EZ1@#>H-6S16+,0%A,.L\HL@*OAWEB0 MB^Z\[5Q!KVSU*G-@\H#!:8,U@)''F4TA6Q5 =X&5/LM1*N28FG\CAA6\_P=5>2> &(0J(JC U"JT:E MB+Z$P9)\0%^&L#@,I%'?,0-16^F"(>=KU?H8[=WP!LM2. J=@XPKV6),6VF& M#A,9E"-6<&\EY^"[[(C%6TE?"R\UIY0T7L:V[L?BF@HMO>\#["/L1I9QU2#& M,:??'OD^+BQWQSQ@A\. TW88OA0VN91*1TV94Q\^SJ07&+B?WGIE^'AQ;F.7 MD.-E3M?_(9;;>+D?&-=RR9$2"D1! M@,A8&RF=8>EJ(4.&")' @DM??XD=? M+_XOI8;H?5%%^<8IUZ4N,EZ>?W0;T8* KSD,2&IV\5$99+6".I]P3&H^*J%Z M9$?KF'">[@TUA3NMVIV7&\5A"P+(M(9:[B4G#NW"F9'3?^9T]S\E0I4(* MJY)SI=5V?W94]4'P 3IEC:\'%+&#''H:.MHDHM" L3)2U&[//8J2*P6DQ\,$Z2N?4:86E+J$[^9?,YN''K'Z$J>1,]#KFI9D4! W M."15D3J!Y"Q7MDQ5XHCU]:@.L2'IX+T*J>@W<:-*:2IW,/71BP&",6HH1A7W M;:F9PAZG*BRY:K7,Z=&9?ET9Z0P#+?TPT3BKC.]K\*8/.D/^'>AE[J ?4DK% MJHA,FG1]([Z^"5R^<'YL;U\1XL[0;/<@+549SPP Z1S#OV<'U7IRN%5TCCL= MAQ^'K#3X!H@]9+?K<*)([6WT*5>LI8VJ/*@E#DDZZ9"V,?^DMP8=9L-&7G&K M07:E\DYG$0[[+JOQ@ZI]*<76XA6FN-N: '\X[LVBE]70.HC]6=9L+!Z[[DT& M%_2&W")^AN"0X/W37;T?[;]TSM(%_]X\?29!^@5W;DT5ED[';U^/A$N?'NDE MV#9>]^&PO=V]R:W-H965T VK:6P#FU*5:C?-9K/GT]K89G1VHM\NP]F)[Y*S#5\&BEU=F["Y8.?7IZ/Y M:/OARJZJ)!^F9R>M6?%'3K^WEP%OTYV5TM;<1.L;"KP\'9W/7UT0F\FOO_K!EJDY'+T=4\M)T+EWY]2\\Q/-,[!7>1?U+ZUXV>S:BHHO)UX,R M$-2VZ?^;FR$/>PHO9_?.ELVM"? MYWE, 6SXZZX8>Q-'=YN0#GD56U/PZ0@M$#E<\^CL\0_SY[/C!P >[0 >/63] M/]7B04MWXZ0//C$]I\<_O,SFV3'=YXY^1;/0E\Z$Q,%MA/0VCBE53*]]W9IF M0[9)W)21DB>_7'*0AW!K*(KEB",J?%VC]T#CXC/)0U=4!+-U)!/!8UAG-)%\ M00@EY1OU<^%-*.&%;(IBHW40(=.49/+H78>7TL8BL'9VUSB.0 AY4?Z[*U<8 M&TG\ES:@_7V(M*X\2;R-3YJ!;'8L40!G@M^60_1-U(/YL6CNA_L$6-'IBG!P M,O_I:$;G17HZ[F.ZC1ZN?.=*=83@!OD:J\*P&'?!@L M75OOC,3?MLX6)G=,SJPG]-L>Q+5U#IEJRJY(7R/J:Q0%BBD*'TK3% R-5"F( MP&B,P)(R!7;5P<%\P3\>'7@HNA @X@ZJ[VQMDUIINCH'$:!_3_4AG?,>JI+* M+MAF16K<.)@T@39LE$W?91*N"]/L1[H+J@V^8 9(R( "C-$?:1E\K:<1[AZP MVV&"!>4>6):"S;O4WT&V@9FDY&J=:29TW@>_1\:ALLK@PZ81MAL7/74 6IA8 M24-4(/6X?S/7QCJMKN+,?<#\0(*B$E]%],!9U*LT6V^141F;+$N!M_"TO08H M2.SV<8]!8+SUY7@3EE:<7E84Q*N_]% B'E7028SR:S1UO<:[U<(6VN M.6!7^+8C[!\Q(6]"L*$%6P0<#AV-I2[@K.N.^ M([C*I(/L#'UWF.-AZ,G($J].(MO&J9G4RD:9'Q)P[J_YL-6_-7RE^>]!"'Q& M\H#V?V*?ZHA2'$#>YZC!&FABQ-]KXSIE26^+GLCQ,#@_G'^B2YSH#3+,S*?W MS;0# W?2,^ZHI.)5M+2.ZB5(87]O:*-B"XI97;'5OLC4'\'R9S5":%&]M+:#I>CI!!% M2-A,Q]2U@+J8P<,F#@$+5.3WL&3#8!:ZHS5OKU8II%)*RK@4$%!:VH"[8A"2 M(&3_Z5O_+>4+?JU"!":9!WQ;>:@@,T)86='O>:8W@Z64Q48!.S7-'%= M#J+;+>NPN??;=+:E%/+: IFXT0&)(E1:)\Q DULG*]:_TS:AN_:CZ=[>6G-8 MZ78NC$%0_0J[^[K[ 7#>[[VWXOVO!\2QLN@:QTNHSB8OL&^'?B/O7Y)O=0O. M?<).K8\5?L1P$ &<+SWZ;7@1![N?16?_ %!+ P04 " "UB:]6;8<@N+P$ M #R"@ &0 'AL+W=OPQ4[I?*TBEGXS"8UG M522CVDQFT^FG2:VTS9;7Z=V#7UZ[-AIM^<%3:.M:^9<;-FZWR$ZRX<4WO:FB MO)@LKQNUX4>.WYL'C]5DCU+HFFW0SI+G)9.W< MDRR^%(ML*H38&QY5LV1H! XT>/F>U=BN'X_X!^GV)'+&L5^-:9/W41 MJT5VD5'!I6I-_.9VOW ?SYG@YV,PJ+7MGNJYUV%D M<#%]PV#6&\P2[\Y18GFGHEI>>[!)G]2J,D:Y+25I#Q&CUT-N[C\G#OK M:IW3'2//!=O\A90MZ-;5M8Y0/X9^;:.V&^QK#M>3"-<",,E[-S>=F]D;;N;T M%0!5H,_P41S:3T!YSWLV\+Z9O0OX5?ECFI\9.B@P'[+V?+CAY-/TZMW M0CC=AW#Z'OK_E\IWW;P>!/WF(M,Y??QP,3N97=%_XD*_5TRK8JL!2I4*A&/L MN2!MHR-%C_"E>4"!2'\T47_DB= M5/'G5X$>(S+208/)*@3N:_Q7K=9:8F,(\*AMG@H#ZHS9B,;\W*!24IR0!L%# M6"J\VEEJ&XE(W$87D[Z#*:G:M7@4#ER%IT41AP"%S LXIQ;%=ME&F5ZY"M50 MDLEQ5W5#IJ7I0EN6&NT((Z-QL(#4HHV(]&_B2&F*%_,8&1P&\F']5$I*F=HA M"P6OXR'&ES>*9RB<0[PT%D(W%3!GTC3NI%;#8$ V*Q73+BXFF!U;",((!*![ M45*I=88[Y3UF@^0[&0Z5@J[2L GV5=M[7DL?M62+B^ MUVQ$#;7:VB?K=DBI$H=XL7.M*886VV?+*%WWC/HFK%4A6 @J',R&[E"EMEVQ MNCQO/3KG,+UK-IJW*48,)AV>1 [<;-AKQ.C6IF^_<,"\C[T3QPD)W.2.7_M@ M34;WD)K])MVV@N33QNY*LG^[O]"MNGO,S^/=;1#UM$&,�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end XML 58 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 59 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 60 FilingSummary.xml IDEA: XBRL DOCUMENT 3.23.1 html 735 262 1 true 226 0 false 5 false false R1.htm 1001 - Document - Cover Page Sheet http://www.npci.com/role/CoverPage Cover Page Cover 1 false false R2.htm 1002 - Statement - Statements of Assets and Liabilities Sheet http://www.npci.com/role/StatementsOfAssetsAndLiabilities Statements of Assets and Liabilities Statements 2 false false R3.htm 1003 - Statement - Statements of Assets and Liabilities (Parenthetical) Sheet http://www.npci.com/role/StatementsOfAssetsAndLiabilitiesParenthetical Statements of Assets and Liabilities (Parenthetical) Statements 3 false false R4.htm 1004 - Statement - Statements of Operations Sheet http://www.npci.com/role/StatementsOfOperations Statements of Operations Statements 4 false false R5.htm 1005 - Statement - Statements of Changes in Net Assets Sheet http://www.npci.com/role/StatementsOfChangesInNetAssets Statements of Changes in Net Assets Statements 5 false false R6.htm 1006 - Statement - Statements of Cash Flows Sheet http://www.npci.com/role/StatementsOfCashFlows Statements of Cash Flows Statements 6 false false R7.htm 1007 - Statement - Schedule of Investments Sheet http://www.npci.com/role/ScheduleOfInvestments Schedule of Investments Statements 7 false false R8.htm 1008 - Statement - Schedule of Investments 1 Sheet http://www.npci.com/role/ScheduleOfInvestments1 Schedule of Investments 1 Statements 8 false false R9.htm 1009 - Statement - Schedule of Investments 2 Sheet http://www.npci.com/role/ScheduleOfInvestments2 Schedule of Investments 2 Statements 9 false false R10.htm 1010 - Statement - Schedule of Investments (Parenthentical) Sheet http://www.npci.com/role/ScheduleOfInvestmentsParenthentical Schedule of Investments (Parenthentical) Statements 10 false false R11.htm 1011 - Disclosure - Organization Sheet http://www.npci.com/role/Organization Organization Notes 11 false false R12.htm 1012 - Disclosure - Summary of Significant Accounting Policies Sheet http://www.npci.com/role/SummaryOfSignificantAccountingPolicies Summary of Significant Accounting Policies Notes 12 false false R13.htm 1013 - Disclosure - Investment Portfolio Sheet http://www.npci.com/role/InvestmentPortfolio Investment Portfolio Notes 13 false false R14.htm 1014 - Disclosure - Related Party Transactions and Arrangements Sheet http://www.npci.com/role/RelatedPartyTransactionsAndArrangements Related Party Transactions and Arrangements Notes 14 false false R15.htm 1015 - Disclosure - U.S. Federal Income Tax Information Sheet http://www.npci.com/role/USFederalIncomeTaxInformation U.S. Federal Income Tax Information Notes 15 false false R16.htm 1016 - Disclosure - Share Repurchase Program Sheet http://www.npci.com/role/ShareRepurchaseProgram Share Repurchase Program Notes 16 false false R17.htm 1017 - Disclosure - Economic Dependency and Commitments and Contingencies Sheet http://www.npci.com/role/EconomicDependencyAndCommitmentsAndContingencies Economic Dependency and Commitments and Contingencies Notes 17 false false R18.htm 1018 - Disclosure - Market and Other Risk Factors Sheet http://www.npci.com/role/MarketAndOtherRiskFactors Market and Other Risk Factors Notes 18 false false R19.htm 1019 - Disclosure - Affiliated Investments Sheet http://www.npci.com/role/AffiliatedInvestments Affiliated Investments Notes 19 false false R20.htm 1020 - Disclosure - Financial Highlights Sheet http://www.npci.com/role/FinancialHighlights Financial Highlights Notes 20 false false R21.htm 1021 - Disclosure - Subsequent Events Sheet http://www.npci.com/role/SubsequentEvents Subsequent Events Notes 21 false false R22.htm 1022 - Disclosure - Summary of Significant Accounting Policies (Policies) Sheet http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesPolicies Summary of Significant Accounting Policies (Policies) Policies http://www.npci.com/role/SummaryOfSignificantAccountingPolicies 22 false false R23.htm 1023 - Disclosure - Summary of Significant Accounting Policies (Tables) Sheet http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesTables Summary of Significant Accounting Policies (Tables) Tables http://www.npci.com/role/SummaryOfSignificantAccountingPolicies 23 false false R24.htm 1024 - Disclosure - Investment Portfolio (Tables) Sheet http://www.npci.com/role/InvestmentPortfolioTables Investment Portfolio (Tables) Tables http://www.npci.com/role/InvestmentPortfolio 24 false false R25.htm 1025 - Disclosure - Related Party Transactions and Arrangements (Tables) Sheet http://www.npci.com/role/RelatedPartyTransactionsAndArrangementsTables Related Party Transactions and Arrangements (Tables) Tables http://www.npci.com/role/RelatedPartyTransactionsAndArrangements 25 false false R26.htm 1026 - Disclosure - Affiliated Investments (Tables) Sheet http://www.npci.com/role/AffiliatedInvestmentsTables Affiliated Investments (Tables) Tables http://www.npci.com/role/AffiliatedInvestments 26 false false R27.htm 1027 - Disclosure - Financial Highlights (Tables) Sheet http://www.npci.com/role/FinancialHighlightsTables Financial Highlights (Tables) Tables http://www.npci.com/role/FinancialHighlights 27 false false R28.htm 1028 - Disclosure - Organization - Additional Information (Detail) Sheet http://www.npci.com/role/OrganizationAdditionalInformationDetail Organization - Additional Information (Detail) Details 28 false false R29.htm 1029 - Disclosure - Summary of Significant Accounting Policies - Additional Information (Detail) Sheet http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail Summary of Significant Accounting Policies - Additional Information (Detail) Details 29 false false R30.htm 1030 - Disclosure - Summary of Significant Accounting Policies - Summary of Investments Using Significant Unobservable Input (Detail) Sheet http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfInvestmentsUsingSignificantUnobservableInputDetail Summary of Significant Accounting Policies - Summary of Investments Using Significant Unobservable Input (Detail) Details 30 false false R31.htm 1031 - Disclosure - Summary of Significant Accounting Policies - Summary of Investments Categorize into Fair Value Hierarchy (Detail) Sheet http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfInvestmentsCategorizeIntoFairValueHierarchyDetail Summary of Significant Accounting Policies - Summary of Investments Categorize into Fair Value Hierarchy (Detail) Details 31 false false R32.htm 1032 - Disclosure - Summary of Significant Accounting Policies - Summary of Changes in the Company's Level 3 investments (Detail) Sheet http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfChangesInTheCompanySLevel3InvestmentsDetail Summary of Significant Accounting Policies - Summary of Changes in the Company's Level 3 investments (Detail) Details 32 false false R33.htm 1033 - Disclosure - Summary of Significant Accounting Policies - Summary of Changes in the Company's Level 3 investments (Parenthetical) (Detail) Sheet http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfChangesInTheCompanySLevel3InvestmentsParentheticalDetail Summary of Significant Accounting Policies - Summary of Changes in the Company's Level 3 investments (Parenthetical) (Detail) Details 33 false false R34.htm 1034 - Disclosure - Summary of Significant Accounting Policies - Summary of Quantitative Information about the Company's Level 3 Asset and Liability (Detail) Sheet http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityDetail Summary of Significant Accounting Policies - Summary of Quantitative Information about the Company's Level 3 Asset and Liability (Detail) Details 34 false false R35.htm 1035 - Disclosure - Summary of Significant Accounting Policies - Summary of Computation of Basic and Diluted Net (Detail) Sheet http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfComputationOfBasicAndDilutedNetDetail Summary of Significant Accounting Policies - Summary of Computation of Basic and Diluted Net (Detail) Details 35 false false R36.htm 1036 - Disclosure - Investment Portfolio - Summary Of Investment Holdings, Schedule of Investments (Detail) Sheet http://www.npci.com/role/InvestmentPortfolioSummaryOfInvestmentHoldingsScheduleOfInvestmentsDetail Investment Portfolio - Summary Of Investment Holdings, Schedule of Investments (Detail) Details 36 false false R37.htm 1037 - Disclosure - Investment Portfolio - Summary Of Investment Company Assets By Industry Classification At Fair Value (Detail) Sheet http://www.npci.com/role/InvestmentPortfolioSummaryOfInvestmentCompanyAssetsByIndustryClassificationAtFairValueDetail Investment Portfolio - Summary Of Investment Company Assets By Industry Classification At Fair Value (Detail) Details 37 false false R38.htm 1038 - Disclosure - Investment Portfolio - Summary Of the Company's invested assets by geographic classification (Detail) Sheet http://www.npci.com/role/InvestmentPortfolioSummaryOfTheCompanySInvestedAssetsByGeographicClassificationDetail Investment Portfolio - Summary Of the Company's invested assets by geographic classification (Detail) Details 38 false false R39.htm 1039 - Disclosure - Related Party Transactions and Arrangements - Schedule Of Fee Waivers And Expense Reimbursements Due From The Adviser Which May Become Subject To Recoupment (Detail) Sheet http://www.npci.com/role/RelatedPartyTransactionsAndArrangementsScheduleOfFeeWaiversAndExpenseReimbursementsDueFromTheAdviserWhichMayBecomeSubjectToRecoupmentDetail Related Party Transactions and Arrangements - Schedule Of Fee Waivers And Expense Reimbursements Due From The Adviser Which May Become Subject To Recoupment (Detail) Details 39 false false R40.htm 1040 - Disclosure - Related Party Transactions and Arrangements - Additional Information (Detail) Sheet http://www.npci.com/role/RelatedPartyTransactionsAndArrangementsAdditionalInformationDetail Related Party Transactions and Arrangements - Additional Information (Detail) Details 40 false false R41.htm 1041 - Disclosure - U.S. Federal Income Tax Information - Additional Information (Detail) Sheet http://www.npci.com/role/USFederalIncomeTaxInformationAdditionalInformationDetail U.S. Federal Income Tax Information - Additional Information (Detail) Details 41 false false R42.htm 1042 - Disclosure - Share Repurchase Program - Additional Information (Detail) Sheet http://www.npci.com/role/ShareRepurchaseProgramAdditionalInformationDetail Share Repurchase Program - Additional Information (Detail) Details 42 false false R43.htm 1043 - Disclosure - Economic Dependency and Commitments and Contingencies - Additional Information (Detail) Sheet http://www.npci.com/role/EconomicDependencyAndCommitmentsAndContingenciesAdditionalInformationDetail Economic Dependency and Commitments and Contingencies - Additional Information (Detail) Details 43 false false R44.htm 1044 - Disclosure - Market and Other Risk Factors - Additional Information (Detail) Sheet http://www.npci.com/role/MarketAndOtherRiskFactorsAdditionalInformationDetail Market and Other Risk Factors - Additional Information (Detail) Details 44 false false R45.htm 1045 - Disclosure - Affiliated Investments - Summary of Affiliated Issuers of the Company (Detail) Sheet http://www.npci.com/role/AffiliatedInvestmentsSummaryOfAffiliatedIssuersOfTheCompanyDetail Affiliated Investments - Summary of Affiliated Issuers of the Company (Detail) Details 45 false false R46.htm 1046 - Disclosure - Financial Highlights - Summary of Share Outstanding (Detail) Sheet http://www.npci.com/role/FinancialHighlightsSummaryOfShareOutstandingDetail Financial Highlights - Summary of Share Outstanding (Detail) Details 46 false false All Reports Book All Reports [dq-0542-Deprecated-Concept] Concept InvestmentsInAndAdvancesToAffiliatesCategorizationAxis in us-gaap/2022 used in 22 facts was deprecated in us-gaap/2023 as of 2023 and should not be used. d421644d10q.htm 120, 123, 127, 130, 133, 137, 457, 461, 467, 471, 686, 690, 696, 700, 709, 713, 719, 723, 1659, 1663 [dq-0542-Deprecated-Concept] Concept DueFromRelatedParties in us-gaap/2022 used in 2 facts was deprecated in us-gaap/2023 as of 2023 and should not be used. d421644d10q.htm 173, 177 [dq-0542-Deprecated-Concept] Concept DueToRelatedPartiesCurrentAndNoncurrent in us-gaap/2022 used in 2 facts was deprecated in us-gaap/2023 as of 2023 and should not be used. d421644d10q.htm 238, 242 [dq-0542-Deprecated-Concept] Concept InvestmentCompanyNetAssetsFromOperationsIncreaseDecrease in us-gaap/2022 used in 4 facts was deprecated in us-gaap/2023 as of 2023 and should not be used. d421644d10q.htm 759, 763, 12418, 12422 [dq-0542-Deprecated-Concept] Concept InvestmentSecondaryCategorizationAxis in us-gaap/2022 used in 430 facts was deprecated in us-gaap/2023 as of 2023 and should not be used. d421644d10q.htm 2068, 2071, 2075, 2079, 2083, 2087, 2091, 2094, 2097, 2101, 2105, 2109, 2113, 2117, 2120, 2123, 2127, 2131, 2135, 2139, 2143, 2146, 2149, 2153, 2157, 2161, 2165, 2169, 2172, 2175, 2183, 2187, 2191, 2195, 2198, 2201, 2205, 2209, 2213, 2217, 2221, 2224, 2227, 2231, 2235, 2239, 2243, 2247, 2250, 2253, 2257, 2261, 2265, 2269, 2273, 2276, 2279, 2283, 2287, 2291, 2295, 2299, 2351, 2414, 2417, 2421, 2425, 2429, 2433, 2437, 2500, 2503, 2507, 2511, 2515, 2519, 2523, 2526, 2529, 2533, 2537, 2541, 2545, 2549, 2552, 2555, 2559, 2563, 2567, 2571, 2575, 2578, 2581, 2585, 2589, 2593, 2597, 2601, 2653, 2776, 2791, 2795, 2799, 2802, 2817, 2821, 2825, 2877, 3018, 3029, 3033, 3037, 3041, 3096, 3107, 3111, 3115, 3119, 3122, 3133, 3137, 3141, 3145, 3197, 3366, 3381, 3385, 3389, 3444, 3459, 3463, 3467, 3522, 3537, 3541, 3545, 3600, 3615, 3619, 3623, 3626, 3641, 3645, 3649, 3701, 3783, 3798, 3802, 3806, 3861, 3876, 3880, 3884, 3939, 3954, 3958, 3962, 4111, 4126, 4130, 4134, 4189, 4204, 4208, 4212, 4215, 4230, 4234, 4238, 4290, 4459, 4462, 4474, 4478, 4482, 4485, 4488, 4500, 4504, 4508, 4560, 4615, 4618, 4630, 4634, 4638, 4641, 4644, 4656, 4660, 4664, 4667, 4670, 4682, 4686, 4690, 4693, 4696, 4708, 4712, 4716, 4768, 4891, 4906, 4910, 4914, 4917, 4932, 4936, 4940, 4992, 5047, 5062, 5066, 5070, 5509, 5511, 5514, 5518, 5522, 5526, 5530, 5533, 5535, 5538, 5542, 5546, 5550, 5554, 5557, 5559, 5566, 5570, 5574, 5578, 5581, 5583, 5586, 5590, 5594, 5598, 5602, 5605, 5607, 5614, 5618, 5622, 5626, 5629, 5631, 5634, 5638, 5642, 5646, 5650, 5653, 5655, 5658, 5662, 5666, 5670, 5674, 5677, 5679, 5682, 5686, 5690, 5694, 5698, 5701, 5703, 5706, 5710, 5714, 5718, 5722, 5725, 5727, 5730, 5734, 5738, 5742, 5746, 5794, 5853, 5855, 5862, 5866, 5870, 5874, 5877, 5879, 5886, 5890, 5894, 5898, 5901, 5903, 5910, 5914, 5918, 5922, 5925, 5927, 5934, 5938, 5942, 5946, 5994, 6133, 6146, 6150, 6154, 6157, 6170, 6174, 6178, 6226, 6365, 6367, 6374, 6378, 6382, 6386, 6437, 6439, 6446, 6450, 6454, 6458, 6461, 6463, 6470, 6474, 6478, 6482, 6530, 6696, 6709, 6713, 6717, 6768, 6781, 6785, 6789, 6840, 6853, 6857, 6861, 6912, 6925, 6929, 6933, 6936, 6949, 6953, 6957, 7005, 7085, 7100, 7104, 7108, 7163, 7178, 7182, 7186, 7241, 7256, 7260, 7264, 7413, 7428, 7432, 7436, 7491, 7506, 7510, 7514, 7517, 7532, 7536, 7540, 7592, 7761, 7768, 7776, 7780, 7784, 7787, 7794, 7802, 7806, 7810, 7862, 7917, 7924, 7932, 7936, 7940, 7943, 7950, 7958, 7962, 7966, 7969, 7976, 7984, 7988, 7992, 7995, 8010, 8014, 8018, 8070, 8219, 8230, 8234, 8238, 8242, 8245, 8256, 8260, 8264, 8268, 8320, 8375, 8386, 8390, 8394, 8398 [dq-0542-Deprecated-Concept] Concept AccountsReceivableRelatedParties in us-gaap/2022 used in 2 facts was deprecated in us-gaap/2023 as of 2023 and should not be used. d421644d10q.htm 13753 [dq-0542-Deprecated-Concept] Concept AccountsPayableRelatedPartiesCurrentAndNoncurrent in us-gaap/2022 used in 2 facts was deprecated in us-gaap/2023 as of 2023 and should not be used. d421644d10q.htm 13753 [dq-0542-Deprecated-Concept] Concept InvestmentsInAndAdvancesToAffiliatesBalanceShares in us-gaap/2022 used in 10 facts was deprecated in us-gaap/2023 as of 2023 and should not be used. d421644d10q.htm 13833, 13865, 13917, 13949, 14001, 14033, 14085, 14117, 14169, 14201 [dq-0542-Deprecated-Concept] Concept InvestmentsInAndAdvancesToAffiliatesAtFairValue in us-gaap/2022 used in 10 facts was deprecated in us-gaap/2023 as of 2023 and should not be used. d421644d10q.htm 13837, 13861, 13921, 13945, 14005, 14029, 14089, 14113, 14173, 14197 [dq-0542-Deprecated-Concept] Concept InvestmentsInAndAdvancesToAffiliatesDividendsOrInterest in us-gaap/2022 used in 5 facts was deprecated in us-gaap/2023 as of 2023 and should not be used. d421644d10q.htm 13869, 13953, 14037, 14121, 14205 [ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 2 fact(s) appearing in ix:hidden were eligible for transformation: us-gaap:CommitmentsAndContingencies - d421644d10q.htm 7 d421644d10q.htm cik0001588272-20230331.xsd cik0001588272-20230331_cal.xml cik0001588272-20230331_def.xml cik0001588272-20230331_lab.xml cik0001588272-20230331_pre.xml d421644dex311.htm d421644dex312.htm d421644dex321.htm http://fasb.org/us-gaap-sup/2022q3 http://fasb.org/us-gaap/2022 http://xbrl.sec.gov/dei/2022 true true JSON 63 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "d421644d10q.htm": { "axisCustom": 8, "axisStandard": 23, "baseTaxonomies": { "http://fasb.org/us-gaap-sup/2022q3": 2, "http://fasb.org/us-gaap/2022": 1073, "http://xbrl.sec.gov/dei/2022": 27 }, "contextCount": 735, "dts": { "calculationLink": { "local": [ "cik0001588272-20230331_cal.xml" ] }, "definitionLink": { "local": [ "cik0001588272-20230331_def.xml" ] }, "inline": { "local": [ "d421644d10q.htm" ] }, "labelLink": { "local": [ "cik0001588272-20230331_lab.xml" ] }, "presentationLink": { "local": [ "cik0001588272-20230331_pre.xml" ] }, "schema": { "local": [ "cik0001588272-20230331.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd", "https://xbrl.fasb.org/srt/2022q3/srt-sup-2022q3.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022q3/us-gaap-sup-2022q3.xsd", "https://xbrl.sec.gov/country/2022/country-2022.xsd", "https://xbrl.sec.gov/currency/2022/currency-2022.xsd", "https://xbrl.sec.gov/dei/2022/dei-2022.xsd", "https://xbrl.sec.gov/exch/2022/exch-2022.xsd", "https://xbrl.sec.gov/naics/2022/naics-2022.xsd", "https://xbrl.sec.gov/sic/2022/sic-2022.xsd", "https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd" ] } }, "elementCount": 594, "entityCount": 1, "hidden": { "http://fasb.org/us-gaap/2022": 2, "http://xbrl.sec.gov/dei/2022": 4, "total": 6 }, "keyCustom": 92, "keyStandard": 170, "memberCustom": 172, "memberStandard": 31, "nsprefix": "cik0001588272", "nsuri": "http://www.npci.com/20230331", "report": { "R1": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d421644d10q.htm", "contextRef": "P01_01_2023To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "1001 - Document - Cover Page", "menuCat": "Cover", "order": "1", "role": "http://www.npci.com/role/CoverPage", "shortName": "Cover Page", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d421644d10q.htm", "contextRef": "P01_01_2023To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R10": { "firstAnchor": { "ancestors": [ "div", "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d421644d10q.htm", "contextRef": "PAsOn03_31_2023", "decimals": "3", "first": true, "lang": null, "name": "cik0001588272:PercentageOfNonQualifyingAssetOnCompanysTotalAsset", "reportCount": 1, "unique": true, "unitRef": "Unit_pure", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1010 - Statement - Schedule of Investments (Parenthentical)", "menuCat": "Statements", "order": "10", "role": "http://www.npci.com/role/ScheduleOfInvestmentsParenthentical", "shortName": "Schedule of Investments (Parenthentical)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "div", "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d421644d10q.htm", "contextRef": "PAsOn03_31_2023", "decimals": "3", "first": true, "lang": null, "name": "cik0001588272:PercentageOfNonQualifyingAssetOnCompanysTotalAsset", "reportCount": 1, "unique": true, "unitRef": "Unit_pure", "xsiNil": "false" } }, "R11": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d421644d10q.htm", "contextRef": "P01_01_2023To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1011 - Disclosure - Organization", "menuCat": "Notes", "order": "11", "role": "http://www.npci.com/role/Organization", "shortName": "Organization", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d421644d10q.htm", "contextRef": "P01_01_2023To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R12": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d421644d10q.htm", "contextRef": "P01_01_2023To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1012 - Disclosure - Summary of Significant Accounting Policies", "menuCat": "Notes", "order": "12", "role": "http://www.npci.com/role/SummaryOfSignificantAccountingPolicies", "shortName": "Summary of Significant Accounting Policies", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d421644d10q.htm", "contextRef": "P01_01_2023To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R13": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d421644d10q.htm", "contextRef": "P01_01_2023To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InvestmentHoldingsScheduleOfInvestmentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1013 - Disclosure - Investment Portfolio", "menuCat": "Notes", "order": "13", "role": "http://www.npci.com/role/InvestmentPortfolio", "shortName": "Investment Portfolio", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d421644d10q.htm", "contextRef": "P01_01_2023To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InvestmentHoldingsScheduleOfInvestmentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R14": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d421644d10q.htm", "contextRef": "P01_01_2023To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1014 - Disclosure - Related Party Transactions and Arrangements", "menuCat": "Notes", "order": "14", "role": "http://www.npci.com/role/RelatedPartyTransactionsAndArrangements", "shortName": "Related Party Transactions and Arrangements", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d421644d10q.htm", "contextRef": "P01_01_2023To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R15": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d421644d10q.htm", "contextRef": "P01_01_2023To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1015 - Disclosure - U.S. Federal Income Tax Information", "menuCat": "Notes", "order": "15", "role": "http://www.npci.com/role/USFederalIncomeTaxInformation", "shortName": "U.S. Federal Income Tax Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d421644d10q.htm", "contextRef": "P01_01_2023To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R16": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d421644d10q.htm", "contextRef": "P01_01_2023To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "cik0001588272:ShareRepurchaseProgram", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1016 - Disclosure - Share Repurchase Program", "menuCat": "Notes", "order": "16", "role": "http://www.npci.com/role/ShareRepurchaseProgram", "shortName": "Share Repurchase Program", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d421644d10q.htm", "contextRef": "P01_01_2023To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "cik0001588272:ShareRepurchaseProgram", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R17": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d421644d10q.htm", "contextRef": "P01_01_2023To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1017 - Disclosure - Economic Dependency and Commitments and Contingencies", "menuCat": "Notes", "order": "17", "role": "http://www.npci.com/role/EconomicDependencyAndCommitmentsAndContingencies", "shortName": "Economic Dependency and Commitments and Contingencies", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d421644d10q.htm", "contextRef": "P01_01_2023To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R18": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d421644d10q.htm", "contextRef": "P01_01_2023To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ConcentrationRiskDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1018 - Disclosure - Market and Other Risk Factors", "menuCat": "Notes", "order": "18", "role": "http://www.npci.com/role/MarketAndOtherRiskFactors", "shortName": "Market and Other Risk Factors", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d421644d10q.htm", "contextRef": "P01_01_2023To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ConcentrationRiskDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R19": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d421644d10q.htm", "contextRef": "P01_01_2023To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InvestmentsInAndAdvancesToAffiliatesScheduleOfInvestmentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1019 - Disclosure - Affiliated Investments", "menuCat": "Notes", "order": "19", "role": "http://www.npci.com/role/AffiliatedInvestments", "shortName": "Affiliated Investments", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d421644d10q.htm", "contextRef": "P01_01_2023To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InvestmentsInAndAdvancesToAffiliatesScheduleOfInvestmentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R2": { "firstAnchor": { "ancestors": [ "div", "div", "td", "tr", "table", "cik0001588272:DisclosureInTabularFormOfInvestmentsCategorizeIntoFairValueHierarchyTableTextBlock", "ix:continuation", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d421644d10q.htm", "contextRef": "PAsOn03_31_2023", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:InvestmentsFairValueDisclosure", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1002 - Statement - Statements of Assets and Liabilities", "menuCat": "Statements", "order": "2", "role": "http://www.npci.com/role/StatementsOfAssetsAndLiabilities", "shortName": "Statements of Assets and Liabilities", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d421644d10q.htm", "contextRef": "PAsOn03_31_2023", "decimals": "0", "lang": null, "name": "us-gaap:SecuritiesPurchasedUnderAgreementsToResell", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R20": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d421644d10q.htm", "contextRef": "P01_01_2023To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InvestmentCompanyFinancialHighlightsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1020 - Disclosure - Financial Highlights", "menuCat": "Notes", "order": "20", "role": "http://www.npci.com/role/FinancialHighlights", "shortName": "Financial Highlights", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d421644d10q.htm", "contextRef": "P01_01_2023To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InvestmentCompanyFinancialHighlightsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R21": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d421644d10q.htm", "contextRef": "P01_01_2023To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1021 - Disclosure - Subsequent Events", "menuCat": "Notes", "order": "21", "role": "http://www.npci.com/role/SubsequentEvents", "shortName": "Subsequent Events", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d421644d10q.htm", "contextRef": "P01_01_2023To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R22": { "firstAnchor": { "ancestors": [ "us-gaap:SignificantAccountingPoliciesTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d421644d10q.htm", "contextRef": "P01_01_2023To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1022 - Disclosure - Summary of Significant Accounting Policies (Policies)", "menuCat": "Policies", "order": "22", "role": "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesPolicies", "shortName": "Summary of Significant Accounting Policies (Policies)", "subGroupType": "policies", "uniqueAnchor": { "ancestors": [ "us-gaap:SignificantAccountingPoliciesTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d421644d10q.htm", "contextRef": "P01_01_2023To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R23": { "firstAnchor": { "ancestors": [ "ix:continuation", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d421644d10q.htm", "contextRef": "P01_01_2023To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "cik0001588272:DisclosureInTabularFormOfInvestmentsUsingSignificantUnobservableInputTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1023 - Disclosure - Summary of Significant Accounting Policies (Tables)", "menuCat": "Tables", "order": "23", "role": "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesTables", "shortName": "Summary of Significant Accounting Policies (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d421644d10q.htm", "contextRef": "P01_01_2023To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "cik0001588272:DisclosureInTabularFormOfInvestmentsUsingSignificantUnobservableInputTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R24": { "firstAnchor": { "ancestors": [ "us-gaap:InvestmentHoldingsScheduleOfInvestmentsTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d421644d10q.htm", "contextRef": "P01_01_2023To03_31_2023_InvestmentsByIndustryMembercik0001588272InvestmentClassificationByTypeAxis", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InvestmentHoldingsScheduleOfInvestmentsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1024 - Disclosure - Investment Portfolio (Tables)", "menuCat": "Tables", "order": "24", "role": "http://www.npci.com/role/InvestmentPortfolioTables", "shortName": "Investment Portfolio (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:InvestmentHoldingsScheduleOfInvestmentsTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d421644d10q.htm", "contextRef": "P01_01_2023To03_31_2023_InvestmentsByIndustryMembercik0001588272InvestmentClassificationByTypeAxis", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InvestmentHoldingsScheduleOfInvestmentsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R25": { "firstAnchor": { "ancestors": [ "div", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "d421644d10q.htm", "contextRef": "P01_01_2023To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "cik0001588272:ScheduleOfFeeWaiversAndExpenseReimbursementsDueFromTheAdviserWhichMayBecomeSubjectToRecoupmentTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1025 - Disclosure - Related Party Transactions and Arrangements (Tables)", "menuCat": "Tables", "order": "25", "role": "http://www.npci.com/role/RelatedPartyTransactionsAndArrangementsTables", "shortName": "Related Party Transactions and Arrangements (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "d421644d10q.htm", "contextRef": "P01_01_2023To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "cik0001588272:ScheduleOfFeeWaiversAndExpenseReimbursementsDueFromTheAdviserWhichMayBecomeSubjectToRecoupmentTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R26": { "firstAnchor": { "ancestors": [ "div", "us-gaap:InvestmentsInAndAdvancesToAffiliatesScheduleOfInvestmentsTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d421644d10q.htm", "contextRef": "P01_01_2023To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InvestmentsInAndAdvancesToAffiliatesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1026 - Disclosure - Affiliated Investments (Tables)", "menuCat": "Tables", "order": "26", "role": "http://www.npci.com/role/AffiliatedInvestmentsTables", "shortName": "Affiliated Investments (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "us-gaap:InvestmentsInAndAdvancesToAffiliatesScheduleOfInvestmentsTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d421644d10q.htm", "contextRef": "P01_01_2023To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InvestmentsInAndAdvancesToAffiliatesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R27": { "firstAnchor": { "ancestors": [ "us-gaap:InvestmentCompanyFinancialHighlightsTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d421644d10q.htm", "contextRef": "P01_01_2023To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InvestmentCompanyFinancialHighlightsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1027 - Disclosure - Financial Highlights (Tables)", "menuCat": "Tables", "order": "27", "role": "http://www.npci.com/role/FinancialHighlightsTables", "shortName": "Financial Highlights (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:InvestmentCompanyFinancialHighlightsTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d421644d10q.htm", "contextRef": "P01_01_2023To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InvestmentCompanyFinancialHighlightsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R28": { "firstAnchor": { "ancestors": [ "div", "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d421644d10q.htm", "contextRef": "P01_01_2023To03_31_2023", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:ProceedsFromIssuanceOfPrivatePlacement", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1028 - Disclosure - Organization - Additional Information (Detail)", "menuCat": "Details", "order": "28", "role": "http://www.npci.com/role/OrganizationAdditionalInformationDetail", "shortName": "Organization - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d421644d10q.htm", "contextRef": "P01_01_2023To03_31_2023", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:ProceedsFromIssuanceOfPrivatePlacement", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R29": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d421644d10q.htm", "contextRef": "PAsOn03_31_2023", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1029 - Disclosure - Summary of Significant Accounting Policies - Additional Information (Detail)", "menuCat": "Details", "order": "29", "role": "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail", "shortName": "Summary of Significant Accounting Policies - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "us-gaap:CashAndCashEquivalentsPolicyTextBlock", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d421644d10q.htm", "contextRef": "PAsOn03_31_2023", "decimals": "0", "lang": null, "name": "us-gaap:RestrictedCashAndCashEquivalents", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R3": { "firstAnchor": { "ancestors": [ "div", "div", "td", "tr", "table", "us-gaap:InvestmentHoldingsScheduleOfInvestmentsTableTextBlock", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d421644d10q.htm", "contextRef": "PAsOn03_31_2023", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:InvestmentOwnedAtCost", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1003 - Statement - Statements of Assets and Liabilities (Parenthetical)", "menuCat": "Statements", "order": "3", "role": "http://www.npci.com/role/StatementsOfAssetsAndLiabilitiesParenthetical", "shortName": "Statements of Assets and Liabilities (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "us-gaap:PreferredStockParOrStatedValuePerShare", "div", "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d421644d10q.htm", "contextRef": "PAsOn03_31_2023", "decimals": "INF", "lang": null, "name": "us-gaap:PreferredStockParOrStatedValuePerShare", "reportCount": 1, "unique": true, "unitRef": "Unit_USD_per_Share", "xsiNil": "false" } }, "R30": { "firstAnchor": { "ancestors": [ "div", "div", "td", "tr", "table", "cik0001588272:DisclosureInTabularFormOfInvestmentsCategorizeIntoFairValueHierarchyTableTextBlock", "ix:continuation", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d421644d10q.htm", "contextRef": "PAsOn03_31_2023", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:InvestmentsFairValueDisclosure", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1030 - Disclosure - Summary of Significant Accounting Policies - Summary of Investments Using Significant Unobservable Input (Detail)", "menuCat": "Details", "order": "30", "role": "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfInvestmentsUsingSignificantUnobservableInputDetail", "shortName": "Summary of Significant Accounting Policies - Summary of Investments Using Significant Unobservable Input (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "td", "tr", "table", "cik0001588272:DisclosureInTabularFormOfInvestmentsUsingSignificantUnobservableInputTableTextBlock", "ix:continuation", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d421644d10q.htm", "contextRef": "P01_01_2023To03_31_2023_AssetBackedSecuritiesMemberusgaapInvestmentTypeAxis_AssetBackedSecuritiesOneMembercik0001588272InvestmentTypeOneAxis_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis_GraysonInvestorCorpMembercik0001588272InvesteeAxis", "decimals": null, "lang": "en-US", "name": "cik0001588272:DescriptionOfTypeOfInvestment", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R31": { "firstAnchor": { "ancestors": [ "div", "div", "td", "tr", "table", "cik0001588272:DisclosureInTabularFormOfInvestmentsCategorizeIntoFairValueHierarchyTableTextBlock", "ix:continuation", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d421644d10q.htm", "contextRef": "PAsOn03_31_2023", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:InvestmentsFairValueDisclosure", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1031 - Disclosure - Summary of Significant Accounting Policies - Summary of Investments Categorize into Fair Value Hierarchy (Detail)", "menuCat": "Details", "order": "31", "role": "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfInvestmentsCategorizeIntoFairValueHierarchyDetail", "shortName": "Summary of Significant Accounting Policies - Summary of Investments Categorize into Fair Value Hierarchy (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "cik0001588272:DisclosureInTabularFormOfInvestmentsCategorizeIntoFairValueHierarchyTableTextBlock", "ix:continuation", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d421644d10q.htm", "contextRef": "PAsOn03_31_2023_HealthCareMembercik0001588272NatureOfBusinessAxis_SeniorSecuredLoansMemberusgaapInvestmentTypeAxis", "decimals": "0", "lang": null, "name": "us-gaap:InvestmentsFairValueDisclosure", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R32": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock", "ix:continuation", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d421644d10q.htm", "contextRef": "PAsOn12_31_2022_InvestmentsMemberusgaapFairValueByAssetClassAxis", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1032 - Disclosure - Summary of Significant Accounting Policies - Summary of Changes in the Company's Level 3 investments (Detail)", "menuCat": "Details", "order": "32", "role": "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfChangesInTheCompanySLevel3InvestmentsDetail", "shortName": "Summary of Significant Accounting Policies - Summary of Changes in the Company's Level 3 investments (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock", "ix:continuation", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d421644d10q.htm", "contextRef": "PAsOn12_31_2022_InvestmentsMemberusgaapFairValueByAssetClassAxis", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R33": { "firstAnchor": { "ancestors": [ "link:footnote", "div", "td", "tr", "table", "us-gaap:FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock", "ix:continuation", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d421644d10q.htm", "contextRef": "P01_01_2023To03_31_2023_PreferredStockMemberusgaapStatementEquityComponentsAxis_PromissoryNoteMemberusgaapDebtInstrumentAxis", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:DebtConversionConvertedInstrumentAmount1", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1033 - Disclosure - Summary of Significant Accounting Policies - Summary of Changes in the Company's Level 3 investments (Parenthetical) (Detail)", "menuCat": "Details", "order": "33", "role": "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfChangesInTheCompanySLevel3InvestmentsParentheticalDetail", "shortName": "Summary of Significant Accounting Policies - Summary of Changes in the Company's Level 3 investments (Parenthetical) (Detail)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "link:footnote", "div", "td", "tr", "table", "us-gaap:FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock", "ix:continuation", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d421644d10q.htm", "contextRef": "P01_01_2023To03_31_2023_PreferredStockMemberusgaapStatementEquityComponentsAxis_PromissoryNoteMemberusgaapDebtInstrumentAxis", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:DebtConversionConvertedInstrumentAmount1", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R34": { "firstAnchor": { "ancestors": [ "div", "div", "td", "tr", "table", "cik0001588272:DisclosureInTabularFormOfInvestmentsCategorizeIntoFairValueHierarchyTableTextBlock", "ix:continuation", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d421644d10q.htm", "contextRef": "PAsOn03_31_2023", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:InvestmentsFairValueDisclosure", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1034 - Disclosure - Summary of Significant Accounting Policies - Summary of Quantitative Information about the Company's Level 3 Asset and Liability (Detail)", "menuCat": "Details", "order": "34", "role": "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityDetail", "shortName": "Summary of Significant Accounting Policies - Summary of Quantitative Information about the Company's Level 3 Asset and Liability (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock", "ix:continuation", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "d421644d10q.htm", "contextRef": "PAsOn12_31_2022_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis_LlcInterestsMemberusgaapFairValueByAssetClassAxis_MeasurementInputDiscountRateMemberusgaapMeasurementInputTypeAxis", "decimals": "0", "lang": null, "name": "us-gaap:InvestmentsFairValueDisclosure", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R35": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d421644d10q.htm", "contextRef": "P01_01_2023To03_31_2023", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:InvestmentCompanyNetAssetsFromOperationsIncreaseDecrease", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1035 - Disclosure - Summary of Significant Accounting Policies - Summary of Computation of Basic and Diluted Net (Detail)", "menuCat": "Details", "order": "35", "role": "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfComputationOfBasicAndDilutedNetDetail", "shortName": "Summary of Significant Accounting Policies - Summary of Computation of Basic and Diluted Net (Detail)", "subGroupType": "details", "uniqueAnchor": null }, "R36": { "firstAnchor": { "ancestors": [ "div", "div", "td", "tr", "table", "us-gaap:InvestmentHoldingsScheduleOfInvestmentsTableTextBlock", "us-gaap:InvestmentHoldingsScheduleOfInvestmentsTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d421644d10q.htm", "contextRef": "PAsOn03_31_2023", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:InvestmentOwnedAtFairValue", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1036 - Disclosure - Investment Portfolio - Summary Of Investment Holdings, Schedule of Investments (Detail)", "menuCat": "Details", "order": "36", "role": "http://www.npci.com/role/InvestmentPortfolioSummaryOfInvestmentHoldingsScheduleOfInvestmentsDetail", "shortName": "Investment Portfolio - Summary Of Investment Holdings, Schedule of Investments (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:InvestmentHoldingsScheduleOfInvestmentsTableTextBlock", "us-gaap:InvestmentHoldingsScheduleOfInvestmentsTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d421644d10q.htm", "contextRef": "PAsOn03_31_2023_HealthCareMembercik0001588272InvestmentsClassificationByIndustryAxis", "decimals": "0", "lang": null, "name": "us-gaap:InvestmentOwnedAtFairValue", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R37": { "firstAnchor": { "ancestors": [ "div", "div", "td", "tr", "table", "us-gaap:InvestmentHoldingsScheduleOfInvestmentsTableTextBlock", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d421644d10q.htm", "contextRef": "PAsOn03_31_2023", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:InvestmentOwnedAtCost", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1037 - Disclosure - Investment Portfolio - Summary Of Investment Company Assets By Industry Classification At Fair Value (Detail)", "menuCat": "Details", "order": "37", "role": "http://www.npci.com/role/InvestmentPortfolioSummaryOfInvestmentCompanyAssetsByIndustryClassificationAtFairValueDetail", "shortName": "Investment Portfolio - Summary Of Investment Company Assets By Industry Classification At Fair Value (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:InvestmentHoldingsScheduleOfInvestmentsTableTextBlock", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d421644d10q.htm", "contextRef": "PAsOn03_31_2023_SeniorSecuredLoansFirstLienMemberusgaapFairValueByAssetClassAxis", "decimals": "0", "lang": null, "name": "us-gaap:InvestmentOwnedAtCost", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R38": { "firstAnchor": { "ancestors": [ "div", "div", "td", "tr", "table", "us-gaap:InvestmentHoldingsScheduleOfInvestmentsTableTextBlock", "us-gaap:InvestmentHoldingsScheduleOfInvestmentsTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d421644d10q.htm", "contextRef": "PAsOn03_31_2023", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:InvestmentOwnedAtFairValue", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1038 - Disclosure - Investment Portfolio - Summary Of the Company's invested assets by geographic classification (Detail)", "menuCat": "Details", "order": "38", "role": "http://www.npci.com/role/InvestmentPortfolioSummaryOfTheCompanySInvestedAssetsByGeographicClassificationDetail", "shortName": "Investment Portfolio - Summary Of the Company's invested assets by geographic classification (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:InvestmentHoldingsScheduleOfInvestmentsTableTextBlock", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d421644d10q.htm", "contextRef": "PAsOn03_31_2023_KYsrtStatementGeographicalAxis", "decimals": "0", "lang": null, "name": "us-gaap:InvestmentOwnedAtFairValue", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R39": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "d421644d10q.htm", "contextRef": "PAsOn03_31_2023_MarchThirtyOneTwoThousandTwentySixMembercik0001588272RecoupmentEligibilityExpirationDateAxis", "decimals": "0", "first": true, "lang": null, "name": "cik0001588272:YearlyCumulativeOtherExpense", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1039 - Disclosure - Related Party Transactions and Arrangements - Schedule Of Fee Waivers And Expense Reimbursements Due From The Adviser Which May Become Subject To Recoupment (Detail)", "menuCat": "Details", "order": "39", "role": "http://www.npci.com/role/RelatedPartyTransactionsAndArrangementsScheduleOfFeeWaiversAndExpenseReimbursementsDueFromTheAdviserWhichMayBecomeSubjectToRecoupmentDetail", "shortName": "Related Party Transactions and Arrangements - Schedule Of Fee Waivers And Expense Reimbursements Due From The Adviser Which May Become Subject To Recoupment (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "d421644d10q.htm", "contextRef": "PAsOn03_31_2023_MarchThirtyOneTwoThousandTwentySixMembercik0001588272RecoupmentEligibilityExpirationDateAxis", "decimals": "0", "first": true, "lang": null, "name": "cik0001588272:YearlyCumulativeOtherExpense", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R4": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d421644d10q.htm", "contextRef": "P01_01_2023To03_31_2023", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:InvestmentIncomeInterest", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1004 - Statement - Statements of Operations", "menuCat": "Statements", "order": "4", "role": "http://www.npci.com/role/StatementsOfOperations", "shortName": "Statements of Operations", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d421644d10q.htm", "contextRef": "P01_01_2023To03_31_2023", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:InvestmentIncomeInterest", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R40": { "firstAnchor": { "ancestors": [ "div", "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d421644d10q.htm", "contextRef": "P01_01_2023To03_31_2023", "decimals": "3", "first": true, "lang": null, "name": "cik0001588272:BaseManagementFeeCalculatedAnnualRateOfPercentageOfAverageValueOfGrossAssets", "reportCount": 1, "unique": true, "unitRef": "Unit_pure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1040 - Disclosure - Related Party Transactions and Arrangements - Additional Information (Detail)", "menuCat": "Details", "order": "40", "role": "http://www.npci.com/role/RelatedPartyTransactionsAndArrangementsAdditionalInformationDetail", "shortName": "Related Party Transactions and Arrangements - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d421644d10q.htm", "contextRef": "P01_01_2023To03_31_2023", "decimals": "3", "first": true, "lang": null, "name": "cik0001588272:BaseManagementFeeCalculatedAnnualRateOfPercentageOfAverageValueOfGrossAssets", "reportCount": 1, "unique": true, "unitRef": "Unit_pure", "xsiNil": "false" } }, "R41": { "firstAnchor": { "ancestors": [ "div", "us-gaap:IncomeTaxDisclosureTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d421644d10q.htm", "contextRef": "PAsOn03_31_2023", "decimals": "2", "first": true, "lang": null, "name": "cik0001588272:PercentageOfDistributionToShareholdersInvestmentCompanyTaxableIncome", "reportCount": 1, "unique": true, "unitRef": "Unit_pure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1041 - Disclosure - U.S. Federal Income Tax Information - Additional Information (Detail)", "menuCat": "Details", "order": "41", "role": "http://www.npci.com/role/USFederalIncomeTaxInformationAdditionalInformationDetail", "shortName": "U.S. Federal Income Tax Information - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "us-gaap:IncomeTaxDisclosureTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d421644d10q.htm", "contextRef": "PAsOn03_31_2023", "decimals": "2", "first": true, "lang": null, "name": "cik0001588272:PercentageOfDistributionToShareholdersInvestmentCompanyTaxableIncome", "reportCount": 1, "unique": true, "unitRef": "Unit_pure", "xsiNil": "false" } }, "R42": { "firstAnchor": { "ancestors": [ "div", "cik0001588272:ShareRepurchaseProgram", "div", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d421644d10q.htm", "contextRef": "PAsOn03_31_2023", "decimals": "3", "first": true, "lang": null, "name": "cik0001588272:MinimumLimitOfSharesToBeRepurchasedPercent", "reportCount": 1, "unique": true, "unitRef": "Unit_pure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1042 - Disclosure - Share Repurchase Program - Additional Information (Detail)", "menuCat": "Details", "order": "42", "role": "http://www.npci.com/role/ShareRepurchaseProgramAdditionalInformationDetail", "shortName": "Share Repurchase Program - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "cik0001588272:ShareRepurchaseProgram", "div", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d421644d10q.htm", "contextRef": "PAsOn03_31_2023", "decimals": "3", "first": true, "lang": null, "name": "cik0001588272:MinimumLimitOfSharesToBeRepurchasedPercent", "reportCount": 1, "unique": true, "unitRef": "Unit_pure", "xsiNil": "false" } }, "R43": { "firstAnchor": { "ancestors": [ "div", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d421644d10q.htm", "contextRef": "PAsOn03_31_2023_UnfundedLoanCommitmentMemberusgaapFinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CommitmentsAndContingencies", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1043 - Disclosure - Economic Dependency and Commitments and Contingencies - Additional Information (Detail)", "menuCat": "Details", "order": "43", "role": "http://www.npci.com/role/EconomicDependencyAndCommitmentsAndContingenciesAdditionalInformationDetail", "shortName": "Economic Dependency and Commitments and Contingencies - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d421644d10q.htm", "contextRef": "PAsOn03_31_2023_UnfundedLoanCommitmentMemberusgaapFinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CommitmentsAndContingencies", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R44": { "firstAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d421644d10q.htm", "contextRef": "PAsOn12_31_2020_StimulusReliefMemberusgaapOtherCommitmentsAxis", "decimals": "-9", "first": true, "lang": null, "name": "us-gaap:FairValueDisclosureOffbalanceSheetRisksFaceAmountAsset", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1044 - Disclosure - Market and Other Risk Factors - Additional Information (Detail)", "menuCat": "Details", "order": "44", "role": "http://www.npci.com/role/MarketAndOtherRiskFactorsAdditionalInformationDetail", "shortName": "Market and Other Risk Factors - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d421644d10q.htm", "contextRef": "PAsOn12_31_2020_StimulusReliefMemberusgaapOtherCommitmentsAxis", "decimals": "-9", "first": true, "lang": null, "name": "us-gaap:FairValueDisclosureOffbalanceSheetRisksFaceAmountAsset", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R45": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "ix:continuation", "us-gaap:InvestmentsInAndAdvancesToAffiliatesScheduleOfInvestmentsTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d421644d10q.htm", "contextRef": "PAsOn12_31_2022", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:InvestmentsInAndAdvancesToAffiliatesBalanceShares", "reportCount": 1, "unique": true, "unitRef": "Unit_shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1045 - Disclosure - Affiliated Investments - Summary of Affiliated Issuers of the Company (Detail)", "menuCat": "Details", "order": "45", "role": "http://www.npci.com/role/AffiliatedInvestmentsSummaryOfAffiliatedIssuersOfTheCompanyDetail", "shortName": "Affiliated Investments - Summary of Affiliated Issuers of the Company (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "ix:continuation", "us-gaap:InvestmentsInAndAdvancesToAffiliatesScheduleOfInvestmentsTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d421644d10q.htm", "contextRef": "PAsOn12_31_2022", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:InvestmentsInAndAdvancesToAffiliatesBalanceShares", "reportCount": 1, "unique": true, "unitRef": "Unit_shares", "xsiNil": "false" } }, "R46": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d421644d10q.htm", "contextRef": "PAsOn12_31_2022", "decimals": "2", "first": true, "lang": null, "name": "us-gaap:NetAssetValuePerShare", "reportCount": 1, "unitRef": "Unit_USD_per_Share", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1046 - Disclosure - Financial Highlights - Summary of Share Outstanding (Detail)", "menuCat": "Details", "order": "46", "role": "http://www.npci.com/role/FinancialHighlightsSummaryOfShareOutstandingDetail", "shortName": "Financial Highlights - Summary of Share Outstanding (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:InvestmentCompanyFinancialHighlightsTableTextBlock", "us-gaap:InvestmentCompanyFinancialHighlightsTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d421644d10q.htm", "contextRef": "PAsOn12_31_2021", "decimals": "2", "lang": null, "name": "us-gaap:NetAssetValuePerShare", "reportCount": 1, "unique": true, "unitRef": "Unit_USD_per_Share", "xsiNil": "false" } }, "R5": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d421644d10q.htm", "contextRef": "PAsOn12_31_2022", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:AssetsNet", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1005 - Statement - Statements of Changes in Net Assets", "menuCat": "Statements", "order": "5", "role": "http://www.npci.com/role/StatementsOfChangesInNetAssets", "shortName": "Statements of Changes in Net Assets", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d421644d10q.htm", "contextRef": "P01_01_2023To03_31_2023", "decimals": "0", "lang": null, "name": "us-gaap:InvestmentIncomeNet", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R6": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d421644d10q.htm", "contextRef": "P01_01_2023To03_31_2023", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ProfitLoss", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1006 - Statement - Statements of Cash Flows", "menuCat": "Statements", "order": "6", "role": "http://www.npci.com/role/StatementsOfCashFlows", "shortName": "Statements of Cash Flows", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d421644d10q.htm", "contextRef": "P01_01_2023To03_31_2023", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ProfitLoss", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R7": { "firstAnchor": { "ancestors": [ "div", "div", "td", "tr", "table", "us-gaap:InvestmentHoldingsScheduleOfInvestmentsTableTextBlock", "us-gaap:InvestmentHoldingsScheduleOfInvestmentsTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d421644d10q.htm", "contextRef": "PAsOn03_31_2023", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:InvestmentOwnedAtFairValue", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1007 - Statement - Schedule of Investments", "menuCat": "Statements", "order": "7", "role": "http://www.npci.com/role/ScheduleOfInvestments", "shortName": "Schedule of Investments", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d421644d10q.htm", "contextRef": "PAsOn03_31_2023_SeniorSecuredLoansAtNineteenPointSixPercentMemberusgaapInvestmentTypeAxis", "decimals": "0", "lang": null, "name": "us-gaap:InvestmentOwnedAtFairValue", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R8": { "firstAnchor": { "ancestors": [ "div", "div", "td", "tr", "table", "us-gaap:InvestmentHoldingsScheduleOfInvestmentsTableTextBlock", "us-gaap:InvestmentHoldingsScheduleOfInvestmentsTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d421644d10q.htm", "contextRef": "PAsOn03_31_2023", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:InvestmentOwnedAtFairValue", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1008 - Statement - Schedule of Investments 1", "menuCat": "Statements", "order": "8", "role": "http://www.npci.com/role/ScheduleOfInvestments1", "shortName": "Schedule of Investments 1", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "td", "tr", "table", "div", "div", "div", "div", "body", "html" ], "baseRef": "d421644d10q.htm", "contextRef": "PAsOn12_31_2022_CommonStocksAtThirtySixPointThreePercentMemberusgaapInvestmentTypeAxis", "decimals": "0", "lang": null, "name": "us-gaap:InvestmentOwnedAtFairValue", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R9": { "firstAnchor": { "ancestors": [ "div", "div", "td", "tr", "table", "us-gaap:InvestmentHoldingsScheduleOfInvestmentsTableTextBlock", "us-gaap:InvestmentHoldingsScheduleOfInvestmentsTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d421644d10q.htm", "contextRef": "PAsOn03_31_2023", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:InvestmentOwnedAtFairValue", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1009 - Statement - Schedule of Investments 2", "menuCat": "Statements", "order": "9", "role": "http://www.npci.com/role/ScheduleOfInvestments2", "shortName": "Schedule of Investments 2", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "td", "tr", "table", "div", "div", "div", "div", "body", "html" ], "baseRef": "d421644d10q.htm", "contextRef": "PAsOn03_31_2023_WarrantsAtZeroPointThreePercentMemberusgaapInvestmentTypeAxis", "decimals": "0", "lang": null, "name": "us-gaap:InvestmentOwnedAtFairValue", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } } }, "segmentCount": 226, "tag": { "cik0001588272_AdditionalPaymentAmountEligibleToReceiveByRelatedPartyPayableInQuarterlyInstallments": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Additional payment amount eligible to receive by related party payable in quarterly installments.", "label": "Additional Payment Amount Eligible To Receive By Related Party Payable In Quarterly Installments", "terseLabel": "Additional Payment Amount Eligible To Receive By Related Party Payable In Quarterly Installments" } } }, "localname": "AdditionalPaymentAmountEligibleToReceiveByRelatedPartyPayableInQuarterlyInstallments", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/RelatedPartyTransactionsAndArrangementsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "cik0001588272_AdviserForfeitedTheRightToReimbursementOfTheRemainingAmountOfCostsSubsequentToTerminationOfTheOffering": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Adviser forfeited the right to reimbursement of the remaining amount of costs subsequent to termination of the offering.", "label": "Adviser Forfeited The Right To Reimbursement of The Remaining Amount Of Costs Subsequent To Termination Of The Offering", "terseLabel": "Adviser Forfeited The Right To Reimbursement of The Remaining Amount Of Costs Subsequent To Termination Of The Offering" } } }, "localname": "AdviserForfeitedTheRightToReimbursementOfTheRemainingAmountOfCostsSubsequentToTerminationOfTheOffering", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/RelatedPartyTransactionsAndArrangementsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "cik0001588272_AdviserMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Adviser.", "label": "Adviser [Member]", "terseLabel": "Adviser [Member]" } } }, "localname": "AdviserMember", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/RelatedPartyTransactionsAndArrangementsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "cik0001588272_AdvisoryFeesAndAdministrationFeesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Advisory fees And administration fees.", "label": "Advisory Fees And Administration Fees [Member]", "terseLabel": "Advisory Fees And Administration Fees [Member]" } } }, "localname": "AdvisoryFeesAndAdministrationFeesMember", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/RelatedPartyTransactionsAndArrangementsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "cik0001588272_AffiliatedInvestmentsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Affiliated Investments [Member]", "terseLabel": "Affiliated investments" } } }, "localname": "AffiliatedInvestmentsMember", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/StatementsOfAssetsAndLiabilities", "http://www.npci.com/role/StatementsOfAssetsAndLiabilitiesParenthetical", "http://www.npci.com/role/StatementsOfOperations" ], "xbrltype": "domainItemType" }, "cik0001588272_AggregateAccruedIncentiveFeesOnCapitalGains": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate accrued incentive fees on capital gains.", "label": "Aggregate Accrued Incentive Fees On Capital Gains", "terseLabel": "Aggregate Accrued Incentive Fees On Capital Gains" } } }, "localname": "AggregateAccruedIncentiveFeesOnCapitalGains", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/RelatedPartyTransactionsAndArrangementsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "cik0001588272_AmericanBanknoteCorpMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "American Banknote Corp .", "label": "American Banknote Corp [Member]", "terseLabel": "American Banknote Corp [Member]" } } }, "localname": "AmericanBanknoteCorpMember", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/ScheduleOfInvestments1", "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfInvestmentsUsingSignificantUnobservableInputDetail" ], "xbrltype": "domainItemType" }, "cik0001588272_AmericanRescuePlanActMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "American rescue plan act.", "label": "American Rescue Plan Act [Member]" } } }, "localname": "AmericanRescuePlanActMember", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/MarketAndOtherRiskFactorsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "cik0001588272_AnnualRatePercentageOfAverageGrossAssets": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Annual rate percentage of average gross assets .", "label": "Annual Rate Percentage Of Average Gross Assets", "terseLabel": "Annual Rate Percentage Of Average Gross Assets" } } }, "localname": "AnnualRatePercentageOfAverageGrossAssets", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/RelatedPartyTransactionsAndArrangementsAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "cik0001588272_AnnualRetainerAmountPayableInQuarterlyInstallmentsToRelatedPartyOverseesAllOfThePortfoliosInTheFundComplex": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Annual retainer amount payable in quarterly installments to related party oversees all of the portfolios in the fund complex .", "label": "Annual Retainer Amount Payable IN Quarterly Installments To Related Party Oversees All Of The Portfolios In The Fund Complex", "terseLabel": "Annual Retainer Amount Payable IN Quarterly Installments To Related Party Oversees All Of The Portfolios In The Fund Complex" } } }, "localname": "AnnualRetainerAmountPayableInQuarterlyInstallmentsToRelatedPartyOverseesAllOfThePortfoliosInTheFundComplex", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/RelatedPartyTransactionsAndArrangementsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "cik0001588272_AnnualRetainerAmountPayableInQuarterlyInstallmentsToRelatedPartyWhoDoesNotOverseesAllPortfoliosOnProratedBasisOfWhoOverseesAllPortfolios": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Annual retainer amount payable in quarterly installments to related party who does not oversees all portfolios on prorated basis of who oversees all portfolios.", "label": "Annual Retainer Amount Payable In Quarterly Installments To Related Party Who Does Not Oversees All Portfolios On Prorated Basis Of Who Oversees All Portfolios", "terseLabel": "Annual Retainer Amount Payable In Quarterly Installments To Related Party Who Does Not Oversees All Portfolios On Prorated Basis Of Who Oversees All Portfolios" } } }, "localname": "AnnualRetainerAmountPayableInQuarterlyInstallmentsToRelatedPartyWhoDoesNotOverseesAllPortfoliosOnProratedBasisOfWhoOverseesAllPortfolios", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/RelatedPartyTransactionsAndArrangementsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "cik0001588272_ApnimedInc.Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Apnimed, Inc.", "label": "Apnimed, Inc. [Member]" } } }, "localname": "ApnimedInc.Member", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/ScheduleOfInvestments2" ], "xbrltype": "domainItemType" }, "cik0001588272_AprimedIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Aprimed inc.", "label": "Aprimed Inc [Member]", "terseLabel": "Apnimed, Inc [Member]" } } }, "localname": "AprimedIncMember", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfInvestmentsUsingSignificantUnobservableInputDetail" ], "xbrltype": "domainItemType" }, "cik0001588272_AsPerAgreementContractuallyObligatedToWaiveFeesAndIfNecessaryPayOrReimburseCertainOtherExpensesToPercentageOfQuarterEndValueOfTheGrossAssets": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "As per agreement contractually obligated to waive fees and if necessary pay or reimburse certain other expenses to percentage of quarter end value of the gross assets.", "label": "As Per Agreement Contractually Obligated To Waive Fees And If Necessary Pay Or Reimburse Certain Other Expenses To Percentage Of Quarter End Value Of The Gross Assets", "terseLabel": "As Per Agreement Contractually Obligated To Waive Fees And If Necessary Pay Or Reimburse Certain Other Expenses To Percentage Of Quarter End Value Of The Gross Assets" } } }, "localname": "AsPerAgreementContractuallyObligatedToWaiveFeesAndIfNecessaryPayOrReimburseCertainOtherExpensesToPercentageOfQuarterEndValueOfTheGrossAssets", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/RelatedPartyTransactionsAndArrangementsAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "cik0001588272_AsPerAgreementObligationRenewalPeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "As per agreement obligation renewal period .", "label": "As Per Agreement Obligation Renewal period", "terseLabel": "As Per Agreement Obligation Renewal period" } } }, "localname": "AsPerAgreementObligationRenewalPeriod", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/RelatedPartyTransactionsAndArrangementsAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "cik0001588272_AsPerAgreementWrittenNoticePeriodForTermination": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "As per agreement written notice period for termination.", "label": "As Per Agreement Written Notice Period For Termination", "terseLabel": "As Per Agreement Written Notice Period For Termination" } } }, "localname": "AsPerAgreementWrittenNoticePeriodForTermination", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/RelatedPartyTransactionsAndArrangementsAdditionalInformationDetail" ], "xbrltype": "durationItemType" }, "cik0001588272_AssetBackedSecuritiesAtZeroPointZeroPercentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Asset Backed Securities At Zero Point Zero Percent [Member]", "terseLabel": "Asset Backed Securities At Zero Point Zero Percent [Member]" } } }, "localname": "AssetBackedSecuritiesAtZeroPointZeroPercentMember", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/ScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "cik0001588272_AssetBackedSecuritiesOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Asset backed securities one.", "label": "Asset Backed Securities One [Member]" } } }, "localname": "AssetBackedSecuritiesOneMember", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfChangesInTheCompanySLevel3InvestmentsDetail", "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfInvestmentsCategorizeIntoFairValueHierarchyDetail", "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfInvestmentsUsingSignificantUnobservableInputDetail" ], "xbrltype": "domainItemType" }, "cik0001588272_AuditAndTaxFees": { "auth_ref": [], "calculation": { "http://www.npci.com/role/StatementsOfOperations": { "order": 8.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Audit And Tax Fees.", "label": "Audit And Tax Fees", "terseLabel": "Audit and tax fees" } } }, "localname": "AuditAndTaxFees", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "cik0001588272_AurisLuxembourgIiiS.a.r.l.Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Auris Luxembourg III S.a.r.l. .", "label": "Auris Luxembourg III S.a.r.l. [Member]", "terseLabel": "Auris Luxembourg III S.a.r.l. [Member]" } } }, "localname": "AurisLuxembourgIiiS.a.r.l.Member", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/ScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "cik0001588272_BaseManagementFeeCalculatedAnnualRateOfPercentageOfAverageValueOfGrossAssets": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Base management fee calculated annual rate of percentage of average value of gross asset", "label": "Base management Fee Calculated Annual Rate Of Percentage Of Average Value Of Gross Assets", "terseLabel": "Base Management Fee Calculated Annual Rate Of Percentage Of Average Value Of Gross Assets" } } }, "localname": "BaseManagementFeeCalculatedAnnualRateOfPercentageOfAverageValueOfGrossAssets", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/RelatedPartyTransactionsAndArrangementsAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "cik0001588272_BaseRateOf1MonthLiborMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Base rate of 1 month LIBOR.", "label": "Base Rate of 1 Month LIBOR [Member]" } } }, "localname": "BaseRateOf1MonthLiborMember", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/ScheduleOfInvestmentsParenthentical" ], "xbrltype": "domainItemType" }, "cik0001588272_BaseRateOf3MonthLiborMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Base rate of 3 month LIBOR.", "label": "Base Rate of 3 Month LIBOR [Member]" } } }, "localname": "BaseRateOf3MonthLiborMember", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/ScheduleOfInvestmentsParenthentical" ], "xbrltype": "domainItemType" }, "cik0001588272_BaseRateOf3MonthSofrMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Base rate of 3 month SOFR.", "label": "Base Rate Of 3 Month Sofr [Member]", "terseLabel": "Base Rate of 3 Month SOFR [Member]" } } }, "localname": "BaseRateOf3MonthSofrMember", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/ScheduleOfInvestmentsParenthentical" ], "xbrltype": "domainItemType" }, "cik0001588272_BaseRateOf6MonthLiborMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Base rate of 6month LIBOR.", "label": "Base Rate of 6 Month LIBOR [Member]" } } }, "localname": "BaseRateOf6MonthLiborMember", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/ScheduleOfInvestmentsParenthentical" ], "xbrltype": "domainItemType" }, "cik0001588272_BoardOfDirectorsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Board of directors.", "label": "Board of Directors [Member]" } } }, "localname": "BoardOfDirectorsMember", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/ScheduleOfInvestmentsParenthentical" ], "xbrltype": "domainItemType" }, "cik0001588272_CarestreamHealthIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Carestream health inc.", "label": "Carestream Health Inc [Member]", "terseLabel": "Carestream Health Inc [Member]" } } }, "localname": "CarestreamHealthIncMember", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/ScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "cik0001588272_CashEquivalentsAtOnePointFivePercentageMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cash equivalents at one point five percentage.", "label": "Cash Equivalents At One Point Five Percentage [Member]", "terseLabel": "Cash Equivalents At One Point Five Percentage [Member]" } } }, "localname": "CashEquivalentsAtOnePointFivePercentageMember", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/ScheduleOfInvestments2" ], "xbrltype": "domainItemType" }, "cik0001588272_CashEquivalentsAtTwoPointSevenPercentageMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash Equivalents At Two Point Seven Percentage [Member]" } } }, "localname": "CashEquivalentsAtTwoPointSevenPercentageMember", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/ScheduleOfInvestments2" ], "xbrltype": "domainItemType" }, "cik0001588272_CatchUpFeeReceiveByTheAdviserPercentageOfThePreIncentiveFeeNetInvestmentIncomeFromTheQuarter": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Catch up fee receive by the adviser percentage of the pre incentive fee net investment income from the quarter.", "label": "Catch UP Fee Receive By The Adviser Percentage Of The Pre Incentive Fee Net Investment Income From The Quarter", "terseLabel": "Catch UP Fee Receive By The Adviser Percentage Of The Pre Incentive Fee Net Investment Income From The Quarter" } } }, "localname": "CatchUpFeeReceiveByTheAdviserPercentageOfThePreIncentiveFeeNetInvestmentIncomeFromTheQuarter", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/RelatedPartyTransactionsAndArrangementsAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "cik0001588272_CcsMedicalIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "CCS Medical, Inc .", "label": "CCS Medical, Inc [Member]", "terseLabel": "CCS Medical, Inc [Member]" } } }, "localname": "CcsMedicalIncMember", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/ScheduleOfInvestments", "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfInvestmentsUsingSignificantUnobservableInputDetail" ], "xbrltype": "domainItemType" }, "cik0001588272_ChemicalsAtZeroPointOnePercentageMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Chemicals At Zero Point One Percentage.", "label": "Chemicals At Zero Point One Percentage [Member]", "terseLabel": "Chemicals At Zero Point One Percentage [Member]" } } }, "localname": "ChemicalsAtZeroPointOnePercentageMember", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/ScheduleOfInvestments1" ], "xbrltype": "domainItemType" }, "cik0001588272_ChemicalsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Chemicals.", "label": "Chemicals [Member]", "terseLabel": "Chemicals" } } }, "localname": "ChemicalsMember", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/InvestmentPortfolioSummaryOfInvestmentHoldingsScheduleOfInvestmentsDetail", "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfInvestmentsCategorizeIntoFairValueHierarchyDetail" ], "xbrltype": "domainItemType" }, "cik0001588272_CntHoldingsICorpMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "CNT Holdings I Corp .", "label": "CNT Holdings I Corp [Member]", "terseLabel": "CNT Holdings I Corp [Member]" } } }, "localname": "CntHoldingsICorpMember", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/ScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "cik0001588272_CommonShareInformationAtEndOfPeriodAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Common share information at end of period.", "label": "Common Share Information at End of Period [Abstract]", "terseLabel": "Common share information at end of period:" } } }, "localname": "CommonShareInformationAtEndOfPeriodAbstract", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/FinancialHighlightsSummaryOfShareOutstandingDetail" ], "xbrltype": "stringItemType" }, "cik0001588272_CommonStockOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Common stock one.", "label": "Common Stock One [Member]" } } }, "localname": "CommonStockOneMember", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfInvestmentsUsingSignificantUnobservableInputDetail" ], "xbrltype": "domainItemType" }, "cik0001588272_CommonStocksAtThirtySixPointThreePercentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Common stocks at thirty six point three percent.", "label": "Common Stocks At Thirty Six Point Three Percent [Member]", "terseLabel": "Common Stocks At Thirty Six Point Three Percent [Member]" } } }, "localname": "CommonStocksAtThirtySixPointThreePercentMember", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/ScheduleOfInvestments1" ], "xbrltype": "domainItemType" }, "cik0001588272_CommonStocksAtTwentySevenPointTwoPercentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Common stocks at twenty seven point two percent.", "label": "Common Stocks At Twenty Seven Point Two Percent [Member]", "terseLabel": "Common Stocks At Twenty Seven Point Two Percent [Member]" } } }, "localname": "CommonStocksAtTwentySevenPointTwoPercentMember", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/ScheduleOfInvestments1" ], "xbrltype": "domainItemType" }, "cik0001588272_ConsumerProductsAtFivePointSevenPercentageMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Consumer products at five point seven percentage.", "label": "Consumer Products At Five Point Seven Percentage [Member]", "terseLabel": "Consumer Products At Five Point Seven Percentage [Member]" } } }, "localname": "ConsumerProductsAtFivePointSevenPercentageMember", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/ScheduleOfInvestments1" ], "xbrltype": "domainItemType" }, "cik0001588272_ConsumerProductsAtFivePointSixPercentageMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Consumer products at five point six percentage.", "label": "Consumer Products At Five Point Six Percentage [Member]", "terseLabel": "Consumer Products At Five Point Six Percentage [Member]" } } }, "localname": "ConsumerProductsAtFivePointSixPercentageMember", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/ScheduleOfInvestments1" ], "xbrltype": "domainItemType" }, "cik0001588272_ConsumerProductsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Consumer Products [Member]", "terseLabel": "Consumer Products" } } }, "localname": "ConsumerProductsMember", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/InvestmentPortfolioSummaryOfInvestmentHoldingsScheduleOfInvestmentsDetail", "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfChangesInTheCompanySLevel3InvestmentsDetail", "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfInvestmentsCategorizeIntoFairValueHierarchyDetail" ], "xbrltype": "domainItemType" }, "cik0001588272_CoronavirusAidReliefAndEconomicSecurityActMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Coronavirus aid, relief, and economic security act .", "label": "Coronavirus Aid, Relief, and Economic Security Act [Member]" } } }, "localname": "CoronavirusAidReliefAndEconomicSecurityActMember", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/MarketAndOtherRiskFactorsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "cik0001588272_CorporateBondsAtFivePointZeroPercentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Corporate bonds at five point zero percent.", "label": "Corporate Bonds At Five Point Zero Percent [Member]", "terseLabel": "Corporate Bonds At Five Point Zero Percent [Member]" } } }, "localname": "CorporateBondsAtFivePointZeroPercentMember", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/ScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "cik0001588272_CorporateBondsAtFourPointNinePercentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Corporate Bonds At Four Point Nine Percent .", "label": "Corporate Bonds At Four Point Nine Percent [Member]" } } }, "localname": "CorporateBondsAtFourPointNinePercentMember", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/ScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "cik0001588272_CorporateBondsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Corporate bonds.", "label": "Corporate Bonds [Member]" } } }, "localname": "CorporateBondsMember", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfInvestmentsCategorizeIntoFairValueHierarchyDetail" ], "xbrltype": "domainItemType" }, "cik0001588272_CovenantSurgicalPartnersInc.Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Covenant Surgical Partners, Inc.", "label": "Covenant Surgical Partners, Inc. [Member]", "terseLabel": "Covenant Surgical Partners, Inc. [Member]" } } }, "localname": "CovenantSurgicalPartnersInc.Member", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/ScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "cik0001588272_CumulativeAggregateAmountOfOrganizationAndOfferingCosts": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Cumulative aggregate amount of organization and offering costs.", "label": "Cumulative Aggregate Amount Of Organization And Offering Costs", "terseLabel": "Cumulative Aggregate Amount Of Organization And Offering Costs" } } }, "localname": "CumulativeAggregateAmountOfOrganizationAndOfferingCosts", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/RelatedPartyTransactionsAndArrangementsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "cik0001588272_CumulativeCommittedAmountToVoluntarilyReimburseTheUnrealizedLosses": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Cumulative committed amount to voluntarily reimburse the unrealized losses.", "label": "Cumulative Committed Amount To Voluntarily Reimburse The Unrealized Losses", "terseLabel": "Cumulative committed amount to voluntarily reimburse the unrealized losses" } } }, "localname": "CumulativeCommittedAmountToVoluntarilyReimburseTheUnrealizedLosses", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/RelatedPartyTransactionsAndArrangementsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "cik0001588272_CumulativeTotalOfFeesWaivedByAdviserUnderAgreementWhichAreRecoupable": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Cumulative total of fees waived by adviser under agreement which are recoupable.", "label": "Cumulative Total Of Fees Waived By Adviser Under Agreement Which Are Recoupable", "terseLabel": "Cumulative Total Of Fees Waived By Adviser Under Agreement Which Are Recoupable" } } }, "localname": "CumulativeTotalOfFeesWaivedByAdviserUnderAgreementWhichAreRecoupable", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/RelatedPartyTransactionsAndArrangementsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "cik0001588272_CustodianAndAccountingServiceFees": { "auth_ref": [], "calculation": { "http://www.npci.com/role/StatementsOfOperations": { "order": 5.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Custodian and accounting service fees.", "label": "Custodian And Accounting Service Fees", "terseLabel": "Custodian and accounting service fees" } } }, "localname": "CustodianAndAccountingServiceFees", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "cik0001588272_DecemberThirtyFirstTwoThousandAndTwentyFiveMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "December thirty first two thousand and twenty five.", "label": "December Thirty First Two Thousand And Twenty Five [Member]", "terseLabel": "December 31, 2025 [Member]" } } }, "localname": "DecemberThirtyFirstTwoThousandAndTwentyFiveMember", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/RelatedPartyTransactionsAndArrangementsScheduleOfFeeWaiversAndExpenseReimbursementsDueFromTheAdviserWhichMayBecomeSubjectToRecoupmentDetail" ], "xbrltype": "domainItemType" }, "cik0001588272_DecemberThirtyFirstTwoThousandAndTwentyFourMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "December thirty first two thousand and twenty four.", "label": "December Thirty First Two Thousand And Twenty Four [Member]", "terseLabel": "December\u00a031,\u00a02024 [Member]" } } }, "localname": "DecemberThirtyFirstTwoThousandAndTwentyFourMember", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/RelatedPartyTransactionsAndArrangementsScheduleOfFeeWaiversAndExpenseReimbursementsDueFromTheAdviserWhichMayBecomeSubjectToRecoupmentDetail" ], "xbrltype": "domainItemType" }, "cik0001588272_DecemberThirtyFirstTwoThousandAndTwentyThreeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "December thirty first two thousand and twenty three.", "label": "December Thirty First Two Thousand And Twenty Three [Member]", "terseLabel": "December\u00a031,\u00a02023 [Member]" } } }, "localname": "DecemberThirtyFirstTwoThousandAndTwentyThreeMember", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/RelatedPartyTransactionsAndArrangementsScheduleOfFeeWaiversAndExpenseReimbursementsDueFromTheAdviserWhichMayBecomeSubjectToRecoupmentDetail" ], "xbrltype": "domainItemType" }, "cik0001588272_DescriptionOfFairValueMeasurementValuationProcess": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of fair value measurement valuation process.", "label": "Description Of Fair Value Measurement Valuation Process", "terseLabel": "Valuation technique" } } }, "localname": "DescriptionOfFairValueMeasurementValuationProcess", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityDetail" ], "xbrltype": "stringItemType" }, "cik0001588272_DescriptionOfSignificantUnobservableInputUsed": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of significant unobservable input used.", "label": "Description Of Significant Unobservable Input Used", "terseLabel": "Unobservable inputs" } } }, "localname": "DescriptionOfSignificantUnobservableInputUsed", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityDetail" ], "xbrltype": "stringItemType" }, "cik0001588272_DescriptionOfTypeOfInvestment": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of type of investment.", "label": "Description Of Type Of Investment", "terseLabel": "Description of type of investment" } } }, "localname": "DescriptionOfTypeOfInvestment", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfInvestmentsUsingSignificantUnobservableInputDetail" ], "xbrltype": "stringItemType" }, "cik0001588272_DirectorFeeExpensePayableAmount": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Director fee expense payable amount.", "label": "Director Fee Expense Payable Amount", "terseLabel": "Director Fee Expense Payable Amount" } } }, "localname": "DirectorFeeExpensePayableAmount", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/RelatedPartyTransactionsAndArrangementsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "cik0001588272_DirectorsFeeExpense": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Directors fee expense.", "label": "Directors Fee Expense", "terseLabel": "Directors Fee Expense" } } }, "localname": "DirectorsFeeExpense", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/RelatedPartyTransactionsAndArrangementsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "cik0001588272_DisclosureInTabularFormOfInvestmentsCategorizeIntoFairValueHierarchyTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure in tabular form of investments categorize into fair value hierarchy [Table text block].", "label": "Disclosure In Tabular Form Of Investments Categorize Into Fair Value Hierarchy [Table Text Block]", "terseLabel": "Summary of Investments Categorize into Fair Value Hierarchy" } } }, "localname": "DisclosureInTabularFormOfInvestmentsCategorizeIntoFairValueHierarchyTableTextBlock", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesTables" ], "xbrltype": "textBlockItemType" }, "cik0001588272_DisclosureInTabularFormOfInvestmentsCateogrizedIntoFairValueHierarchyLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure in tabular form of investments cateogrized into fair value hierarchy.", "label": "Disclosure In Tabular Form Of Investments Cateogrized Into Fair Value Hierarchy [Line Items]" } } }, "localname": "DisclosureInTabularFormOfInvestmentsCateogrizedIntoFairValueHierarchyLineItems", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfInvestmentsCategorizeIntoFairValueHierarchyDetail" ], "xbrltype": "stringItemType" }, "cik0001588272_DisclosureInTabularFormOfInvestmentsCateogrizedIntoFairValueHierarchyTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure in tabular form of investments cateogrized into fair value hierarchy.", "label": "Disclosure In Tabular Form Of Investments Cateogrized Into Fair Value Hierarchy [Table]" } } }, "localname": "DisclosureInTabularFormOfInvestmentsCateogrizedIntoFairValueHierarchyTable", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfInvestmentsCategorizeIntoFairValueHierarchyDetail" ], "xbrltype": "stringItemType" }, "cik0001588272_DisclosureInTabularFormOfInvestmentsUsingSignificantUnobservableInputLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure in tabular form of investments using significant unobservable input.", "label": "Disclosure In Tabular Form Of Investments Using Significant Unobservable Input [Line Items]" } } }, "localname": "DisclosureInTabularFormOfInvestmentsUsingSignificantUnobservableInputLineItems", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfInvestmentsUsingSignificantUnobservableInputDetail" ], "xbrltype": "stringItemType" }, "cik0001588272_DisclosureInTabularFormOfInvestmentsUsingSignificantUnobservableInputTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure in tabular form of investments using significant unobservable input.", "label": "Disclosure In Tabular Form Of Investments Using Significant Unobservable Input [Table]" } } }, "localname": "DisclosureInTabularFormOfInvestmentsUsingSignificantUnobservableInputTable", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfInvestmentsUsingSignificantUnobservableInputDetail" ], "xbrltype": "stringItemType" }, "cik0001588272_DisclosureInTabularFormOfInvestmentsUsingSignificantUnobservableInputTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure in tabular form of investments using significant unobservable input [Table text block].", "label": "Disclosure In Tabular Form Of Investments Using Significant Unobservable Input [Table Text Block]", "terseLabel": "Summary of Investments Using Significant Unobservable Input" } } }, "localname": "DisclosureInTabularFormOfInvestmentsUsingSignificantUnobservableInputTableTextBlock", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesTables" ], "xbrltype": "textBlockItemType" }, "cik0001588272_DistributionsDeclaredToCommonShareholders": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Distributions declared to common shareholders.", "label": "Distributions Declared To Common Shareholders", "negatedLabel": "Total distributions declared to common shareholders" } } }, "localname": "DistributionsDeclaredToCommonShareholders", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/FinancialHighlightsSummaryOfShareOutstandingDetail" ], "xbrltype": "perShareItemType" }, "cik0001588272_DistributionsPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Distributions [Policy Text Block].", "label": "Distributions [Policy Text Block]", "terseLabel": "Distributions" } } }, "localname": "DistributionsPolicyTextBlock", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "cik0001588272_DividendsAndInterestReceivable": { "auth_ref": [], "calculation": { "http://www.npci.com/role/StatementsOfAssetsAndLiabilities": { "order": 12.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Dividends and Interest Receivable.", "label": "Dividends and Interest Receivable", "terseLabel": "Dividends and interest receivable" } } }, "localname": "DividendsAndInterestReceivable", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/StatementsOfAssetsAndLiabilities" ], "xbrltype": "monetaryItemType" }, "cik0001588272_EnergyAtThreePointTwoPercentageMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Energy at three point two percentage.", "label": "Energy At Three Point Two Percentage [Member]", "terseLabel": "Energy At Three Point Two Percentage [Member]" } } }, "localname": "EnergyAtThreePointTwoPercentageMember", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/ScheduleOfInvestments1" ], "xbrltype": "domainItemType" }, "cik0001588272_EnergyAtThreePointZeroPercentageMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Energy at three point zero percentage.", "label": "Energy At Three Point Zero Percentage [Member]", "terseLabel": "Energy At Three Point Zero Percentage [Member]" } } }, "localname": "EnergyAtThreePointZeroPercentageMember", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/ScheduleOfInvestments1" ], "xbrltype": "domainItemType" }, "cik0001588272_EnergyAtZeroPointThreePercentageMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Energy At Zero Point Three Percentage [Member]", "terseLabel": "Energy At Zero Point Three Percentage [Member]" } } }, "localname": "EnergyAtZeroPointThreePercentageMember", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/ScheduleOfInvestments2" ], "xbrltype": "domainItemType" }, "cik0001588272_EnergyMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Energy [Member]", "terseLabel": "Energy" } } }, "localname": "EnergyMember", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/InvestmentPortfolioSummaryOfInvestmentHoldingsScheduleOfInvestmentsDetail", "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfInvestmentsCategorizeIntoFairValueHierarchyDetail" ], "xbrltype": "domainItemType" }, "cik0001588272_EnvisionHealthcareCorp.Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Envision Healthcare Corp.", "label": "Envision Healthcare Corp. [Member]", "terseLabel": "Envision Healthcare Corp. [Member]" } } }, "localname": "EnvisionHealthcareCorp.Member", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/ScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "cik0001588272_EquityMethodInvesteeAffiliatedInvestmentsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Equity Method Investee Affiliated Investments [Member]" } } }, "localname": "EquityMethodInvesteeAffiliatedInvestmentsMember", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/ScheduleOfInvestmentsParenthentical" ], "xbrltype": "domainItemType" }, "cik0001588272_EquityMethodInvesteeControllingInvestmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Equity Method Investee Controlling Investment [Member]" } } }, "localname": "EquityMethodInvesteeControllingInvestmentMember", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/ScheduleOfInvestmentsParenthentical" ], "xbrltype": "domainItemType" }, "cik0001588272_ExpenseLimitationAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Expense limitation agreement.", "label": "Expense Limitation Agreement [Member]", "terseLabel": "Expense Limitation Agreement [Member]" } } }, "localname": "ExpenseLimitationAgreementMember", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/RelatedPartyTransactionsAndArrangementsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "cik0001588272_ExpenseReimbursementsAmountThatAreEligibleForRecoupmentByTheAdviserExpired": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Expense reimbursements amount that are eligible for recoupment by the adviser expired.", "label": "Expense Reimbursements Amount That Are Eligible For Recoupment By The Adviser Expired", "terseLabel": "Expense reimbursements amount that are eligible for recoupment by the adviser expired" } } }, "localname": "ExpenseReimbursementsAmountThatAreEligibleForRecoupmentByTheAdviserExpired", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/RelatedPartyTransactionsAndArrangementsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "cik0001588272_ExpensesWaivedOrRecoupedByAdviser": { "auth_ref": [], "calculation": { "http://www.npci.com/role/StatementsOfOperations": { "order": 3.0, "parentTag": "cik0001588272_OperatingExpensesNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Expenses Waived Or Recouped By Adviser", "label": "Expenses Waived Or Recouped By Adviser", "negatedLabel": "Expenses (waived) or recouped by the Adviser" } } }, "localname": "ExpensesWaivedOrRecoupedByAdviser", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "cik0001588272_ExpirationMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Expiration [Member]" } } }, "localname": "ExpirationMember", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/RelatedPartyTransactionsAndArrangementsScheduleOfFeeWaiversAndExpenseReimbursementsDueFromTheAdviserWhichMayBecomeSubjectToRecoupmentDetail" ], "xbrltype": "domainItemType" }, "cik0001588272_FairValueMeasurementWithUnobservableInputsReconciliationNetAmortizationAccretionOfPremiumDiscount": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value measurement with unobservable inputs reconciliation net amortization accretion of premium discount.", "label": "Fair Value Measurement With Unobservable Inputs Reconciliation Net Amortization Accretion Of Premium Discount", "terseLabel": "Net amortization (accretion) of premium/ (discount)" } } }, "localname": "FairValueMeasurementWithUnobservableInputsReconciliationNetAmortizationAccretionOfPremiumDiscount", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfChangesInTheCompanySLevel3InvestmentsDetail" ], "xbrltype": "monetaryItemType" }, "cik0001588272_FairValueMeasurementWithUnoservableInputReconciliationRecurringBasisAssetSettlementsNetRealizedGainsLosses": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value measurement with unoservable input reconciliation recurring basis asset settlements net realized gains losses.", "label": "Fair Value Measurement With Unoservable Input Reconciliation Recurring Basis Asset Settlements Net Realized Gains Losses", "terseLabel": "Net realized gains/ (losses)" } } }, "localname": "FairValueMeasurementWithUnoservableInputReconciliationRecurringBasisAssetSettlementsNetRealizedGainsLosses", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfChangesInTheCompanySLevel3InvestmentsDetail" ], "xbrltype": "monetaryItemType" }, "cik0001588272_FeeWaiversAndExpenseReimbursementsDueFromTheAdviserWhichMayBecomeSubjectToRecoupmentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fee waivers and expense reimbursements due from the adviser which may become subject to recoupment.", "label": "Fee Waivers And Expense Reimbursements Due From The Adviser Which May Become Subject To Recoupment [Abstract]", "terseLabel": "Fee Waivers And Expense Reimbursements Due From The Adviser Which May Become Subject To Recoupment [Abstract]" } } }, "localname": "FeeWaiversAndExpenseReimbursementsDueFromTheAdviserWhichMayBecomeSubjectToRecoupmentAbstract", "nsuri": "http://www.npci.com/20230331", "xbrltype": "stringItemType" }, "cik0001588272_FeeWaiversAndExpenseReimbursementsDueFromTheAdviserWhichMayBecomeSubjectToRecoupmentLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fee waivers and expense reimbursements due from the adviser which may become subject to recoupment.", "label": "Fee Waivers And Expense Reimbursements Due From The Adviser Which May Become Subject To Recoupment [Line Items]", "terseLabel": "Fee Waivers And Expense Reimbursements Due From The Adviser Which May Become Subject To Recoupment [Line Items]" } } }, "localname": "FeeWaiversAndExpenseReimbursementsDueFromTheAdviserWhichMayBecomeSubjectToRecoupmentLineItems", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/RelatedPartyTransactionsAndArrangementsScheduleOfFeeWaiversAndExpenseReimbursementsDueFromTheAdviserWhichMayBecomeSubjectToRecoupmentDetail" ], "xbrltype": "stringItemType" }, "cik0001588272_FeeWaiversAndExpenseReimbursementsDueFromTheAdviserWhichMayBecomeSubjectToRecoupmentTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fee waivers and expense reimbursements due from the adviser which may become subject to recoupment.", "label": "Fee Waivers And Expense Reimbursements Due From The Adviser Which May Become Subject To Recoupment [Table]", "terseLabel": "Fee Waivers And Expense Reimbursements Due From The Adviser Which May Become Subject To Recoupment [Table]" } } }, "localname": "FeeWaiversAndExpenseReimbursementsDueFromTheAdviserWhichMayBecomeSubjectToRecoupmentTable", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/RelatedPartyTransactionsAndArrangementsScheduleOfFeeWaiversAndExpenseReimbursementsDueFromTheAdviserWhichMayBecomeSubjectToRecoupmentDetail" ], "xbrltype": "stringItemType" }, "cik0001588272_FinancialsAtThreePointFourPercentageMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Financials at three point four percentage.", "label": "Financials At Three Point Four Percentage [Member]", "terseLabel": "Financials At Three Point Four Percentage [Member]" } } }, "localname": "FinancialsAtThreePointFourPercentageMember", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/ScheduleOfInvestments1" ], "xbrltype": "domainItemType" }, "cik0001588272_FinancialsAtThreePointTwoPercentageMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Financials at three point two percentage.", "label": "Financials At Three Point Two Percentage [Member]", "terseLabel": "Financials At Three Point Two Percentage [Member]" } } }, "localname": "FinancialsAtThreePointTwoPercentageMember", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/ScheduleOfInvestments1" ], "xbrltype": "domainItemType" }, "cik0001588272_FinancialsAtTwoPointSevenPercentageMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Financials At Two Point Seven Percentage.", "label": "Financials At Two Point Seven Percentage [Member]", "terseLabel": "Financials At Two Point Seven Percentage [Member]" } } }, "localname": "FinancialsAtTwoPointSevenPercentageMember", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/ScheduleOfInvestments2" ], "xbrltype": "domainItemType" }, "cik0001588272_FinancialsAtZeroPointZeroPercentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Financials At Zero Point Zero Percent [Member]", "terseLabel": "Financials At Zero Point Zero Percent [Member]" } } }, "localname": "FinancialsAtZeroPointZeroPercentMember", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/ScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "cik0001588272_FinancialsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Financials.", "label": "Financials [Member]" } } }, "localname": "FinancialsMember", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfChangesInTheCompanySLevel3InvestmentsDetail", "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfInvestmentsCategorizeIntoFairValueHierarchyDetail" ], "xbrltype": "domainItemType" }, "cik0001588272_FirstLienDelayedDrawTermLoanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "First Lien Delayed Draw Term Loan.", "label": "First Lien Delayed Draw Term Loan [Member]", "terseLabel": "First Lien Delayed Draw Term Loan [Member]" } } }, "localname": "FirstLienDelayedDrawTermLoanMember", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/ScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "cik0001588272_FirstLienTermLoanEMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "First Lien Term Loan E.", "label": "First Lien Term Loan E [Member]", "terseLabel": "First Lien Term Loan E [Member]" } } }, "localname": "FirstLienTermLoanEMember", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/ScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "cik0001588272_FirstLienTermLoanFMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "First Lien Term Loan F.", "label": "First Lien Term Loan F [Member]", "terseLabel": "First Lien Term Loan F [Member]" } } }, "localname": "FirstLienTermLoanFMember", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/ScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "cik0001588272_FirstLienTermLoanGMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "First Lien Term Loan G.", "label": "First Lien Term Loan G [Member]", "terseLabel": "First Lien Term Loan G [Member]" } } }, "localname": "FirstLienTermLoanGMember", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/ScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "cik0001588272_FirstLienTermLoanHMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "First Lien Term Loan H.", "label": "First Lien Term Loan H [Member]", "terseLabel": "First Lien Term Loan H [Member]" } } }, "localname": "FirstLienTermLoanHMember", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/ScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "cik0001588272_FirstLienTermLoanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "First Lien Term Loan.", "label": "First Lien Term Loan [Member]", "terseLabel": "First Lien Term Loan [Member]" } } }, "localname": "FirstLienTermLoanMember", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/ScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "cik0001588272_FirstQuarterTenderOfferMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "First quarter tender offer.", "label": "First Quarter Tender Offer [Member]" } } }, "localname": "FirstQuarterTenderOfferMember", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/ShareRepurchaseProgramAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "cik0001588272_FundsAllotedGtoOvercomeThePandemicAndEconomicDistress": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Funds alloted gto overcome the pandemic and economic distress.", "label": "Funds Alloted Gto Overcome the Pandemic and Economic Distress", "terseLabel": "Funds alloted gto overcome the pandemic and economic distress" } } }, "localname": "FundsAllotedGtoOvercomeThePandemicAndEconomicDistress", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/MarketAndOtherRiskFactorsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "cik0001588272_GraysonInvestorCorp.Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Grayson Investor Corp.", "label": "Grayson Investor Corp. [Member]", "terseLabel": "Grayson Investor Corp. [Member]" } } }, "localname": "GraysonInvestorCorp.Member", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/ScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "cik0001588272_GraysonInvestorCorpMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Grayson investor corp.", "label": "Grayson Investor Corp [Member]" } } }, "localname": "GraysonInvestorCorpMember", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfInvestmentsUsingSignificantUnobservableInputDetail" ], "xbrltype": "domainItemType" }, "cik0001588272_HadrianMergerSubInc.Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Hadrian Merger Sub, Inc.", "label": "Hadrian Merger Sub, Inc. [Member]", "terseLabel": "Hadrian Merger Sub, Inc. [Member]" } } }, "localname": "HadrianMergerSubInc.Member", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/ScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "cik0001588272_HealthcareAtFourPointFivePercentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Corporate bonds at five point zero percent.", "label": "Healthcare At Four Point Five Percent [Member]", "terseLabel": "Healthcare At Four Point Five Percent [Member]" } } }, "localname": "HealthcareAtFourPointFivePercentMember", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/ScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "cik0001588272_HealthcareAtFourPointFourPercentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Healthcare At Four Point Four Percent.", "label": "Healthcare At Four Point Four Percent [Member]" } } }, "localname": "HealthcareAtFourPointFourPercentMember", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/ScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "cik0001588272_HealthcareAtNinteenPointSixPercentageMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Healthcare At Ninteen Point Six Percentage [Member]", "terseLabel": "Healthcare At Ninteen Point Six Percentage [Member]" } } }, "localname": "HealthcareAtNinteenPointSixPercentageMember", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/ScheduleOfInvestments2" ], "xbrltype": "domainItemType" }, "cik0001588272_HealthcareAtSixteenPointFivePercentageMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Healthcare At Sixteen Point Five Percentage [Member]", "terseLabel": "Healthcare At Sixteen Point Five Percentage [Member]" } } }, "localname": "HealthcareAtSixteenPointFivePercentageMember", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/ScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "cik0001588272_HealthcareAtTwentyFourPointFivePercentageMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Healthcare At Twenty Four Point Five Percentage [Member]" } } }, "localname": "HealthcareAtTwentyFourPointFivePercentageMember", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/ScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "cik0001588272_HealthcareAtTwentyPointSevenPercentageMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Healthcare at twenty point seven percentage.", "label": "Healthcare At Twenty Point Seven Percentage [Member]", "terseLabel": "Healthcare At Twenty Point Seven Percentage [Member]" } } }, "localname": "HealthcareAtTwentyPointSevenPercentageMember", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/ScheduleOfInvestments2" ], "xbrltype": "domainItemType" }, "cik0001588272_HurdleRate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Hurdle rate.", "label": "Hurdle Rate", "terseLabel": "Hurdle Rate" } } }, "localname": "HurdleRate", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/RelatedPartyTransactionsAndArrangementsAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "cik0001588272_HurdleRateExpressedAsRateOfReturnOnNetAssetsEqualToPercentagePerQuarter": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Hurdle rate expressed as rate of return on net assets equal to percentage per quarter.", "label": "Hurdle Rate Expressed As Rate of Return ON Net Assets Equal To Percentage Per Quarter", "terseLabel": "Hurdle Rate Expressed As Rate of Return ON Net Assets Equal To Percentage Per Quarter" } } }, "localname": "HurdleRateExpressedAsRateOfReturnOnNetAssetsEqualToPercentagePerQuarter", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/RelatedPartyTransactionsAndArrangementsAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "cik0001588272_IheartcommunicationsInc.Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "iHeartCommunications, Inc.", "label": "iHeartCommunications, Inc. [Member]", "terseLabel": "iHeartCommunications, Inc. [Member]" } } }, "localname": "IheartcommunicationsInc.Member", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/ScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "cik0001588272_IheartmediaInc.Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "iHeartMedia, Inc.", "label": "iHeartMedia, Inc. [Member]", "terseLabel": "iHeartMedia, Inc. [Member]" } } }, "localname": "IheartmediaInc.Member", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/ScheduleOfInvestments2" ], "xbrltype": "domainItemType" }, "cik0001588272_IncentiveFeeExpenseOnCapitalGains": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "incentive fee expense on capital gains", "label": "Incentive Fee Expense On Capital Gains", "terseLabel": "Incentive fee incurred on capital gains" } } }, "localname": "IncentiveFeeExpenseOnCapitalGains", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/RelatedPartyTransactionsAndArrangementsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "cik0001588272_IncreaseDecreaseInPayableForFundSharesRepurchased": { "auth_ref": [], "calculation": { "http://www.npci.com/role/StatementsOfCashFlows": { "order": 19.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Increase decrease in payable for fund shares repurchased.", "label": "Increase Decrease In Payable For Fund Shares Repurchased", "terseLabel": "Increase (decrease) in payable for fund shares repurchased" } } }, "localname": "IncreaseDecreaseInPayableForFundSharesRepurchased", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "cik0001588272_IncreaseDecreaseInPayableForInvestmentsPurchased": { "auth_ref": [], "calculation": { "http://www.npci.com/role/StatementsOfCashFlows": { "order": 13.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Increase Decrease In Payable For Investments Purchased", "label": "Increase Decrease In Payable For Investments Purchased", "terseLabel": "Increase (decrease) in payable for investments purchased" } } }, "localname": "IncreaseDecreaseInPayableForInvestmentsPurchased", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "cik0001588272_IncreaseDecreaseInReceivableForInvestmentsSold": { "auth_ref": [], "calculation": { "http://www.npci.com/role/StatementsOfCashFlows": { "order": 9.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Increase decrease in receivable for investments sold.", "label": "Increase decrease in receivable for investments sold", "terseLabel": "(Increase) decrease in receivable for investments sold" } } }, "localname": "IncreaseDecreaseInReceivableForInvestmentsSold", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "cik0001588272_InterestRateAtEightPointThreeEightPercentageMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Interest Rate At Eight Point Three Eight Percentage.", "label": "Interest Rate At Eight Point Three Eight Percentage [Member]", "terseLabel": "Interest Rate At Eight Point Three Eight Percentage [Member]" } } }, "localname": "InterestRateAtEightPointThreeEightPercentageMember", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/ScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "cik0001588272_InterestRateAtSixPointThreeEightPercentageMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Interest Rate At Six Point Three Eight Percentage .", "label": "Interest Rate At Six Point Three Eight Percentage [Member]", "terseLabel": "Interest Rate At Six Point Three Eight Percentage [Member]" } } }, "localname": "InterestRateAtSixPointThreeEightPercentageMember", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/ScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "cik0001588272_InterestTypeAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Interest type.", "label": "Interest Type [Axis]" } } }, "localname": "InterestTypeAxis", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/ScheduleOfInvestmentsParenthentical" ], "xbrltype": "stringItemType" }, "cik0001588272_InterestTypeDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Interest type.", "label": "Interest Type [Domain]" } } }, "localname": "InterestTypeDomain", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/ScheduleOfInvestmentsParenthentical" ], "xbrltype": "domainItemType" }, "cik0001588272_InvesteeAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Investee.", "label": "Investee [Axis]" } } }, "localname": "InvesteeAxis", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfInvestmentsUsingSignificantUnobservableInputDetail" ], "xbrltype": "stringItemType" }, "cik0001588272_InvesteeDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Investee.", "label": "Investee [Domain]" } } }, "localname": "InvesteeDomain", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfInvestmentsUsingSignificantUnobservableInputDetail" ], "xbrltype": "domainItemType" }, "cik0001588272_InvestmentAdvisoryFee": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Investment advisory fee.", "label": "Investment Advisory Fee", "terseLabel": "Investment Advisory Fee payable incurred during period" } } }, "localname": "InvestmentAdvisoryFee", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/RelatedPartyTransactionsAndArrangementsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "cik0001588272_InvestmentBaseFloorRateOfInterest": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Investment base floor rate of interest.", "label": "Investment Base Floor Rate Of Interest", "terseLabel": "Base Rate Floor" } } }, "localname": "InvestmentBaseFloorRateOfInterest", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/ScheduleOfInvestments" ], "xbrltype": "stringItemType" }, "cik0001588272_InvestmentClassificationByTypeAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Investment Classification By Type [Axis]" } } }, "localname": "InvestmentClassificationByTypeAxis", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/InvestmentPortfolioTables" ], "xbrltype": "stringItemType" }, "cik0001588272_InvestmentClassificationByTypeDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Investment Classification By Type [Domain]" } } }, "localname": "InvestmentClassificationByTypeDomain", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/InvestmentPortfolioTables" ], "xbrltype": "domainItemType" }, "cik0001588272_InvestmentCompanyassetCoverageRatio": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Investment company,\u00a0asset coverage ratio.", "label": "Investment Company,Asset Coverage Ratio", "terseLabel": "Asset coverage ratio" } } }, "localname": "InvestmentCompanyassetCoverageRatio", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/FinancialHighlightsSummaryOfShareOutstandingDetail" ], "xbrltype": "percentItemType" }, "cik0001588272_InvestmentCompanyfromNetInvestmentIncomePerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Investment company,\u00a0from net investment income, per share.", "label": "Investment Company,From Net Investment Income, Per Share", "terseLabel": "From net investment income (per share)" } } }, "localname": "InvestmentCompanyfromNetInvestmentIncomePerShare", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/FinancialHighlightsSummaryOfShareOutstandingDetail" ], "xbrltype": "decimalItemType" }, "cik0001588272_InvestmentCompanyissuanceOfCommonStockPerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Investment Company,\u00a0issuance of common stock, per share.", "label": "Investment Company,Issuance of Common Stock, Per Share", "terseLabel": "Issuance of common stock(2) (per share)" } } }, "localname": "InvestmentCompanyissuanceOfCommonStockPerShare", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/FinancialHighlightsSummaryOfShareOutstandingDetail" ], "xbrltype": "decimalItemType" }, "cik0001588272_InvestmentCompanyportfolioTurnoverRate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Investment company,\u00a0portfolio turnover rate.", "label": "Investment Company,Portfolio Turnover Rate", "terseLabel": "Portfolio turnover rate(4)" } } }, "localname": "InvestmentCompanyportfolioTurnoverRate", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/FinancialHighlightsSummaryOfShareOutstandingDetail" ], "xbrltype": "percentItemType" }, "cik0001588272_InvestmentCompanysharesTenderedPerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Investment company,\u00a0shares tendered, per share.", "label": "Investment Company,Shares Tendered, Per Share", "terseLabel": "Shares tendered(1) (per share)" } } }, "localname": "InvestmentCompanysharesTenderedPerShare", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/FinancialHighlightsSummaryOfShareOutstandingDetail" ], "xbrltype": "decimalItemType" }, "cik0001588272_InvestmentDescriptionOfInterestRate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Investment description of interest rate.", "label": "Investment Description Of Interest Rate", "terseLabel": "Interest Rate" } } }, "localname": "InvestmentDescriptionOfInterestRate", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/ScheduleOfInvestments" ], "xbrltype": "stringItemType" }, "cik0001588272_InvestmentOwnedAtAmortizedCost": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Investment Owned At Amortized Cost", "label": "Investment Owned At Amortized Cost", "terseLabel": "Amortized Cost" } } }, "localname": "InvestmentOwnedAtAmortizedCost", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/ScheduleOfInvestments", "http://www.npci.com/role/ScheduleOfInvestments1", "http://www.npci.com/role/ScheduleOfInvestments2" ], "xbrltype": "monetaryItemType" }, "cik0001588272_InvestmentOwnedNameOfTheCompany": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Investment owned name of the company.", "label": "Investment Owned Name Of The Company", "terseLabel": "Portfolio Company" } } }, "localname": "InvestmentOwnedNameOfTheCompany", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/ScheduleOfInvestments", "http://www.npci.com/role/ScheduleOfInvestments1", "http://www.npci.com/role/ScheduleOfInvestments2" ], "xbrltype": "stringItemType" }, "cik0001588272_InvestmentOwnedPercentageOfTotalAssets": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Investment owned percentage of total assets.", "label": "Investment Owned Percentage Of Total Assets", "terseLabel": "Percentage", "verboseLabel": "Percentage of Portfolio (at Fair Value)" } } }, "localname": "InvestmentOwnedPercentageOfTotalAssets", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/InvestmentPortfolioSummaryOfInvestmentCompanyAssetsByIndustryClassificationAtFairValueDetail", "http://www.npci.com/role/InvestmentPortfolioSummaryOfInvestmentHoldingsScheduleOfInvestmentsDetail", "http://www.npci.com/role/InvestmentPortfolioSummaryOfTheCompanySInvestedAssetsByGeographicClassificationDetail" ], "xbrltype": "percentItemType" }, "cik0001588272_InvestmentOwnedinterestRates": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Investment owned ,interest rates.", "label": "Investment owned ,Interest Rates", "terseLabel": "Investment owned ,Interest Rates" } } }, "localname": "InvestmentOwnedinterestRates", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/ScheduleOfInvestmentsParenthentical" ], "xbrltype": "percentItemType" }, "cik0001588272_InvestmentTypeOneAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Investment type one.", "label": "Investment Type One [Axis]" } } }, "localname": "InvestmentTypeOneAxis", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfInvestmentsUsingSignificantUnobservableInputDetail" ], "xbrltype": "stringItemType" }, "cik0001588272_InvestmentTypeOneDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Investment type one.", "label": "Investment Type One [Domain]" } } }, "localname": "InvestmentTypeOneDomain", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfInvestmentsUsingSignificantUnobservableInputDetail" ], "xbrltype": "domainItemType" }, "cik0001588272_InvestmentsByGeographyMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Investments by geography.", "label": "Investments By Geography [Member]" } } }, "localname": "InvestmentsByGeographyMember", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/InvestmentPortfolioTables" ], "xbrltype": "domainItemType" }, "cik0001588272_InvestmentsByIndustryMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Investments by industry.", "label": "Investments By Industry [Member]" } } }, "localname": "InvestmentsByIndustryMember", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/InvestmentPortfolioTables" ], "xbrltype": "domainItemType" }, "cik0001588272_InvestmentsClassificationByIndustryAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Investments classification by industry.", "label": "Investments Classification By Industry [Axis]" } } }, "localname": "InvestmentsClassificationByIndustryAxis", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/InvestmentPortfolioSummaryOfInvestmentHoldingsScheduleOfInvestmentsDetail" ], "xbrltype": "stringItemType" }, "cik0001588272_InvestmentsClassificationByIndustryDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Investments classification by industry.", "label": "Investments Classification By Industry [Domain]" } } }, "localname": "InvestmentsClassificationByIndustryDomain", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/InvestmentPortfolioSummaryOfInvestmentHoldingsScheduleOfInvestmentsDetail" ], "xbrltype": "domainItemType" }, "cik0001588272_InvestmentsInAndAdvancesToAffiliatesAtFairValueChangeinUnrealizedAppreciationDepreciation": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Investments in and advances to affiliates, at Fair Value, change\u00a0in unrealized appreciation (depreciation).", "label": "Investments in and Advances to Affiliates, at Fair Value, Changein unrealized appreciation (depreciation)", "terseLabel": "Change in unrealized appreciation (depreciation)" } } }, "localname": "InvestmentsInAndAdvancesToAffiliatesAtFairValueChangeinUnrealizedAppreciationDepreciation", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/AffiliatedInvestmentsSummaryOfAffiliatedIssuersOfTheCompanyDetail" ], "xbrltype": "monetaryItemType" }, "cik0001588272_InvestmentsInAndAdvancesToAffiliatesAtFairValueRealizedGainsLosses": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Investments in and advances to affiliates, at fair Value, realized gains (losses).", "label": "Investments in and Advances to Affiliates, at Fair Value, Realized gains (losses)", "terseLabel": "Realized gains (losses)" } } }, "localname": "InvestmentsInAndAdvancesToAffiliatesAtFairValueRealizedGainsLosses", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/AffiliatedInvestmentsSummaryOfAffiliatedIssuersOfTheCompanyDetail" ], "xbrltype": "monetaryItemType" }, "cik0001588272_IqhqIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "IQHQ, Inc .", "label": "IQHQ, Inc [Member]", "terseLabel": "IQHQ, Inc [Member]" } } }, "localname": "IqhqIncMember", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/ScheduleOfInvestments1" ], "xbrltype": "domainItemType" }, "cik0001588272_IqhqMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "IQHQ.", "label": "IQHQ [Member]", "terseLabel": "IQHQ, Inc [Member]" } } }, "localname": "IqhqMember", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfInvestmentsUsingSignificantUnobservableInputDetail" ], "xbrltype": "domainItemType" }, "cik0001588272_JuneThirtyTwoThousandAndTwentyFiveMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "June thirty two thousand and twenty five.", "label": "June Thirty Two Thousand And twenty Five [Member]", "terseLabel": "June 30, 2025 [Member]" } } }, "localname": "JuneThirtyTwoThousandAndTwentyFiveMember", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/RelatedPartyTransactionsAndArrangementsScheduleOfFeeWaiversAndExpenseReimbursementsDueFromTheAdviserWhichMayBecomeSubjectToRecoupmentDetail" ], "xbrltype": "domainItemType" }, "cik0001588272_JuneThirtyTwoThousandAndTwentyFourMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "June thirty two thousand and twenty four.", "label": "June Thirty Two Thousand And Twenty Four [Member]", "terseLabel": "June\u00a030, 2024 [Member]" } } }, "localname": "JuneThirtyTwoThousandAndTwentyFourMember", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/RelatedPartyTransactionsAndArrangementsScheduleOfFeeWaiversAndExpenseReimbursementsDueFromTheAdviserWhichMayBecomeSubjectToRecoupmentDetail" ], "xbrltype": "domainItemType" }, "cik0001588272_JuneThirtyTwoThousandAndTwentyThreeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "June thirty two thousand and twenty three.", "label": "June Thirty Two Thousand And Twenty Three [Member]", "terseLabel": "June\u00a030, 2023 [Member]" } } }, "localname": "JuneThirtyTwoThousandAndTwentyThreeMember", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/RelatedPartyTransactionsAndArrangementsScheduleOfFeeWaiversAndExpenseReimbursementsDueFromTheAdviserWhichMayBecomeSubjectToRecoupmentDetail" ], "xbrltype": "domainItemType" }, "cik0001588272_LLCInterestsAtEightPointSevenPercentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "LLC interests at eight point seven percent.", "label": "LLC Interests At Eight Point Seven Percent [Member]", "terseLabel": "LLC Interests At Eight Point Seven Percent [Member]" } } }, "localname": "LLCInterestsAtEightPointSevenPercentMember", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/ScheduleOfInvestments1" ], "xbrltype": "domainItemType" }, "cik0001588272_LLCInterestsAtNineteenPointNinePercentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "LLC interests at nineteen point nine percent.", "label": "LLC Interests At Nineteen Point Nine Percent [Member]" } } }, "localname": "LLCInterestsAtNineteenPointNinePercentMember", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/ScheduleOfInvestments1" ], "xbrltype": "domainItemType" }, "cik0001588272_LessDistributionDeclaredToCommonShareholdersAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Less distribution declared to common shareholders.", "label": "Less Distribution Declared to Common Shareholders [Abstract]", "terseLabel": "Less distribution declared to common shareholders:" } } }, "localname": "LessDistributionDeclaredToCommonShareholdersAbstract", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/FinancialHighlightsSummaryOfShareOutstandingDetail" ], "xbrltype": "stringItemType" }, "cik0001588272_LlcInterestsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "LLC interests.", "label": "LLC Interests [Member]" } } }, "localname": "LlcInterestsMember", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfChangesInTheCompanySLevel3InvestmentsDetail", "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfInvestmentsCategorizeIntoFairValueHierarchyDetail", "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfInvestmentsUsingSignificantUnobservableInputDetail", "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityDetail" ], "xbrltype": "domainItemType" }, "cik0001588272_LlcInterestsOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "LLC interests one.", "label": "LLC Interests One [Member]" } } }, "localname": "LlcInterestsOneMember", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfInvestmentsUsingSignificantUnobservableInputDetail" ], "xbrltype": "domainItemType" }, "cik0001588272_LlcMemberInterestsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "LLC Member Interests [Member]", "terseLabel": "LLC Interests" } } }, "localname": "LlcMemberInterestsMember", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/InvestmentPortfolioSummaryOfInvestmentCompanyAssetsByIndustryClassificationAtFairValueDetail" ], "xbrltype": "domainItemType" }, "cik0001588272_LongTermInvestmentsMeasurementInput": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Long Term Investments Measurement Input", "label": "Long Term Investments Measurement Input", "terseLabel": "Range of input values (weighted average)" } } }, "localname": "LongTermInvestmentsMeasurementInput", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityDetail" ], "xbrltype": "pureItemType" }, "cik0001588272_MarchThirtyFirstTwoThousandAndTwentyFiveMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "March thirty first two thousand and twenty five.", "label": "March Thirty First Two Thousand And Twenty Five [Member]", "terseLabel": "March\u00a031,\u00a02025 [Member]" } } }, "localname": "MarchThirtyFirstTwoThousandAndTwentyFiveMember", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/RelatedPartyTransactionsAndArrangementsScheduleOfFeeWaiversAndExpenseReimbursementsDueFromTheAdviserWhichMayBecomeSubjectToRecoupmentDetail" ], "xbrltype": "domainItemType" }, "cik0001588272_MarchThirtyFirstTwoThousandAndTwentyFourMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "March thirty first two thousand and twenty four.", "label": "March Thirty First Two Thousand And Twenty Four [Member]", "terseLabel": "March\u00a031, 2024 [Member]" } } }, "localname": "MarchThirtyFirstTwoThousandAndTwentyFourMember", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/RelatedPartyTransactionsAndArrangementsScheduleOfFeeWaiversAndExpenseReimbursementsDueFromTheAdviserWhichMayBecomeSubjectToRecoupmentDetail" ], "xbrltype": "domainItemType" }, "cik0001588272_MarchThirtyOneTwoThousandTwentySixMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "March Thirty one Two Thousand Twenty Six [Member]", "terseLabel": "March 31, 2026 [Member]" } } }, "localname": "MarchThirtyOneTwoThousandTwentySixMember", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/RelatedPartyTransactionsAndArrangementsScheduleOfFeeWaiversAndExpenseReimbursementsDueFromTheAdviserWhichMayBecomeSubjectToRecoupmentDetail" ], "xbrltype": "domainItemType" }, "cik0001588272_MaximumRecoupmentOfOtherExpensesExceedsTheAnnualRatePercentageOfAverageGrossAssets": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Maximum recoupment of other expenses exceeds the annual rate percentage of average gross assets.", "label": "Maximum Recoupment Of Other Expenses Exceeds The Annual Rate Percentage Of Average Gross Assets", "terseLabel": "Maximum Recoupment Of Other Expenses Exceeds TheAnnual Rate Percentage Of Average Gross Assets" } } }, "localname": "MaximumRecoupmentOfOtherExpensesExceedsTheAnnualRatePercentageOfAverageGrossAssets", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/RelatedPartyTransactionsAndArrangementsAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "cik0001588272_MeasurementInputEnterpriseValueMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Measurement input enterprise value.", "label": "Measurement Input Enterprise Value [Member]" } } }, "localname": "MeasurementInputEnterpriseValueMember", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityDetail" ], "xbrltype": "domainItemType" }, "cik0001588272_MeasurementInputNavMultipleMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Measurement input NAV multiple.", "label": "Measurement Input NAV Multiple [Member]" } } }, "localname": "MeasurementInputNavMultipleMember", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityDetail" ], "xbrltype": "domainItemType" }, "cik0001588272_MeasurementInputRecoveryRateMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Measurement input recovery rate.", "label": "Measurement Input Recovery Rate [Member]" } } }, "localname": "MeasurementInputRecoveryRateMember", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityDetail" ], "xbrltype": "domainItemType" }, "cik0001588272_MeasurementInputUnadjustedPriceMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Measurement input unadjusted price.", "label": "Measurement Input Unadjusted Price [Member]" } } }, "localname": "MeasurementInputUnadjustedPriceMember", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityDetail" ], "xbrltype": "domainItemType" }, "cik0001588272_MediaAndTelecommunicationsAtZeroPointFivePercentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Media And Telecommunications At Zero Point Five Percent.", "label": "Media And Telecommunications At Zero Point Five Percent [Member]", "terseLabel": "Media And Telecommunications At Zero Point Five Percent [Member]" } } }, "localname": "MediaAndTelecommunicationsAtZeroPointFivePercentMember", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/ScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "cik0001588272_MediaAndTelecommunicationsAtZeroPointOnePercentageMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Media And Telecommunications At Zero Point One Percentage.", "label": "Media And Telecommunications At Zero Point One Percentage [Member]", "terseLabel": "Media And Telecommunications At Zero Point One Percentage [Member]" } } }, "localname": "MediaAndTelecommunicationsAtZeroPointOnePercentageMember", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/ScheduleOfInvestments2" ], "xbrltype": "domainItemType" }, "cik0001588272_MediaAndTelecommunicationsAtZeroPointZeroPercentageMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Media And Telecommunications At Zero Point Zero Percentage.", "label": "Media And Telecommunications At Zero Point Zero Percentage [Member]" } } }, "localname": "MediaAndTelecommunicationsAtZeroPointZeroPercentageMember", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/ScheduleOfInvestments2" ], "xbrltype": "domainItemType" }, "cik0001588272_MediaAndTelecommunicationsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Media and telecommunications.", "label": "Media And Telecommunications [Member]", "terseLabel": "Media/Telecommunications" } } }, "localname": "MediaAndTelecommunicationsMember", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/InvestmentPortfolioSummaryOfInvestmentHoldingsScheduleOfInvestmentsDetail", "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfInvestmentsCategorizeIntoFairValueHierarchyDetail" ], "xbrltype": "domainItemType" }, "cik0001588272_MinimumLimitOfSharesToBeRepurchasedPercent": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Minimum limit of shares to be repurchased, percent.", "label": "Minimum Limit of Shares to be Repurchased, Percent", "terseLabel": "Minimum limit of shares to be repurchased, percent" } } }, "localname": "MinimumLimitOfSharesToBeRepurchasedPercent", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/ShareRepurchaseProgramAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "cik0001588272_MinimumNoticePeriodOfSharesToBeSuspendOrTerminate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Minimum notice period of shares to be suspend or terminate.", "label": "Minimum Notice Period of Shares to be Suspend or Terminate", "terseLabel": "Minimum notice period of shares to be suspend or terminate" } } }, "localname": "MinimumNoticePeriodOfSharesToBeSuspendOrTerminate", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/ShareRepurchaseProgramAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "cik0001588272_MinimumReimbursementAmountAsAPercentageOfAverageGrossAssets": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "minimum reimbursement amount as a percentage of average gross assets.", "label": "Minimum Reimbursement Amount As A Percentage Of Average Gross Assets", "terseLabel": "Minimum Reimbursement Amount As A Percentage Of Average Gross Assets" } } }, "localname": "MinimumReimbursementAmountAsAPercentageOfAverageGrossAssets", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/RelatedPartyTransactionsAndArrangementsAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "cik0001588272_MpmHoldingsIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "MPM Holdings, Inc .", "label": "MPM Holdings, Inc [Member]", "terseLabel": "MPM Holdings, Inc [Member]" } } }, "localname": "MpmHoldingsIncMember", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/ScheduleOfInvestments1" ], "xbrltype": "domainItemType" }, "cik0001588272_NatureOfBusinessAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Nature of business.", "label": "Nature Of Business [Axis]" } } }, "localname": "NatureOfBusinessAxis", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfChangesInTheCompanySLevel3InvestmentsDetail", "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfInvestmentsCategorizeIntoFairValueHierarchyDetail" ], "xbrltype": "stringItemType" }, "cik0001588272_NatureOfBusinessDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Nature of business.", "label": "Nature Of Business [Domain]" } } }, "localname": "NatureOfBusinessDomain", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfChangesInTheCompanySLevel3InvestmentsDetail", "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfInvestmentsCategorizeIntoFairValueHierarchyDetail" ], "xbrltype": "domainItemType" }, "cik0001588272_NetChangeInUnrealizedAppreciationDepreciationOnInvestment": { "auth_ref": [], "calculation": { "http://www.npci.com/role/StatementsOfOperations": { "order": 20.0, "parentTag": "us-gaap_InvestmentCompanyRealizedAndUnrealizedGainLossOnInvestmentAndForeignCurrency", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Net change in unrealized appreciation (depreciation) on investment.", "label": "Net Change In Unrealized Appreciation (Depreciation) On Investment", "terseLabel": "Net change in unrealized appreciation (depreciation) on:" } } }, "localname": "NetChangeInUnrealizedAppreciationDepreciationOnInvestment", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "cik0001588272_NetRealizedGainLossOnTotalReturnSwaps": { "auth_ref": [], "calculation": { "http://www.npci.com/role/StatementsOfOperations": { "order": 19.0, "parentTag": "us-gaap_InvestmentCompanyRealizedAndUnrealizedGainLossOnInvestmentAndForeignCurrency", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Net realized gain loss on total return swaps.", "label": "Net Realized Gain Loss On Total Return Swaps", "terseLabel": "Net realized gain (loss) on:" } } }, "localname": "NetRealizedGainLossOnTotalReturnSwaps", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "cik0001588272_NexpointCapitalReitLlc.Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "NexPoint Capital REIT, LLC.", "label": "NexPoint Capital REIT, LLC. [Member]", "terseLabel": "NexPoint Capital REIT, LLC. [Member]" } } }, "localname": "NexpointCapitalReitLlc.Member", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfInvestmentsUsingSignificantUnobservableInputDetail" ], "xbrltype": "domainItemType" }, "cik0001588272_NexpointCapitalReitLlcSeniorLoansCommonStocksMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "NexPoint Capital REIT, LLC (Senior Loans & Common Stocks).", "label": "NexPoint Capital REIT, LLC (Senior Loans Common Stocks) [Member]", "terseLabel": "NexPoint Capital REIT, LLC [Member]" } } }, "localname": "NexpointCapitalReitLlcSeniorLoansCommonStocksMember", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/AffiliatedInvestmentsSummaryOfAffiliatedIssuersOfTheCompanyDetail", "http://www.npci.com/role/ScheduleOfInvestments", "http://www.npci.com/role/ScheduleOfInvestments1", "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfInvestmentsUsingSignificantUnobservableInputDetail" ], "xbrltype": "domainItemType" }, "cik0001588272_NexpointRealEstateFinanceInc.Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "NexPoint Real Estate Finance, Inc.", "label": "NexPoint Real Estate Finance, Inc. [Member]", "terseLabel": "NexPoint Real Estate Finance, Inc. [Member]" } } }, "localname": "NexpointRealEstateFinanceInc.Member", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/AffiliatedInvestmentsSummaryOfAffiliatedIssuersOfTheCompanyDetail", "http://www.npci.com/role/ScheduleOfInvestments1" ], "xbrltype": "domainItemType" }, "cik0001588272_NexpointResidentialTrustInc.Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "NexPoint Residential Trust, Inc.", "label": "NexPoint Residential Trust, Inc. [Member]", "terseLabel": "NexPoint Residential Trust, Inc. [Member]" } } }, "localname": "NexpointResidentialTrustInc.Member", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/AffiliatedInvestmentsSummaryOfAffiliatedIssuersOfTheCompanyDetail", "http://www.npci.com/role/ScheduleOfInvestments1" ], "xbrltype": "domainItemType" }, "cik0001588272_NextPointAdvisorsL.pMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Next Point Advisors L.P [Member]" } } }, "localname": "NextPointAdvisorsL.pMember", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/OrganizationAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "cik0001588272_NonControlledOrNonAffiliatedInvestmentsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Non Controlled or Non Affiliated Investments [Member]", "terseLabel": "Unaffiliated investments" } } }, "localname": "NonControlledOrNonAffiliatedInvestmentsMember", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/StatementsOfAssetsAndLiabilities", "http://www.npci.com/role/StatementsOfAssetsAndLiabilitiesParenthetical", "http://www.npci.com/role/StatementsOfCashFlows", "http://www.npci.com/role/StatementsOfOperations" ], "xbrltype": "domainItemType" }, "cik0001588272_OfferingCostsAsAPercentageOfTotalProceedsRaised": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Offering costs as a percentage of total proceeds raised.", "label": "Offering Costs As A Percentage Of Total Proceeds Raised", "terseLabel": "Offering costs as a percentage of total proceeds raised" } } }, "localname": "OfferingCostsAsAPercentageOfTotalProceedsRaised", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "cik0001588272_OperatingExpensesNet": { "auth_ref": [], "calculation": { "http://www.npci.com/role/StatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_NetInvestmentIncome", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Operating Expenses Net", "label": "Operating Expenses Net", "totalLabel": "Net expenses" } } }, "localname": "OperatingExpensesNet", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "cik0001588272_OptionsPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Options [Policy Text Block].", "label": "Options [Policy Text Block]", "terseLabel": "Options" } } }, "localname": "OptionsPolicyTextBlock", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "cik0001588272_OrganizationAndOfferingCostsPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Organization and offering costs [Policy Text Block].", "label": "Organization And Offering Costs [Policy Text Block]", "terseLabel": "Organization and Offering Costs" } } }, "localname": "OrganizationAndOfferingCostsPolicyTextBlock", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "cik0001588272_OrganizationCostsAndOfferingCostsAreLimitedToPercentageOfTotalGrossProceedsRaisedInTheOffering": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Organization costs and offering costs are limited to percentage of total gross proceeds raised in the offering.", "label": "Organization Costs And Offering Costs Are Limited To Percentage Of Total Gross Proceeds Raised In The Offering", "terseLabel": "Organization costs and offering costs are limited to percentage of total gross proceeds raised in the offering" } } }, "localname": "OrganizationCostsAndOfferingCostsAreLimitedToPercentageOfTotalGrossProceedsRaisedInTheOffering", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/RelatedPartyTransactionsAndArrangementsAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "cik0001588272_OrganizationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Organization [Line Items]" } } }, "localname": "OrganizationLineItems", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/OrganizationAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "cik0001588272_OrganizationTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Organization [Table]" } } }, "localname": "OrganizationTable", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/OrganizationAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "cik0001588272_OtherAssetsLiabilitiesNetAtOnePointEightPercentageMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other Assets Liabilities, net At One Point Eight Percentage [Member]" } } }, "localname": "OtherAssetsLiabilitiesNetAtOnePointEightPercentageMember", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/ScheduleOfInvestments2" ], "xbrltype": "domainItemType" }, "cik0001588272_OtherAssetsLiabilitiesNetAtThreePointTwoPercentageMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Other assets liabilities net at three point two percentage.", "label": "Other Assets Liabilities Net At Three Point Two Percentage [Member]", "terseLabel": "Other Assets Liabilities Net At Three Point Two Percentage [Member]" } } }, "localname": "OtherAssetsLiabilitiesNetAtThreePointTwoPercentageMember", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/ScheduleOfInvestments2" ], "xbrltype": "domainItemType" }, "cik0001588272_OtherFeeIncomePolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Other fee income [Policy Text Block].", "label": "Other Fee Income [Policy Text Block]", "terseLabel": "Other Fee Income" } } }, "localname": "OtherFeeIncomePolicyTextBlock", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "cik0001588272_PamcoClo19971abMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "PAMCO CLO\u00a01997-1A\u00a0B.", "label": "PAMCO CLO19971AB [Member]", "terseLabel": "PAMCO CLO19971AB [Member]" } } }, "localname": "PamcoClo19971abMember", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/ScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "cik0001588272_PamcoCloNineteenNinetySevenOneABMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "PAMCO CLO nineteen ninety seven one A B.", "label": "PAMCO CLO Nineteen Ninety Seven One A B [Member]", "terseLabel": "PAMCO CLO 1997-1A B [Member]" } } }, "localname": "PamcoCloNineteenNinetySevenOneABMember", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfInvestmentsUsingSignificantUnobservableInputDetail" ], "xbrltype": "domainItemType" }, "cik0001588272_PaymentInKindInterestIncome": { "auth_ref": [], "calculation": { "http://www.npci.com/role/StatementsOfOperations": { "order": 16.0, "parentTag": "us-gaap_GrossInvestmentIncomeOperating", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Payment In kind Interest Income.", "label": "Payment In kind Interest Income", "terseLabel": "Interest\u00a0paid-in-kind" } } }, "localname": "PaymentInKindInterestIncome", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "cik0001588272_PaymentInKindInvestments": { "auth_ref": [], "calculation": { "http://www.npci.com/role/StatementsOfCashFlows": { "order": 17.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Payment-in-kind investments.", "label": "Payment In Kind Investments", "negatedLabel": "Payment-in-kind\u00a0investments" } } }, "localname": "PaymentInKindInvestments", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "cik0001588272_PaymentOfIncentiveFeesWithRespectToRealizedGainsToTheAdviser": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Payment of incentive fees with respect to realized gains to the adviser.", "label": "Payment Of Incentive fees With Respect TO Realized Gains To The Adviser", "terseLabel": "Payment Of Incentive fees With Respect TO Realized Gains To The Adviser" } } }, "localname": "PaymentOfIncentiveFeesWithRespectToRealizedGainsToTheAdviser", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/RelatedPartyTransactionsAndArrangementsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "cik0001588272_PercentageOfDistributionToShareholdersInvestmentCompanyTaxableIncome": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of distribution to shareholders, investment company taxable income.", "label": "Percentage of Distribution to Shareholders, Investment Company Taxable Income", "terseLabel": "Percentage of Distribution to Shareholders,investment company taxable income" } } }, "localname": "PercentageOfDistributionToShareholdersInvestmentCompanyTaxableIncome", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/USFederalIncomeTaxInformationAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "cik0001588272_PercentageOfIncentiveFeeCapitalGainsIsDeterminedAndPayableInArrearsAsAtEndOfEachCalenderYear": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of incentive fee capital gains is determined and payable in arrears as at end of each calender year.", "label": "Percentage Of Incentive Fee Capital Gains Is Determined And Payable In Arrears As At End Of Each Calender Year", "terseLabel": "Percentage Of Incentive Fee Capital Gains Is Determined And Payable In Arrears As At End Of Each Calender Year" } } }, "localname": "PercentageOfIncentiveFeeCapitalGainsIsDeterminedAndPayableInArrearsAsAtEndOfEachCalenderYear", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/RelatedPartyTransactionsAndArrangementsAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "cik0001588272_PercentageOfNetAssetsUnderValuationProcedure": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of net assets under valuation procedure.", "label": "Percentage of Net Assets Under Valuation Procedure", "terseLabel": "Percentage of Net Assets under valuation procedure" } } }, "localname": "PercentageOfNetAssetsUnderValuationProcedure", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/ScheduleOfInvestmentsParenthentical" ], "xbrltype": "percentItemType" }, "cik0001588272_PercentageOfNonQualifyingAssetOnCompanysTotalAsset": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of non qualifying asset on company's total asset.", "label": "Percentage of Non Qualifying Asset on Companys Total Asset", "terseLabel": "Percentage of Non Qualifying Asset on Company's total asset" } } }, "localname": "PercentageOfNonQualifyingAssetOnCompanysTotalAsset", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/ScheduleOfInvestmentsParenthentical" ], "xbrltype": "percentItemType" }, "cik0001588272_PercentageOfShareOfferedToPurchaseForCash": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of share offered to purchase for cash.", "label": "Percentage of Share Offered to Purchase for Cash", "terseLabel": "Percentage of share offered to purchase for cash" } } }, "localname": "PercentageOfShareOfferedToPurchaseForCash", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/ShareRepurchaseProgramAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "cik0001588272_PercentageOfSharesToBeIssuedUnderCeilingLimitOfNetAssetValuePerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of shares to be issued under ceiling limit of net asset value per share.", "label": "Percentage of Shares to be Issued Under Ceiling Limit of Net Asset Value Per Share", "terseLabel": "Percentage of shares tobe issued under ceiling limit of net asset value per share" } } }, "localname": "PercentageOfSharesToBeIssuedUnderCeilingLimitOfNetAssetValuePerShare", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/ShareRepurchaseProgramAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "cik0001588272_PlanActAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Plan act.", "label": "Plan Act [Axis]" } } }, "localname": "PlanActAxis", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/MarketAndOtherRiskFactorsAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "cik0001588272_PlanActDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Plan act.", "label": "Plan Act [Domain]" } } }, "localname": "PlanActDomain", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/MarketAndOtherRiskFactorsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "cik0001588272_PreIncentiveFeeNetInvestmentIncomeForQuarterEqualsPercentageOfNetAssetsAtTheEndOfQuarter": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Pre incentive fee net investment income for quarter equals percentage of net assets at the end of quarter.", "label": "Pre Incentive Fee Net Investment Income For Quarter Equals Percentage Of Net Assets At The End Of Quarter", "terseLabel": "Pre Incentive Fee Net Investment Income For Quarter Equals Percentage Of Net Assets At The End Of Quarter" } } }, "localname": "PreIncentiveFeeNetInvestmentIncomeForQuarterEqualsPercentageOfNetAssetsAtTheEndOfQuarter", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/RelatedPartyTransactionsAndArrangementsAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "cik0001588272_PreferredStockOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Preferred stock one.", "label": "Preferred Stock One [Member]" } } }, "localname": "PreferredStockOneMember", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfInvestmentsUsingSignificantUnobservableInputDetail" ], "xbrltype": "domainItemType" }, "cik0001588272_PreferredStocksAtTwentyThreePointFourPercentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Preferred stocks at twenty three point four percent.", "label": "Preferred Stocks At Twenty Three Point Four Percent [Member]", "terseLabel": "Preferred Stocks At Twenty Three Point Four Percent [Member]" } } }, "localname": "PreferredStocksAtTwentyThreePointFourPercentMember", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/ScheduleOfInvestments2" ], "xbrltype": "domainItemType" }, "cik0001588272_PreferredStocksAtTwentyTwoPointThreePercentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Preferred Stocks At Twenty Two Point Three Percent", "label": "Preferred Stocks At Twenty Two Point Three Percent [Member]", "terseLabel": "Preferred Stocks At Twenty Two Point Three Percent [Member]" } } }, "localname": "PreferredStocksAtTwentyTwoPointThreePercentMember", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/ScheduleOfInvestments2" ], "xbrltype": "domainItemType" }, "cik0001588272_ProceedsFromSalesAndPrincipalRepaymentsOfInvestmentSecurities": { "auth_ref": [], "calculation": { "http://www.npci.com/role/StatementsOfCashFlows": { "order": 18.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Proceeds from sales and principal repayments of investment securities.", "label": "Proceeds From Sales And Principal Repayments Of Investment Securities", "terseLabel": "Proceeds from sales and principal repayments of investment securities" } } }, "localname": "ProceedsFromSalesAndPrincipalRepaymentsOfInvestmentSecurities", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "cik0001588272_PromissoryNoteMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Promissory Note [Member]" } } }, "localname": "PromissoryNoteMember", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfChangesInTheCompanySLevel3InvestmentsParentheticalDetail" ], "xbrltype": "domainItemType" }, "cik0001588272_PurchasesOfInvestmentSecurities": { "auth_ref": [], "calculation": { "http://www.npci.com/role/StatementsOfCashFlows": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Purchases of investment securities.", "label": "Purchases of investment securities", "terseLabel": "Purchases of investment securities" } } }, "localname": "PurchasesOfInvestmentSecurities", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "cik0001588272_QuarterlyRecoupableOrRecoupedAmount": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Quarterly recoupable or recouped amount.", "label": "Quarterly Recoupable Or Recouped Amount", "terseLabel": "Quarterly recoupable/ (recouped) amount" } } }, "localname": "QuarterlyRecoupableOrRecoupedAmount", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/RelatedPartyTransactionsAndArrangementsScheduleOfFeeWaiversAndExpenseReimbursementsDueFromTheAdviserWhichMayBecomeSubjectToRecoupmentDetail" ], "xbrltype": "monetaryItemType" }, "cik0001588272_QuarternorthEnergyInc.Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Quarternorth Energy, Inc.", "label": "Quarternorth Energy, Inc. [Member]", "terseLabel": "Quarternorth Energy, Inc. [Member]" } } }, "localname": "QuarternorthEnergyInc.Member", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/ScheduleOfInvestments1" ], "xbrltype": "domainItemType" }, "cik0001588272_QuarternorthTranche1Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "QuarterNorth Tranche 1.", "label": "QuarterNorth Tranche 1 [Member]", "terseLabel": "QuarterNorth Tranche 1 [Member]" } } }, "localname": "QuarternorthTranche1Member", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/ScheduleOfInvestments2" ], "xbrltype": "domainItemType" }, "cik0001588272_QuarternorthTranche2Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "QuarterNorth Tranche 2.", "label": "QuarterNorth Tranche 2 [Member]", "terseLabel": "QuarterNorth Tranche 2 [Member]" } } }, "localname": "QuarternorthTranche2Member", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/ScheduleOfInvestments2" ], "xbrltype": "domainItemType" }, "cik0001588272_RatiosBasedOnWeightedAverageNetAssetsOfCommonSharesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Ratios based on weighted average net assets of common shares.", "label": "Ratios Based on Weighted Average Net Assets of Common Shares [Abstract]", "terseLabel": "Ratios based on weighted average net assets of common shares:" } } }, "localname": "RatiosBasedOnWeightedAverageNetAssetsOfCommonSharesAbstract", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/FinancialHighlightsSummaryOfShareOutstandingDetail" ], "xbrltype": "stringItemType" }, "cik0001588272_RealEstateAtEightPointSevenPercentageMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Real estate at eight point seven percentage.", "label": "Real Estate At Eight Point Seven Percentage [Member]", "terseLabel": "Real Estate At Eight Point Seven Percentage [Member]" } } }, "localname": "RealEstateAtEightPointSevenPercentageMember", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/ScheduleOfInvestments1" ], "xbrltype": "domainItemType" }, "cik0001588272_RealEstateAtEighteenPointSixPercentageMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Real estate at eighteen point six percentage.", "label": "Real Estate At Eighteen Point Six Percentage [Member]", "terseLabel": "Real Estate At Eighteen Point Six Percentage [Member]" } } }, "localname": "RealEstateAtEighteenPointSixPercentageMember", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/ScheduleOfInvestments1" ], "xbrltype": "domainItemType" }, "cik0001588272_RealEstateAtFourteenPointThreePercentageMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Real estate at fourteen point three percentage.", "label": "Real Estate At Fourteen Point Three Percentage [Member]" } } }, "localname": "RealEstateAtFourteenPointThreePercentageMember", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/ScheduleOfInvestments1" ], "xbrltype": "domainItemType" }, "cik0001588272_RealEstateAtThreePointZeroPercentageMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Real estate at three point zero percentage.", "label": "Real Estate At Three Point Zero Percentage [Member]", "terseLabel": "Real Estate At Three Point Zero Percentage [Member]" } } }, "localname": "RealEstateAtThreePointZeroPercentageMember", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/ScheduleOfInvestments1" ], "xbrltype": "domainItemType" }, "cik0001588272_RealEstateAtZeroPointNinePercentageMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Real Estate At Zero Point Nine Percentage [Member]", "terseLabel": "Real Estate At Zero Point Nine Percentage [Member]" } } }, "localname": "RealEstateAtZeroPointNinePercentageMember", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/ScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "cik0001588272_RealEstateInvestmentTrustAtOnePointNinePercentageMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Real estate investment trust at one point nine percentage.", "label": "Real Estate Investment Trust At One Point Nine Percentage [Member]", "terseLabel": "Real Estate Investment Trust At One Point Nine Percentage [Member]" } } }, "localname": "RealEstateInvestmentTrustAtOnePointNinePercentageMember", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/ScheduleOfInvestments1" ], "xbrltype": "domainItemType" }, "cik0001588272_RealEstateInvestmentTrustAtTwoPointZeroPercentageMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Real estate investment trust at two point zero percentage.", "label": "Real Estate Investment Trust At Two Point Zero Percentage [Member]", "terseLabel": "Real Estate Investment Trust At Two Point Zero Percentage [Member]" } } }, "localname": "RealEstateInvestmentTrustAtTwoPointZeroPercentageMember", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/ScheduleOfInvestments1" ], "xbrltype": "domainItemType" }, "cik0001588272_RealEstateInvestmentTrustsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Real Estate Investment Trusts [Member]", "terseLabel": "Real Estate Investment Trusts (REITs)" } } }, "localname": "RealEstateInvestmentTrustsMember", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/InvestmentPortfolioSummaryOfInvestmentHoldingsScheduleOfInvestmentsDetail", "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfInvestmentsCategorizeIntoFairValueHierarchyDetail" ], "xbrltype": "domainItemType" }, "cik0001588272_RecentAccountingPronouncementsIssuedButNotYetAdoptedPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Recent accounting pronouncements issued but not yet adopted [Policy Text Block].", "label": "Recent Accounting Pronouncements Issued But Not Yet Adopted [Policy Text Block]", "verboseLabel": "Recent Accounting Pronouncements" } } }, "localname": "RecentAccountingPronouncementsIssuedButNotYetAdoptedPolicyTextBlock", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "cik0001588272_RecoupmentEligibilityExpiration": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Recoupment eligibility expiration.", "label": "Recoupment Eligibility Expiration", "terseLabel": "Recoupment eligibility expiration" } } }, "localname": "RecoupmentEligibilityExpiration", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/RelatedPartyTransactionsAndArrangementsScheduleOfFeeWaiversAndExpenseReimbursementsDueFromTheAdviserWhichMayBecomeSubjectToRecoupmentDetail" ], "xbrltype": "dateItemType" }, "cik0001588272_RecoupmentEligibilityExpirationDateAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Recoupment eligibility expiration date.", "label": "Recoupment Eligibility Expiration Date [Axis]", "terseLabel": "Recoupment Eligibility Expiration Date [Axis]" } } }, "localname": "RecoupmentEligibilityExpirationDateAxis", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/RelatedPartyTransactionsAndArrangementsScheduleOfFeeWaiversAndExpenseReimbursementsDueFromTheAdviserWhichMayBecomeSubjectToRecoupmentDetail" ], "xbrltype": "stringItemType" }, "cik0001588272_RecoupmentEligibilityExpirationDateDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Recoupment eligibility expiration date.", "label": "Recoupment Eligibility Expiration Date [Domain]", "terseLabel": "Recoupment Eligibility Expiration Date [Domain]" } } }, "localname": "RecoupmentEligibilityExpirationDateDomain", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/RelatedPartyTransactionsAndArrangementsScheduleOfFeeWaiversAndExpenseReimbursementsDueFromTheAdviserWhichMayBecomeSubjectToRecoupmentDetail" ], "xbrltype": "domainItemType" }, "cik0001588272_RecoupmentEligibilityExpired": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Recoupment eligibility expired.", "label": "Recoupment Eligibility Expired", "terseLabel": "Recoupment eligibility expired" } } }, "localname": "RecoupmentEligibilityExpired", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/RelatedPartyTransactionsAndArrangementsScheduleOfFeeWaiversAndExpenseReimbursementsDueFromTheAdviserWhichMayBecomeSubjectToRecoupmentDetail" ], "xbrltype": "stringItemType" }, "cik0001588272_ReinvestmentOfDistributionsPaid": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Reinvestment Of Distributions Paid", "label": "Reinvestment Of Distributions Paid", "terseLabel": "Reinvestment of distributions paid" } } }, "localname": "ReinvestmentOfDistributionsPaid", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "cik0001588272_ReportsToStockholders": { "auth_ref": [], "calculation": { "http://www.npci.com/role/StatementsOfOperations": { "order": 10.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Reports To Stockholders", "label": "Reports To Stockholders", "terseLabel": "Reports to stockholders" } } }, "localname": "ReportsToStockholders", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "cik0001588272_RestrictedSecuritiesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Restricted securities.", "label": "Restricted Securities [Member]" } } }, "localname": "RestrictedSecuritiesMember", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/ScheduleOfInvestmentsParenthentical" ], "xbrltype": "domainItemType" }, "cik0001588272_RxbenefitsInc.Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "RxBenefits, Inc.", "label": "RxBenefits, Inc. [Member]", "terseLabel": "RxBenefits, Inc. [Member]" } } }, "localname": "RxbenefitsInc.Member", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/ScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "cik0001588272_SapienceTherapauticsIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Sapience therapautics inc.", "label": "Sapience Therapautics Inc [Member]", "terseLabel": "Sapience Therapeutics, Inc [Member]" } } }, "localname": "SapienceTherapauticsIncMember", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfInvestmentsUsingSignificantUnobservableInputDetail" ], "xbrltype": "domainItemType" }, "cik0001588272_SapienceTherapeuticsInc.Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Sapience Therapeutics, Inc.", "label": "Sapience Therapeutics, Inc. [Member]" } } }, "localname": "SapienceTherapeuticsInc.Member", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/ScheduleOfInvestments2" ], "xbrltype": "domainItemType" }, "cik0001588272_ScheduleOfEarningsPerShareBasicAndDilutedLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule of earnings per share basic and diluted.", "label": "Schedule Of Earnings Per Share Basic And Diluted [Line Items]" } } }, "localname": "ScheduleOfEarningsPerShareBasicAndDilutedLineItems", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfComputationOfBasicAndDilutedNetDetail" ], "xbrltype": "stringItemType" }, "cik0001588272_ScheduleOfEarningsPerShareBasicAndDilutedTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule of earnings per share basic and diluted.", "label": "Schedule Of Earnings Per Share Basic And Diluted [Table]" } } }, "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTable", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfComputationOfBasicAndDilutedNetDetail" ], "xbrltype": "stringItemType" }, "cik0001588272_ScheduleOfFeeWaiversAndExpenseReimbursementsDueFromTheAdviserWhichMayBecomeSubjectToRecoupmentTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule of fee waivers and expense reimbursements due from the adviser which may become subject to recoupment.", "label": "Schedule Of Fee Waivers And Expense Reimbursements Due From The Adviser Which May Become Subject To Recoupment [Table Text Block]", "terseLabel": "Schedule of fee waivers and expense reimbursements due from the adviser which may become subject to recoupment" } } }, "localname": "ScheduleOfFeeWaiversAndExpenseReimbursementsDueFromTheAdviserWhichMayBecomeSubjectToRecoupmentTableTextBlock", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/RelatedPartyTransactionsAndArrangementsTables" ], "xbrltype": "textBlockItemType" }, "cik0001588272_SecondLienTermLoanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Second Lien Term Loan .", "label": "Second Lien Term Loan [Member]", "terseLabel": "Second Lien Term Loan [Member]" } } }, "localname": "SecondLienTermLoanMember", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/ScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "cik0001588272_SecuritiesSoldShortAndRestrictedCashPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Securities sold short and restricted cash [Policy Text Block].", "label": "Securities Sold Short And Restricted Cash [Policy Text Block]", "terseLabel": "Securities Sold Short and Restricted Cash" } } }, "localname": "SecuritiesSoldShortAndRestrictedCashPolicyTextBlock", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "cik0001588272_SeniorSecuredLoansAtNineteenPointSixPercentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Senior Secured Loans At Nineteen Point Six Percent [Member]", "terseLabel": "Senior Secured Loans At Nineteen Point Six Percent [Member]" } } }, "localname": "SeniorSecuredLoansAtNineteenPointSixPercentMember", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/ScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "cik0001588272_SeniorSecuredLoansAtTwentySixPointZeroFivePercentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Senior Secured Loans At Twenty Six Point Zero Five Percent .", "label": "Senior Secured Loans At Twenty Six Point Zero Five Percent [Member]", "terseLabel": "Senior Secured Loans At Twenty Six Point Zero Five Percent [Member]" } } }, "localname": "SeniorSecuredLoansAtTwentySixPointZeroFivePercentMember", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/ScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "cik0001588272_SeniorSecuredLoansFirstLienMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Senior Secured Loans First Lien [Member]", "terseLabel": "Senior Secured Loans - First Lien" } } }, "localname": "SeniorSecuredLoansFirstLienMember", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/InvestmentPortfolioSummaryOfInvestmentCompanyAssetsByIndustryClassificationAtFairValueDetail" ], "xbrltype": "domainItemType" }, "cik0001588272_SeniorSecuredLoansFourMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Senior secured loans four.", "label": "Senior Secured Loans Four [Member]" } } }, "localname": "SeniorSecuredLoansFourMember", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfInvestmentsUsingSignificantUnobservableInputDetail" ], "xbrltype": "domainItemType" }, "cik0001588272_SeniorSecuredLoansMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Senior secured loans.", "label": "Senior Secured Loans [Member]" } } }, "localname": "SeniorSecuredLoansMember", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfChangesInTheCompanySLevel3InvestmentsDetail", "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfInvestmentsCategorizeIntoFairValueHierarchyDetail", "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfInvestmentsUsingSignificantUnobservableInputDetail", "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityDetail" ], "xbrltype": "domainItemType" }, "cik0001588272_SeniorSecuredLoansOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Senior secured loans one.", "label": "Senior Secured Loans One [Member]" } } }, "localname": "SeniorSecuredLoansOneMember", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfInvestmentsUsingSignificantUnobservableInputDetail" ], "xbrltype": "domainItemType" }, "cik0001588272_SeniorSecuredLoansSecondLienMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Senior Secured Loans Second Lien [Member]", "terseLabel": "Senior Secured Loans - Second Lien" } } }, "localname": "SeniorSecuredLoansSecondLienMember", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/InvestmentPortfolioSummaryOfInvestmentCompanyAssetsByIndustryClassificationAtFairValueDetail" ], "xbrltype": "domainItemType" }, "cik0001588272_SeniorSecuredLoansThreeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Senior secured loans three.", "label": "Senior Secured Loans Three [Member]" } } }, "localname": "SeniorSecuredLoansThreeMember", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfInvestmentsUsingSignificantUnobservableInputDetail" ], "xbrltype": "domainItemType" }, "cik0001588272_SeniorSecuredLoansTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Senior secured loans two.", "label": "Senior Secured Loans Two [Member]" } } }, "localname": "SeniorSecuredLoansTwoMember", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfInvestmentsUsingSignificantUnobservableInputDetail" ], "xbrltype": "domainItemType" }, "cik0001588272_SeptemberThirtyTwoThousandAndTwentyFiveMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "September thirty two thousand and twenty five.", "label": "September Thirty Two Thousand And Twenty Five [Member]", "terseLabel": "September 30, 2025 [Member]" } } }, "localname": "SeptemberThirtyTwoThousandAndTwentyFiveMember", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/RelatedPartyTransactionsAndArrangementsScheduleOfFeeWaiversAndExpenseReimbursementsDueFromTheAdviserWhichMayBecomeSubjectToRecoupmentDetail" ], "xbrltype": "domainItemType" }, "cik0001588272_SeptemberThirtyTwoThousandAndTwentyFourMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "September thirty two thousand and twenty four.", "label": "September Thirty Two Thousand And Twenty Four [Member]", "terseLabel": "September\u00a030,\u00a02024 [Member]" } } }, "localname": "SeptemberThirtyTwoThousandAndTwentyFourMember", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/RelatedPartyTransactionsAndArrangementsScheduleOfFeeWaiversAndExpenseReimbursementsDueFromTheAdviserWhichMayBecomeSubjectToRecoupmentDetail" ], "xbrltype": "domainItemType" }, "cik0001588272_SeptemberThirtyTwoThousandAndTwentyThreeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "September thirty two thousand and twenty three.", "label": "September Thirty Two Thousand And Twenty Three [Member]", "terseLabel": "September\u00a030,\u00a02023 [Member]" } } }, "localname": "SeptemberThirtyTwoThousandAndTwentyThreeMember", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/RelatedPartyTransactionsAndArrangementsScheduleOfFeeWaiversAndExpenseReimbursementsDueFromTheAdviserWhichMayBecomeSubjectToRecoupmentDetail" ], "xbrltype": "domainItemType" }, "cik0001588272_SeriesBOnePreferredStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Series B one preferred stock.", "label": "Series B One Preferred Stock [Member]" } } }, "localname": "SeriesBOnePreferredStockMember", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfInvestmentsUsingSignificantUnobservableInputDetail" ], "xbrltype": "domainItemType" }, "cik0001588272_SeriesC2Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Series C2.", "label": "Series C2 [Member]" } } }, "localname": "SeriesC2Member", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/ScheduleOfInvestments2" ], "xbrltype": "domainItemType" }, "cik0001588272_SeriesCTwoPreferredStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Series c two preferred stock.", "label": "Series C Two Preferred Stock [Member]", "terseLabel": "Series C-2 preferred stock [Member]" } } }, "localname": "SeriesCTwoPreferredStockMember", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfInvestmentsUsingSignificantUnobservableInputDetail" ], "xbrltype": "domainItemType" }, "cik0001588272_Seriesb1preferredSharesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Series\u00a0B-1\u00a0Preferred Shares .", "label": "SeriesB1Preferred Shares [Member]" } } }, "localname": "Seriesb1preferredSharesMember", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/ScheduleOfInvestments2" ], "xbrltype": "domainItemType" }, "cik0001588272_ServiceAtZeroPointZeroPercentageMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Service At Zero Point Zero Percentage.", "label": "Service At Zero Point Zero Percentage [Member]", "terseLabel": "Service At Zero Point Zero Percentage [Member]" } } }, "localname": "ServiceAtZeroPointZeroPercentageMember", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/ScheduleOfInvestments1" ], "xbrltype": "domainItemType" }, "cik0001588272_SevenHundredSeventySevenPartnersLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Seven hundred seventy seven partners Llc.", "label": "Seven Hundred Seventy Seven Partners Llc [Member]", "terseLabel": "777 Partners, LLC [Member]" } } }, "localname": "SevenHundredSeventySevenPartnersLlcMember", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/ScheduleOfInvestments2" ], "xbrltype": "domainItemType" }, "cik0001588272_SfrWlifIiiLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "SFR WLIF III, LLC.", "label": "SFR WLIF III, LLC [Member]", "terseLabel": "SFR WLIF III, LLC [Member]" } } }, "localname": "SfrWlifIiiLlcMember", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/AffiliatedInvestmentsSummaryOfAffiliatedIssuersOfTheCompanyDetail", "http://www.npci.com/role/ScheduleOfInvestments1" ], "xbrltype": "domainItemType" }, "cik0001588272_SfrWlifThreeLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "SFR WLIF three LLC.", "label": "SFR WLIF Three LLC [Member]", "terseLabel": "SFR WLIF III, LLC [Member]" } } }, "localname": "SfrWlifThreeLlcMember", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfInvestmentsUsingSignificantUnobservableInputDetail" ], "xbrltype": "domainItemType" }, "cik0001588272_ShareRepurchaseProgram": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share repurchase program.", "label": "Share Repurchase Program" } } }, "localname": "ShareRepurchaseProgram", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/ShareRepurchaseProgram" ], "xbrltype": "textBlockItemType" }, "cik0001588272_SoundInpatientPhysiciansMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Sound Inpatient Physicians.", "label": "Sound Inpatient Physicians [Member]", "terseLabel": "Sound Inpatient Physicians [Member]" } } }, "localname": "SoundInpatientPhysiciansMember", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/ScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "cik0001588272_StatementOfCashFlowsPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Statement of cash flows [Policy Text Block].", "label": "Statement Of Cash Flows [Policy Text Block]", "terseLabel": "Statements of Cash Flows" } } }, "localname": "StatementOfCashFlowsPolicyTextBlock", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "cik0001588272_StimulusReliefMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Stimulus relief.", "label": "Stimulus Relief [Member]", "terseLabel": "Stimulus Relief [Member]" } } }, "localname": "StimulusReliefMember", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/MarketAndOtherRiskFactorsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "cik0001588272_StockIssuanceCosts": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Stock issuance costs.", "label": "Stock Issuance Costs", "terseLabel": "Stock issuance costs" } } }, "localname": "StockIssuanceCosts", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "cik0001588272_SubordinatedIncentiveFeeOnIncomeIsDeterminedAndPayableQuarterlyInArrearsEqualsPercentageOfPreIncentiveFeeNetInvestmentIncome": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Subordinated incentive fee on income is determined and payable quarterly in arrears equals percentage of pre incentive fee net investment income.", "label": "Subordinated Incentive Fee On Income Is Determined And Payable Quarterly In Arrears Equals Percentage Of Pre Incentive Fee Net Investment Income", "terseLabel": "Subordinated Incentive Fee On Income Is Determined And Payable Quarterly In Arrears Equals Percentage Of Pre Incentive Fee Net Investment Income" } } }, "localname": "SubordinatedIncentiveFeeOnIncomeIsDeterminedAndPayableQuarterlyInArrearsEqualsPercentageOfPreIncentiveFeeNetInvestmentIncome", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/RelatedPartyTransactionsAndArrangementsAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "cik0001588272_TelcommunicationServicesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Telcommunication services.", "label": "Telcommunication Services [Member]" } } }, "localname": "TelcommunicationServicesMember", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfChangesInTheCompanySLevel3InvestmentsDetail", "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfInvestmentsCategorizeIntoFairValueHierarchyDetail" ], "xbrltype": "domainItemType" }, "cik0001588272_TeleCommunicationServicesAtTwoPointTwoPercentageMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Tele Communication Services At Two Point Two Percentage [Member]", "terseLabel": "Tele Communication Services At Two Point Two Percentage [Member]" } } }, "localname": "TeleCommunicationServicesAtTwoPointTwoPercentageMember", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/ScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "cik0001588272_TeleCommunicationServicesAtTwoPointZeroPercentageMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tele communication services at two point zero percentage.", "label": "Tele Communication Services At Two point Zero Percentage [Member]", "terseLabel": "Tele Communication Services At Two point Zero Percentage [Member]" } } }, "localname": "TeleCommunicationServicesAtTwoPointZeroPercentageMember", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/ScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "cik0001588272_TeleCommunicationServicesAtZeroPointFivePercentageMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tele communication services at zero point five percentage.", "label": "Tele Communication Services At Zero Point Five Percentage [Member]", "terseLabel": "Tele Communication Services At Zero Point Five Percentage [Member]" } } }, "localname": "TeleCommunicationServicesAtZeroPointFivePercentageMember", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/ScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "cik0001588272_TelecommunicationServicesAtNinePointEightPercentageMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Telecommunication services at nine point eight percentage.", "label": "Telecommunication Services At Nine Point Eight Percentage [Member]", "terseLabel": "Telecommunication Services At Nine Point Eight Percentage [Member]" } } }, "localname": "TelecommunicationServicesAtNinePointEightPercentageMember", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/ScheduleOfInvestments1" ], "xbrltype": "domainItemType" }, "cik0001588272_TelecommunicationServicesAtNinePointFivePercentageMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Telecommunication services at nine point five percentage.", "label": "Telecommunication Services At Nine Point Five Percentage [Member]", "terseLabel": "Telecommunication Services At Nine Point Five Percentage [Member]" } } }, "localname": "TelecommunicationServicesAtNinePointFivePercentageMember", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/ScheduleOfInvestments1" ], "xbrltype": "domainItemType" }, "cik0001588272_TelecommunicationServicesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "TeleCommunication Services [Member]", "terseLabel": "Telecommunication Services" } } }, "localname": "TelecommunicationServicesMember", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/InvestmentPortfolioSummaryOfInvestmentHoldingsScheduleOfInvestmentsDetail", "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfChangesInTheCompanySLevel3InvestmentsDetail", "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfInvestmentsCategorizeIntoFairValueHierarchyDetail" ], "xbrltype": "domainItemType" }, "cik0001588272_TereeStarCorpMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Teree star corp.", "label": "Teree Star Corp [Member]", "terseLabel": "TerreStar Corp [Member]" } } }, "localname": "TereeStarCorpMember", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfInvestmentsUsingSignificantUnobservableInputDetail" ], "xbrltype": "domainItemType" }, "cik0001588272_TerreStarCorpMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Terre star corp.", "label": "Terre Star Corp [Member]", "terseLabel": "TerreStar Corp [Member]" } } }, "localname": "TerreStarCorpMember", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfInvestmentsUsingSignificantUnobservableInputDetail" ], "xbrltype": "domainItemType" }, "cik0001588272_TerrestarCorp..Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "TerreStar Corp..", "label": "TerreStar Corp.. [Member]", "terseLabel": "TerreStar Corp.. [Member]" } } }, "localname": "TerrestarCorp..Member", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/ScheduleOfInvestments1" ], "xbrltype": "domainItemType" }, "cik0001588272_TerrestarCorp.Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "TerreStar Corp.", "label": "TerreStar Corp. [Member]", "terseLabel": "TerreStar Corp. [Member]" } } }, "localname": "TerrestarCorp.Member", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/ScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "cik0001588272_TotalInvestmentNinetyFivePointThreeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Total investment ninety five point three.", "label": "Total Investment Ninety Five Point Three [Member]", "terseLabel": "Total Investment Ninety Five Point Three [Member]" } } }, "localname": "TotalInvestmentNinetyFivePointThreeMember", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/ScheduleOfInvestments2" ], "xbrltype": "domainItemType" }, "cik0001588272_TotalInvestmentNinetyNinePointTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Total Investment Ninety Nine Point Two [Member]" } } }, "localname": "TotalInvestmentNinetyNinePointTwoMember", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/ScheduleOfInvestments2" ], "xbrltype": "domainItemType" }, "cik0001588272_TypeOfInvestmentDebtOrEquityMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Type of Investment Debt or Equity [Member]" } } }, "localname": "TypeOfInvestmentDebtOrEquityMember", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/InvestmentPortfolioTables" ], "xbrltype": "domainItemType" }, "cik0001588272_U.s.FederalReserveMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "U.S. federal reserve.", "label": "U.S. Federal Reserve [Member]" } } }, "localname": "U.s.FederalReserveMember", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/MarketAndOtherRiskFactorsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "cik0001588272_UnitedFidelityBankFsbMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "United Fidelity Bank FSB .", "label": "United Fidelity Bank FSB [Member]", "terseLabel": "United Fidelity Bank FSB [Member]" } } }, "localname": "UnitedFidelityBankFsbMember", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/ScheduleOfInvestments2" ], "xbrltype": "domainItemType" }, "cik0001588272_UsGamingLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "US Gaming, LLC.", "label": "US Gaming, LLC [Member]", "terseLabel": "US Gaming, LLC [Member]" } } }, "localname": "UsGamingLlcMember", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/ScheduleOfInvestments1", "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfInvestmentsUsingSignificantUnobservableInputDetail" ], "xbrltype": "domainItemType" }, "cik0001588272_ValuationTechniqueLiquidationAnalysisMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Valuation technique liquidation analysis.", "label": "Valuation Technique Liquidation Analysis [Member]" } } }, "localname": "ValuationTechniqueLiquidationAnalysisMember", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityDetail" ], "xbrltype": "domainItemType" }, "cik0001588272_ValuationTechniqueMultipleAnalysisMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Valuation technique multiple analysis.", "label": "Valuation Technique Multiple Analysis [Member]" } } }, "localname": "ValuationTechniqueMultipleAnalysisMember", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityDetail" ], "xbrltype": "domainItemType" }, "cik0001588272_ValuationTechniqueNetAssetValueMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Valuation technique net asset value.", "label": "Valuation Technique Net Asset Value [Member]" } } }, "localname": "ValuationTechniqueNetAssetValueMember", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityDetail" ], "xbrltype": "domainItemType" }, "cik0001588272_ValuationTechniqueTransactionIndicationOfValueMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Valuation technique transaction indication of value.", "label": "Valuation Technique Transaction Indication Of Value [Member]" } } }, "localname": "ValuationTechniqueTransactionIndicationOfValueMember", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityDetail" ], "xbrltype": "domainItemType" }, "cik0001588272_VoluntarilyReimburseAmountForUnrealizedLosses": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Voluntarily reimburse amount for unrealized losses.", "label": "Voluntarily Reimburse Amount For Unrealized Losses", "terseLabel": "Voluntarily reimburse amount for unrealized losses" } } }, "localname": "VoluntarilyReimburseAmountForUnrealizedLosses", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/RelatedPartyTransactionsAndArrangementsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "cik0001588272_WarrantsAtZeroPointFourPercentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Warrants At Zero Point Four Percent [Member]", "terseLabel": "Warrants At Zero Point Four Percent [Member]" } } }, "localname": "WarrantsAtZeroPointFourPercentMember", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/ScheduleOfInvestments2" ], "xbrltype": "domainItemType" }, "cik0001588272_WarrantsAtZeroPointThreePercentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Warrants at zero point three percent .", "label": "Warrants At Zero Point Three Percent [Member]", "terseLabel": "Warrants At Zero Point Three Percent [Member]" } } }, "localname": "WarrantsAtZeroPointThreePercentMember", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/ScheduleOfInvestments2" ], "xbrltype": "domainItemType" }, "cik0001588272_WayneServicesLegacyInc.Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Wayne Services Legacy, Inc.", "label": "Wayne Services Legacy, Inc. [Member]", "terseLabel": "Wayne Services Legacy, Inc. [Member]" } } }, "localname": "WayneServicesLegacyInc.Member", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/ScheduleOfInvestments1" ], "xbrltype": "domainItemType" }, "cik0001588272_WayneServicesLegacyIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Wayne services legacy inc.", "label": "Wayne Services Legacy Inc [Member]", "terseLabel": "Wayne Services Legacy, Inc [Member]" } } }, "localname": "WayneServicesLegacyIncMember", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfInvestmentsUsingSignificantUnobservableInputDetail" ], "xbrltype": "domainItemType" }, "cik0001588272_WellpathHoldingsInc.Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Wellpath Holdings, Inc.", "label": "Wellpath Holdings, Inc. [Member]", "terseLabel": "Wellpath Holdings, Inc. [Member]" } } }, "localname": "WellpathHoldingsInc.Member", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/ScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "cik0001588272_YearlyCumulativeExpenseReimbursement": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Yearly cumulative expense reimbursement.", "label": "Yearly Cumulative Expense Reimbursement", "terseLabel": "Yearly cumulative expense reimbursement" } } }, "localname": "YearlyCumulativeExpenseReimbursement", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/RelatedPartyTransactionsAndArrangementsScheduleOfFeeWaiversAndExpenseReimbursementsDueFromTheAdviserWhichMayBecomeSubjectToRecoupmentDetail" ], "xbrltype": "monetaryItemType" }, "cik0001588272_YearlyCumulativeOtherExpense": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Yearly\u00a0cumulative other expense.", "label": "Yearly Cumulative Other Expense", "terseLabel": "Yearly cumulative other expense" } } }, "localname": "YearlyCumulativeOtherExpense", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/RelatedPartyTransactionsAndArrangementsScheduleOfFeeWaiversAndExpenseReimbursementsDueFromTheAdviserWhichMayBecomeSubjectToRecoupmentDetail" ], "xbrltype": "monetaryItemType" }, "cik0001588272_YearlyExpenseLimitation": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Yearly expense limitation.", "label": "Yearly Expense Limitation", "terseLabel": "Yearly expense limitation" } } }, "localname": "YearlyExpenseLimitation", "nsuri": "http://www.npci.com/20230331", "presentation": [ "http://www.npci.com/role/RelatedPartyTransactionsAndArrangementsScheduleOfFeeWaiversAndExpenseReimbursementsDueFromTheAdviserWhichMayBecomeSubjectToRecoupmentDetail" ], "xbrltype": "monetaryItemType" }, "country_KY": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "CAYMAN ISLANDS", "terseLabel": "Cayman Islands" } } }, "localname": "KY", "nsuri": "http://xbrl.sec.gov/country/2022", "presentation": [ "http://www.npci.com/role/InvestmentPortfolioSummaryOfTheCompanySInvestedAssetsByGeographicClassificationDetail" ], "xbrltype": "domainItemType" }, "country_LU": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "LUXEMBOURG", "terseLabel": "Luxembourg" } } }, "localname": "LU", "nsuri": "http://xbrl.sec.gov/country/2022", "presentation": [ "http://www.npci.com/role/InvestmentPortfolioSummaryOfTheCompanySInvestedAssetsByGeographicClassificationDetail" ], "xbrltype": "domainItemType" }, "country_US": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "UNITED STATES", "terseLabel": "United States" } } }, "localname": "US", "nsuri": "http://xbrl.sec.gov/country/2022", "presentation": [ "http://www.npci.com/role/InvestmentPortfolioSummaryOfTheCompanySInvestedAssetsByGeographicClassificationDetail" ], "xbrltype": "domainItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.npci.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.npci.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2022", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.npci.com/role/CoverPage" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.npci.com/role/CoverPage" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.npci.com/role/CoverPage" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.npci.com/role/CoverPage" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r453" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.npci.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r454" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.npci.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.npci.com/role/CoverPage" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.npci.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.npci.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.npci.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.npci.com/role/CoverPage" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r451" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.npci.com/role/CoverPage" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.npci.com/role/CoverPage" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.npci.com/role/CoverPage" ], "xbrltype": "yesNoItemType" }, "dei_EntityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains.", "label": "Entity [Domain]" } } }, "localname": "EntityDomain", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.npci.com/role/AffiliatedInvestmentsSummaryOfAffiliatedIssuersOfTheCompanyDetail", "http://www.npci.com/role/MarketAndOtherRiskFactorsAdditionalInformationDetail", "http://www.npci.com/role/ScheduleOfInvestments", "http://www.npci.com/role/ScheduleOfInvestments1", "http://www.npci.com/role/ScheduleOfInvestments2" ], "xbrltype": "domainItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r451" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.npci.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.npci.com/role/CoverPage" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r451" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.npci.com/role/CoverPage" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.npci.com/role/CoverPage" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r455" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.npci.com/role/CoverPage" ], "xbrltype": "yesNoItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r451" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.npci.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r451" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.npci.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r451" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.npci.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r451" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.npci.com/role/CoverPage" ], "xbrltype": "employerIdItemType" }, "dei_LegalEntityAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The set of legal entities associated with a report.", "label": "Legal Entity [Axis]" } } }, "localname": "LegalEntityAxis", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.npci.com/role/AffiliatedInvestmentsSummaryOfAffiliatedIssuersOfTheCompanyDetail", "http://www.npci.com/role/MarketAndOtherRiskFactorsAdditionalInformationDetail", "http://www.npci.com/role/ScheduleOfInvestments", "http://www.npci.com/role/ScheduleOfInvestments1", "http://www.npci.com/role/ScheduleOfInvestments2" ], "xbrltype": "stringItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.npci.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_Security12gTitle": { "auth_ref": [ "r452" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(g) registered security.", "label": "Title of 12(g) Security" } } }, "localname": "Security12gTitle", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.npci.com/role/CoverPage" ], "xbrltype": "securityTitleItemType" }, "srt_AffiliatedEntityMember": { "auth_ref": [ "r417", "r488", "r494", "r495", "r497" ], "lang": { "en-us": { "role": { "label": "Affiliated Entity [Member]" } } }, "localname": "AffiliatedEntityMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.npci.com/role/ScheduleOfInvestmentsParenthentical" ], "xbrltype": "domainItemType" }, "srt_EquityMethodInvesteeNameDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Investment, Name [Domain]" } } }, "localname": "EquityMethodInvesteeNameDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.npci.com/role/OrganizationAdditionalInformationDetail", "http://www.npci.com/role/ScheduleOfInvestmentsParenthentical" ], "xbrltype": "domainItemType" }, "srt_MaximumMember": { "auth_ref": [ "r230", "r231", "r232", "r233", "r277", "r359", "r377", "r418", "r419", "r439", "r445", "r450", "r483", "r500", "r501", "r502", "r503", "r504", "r505" ], "lang": { "en-us": { "role": { "label": "Maximum [Member]" } } }, "localname": "MaximumMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.npci.com/role/ScheduleOfInvestmentsParenthentical", "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityDetail" ], "xbrltype": "domainItemType" }, "srt_MinimumMember": { "auth_ref": [ "r230", "r231", "r232", "r233", "r277", "r359", "r377", "r418", "r419", "r439", "r445", "r450", "r483", "r500", "r501", "r502", "r503", "r504", "r505" ], "lang": { "en-us": { "role": { "label": "Minimum [Member]" } } }, "localname": "MinimumMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.npci.com/role/ScheduleOfInvestmentsParenthentical", "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityDetail" ], "xbrltype": "domainItemType" }, "srt_RangeAxis": { "auth_ref": [ "r230", "r231", "r232", "r233", "r269", "r277", "r278", "r279", "r280", "r335", "r359", "r377", "r418", "r419", "r439", "r445", "r450", "r479", "r483", "r501", "r502", "r503", "r504", "r505" ], "lang": { "en-us": { "role": { "label": "Statistical Measurement [Axis]" } } }, "localname": "RangeAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.npci.com/role/ScheduleOfInvestmentsParenthentical", "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityDetail" ], "xbrltype": "stringItemType" }, "srt_RangeMember": { "auth_ref": [ "r230", "r231", "r232", "r233", "r269", "r277", "r278", "r279", "r280", "r335", "r359", "r377", "r418", "r419", "r439", "r445", "r450", "r479", "r483", "r501", "r502", "r503", "r504", "r505" ], "lang": { "en-us": { "role": { "label": "Statistical Measurement [Domain]" } } }, "localname": "RangeMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.npci.com/role/ScheduleOfInvestmentsParenthentical", "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityDetail" ], "xbrltype": "domainItemType" }, "srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis": { "auth_ref": [ "r216" ], "lang": { "en-us": { "role": { "label": "Investment, Name [Axis]" } } }, "localname": "ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.npci.com/role/OrganizationAdditionalInformationDetail", "http://www.npci.com/role/ScheduleOfInvestmentsParenthentical" ], "xbrltype": "stringItemType" }, "srt_SegmentGeographicalDomain": { "auth_ref": [ "r211", "r212", "r408", "r409", "r410", "r411", "r412", "r413", "r414", "r415", "r416", "r441", "r449", "r485" ], "lang": { "en-us": { "role": { "label": "Geographical [Domain]" } } }, "localname": "SegmentGeographicalDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.npci.com/role/InvestmentPortfolioSummaryOfTheCompanySInvestedAssetsByGeographicClassificationDetail" ], "xbrltype": "domainItemType" }, "srt_StatementGeographicalAxis": { "auth_ref": [ "r211", "r212", "r406", "r408", "r409", "r410", "r411", "r412", "r413", "r414", "r415", "r416", "r441", "r449", "r485" ], "lang": { "en-us": { "role": { "label": "Geographical [Axis]" } } }, "localname": "StatementGeographicalAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.npci.com/role/InvestmentPortfolioSummaryOfTheCompanySInvestedAssetsByGeographicClassificationDetail" ], "xbrltype": "stringItemType" }, "srt_TitleOfIndividualAxis": { "auth_ref": [ "r471", "r496" ], "lang": { "en-us": { "role": { "label": "Title of Individual [Axis]" } } }, "localname": "TitleOfIndividualAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.npci.com/role/ScheduleOfInvestmentsParenthentical" ], "xbrltype": "stringItemType" }, "srt_TitleOfIndividualWithRelationshipToEntityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Title of Individual [Domain]" } } }, "localname": "TitleOfIndividualWithRelationshipToEntityDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.npci.com/role/ScheduleOfInvestmentsParenthentical" ], "xbrltype": "domainItemType" }, "srt_WeightedAverageMember": { "auth_ref": [ "r418", "r419", "r500", "r502", "r505" ], "lang": { "en-us": { "role": { "label": "Weighted Average [Member]" } } }, "localname": "WeightedAverageMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityDetail" ], "xbrltype": "domainItemType" }, "us-gaap_AccountingPoliciesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Accounting Policies [Abstract]" } } }, "localname": "AccountingPoliciesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_AccountsPayableRelatedPartiesCurrentAndNoncurrent": { "auth_ref": [ "r73", "r87", "r98", "r465" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount for accounts payable to related parties.", "label": "Accounts Payable, Related Parties", "terseLabel": "Payable to Adviser" } } }, "localname": "AccountsPayableRelatedPartiesCurrentAndNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.npci.com/role/RelatedPartyTransactionsAndArrangementsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsReceivableRelatedParties": { "auth_ref": [ "r73", "r75", "r95", "r152", "r465" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "For an unclassified balance sheet, amount of receivables arising from transactions with related parties.", "label": "Accounts Receivable, Related Parties", "terseLabel": "Receivable from advisor" } } }, "localname": "AccountsReceivableRelatedParties", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.npci.com/role/RelatedPartyTransactionsAndArrangementsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedLiabilitiesAndOtherLiabilities": { "auth_ref": [], "calculation": { "http://www.npci.com/role/StatementsOfAssetsAndLiabilities": { "order": 3.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of expenses incurred but not yet paid nor invoiced, and liabilities classified as other.", "label": "Accrued Liabilities and Other Liabilities", "terseLabel": "Accrued expenses and other liabilities" } } }, "localname": "AccruedLiabilitiesAndOtherLiabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.npci.com/role/StatementsOfAssetsAndLiabilities" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapital": { "auth_ref": [ "r8", "r448" ], "calculation": { "http://www.npci.com/role/StatementsOfAssetsAndLiabilities": { "order": 7.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.", "label": "Additional Paid in Capital", "terseLabel": "Paid-in\u00a0capital in excess of par" } } }, "localname": "AdditionalPaidInCapital", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.npci.com/role/StatementsOfAssetsAndLiabilities" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapitalMember": { "auth_ref": [ "r281", "r282", "r283", "r466", "r467", "r468", "r491" ], "lang": { "en-us": { "role": { "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.", "label": "Additional Paid-in Capital [Member]", "terseLabel": "Paid\u00a0in\u00a0Capital in Excess\u00a0of\u00a0Par" } } }, "localname": "AdditionalPaidInCapitalMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.npci.com/role/StatementsOfChangesInNetAssets" ], "xbrltype": "domainItemType" }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]", "terseLabel": "Adjustments to reconcile net increase (decrease) in net assets resulting from operations to net cash provided by (used in) operating activities:" } } }, "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.npci.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_AdministrativeFeesExpense": { "auth_ref": [ "r74" ], "calculation": { "http://www.npci.com/role/StatementsOfOperations": { "order": 6.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense for administrative services provided to the limited liability company (LLC) or limited partnership (LP) by the managing member or general partner, affiliate of managing member or general partner, or affiliate of LLC or LP, for example, but not limited to, salaries, rent, or overhead costs.", "label": "Administrative Fees Expense", "terseLabel": "Administration fees", "verboseLabel": "Administration fees payable to related party incurred during period" } } }, "localname": "AdministrativeFeesExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.npci.com/role/RelatedPartyTransactionsAndArrangementsAdditionalInformationDetail", "http://www.npci.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_AmortizationOfDebtDiscountPremium": { "auth_ref": [ "r21", "r27", "r72", "r260" ], "calculation": { "http://www.npci.com/role/StatementsOfCashFlows": { "order": 8.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense.", "label": "Amortization of Debt Discount (Premium)", "terseLabel": "Amortization of premium/discount, net" } } }, "localname": "AmortizationOfDebtDiscountPremium", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.npci.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetBackedSecuritiesMember": { "auth_ref": [ "r442", "r474" ], "lang": { "en-us": { "role": { "documentation": "Securities that are primarily serviced by the cash flows of a discrete pool of receivables or other financial assets for example, but not limited to, credit card receivables, car loans, recreational vehicle loans, and mobile home loans.", "label": "Asset-Backed Securities [Member]", "terseLabel": "Asset-Backed Securities" } } }, "localname": "AssetBackedSecuritiesMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.npci.com/role/InvestmentPortfolioSummaryOfInvestmentCompanyAssetsByIndustryClassificationAtFairValueDetail", "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfInvestmentsUsingSignificantUnobservableInputDetail", "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityDetail" ], "xbrltype": "domainItemType" }, "us-gaap_Assets": { "auth_ref": [ "r78", "r91", "r147", "r168", "r204", "r207", "r209", "r218", "r234", "r235", "r237", "r238", "r239", "r240", "r241", "r243", "r244", "r295", "r299", "r312", "r448", "r481", "r482", "r498" ], "calculation": { "http://www.npci.com/role/StatementsOfAssetsAndLiabilities": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets", "totalLabel": "Total assets" } } }, "localname": "Assets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.npci.com/role/StatementsOfAssetsAndLiabilities" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets [Abstract]", "terseLabel": "Assets" } } }, "localname": "AssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.npci.com/role/StatementsOfAssetsAndLiabilities" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsNet": { "auth_ref": [ "r0", "r107", "r123", "r127", "r128" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of net assets (liabilities).", "label": "Net Assets", "periodEndLabel": "Ending Balance", "periodStartLabel": "Beginning Balance", "terseLabel": "Net assets, end of period (in 000's)", "verboseLabel": "Net Assets \u2013 100.0%" } } }, "localname": "AssetsNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.npci.com/role/FinancialHighlightsSummaryOfShareOutstandingDetail", "http://www.npci.com/role/ScheduleOfInvestments2", "http://www.npci.com/role/StatementsOfChangesInNetAssets" ], "xbrltype": "monetaryItemType" }, "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).", "label": "Basis of Accounting, Policy [Policy Text Block]", "terseLabel": "Basis of Accounting" } } }, "localname": "BasisOfAccountingPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "auth_ref": [ "r29", "r146", "r425" ], "calculation": { "http://www.npci.com/role/StatementsOfAssetsAndLiabilities": { "order": 10.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash and Cash Equivalents, at Carrying Value", "terseLabel": "Cash and cash equivalents" } } }, "localname": "CashAndCashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.npci.com/role/StatementsOfAssetsAndLiabilities", "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsAxis": { "auth_ref": [ "r146" ], "lang": { "en-us": { "role": { "documentation": "Information by type of cash and cash equivalent balance.", "label": "Cash and Cash Equivalents [Axis]" } } }, "localname": "CashAndCashEquivalentsAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_CashAndCashEquivalentsPolicyTextBlock": { "auth_ref": [ "r30" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.", "label": "Cash and Cash Equivalents, Policy [Policy Text Block]", "terseLabel": "Cash and Cash Equivalents" } } }, "localname": "CashAndCashEquivalentsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "auth_ref": [ "r24", "r29", "r34" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents", "periodEndLabel": "End of the period", "periodStartLabel": "Beginning of the period" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.npci.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperationsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations [Abstract]", "terseLabel": "Cash and cash equivalents" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperationsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.npci.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": { "auth_ref": [ "r24", "r71" ], "calculation": { "http://www.npci.com/role/StatementsOfCashFlows": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect", "totalLabel": "Net decrease in cash and cash equivalents" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.npci.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ClassOfStockDomain": { "auth_ref": [ "r148", "r149", "r150", "r168", "r190", "r191", "r192", "r194", "r197", "r198", "r218", "r234", "r237", "r238", "r239", "r243", "r244", "r262", "r263", "r264", "r265", "r267", "r312", "r420", "r456", "r462", "r469" ], "lang": { "en-us": { "role": { "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock.", "label": "Class of Stock [Domain]" } } }, "localname": "ClassOfStockDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.npci.com/role/ScheduleOfInvestments2" ], "xbrltype": "domainItemType" }, "us-gaap_ClassOfTreasuryStockTable": { "auth_ref": [ "r51", "r52", "r53", "r54" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about treasury stock, including, but not limited to, average cost per share, description of share repurchase program, shares repurchased, shares held for each class of treasury stock.", "label": "Class of Treasury Stock [Table]" } } }, "localname": "ClassOfTreasuryStockTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.npci.com/role/ShareRepurchaseProgramAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingencies": { "auth_ref": [ "r14", "r88", "r96" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.", "label": "Commitments and Contingencies", "terseLabel": "Commitments and Contingencies" } } }, "localname": "CommitmentsAndContingencies", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.npci.com/role/EconomicDependencyAndCommitmentsAndContingenciesAdditionalInformationDetail", "http://www.npci.com/role/StatementsOfAssetsAndLiabilities" ], "xbrltype": "monetaryItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Commitments and Contingencies Disclosure [Abstract]" } } }, "localname": "CommitmentsAndContingenciesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "auth_ref": [ "r47", "r228", "r229", "r407", "r480" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for commitments and contingencies.", "label": "Commitments and Contingencies Disclosure [Text Block]", "terseLabel": "Economic Dependency and Commitments and Contingencies" } } }, "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.npci.com/role/EconomicDependencyAndCommitmentsAndContingencies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CommonStockMember": { "auth_ref": [ "r466", "r467", "r491" ], "lang": { "en-us": { "role": { "documentation": "Stock that is subordinate to all other stock of the issuer.", "label": "Common Stock [Member]", "terseLabel": "Common Stock" } } }, "localname": "CommonStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.npci.com/role/InvestmentPortfolioSummaryOfInvestmentCompanyAssetsByIndustryClassificationAtFairValueDetail", "http://www.npci.com/role/StatementsOfChangesInNetAssets", "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfChangesInTheCompanySLevel3InvestmentsDetail", "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfInvestmentsCategorizeIntoFairValueHierarchyDetail", "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfInvestmentsUsingSignificantUnobservableInputDetail", "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityDetail" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockParOrStatedValuePerShare": { "auth_ref": [ "r7" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of common stock.", "label": "Common Stock, Par or Stated Value Per Share", "terseLabel": "Common stock stated or par value per share" } } }, "localname": "CommonStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.npci.com/role/StatementsOfAssetsAndLiabilitiesParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockSharesAuthorized": { "auth_ref": [ "r7" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.", "label": "Common Stock, Shares Authorized", "terseLabel": "Common stock shares authorized" } } }, "localname": "CommonStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.npci.com/role/StatementsOfAssetsAndLiabilitiesParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesIssued": { "auth_ref": [ "r7" ], "lang": { "en-us": { "role": { "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.", "label": "Common Stock, Shares, Issued", "terseLabel": "Common stock shares issued" } } }, "localname": "CommonStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.npci.com/role/StatementsOfAssetsAndLiabilitiesParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesOutstanding": { "auth_ref": [ "r7", "r49" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.", "label": "Common Stock, Shares, Outstanding", "terseLabel": "Common stock shares outstanding", "verboseLabel": "Shares outstanding, end of period" } } }, "localname": "CommonStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.npci.com/role/FinancialHighlightsSummaryOfShareOutstandingDetail", "http://www.npci.com/role/StatementsOfAssetsAndLiabilitiesParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockValue": { "auth_ref": [ "r7", "r448" ], "calculation": { "http://www.npci.com/role/StatementsOfAssetsAndLiabilities": { "order": 6.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Common Stock, Value, Issued", "terseLabel": "Common stock, $0.001 par value (200,000,000 shares authorized, 9,677,593 and 9,956,228 shares issued and outstanding, respectively)" } } }, "localname": "CommonStockValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.npci.com/role/StatementsOfAssetsAndLiabilities" ], "xbrltype": "monetaryItemType" }, "us-gaap_ConcentrationRiskDisclosureTextBlock": { "auth_ref": [ "r41" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for any concentrations existing at the date of the financial statements that make an entity vulnerable to a reasonably possible, near-term, severe impact. This disclosure informs financial statement users about the general nature of the risk associated with the concentration, and may indicate the percentage of concentration risk as of the balance sheet date.", "label": "Concentration Risk Disclosure [Text Block]", "terseLabel": "Market and Other Factors" } } }, "localname": "ConcentrationRiskDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.npci.com/role/MarketAndOtherRiskFactors" ], "xbrltype": "textBlockItemType" }, "us-gaap_CorporateBondSecuritiesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This category includes information about long-term debt securities that are issued by either a domestic or foreign corporate business entity with a date certain promise of repayment and a return to the holder for the time value of money (for example, variable or fixed interest, original issue discount).", "label": "Corporate Bond Securities [Member]", "terseLabel": "Corporate Bonds" } } }, "localname": "CorporateBondSecuritiesMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.npci.com/role/InvestmentPortfolioSummaryOfInvestmentCompanyAssetsByIndustryClassificationAtFairValueDetail" ], "xbrltype": "domainItemType" }, "us-gaap_DebtConversionConvertedInstrumentAmount1": { "auth_ref": [ "r32", "r33" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The value of the financial instrument(s) that the original debt is being converted into in a noncash (or part noncash) transaction. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.", "label": "Debt Conversion, Converted Instrument, Amount", "terseLabel": "Debt Conversion, Converted Instrument, Amount" } } }, "localname": "DebtConversionConvertedInstrumentAmount1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfChangesInTheCompanySLevel3InvestmentsParentheticalDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentAxis": { "auth_ref": [ "r2", "r3", "r4", "r79", "r81", "r90", "r174", "r245", "r246", "r247", "r248", "r249", "r250", "r251", "r252", "r253", "r254", "r255", "r256", "r257", "r258", "r259", "r260", "r319", "r434", "r435", "r436", "r437", "r438", "r463" ], "lang": { "en-us": { "role": { "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.", "label": "Debt Instrument [Axis]" } } }, "localname": "DebtInstrumentAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.npci.com/role/ScheduleOfInvestments", "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfChangesInTheCompanySLevel3InvestmentsParentheticalDetail" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentNameDomain": { "auth_ref": [ "r13", "r174", "r245", "r246", "r247", "r248", "r249", "r250", "r251", "r252", "r253", "r254", "r255", "r256", "r257", "r258", "r259", "r260", "r319", "r434", "r435", "r436", "r437", "r438", "r463" ], "lang": { "en-us": { "role": { "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.", "label": "Debt Instrument, Name [Domain]" } } }, "localname": "DebtInstrumentNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.npci.com/role/ScheduleOfInvestments", "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfChangesInTheCompanySLevel3InvestmentsParentheticalDetail" ], "xbrltype": "domainItemType" }, "us-gaap_DerivativesPolicyTextBlock": { "auth_ref": [ "r56", "r57", "r58", "r59", "r60", "r173" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for its derivative instruments and hedging activities.", "label": "Derivatives, Policy [Policy Text Block]", "terseLabel": "Derivative Transactions" } } }, "localname": "DerivativesPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_DividendsPayableAmountPerShare": { "auth_ref": [ "r32" ], "lang": { "en-us": { "role": { "documentation": "The per share amount of a dividend declared, but not paid, as of the financial reporting date.", "label": "Dividends Payable, Amount Per Share", "terseLabel": "Dividend per share declared" } } }, "localname": "DividendsPayableAmountPerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "perShareItemType" }, "us-gaap_DividendsPayableCurrentAndNoncurrent": { "auth_ref": [ "r3", "r5", "r80", "r92" ], "calculation": { "http://www.npci.com/role/StatementsOfAssetsAndLiabilities": { "order": 4.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of dividends declared but unpaid on equity securities issued by the entity and outstanding.", "label": "Dividends Payable", "terseLabel": "Distributions payable" } } }, "localname": "DividendsPayableCurrentAndNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.npci.com/role/StatementsOfAssetsAndLiabilities" ], "xbrltype": "monetaryItemType" }, "us-gaap_DueFromRelatedParties": { "auth_ref": [ "r83", "r99", "r151", "r236", "r237", "r238", "r242", "r243", "r244", "r324", "r465" ], "calculation": { "http://www.npci.com/role/StatementsOfAssetsAndLiabilities": { "order": 13.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "For an unclassified balance sheet, amounts due from related parties including affiliates, employees, joint ventures, officers and stockholders, immediate families thereof, and pension funds.", "label": "Due from Related Parties", "terseLabel": "Receivable from Adviser" } } }, "localname": "DueFromRelatedParties", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.npci.com/role/StatementsOfAssetsAndLiabilities" ], "xbrltype": "monetaryItemType" }, "us-gaap_DueToRelatedPartiesCurrentAndNoncurrent": { "auth_ref": [ "r86", "r98", "r236", "r237", "r238", "r242", "r243", "r244", "r324", "r465" ], "calculation": { "http://www.npci.com/role/StatementsOfAssetsAndLiabilities": { "order": 2.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying amount as of the balance sheet date of obligations due all related parties.", "label": "Due to Related Parties", "terseLabel": "Payable to Adviser" } } }, "localname": "DueToRelatedPartiesCurrentAndNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.npci.com/role/StatementsOfAssetsAndLiabilities" ], "xbrltype": "monetaryItemType" }, "us-gaap_EarningsPerShareBasic": { "auth_ref": [ "r161", "r180", "r181", "r182", "r183", "r184", "r188", "r190", "r192", "r193", "r194", "r195", "r303", "r304", "r373", "r376", "r426" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.", "label": "Earnings Per Share, Basic", "terseLabel": "Earnings (loss) per share: Basic" } } }, "localname": "EarningsPerShareBasic", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.npci.com/role/StatementsOfOperations", "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfComputationOfBasicAndDilutedNetDetail" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareDiluted": { "auth_ref": [ "r161", "r180", "r181", "r182", "r183", "r184", "r190", "r192", "r193", "r194", "r195", "r303", "r304", "r373", "r376", "r426" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.", "label": "Earnings Per Share, Diluted", "terseLabel": "Earnings (loss) per share: Diluted" } } }, "localname": "EarningsPerShareDiluted", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.npci.com/role/StatementsOfOperations", "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfComputationOfBasicAndDilutedNetDetail" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerSharePolicyTextBlock": { "auth_ref": [ "r36", "r37" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.", "label": "Earnings Per Share, Policy [Policy Text Block]", "terseLabel": "Earnings Per Share" } } }, "localname": "EarningsPerSharePolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationDispositionOfAssets": { "auth_ref": [ "r489", "r490" ], "lang": { "en-us": { "role": { "documentation": "Percentage of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operations, attributable to disposition of asset. Includes, but is not limited to, intra-entity transfer of asset other than inventory.", "label": "Effective Income Tax Rate Reconciliation, Disposition of Asset, Percent", "terseLabel": "Effective Income Tax Rate Reconciliation, Disposition of Asset, Percent" } } }, "localname": "EffectiveIncomeTaxRateReconciliationDispositionOfAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.npci.com/role/USFederalIncomeTaxInformationAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense": { "auth_ref": [ "r489", "r490" ], "lang": { "en-us": { "role": { "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible expenses.", "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent", "terseLabel": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent" } } }, "localname": "EffectiveIncomeTaxRateReconciliationNondeductibleExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.npci.com/role/USFederalIncomeTaxInformationAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "us-gaap_EquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Equity [Abstract]" } } }, "localname": "EquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_EquityClassOfTreasuryStockLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Equity, Class of Treasury Stock [Line Items]" } } }, "localname": "EquityClassOfTreasuryStockLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.npci.com/role/ShareRepurchaseProgramAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_EquityComponentDomain": { "auth_ref": [ "r49", "r144", "r158", "r159", "r160", "r175", "r176", "r177", "r179", "r185", "r187", "r196", "r219", "r268", "r281", "r282", "r283", "r287", "r288", "r302", "r313", "r314", "r315", "r316", "r317", "r318", "r320", "r378", "r379", "r380" ], "lang": { "en-us": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.", "label": "Equity Component [Domain]" } } }, "localname": "EquityComponentDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.npci.com/role/StatementsOfChangesInNetAssets", "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfChangesInTheCompanySLevel3InvestmentsParentheticalDetail" ], "xbrltype": "domainItemType" }, "us-gaap_EquityMethodInvestmentOwnershipPercentage": { "auth_ref": [ "r46" ], "lang": { "en-us": { "role": { "documentation": "The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.", "label": "Equity Method Investment, Ownership Percentage", "terseLabel": "Equity method investments ownership percentage" } } }, "localname": "EquityMethodInvestmentOwnershipPercentage", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.npci.com/role/OrganizationAdditionalInformationDetail", "http://www.npci.com/role/ScheduleOfInvestmentsParenthentical" ], "xbrltype": "percentItemType" }, "us-gaap_EquityMethodInvestments": { "auth_ref": [ "r45", "r205", "r457" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.", "label": "Equity Method Investments", "verboseLabel": "Equity Method Investments" } } }, "localname": "EquityMethodInvestments", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.npci.com/role/ScheduleOfInvestmentsParenthentical" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Fair Value Measurement Inputs and Valuation Techniques [Line Items]" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityDetail" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable": { "auth_ref": [ "r64" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis.", "label": "Fair Value Measurement Inputs and Valuation Techniques [Table]" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityDetail" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock": { "auth_ref": [ "r64" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis.", "label": "Fair Value Measurement Inputs and Valuation Techniques [Table Text Block]", "terseLabel": "Summary of Quantitative Information about the Company's Level 3 Asset and Liability" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss": { "auth_ref": [ "r310" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of unrealized gain (loss) recognized in income from asset measured at fair value on recurring basis using unobservable input (level 3) and still held.", "label": "Fair Value, Asset, Recurring Basis, Still Held, Unrealized Gain (Loss)", "terseLabel": "Change in unrealized gain/(loss) on Level 3 securities still held at period end" } } }, "localname": "FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfChangesInTheCompanySLevel3InvestmentsDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain": { "auth_ref": [ "r65" ], "lang": { "en-us": { "role": { "documentation": "Class of asset.", "label": "Asset Class [Domain]" } } }, "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.npci.com/role/InvestmentPortfolioSummaryOfInvestmentCompanyAssetsByIndustryClassificationAtFairValueDetail", "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfChangesInTheCompanySLevel3InvestmentsDetail", "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityDetail" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]" } } }, "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfChangesInTheCompanySLevel3InvestmentsDetail", "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfChangesInTheCompanySLevel3InvestmentsParentheticalDetail" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable": { "auth_ref": [ "r65", "r67" ], "lang": { "en-us": { "role": { "documentation": "Schedule of information required and determined to be provided for purposes of reconciling beginning and ending balances of fair value measurements of assets using significant unobservable inputs (level 3). Such reconciliation, separately presenting changes during the period, at a minimum, may include, but is not limited to: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets) and gains or losses recognized in other comprehensive income, and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of level 3 (for example, transfers due to changes in the observability of significant inputs), by class of asset.", "label": "Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table]" } } }, "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfChangesInTheCompanySLevel3InvestmentsDetail", "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfChangesInTheCompanySLevel3InvestmentsParentheticalDetail" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock": { "auth_ref": [ "r65", "r67" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the fair value measurement of assets using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes during the period attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets) and gains or losses recognized in other comprehensive income (loss), and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs), by class of asset.", "label": "Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]", "terseLabel": "Summary of Fair Value Assets Measured on Recurring Basis Unobservable input Reconciliation" } } }, "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueByAssetClassAxis": { "auth_ref": [ "r63", "r67" ], "lang": { "en-us": { "role": { "documentation": "Information by class of asset.", "label": "Asset Class [Axis]" } } }, "localname": "FairValueByAssetClassAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.npci.com/role/InvestmentPortfolioSummaryOfInvestmentCompanyAssetsByIndustryClassificationAtFairValueDetail", "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfChangesInTheCompanySLevel3InvestmentsDetail", "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityDetail" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueByFairValueHierarchyLevelAxis": { "auth_ref": [ "r253", "r270", "r271", "r272", "r273", "r274", "r275", "r306", "r332", "r333", "r334", "r435", "r436", "r442", "r443", "r444" ], "lang": { "en-us": { "role": { "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.", "label": "Fair Value Hierarchy and NAV [Axis]" } } }, "localname": "FairValueByFairValueHierarchyLevelAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfInvestmentsCategorizeIntoFairValueHierarchyDetail", "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfInvestmentsUsingSignificantUnobservableInputDetail", "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityDetail" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueDisclosureOffbalanceSheetRisksAmountAsset": { "auth_ref": [ "r311" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The fair value of financial assets, which are not recognized in the financial statements (off-balance sheet) because they fail to meet some other criterion for recognition.", "label": "Fair Value Disclosure, off-Balance-Sheet Risks, Amount, Asset", "terseLabel": "Fair value of options held" } } }, "localname": "FairValueDisclosureOffbalanceSheetRisksAmountAsset", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueDisclosureOffbalanceSheetRisksFaceAmountAsset": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The face amount of financial assets, which are not recognized in the financial statements (off-balance sheet) because they fail to meet some other criterion for recognition.", "label": "Fair Value Disclosure, off-Balance-Sheet Risks, Face Amount, Asset", "terseLabel": "Off balance sheet asset face amount" } } }, "localname": "FairValueDisclosureOffbalanceSheetRisksFaceAmountAsset", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.npci.com/role/MarketAndOtherRiskFactorsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueInputsLevel1Member": { "auth_ref": [ "r253", "r270", "r275", "r306", "r332", "r442", "r443", "r444" ], "lang": { "en-us": { "role": { "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.", "label": "Fair Value, Inputs, Level 1 [Member]" } } }, "localname": "FairValueInputsLevel1Member", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfInvestmentsCategorizeIntoFairValueHierarchyDetail" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueInputsLevel2Member": { "auth_ref": [ "r253", "r270", "r275", "r306", "r333", "r435", "r436", "r442", "r443", "r444" ], "lang": { "en-us": { "role": { "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.", "label": "Fair Value, Inputs, Level 2 [Member]" } } }, "localname": "FairValueInputsLevel2Member", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfInvestmentsCategorizeIntoFairValueHierarchyDetail" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueInputsLevel3Member": { "auth_ref": [ "r253", "r270", "r271", "r272", "r273", "r274", "r275", "r306", "r334", "r435", "r436", "r442", "r443", "r444" ], "lang": { "en-us": { "role": { "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Fair Value, Inputs, Level 3 [Member]" } } }, "localname": "FairValueInputsLevel3Member", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfInvestmentsCategorizeIntoFairValueHierarchyDetail", "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfInvestmentsUsingSignificantUnobservableInputDetail", "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityDetail" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1": { "auth_ref": [ "r308" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of gain (loss) recognized in income from asset measured at fair value on recurring basis using unobservable input (level 3).", "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Earnings", "terseLabel": "Net change in unrealized gains/ (losses)" } } }, "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfChangesInTheCompanySLevel3InvestmentsDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases": { "auth_ref": [ "r66" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of purchases of financial instrument classified as an asset measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Purchases", "terseLabel": "Purchases/ PIK" } } }, "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfChangesInTheCompanySLevel3InvestmentsDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales": { "auth_ref": [ "r66" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of sale of financial instrument classified as an asset measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Sales", "terseLabel": "Sales and redemptions" } } }, "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfChangesInTheCompanySLevel3InvestmentsDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements": { "auth_ref": [ "r66" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of settlement of financial instrument classified as an asset measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Settlements", "terseLabel": "Distribution to Return Capital" } } }, "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfChangesInTheCompanySLevel3InvestmentsDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3": { "auth_ref": [ "r309" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of transfer of financial instrument classified as an asset into level 3 of the fair value hierarchy.", "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Transfers Into Level 3", "terseLabel": "Transfers into Level 3" } } }, "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfChangesInTheCompanySLevel3InvestmentsDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3": { "auth_ref": [ "r309" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of transfers of financial instrument classified as an asset out of level 3 of the fair value hierarchy.", "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers out of Level 3", "terseLabel": "Transfers out of Level 3" } } }, "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfChangesInTheCompanySLevel3InvestmentsDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue": { "auth_ref": [ "r65" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value of financial instrument classified as an asset measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value", "periodEndLabel": "Balance as of Ending", "periodStartLabel": "Balance as of beginning" } } }, "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfChangesInTheCompanySLevel3InvestmentsDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": { "auth_ref": [ "r253", "r270", "r271", "r272", "r273", "r274", "r275", "r332", "r333", "r334", "r435", "r436", "r442", "r443", "r444" ], "lang": { "en-us": { "role": { "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.", "label": "Fair Value Hierarchy and NAV [Domain]" } } }, "localname": "FairValueMeasurementsFairValueHierarchyDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfInvestmentsCategorizeIntoFairValueHierarchyDetail", "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfInvestmentsUsingSignificantUnobservableInputDetail", "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityDetail" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueOfFinancialInstrumentsPolicy": { "auth_ref": [ "r69", "r70" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments.", "label": "Fair Value of Financial Instruments, Policy [Policy Text Block]", "terseLabel": "Fair Value of Financial Instruments" } } }, "localname": "FairValueOfFinancialInstrumentsPolicy", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_FeeIncome": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Fee Income" } } }, "localname": "FeeIncome", "nsuri": "http://fasb.org/us-gaap-sup/2022q3", "presentation": [ "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinancialInstrumentAxis": { "auth_ref": [ "r214", "r215", "r220", "r221", "r222", "r223", "r224", "r225", "r226", "r227", "r261", "r266", "r301", "r329", "r330", "r331", "r332", "r333", "r334", "r335", "r336", "r337", "r338", "r339", "r340", "r341", "r342", "r343", "r344", "r345", "r346", "r347", "r348", "r349", "r350", "r351", "r352", "r353", "r354", "r355", "r356", "r357", "r358", "r433", "r475", "r476", "r477", "r508", "r509", "r510", "r511", "r512", "r513", "r514" ], "lang": { "en-us": { "role": { "documentation": "Information by type of financial instrument.", "label": "Financial Instrument [Axis]" } } }, "localname": "FinancialInstrumentAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.npci.com/role/ScheduleOfInvestmentsParenthentical" ], "xbrltype": "stringItemType" }, "us-gaap_FinancialInstrumentsSoldNotYetPurchasedAtFairValue": { "auth_ref": [ "r76" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value of obligations incurred from short sales.", "label": "Financial Instruments Sold, Not yet Purchased, at Fair Value", "terseLabel": "Securities sold short value" } } }, "localname": "FinancialInstrumentsSoldNotYetPurchasedAtFairValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinancialServiceMember": { "auth_ref": [ "r486" ], "lang": { "en-us": { "role": { "documentation": "Financial assistance, including, but not limited to, management and maintenance of depositor account, credit card, merchant discount, trust, investment and insurance.", "label": "Financial Service [Member]", "terseLabel": "Financials" } } }, "localname": "FinancialServiceMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.npci.com/role/InvestmentPortfolioSummaryOfInvestmentHoldingsScheduleOfInvestmentsDetail" ], "xbrltype": "domainItemType" }, "us-gaap_FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis": { "auth_ref": [ "r42", "r43", "r213", "r222", "r223", "r224", "r421", "r422", "r423", "r424", "r429", "r430", "r431", "r432", "r508", "r509", "r510", "r511", "r512", "r513", "r514", "r515", "r516", "r517" ], "lang": { "en-us": { "role": { "documentation": "Information by class of financing receivable determined on the basis of initial measurement attribute, risk characteristics and method of monitoring and assessing credit risk.", "label": "Class of Financing Receivable [Axis]" } } }, "localname": "FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.npci.com/role/EconomicDependencyAndCommitmentsAndContingenciesAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_FinancingReceivableRecordedInvestmentClassOfFinancingReceivableDomain": { "auth_ref": [ "r421", "r422", "r423", "r424", "r508", "r509", "r510", "r511", "r512", "r513", "r514", "r515", "r516", "r517" ], "lang": { "en-us": { "role": { "documentation": "Financing receivables determined on the basis of initial measurement attribute, risk characteristics and method of monitoring and assessing credit risk.", "label": "Class of Financing Receivable [Domain]" } } }, "localname": "FinancingReceivableRecordedInvestmentClassOfFinancingReceivableDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.npci.com/role/EconomicDependencyAndCommitmentsAndContingenciesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_GrossInvestmentIncomeOperating": { "auth_ref": [ "r100" ], "calculation": { "http://www.npci.com/role/StatementsOfOperations": { "order": 14.0, "parentTag": "us-gaap_NetInvestmentIncome", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, before investment expense, of income earned from investments in securities and real estate. Includes, but is not limited to, real estate investment, policy loans, dividends, and interest. Excludes realized gain (loss) on investments.", "label": "Gross Investment Income, Operating", "totalLabel": "Total investment income" } } }, "localname": "GrossInvestmentIncomeOperating", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.npci.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_HealthCareMember": { "auth_ref": [ "r486" ], "lang": { "en-us": { "role": { "documentation": "Service provided for prevention, maintenance, diagnosis or treatment of physical and mental health.", "label": "Health Care [Member]", "terseLabel": "Healthcare" } } }, "localname": "HealthCareMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.npci.com/role/InvestmentPortfolioSummaryOfInvestmentHoldingsScheduleOfInvestmentsDetail", "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfChangesInTheCompanySLevel3InvestmentsDetail", "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfInvestmentsCategorizeIntoFairValueHierarchyDetail" ], "xbrltype": "domainItemType" }, "us-gaap_IncomeStatementAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Statement [Abstract]" } } }, "localname": "IncomeStatementAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Tax Disclosure [Abstract]" } } }, "localname": "IncomeTaxDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxDisclosureTextBlock": { "auth_ref": [ "r169", "r284", "r285", "r286", "r289", "r290", "r291", "r292", "r293" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.", "label": "Income Tax Disclosure [Text Block]", "terseLabel": "U.S. Federal Income Tax Information" } } }, "localname": "IncomeTaxDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.npci.com/role/USFederalIncomeTaxInformation" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeTaxesPaidNet": { "auth_ref": [ "r31" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.", "label": "Income Taxes Paid, Net", "terseLabel": "Local and excise taxes paid" } } }, "localname": "IncomeTaxesPaidNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.npci.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities": { "auth_ref": [ "r461" ], "calculation": { "http://www.npci.com/role/StatementsOfCashFlows": { "order": 15.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in accrued expenses, and obligations classified as other.", "label": "Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities", "terseLabel": "Increase (decrease) in accrued expenses and other liabilities" } } }, "localname": "IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.npci.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInDueFromRelatedPartiesCurrent": { "auth_ref": [ "r26" ], "calculation": { "http://www.npci.com/role/StatementsOfCashFlows": { "order": 11.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate increase (decrease) during the reporting period in the amount due from the following types of related parties: a parent company and its subsidiaries; subsidiaries of a common parent; an entity and trust for the benefit of employees, such as pension and profit-sharing trusts that are managed by or under the trusteeship of the entity's management; an entity and its principal owners, management, or member of their immediate families, affiliates, or other parties with the ability to exert significant influence.", "label": "Increase (Decrease) in Due from Related Parties, Current", "negatedLabel": "(Increase) decrease in receivable from Adviser" } } }, "localname": "IncreaseDecreaseInDueFromRelatedPartiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.npci.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInDueToRelatedPartiesCurrent": { "auth_ref": [ "r26" ], "calculation": { "http://www.npci.com/role/StatementsOfCashFlows": { "order": 14.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate amount of obligations to be paid to the following types of related parties: a parent company and its subsidiaries; subsidiaries of a common parent; an entity and trust for the benefit of employees, such as pension and profit-sharing trusts that are managed by or under the trusteeship of the entities' management; an entity and its principal owners, management, or member of their immediate families, affiliates, or other parties with the ability to exert significant influence.", "label": "Increase (Decrease) in Due to Related Parties, Current", "terseLabel": "Increase (decrease) in payable to Adviser" } } }, "localname": "IncreaseDecreaseInDueToRelatedPartiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.npci.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInInterestAndDividendsReceivable": { "auth_ref": [ "r26" ], "calculation": { "http://www.npci.com/role/StatementsOfCashFlows": { "order": 10.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate amount due to the entity in the form of unpaid interest and dividends.", "label": "Increase (Decrease) in Interest and Dividends Receivable", "negatedLabel": "(Increase) decrease in dividends and interest receivable" } } }, "localname": "IncreaseDecreaseInInterestAndDividendsReceivable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.npci.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOperatingAssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Increase (Decrease) in Operating Assets [Abstract]", "terseLabel": "Change in operating assets and liabilities:" } } }, "localname": "IncreaseDecreaseInOperatingAssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.npci.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_IncreaseDecreaseInPrepaidExpense": { "auth_ref": [ "r26" ], "calculation": { "http://www.npci.com/role/StatementsOfCashFlows": { "order": 12.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for future periods.", "label": "Increase (Decrease) in Prepaid Expense", "negatedLabel": "(Increase) decrease in prepaid expenses" } } }, "localname": "IncreaseDecreaseInPrepaidExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.npci.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestPaidNet": { "auth_ref": [ "r162", "r165", "r166" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.", "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities", "terseLabel": "Paid-in-kind\u00a0interest income" } } }, "localname": "InterestPaidNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.npci.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentCompanyCapitalShareTransactionsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Investment Company, Capital Share Transactions [Abstract]" } } }, "localname": "InvestmentCompanyCapitalShareTransactionsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.npci.com/role/FinancialHighlightsSummaryOfShareOutstandingDetail" ], "xbrltype": "stringItemType" }, "us-gaap_InvestmentCompanyDistributionToShareholdersPerShare": { "auth_ref": [ "r118" ], "lang": { "en-us": { "role": { "documentation": "Per share or unit amount of distribution to shareholders. Includes, but is not limited to, dividend and capital gain. Excludes distribution for tax return of capital.", "label": "Investment Company, Distribution to Shareholders, Per Share", "terseLabel": "Distributions to stockholders per share" } } }, "localname": "InvestmentCompanyDistributionToShareholdersPerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.npci.com/role/StatementsOfChangesInNetAssets" ], "xbrltype": "perShareItemType" }, "us-gaap_InvestmentCompanyDividendDistribution": { "auth_ref": [ "r104", "r106" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of dividend distribution from ordinary income and capital gain. Excludes distribution for tax return of capital.", "label": "Investment Company, Dividend Distribution", "negatedLabel": "Distributions to stockholders from net investment income" } } }, "localname": "InvestmentCompanyDividendDistribution", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.npci.com/role/StatementsOfChangesInNetAssets" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentCompanyExpenseRatioIncludingVoluntaryFeeWaiver": { "auth_ref": [ "r103" ], "lang": { "en-us": { "role": { "documentation": "Percentage, after deduction of voluntary fee waiver, of expense to average net assets.", "label": "Investment Company, Expense Ratio Including Voluntary Fee Waiver", "terseLabel": "Net operating expenses(5)" } } }, "localname": "InvestmentCompanyExpenseRatioIncludingVoluntaryFeeWaiver", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.npci.com/role/FinancialHighlightsSummaryOfShareOutstandingDetail" ], "xbrltype": "percentItemType" }, "us-gaap_InvestmentCompanyExpenseRatioVoluntaryFeeWaiver": { "auth_ref": [ "r103" ], "lang": { "en-us": { "role": { "documentation": "Percentage of voluntary fee waiver to average net assets.", "label": "Investment Company, Expense Ratio, Voluntary Fee Waiver", "negatedLabel": "Fees and expenses waived or reimbursed(5)" } } }, "localname": "InvestmentCompanyExpenseRatioVoluntaryFeeWaiver", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.npci.com/role/FinancialHighlightsSummaryOfShareOutstandingDetail" ], "xbrltype": "percentItemType" }, "us-gaap_InvestmentCompanyFinancialHighlightsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Investment Company, Financial Highlights [Abstract]" } } }, "localname": "InvestmentCompanyFinancialHighlightsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_InvestmentCompanyFinancialHighlightsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Investment Company, Financial Highlights [Line Items]" } } }, "localname": "InvestmentCompanyFinancialHighlightsLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.npci.com/role/FinancialHighlightsSummaryOfShareOutstandingDetail" ], "xbrltype": "stringItemType" }, "us-gaap_InvestmentCompanyFinancialHighlightsTable": { "auth_ref": [ "r108" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about financial highlights. Includes, but is not limited to, per share information, income and expense ratios, total return, capital commitment and fee waiver.", "label": "Investment Company, Financial Highlights [Table]" } } }, "localname": "InvestmentCompanyFinancialHighlightsTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.npci.com/role/FinancialHighlightsSummaryOfShareOutstandingDetail" ], "xbrltype": "stringItemType" }, "us-gaap_InvestmentCompanyFinancialHighlightsTableTextBlock": { "auth_ref": [ "r108" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of financial highlights. Includes, but is not limited to, per share information, income and expense ratios, total return, capital commitment and fee waiver.", "label": "Investment Company, Financial Highlights [Table Text Block]", "terseLabel": "Summary of share outstanding" } } }, "localname": "InvestmentCompanyFinancialHighlightsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.npci.com/role/FinancialHighlightsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_InvestmentCompanyFinancialHighlightsTextBlock": { "auth_ref": [ "r120", "r383" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure of financial highlights reported by investment company.", "label": "Investment Company, Financial Highlights [Text Block]", "terseLabel": "Financial Highlights" } } }, "localname": "InvestmentCompanyFinancialHighlightsTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.npci.com/role/FinancialHighlights" ], "xbrltype": "textBlockItemType" }, "us-gaap_InvestmentCompanyFinancialRatiosAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Investment Company, Financial Ratios [Abstract]" } } }, "localname": "InvestmentCompanyFinancialRatiosAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.npci.com/role/FinancialHighlightsSummaryOfShareOutstandingDetail" ], "xbrltype": "stringItemType" }, "us-gaap_InvestmentCompanyGainLossOnInvestmentPerShare": { "auth_ref": [ "r116" ], "calculation": { "http://www.npci.com/role/FinancialHighlightsSummaryOfShareOutstandingDetail": { "order": 2.0, "parentTag": "us-gaap_InvestmentCompanyInvestmentIncomeLossFromOperationsPerShare", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Per share or unit amount of realized and unrealized gain (loss) on investment.", "label": "Investment Company, Gain (Loss) on Investment, Per Share", "terseLabel": "Net realized and unrealized gain (loss)" } } }, "localname": "InvestmentCompanyGainLossOnInvestmentPerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.npci.com/role/FinancialHighlightsSummaryOfShareOutstandingDetail" ], "xbrltype": "perShareItemType" }, "us-gaap_InvestmentCompanyIncentiveFeeToAverageNetAssets": { "auth_ref": [ "r110" ], "lang": { "en-us": { "role": { "documentation": "Percentage of incentive fee expense to average net assets.", "label": "Investment Company, Incentive Fee to Average Net Assets", "terseLabel": "Weighted average commission rate paid(6)" } } }, "localname": "InvestmentCompanyIncentiveFeeToAverageNetAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.npci.com/role/FinancialHighlightsSummaryOfShareOutstandingDetail" ], "xbrltype": "percentItemType" }, "us-gaap_InvestmentCompanyInvestmentIncomeLossFromOperationsPerShare": { "auth_ref": [ "r117" ], "calculation": { "http://www.npci.com/role/FinancialHighlightsSummaryOfShareOutstandingDetail": { "order": null, "parentTag": null, "root": true, "weight": null } }, "lang": { "en-us": { "role": { "documentation": "Per share or unit amount of investment income (loss) and realized and unrealized gain (loss) on investment.", "label": "Investment Company, Investment Income (Loss) from Operations, Per Share", "totalLabel": "Total from investment operations" } } }, "localname": "InvestmentCompanyInvestmentIncomeLossFromOperationsPerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.npci.com/role/FinancialHighlightsSummaryOfShareOutstandingDetail" ], "xbrltype": "perShareItemType" }, "us-gaap_InvestmentCompanyInvestmentIncomeLossFromOperationsPerShareAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Investment Company, Investment Income (Loss) from Operations, Per Share [Abstract]" } } }, "localname": "InvestmentCompanyInvestmentIncomeLossFromOperationsPerShareAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.npci.com/role/FinancialHighlightsSummaryOfShareOutstandingDetail" ], "xbrltype": "stringItemType" }, "us-gaap_InvestmentCompanyInvestmentIncomeLossPerShare": { "auth_ref": [ "r115" ], "calculation": { "http://www.npci.com/role/FinancialHighlightsSummaryOfShareOutstandingDetail": { "order": 1.0, "parentTag": "us-gaap_InvestmentCompanyInvestmentIncomeLossFromOperationsPerShare", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Per share or unit amount, after investment expense, of dividend and interest investment income (loss).", "label": "Investment Company, Investment Income (Loss), Per Share", "terseLabel": "Net investment income(1)", "verboseLabel": "Net investment income:" } } }, "localname": "InvestmentCompanyInvestmentIncomeLossPerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.npci.com/role/FinancialHighlightsSummaryOfShareOutstandingDetail", "http://www.npci.com/role/StatementsOfOperations" ], "xbrltype": "perShareItemType" }, "us-gaap_InvestmentCompanyInvestmentIncomeLossRatio": { "auth_ref": [ "r109" ], "lang": { "en-us": { "role": { "documentation": "Percentage of investment income (loss) to average net assets.", "label": "Investment Company, Investment Income (Loss) Ratio", "terseLabel": "Gross operating expenses(5)" } } }, "localname": "InvestmentCompanyInvestmentIncomeLossRatio", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.npci.com/role/FinancialHighlightsSummaryOfShareOutstandingDetail" ], "xbrltype": "percentItemType" }, "us-gaap_InvestmentCompanyInvestmentIncomeLossRatioAfterIncentiveAllocation": { "auth_ref": [ "r110" ], "lang": { "en-us": { "role": { "documentation": "Percentage, after incentive allocation, of investment income (loss) to average net assets.", "label": "Investment Company, Investment Income (Loss) Ratio, after Incentive Allocation", "terseLabel": "Net investment income (loss) after fees waived or reimbursed(5)" } } }, "localname": "InvestmentCompanyInvestmentIncomeLossRatioAfterIncentiveAllocation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.npci.com/role/FinancialHighlightsSummaryOfShareOutstandingDetail" ], "xbrltype": "percentItemType" }, "us-gaap_InvestmentCompanyInvestmentIncomeLossRatioBeforeIncentiveAllocation": { "auth_ref": [ "r110" ], "lang": { "en-us": { "role": { "documentation": "Percentage, before incentive allocation, of investment income (loss) to average net assets.", "label": "Investment Company, Investment Income (Loss) Ratio, before Incentive Allocation", "terseLabel": "Net investment income (loss) before fees waived or reimbursed(5)" } } }, "localname": "InvestmentCompanyInvestmentIncomeLossRatioBeforeIncentiveAllocation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.npci.com/role/FinancialHighlightsSummaryOfShareOutstandingDetail" ], "xbrltype": "percentItemType" }, "us-gaap_InvestmentCompanyNetAssetsFromOperationsIncreaseDecrease": { "auth_ref": [ "r105", "r126" ], "calculation": { "http://www.npci.com/role/StatementsOfOperations": { "order": null, "parentTag": null, "root": true, "weight": null } }, "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in net assets from operations of investment company.", "label": "Investment Company, Net Assets from Operations, Increase (Decrease)", "totalLabel": "Net increase (decrease) in net assets resulting from operations", "verboseLabel": "Net increase (decrease) in net assets resulting from operations" } } }, "localname": "InvestmentCompanyNetAssetsFromOperationsIncreaseDecrease", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.npci.com/role/StatementsOfOperations", "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfComputationOfBasicAndDilutedNetDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentCompanyNetAssetsRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Investment Company, Net Assets [Roll Forward]" } } }, "localname": "InvestmentCompanyNetAssetsRollForward", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_InvestmentCompanyRealizedAndUnrealizedGainLossOnInvestmentAndForeignCurrency": { "auth_ref": [ "r125" ], "calculation": { "http://www.npci.com/role/StatementsOfOperations": { "order": 18.0, "parentTag": "us-gaap_InvestmentCompanyNetAssetsFromOperationsIncreaseDecrease", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of realized and unrealized gain (loss) on investment, foreign currency translation and foreign currency denominated asset and liability.", "label": "Investment Company, Realized and Unrealized Gain (Loss) on Investment and Foreign Currency", "totalLabel": "Net realized and unrealized gains (losses)" } } }, "localname": "InvestmentCompanyRealizedAndUnrealizedGainLossOnInvestmentAndForeignCurrency", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.npci.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentCompanyRealizedAndUnrealizedGainLossOnInvestmentAndForeignCurrencyAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Investment Company, Realized and Unrealized Gain (Loss) on Investment and Foreign Currency [Abstract]", "terseLabel": "Net realized and unrealized gains (losses) on investments:" } } }, "localname": "InvestmentCompanyRealizedAndUnrealizedGainLossOnInvestmentAndForeignCurrencyAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.npci.com/role/StatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_InvestmentCompanyShareholderServiceFeeExpense": { "auth_ref": [ "r124" ], "calculation": { "http://www.npci.com/role/StatementsOfOperations": { "order": 7.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense for shareholder services. Includes, but is not limited to, fee and expense for transfer and dividend disbursing agent.", "label": "Investment Company, Shareholder Service Fee Expense", "terseLabel": "Stock transfer fee" } } }, "localname": "InvestmentCompanyShareholderServiceFeeExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.npci.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentCompanyTotalReturn": { "auth_ref": [ "r111", "r112", "r113" ], "lang": { "en-us": { "role": { "documentation": "Percentage increase (decrease) in fund net asset value, assuming reinvestment of dividends and capital gain distributions.", "label": "Investment Company, Total Return", "terseLabel": "Net asset value total return(3)(4)" } } }, "localname": "InvestmentCompanyTotalReturn", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.npci.com/role/FinancialHighlightsSummaryOfShareOutstandingDetail" ], "xbrltype": "percentItemType" }, "us-gaap_InvestmentHoldingsScheduleOfInvestmentsTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of data and information required in the supplementary schedule applicable to management investment companies listing holdings of unaffiliated investments.", "label": "Investment Holdings, Schedule of Investments [Table Text Block]", "terseLabel": "Investment Holdings, Schedule of Investments" } } }, "localname": "InvestmentHoldingsScheduleOfInvestmentsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.npci.com/role/InvestmentPortfolioTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_InvestmentHoldingsScheduleOfInvestmentsTextBlock": { "auth_ref": [ "r142" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for investment holdings. This includes the information required in the supplementary schedule applicable to management investment companies listing holdings of unaffiliated investments.", "label": "Investment Holdings, Schedule of Investments [Text Block]", "terseLabel": "Investment Portfolio" } } }, "localname": "InvestmentHoldingsScheduleOfInvestmentsTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.npci.com/role/InvestmentPortfolio" ], "xbrltype": "textBlockItemType" }, "us-gaap_InvestmentHoldingsTable": { "auth_ref": [ "r129", "r137", "r398", "r507" ], "lang": { "en-us": { "role": { "documentation": "The investment holdings table is used for any listing of investments. The \"Investment [Axis]\" identifies the investment for which the line items apply. The other axes are used for categorizing the investments and creating useful subtotals. These axes cover different categorizations. The appropriate axes are expected to be used. Additional axes can be added for alternative categorizations.", "label": "Investment Holdings [Table]" } } }, "localname": "InvestmentHoldingsTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.npci.com/role/ScheduleOfInvestments", "http://www.npci.com/role/ScheduleOfInvestments1", "http://www.npci.com/role/ScheduleOfInvestments2", "http://www.npci.com/role/ScheduleOfInvestmentsParenthentical" ], "xbrltype": "stringItemType" }, "us-gaap_InvestmentIncomeDividend": { "auth_ref": [ "r18" ], "calculation": { "http://www.npci.com/role/StatementsOfOperations": { "order": 17.0, "parentTag": "us-gaap_GrossInvestmentIncomeOperating", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of dividend income on nonoperating securities.", "label": "Investment Income, Dividend", "terseLabel": "Dividend income" } } }, "localname": "InvestmentIncomeDividend", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.npci.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentIncomeInterest": { "auth_ref": [ "r20", "r203" ], "calculation": { "http://www.npci.com/role/StatementsOfOperations": { "order": 15.0, "parentTag": "us-gaap_GrossInvestmentIncomeOperating", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.", "label": "Investment Income, Interest", "terseLabel": "Interest" } } }, "localname": "InvestmentIncomeInterest", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.npci.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentIncomeNet": { "auth_ref": [ "r19", "r21" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after accretion (amortization) of discount (premium), and investment expense, of interest income and dividend income on nonoperating securities.", "label": "Investment Income, Net", "terseLabel": "Net investment income" } } }, "localname": "InvestmentIncomeNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.npci.com/role/StatementsOfChangesInNetAssets" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentIncomeNetAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Investment Income, Net [Abstract]", "terseLabel": "Investment income:" } } }, "localname": "InvestmentIncomeNetAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.npci.com/role/StatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_InvestmentMaturityDate": { "auth_ref": [ "r472", "r473" ], "lang": { "en-us": { "role": { "documentation": "Maturity date of investment, in YYYY-MM-DD format.", "label": "Investment Maturity Date", "terseLabel": "Maturity Date" } } }, "localname": "InvestmentMaturityDate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.npci.com/role/ScheduleOfInvestments", "http://www.npci.com/role/ScheduleOfInvestments2" ], "xbrltype": "dateItemType" }, "us-gaap_InvestmentOwnedAtCost": { "auth_ref": [ "r121" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Cost of the investment.", "label": "Investment Owned, at Cost", "terseLabel": "Investments owned at cost", "verboseLabel": "Amortized Cost" } } }, "localname": "InvestmentOwnedAtCost", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.npci.com/role/InvestmentPortfolioSummaryOfInvestmentCompanyAssetsByIndustryClassificationAtFairValueDetail", "http://www.npci.com/role/StatementsOfAssetsAndLiabilitiesParenthetical" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentOwnedAtFairValue": { "auth_ref": [ "r121", "r393", "r401" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Value of the investment at close of period. For schedules of investments that are categorized, the value would be aggregated by category. For investment in and advances to affiliates, if operations of any controlled companies are different in character from those of the company, group such affiliates within divisions and by type of activities.", "label": "Investment Owned, at Fair Value", "terseLabel": "Fair Value", "verboseLabel": "Fair value" } } }, "localname": "InvestmentOwnedAtFairValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.npci.com/role/InvestmentPortfolioSummaryOfInvestmentCompanyAssetsByIndustryClassificationAtFairValueDetail", "http://www.npci.com/role/InvestmentPortfolioSummaryOfInvestmentHoldingsScheduleOfInvestmentsDetail", "http://www.npci.com/role/InvestmentPortfolioSummaryOfTheCompanySInvestedAssetsByGeographicClassificationDetail", "http://www.npci.com/role/ScheduleOfInvestments", "http://www.npci.com/role/ScheduleOfInvestments1", "http://www.npci.com/role/ScheduleOfInvestments2" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentOwnedBalancePrincipalAmount": { "auth_ref": [ "r122", "r388" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "For investments which are quantified by principal amount, the principle balance held at close of period.", "label": "Investment Owned, Balance, Principal Amount", "terseLabel": "Principal Amount" } } }, "localname": "InvestmentOwnedBalancePrincipalAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.npci.com/role/ScheduleOfInvestments", "http://www.npci.com/role/ScheduleOfInvestments2" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentOwnedBalanceShares": { "auth_ref": [ "r122", "r388" ], "lang": { "en-us": { "role": { "documentation": "Balance held at close of period in number of shares.", "label": "Investment Owned, Balance, Shares", "terseLabel": "Shares" } } }, "localname": "InvestmentOwnedBalanceShares", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.npci.com/role/ScheduleOfInvestments1" ], "xbrltype": "sharesItemType" }, "us-gaap_InvestmentPolicyTextBlock": { "auth_ref": [ "r217", "r506" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for investment in financial asset.", "label": "Investment, Policy [Policy Text Block]", "terseLabel": "Investment Transactions" } } }, "localname": "InvestmentPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_InvestmentSecondaryCategorizationAxis": { "auth_ref": [ "r385", "r390", "r395" ], "lang": { "en-us": { "role": { "documentation": "Information by second categorization of investments, which may include, but is not limited to industry.", "label": "Investment Secondary Categorization [Axis]" } } }, "localname": "InvestmentSecondaryCategorizationAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.npci.com/role/ScheduleOfInvestments", "http://www.npci.com/role/ScheduleOfInvestments1", "http://www.npci.com/role/ScheduleOfInvestments2" ], "xbrltype": "stringItemType" }, "us-gaap_InvestmentSoldNotYetPurchasedPercentOfNetAssets": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For schedules of investments sold, not yet purchased (short sales) that are categorized, each category would be expected to have a percent of net assets for the aggregated value of the investments sold short in the category.", "label": "Investment Sold, Not yet Purchased, Percent of Net Assets", "terseLabel": "Investments sold not yet purchased percentage of net assets" } } }, "localname": "InvestmentSoldNotYetPurchasedPercentOfNetAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "us-gaap_InvestmentTypeAxis": { "auth_ref": [ "r384", "r386", "r387", "r389", "r391", "r392", "r394", "r396", "r397", "r399", "r400", "r402", "r403", "r404", "r405" ], "lang": { "en-us": { "role": { "documentation": "Information by type of investments.", "label": "Investment Type [Axis]" } } }, "localname": "InvestmentTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.npci.com/role/ScheduleOfInvestments", "http://www.npci.com/role/ScheduleOfInvestments1", "http://www.npci.com/role/ScheduleOfInvestments2", "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfChangesInTheCompanySLevel3InvestmentsDetail", "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfInvestmentsCategorizeIntoFairValueHierarchyDetail", "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfInvestmentsUsingSignificantUnobservableInputDetail" ], "xbrltype": "stringItemType" }, "us-gaap_InvestmentTypeCategorizationMember": { "auth_ref": [ "r384", "r386", "r387", "r389", "r391", "r392", "r394", "r396", "r397", "r399", "r400", "r402", "r403", "r404", "r405" ], "lang": { "en-us": { "role": { "documentation": "Asset obtained to generate income or appreciate in value.", "label": "Investments [Domain]" } } }, "localname": "InvestmentTypeCategorizationMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.npci.com/role/ScheduleOfInvestments", "http://www.npci.com/role/ScheduleOfInvestments1", "http://www.npci.com/role/ScheduleOfInvestments2", "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfChangesInTheCompanySLevel3InvestmentsDetail", "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfInvestmentsCategorizeIntoFairValueHierarchyDetail", "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfInvestmentsUsingSignificantUnobservableInputDetail" ], "xbrltype": "domainItemType" }, "us-gaap_InvestmentsBySecondaryCategorizationDomain": { "auth_ref": [ "r130", "r385", "r390", "r395" ], "lang": { "en-us": { "role": { "documentation": "Investments in the \"Investment Holdings [Table]\" and the \"Summary of Investment Holdings [Table]\" are often categorized at two levels. The first categorization is the investment type. The second categorization can vary. The usual secondary categorizations are industry, country or geography.", "label": "Investments by Secondary Categorization [Domain]" } } }, "localname": "InvestmentsBySecondaryCategorizationDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.npci.com/role/ScheduleOfInvestments", "http://www.npci.com/role/ScheduleOfInvestments1", "http://www.npci.com/role/ScheduleOfInvestments2" ], "xbrltype": "domainItemType" }, "us-gaap_InvestmentsFairValueDisclosure": { "auth_ref": [ "r305" ], "calculation": { "http://www.npci.com/role/StatementsOfAssetsAndLiabilities": { "order": 9.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "definitionGuidance": "Total asset investment", "documentation": "Fair value portion of investment securities, including, but not limited to, marketable securities, derivative financial instruments, and investments accounted for under the equity method.", "label": "Investments, Fair Value Disclosure", "terseLabel": "Investments, fair value disclosure", "verboseLabel": "Fair value" } } }, "localname": "InvestmentsFairValueDisclosure", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.npci.com/role/StatementsOfAssetsAndLiabilities", "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfInvestmentsCategorizeIntoFairValueHierarchyDetail", "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfInvestmentsUsingSignificantUnobservableInputDetail", "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValue": { "auth_ref": [ "r132", "r133", "r136" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Value of the investment at close of period. For investment in and advances to affiliates, if operations of any controlled companies are different in character from those of the company, group such affiliates within divisions and by type of activities.", "label": "Investments in and Advances to Affiliates, at Fair Value", "periodEndLabel": "Fair value at the ending period", "periodStartLabel": "Fair value at the beginning period" } } }, "localname": "InvestmentsInAndAdvancesToAffiliatesAtFairValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.npci.com/role/AffiliatedInvestmentsSummaryOfAffiliatedIssuersOfTheCompanyDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueGrossAdditions": { "auth_ref": [ "r138" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Gross additions to the investment in and advance to the affiliate.", "label": "Investments in and Advances to Affiliates, at Fair Value, Gross Additions", "terseLabel": "Purchases" } } }, "localname": "InvestmentsInAndAdvancesToAffiliatesAtFairValueGrossAdditions", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.npci.com/role/AffiliatedInvestmentsSummaryOfAffiliatedIssuersOfTheCompanyDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueGrossReductions": { "auth_ref": [ "r139" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Gross reductions to the investment in and advance to the affiliate.", "label": "Investments in and Advances to Affiliates, at Fair Value, Gross Reductions", "negatedLabel": "Sales" } } }, "localname": "InvestmentsInAndAdvancesToAffiliatesAtFairValueGrossReductions", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.npci.com/role/AffiliatedInvestmentsSummaryOfAffiliatedIssuersOfTheCompanyDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValuePeriodIncreaseDecrease": { "auth_ref": [ "r140" ], "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in the investments in and advances to affiliates.", "label": "Investments in and Advances to Affiliates, at Fair Value, Period Increase (Decrease)", "terseLabel": "Transfers in (out) (at cost)" } } }, "localname": "InvestmentsInAndAdvancesToAffiliatesAtFairValuePeriodIncreaseDecrease", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.npci.com/role/AffiliatedInvestmentsSummaryOfAffiliatedIssuersOfTheCompanyDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentsInAndAdvancesToAffiliatesBalanceShares": { "auth_ref": [ "r141" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of affiliates held for management investment companies.", "label": "Investments in and Advances to Affiliates, Balance, Shares", "periodEndLabel": "Shares at the ending period", "periodStartLabel": "Shares at the beginning period" } } }, "localname": "InvestmentsInAndAdvancesToAffiliatesBalanceShares", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.npci.com/role/AffiliatedInvestmentsSummaryOfAffiliatedIssuersOfTheCompanyDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_InvestmentsInAndAdvancesToAffiliatesCategorizationAxis": { "auth_ref": [ "r131" ], "lang": { "en-us": { "role": { "documentation": "Information by category of investments used to group investments in and advances to affiliates.", "label": "Investments in and Advances to Affiliates Categorization [Axis]" } } }, "localname": "InvestmentsInAndAdvancesToAffiliatesCategorizationAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.npci.com/role/StatementsOfAssetsAndLiabilities", "http://www.npci.com/role/StatementsOfAssetsAndLiabilitiesParenthetical", "http://www.npci.com/role/StatementsOfCashFlows", "http://www.npci.com/role/StatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_InvestmentsInAndAdvancesToAffiliatesCategorizationDomain": { "auth_ref": [ "r131" ], "lang": { "en-us": { "role": { "documentation": "Used to categorize investments in and advances of affiliate. Lists the categories for (1) Investments in majority owned subsidiaries, segregating subsidiaries consolidated; (2) other controlled companies; and (3) other affiliates.", "label": "Investments in and Advances to Affiliates Categorization [Domain]" } } }, "localname": "InvestmentsInAndAdvancesToAffiliatesCategorizationDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.npci.com/role/StatementsOfAssetsAndLiabilities", "http://www.npci.com/role/StatementsOfAssetsAndLiabilitiesParenthetical", "http://www.npci.com/role/StatementsOfCashFlows", "http://www.npci.com/role/StatementsOfOperations" ], "xbrltype": "domainItemType" }, "us-gaap_InvestmentsInAndAdvancesToAffiliatesDividendsOrInterest": { "auth_ref": [ "r132", "r134", "r135" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of dividends or interest. Give totals for each group. If operations of any controlled companies are different in character from those of the company, group such affiliates (1) within divisions and (2) by type of activities.", "label": "Investments in and Advances to Affiliates, Dividends or Interest", "terseLabel": "Affiliated Dividend income" } } }, "localname": "InvestmentsInAndAdvancesToAffiliatesDividendsOrInterest", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.npci.com/role/AffiliatedInvestmentsSummaryOfAffiliatedIssuersOfTheCompanyDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentsInAndAdvancesToAffiliatesLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Investments in and Advances to Affiliates [Line Items]" } } }, "localname": "InvestmentsInAndAdvancesToAffiliatesLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.npci.com/role/AffiliatedInvestmentsSummaryOfAffiliatedIssuersOfTheCompanyDetail" ], "xbrltype": "stringItemType" }, "us-gaap_InvestmentsInAndAdvancesToAffiliatesScheduleOfInvestmentsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Investments in and Advances to Affiliates, Schedule of Investments [Abstract]" } } }, "localname": "InvestmentsInAndAdvancesToAffiliatesScheduleOfInvestmentsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_InvestmentsInAndAdvancesToAffiliatesScheduleOfInvestmentsTextBlock": { "auth_ref": [ "r142" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the information summarizing investments in and advances to majority-owned subsidiaries, other controlled companies, and other affiliates. It reflects specified information about ownership, financial results from, and financial position in such entities.", "label": "Investments in and Advances to Affiliates, Schedule of Investments [Text Block]", "terseLabel": "Affiliated Investments" } } }, "localname": "InvestmentsInAndAdvancesToAffiliatesScheduleOfInvestmentsTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.npci.com/role/AffiliatedInvestments" ], "xbrltype": "textBlockItemType" }, "us-gaap_InvestmentsInAndAdvancesToAffiliatesTable": { "auth_ref": [ "r137" ], "lang": { "en-us": { "role": { "documentation": "Listing of investments in affiliates and investments that are advances to affiliates.", "label": "Investments in and Advances to Affiliates [Table]" } } }, "localname": "InvestmentsInAndAdvancesToAffiliatesTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.npci.com/role/AffiliatedInvestmentsSummaryOfAffiliatedIssuersOfTheCompanyDetail" ], "xbrltype": "stringItemType" }, "us-gaap_InvestmentsInAndAdvancesToAffiliatesTextBlock": { "auth_ref": [ "r137" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of investments in and advances to affiliates. Does not include the tabular disclosure of the disaggregation of investments in and advances to affiliates across legal entities.", "label": "Investments in and Advances to Affiliates [Table Text Block]", "terseLabel": "Summary of affiliated issuers of the company" } } }, "localname": "InvestmentsInAndAdvancesToAffiliatesTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.npci.com/role/AffiliatedInvestmentsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_InvestmentsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Assets held for their financial return, rather than for the entity's operations.", "label": "Investments [Member]" } } }, "localname": "InvestmentsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfChangesInTheCompanySLevel3InvestmentsDetail" ], "xbrltype": "domainItemType" }, "us-gaap_LegalFees": { "auth_ref": [ "r16" ], "calculation": { "http://www.npci.com/role/StatementsOfOperations": { "order": 11.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of expense provided in the period for legal costs incurred on or before the balance sheet date pertaining to resolved, pending or threatened litigation, including arbitration and mediation proceedings.", "label": "Legal Fees", "terseLabel": "Legal fees" } } }, "localname": "LegalFees", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.npci.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_Liabilities": { "auth_ref": [ "r12", "r168", "r218", "r234", "r235", "r237", "r238", "r239", "r240", "r241", "r243", "r244", "r296", "r299", "r300", "r312", "r427", "r481", "r498", "r499" ], "calculation": { "http://www.npci.com/role/StatementsOfAssetsAndLiabilities": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.", "label": "Liabilities", "totalLabel": "Total liabilities" } } }, "localname": "Liabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.npci.com/role/StatementsOfAssetsAndLiabilities" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities [Abstract]", "terseLabel": "Liabilities" } } }, "localname": "LiabilitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.npci.com/role/StatementsOfAssetsAndLiabilities" ], "xbrltype": "stringItemType" }, "us-gaap_MeasurementInputCapRateMember": { "auth_ref": [ "r492" ], "lang": { "en-us": { "role": { "documentation": "Measurement input using ratio of net operating income produced by asset to its capital cost.", "label": "Measurement Input, Cap Rate [Member]" } } }, "localname": "MeasurementInputCapRateMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityDetail" ], "xbrltype": "domainItemType" }, "us-gaap_MeasurementInputDiscountRateMember": { "auth_ref": [ "r492" ], "lang": { "en-us": { "role": { "documentation": "Measurement input using interest rate to determine present value of future cash flows.", "label": "Measurement Input, Discount Rate [Member]" } } }, "localname": "MeasurementInputDiscountRateMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityDetail" ], "xbrltype": "domainItemType" }, "us-gaap_MeasurementInputEbitdaMultipleMember": { "auth_ref": [ "r492" ], "lang": { "en-us": { "role": { "documentation": "Measurement input using earnings before interest, tax, depreciation and amortization (EBITDA) multiple.", "label": "Measurement Input, EBITDA Multiple [Member]" } } }, "localname": "MeasurementInputEbitdaMultipleMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityDetail" ], "xbrltype": "domainItemType" }, "us-gaap_MeasurementInputOptionVolatilityMember": { "auth_ref": [ "r492" ], "lang": { "en-us": { "role": { "documentation": "Measurement input using rate at which price of option increases (decreases) for given set of returns.", "label": "Measurement Input, Option Volatility [Member]" } } }, "localname": "MeasurementInputOptionVolatilityMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityDetail" ], "xbrltype": "domainItemType" }, "us-gaap_MeasurementInputTypeAxis": { "auth_ref": [ "r307" ], "lang": { "en-us": { "role": { "documentation": "Information by type of measurement input used to determine value of asset and liability.", "label": "Measurement Input Type [Axis]" } } }, "localname": "MeasurementInputTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityDetail" ], "xbrltype": "stringItemType" }, "us-gaap_MeasurementInputTypeDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Measurement input used to determine value of asset and liability.", "label": "Measurement Input Type [Domain]" } } }, "localname": "MeasurementInputTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityDetail" ], "xbrltype": "domainItemType" }, "us-gaap_MoneyMarketFundsMember": { "auth_ref": [ "r487" ], "lang": { "en-us": { "role": { "documentation": "Fund that invests in short-term money-market instruments, for example, but not limited to, commercial paper, banker's acceptances, repurchase agreements, government securities, certificates of deposit, and other highly liquid securities.", "label": "Money Market Funds [Member]" } } }, "localname": "MoneyMarketFundsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_NetAssetValuePerShare": { "auth_ref": [ "r61", "r62", "r68", "r114", "r119" ], "lang": { "en-us": { "role": { "documentation": "Net asset value per share or per unit of investments in certain entities that calculate net asset value per share. Includes, but is not limited to, by unit, membership interest, or other ownership interest. Investment includes, but is not limited to, investment in certain hedge funds, venture capital funds, private equity funds, real estate partnerships or funds. Excludes fair value disclosure.", "label": "Net Asset Value Per Share", "periodEndLabel": "Net asset value, end of period", "periodStartLabel": "Net asset value, beginning of period", "terseLabel": "Net asset value per share of common stock" } } }, "localname": "NetAssetValuePerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.npci.com/role/FinancialHighlightsSummaryOfShareOutstandingDetail", "http://www.npci.com/role/StatementsOfAssetsAndLiabilities" ], "xbrltype": "perShareItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "auth_ref": [ "r164" ], "calculation": { "http://www.npci.com/role/StatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.", "label": "Net Cash Provided by (Used in) Financing Activities", "totalLabel": "Net cash flows (used in) financing activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.npci.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]", "terseLabel": "Cash flows provided by (used in) financing activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.npci.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "auth_ref": [ "r24", "r25", "r28" ], "calculation": { "http://www.npci.com/role/StatementsOfCashFlows": { "order": 4.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.", "label": "Net Cash Provided by (Used in) Operating Activities", "totalLabel": "Net cash flows provided by (used in) operating activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.npci.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]", "terseLabel": "Cash flows provided by (used in) operating activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.npci.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetInvestmentIncome": { "auth_ref": [ "r375" ], "calculation": { "http://www.npci.com/role/StatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_InvestmentCompanyNetAssetsFromOperationsIncreaseDecrease", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after investment expense, of income earned from investments in securities and real estate. Includes, but is not limited to, real estate investment, policy loans, dividends, and interest. Excludes realized gain (loss) on investments.", "label": "Net Investment Income", "totalLabel": "Net investment income" } } }, "localname": "NetInvestmentIncome", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.npci.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_NoninterestExpenseDirectorsFees": { "auth_ref": [ "r89" ], "calculation": { "http://www.npci.com/role/StatementsOfOperations": { "order": 12.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Noninterest expense related to directors' fees which are fees paid by an Entity to its directors. Directors' fees may be paid in addition to salary and other benefits.", "label": "Noninterest Expense Directors Fees", "terseLabel": "Directors' fees" } } }, "localname": "NoninterestExpenseDirectorsFees", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.npci.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_NoninterestExpenseInvestmentAdvisoryFees": { "auth_ref": [ "r89" ], "calculation": { "http://www.npci.com/role/StatementsOfOperations": { "order": 13.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "This represents the company's cost incurred during an accounting period for managing the money in a fund, which will be billed back to the client and is a component of noninterest expenses.", "label": "Noninterest Expense Investment Advisory Fees", "terseLabel": "Investment advisory fees" } } }, "localname": "NoninterestExpenseInvestmentAdvisoryFees", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.npci.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingExpenses": { "auth_ref": [], "calculation": { "http://www.npci.com/role/StatementsOfOperations": { "order": 4.0, "parentTag": "cik0001588272_OperatingExpensesNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.", "label": "Operating Expenses", "totalLabel": "Total expenses" } } }, "localname": "OperatingExpenses", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.npci.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingExpensesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Operating Expenses [Abstract]", "terseLabel": "Expenses:" } } }, "localname": "OperatingExpensesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.npci.com/role/StatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": { "auth_ref": [ "r1", "r55" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.", "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]", "terseLabel": "Organization" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.npci.com/role/Organization" ], "xbrltype": "textBlockItemType" }, "us-gaap_OtherCommitmentsAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by type of other commitment.", "label": "Other Commitments [Axis]" } } }, "localname": "OtherCommitmentsAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.npci.com/role/MarketAndOtherRiskFactorsAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_OtherCommitmentsDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Other future obligation.", "label": "Other Commitments [Domain]" } } }, "localname": "OtherCommitmentsDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.npci.com/role/MarketAndOtherRiskFactorsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_OtherCommitmentsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Other Commitments [Line Items]" } } }, "localname": "OtherCommitmentsLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.npci.com/role/EconomicDependencyAndCommitmentsAndContingenciesAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_OtherCommitmentsTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about obligations resulting from other commitments.", "label": "Other Commitments [Table]" } } }, "localname": "OtherCommitmentsTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.npci.com/role/EconomicDependencyAndCommitmentsAndContingenciesAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_OtherExpenses": { "auth_ref": [ "r17", "r102" ], "calculation": { "http://www.npci.com/role/StatementsOfOperations": { "order": 9.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense classified as other.", "label": "Other Expenses", "terseLabel": "Other expenses" } } }, "localname": "OtherExpenses", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.npci.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsForRepurchaseOfCommonStock": { "auth_ref": [ "r23" ], "calculation": { "http://www.npci.com/role/StatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow to reacquire common stock during the period.", "label": "Payments for Repurchase of Common Stock", "negatedLabel": "Repurchase of common stock, net of payable" } } }, "localname": "PaymentsForRepurchaseOfCommonStock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.npci.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsOfDividends": { "auth_ref": [ "r23" ], "calculation": { "http://www.npci.com/role/StatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Cash outflow in the form of capital distributions and dividends to common shareholders, preferred shareholders and noncontrolling interests.", "label": "Payments of Dividends", "negatedLabel": "Distributions paid in cash" } } }, "localname": "PaymentsOfDividends", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.npci.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PreferredStockDividendRatePercentage": { "auth_ref": [ "r263" ], "lang": { "en-us": { "role": { "documentation": "The percentage rate used to calculate dividend payments on preferred stock.", "label": "Preferred Stock, Dividend Rate, Percentage", "terseLabel": "Preferred Dividend Rate" } } }, "localname": "PreferredStockDividendRatePercentage", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.npci.com/role/ScheduleOfInvestments2" ], "xbrltype": "percentItemType" }, "us-gaap_PreferredStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Preferred shares may provide a preferential dividend to the dividend on common stock and may take precedence over common stock in the event of a liquidation. Preferred shares typically represent an ownership interest in the company.", "label": "Preferred Stock [Member]", "terseLabel": "Preferred Stocks" } } }, "localname": "PreferredStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.npci.com/role/InvestmentPortfolioSummaryOfInvestmentCompanyAssetsByIndustryClassificationAtFairValueDetail", "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfChangesInTheCompanySLevel3InvestmentsDetail", "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfChangesInTheCompanySLevel3InvestmentsParentheticalDetail", "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfInvestmentsCategorizeIntoFairValueHierarchyDetail", "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfInvestmentsUsingSignificantUnobservableInputDetail", "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityDetail" ], "xbrltype": "domainItemType" }, "us-gaap_PreferredStockParOrStatedValuePerShare": { "auth_ref": [ "r6", "r262" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.", "label": "Preferred Stock, Par or Stated Value Per Share", "terseLabel": "Preferred stock stated or par value per share" } } }, "localname": "PreferredStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.npci.com/role/StatementsOfAssetsAndLiabilitiesParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_PreferredStockSharesAuthorized": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.", "label": "Preferred Stock, Shares Authorized", "terseLabel": "Preferred stock shares authorized" } } }, "localname": "PreferredStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.npci.com/role/StatementsOfAssetsAndLiabilitiesParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesIssued": { "auth_ref": [ "r6", "r262" ], "lang": { "en-us": { "role": { "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.", "label": "Preferred Stock, Shares Issued", "terseLabel": "Preferred stock shares issued" } } }, "localname": "PreferredStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.npci.com/role/StatementsOfAssetsAndLiabilitiesParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesOutstanding": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.", "label": "Preferred Stock, Shares Outstanding", "terseLabel": "Preferred stock shares outstanding" } } }, "localname": "PreferredStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.npci.com/role/StatementsOfAssetsAndLiabilitiesParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockValue": { "auth_ref": [ "r6", "r448" ], "calculation": { "http://www.npci.com/role/StatementsOfAssetsAndLiabilities": { "order": 5.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Preferred Stock, Value, Issued", "terseLabel": "Preferred stock, $0.001 par value (25,000,000 shares authorized, 0 shares issued and outstanding)" } } }, "localname": "PreferredStockValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.npci.com/role/StatementsOfAssetsAndLiabilities" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrepaidExpenseCurrentAndNoncurrent": { "auth_ref": [ "r84", "r97", "r153" ], "calculation": { "http://www.npci.com/role/StatementsOfAssetsAndLiabilities": { "order": 14.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Carrying amount as of the balance sheet date of expenditures made in advance of when the economic benefit of the cost will be realized, and which will be expensed in future periods with the passage of time or when a triggering event occurs.", "label": "Prepaid Expense", "terseLabel": "Prepaid expenses" } } }, "localname": "PrepaidExpenseCurrentAndNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.npci.com/role/StatementsOfAssetsAndLiabilities" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOfPrivatePlacement": { "auth_ref": [ "r22" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow associated with the amount received from entity's raising of capital via private rather than public placement.", "label": "Proceeds from Issuance of Private Placement", "terseLabel": "Proceeds from private placement issue" } } }, "localname": "ProceedsFromIssuanceOfPrivatePlacement", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.npci.com/role/OrganizationAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProfitLoss": { "auth_ref": [ "r145", "r156", "r157", "r163", "r168", "r178", "r186", "r187", "r204", "r206", "r208", "r210", "r218", "r234", "r235", "r237", "r238", "r239", "r240", "r241", "r243", "r244", "r294", "r297", "r298", "r304", "r312", "r374", "r428", "r446", "r447", "r460", "r481" ], "calculation": { "http://www.npci.com/role/StatementsOfCashFlows": { "order": 16.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.", "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest", "terseLabel": "Net increase (decrease) in net assets resulting from operations" } } }, "localname": "ProfitLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.npci.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_RealEstateMember": { "auth_ref": [ "r486" ], "lang": { "en-us": { "role": { "documentation": "Property consisting of land, land improvement and buildings.", "label": "Real Estate [Member]", "terseLabel": "Real Estate" } } }, "localname": "RealEstateMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.npci.com/role/InvestmentPortfolioSummaryOfInvestmentHoldingsScheduleOfInvestmentsDetail", "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfChangesInTheCompanySLevel3InvestmentsDetail", "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfInvestmentsCategorizeIntoFairValueHierarchyDetail" ], "xbrltype": "domainItemType" }, "us-gaap_RealizedInvestmentGainsLosses": { "auth_ref": [ "r101" ], "calculation": { "http://www.npci.com/role/StatementsOfCashFlows": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of realized gain (loss) on investment.", "label": "Realized Investment Gains (Losses)", "negatedLabel": "Net realized (gain) loss on Unaffiliated investments", "verboseLabel": "Net realized gain (loss) on investments" } } }, "localname": "RealizedInvestmentGainsLosses", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.npci.com/role/StatementsOfCashFlows", "http://www.npci.com/role/StatementsOfChangesInNetAssets" ], "xbrltype": "monetaryItemType" }, "us-gaap_RelatedPartyDomain": { "auth_ref": [ "r276", "r323", "r324" ], "lang": { "en-us": { "role": { "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.", "label": "Related Party [Domain]", "terseLabel": "Related Party [Domain]" } } }, "localname": "RelatedPartyDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.npci.com/role/RelatedPartyTransactionsAndArrangementsAdditionalInformationDetail", "http://www.npci.com/role/ScheduleOfInvestmentsParenthentical" ], "xbrltype": "domainItemType" }, "us-gaap_RelatedPartyTransactionAxis": { "auth_ref": [ "r143", "r323", "r324", "r497" ], "lang": { "en-us": { "role": { "documentation": "Information by type of related party transaction.", "label": "Related Party Transaction [Axis]", "terseLabel": "Related Party Transaction [Axis]" } } }, "localname": "RelatedPartyTransactionAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.npci.com/role/RelatedPartyTransactionsAndArrangementsAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionDomain": { "auth_ref": [ "r143" ], "lang": { "en-us": { "role": { "documentation": "Transaction between related party.", "label": "Related Party Transaction [Domain]", "terseLabel": "Related Party Transaction [Domain]" } } }, "localname": "RelatedPartyTransactionDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.npci.com/role/RelatedPartyTransactionsAndArrangementsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_RelatedPartyTransactionLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Related Party Transaction [Line Items]" } } }, "localname": "RelatedPartyTransactionLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.npci.com/role/RelatedPartyTransactionsAndArrangementsAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Related Party Transactions [Abstract]" } } }, "localname": "RelatedPartyTransactionsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": { "auth_ref": [ "r276", "r323", "r361", "r362", "r363", "r364", "r365", "r366", "r367", "r368", "r369", "r370", "r371", "r372", "r497" ], "lang": { "en-us": { "role": { "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.", "label": "Related Party [Axis]", "terseLabel": "Related Party [Axis]" } } }, "localname": "RelatedPartyTransactionsByRelatedPartyAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.npci.com/role/RelatedPartyTransactionsAndArrangementsAdditionalInformationDetail", "http://www.npci.com/role/ScheduleOfInvestmentsParenthentical" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": { "auth_ref": [ "r321", "r322", "r324", "r325", "r326" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.", "label": "Related Party Transactions Disclosure [Text Block]", "terseLabel": "Related Party Transactions and Arrangements" } } }, "localname": "RelatedPartyTransactionsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.npci.com/role/RelatedPartyTransactionsAndArrangements" ], "xbrltype": "textBlockItemType" }, "us-gaap_RestrictedCashAndCashEquivalents": { "auth_ref": [ "r29", "r34", "r77", "r93", "r146" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash and cash equivalents restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Restricted Cash and Cash Equivalents", "terseLabel": "Restricted cash and cash equivalents" } } }, "localname": "RestrictedCashAndCashEquivalents", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember": { "auth_ref": [ "r146" ], "lang": { "en-us": { "role": { "documentation": "Type of cash and cash equivalent. Cash is currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash and Cash Equivalents [Domain]" } } }, "localname": "RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "auth_ref": [ "r9", "r50", "r94", "r381", "r382", "r448" ], "calculation": { "http://www.npci.com/role/StatementsOfAssetsAndLiabilities": { "order": 8.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings (Accumulated Deficit)", "terseLabel": "Distributable earnings (accumulated loss)" } } }, "localname": "RetainedEarningsAccumulatedDeficit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.npci.com/role/StatementsOfAssetsAndLiabilities" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsMember": { "auth_ref": [ "r144", "r175", "r176", "r177", "r179", "r185", "r187", "r219", "r281", "r282", "r283", "r287", "r288", "r302", "r378", "r380" ], "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings [Member]", "terseLabel": "Distributable Earnings" } } }, "localname": "RetainedEarningsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.npci.com/role/StatementsOfChangesInNetAssets" ], "xbrltype": "domainItemType" }, "us-gaap_RevenueRecognitionInterest": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for recognition of interest revenue. Disclosure may include the method of recognizing interest income on loan and trade receivables, the method of amortizing premiums or accreting discounts, and a statement about the policy for the treatment of related fees and costs, including the method of amortizing net deferred fees and costs.", "label": "Revenue Recognition, Interest [Policy Text Block]", "terseLabel": "Income Recognition" } } }, "localname": "RevenueRecognitionInterest", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_RisksAndUncertaintiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Risks and Uncertainties [Abstract]" } } }, "localname": "RisksAndUncertaintiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": { "auth_ref": [ "r470" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.", "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]", "terseLabel": "Summary of Computation of Basic and Diluted Net" } } }, "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfInvestmentsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of Investments [Abstract]" } } }, "localname": "ScheduleOfInvestmentsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfInvestmentsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Schedule of Investments [Line Items]" } } }, "localname": "ScheduleOfInvestmentsLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.npci.com/role/InvestmentPortfolioTables" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfInvestmentsTable": { "auth_ref": [ "r129" ], "lang": { "en-us": { "role": { "documentation": "A container table for all schedule of investment items. It ties in the \"Legal Entity [Axis]\" to all of its contained line items.", "label": "Schedule of Investments [Table]" } } }, "localname": "ScheduleOfInvestmentsTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.npci.com/role/InvestmentPortfolioTables" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable": { "auth_ref": [ "r74", "r75" ], "lang": { "en-us": { "role": { "documentation": "Schedule of quantitative and qualitative information pertaining to related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.", "label": "Schedule of Related Party Transactions, by Related Party [Table]" } } }, "localname": "ScheduleOfRelatedPartyTransactionsByRelatedPartyTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.npci.com/role/RelatedPartyTransactionsAndArrangementsAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_SecuritiesPurchasedUnderAgreementsToResell": { "auth_ref": [ "r82", "r154", "r155", "r172" ], "calculation": { "http://www.npci.com/role/StatementsOfAssetsAndLiabilities": { "order": 11.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after the effects of master netting arrangements, of funds outstanding loaned in the form of a security resale agreement between the entity and another party for the purchase and resale of identical or substantially the same securities at a date certain for a specified price. Includes purchases of participations in pools of securities that are subject to a resale agreement, assets not subject to a master netting arrangement and not elected to be offset.", "label": "Securities Purchased under Agreements to Resell", "terseLabel": "Receivable for investments sold" } } }, "localname": "SecuritiesPurchasedUnderAgreementsToResell", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.npci.com/role/StatementsOfAssetsAndLiabilities" ], "xbrltype": "monetaryItemType" }, "us-gaap_SecuritiesSoldUnderAgreementsToRepurchase": { "auth_ref": [ "r85", "r154", "r155", "r170", "r171" ], "calculation": { "http://www.npci.com/role/StatementsOfAssetsAndLiabilities": { "order": 1.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after the effects of master netting arrangements, of funds outstanding borrowed in the form of a security repurchase agreement between the entity and another party for the sale and repurchase of identical or substantially the same securities at a date certain for a specified price. Includes liabilities not subject to a master netting arrangement and not elected to be offset.", "label": "Securities Sold under Agreements to Repurchase", "terseLabel": "Payable for investments purchased" } } }, "localname": "SecuritiesSoldUnderAgreementsToRepurchase", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.npci.com/role/StatementsOfAssetsAndLiabilities" ], "xbrltype": "monetaryItemType" }, "us-gaap_SeriesBPreferredStockMember": { "auth_ref": [ "r458", "r459", "r484" ], "lang": { "en-us": { "role": { "documentation": "Series B preferred stock.", "label": "Series B Preferred Stock [Member]" } } }, "localname": "SeriesBPreferredStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.npci.com/role/ScheduleOfInvestments2", "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfInvestmentsUsingSignificantUnobservableInputDetail" ], "xbrltype": "domainItemType" }, "us-gaap_ServiceMember": { "auth_ref": [ "r440" ], "lang": { "en-us": { "role": { "documentation": "Assistance, including, but not limited to, technology, license and maintenance, license and service, maintenance, oil and gas, and financial service.", "label": "Service [Member]", "terseLabel": "Service" } } }, "localname": "ServiceMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.npci.com/role/InvestmentPortfolioSummaryOfInvestmentHoldingsScheduleOfInvestmentsDetail", "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfChangesInTheCompanySLevel3InvestmentsDetail", "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfInvestmentsCategorizeIntoFairValueHierarchyDetail" ], "xbrltype": "domainItemType" }, "us-gaap_ShareRepurchaseProgramAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by share repurchase program.", "label": "Share Repurchase Program [Axis]" } } }, "localname": "ShareRepurchaseProgramAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.npci.com/role/ShareRepurchaseProgramAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_ShareRepurchaseProgramDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the share repurchase program.", "label": "Share Repurchase Program [Domain]" } } }, "localname": "ShareRepurchaseProgramDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.npci.com/role/ShareRepurchaseProgramAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_SharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares issued which are neither cancelled nor held in the treasury.", "label": "Shares, Outstanding", "periodEndLabel": "Ending Balance, Shares", "periodStartLabel": "Beginning Balance, Shares" } } }, "localname": "SharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.npci.com/role/StatementsOfChangesInNetAssets" ], "xbrltype": "sharesItemType" }, "us-gaap_SignificantAccountingPoliciesTextBlock": { "auth_ref": [ "r35", "r167" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.", "label": "Significant Accounting Policies [Text Block]", "terseLabel": "Summary of Significant Accounting Policies" } } }, "localname": "SignificantAccountingPoliciesTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.npci.com/role/SummaryOfSignificantAccountingPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_StatementClassOfStockAxis": { "auth_ref": [ "r148", "r149", "r150", "r168", "r190", "r191", "r192", "r194", "r197", "r198", "r218", "r234", "r237", "r238", "r239", "r243", "r244", "r262", "r263", "r264", "r265", "r267", "r312", "r420", "r456", "r462", "r469" ], "lang": { "en-us": { "role": { "documentation": "Information by the different classes of stock of the entity.", "label": "Class of Stock [Axis]" } } }, "localname": "StatementClassOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.npci.com/role/ScheduleOfInvestments2" ], "xbrltype": "stringItemType" }, "us-gaap_StatementEquityComponentsAxis": { "auth_ref": [ "r15", "r49", "r144", "r158", "r159", "r160", "r175", "r176", "r177", "r179", "r185", "r187", "r196", "r219", "r268", "r281", "r282", "r283", "r287", "r288", "r302", "r313", "r314", "r315", "r316", "r317", "r318", "r320", "r378", "r379", "r380" ], "lang": { "en-us": { "role": { "documentation": "Information by component of equity.", "label": "Equity Components [Axis]" } } }, "localname": "StatementEquityComponentsAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.npci.com/role/StatementsOfChangesInNetAssets", "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfChangesInTheCompanySLevel3InvestmentsParentheticalDetail" ], "xbrltype": "stringItemType" }, "us-gaap_StatementLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Statement [Line Items]" } } }, "localname": "StatementLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.npci.com/role/InvestmentPortfolioSummaryOfInvestmentCompanyAssetsByIndustryClassificationAtFairValueDetail", "http://www.npci.com/role/InvestmentPortfolioSummaryOfInvestmentHoldingsScheduleOfInvestmentsDetail", "http://www.npci.com/role/InvestmentPortfolioSummaryOfTheCompanySInvestedAssetsByGeographicClassificationDetail", "http://www.npci.com/role/StatementsOfAssetsAndLiabilities", "http://www.npci.com/role/StatementsOfAssetsAndLiabilitiesParenthetical", "http://www.npci.com/role/StatementsOfCashFlows", "http://www.npci.com/role/StatementsOfChangesInNetAssets", "http://www.npci.com/role/StatementsOfOperations", "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_StatementOfCashFlowsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Cash Flows [Abstract]" } } }, "localname": "StatementOfCashFlowsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementOfFinancialPositionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Financial Position [Abstract]" } } }, "localname": "StatementOfFinancialPositionAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementTable": { "auth_ref": [ "r175", "r176", "r177", "r196", "r360" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.", "label": "Statement [Table]" } } }, "localname": "StatementTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.npci.com/role/InvestmentPortfolioSummaryOfInvestmentCompanyAssetsByIndustryClassificationAtFairValueDetail", "http://www.npci.com/role/InvestmentPortfolioSummaryOfInvestmentHoldingsScheduleOfInvestmentsDetail", "http://www.npci.com/role/InvestmentPortfolioSummaryOfTheCompanySInvestedAssetsByGeographicClassificationDetail", "http://www.npci.com/role/StatementsOfAssetsAndLiabilities", "http://www.npci.com/role/StatementsOfAssetsAndLiabilitiesParenthetical", "http://www.npci.com/role/StatementsOfCashFlows", "http://www.npci.com/role/StatementsOfChangesInNetAssets", "http://www.npci.com/role/StatementsOfOperations", "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_StockIssuedDuringPeriodSharesDividendReinvestmentPlan": { "auth_ref": [ "r49" ], "lang": { "en-us": { "role": { "documentation": "Number of shares issued during the period from a dividend reinvestment plan (DRIP). A dividend reinvestment plan allows the shareholders to reinvest dividends paid to them by the entity on new issues of stock by the entity.", "label": "Stock Issued During Period, Shares, Dividend Reinvestment Plan", "verboseLabel": "Reinvestment of common stock, Shares" } } }, "localname": "StockIssuedDuringPeriodSharesDividendReinvestmentPlan", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.npci.com/role/StatementsOfChangesInNetAssets" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesNewIssues": { "auth_ref": [ "r6", "r7", "r49", "r50" ], "lang": { "en-us": { "role": { "documentation": "Number of new stock issued during the period.", "label": "Stock Issued During Period, Shares, New Issues", "terseLabel": "Stock issued during period new shares issued in private placement" } } }, "localname": "StockIssuedDuringPeriodSharesNewIssues", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.npci.com/role/OrganizationAdditionalInformationDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesPeriodIncreaseDecrease": { "auth_ref": [ "r49" ], "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the period in the number of shares issued.", "label": "Stock Issued During Period, Shares, Period Increase (Decrease)", "terseLabel": "Total increase (decrease), Shares" } } }, "localname": "StockIssuedDuringPeriodSharesPeriodIncreaseDecrease", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.npci.com/role/StatementsOfChangesInNetAssets" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodValueDividendReinvestmentPlan": { "auth_ref": [ "r49" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of stock issued during the period from a dividend reinvestment plan (DRIP). A dividend reinvestment plan allows the holder of the stock to reinvest dividends paid to them by the entity on new issues of stock by the entity.", "label": "Stock Issued During Period, Value, Dividend Reinvestment Plan", "terseLabel": "Stock issued during period value, reinvestment of dividends", "verboseLabel": "Reinvestment of common stock" } } }, "localname": "StockIssuedDuringPeriodValueDividendReinvestmentPlan", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.npci.com/role/OrganizationAdditionalInformationDetail", "http://www.npci.com/role/StatementsOfChangesInNetAssets" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockRepurchaseProgramExpirationDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Expiration date for the purchase of an entity's own shares under a stock repurchase plan, in the YYYY-MM-DD format.", "label": "Stock Repurchase Program Expiration Date", "terseLabel": "Stock Repurchase Program Expiration Date" } } }, "localname": "StockRepurchaseProgramExpirationDate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.npci.com/role/ShareRepurchaseProgramAdditionalInformationDetail" ], "xbrltype": "dateItemType" }, "us-gaap_StockRepurchasedDuringPeriodShares": { "auth_ref": [ "r6", "r7", "r49", "r50" ], "lang": { "en-us": { "role": { "documentation": "Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.", "label": "Stock Repurchased During Period, Shares", "negatedLabel": "Repurchase of common stock, Shares", "terseLabel": "Stock Repurchased During Period, Shares" } } }, "localname": "StockRepurchasedDuringPeriodShares", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.npci.com/role/ShareRepurchaseProgramAdditionalInformationDetail", "http://www.npci.com/role/StatementsOfChangesInNetAssets" ], "xbrltype": "sharesItemType" }, "us-gaap_StockRepurchasedDuringPeriodValue": { "auth_ref": [ "r6", "r7", "r49", "r50" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.", "label": "Stock Repurchased During Period, Value", "negatedLabel": "Repurchase of common stock" } } }, "localname": "StockRepurchasedDuringPeriodValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.npci.com/role/StatementsOfChangesInNetAssets" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquity": { "auth_ref": [ "r7", "r10", "r11", "r44", "r448", "r464", "r478", "r493" ], "calculation": { "http://www.npci.com/role/StatementsOfAssetsAndLiabilities": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.", "label": "Stockholders' Equity Attributable to Parent", "totalLabel": "Total net assets" } } }, "localname": "StockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.npci.com/role/StatementsOfAssetsAndLiabilities" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stockholders' Equity Attributable to Parent [Abstract]", "terseLabel": "Net assets" } } }, "localname": "StockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.npci.com/role/StatementsOfAssetsAndLiabilities" ], "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquityPeriodIncreaseDecrease": { "auth_ref": [ "r49", "r50" ], "lang": { "en-us": { "role": { "definitionGuidance": "Total increase (decrease)", "documentation": "The increase (decrease) in stockholders' equity during the period.", "label": "Stockholders' Equity, Period Increase (Decrease)" } } }, "localname": "StockholdersEquityPeriodIncreaseDecrease", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.npci.com/role/StatementsOfChangesInNetAssets" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityPolicyTextBlock": { "auth_ref": [ "r48" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for its capital stock transactions, including dividends and accumulated other comprehensive income.", "label": "Stockholders' Equity, Policy [Policy Text Block]", "terseLabel": "Paid-in\u00a0Capital" } } }, "localname": "StockholdersEquityPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_SubsequentEventsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Subsequent Events [Abstract]" } } }, "localname": "SubsequentEventsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventsTextBlock": { "auth_ref": [ "r327", "r328" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.", "label": "Subsequent Events [Text Block]", "verboseLabel": "Subseqent Events" } } }, "localname": "SubsequentEventsTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.npci.com/role/SubsequentEvents" ], "xbrltype": "textBlockItemType" }, "us-gaap_SummaryOfInvestmentHoldingsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Summary of Investment Holdings [Line Items]" } } }, "localname": "SummaryOfInvestmentHoldingsLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.npci.com/role/ScheduleOfInvestments", "http://www.npci.com/role/ScheduleOfInvestments1", "http://www.npci.com/role/ScheduleOfInvestments2", "http://www.npci.com/role/ScheduleOfInvestmentsParenthentical" ], "xbrltype": "stringItemType" }, "us-gaap_SupplementalCashFlowElementsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Supplemental Cash Flow Elements [Abstract]", "terseLabel": "Supplemental disclosure and\u00a0non-cash\u00a0financing activities" } } }, "localname": "SupplementalCashFlowElementsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.npci.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": { "auth_ref": [ "r214", "r215", "r261", "r266", "r301", "r329", "r330", "r331", "r332", "r333", "r334", "r335", "r336", "r337", "r338", "r339", "r340", "r341", "r342", "r343", "r344", "r345", "r346", "r347", "r348", "r349", "r350", "r351", "r352", "r353", "r354", "r355", "r356", "r357", "r358", "r475", "r476", "r477", "r508", "r509", "r510", "r511", "r512", "r513", "r514" ], "lang": { "en-us": { "role": { "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms.", "label": "Financial Instruments [Domain]" } } }, "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.npci.com/role/ScheduleOfInvestmentsParenthentical" ], "xbrltype": "domainItemType" }, "us-gaap_UnfundedLoanCommitmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Undisbursed funds of a credit facility in which the borrower may draw upon.", "label": "Unfunded Loan Commitment [Member]" } } }, "localname": "UnfundedLoanCommitmentMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.npci.com/role/EconomicDependencyAndCommitmentsAndContingenciesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_UnrealizedGainLossOnInvestments": { "auth_ref": [ "r27" ], "calculation": { "http://www.npci.com/role/StatementsOfCashFlows": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of unrealized gain (loss) on investment.", "label": "Unrealized Gain (Loss) on Investments", "negatedLabel": "Net change in unrealized (appreciation) depreciation on investments", "verboseLabel": "Net change in unrealized appreciation (depreciation) on investments" } } }, "localname": "UnrealizedGainLossOnInvestments", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.npci.com/role/StatementsOfCashFlows", "http://www.npci.com/role/StatementsOfChangesInNetAssets" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnusualRiskOrUncertaintyByNatureAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by nature of risk and uncertainty, for example, but not limited to, threat of expropriation of its assets by a foreign government, rapid technological obsolescence in the industry, risk of natural disaster from earthquake or weather events, and availability of or continuation of a labor force at a reasonable cost.", "label": "Unusual Risk or Uncertainty, Nature [Axis]" } } }, "localname": "UnusualRiskOrUncertaintyByNatureAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.npci.com/role/MarketAndOtherRiskFactorsAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_UnusualRiskOrUncertaintyLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Unusual Risk or Uncertainty [Line Items]" } } }, "localname": "UnusualRiskOrUncertaintyLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.npci.com/role/MarketAndOtherRiskFactorsAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_UnusualRiskOrUncertaintyNatureDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Describes the nature of the unusual risk or uncertainty, such as the threat of expropriation of its assets by a foreign government, rapid technological obsolescence in the industry, risk of natural disaster from earthquake or weather events, and availability of or continuation of a labor force at a reasonable cost.", "label": "Unusual Risk or Uncertainty, Nature [Domain]" } } }, "localname": "UnusualRiskOrUncertaintyNatureDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.npci.com/role/MarketAndOtherRiskFactorsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_UnusualRiskOrUncertaintyTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Describes the unusual risk or uncertainty and its financial impact or potential financial impact.", "label": "Unusual Risk or Uncertainty [Table]" } } }, "localname": "UnusualRiskOrUncertaintyTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.npci.com/role/MarketAndOtherRiskFactorsAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_UseOfEstimates": { "auth_ref": [ "r38", "r39", "r40", "r199", "r200", "r201", "r202" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.", "label": "Use of Estimates, Policy [Policy Text Block]", "verboseLabel": "Use of Estimates" } } }, "localname": "UseOfEstimates", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ValuationTechniqueAxis": { "auth_ref": [ "r64" ], "lang": { "en-us": { "role": { "documentation": "Information by valuation approach and technique.", "label": "Valuation Approach and Technique [Axis]" } } }, "localname": "ValuationTechniqueAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityDetail" ], "xbrltype": "stringItemType" }, "us-gaap_ValuationTechniqueDiscountedCashFlowMember": { "auth_ref": [ "r492" ], "lang": { "en-us": { "role": { "documentation": "Valuation technique calculating present value of future cash flows.", "label": "Valuation Technique, Discounted Cash Flow [Member]" } } }, "localname": "ValuationTechniqueDiscountedCashFlowMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityDetail" ], "xbrltype": "domainItemType" }, "us-gaap_ValuationTechniqueDomain": { "auth_ref": [ "r64" ], "lang": { "en-us": { "role": { "documentation": "Valuation approach and technique.", "label": "Valuation Approach and Technique [Domain]" } } }, "localname": "ValuationTechniqueDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityDetail" ], "xbrltype": "domainItemType" }, "us-gaap_ValuationTechniqueOptionPricingModelMember": { "auth_ref": [ "r492" ], "lang": { "en-us": { "role": { "documentation": "Valuation technique calculating price of option.", "label": "Valuation Technique, Option Pricing Model [Member]" } } }, "localname": "ValuationTechniqueOptionPricingModelMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityDetail" ], "xbrltype": "domainItemType" }, "us-gaap_WarrantMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount.", "label": "Warrant [Member]", "terseLabel": "Warrants" } } }, "localname": "WarrantMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.npci.com/role/InvestmentPortfolioSummaryOfInvestmentCompanyAssetsByIndustryClassificationAtFairValueDetail", "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfInvestmentsCategorizeIntoFairValueHierarchyDetail" ], "xbrltype": "domainItemType" }, "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": { "auth_ref": [ "r189", "r194" ], "lang": { "en-us": { "role": { "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.", "label": "Weighted Average Number of Shares Outstanding, Diluted", "terseLabel": "Weighted average shares outstanding: Diluted" } } }, "localname": "WeightedAverageNumberOfDilutedSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.npci.com/role/StatementsOfOperations", "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfComputationOfBasicAndDilutedNetDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "auth_ref": [ "r188", "r194" ], "lang": { "en-us": { "role": { "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.", "label": "Weighted Average Number of Shares Outstanding, Basic", "terseLabel": "Weighted average shares outstanding: Basic" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.npci.com/role/StatementsOfOperations", "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfComputationOfBasicAndDilutedNetDetail" ], "xbrltype": "sharesItemType" } }, "unitCount": 5 } }, "std_ref": { "r0": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=77885760&loc=SL35686385-199418", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r1": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "205", "URI": "https://asc.fasb.org/topic&trid=2122149", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r10": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r100": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04.2)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r101": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04.3(a))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r102": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04.7)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r103": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=66023616&loc=d3e9046-115832", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r104": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=66023616&loc=d3e9079-115832", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r105": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "205", "Subparagraph": "(a)", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=118262037&loc=d3e9915-115836", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r106": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "205", "Subparagraph": "(c)", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=118262037&loc=d3e9915-115836", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r107": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "205", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=118262037&loc=d3e9915-115836", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r108": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=25866437&loc=d3e10177-115837", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r109": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=25866437&loc=d3e10328-115837", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r11": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(31))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r110": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=25866437&loc=d3e10342-115837", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r111": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=25866437&loc=d3e10396-115837", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r112": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=25866437&loc=d3e10403-115837", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r113": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=25866437&loc=d3e10411-115837", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r114": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Subparagraph": "(a)", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=25866437&loc=d3e10246-115837", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r115": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Subparagraph": "(b)", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=25866437&loc=d3e10246-115837", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r116": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Subparagraph": "(c)", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=25866437&loc=d3e10246-115837", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r117": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Subparagraph": "(d)", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=25866437&loc=d3e10246-115837", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r118": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Subparagraph": "(e)", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=25866437&loc=d3e10246-115837", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r119": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Subparagraph": "(h)", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=25866437&loc=d3e10246-115837", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r12": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19-26)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r120": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "205", "Topic": "946", "URI": "https://asc.fasb.org/subtopic&trid=2324234", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r121": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Subparagraph": "(b)", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=99383244&loc=d3e12121-115841", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r122": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Subparagraph": "(c)", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=99383244&loc=d3e12121-115841", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r123": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-05(4))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=120401414&loc=d3e604008-122996", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r124": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "220", "Subparagraph": "(c)", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=124433917&loc=SL114874205-224268", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r125": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "220", "Subparagraph": "(c)", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=124433917&loc=SL114874225-224268", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r126": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "45", "SubTopic": "220", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=124433917&loc=SL114874234-224268", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r127": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-09(6))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=120401555&loc=SL114874367-224272", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r128": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-09(7))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=120401555&loc=SL114874367-224272", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r129": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12)", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611133-123010", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r13": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r130": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12.2(ii))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611133-123010", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r131": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-14(1)(a))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611322-123010", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r132": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-14(2))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611322-123010", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r133": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-14(3))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611322-123010", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r134": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-14(5))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611322-123010", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r135": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-14(Column D))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611322-123010", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r136": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-14(Column E))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611322-123010", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r137": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-14)", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611322-123010", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r138": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-14.1(b)(3))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611322-123010", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r139": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-14.1(b)(4))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611322-123010", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r14": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.25)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r140": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-14.1(b))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611322-123010", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r141": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-14.Column B)", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611322-123010", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r142": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "320", "Topic": "946", "URI": "https://asc.fasb.org/subtopic&trid=2324412", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r143": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(n)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef" }, "r144": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "105", "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r145": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r146": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r147": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(18))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r148": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(27)(b))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r149": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r15": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-31)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r150": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r151": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(3)(a)(2))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r152": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(3)(b))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r153": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(7))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r154": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r155": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226008-175313", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r156": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r157": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r158": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r159": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r16": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.3)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r160": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r161": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(25))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r162": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3367-108585", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r163": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3000-108585", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r164": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r165": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r166": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4297-108586", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r167": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18726-107790", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r168": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r169": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h)(2))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r17": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.4,6)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r170": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(m)(1)(i))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r171": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(m)(1)(ii)(A)(i))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r172": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(m)(2)(i)(A))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r173": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(n))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r174": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-04(a))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r175": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r176": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r177": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r178": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r179": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(3)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r18": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.7(a))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r180": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r181": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r182": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r183": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r184": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r185": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r186": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r187": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r188": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1448-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r189": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1505-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r19": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.7(a),(b))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r190": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1252-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r191": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1278-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r192": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r193": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1337-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r194": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r195": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e3842-109258", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r196": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r197": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r198": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r199": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r2": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(19))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r20": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.7(b))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r200": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r201": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r202": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r203": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r204": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r205": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r206": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r207": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r208": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r209": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r21": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.8)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r210": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r211": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r212": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r213": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e5066-111524", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r214": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27232-111563", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r215": { "Name": "Accounting Standards Codification", "Paragraph": "5A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=SL120269820-111563", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r216": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "323", "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r217": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "323", "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r218": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r219": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r22": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r220": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919244-210447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r221": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r222": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919253-210447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r223": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919258-210447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r224": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919230-210447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r225": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922888-210455", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r226": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922895-210455", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r227": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922900-210455", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r228": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "440", "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r229": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "440", "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r23": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r230": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r231": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r232": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r233": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Subparagraph": "(SAB Topic 5.Y.Q4)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r234": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r235": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r236": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r237": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r238": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r239": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r24": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r240": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r241": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r242": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r243": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r244": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r245": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r246": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r247": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r248": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r249": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r25": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r250": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r251": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r252": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r253": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r254": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r255": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r256": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r257": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r258": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r259": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r26": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r260": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r261": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r262": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r263": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r264": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r265": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r266": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r267": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r268": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r269": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(i)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r27": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r270": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(01)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r271": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r272": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(A)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r273": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(B)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r274": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(C)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r275": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(03)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r276": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(n)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r277": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(d)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r278": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r279": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r28": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r280": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iv)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r281": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r282": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r283": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r284": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r285": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r286": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r287": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r288": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(3)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r289": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.5.Q1)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r29": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3044-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r290": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.C)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r291": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "270", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r292": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r293": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "740", "URI": "https://asc.fasb.org/topic&trid=2144680", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r294": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569616-111683", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r295": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r296": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r297": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r298": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r299": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r3": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(20))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r30": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4273-108586", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r300": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r301": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=d3e90205-114008", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r302": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r303": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(4)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r304": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r305": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r306": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r307": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r308": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r309": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(3)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r31": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4297-108586", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r310": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r311": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13433-108611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r312": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r313": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r314": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r315": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r316": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r317": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r318": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r319": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r32": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4304-108586", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r320": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(3)(iii)(03)", "Topic": "848", "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r321": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r322": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r323": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r324": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r325": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39691-107864", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r326": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "850", "URI": "https://asc.fasb.org/topic&trid=2122745", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r327": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "855", "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r328": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "855", "URI": "https://asc.fasb.org/topic&trid=2122774", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r329": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)(i)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r33": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4332-108586", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r330": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)(ii)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r331": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r332": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r333": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r334": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r335": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r336": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r337": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r338": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r339": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r34": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r340": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r341": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r342": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=66007379&loc=d3e113888-111728", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r343": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=109249958&loc=SL34722452-111729", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r344": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r345": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r346": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r347": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(4)(i)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r348": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r349": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r35": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "235", "URI": "https://asc.fasb.org/topic&trid=2122369", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r350": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r351": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(4)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r352": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(5)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r353": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(6)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r354": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(7)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r355": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(b)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r356": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(e)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r357": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(e)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r358": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(e)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r359": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "910", "URI": "https://asc.fasb.org/extlink&oid=126937589&loc=SL119991595-234733", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r36": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r360": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.L)", "Topic": "924", "URI": "https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r361": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61929-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r362": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61929-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r363": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62059-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r364": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62059-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r365": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62395-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r366": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62395-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r367": { "Name": "Accounting Standards Codification", "Paragraph": "33", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62479-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r368": { "Name": "Accounting Standards Codification", "Paragraph": "33", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62479-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r369": { "Name": "Accounting Standards Codification", "Paragraph": "35A", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=SL6807758-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r37": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r370": { "Name": "Accounting Standards Codification", "Paragraph": "35A", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=SL6807758-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r371": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)(1)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61872-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r372": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)(2)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61872-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r373": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(27))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r374": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.9-05(b)(2))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r375": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(2))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r376": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(23))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r377": { "Name": "Accounting Standards Codification", "Paragraph": "7A", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(d)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r378": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r379": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(1)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r38": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r380": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(2)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r381": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(i)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r382": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(2)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r383": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "220", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=124439613&loc=SL124453110-224270", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r384": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 1))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r385": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 2))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r386": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 6))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r387": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 7))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r388": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column B))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r389": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 1))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r39": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r390": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 2))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r391": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 6))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r392": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 7))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r393": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column C))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r394": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 1))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r395": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 2))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r396": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 6))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r397": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 7))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r398": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B)", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r399": { "Name": "Accounting Standards Codification", "Paragraph": "5D", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-13D(Column B)(Footnote 2))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=SL120429264-123010", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r4": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(22))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r40": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r400": { "Name": "Accounting Standards Codification", "Paragraph": "5D", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-13D(Column C)(Footnote 2))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=SL120429264-123010", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r401": { "Name": "Accounting Standards Codification", "Paragraph": "5D", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-13D(Column C))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=SL120429264-123010", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r402": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-15(Column A))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r403": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-15(Column B))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r404": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-15(Column C))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r405": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-15(Column D))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r406": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "310", "Subparagraph": "(SX 210.12-29(Footnote 4))", "Topic": "948", "URI": "https://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r407": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "440", "Subparagraph": "(a)", "Topic": "954", "URI": "https://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r408": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column B))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r409": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column C))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r41": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "275", "URI": "https://asc.fasb.org/topic&trid=2134479", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r410": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column D))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r411": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column E))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r412": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column F))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r413": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column G))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r414": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column H))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r415": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column I))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r416": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Footnote 2))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r417": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Footnote 4))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r418": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(c)", "Topic": "976", "URI": "https://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r419": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(b)", "Topic": "978", "URI": "https://asc.fasb.org/extlink&oid=126945304&loc=d3e27327-108691", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r42": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e5111-111524", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r420": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(a)", "Publisher": "SEC", "Section": "1402", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r421": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(a)", "Publisher": "SEC", "Section": "1404", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r422": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(b)", "Publisher": "SEC", "Section": "1404", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r423": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(a)", "Publisher": "SEC", "Section": "1405", "Subparagraph": "(4)", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r424": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(c)", "Publisher": "SEC", "Section": "1405", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r425": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r426": { "Name": "Accounting Standards Codification", "Paragraph": "52", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e4984-109258", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r427": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r428": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r429": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124267575&loc=SL82921833-210448", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r43": { "Name": "Accounting Standards Codification", "Paragraph": "7A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=SL6953401-111524", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r430": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124267575&loc=SL82921835-210448", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r431": { "Name": "Accounting Standards Codification", "Paragraph": "79", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124267575&loc=SL82922352-210448", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r432": { "Name": "Accounting Standards Codification", "Paragraph": "80", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124267575&loc=SL82922355-210448", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r433": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "30", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=121590138&loc=SL82922954-210456", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r434": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r435": { "Name": "Accounting Standards Codification", "Paragraph": "69B", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r436": { "Name": "Accounting Standards Codification", "Paragraph": "69C", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r437": { "Name": "Accounting Standards Codification", "Paragraph": "69E", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r438": { "Name": "Accounting Standards Codification", "Paragraph": "69F", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r439": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r44": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 4.E)", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r440": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r441": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r442": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(ii)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r443": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(01)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r444": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r445": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "80", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r446": { "Name": "Accounting Standards Codification", "Paragraph": "4J", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r447": { "Name": "Accounting Standards Codification", "Paragraph": "4K", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r448": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r449": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(b)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r45": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "323", "URI": "https://asc.fasb.org/extlink&oid=109237563&loc=d3e33749-111570", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r450": { "Name": "Accounting Standards Codification", "Paragraph": "29F", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117819544-158441", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r451": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r452": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "g", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r453": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "308", "Subsection": "a", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r454": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r455": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r456": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70229-108054", "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef" }, "r457": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(10))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r458": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(27)(b))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r459": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r46": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "323", "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r460": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r461": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r462": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(d))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r463": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(f))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r464": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r465": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(k)(1))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r466": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r467": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r468": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r469": { "Name": "Accounting Standards Codification", "Paragraph": "55", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e2626-109256", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r47": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "440", "URI": "https://asc.fasb.org/topic&trid=2144648", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r470": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r471": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4647-111522", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r472": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "320", "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27161-111563", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r473": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "320", "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27232-111563", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r474": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27232-111563", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r475": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "321", "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r476": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "321", "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r477": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "321", "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r478": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r479": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "410", "URI": "https://asc.fasb.org/extlink&oid=6393242&loc=d3e13237-110859", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r48": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21459-112644", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r480": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "450", "URI": "https://asc.fasb.org/topic&trid=2127136", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r481": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r482": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r483": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r484": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r485": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r486": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r487": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(ii)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r488": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(n)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r489": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r49": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r490": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.Fact.4)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r491": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r492": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r493": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r494": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r495": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r496": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39599-107864", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r497": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r498": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r499": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r5": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(24))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r50": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r500": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r501": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r502": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r503": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r504": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r505": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r506": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(3)(b))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r507": { "Name": "Accounting Standards Codification", "Paragraph": "5D", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-13D)", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=SL120429264-123010", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r508": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(a)", "Publisher": "SEC", "Section": "1402", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r509": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(b)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(1)", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r51": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r510": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(b)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(2)", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r511": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(b)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(3)", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r512": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(c)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(2)(i)", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r513": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(c)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(2)(ii)", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r514": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(c)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(2)(iii)", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r515": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(a)", "Publisher": "SEC", "Section": "1405", "Subparagraph": "(1)", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r516": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(a)", "Publisher": "SEC", "Section": "1405", "Subparagraph": "(2)", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r517": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(a)", "Publisher": "SEC", "Section": "1405", "Subparagraph": "(3)", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r52": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=6405834&loc=d3e23285-112656", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r53": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=6405834&loc=d3e23309-112656", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r54": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=6405834&loc=d3e23315-112656", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r55": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "810", "URI": "https://asc.fasb.org/topic&trid=2197479", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r56": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579240-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r57": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r58": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r59": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41638-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r6": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r60": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41675-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r61": { "Name": "Accounting Standards Codification", "Paragraph": "54B", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126972413&loc=SL7495116-110257", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r62": { "Name": "Accounting Standards Codification", "Paragraph": "59", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126972413&loc=SL6740821-110257", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r63": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r64": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r65": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r66": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r67": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19279-110258", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r68": { "Name": "Accounting Standards Codification", "Paragraph": "6A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=SL6742756-110258", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r69": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "60", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=7493716&loc=d3e21868-110260", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r7": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r70": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13279-108611", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r71": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r72": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r73": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r74": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r75": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r76": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "35", "SubTopic": "320", "Subparagraph": "(b)", "Topic": "940", "URI": "https://asc.fasb.org/extlink&oid=35711043&loc=d3e42429-110968", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r77": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(1)(a))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r78": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(11))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r79": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(13))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r8": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r80": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(15)(5))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r81": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(16))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r82": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(3))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r83": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.10(3))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r84": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.10)", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r85": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.13(1))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r86": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.15(3),(4))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r87": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.15(5))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r88": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.17)", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r89": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04.14)", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r9": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r90": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(16))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r91": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(12))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r92": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(15)(5))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r93": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(2))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r94": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r95": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(3))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r96": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.(a),19)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r97": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.10)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r98": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.17)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r99": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.3)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" } }, "version": "2.2" } ZIP 64 0001193125-23-145196-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001193125-23-145196-xbrl.zip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�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

5,?8$NA2 O<.?"J6_!0&VD5X%\U87P8UVC!CH$@'VQ"\ !U8CP)X= MVUI5T5/H8CV0=D$-:L#J"3CR..].G='34U=29HBUI<_'=QDM[A=(L%>IZ/1T M+W+ R<0I.^W*6/&W<(*M^D:G9WOATZ.O''J,@!5@Z*P8W4O4G9[MA>.-N4I( MZ "KY0!O"(>R+4P1\W+2M&AIP;67J'U(C:(+V5;*PUKK0 MT NCY6+/%@@I4%N9ZUTX8C*?!.J,2.Y>7]((Q2V.F*).N&L#\)NNO2.F&J>M MS.^@C_FK/W[&*"-<3Q=5])_^R[ZD ^[]Y,KC*>PSOQ9/MC*H ZI4S1,FW\6L M_Y"OTP\GSA4CF*:0%:IB!MQ6HG% C6&I3UG0L7)#DK1BI!R[\N9F)D>%4LC0 MVDK+;4D%\JRHB9_\;2UZ\I<_GFBB3,'VLO'O%1BQ? E^XEDYDPIFXQL&%.H%0!$+9[Z-QPHT*9G(I[F40O$ Q45K1#/-X3?I@6*1N]D&UMK0[\U3B5G_:7XD=,O1".:^W3O#@@G@@5VPEI!^11=] M3XU3RHY$?>4-.35NU5OJ40&:%5"7(X'Z&-L.R>K\FO99-_(:Y6&&Y^S-K.EN MNV+K,4M#U%B.HV./G+7]O @J-0*5&Z@Z8SN%JZ6UV_$S_)JOT^3I*9NJ M-\:58Y4175 T?>($2C90W4/]F* T>7M!V:RV7&]'<*J#A-1]$%Z.+\X/W H, M 5(H([H$:K1_&3EIRLVRX"XIE.F0L'^-XY)(_:_6Q=JL M2\XFT,7(GBZHKM)M6;&4<+/M';NSJFW98!]*:H,E)PO*:CXNB[P(DHB?T$*) M?AGUP^D#RMG;MU*UI,)2VDZ@>L$"T)R['>SFFB3JB1,(Y!,(I$MJ,BRE_@32 MID;Z)#K3^#TG \@UL&_-4$"VE/G3$?ES<@PT@+?@A !Y[PVM SN@+:7_'-[$ ML3Z8/:99,2$7SW1ESUC_V^OF:V9OD9W*[1. H-TX:T'97ER<$J)0[>Q0#MJQS8#WI;<^(R" MN)A>$:J5'O';GW+T3ARK6HBL>>T7@_3[:OY$<-WDA4[^W.U/&06'0)Z?/&ALP.HZ!SG@]37X5U+YNS':7@*LTR*@Z M";U.>!5@2V4R>I;V38*R-W$1!/'''*@3[RR6)=L,LZ\BNW;EN3Z K$EYR4K] MW-&J#C@A3EB^+TWYU[L?<]* 74#U[.PZ*/RMX;#6\_&/!$6C8N7RKN5UM]V(*SAP M*)M,5,W"U4%DJQY#[X%G6V >4192(;RA\>0E+8*8N0(:/)O(NJ&1!^=@3F_F M$N^&T58-!E==#[B_*(.]WNHVM\#:[-@C;X2C0Z-8"U!OA"/HHJ^:=&I[(QR) MJ[O^5ZSP=W)T!)R+2R0C@?E9#<;;J(4]*\E'I.%*E*Y8611:UALM4$X/'2HL MW>(L)Z<>E+0NM;35 V?#K6P4/:G<18H!ODD.KCQ$Q?CMP7*79/,W(N?*23 @#G9&VX^0 N^Q" M:8TF-:#N'Q;TIF,Y44*"6P73!]0/(1U^.(G(M"U(T-.0%N9=8?^)"B MY@;4XZ3S@F&I,#6API7\^ ,O&W)&8%U0NL=T!UD6)(52+3:^8^B=R9 _L#X( MJ(!U/W'B$?OH"#A%F9FA5H;"ELN) X_85VDN>PQJ_)ZKM2L^"0T"TGRZW@1C MR]$$+)5+'QX*1XYZ*)B(N0&1+3>4GL_T0_LG4': C9+Z\NZ&L4)- 4Y"C^\I>^_5QEELP43*?_+6J+\/_SQ'__9=+19_2/'!EC02X/V MK3-+P^#=22Y@)IW[KQ+IW'_E (&>$SI)ISYX=YZ>S:3S]5DBG:_/'""0U;:3 M=.J#]_N9UXI9[<25"[KTT*&#PM+;JP-6-1N&EU/HVX%$4NT,+Z?"ZX%K;ZD M=I=35]R8E>+NAK&O]]+>C2Y/*"8,18]!5BQ>LB#)R2691AJ/DFA$WWS>6!7F M]:7Z%J%O 7XG R6?W/R]CL!*+SG _3C3O\/#P_*R7=:*/ M@>L5$NGMEQE?%TZ$%@^C%[+5;0":+1G,>D]9LAS^38S?<%79:4$(P:Q PC59 M&K72BVKVP^CYZ$15DP%T0*:"QHQ9,MS!*Y1FTE+MGCA%3N2Y,I9J1Q799L"2 M-;#OW#B$VNG+%),CUSA!+S_2EVE:YD$2O?P@8!?/^*=NCAS-C@A!%^>G4&:1 MSE*5*8DY!7X$[%RCL!HW@U9%']7 C9;X;LD*KJDLQCU6E)U !8+UJC4=N/ C MF>HSFA?*,2+"#[NS[FZ;EIGEL\RJQXJRHP,G,KX# MG64:N/ CKZS.KJNO.D:]<:KV\0COJJXI9=YRM?3S]MB4"-N>M[>/,"^G6LFVFUB5CS8T2-C 'FD8R8-/JVCS2 MF*B/67>XF3[H"_SKT&G+AI [M&#,2S0-U=,SG_ M)PJR>'%5SLJ8:,,[&A=3E'%6E"HK:\Q6=3>>-P<2N4SK]*@2*(UK%F<&AH_^ M'L\PDZNFONRTX_B=.#$[HRH2E@1:XIIA>5OEF]@T7F*:.N',.%&PSAG]T:5, MX/CGFL7Y'V60D9^(%XP6NMV/,_9G%(UF-,I+J4L:?7!>G# ;.J!*1HP)-,DU ML[3BPM/5-8Q02U4!T7\HNR$Q=EIO:E3)5": M[O9H5P+#1E&$&;J[9))F,YC4.\+!JK/OJ)I6VG"\\AP9!L\ZW$XTO,O%QK^H M\O2TZ8\C!TZ(IR^?S=EJ";I;B7\L3(E-M(HB1?J=,,8.HU^S&D 3LG?1FQJ!=A&Z$?$$3\#:;X&;7S-H0+G2Y>)0'9*$T!Q M)SF1Q:6]W5J^G@#@)><&7+PW4;N3#UP3J1\1-M8&EV>(6H>KJ'3/5W=#Z<'N%J.!3TPQ@L:2M/7'B!S[M!MRG=8Z'QL QX.&J!;BI3I MSS7H,LC1ER )F%F.*/A5$(=E!6^4)&40/Y$_CB?U1%:C=Y21/U2IS,:33UF: MYYH9P&S^6,7Q&732:'U-D"TZ_?#B2U5JE)C*XX=N/B2'9U0 /0F M5.8GGI6S]:/'>%)W$,IO?H8(13E];EDI>H.:FRPR]G^2L7X*O)/94:L^V?$D M#J?QW8^]^;],@V*4(?8R%Z/;-%L3=;E8/PKJOHO:^RDN73KFO*KBJ>;HCE*V)@<:YKP&"QV45Z5&26; M7$P?TB1D?]%0#>V^&(O'GAZJ+<#V)%#GN7PE0\,)Q767T,T9OR-R/APGY&_I M#-WEUX@,889IXNDDXD2LG-[NB#0S%&3YS9]DB\_K^_MCANH=/J!B?1!E?:NC M"@$'QP\C>[%-NL&CK>BFGF?$YS*+R%0G7)&C 9%Z3@M]L6OS$RK*+!DG!"8[ ML5:$O*1K1LB?.&U*Y;;T.YQ?3S?EGBGQ),)HC=M :QC*,S<-Y:T%OT;E2:"/ M>@4D5P^NF+OKYTJ=1^3"@FZ2:#S173_Z^F$F@7/@IW@[>M4_1YX$&ET%13C] M.B<7U=1">/(F: MJA/ #9/CI,Z$QE.4H@?&"52F?=O/4MI@/0E\&KV]9>B-5A@(PZST8,&>R39 ?V&9 ML$*#0)U\<>^NNRZR^23.?J-LPUB!2A]@[6%(#4\@=&-S-]&KU[378XLM?QDC M/X]S7]\&NV(6Z(5K-NEQ]A8D^-^55*[2O* ^S.,)&1].WMC?,^;CCJ*Z%9Y7 M)ZV0/V9IY0+T%)#=E1SER$Z[[$&I2_W^/)/&?KA\#L640&]=L\>OD_JL[Q+5 M?CV>U)G:)DEMQ&S7+^?/T^W.,@4"%7+-6,ZO [=I-D'5M)FB)_PVK:X.M6-@ M98=]0C0BA$!=,E%!?BY?<_1G23XB]XO*]E4Q4[707@*'&0:7SGY8#P9F3!!Z M[9HIG9]1:$J4!&4,[\H,6_/RR,E^$%CC'Y]&>0X'T_(]XT?]J[YM@;*);P7!Q+W.!7,&N=>*E8YL[B]E'&W M=):ODI*Q!^@Z77)J-/C8B\V-6VH M&[%F$PHCYUJQP8 M5VE2)*N%N\D!6NCP/,KJZT6RZ_/)VA3*ZU6^$ M&6[:M):^?$G$XYG)\=;(A.W08)FDH:K-6M[;G.15,(->L:3RA6&KK'1Y8+;2K]2=\LU!S1%]2A# MZUSV!N\B[7^$,>MHSJ?6CR0V^!!HFFLO)O],8W(T#3),RR#P?9H=5\D4^IID MW./JGNS!C1'H'7KC*37WXJ;7$K@@EZAKSQ#KF7&5SF9TL>7U,5[2)N#DT&:L M.=U_@K.Z%Q[6-MD0Z%CWYX#>RPA\?;Y%9+"T/ -BWD)?M;J!+A1/& ULFN< MAW&:EQG2J!L@:47D=G#V<;6A]A>9-4F*NZ\:!KT?+JH5^ G-RRR3%W+\)(JW>"[2\+NJI)"P#4< [-(F8K5Y"FF M\;80D&"2R(M%B!MQ1H"72PV!-4M:!YBEC=4542L+0]_B+"_XR]I+%:1?^<-J)O^7MOZ#%BL\.7)2PMMRDEW4-$%:*OTS M_.1F.UK3PKHC]&])09"3?\,H=^,M0#) (Y\#HWXJ<5^L7DB'05KYA=>&J7I%:/R>CQS: MQ-R.[.;9J<#I[>/"+3F?$DJ2MWH]EY"./UJ[1%PN5[:&KQ7O$%;Z9SR? %\? M%"K0K#>6\7O[LJ'%@Y@%Y1.(E?XYS\!W$,LJTT$O]?F">G_IK)=?DTE)CR_W M:9"LY[;P64:G&6<%>/>S+.!F+=*CP=L7F^T57^>=1MB&\P%LFV^UB6E@@GJ/ MZ?-HW^X@SSB!?H73$)G DT8'65^/++U?/[\$V7=$:\Y5_#SA_/MM4"4'<..> M20=$:?^:A"Q,EQ;*T[A72MM58CL_OQAX7RUSFER&#&RU4-TGI>T8$O"0 M;CVR13NF%CXG[I,Y"C^\I>^_1P@SD9,_K"5-_O+'/7H+XAM"0+$0W ,;OF++ MR 'P JDIB$TI2M$X<3=3RXP-77BAVOZ$XP,ZMD@)WY5-\\"==P[[^B'_P*.L MG@B]V3O2] L3->38@5[MQ9*0O9BIL7A[CQ"M-9>+AZ"@1DBY#4VG.5^Q@"^= MK1;5=C"]O7"(8#*02D.73G,^98 ]0LWD::83S6@M74OZ6^BOTHP,[1UG93[" MT1.*,9J0D^3R4>P9A65&M[E0;('JUB'G"CCAN?A*VG(&@&Y-6J*125,+F2V_)'B[ON+\W?1Y1:1N;L"I<.R]9E-(>H+=QB,0;?^6*NU5^;G LS(N0W(F35$SU.$BNJ][C8(T;+P:(YD;ZGM M.N1+LJ.&%:5&V0(O4"8// -&DTF5:Z?N'I4_E[-9D"W&D]J_TEC!+*^R8O-4 M80 )[U8CO*/UXD;1.Y5/_I*NQID_AU,4E3&BI9Q77VNEQ>O8=Z5B9X?'@ZX" M.J-6N1YH]\$1 KLC6Q14\UK0@H^]=ULX.P0^3K80BIX+0X5LCUT8SHZ ;#52 MPC5<&*J!.^_"\(!^SE-RU'A".8X(&SB(7[(R+^Z2\(/F_5W=!><#:.$52T=V M.C=!!>7@8"SEJV"."^JG@8O[.'Q&"4XSZ@.>4R-'FE2AC+FAV WZY(P!^0%V MTX-6,"TY._2<-6"MZF2QRXD\$ LL0*T6 6$?G!:@C;CK*J !RWDWAN=)]BW& MDSN,B0KK6F=WVW#$0$_5[00IA0'E4S#(]4G')FO4#^/M&/B!I?.!NB-V*(^& M073F>/;R5R-OKCX #2UX6V*52>RKV[ICSJ\' M1_Q>]:V)D,Z>.Q^9PB6HJO[;GU7'$/ 3KX#VB5RI<\VZ<]U_@O.Z#_>!_JBQ MY2+4LQG1$/+5-$C>$$[6Q?=&Y##QX.^Q7/=LPYKE_ MD@Y#U_B=O@U%^3B[2\@X28..6W)#CXQ1Z.0)@^_%4B9Z'$QX:V_Z9Y>0F,3_0>6Z!.S_8A\-;9P8$>F3\'M"H1[T[4?)$% M5/3!$3IC43*1B6KJ:D-WPNVQ+U4Q>_?5Z(?SYHQ12%O,[?6E ;L3KI9M=$:W M%I'T>\X#>&WQ5J)KU@,%3DL>G(Z\K'&^UO^!E2ZF%J=;0O.8#+,29KXDHLW& M:MX[I]L9SWP+:F65%6\S:&FQH+$8&?7#>7/F7F)! 3KHV"XKH%ZI]E6*VLPI MT'&R_JB/D_MC/OLB)=>;= 78%4W%DJYQC6@1Q M?\]C]RC/JRAN_%JR5Y,P#JK**U?!?O+UVC/TJ0"UH6VO>+DK' W M?>/8N4MY6XW0Q&K+^=0)!QE.V4M: M1?(7929++RIK5O%S ITVS+HNZ$'>&\_.[;/:$Q5@-U^2S2X89^[X#_=Q.%5" MM^6L.?SK5;4NY@_2M(.K;QC@4V?B477%TRSF!EBV7"6!IGWM#,R<0&L^;1+Y MRIIQ;EP[([84N1Y26XZ.[RA[3?N\+]1,+K72D*."'$'&$Q;$JFUF-^B+,^7: MXW-WZWHK#@3:XIHYE$V4RR!'T3CYAB@]*!H1%0W>T/)\G*^NT=7DT-:=#GTS M'L^CZTIV*2+CFK0+=I-W1-BQZ!TOEBK=5?OR\1.8G07(SD MGP@%M)A"* H9M]@[9QK(@\;!?52#*8%.#I3$8$"='$W($/M225'GC.=S)VX* M3FBDFBB!0KJ6G'<'\CS-BDD:X_2ES)*4T$KPMGCU;.R&L^.$CTX/:M2-$H'" M#.3DW%YA LK45S?WG4.V^]:V#81'N]WN')^>=D^ZO[T;>][TTX&,_G0;7=[[5ZO\VXN8A'[1^S.MV=J'3ITQ.YL]S[PR\_(Q8O; M^563+ 6B-W_\$%Y<&_G[.SL0W!U>:M+1#>RAW8^_/?7VR=CC"?H M/;%=#]E&K"TDI>WK]YMXK>$N-@Y'SLL'=H'KI;NXD;C.4;=SDO;H\([5DZ<4 M&\C#9J+,V0=$#>I8^,/JYH6XX?BV1V?BQLTOQAIH^)0R9TB2F%^-B> W8RR^ MG5^)W6HC8KCB>X-+L9M=8HAO91?B-WI3FG GNQ*[U7??CQ":+N\>(O]=?SJU\ 3;7F*;^3V![,_> M4B/42Y6<7]^4$MX:]^"WI)YV."X8]O!_7SS>KF[WQ/>O;OW@462[0X=.D,<8 MB;^M_;[=?=_I1N&89HMU*F$O?<\4&Y-8*#KMO9WC]^W3]TL&2V883HSO H;$ MR.3_]8AGX=\[[?=__]N'\&?VQPGV4,MP;"^P@8??O ]<\'/+&"/J8N^W;X-K MSK7\+>_Q3Y^\_/:N'][^?C";XG__\TD+_/? M_H])W*F%9I]:MF/C__/[W\C;)RZ$:?@C,4UL!S^RZ]<4&;R[+1M-V(/F/O2I M[TPFQ./>XI[;)F\%&PT8U EVW[4()Y_@*2=G1Z=G[1-FF:!?;]XC=^B'<_?> M[G2_]SK?0U?Q;1)>^<9^^/[MZ?)=R\0&F2"+*;7][O?VWS[$6Y-IZWJ"UK5[ M\];U-%IWYT\P)<:\<8S;/YVS-IF\7=<6&JV]MMWYW@Y?.7 BK_]]R-Z#%Z^8 M/S+Y#9>.X0F6;EVPTD7S3 M>X98!A[IUUTQ*WJS/GLC1=:-;>*W_\(SR7>M8A'1ZX:.X]F.AP/7N+[[SFYK M]\X"5'^R$(]RL/W^V].[WP=C=H_]@MW MUK$90CR6JCUTT<6&$=MLY;S[[+F,5UF3.]8,N9!H]D@=$4 MV;/6+__YE]-NM_WYXK(?_-3Y_.M!R_6-,7M!\*1^>.-!:X)F82L,Q@@4M[AT MV B'W4?9S<@6-/& M='B;T=>\#R/3'#P0_ $V]/;;&GKE77A M^+!S]-?#%G]Q(! ^QG>9)MBC&>0,W^)_6;:*A)XQ)B-N][FBF/I>$+&X2C^V M)JO7AT\C=@L/A[RU86]:YKRI_&<73PBR;6:3%KH8^;QE#W:FF6OXJ..0,6/"SRYK2$BM/6" M+!]SP)B8-6/"0&NVGF=!$\[-%^*R3DY]ZOK(#I0=]-:Q"!])&=.8K.N.@4V? M\E^G[)>7E?R%@ZC)^SF@ONMA=L-<PT84ES#^CJK(9&A@ MV0RC1\P9'*;]61.J:_,_6/J M"$'K0<^<''U8S;\L#=V TNR\1*_L0!YI6_V1'6*7%V%(DS MN#L/VCP^%B@X B;V?L.Q>.=8&$K^S3IL.+C.:0?QWC(!!KH>&0]2[2 MZ@7%<#\)4;%Z%H.^C4:82C?T2"I"7;!9:)GG,,CCV:/':)IEM,9XV3KBNK[\ M^S^VTQ6%W_!DZK6&U)DP*XT82FCH_B%U!&3<.3HZ7[P](KJ@Y$UJ=&PKX$=F M=L<*H<6S\C#O2GDGZWH87)( D"Y+)7Q^@:G]V9\QKF<1N9BB#C8Y&DWX3%BH MT/_H'AQU.P>G)\>!$QX='J]1I[0Y/R:9,[ *-R7AP]T0^5; -X0A>HIF@9U7 MWA>T8GXO>U*(M;F4=%-$D4.>P=E7SJL+C?<6T6^V!%.BR.Q8A!S(+?>;6YZI MY)9QAY6VNRB*R1)73_?76V#%^*GS5]F@2Q1J[)! _!)<'0:7&.2"2*OSJWY> M<T8JAV))@C/)P[U@GS <#B3 MK]R(*\JA9$1X^X.+R/P7GQ(QEZ2"0N$E#IGLA/B3@ L_\)34,"A>7#2)&RS% MND$BRNB1\29'Z $?.2)CAG1W1$[!ATQB,WK@091C^@;GB[EB9])/%@4Z.0"L M>]([:+<[@5D[9X>=70&V.3^QPEBG+=UK40;Y+8R(@KCIE8T&G+JQ>1!KA$G, M@-'G8Q%?V:".M1B ."'S(3P(R.S%39%.31DP''MQ.^L.?^8B46#^-60#K#./ ME!@V#EH8A3%?9'#FS;E91:&+EIT;06Y[$*'UQ7WQOK\Z/F.(YR!D=_U)B-@$16ST9M8BO)LM%H,SP2Y/P2@+]RE> M=/_%\2+^&Z3QE 4$YCSP>.5-'L3- M&^TY"*VUZ).DN;;T2Z);##RF24*JM%@KEL:>ZY_]SK*@9?]^P8>CP^A=<\S- M;^.O#5(IACT^1Q'&^]WC1:3,!FUFK"G/1%[P9F-^#4*498]=@0](0TJ4')]; M5BQ$YF\SL>U,2!CA,7?F*[;LIR/\EGVNA\KPHFF )'L4>2#&CEV^'3X>M M/[B7V(%OL"@-@*"J ^>;,I_NV=2R93BQ=&!'\;4[ZJ M&JOE>K\HVSI\<\UWK0_SIRU**G9_WG?6V4.F@\6]O$(II88C*&":ZR<8-F]7 M+5@\8E[GE%[YQ1[B,"ARA]VL,9,O').N7LM08XRW53464#UIJ+Y8=J2J+R:" MK0:JRD"6JJH6FM^-@SJ5 MY:\LX6=_&/)%J(!RL;#,K'_S7_$JE75A]KP/PN=/@Q*?Y:^NAZC'JW!^Y\UZ MW^ZP_R\D5]=6;34C]_:"5KE^_Y$%.*4$?K]5TET4U8ANOQWG87Q4?Q M*SOWMH2>$.GMFFVU>KOT_V[$_\MCXYC_=Q7\OYNQ_Y=0-S'_S\XC8FCOE+&W MG8S1ON*V[^?+A&Z5-KM?@UD$W^7%J)$_W]CGMGENOO"M .[ 68JZ??;/R*'S M":#S-^(6H<4Y*/"(-V[^N\G>]\8GE(@7=J)E$G8YW/JQ**_=N4NQ8.-3BNK^ M]D'8F)6%5JW>-_-'?.'.L?MA9FUA\YZR7\$[=O8.)656TU\6TXV#,:'>[)I0 MUQN\.H.QX[N(ZS""P[[$]/0(S8A56E^)FUJ^)W$Y9?U5TTV8)IC>\"V9D'"JXWQ$<3 9&6621\SK(>*[_A!5K"I MI>Q&36WVXB9QOZMIPV")WZ&S:XS=8,R;$'NYGLG_V#2H2BJDHM;V*7%O_3?6 M5L>GHQM"G@[1(3VT#L/FFYC '%@SPF>\1%D>33VQ(M4U$9YN1 MUOO>")OP1O^!U,G\A;Q*_B6P]*Z+-\PMF:"31?=8L5D MWY1&S*9A-UJ1X!@9O%QHJOC+=W2%3!N7XJH;[55$1379I8]X+2#%:!)V]\8V M@%:J0RN)Y@,^ 3[9"Y\8+-@RB<%W30.35(E)-@T'' ($QBN&2I*,!ES27"YQ7K#-'O;$DFX^N/'Y)!M3 MEPUR$O,GE]A",VQ>4O0*D4II&&:K20L.7!*]!'@'>&"5??!*B7CB\>T9VWA(O/2P">AD7MHF4!>P M"+#(/EBDQE.SWY\GI->.4:> 5XI9:\ M<@V\LD=>N0)> 5ZI):]< :_LD5?^ %X!7JDEK_P!O%)D-1R=.OP# A=,/ZR' M@1.L=7$+,WQ!)B5\JHZ.,'WRGU-7A*.35J+I*F76J"P=)*NM&%*0MWPI9CB3 MG:6QP+L98T0](TI5Z>48-_,/C#SRHW2\!?C(7ZR M#J/*^/O/P_8W%M7I-MD;DG8S6 V)2"(@444)\,]N_!,J$QBHN@Q4#DA7C!&5 M&4@&)]7DH. 3+Q?(^('-U=>'(NJ7IZ)K8B/;(,A2$D^;C/B#HIGKV.'-3DVG M))([60Q/*#O WNA"SL$ AEG#\ %-#*=O.9VSLY,.>JX= H7] _ U!WS5*8$L M)<8J,0L.]7V)[E^]92J 2S'5 4.X*L5LGV)P_"J^Q&$NK5R<'#'2M@[@R6& M9D[SPTQ['++L%N8?Q7[R'.,'#T:#;P[%UHCEB.V.=9J+/&(W- VR!NQN M+W7]]!&S7UW^Z>G($[G4N7=OAUJ^([;.G%$IO4]F'G6[/O?&?SM:K:B56A5W M;C1DY_,.XCAMIPG:/]',QHOI#.[AQJR>V\K3^KDW7,K9$V!8,AANA)&K^<" M1K-8.8F7ZE<+D/JSK;MH5P,FZGLG"JYE:@(T;=>?8/I '=,WO&C8_H1?L*V# MI=O;_J*>R8T6,T4?O 7RW]P_T(38HULK\<,EI82BC&=O]&UOXZ&J$Q0#/WGW MJ2;T,H#'*L$XGS-2%L'ITY#^:9'A#2%UA)V@=R5($+?9#R!7$L@MIAOZ:$H\ M9#UBXC$_"IZV9SJS2 MT:_32>2TO$J-DWM(@O(.8>7<).=D5>02%85=-ABYLC$=S;(,3O_N(\KHSG:H M-PZ?7KF)T_JA3\[,.8,OS3.J"<)SEI,S4K,OD/W#=CR<^N'%C! ;+4-:F9/7 M6]8L,*T?"J5-ES,0D]VVFC#,?.%_D4&$!L.2*__SZ!ZSL#X(\%D+ )(EAZ2* M]7)&I83[-1J>-S_'/].^CPY !"!F L28HS49I*N([,+-<9]>N MB!,VUL(91880^4'D5V8W7\R^+A<^HMK7GF0?4)8DCG$G,3'Z$U%VBQ?;T\./ M*Z@L@ZI.-L*+EA&\C39TD ME]IHJEDU4COD%;"W-]L*C/(@5OXTUC7?K28,8PN+\Y-WM'<'/% \Y'L[S&4& M$1SOLGB^TO8\UI0OOFWRA_&?61X2M([IGY&C6\LJ9MD^%X,W96.68Y$\S9,WQ83%6\0.#:K=_1GBF]!#@V"H[G4YMIRI3^,,X=ZWXVLXO9 M@;:R,-Q0/H O^9S1+9X'\-MC>$L)=OO=Z&U/?#Z;W]6WD.O>#X.7E!:L"R]- M:_7&"0V1/E<;(%7EEHPIMLP\47X.0%.";0,/QIBB*?8]8J1_<"<$T$6\!?5F MD.4]R5T'(BDKD:0[.+!*F5CEN3-=-F',>N?6FU=$D4F""H!?@%]@KJ_$TP8E M]6"80ZOP, J.7JE1KLRN#CZ9O4^6V=[9%Y,UH$H%RK3*YL;@=+LZ79FM.G \ M9*TTP ^!]6;+HV 9%=?;L)+=KZ9M^\@=7_WTR0NR<."\2OEC74RLIH5J6OK> M&V,:?';(O27HF5C!)X?N<.0;!,+OBM?5YKOJHYK6%WYO:LNLL%"&Z284BVDS M+LWN"8\00H3^ UD^OK&G/E,S Y/5B[YT>([@&^6) M;< 5=<[%Q11#:82L:Q7)(FO)?:)L:?Z,&X/%;4BT? ;ANYSS14R3XLY "H63 MPN*SZ4$\AK$=QF7!@,U?=0$,T0B&D',#H(LLZ"+Q.+=$E$5WWF\AELB=>Z"3 MZM+!AH8+)@&1W8J!_B['"P+<=SDTH]30#0YLJ^UHWUQXK\P*<&X2G >88OPT M_] 7X+IVN!;8%P#>)("+OP4*2*\=TM,,#9#/HO S(T3>6L;R_+\MW!&]584\ M=OBT4XVX8.VXQ0UU%TP)0B,6PPG[^<074$6%J&+^8<:@+FIY? F000W)0&AI M@'NSX+[Q^6. >@VAGL='K@'FYU,ZWW:_;2$NLV7WQ(WD DJ(WZQ "M5#^N)B MQKO-=T%Y@M8+6I1;\TB >?UA/C^DA1?-"L0JCO9BO*^D$-R%?M*](0,^R)!_ MRPSZ_4 YMCT>+;;';Z.=E*-6*@[_\@WV^1YOHY*]I_D*C/O-I "^=P)88#]C M;I+R@0[J00=]P^6G[1M\.V)AF4"X-!/4=V,S6*'9F@VL"]0Z\5\'HEA;A?-! MH@V*(0.!JP(%E"@B*!;5O*:/UK>F#R@@H9 ?6B@.7A!T !U: B=,J M@ * E0H@-=N E4B@16)@,: !H0H9J?7"4-:F46 18H 0NL3 PD4&42",]" M[2.:/@J[P8'FS./#CW->S&YLTW<]6MX/K"6Y^;:>+"R]KIAJFG?UU7HP;\R\ MZXJIIGDWOIJ[V"X%UA:.(:G:JJ8+]!W;]2>8/E#'] T/+"_>Q"A24C4-OCRF M?^Z]8/!XA"943S5-'1[V# 9./ >[RL9=12"1'(QEO4#A0H-O4U2%=G&TJ?]%9FNRV/:!">_%$_\VVZ0YU-\/[SP76+CD/^5BT=+Z1Z95B-V,BN.+$-YJLCHM2O2$YFQ"_#9"WRZ M )\ZP&>7?0P GS*<5 ;P*1@^#7=[\+.*)0D[[!>S9&OD$PQ17N^%E$$63!M; M 6JW$R"K- ( !DD% *Q,YR8 P"#M: + !C@B>7P1&%UW/($M$1_S"K'66YB MJX4G5R])23=_L?!:]X7& VJ7G 8 M=^D! !58D#MDL, H/:;A "@R@*H6@$! M/&_?.U>VI;Q[J[4JM=^6),7(:5DO2_B*G*VAL"FDQJK^L-%/) V58)-(;55 M]8=-UA]U!-B4!S;U<'?PK[+Z5U9)@-+Q4Y7QVRHF!5F=N'\O3#FA5+A%*.'PIOQ2F5)Z;LD2$:G/ MD2N<0I4'5AHIW"?977^.N M@X="L"^QP6?=Y$V$RBYA/D"E,6$^0$4OP >H-"; ;RI4ZN7BX%-E\*GL@_K( M2]@CO%JDH1#D2V?%VQRAB8#2"_T!4 U+!0!0^28( *B&)0P *'$:44<@@.>5 MU_.R2C;F7XFH@[M"9B&1E,?LW420[/8I-@!)$[(% (G6Y]0 )$W( !H)DAHY M-WC3WKTIJ^!]XURE.GUX#\)YZ61XBQ\T$4Z[A/D IZ8&_@"G'!("@%-34P2 M4_SCR/6% ?A=X7YGN_X$TP?JF+XAO/ 43E!-$NZ06 :$_?/ 80[1]$-7%^\+9"O:WX M)*!F&VT@;6C:]I_B0WZ 3..2A/I#)M\ 'R#3N)2@7I!IK*N#;U4FZ%<^#>O[ M \5#3"DVJ_[-BRJ$_8N+(J47FS'7XS"OO1TO"K#91\D1P*9O@<, M "DTH@> [!4@NX3^ ) B(W@ 2&$ J;YC@R>5?6;^*S8).K?-C5W/TBM*U?=2 M"."E0+/-5>H#I%W"= 2!/H I S">0 2) 2-!A( #QN_]2]0S)1:H\J)LBO MFI5WB'3K;^6M$6C5K+Q#&%9_*V\-C\ILY:N?/FO#5^R-'3,<*S'NL_NI8UG$ M'JV&S[ W+O6>F*U,WV(#W*8LOU'TQ#LT"7:,0,_%DZJMR-]J#L[IIB MR6JZZP5R\2/KS_WPXU=VV_B6/#M4D'PM-AB7.J6*VT_0Y/@-*7VONC%[#3;F M1M^K;LQ.@XVYT?>*&M-!U+P?7A**#<^AJ\%_0#P^7-W8)GDAIH_*FY'P\36I MM6O6$W:VFH9[9&Y*B<$&_"=L^)1X!,?.'UEN?KMA+Z4^[T!I+;A,$1/;O/X% MT:2^5].6J^#M*FA-U(Z/V.(7'A#U9@.*;!<9P5SGQ2QZI?2F5>H&1[18)]6T M;][':D7$SUT7>WT+S5$"&3\2YX)*/T0#AY2#0Q;WI+@4$$CM"*2Z\U/)90; M*.5@E (FP)I()UN;HU'1 E0EI*JD^CL(?H"J@*JRIBJY6E&@JERBJFP(Z?N? MF(S&3.3\A75JA#>I$R@+**LVE"7T=J N/>JZ>B:>B;[ZED>F5O8IX>+!YS:R M9BYQMY-:W2A+I. :DU;\W;(.46_B@K2PD+1P!RH#P@+" L*"Y+!D$586M-2\ MY!"(J_'$!2EB/C6WR2D?5.-"-2YD4_O"MG1N!)7V@.TJ8!L2CWWOE6E>W@ 8 MAQB]7%COHZGT4C(,TG%U 6ZK72M;V5UP%3N1JTI5&-7?']?43'=_:,ZMFA30 M#&AN:&Y;W;&Y<4DMH!JRV:JB.\N:Q+KA>@^+W U%-D3?143?ZE@'1 .B(0*O MX!C=N!@'41_LU&YK]\EQ\=2XG1T#!\_ MD W(AJB\PF-V;<-R0'A)$ [1>0[Y-]]H-*7$Q8&$7G0NV'!VR_XA9O"W^F^% M36<*H:HKS!0[[RA+](EZTQ>D'H4L!.Q :$!;0%M 6Y!7E3+:RHBQAZQX3!USIJ[I2&=2;@'?:"MFY,231IEG-#C15F@)VG" 2>4!E"*C-9E&;[ M8O+*+7Q3=!=.*8VKTEC7WEZAR,"?5FUX2ZWN#5&8P=WT6V>6Z;@U?61G;A9=['F"OR M^4Q_RKMT99$1>0Z.([UZFQ(:^,@EPT=I\1_'E'Q/UJ9WE)27JX.T>UDY2+OS MO1TZQ\")C'?G/B7NK?_&VNSX='1#R-,A.J2'UF'8#1.36SQ"UE70YG RDNOD MEF!&%W3"J2HZG%SB9\:GKD=]WN?@_B\86=[80!2?>W/EL5<].,3VN!8?F/^Q M/RX!%S[GQG[!KL>?P3C1L4U$9WUFKY%#R;_#,A3Q(+EXQ1-Y"][P/Y@ZD;>( M7U&)Q<=-S6XX;H)E-&B2F?_3FOTWWKK-A3(8-(2FVC: 2KE"IHU+<=6-]BJB M(FN684Q"/"C&/[7UQ6%_M MD7O3=^@TD7QR)1-^38'8@'WF[",T7C$$E&0T8"!@(#4&"E[7KJR7PA7\4I%/"$ 2JH0):6:$-@(V*@Z;%0B=GE\>\8V'A(O/40#$IK7 ML0C4!=P#W%,=[JGQ1/7W)\>WS1M[RIK$_OPPGKG,F,OZS4U:JRP-I7<49KB! MD2K$2"6*AK(FI#^Q93&0CI?+4"DQ5F7)*+F3$!D!#U68A[X4'+X,L(7Y.0*^ M38S @D^8OA #!X]UE@_4(3C6-5X1B&CJ]%=EJ4C4O3V1T!=@H606VM'3&\U& MU\!&P$:[LM$UL!&P499L= 5L!&RT*QM= 1L!&V7)1G\ &P$;[RJ ,EZ.OU], MR,WA AC0I?A@-P"M--Z2P4FSF&OYE3B^@!J< M:Q[C=CGVNF.JXB*/V U!B:P!N]M+9;!'%OU>,05X./)$+G7NW=NAB]\1NW83 M('I0VU%I&EB3XGLJ(_TK>:+@S$CBPVK\3*Z)L%X5^WF#&RA00#0^P:T M[;*4A3Y0Q_0-+YK5/>$7;.L@\/:VO\AYW&C"$WWP%J+XYOZ!)L0>W5J)A]N7 M$L R>-CHV]ZR9E4G* :T\N[3),!F *I5YG8^9[\LPN>G(?W3(L,;0NH(5D'O M]@97>?L!4"L-U,5D1A]-B8>L1TP\YGWA/HE@@T0TKI&8WJ8E3-SSI!-\XPF0?=\PIYA(/L" MV3]LQ\.I'QW+".?1+48K)^#;>VL6.MH55ER2Z'X!:&=0W/\<_T[Y>W"3X2M6"1O55 M=UC"*F\FIT)%8J'YV33:R[L/% _YDKZYU'BPEW?Q?*5:+M:4+[YM\H?QGYG= M@M;-/ZU6RP4EV3Z7(X!.U7W'-)9-*)P=U"L+W@WE[PVR"B8&T )HLPG *<%N MOQN][8FG=ORNOH5<]WX8O 0@O@:?-"UM;*Z(Z!C8!=A%\9.$Y60.-"78-O!@ MC"F:8M\CQK;/I7(87,1;4&_>2==1SB2TO"=9[\!%P$4-YJ+GSG39A#'KG0ML M5&A(E*!_8"5@)0E66I1H+6LJH^K0KL0;4&0S#'<2*>1/1-DM7NQX$7Y^6JWG M2I(UM/=*O70W* :O,CX!$,T8HEV Z!:([GOF 2!:7HB&QXM-^.E9J1&SU/E: MFIM?&HE7H0&J@(6<26-7AVL2> >.AZR5>OD9']YL>=('2Q,JB!D%_Y7L?I,\ M0O@-ERVS)T(9AJQ0+*;RN#2[)]PK@0C]![)\?&-/?<^]Q2_8ZD5?NKSA8K;\ M\0OS#T2-\2RX/7B.X)M5B6W %?7@Q<440VE0[OJYDP)KR7WV9VG^C!N#Q6U( MM'P&PX^<\T5,D^+.0"45H9+%9[2",0%C.QP;@OHG_JH+X)5&\(J<&P#)E'!K M9R(VHYM/MM!1Y,X]D%!U261#PP53A\ANQ1#&+GLV@22*VVU6:L '^]EJ&UDT MEQ169@42 !+81@(#3#%^FI]V"VQ0.S80V!=H 6AA&RV(3[<'?J@=/Z09&HAB M?QME,\+QK64LC\+32FO$(&LGCVZHNV B$1JQ&";9SXFU0#"U M)YCYF>9!&=;RN F@D!I2B-#20!) $MM)8N,K)4 0-22(/+Y% ^2PXV+HE,ZW MJ6]; LVL3")Q,ZZ 2.(W*U!)]?AA<3'C3;.[<$."U@M:#EWS2" '((?4@T3X MUD2!6,4YHAB?+2EP=R&M=&_(@$4R9.WZ4<5^"""VNQPM=I=O(ZN4TRDJ3AKE M"RSR/1%$958BS5<@Q@#BD"<.O@,,N&,_XWN2\H%$FDPB?S<-OC6OL%PE M7!0+]AE@,U@;VYJOK O4>D)C';YB;17.(HDV*(9"!*X*Q%'YZ*-8+N#UGK2^ M]9Y ' DUH.LV!^( XK#=Y:$#0!S5( Z)4R* .( X\B<.7J$#U%$IZEB9#,@# MR",[\N"'<$E3@3+W '>4@#M6)@;J .K(N@HT(AZ\)$?3>4$7HY>N4KT": =H)U' M;#@OF,[J'I:G<\6F%BI,%(#)BF/R#KUHKE[=82]HZT8HT:0 8$.-%<;TSH._ MP!. 8FHW+ZXZN;:E[BV9\C8=;/%J;/:1.[ZVG-?Z\DUIYO9RK]/;RCO)-R0Y M!-!.>3]&5_[E &">=DC]A"QL7F% MJ$WL4J_9UO+%?>+>-\G^"1%D_4VO$"S5 MS^KGIDDX5R+K 1%&@/,O^#3+ U*5T"QO>"$NIE'K/V*+#XT/K&&S 46VBPRN M*O=B%KU2>E=0ZL9:%!I52I.\X0M&EC?N(RHZ[N,.>2S;O1]>^"X;-^>3"@G1 M:/(LA,KYJZ7V+YFL7"&\W"$J+OK\59$#1-Z][CQ- HXR#!0^DO3(]'KE>LLY MZ*V@+"5LE%QIO>[]O$"";;%M^1KO*H5$I0Y;&FLP.: MMA@<8)4)K.9*!1#5!421+]F\2*P" U@4P *I4.U2(9B35X+,-;&1;1!DY98G ME1(R=7'=/.*T=9=H$G!V"+>4CZ2U(.LI?BHA]]-Q95,@R("*6AE2A29 JUK0 M@G6BA+TBRP\$0=17.3"E&Q0"P;(&@DWR]PI;^YQA:6GE'E365Z*RGMC,/]CM MW&1Q7UASK\VXE+OB9G/]"TVPH:% MHU^Q-W8B/=_\*\9W:%+>/(3UZ9-FI]8\)%%]U72';_;0M\TP >(3>"1022QV M",,I>_2(#4Q>T+.%^4E&U(Q"XF(6#,[W0\'=I76.99R140\7STO3:36]Y)I0 MU_N[SZ(=3 P#L:$>C.6K U>G<'8\5UDFX-7UKS9$WD3)-H<&_XT8$Z+C,ASMZA\3]9V/$NJK9I.P13 U(5O"2.N,%0:48S7AX6$?06E MM?R6_1!".V_31#7M^]6Q\8RY\ _L7;-Q*I8:\&,M6/C,_\/#HA=DX2KL=TIM M]O) V&_JVG#>?0YN\;8#=*=";&)ZX6\Q?_8-*A**J3"UH;=:07N3BO(KCXE M[JW_QMKJ^'1T0\C3(3JDA]9AV'P3DUL\0M95T-;Y$@@+0F\)M@>83GB"$76* M2_SLW;#V49_W-;@_7&4R6)![[K&XA*6V=I"^7I,7_, ".W8?&B6LNSRQ\,@V M$9UMSIP(5BG/O3MBX^4+V,OFSZ_P\N6F0L59P:9!]K6&N<4*&LUBSOAIS1LW M,;G%H3/52HI[;C1,!0;5Y!*^D,P<%:-)V-<;VP 2V2N)R FT6KUXX\R 'BO MQ%]J]C!8@&P2 UG &_OF#0@^=N3231^N.%V5FC%L[XO#6FV/W)N^0Z>)I)$? M"?!K"FP$K+$$KEAS#:4-H2,#<^3'',X+MMG#GEB&R-F:3_'8F+J,M27F/2ZQ MA6;8O*3H%:*0LJ# M1: 2H)(J4DFJ-P.+Y,8B]9L,^?[D^+9Y8T]98]B?'\8SEUECN9MRDQFKSB,P M>Q)K3ZKU@4GR+HD L%(I#W)A@?^*(X_K@J+ M&/B)BGW1>2+GWN#5"9[%_ZM!2@-^^#??G9N:HY6:1"J(8Y'6]U2+<;5G_MC- MQ6O")'\ DP"3U(5)_@ FV1^3? $F 28I(Y.4 \NY$M^76C')-3 ), DPR5Z8 MY+K*3,*M[5!FD0MF'*;>:\>G@7ZY+\HQPA=D4L*G^.@(TR?_.;4$)3KSM'Q7 M\$/:N])]IWP\( .X9+658EHPV3C%S.+*.V9C@7N0G M?P0#3,"D8XKQ%1F-/?&H+0@G^$8$=&Z;&Q^/81WY'TR=]J!:89!0U73. M@WNZIU0'T#GSWVYN#?RS&_^$0 &*H*!9'0-' 0<5.XBCSO6.][]^7?<'S'Q M;BTCS*2#%#KRC9;$ JW(YZ4B&HTX -2A0NE'[C"7=L*<67D'2%63:X1'^$=T M'_P@%?:L#N!7$4\CCS\HFKF.'=[L5'#>4\;3DCM9##N$'.P0"&6

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b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�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end